id	sid	tid	token	lemma	pos
eurjchem-2084	1	1	the	the	DET
eurjchem-2084	1	2	scientific	scientific	ADJ
eurjchem-2084	1	3	community	community	NOUN
eurjchem-2084	1	4	in	in	ADP
eurjchem-2084	1	5	covid-19	covid-19	PROPN
eurjchem-2084	1	6	global	global	ADJ
eurjchem-2084	1	7	pandemic	pandemic	NOUN
eurjchem-2084	1	8	:	:	PUNCT
eurjchem-2084	1	9	a	a	DET
eurjchem-2084	1	10	systematic	systematic	ADJ
eurjchem-2084	1	11	update	update	NOUN
eurjchem-2084	1	12	on	on	ADP
eurjchem-2084	1	13	recent	recent	ADJ
eurjchem-2084	1	14	progress	progress	NOUN
eurjchem-2084	1	15	and	and	CCONJ
eurjchem-2084	1	16	challenges	challenge	VERB
eurjchem-2084	1	17	european	european	ADJ
eurjchem-2084	1	18	journal	journal	PROPN
eurjchem-2084	1	19	of	of	ADP
eurjchem-2084	1	20	chemistry	chemistry	NOUN
eurjchem-2084	1	21	12	12	NUM
eurjchem-2084	1	22	(	(	PUNCT
eurjchem-2084	1	23	2	2	NUM
eurjchem-2084	1	24	)	)	PUNCT
eurjchem-2084	1	25	(	(	PUNCT
eurjchem-2084	1	26	2021	2021	NUM
eurjchem-2084	1	27	)	)	PUNCT
eurjchem-2084	1	28	222	222	NUM
eurjchem-2084	1	29	-	-	SYM
eurjchem-2084	1	30	234	234	NUM
eurjchem-2084	1	31	european	european	ADJ
eurjchem-2084	1	32	journal	journal	NOUN
eurjchem-2084	1	33	of	of	ADP
eurjchem-2084	1	34	chemistry	chemistry	NOUN
eurjchem-2084	1	35	issn	issn	VERB
eurjchem-2084	1	36	2153	2153	NUM
eurjchem-2084	1	37	-	-	SYM
eurjchem-2084	1	38	2249	2249	NUM
eurjchem-2084	1	39	(	(	PUNCT
eurjchem-2084	1	40	print	print	NOUN
eurjchem-2084	1	41	)	)	PUNCT
eurjchem-2084	1	42	/	/	PUNCT
eurjchem-2084	1	43	issn	issn	PROPN
eurjchem-2084	1	44	2153	2153	NUM
eurjchem-2084	1	45	-	-	SYM
eurjchem-2084	1	46	2257	2257	NUM
eurjchem-2084	1	47	(	(	PUNCT
eurjchem-2084	1	48	online	online	ADJ
eurjchem-2084	1	49	)	)	PUNCT
eurjchem-2084	1	50	–	–	PUNCT
eurjchem-2084	2	1	copyright	copyright	NOUN
eurjchem-2084	2	2	©	©	PROPN
eurjchem-2084	2	3	2021	2021	NUM
eurjchem-2084	2	4	the	the	DET
eurjchem-2084	2	5	authors	author	NOUN
eurjchem-2084	2	6	–	–	PUNCT
eurjchem-2084	2	7	atlanta	atlanta	PROPN
eurjchem-2084	2	8	publishing	publishing	PROPN
eurjchem-2084	2	9	house	house	PROPN
eurjchem-2084	2	10	llc	llc	PROPN
eurjchem-2084	2	11	–	–	PUNCT
eurjchem-2084	2	12	printed	print	VERB
eurjchem-2084	2	13	in	in	ADP
eurjchem-2084	2	14	the	the	DET
eurjchem-2084	2	15	usa	usa	PROPN
eurjchem-2084	2	16	.	.	PUNCT
eurjchem-2084	3	1	this	this	DET
eurjchem-2084	3	2	work	work	NOUN
eurjchem-2084	3	3	is	be	AUX
eurjchem-2084	3	4	published	publish	VERB
eurjchem-2084	3	5	and	and	CCONJ
eurjchem-2084	3	6	licensed	license	VERB
eurjchem-2084	3	7	by	by	ADP
eurjchem-2084	3	8	atlanta	atlanta	PROPN
eurjchem-2084	3	9	publishing	publishing	PROPN
eurjchem-2084	3	10	house	house	PROPN
eurjchem-2084	3	11	llc	llc	PROPN
eurjchem-2084	3	12	–	–	PUNCT
eurjchem-2084	3	13	cc	cc	PROPN
eurjchem-2084	3	14	by	by	ADP
eurjchem-2084	3	15	nc	nc	PROPN
eurjchem-2084	3	16	–	–	PUNCT
eurjchem-2084	3	17	some	some	DET
eurjchem-2084	3	18	rights	right	NOUN
eurjchem-2084	3	19	reserved	reserve	VERB
eurjchem-2084	3	20	.	.	PUNCT
eurjchem-2084	4	1	https://dx.doi.org/10.5155/eurjchem.12.2.222-234.2084	https://dx.doi.org/10.5155/eurjchem.12.2.222-234.2084	PROPN
eurjchem-2084	4	2	european	european	PROPN
eurjchem-2084	4	3	journal	journal	PROPN
eurjchem-2084	4	4	of	of	ADP
eurjchem-2084	4	5	chemistry	chemistry	NOUN
eurjchem-2084	4	6	view	view	NOUN
eurjchem-2084	4	7	journal	journal	PROPN
eurjchem-2084	4	8	online	online	PROPN
eurjchem-2084	4	9	view	view	NOUN
eurjchem-2084	4	10	article	article	NOUN
eurjchem-2084	4	11	online	online	ADV
eurjchem-2084	4	12	the	the	DET
eurjchem-2084	4	13	scientific	scientific	ADJ
eurjchem-2084	4	14	community	community	NOUN
eurjchem-2084	4	15	in	in	ADP
eurjchem-2084	4	16	covid-19	covid-19	PROPN
eurjchem-2084	4	17	global	global	ADJ
eurjchem-2084	4	18	pandemic	pandemic	NOUN
eurjchem-2084	4	19	:	:	PUNCT
eurjchem-2084	4	20	a	a	DET
eurjchem-2084	4	21	systematic	systematic	ADJ
eurjchem-2084	4	22	update	update	NOUN
eurjchem-2084	4	23	on	on	ADP
eurjchem-2084	4	24	recent	recent	ADJ
eurjchem-2084	4	25	progress	progress	NOUN
eurjchem-2084	4	26	and	and	CCONJ
eurjchem-2084	4	27	challenges	challenge	NOUN
eurjchem-2084	4	28	zeba	zeba	PROPN
eurjchem-2084	4	29	firdaus	firdaus	PROPN
eurjchem-2084	4	30	1	1	NUM
eurjchem-2084	4	31	,	,	PUNCT
eurjchem-2084	4	32	sushil	sushil	PROPN
eurjchem-2084	4	33	kumar	kumar	PROPN
eurjchem-2084	4	34	singh	singh	PROPN
eurjchem-2084	4	35	2	2	NUM
eurjchem-2084	4	36	,	,	PUNCT
eurjchem-2084	4	37	tryambak	tryambak	VERB
eurjchem-2084	4	38	deo	deo	NOUN
eurjchem-2084	4	39	singh	singh	PROPN
eurjchem-2084	4	40	1	1	NUM
eurjchem-2084	4	41	,	,	PUNCT
eurjchem-2084	4	42	*	*	PUNCT
eurjchem-2084	4	43	and	and	CCONJ
eurjchem-2084	4	44	meenakshi	meenakshi	PROPN
eurjchem-2084	4	45	singh	singh	PROPN
eurjchem-2084	4	46	1	1	NUM
eurjchem-2084	4	47	,	,	PUNCT
eurjchem-2084	4	48	*	*	PROPN
eurjchem-2084	4	49	1	1	NUM
eurjchem-2084	4	50	department	department	NOUN
eurjchem-2084	4	51	of	of	ADP
eurjchem-2084	4	52	medicinal	medicinal	ADJ
eurjchem-2084	4	53	chemistry	chemistry	PROPN
eurjchem-2084	4	54	,	,	PUNCT
eurjchem-2084	4	55	institute	institute	NOUN
eurjchem-2084	4	56	of	of	ADP
eurjchem-2084	4	57	medical	medical	PROPN
eurjchem-2084	4	58	sciences	sciences	PROPN
eurjchem-2084	4	59	,	,	PUNCT
eurjchem-2084	4	60	banaras	banaras	PROPN
eurjchem-2084	4	61	hindu	hindu	PROPN
eurjchem-2084	4	62	university	university	PROPN
eurjchem-2084	4	63	,	,	PUNCT
eurjchem-2084	4	64	varanasi	varanasi	NOUN
eurjchem-2084	4	65	,	,	PUNCT
eurjchem-2084	4	66	221005	221005	NUM
eurjchem-2084	4	67	,	,	PUNCT
eurjchem-2084	4	68	india	india	PROPN
eurjchem-2084	4	69	zubi.yazdani@gmail.com	zubi.yazdani@gmail.com	X
eurjchem-2084	4	70	(	(	PUNCT
eurjchem-2084	4	71	z.f	z.f	PROPN
eurjchem-2084	4	72	.	.	PROPN
eurjchem-2084	4	73	)	)	PUNCT
eurjchem-2084	4	74	,	,	PUNCT
eurjchem-2084	4	75	tryambak@bhu.ac.in	tryambak@bhu.ac.in	NOUN
eurjchem-2084	4	76	(	(	PUNCT
eurjchem-2084	4	77	t.d.s	t.d.s	PROPN
eurjchem-2084	4	78	.	.	PUNCT
eurjchem-2084	4	79	)	)	PUNCT
eurjchem-2084	4	80	,	,	PUNCT
eurjchem-2084	4	81	meenakshisingh@bhu.ac.in	meenakshisingh@bhu.ac.in	PROPN
eurjchem-2084	4	82	(	(	PUNCT
eurjchem-2084	4	83	m.s	m.s	PROPN
eurjchem-2084	4	84	.	.	PROPN
eurjchem-2084	4	85	)	)	PUNCT
eurjchem-2084	4	86	2	2	NUM
eurjchem-2084	4	87	department	department	NOUN
eurjchem-2084	4	88	of	of	ADP
eurjchem-2084	4	89	pharmaceutical	pharmaceutical	NOUN
eurjchem-2084	4	90	engineering	engineering	PROPN
eurjchem-2084	4	91	&	&	CCONJ
eurjchem-2084	4	92	technology	technology	PROPN
eurjchem-2084	4	93	,	,	PUNCT
eurjchem-2084	4	94	indian	indian	PROPN
eurjchem-2084	4	95	institute	institute	PROPN
eurjchem-2084	4	96	of	of	ADP
eurjchem-2084	4	97	technology	technology	PROPN
eurjchem-2084	4	98	,	,	PUNCT
eurjchem-2084	4	99	banaras	banaras	PROPN
eurjchem-2084	4	100	hindu	hindu	PROPN
eurjchem-2084	4	101	university	university	PROPN
eurjchem-2084	4	102	,	,	PUNCT
eurjchem-2084	4	103	varanasi	varanasi	NOUN
eurjchem-2084	4	104	,	,	PUNCT
eurjchem-2084	4	105	221005	221005	NUM
eurjchem-2084	4	106	,	,	PUNCT
eurjchem-2084	4	107	india	india	PROPN
eurjchem-2084	4	108	sksingh.phe@iitbhu.ac.in	sksingh.phe@iitbhu.ac.in	PROPN
eurjchem-2084	4	109	(	(	PUNCT
eurjchem-2084	4	110	s.k.s	s.k.	NOUN
eurjchem-2084	4	111	.	.	PUNCT
eurjchem-2084	4	112	)	)	PUNCT
eurjchem-2084	5	1	*	*	PUNCT
eurjchem-2084	5	2	corresponding	correspond	VERB
eurjchem-2084	5	3	author	author	NOUN
eurjchem-2084	5	4	at	at	ADP
eurjchem-2084	5	5	:	:	PUNCT
eurjchem-2084	5	6	department	department	NOUN
eurjchem-2084	5	7	of	of	ADP
eurjchem-2084	5	8	medicinal	medicinal	ADJ
eurjchem-2084	5	9	chemistry	chemistry	PROPN
eurjchem-2084	5	10	,	,	PUNCT
eurjchem-2084	5	11	institute	institute	NOUN
eurjchem-2084	5	12	of	of	ADP
eurjchem-2084	5	13	medical	medical	PROPN
eurjchem-2084	5	14	sciences	sciences	PROPN
eurjchem-2084	5	15	,	,	PUNCT
eurjchem-2084	5	16	banaras	banaras	PROPN
eurjchem-2084	5	17	hindu	hindu	PROPN
eurjchem-2084	5	18	university	university	PROPN
eurjchem-2084	5	19	,	,	PUNCT
eurjchem-2084	5	20	varanasi	varanasi	NOUN
eurjchem-2084	5	21	,	,	PUNCT
eurjchem-2084	5	22	221005	221005	NUM
eurjchem-2084	5	23	,	,	PUNCT
eurjchem-2084	5	24	india	india	PROPN
eurjchem-2084	5	25	.	.	PUNCT
eurjchem-2084	6	1	e	e	X
eurjchem-2084	6	2	-	-	NOUN
eurjchem-2084	6	3	mail	mail	NOUN
eurjchem-2084	6	4	:	:	PUNCT
eurjchem-2084	6	5	tryambak@bhu.ac.in	tryambak@bhu.ac.in	NOUN
eurjchem-2084	6	6	(	(	PUNCT
eurjchem-2084	6	7	t.d	t.d	PROPN
eurjchem-2084	6	8	.	.	PROPN
eurjchem-2084	6	9	singh	singh	PROPN
eurjchem-2084	6	10	)	)	PUNCT
eurjchem-2084	6	11	and	and	CCONJ
eurjchem-2084	6	12	meenakshisingh@bhu.ac.in	meenakshisingh@bhu.ac.in	PROPN
eurjchem-2084	6	13	(	(	PUNCT
eurjchem-2084	6	14	m.	m.	NOUN
eurjchem-2084	6	15	singh	singh	PROPN
eurjchem-2084	6	16	)	)	PUNCT
eurjchem-2084	6	17	.	.	PUNCT
eurjchem-2084	7	1	10.5155	10.5155	NUM
eurjchem-2084	7	2	/	/	SYM
eurjchem-2084	7	3	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	7	4	-	-	PUNCT
eurjchem-2084	7	5	234.2084	234.2084	NOUN
eurjchem-2084	7	6	received	receive	VERB
eurjchem-2084	7	7	:	:	PUNCT
eurjchem-2084	7	8	25	25	NUM
eurjchem-2084	7	9	january	january	NOUN
eurjchem-2084	7	10	2021	2021	NUM
eurjchem-2084	7	11	received	receive	VERB
eurjchem-2084	7	12	in	in	ADP
eurjchem-2084	7	13	revised	revise	VERB
eurjchem-2084	7	14	form	form	NOUN
eurjchem-2084	7	15	:	:	PUNCT
eurjchem-2084	7	16	22	22	NUM
eurjchem-2084	7	17	march	march	NOUN
eurjchem-2084	7	18	2021	2021	NUM
eurjchem-2084	7	19	accepted	accept	VERB
eurjchem-2084	7	20	:	:	PUNCT
eurjchem-2084	7	21	28	28	NUM
eurjchem-2084	7	22	march	march	NOUN
eurjchem-2084	7	23	2021	2021	NUM
eurjchem-2084	7	24	published	publish	VERB
eurjchem-2084	7	25	online	online	ADV
eurjchem-2084	7	26	:	:	PUNCT
eurjchem-2084	7	27	30	30	NUM
eurjchem-2084	7	28	june	june	PROPN
eurjchem-2084	7	29	2021	2021	NUM
eurjchem-2084	7	30	printed	print	VERB
eurjchem-2084	7	31	:	:	PUNCT
eurjchem-2084	7	32	30	30	NUM
eurjchem-2084	7	33	june	june	PROPN
eurjchem-2084	7	34	2021	2021	NUM
eurjchem-2084	7	35	the	the	DET
eurjchem-2084	7	36	novel	novel	ADJ
eurjchem-2084	7	37	coronavirus	coronavirus	NOUN
eurjchem-2084	7	38	,	,	PUNCT
eurjchem-2084	7	39	which	which	PRON
eurjchem-2084	7	40	emerged	emerge	VERB
eurjchem-2084	7	41	in	in	ADP
eurjchem-2084	7	42	china	china	PROPN
eurjchem-2084	7	43	in	in	ADP
eurjchem-2084	7	44	late	late	ADJ
eurjchem-2084	7	45	december	december	PROPN
eurjchem-2084	7	46	2019	2019	NUM
eurjchem-2084	7	47	,	,	PUNCT
eurjchem-2084	7	48	is	be	AUX
eurjchem-2084	7	49	officially	officially	ADV
eurjchem-2084	7	50	named	name	VERB
eurjchem-2084	7	51	as	as	ADP
eurjchem-2084	7	52	severe	severe	ADJ
eurjchem-2084	7	53	acute	acute	ADJ
eurjchem-2084	7	54	respiratory	respiratory	ADJ
eurjchem-2084	7	55	syndrome	syndrome	NOUN
eurjchem-2084	7	56	coronavirus	coronavirus	NOUN
eurjchem-2084	7	57	2	2	NUM
eurjchem-2084	7	58	(	(	PUNCT
eurjchem-2084	7	59	sars	sar	NOUN
eurjchem-2084	7	60	-	-	PUNCT
eurjchem-2084	7	61	cov-2	cov-2	NOUN
eurjchem-2084	7	62	)	)	PUNCT
eurjchem-2084	7	63	.	.	PUNCT
eurjchem-2084	8	1	the	the	DET
eurjchem-2084	8	2	rapid	rapid	ADJ
eurjchem-2084	8	3	spread	spread	NOUN
eurjchem-2084	8	4	of	of	ADP
eurjchem-2084	8	5	the	the	DET
eurjchem-2084	8	6	virus	virus	NOUN
eurjchem-2084	8	7	across	across	ADP
eurjchem-2084	8	8	the	the	DET
eurjchem-2084	8	9	continent	continent	NOUN
eurjchem-2084	8	10	has	have	AUX
eurjchem-2084	8	11	disrupted	disrupt	VERB
eurjchem-2084	8	12	human	human	ADJ
eurjchem-2084	8	13	life	life	NOUN
eurjchem-2084	8	14	in	in	ADP
eurjchem-2084	8	15	every	every	DET
eurjchem-2084	8	16	aspect	aspect	NOUN
eurjchem-2084	8	17	leading	lead	VERB
eurjchem-2084	8	18	to	to	ADP
eurjchem-2084	8	19	health	health	NOUN
eurjchem-2084	8	20	and	and	CCONJ
eurjchem-2084	8	21	economic	economic	ADJ
eurjchem-2084	8	22	crises	crisis	NOUN
eurjchem-2084	8	23	.	.	PUNCT
eurjchem-2084	9	1	the	the	DET
eurjchem-2084	9	2	world	world	PROPN
eurjchem-2084	9	3	health	health	PROPN
eurjchem-2084	9	4	organization	organization	NOUN
eurjchem-2084	9	5	(	(	PUNCT
eurjchem-2084	9	6	who	who	PRON
eurjchem-2084	9	7	)	)	PUNCT
eurjchem-2084	9	8	declared	declare	VERB
eurjchem-2084	9	9	the	the	DET
eurjchem-2084	9	10	novel	novel	ADJ
eurjchem-2084	9	11	coronavirus	coronavirus	NOUN
eurjchem-2084	9	12	outbreak	outbreak	NOUN
eurjchem-2084	9	13	as	as	ADP
eurjchem-2084	9	14	a	a	DET
eurjchem-2084	9	15	global	global	ADJ
eurjchem-2084	9	16	pandemic	pandemic	NOUN
eurjchem-2084	9	17	on	on	ADP
eurjchem-2084	9	18	march	march	PROPN
eurjchem-2084	9	19	11	11	NUM
eurjchem-2084	9	20	,	,	PUNCT
eurjchem-2084	9	21	2020	2020	NUM
eurjchem-2084	9	22	.	.	PUNCT
eurjchem-2084	10	1	in	in	ADP
eurjchem-2084	10	2	spite	spite	NOUN
eurjchem-2084	10	3	of	of	ADP
eurjchem-2084	10	4	complete	complete	ADJ
eurjchem-2084	10	5	lockdown	lockdown	NOUN
eurjchem-2084	10	6	and	and	CCONJ
eurjchem-2084	10	7	quarantine	quarantine	NOUN
eurjchem-2084	10	8	efforts	effort	NOUN
eurjchem-2084	10	9	in	in	ADP
eurjchem-2084	10	10	many	many	ADJ
eurjchem-2084	10	11	countries	country	NOUN
eurjchem-2084	10	12	,	,	PUNCT
eurjchem-2084	10	13	the	the	DET
eurjchem-2084	10	14	occurrence	occurrence	NOUN
eurjchem-2084	10	15	of	of	ADP
eurjchem-2084	10	16	infections	infection	NOUN
eurjchem-2084	10	17	continues	continue	VERB
eurjchem-2084	10	18	to	to	PART
eurjchem-2084	10	19	rise	rise	VERB
eurjchem-2084	10	20	,	,	PUNCT
eurjchem-2084	10	21	with	with	ADP
eurjchem-2084	10	22	more	more	ADJ
eurjchem-2084	10	23	than	than	ADP
eurjchem-2084	10	24	88	88	NUM
eurjchem-2084	10	25	million	million	NUM
eurjchem-2084	10	26	laboratory	laboratory	NOUN
eurjchem-2084	10	27	-	-	PUNCT
eurjchem-2084	10	28	confirmed	confirm	VERB
eurjchem-2084	10	29	cases	case	NOUN
eurjchem-2084	10	30	and	and	CCONJ
eurjchem-2084	10	31	over	over	ADP
eurjchem-2084	10	32	1.9	1.9	NUM
eurjchem-2084	10	33	million	million	NUM
eurjchem-2084	10	34	deaths	death	NOUN
eurjchem-2084	10	35	worldwide	worldwide	ADV
eurjchem-2084	10	36	as	as	ADP
eurjchem-2084	10	37	on	on	ADP
eurjchem-2084	10	38	january	january	PROPN
eurjchem-2084	10	39	10	10	NUM
eurjchem-2084	10	40	,	,	PUNCT
eurjchem-2084	10	41	2021	2021	NUM
eurjchem-2084	10	42	.	.	PUNCT
eurjchem-2084	11	1	since	since	SCONJ
eurjchem-2084	11	2	the	the	DET
eurjchem-2084	11	3	beginning	beginning	NOUN
eurjchem-2084	11	4	of	of	ADP
eurjchem-2084	11	5	the	the	DET
eurjchem-2084	11	6	outbreak	outbreak	NOUN
eurjchem-2084	11	7	,	,	PUNCT
eurjchem-2084	11	8	lot	lot	NOUN
eurjchem-2084	11	9	of	of	ADP
eurjchem-2084	11	10	intriguing	intriguing	ADJ
eurjchem-2084	11	11	studies	study	NOUN
eurjchem-2084	11	12	about	about	ADP
eurjchem-2084	11	13	the	the	DET
eurjchem-2084	11	14	phylogenetic	phylogenetic	ADJ
eurjchem-2084	11	15	evolution	evolution	NOUN
eurjchem-2084	11	16	,	,	PUNCT
eurjchem-2084	11	17	epidemiology	epidemiology	NOUN
eurjchem-2084	11	18	,	,	PUNCT
eurjchem-2084	11	19	pathogenesis	pathogenesis	NOUN
eurjchem-2084	11	20	,	,	PUNCT
eurjchem-2084	11	21	transmission	transmission	NOUN
eurjchem-2084	11	22	,	,	PUNCT
eurjchem-2084	11	23	clinical	clinical	ADJ
eurjchem-2084	11	24	characteristics	characteristic	NOUN
eurjchem-2084	11	25	,	,	PUNCT
eurjchem-2084	11	26	and	and	CCONJ
eurjchem-2084	11	27	possible	possible	ADJ
eurjchem-2084	11	28	treatment	treatment	NOUN
eurjchem-2084	11	29	of	of	ADP
eurjchem-2084	11	30	corona	corona	NOUN
eurjchem-2084	11	31	virus	virus	NOUN
eurjchem-2084	11	32	disease	disease	NOUN
eurjchem-2084	11	33	2019	2019	NUM
eurjchem-2084	11	34	(	(	PUNCT
eurjchem-2084	11	35	covid-19	covid-19	PROPN
eurjchem-2084	11	36	)	)	PUNCT
eurjchem-2084	11	37	have	have	AUX
eurjchem-2084	11	38	been	be	AUX
eurjchem-2084	11	39	published	publish	VERB
eurjchem-2084	11	40	.	.	PUNCT
eurjchem-2084	12	1	this	this	DET
eurjchem-2084	12	2	review	review	NOUN
eurjchem-2084	12	3	aims	aim	VERB
eurjchem-2084	12	4	to	to	PART
eurjchem-2084	12	5	provide	provide	VERB
eurjchem-2084	12	6	an	an	DET
eurjchem-2084	12	7	insight	insight	NOUN
eurjchem-2084	12	8	into	into	ADP
eurjchem-2084	12	9	the	the	DET
eurjchem-2084	12	10	progress	progress	NOUN
eurjchem-2084	12	11	in	in	ADP
eurjchem-2084	12	12	this	this	DET
eurjchem-2084	12	13	regard	regard	NOUN
eurjchem-2084	12	14	and	and	CCONJ
eurjchem-2084	12	15	provides	provide	VERB
eurjchem-2084	12	16	a	a	DET
eurjchem-2084	12	17	reference	reference	NOUN
eurjchem-2084	12	18	for	for	ADP
eurjchem-2084	12	19	future	future	ADJ
eurjchem-2084	12	20	studies	study	NOUN
eurjchem-2084	12	21	including	include	VERB
eurjchem-2084	12	22	general	general	ADJ
eurjchem-2084	12	23	awareness	awareness	NOUN
eurjchem-2084	12	24	.	.	PUNCT
eurjchem-2084	13	1	we	we	PRON
eurjchem-2084	13	2	have	have	AUX
eurjchem-2084	13	3	discussed	discuss	VERB
eurjchem-2084	13	4	the	the	DET
eurjchem-2084	13	5	origin	origin	NOUN
eurjchem-2084	13	6	,	,	PUNCT
eurjchem-2084	13	7	transmission	transmission	NOUN
eurjchem-2084	13	8	,	,	PUNCT
eurjchem-2084	13	9	and	and	CCONJ
eurjchem-2084	13	10	infection	infection	NOUN
eurjchem-2084	13	11	mechanism	mechanism	NOUN
eurjchem-2084	13	12	of	of	ADP
eurjchem-2084	13	13	coronaviruses	coronaviruse	NOUN
eurjchem-2084	13	14	in	in	ADP
eurjchem-2084	13	15	host	host	NOUN
eurjchem-2084	13	16	cells	cell	NOUN
eurjchem-2084	13	17	as	as	ADV
eurjchem-2084	13	18	well	well	ADV
eurjchem-2084	13	19	as	as	ADP
eurjchem-2084	13	20	available	available	ADJ
eurjchem-2084	13	21	treatment	treatment	NOUN
eurjchem-2084	13	22	options	option	NOUN
eurjchem-2084	13	23	with	with	ADP
eurjchem-2084	13	24	relevant	relevant	ADJ
eurjchem-2084	13	25	case	case	NOUN
eurjchem-2084	13	26	studies	study	NOUN
eurjchem-2084	13	27	.	.	PUNCT
eurjchem-2084	14	1	furthermore	furthermore	ADV
eurjchem-2084	14	2	,	,	PUNCT
eurjchem-2084	14	3	the	the	DET
eurjchem-2084	14	4	stages	stage	NOUN
eurjchem-2084	14	5	of	of	ADP
eurjchem-2084	14	6	vaccine	vaccine	NOUN
eurjchem-2084	14	7	development	development	NOUN
eurjchem-2084	14	8	,	,	PUNCT
eurjchem-2084	14	9	types	type	NOUN
eurjchem-2084	14	10	of	of	ADP
eurjchem-2084	14	11	vaccines	vaccine	NOUN
eurjchem-2084	14	12	,	,	PUNCT
eurjchem-2084	14	13	and	and	CCONJ
eurjchem-2084	14	14	candidate	candidate	NOUN
eurjchem-2084	14	15	vaccines	vaccine	NOUN
eurjchem-2084	14	16	with	with	ADP
eurjchem-2084	14	17	their	their	PRON
eurjchem-2084	14	18	phases	phase	NOUN
eurjchem-2084	14	19	of	of	ADP
eurjchem-2084	14	20	clinical	clinical	ADJ
eurjchem-2084	14	21	trial	trial	NOUN
eurjchem-2084	14	22	are	be	AUX
eurjchem-2084	14	23	also	also	ADV
eurjchem-2084	14	24	incorporated	incorporate	VERB
eurjchem-2084	14	25	.	.	PUNCT
eurjchem-2084	15	1	in	in	ADP
eurjchem-2084	15	2	a	a	DET
eurjchem-2084	15	3	nutshell	nutshell	NOUN
eurjchem-2084	15	4	,	,	PUNCT
eurjchem-2084	15	5	the	the	DET
eurjchem-2084	15	6	article	article	NOUN
eurjchem-2084	15	7	is	be	AUX
eurjchem-2084	15	8	an	an	DET
eurjchem-2084	15	9	attempt	attempt	NOUN
eurjchem-2084	15	10	to	to	PART
eurjchem-2084	15	11	retrieve	retrieve	VERB
eurjchem-2084	15	12	the	the	DET
eurjchem-2084	15	13	latest	late	ADJ
eurjchem-2084	15	14	information	information	NOUN
eurjchem-2084	15	15	available	available	ADJ
eurjchem-2084	15	16	on	on	ADP
eurjchem-2084	15	17	virus	virus	NOUN
eurjchem-2084	15	18	behavior	behavior	NOUN
eurjchem-2084	15	19	,	,	PUNCT
eurjchem-2084	15	20	efficacy	efficacy	NOUN
eurjchem-2084	15	21	of	of	ADP
eurjchem-2084	15	22	the	the	DET
eurjchem-2084	15	23	available	available	ADJ
eurjchem-2084	15	24	drugs	drug	NOUN
eurjchem-2084	15	25	,	,	PUNCT
eurjchem-2084	15	26	and	and	CCONJ
eurjchem-2084	15	27	development	development	NOUN
eurjchem-2084	15	28	of	of	ADP
eurjchem-2084	15	29	candidate	candidate	NOUN
eurjchem-2084	15	30	vaccines	vaccine	NOUN
eurjchem-2084	15	31	on	on	ADP
eurjchem-2084	15	32	sarscov-2	sarscov-2	PROPN
eurjchem-2084	15	33	.	.	PUNCT
eurjchem-2084	16	1	covid-19	covid-19	PROPN
eurjchem-2084	16	2	sars	sars	PROPN
eurjchem-2084	16	3	-	-	PUNCT
eurjchem-2084	16	4	cov-2	cov-2	NOUN
eurjchem-2084	16	5	pathogenicity	pathogenicity	NOUN
eurjchem-2084	16	6	entry	entry	NOUN
eurjchem-2084	16	7	mechanism	mechanism	NOUN
eurjchem-2084	16	8	hydroxychloroquine	hydroxychloroquine	PROPN
eurjchem-2084	16	9	vaccine	vaccine	NOUN
eurjchem-2084	16	10	development	development	NOUN
eurjchem-2084	16	11	cite	cite	VERB
eurjchem-2084	16	12	this	this	PRON
eurjchem-2084	16	13	:	:	PUNCT
eurjchem-2084	16	14	eur	eur	PROPN
eurjchem-2084	16	15	.	.	PUNCT
eurjchem-2084	17	1	j.	j.	PROPN
eurjchem-2084	17	2	chem	chem	PROPN
eurjchem-2084	17	3	.	.	PUNCT
eurjchem-2084	18	1	2021	2021	NUM
eurjchem-2084	18	2	,	,	PUNCT
eurjchem-2084	18	3	12(2	12(2	NUM
eurjchem-2084	18	4	)	)	PUNCT
eurjchem-2084	18	5	,	,	PUNCT
eurjchem-2084	18	6	222	222	NUM
eurjchem-2084	18	7	-	-	SYM
eurjchem-2084	18	8	234	234	NUM
eurjchem-2084	18	9	journal	journal	NOUN
eurjchem-2084	18	10	website	website	NOUN
eurjchem-2084	18	11	:	:	PUNCT
eurjchem-2084	18	12	www.eurjchem.com	www.eurjchem.com	X
eurjchem-2084	18	13	1	1	X
eurjchem-2084	18	14	.	.	PUNCT
eurjchem-2084	18	15	introduction	introduction	NOUN
eurjchem-2084	18	16	viral	viral	ADJ
eurjchem-2084	18	17	diseases	disease	NOUN
eurjchem-2084	18	18	have	have	AUX
eurjchem-2084	18	19	always	always	ADV
eurjchem-2084	18	20	been	be	AUX
eurjchem-2084	18	21	dreadful	dreadful	ADJ
eurjchem-2084	18	22	to	to	ADP
eurjchem-2084	18	23	humans	human	NOUN
eurjchem-2084	18	24	and	and	CCONJ
eurjchem-2084	18	25	new	new	ADJ
eurjchem-2084	18	26	viral	viral	ADJ
eurjchem-2084	18	27	infections	infection	NOUN
eurjchem-2084	18	28	are	be	AUX
eurjchem-2084	18	29	being	be	AUX
eurjchem-2084	18	30	reported	report	VERB
eurjchem-2084	18	31	frequently	frequently	ADV
eurjchem-2084	18	32	[	[	X
eurjchem-2084	18	33	1	1	NUM
eurjchem-2084	18	34	]	]	PUNCT
eurjchem-2084	18	35	.	.	PUNCT
eurjchem-2084	19	1	coronavirus	coronavirus	NOUN
eurjchem-2084	19	2	comprises	comprise	VERB
eurjchem-2084	19	3	a	a	DET
eurjchem-2084	19	4	group	group	NOUN
eurjchem-2084	19	5	of	of	ADP
eurjchem-2084	19	6	viruses	virus	NOUN
eurjchem-2084	19	7	that	that	PRON
eurjchem-2084	19	8	cause	cause	VERB
eurjchem-2084	19	9	infections	infection	NOUN
eurjchem-2084	19	10	in	in	ADP
eurjchem-2084	19	11	birds	bird	NOUN
eurjchem-2084	19	12	and	and	CCONJ
eurjchem-2084	19	13	mammals	mammal	NOUN
eurjchem-2084	19	14	.	.	PUNCT
eurjchem-2084	20	1	a	a	DET
eurjchem-2084	20	2	novel	novel	NOUN
eurjchem-2084	20	3	and	and	CCONJ
eurjchem-2084	20	4	highly	highly	ADV
eurjchem-2084	20	5	contagious	contagious	ADJ
eurjchem-2084	20	6	viral	viral	ADJ
eurjchem-2084	20	7	disease	disease	NOUN
eurjchem-2084	20	8	,	,	PUNCT
eurjchem-2084	20	9	first	first	ADV
eurjchem-2084	20	10	reported	report	VERB
eurjchem-2084	20	11	in	in	ADP
eurjchem-2084	20	12	wuhan	wuhan	PROPN
eurjchem-2084	20	13	(	(	PUNCT
eurjchem-2084	20	14	china	china	PROPN
eurjchem-2084	20	15	)	)	PUNCT
eurjchem-2084	20	16	in	in	ADP
eurjchem-2084	20	17	december	december	PROPN
eurjchem-2084	20	18	2019	2019	NUM
eurjchem-2084	20	19	,	,	PUNCT
eurjchem-2084	20	20	is	be	AUX
eurjchem-2084	20	21	named	name	VERB
eurjchem-2084	20	22	‘	'	PUNCT
eurjchem-2084	20	23	corona	corona	NOUN
eurjchem-2084	20	24	virus	virus	NOUN
eurjchem-2084	20	25	disease	disease	NOUN
eurjchem-2084	20	26	2019	2019	NUM
eurjchem-2084	20	27	which	which	PRON
eurjchem-2084	20	28	is	be	AUX
eurjchem-2084	20	29	caused	cause	VERB
eurjchem-2084	20	30	by	by	ADP
eurjchem-2084	20	31	a	a	DET
eurjchem-2084	20	32	new	new	ADJ
eurjchem-2084	20	33	strain	strain	NOUN
eurjchem-2084	20	34	of	of	ADP
eurjchem-2084	20	35	sars	sar	NOUN
eurjchem-2084	20	36	-	-	PUNCT
eurjchem-2084	20	37	cov	cov	NOUN
eurjchem-2084	20	38	(	(	PUNCT
eurjchem-2084	20	39	severe	severe	ADJ
eurjchem-2084	20	40	acute	acute	ADJ
eurjchem-2084	20	41	respiratory	respiratory	ADJ
eurjchem-2084	20	42	syndrome	syndrome	NOUN
eurjchem-2084	20	43	coronavirus	coronavirus	NOUN
eurjchem-2084	20	44	)	)	PUNCT
eurjchem-2084	20	45	called	call	VERB
eurjchem-2084	20	46	as	as	ADP
eurjchem-2084	20	47	sars	sar	NOUN
eurjchem-2084	20	48	-	-	PUNCT
eurjchem-2084	20	49	cov-2	cov-2	NOUN
eurjchem-2084	20	50	[	[	NOUN
eurjchem-2084	20	51	2	2	NUM
eurjchem-2084	20	52	]	]	PUNCT
eurjchem-2084	20	53	.	.	PUNCT
eurjchem-2084	21	1	taxonomically	taxonomically	ADV
eurjchem-2084	21	2	,	,	PUNCT
eurjchem-2084	21	3	the	the	DET
eurjchem-2084	21	4	sars	sar	NOUN
eurjchem-2084	21	5	-	-	PUNCT
eurjchem-2084	21	6	cov-2	cov-2	PART
eurjchem-2084	21	7	virus	virus	NOUN
eurjchem-2084	21	8	belongs	belong	VERB
eurjchem-2084	21	9	to	to	ADP
eurjchem-2084	21	10	family	family	NOUN
eurjchem-2084	21	11	coronaviridae	coronaviridae	NOUN
eurjchem-2084	21	12	,	,	PUNCT
eurjchem-2084	21	13	and	and	CCONJ
eurjchem-2084	21	14	order	order	NOUN
eurjchem-2084	21	15	nidovirales	nidovirale	NOUN
eurjchem-2084	21	16	(	(	PUNCT
eurjchem-2084	21	17	figure	figure	NOUN
eurjchem-2084	21	18	1	1	NUM
eurjchem-2084	21	19	)	)	PUNCT
eurjchem-2084	21	20	.	.	PUNCT
eurjchem-2084	22	1	this	this	PRON
eurjchem-2084	22	2	is	be	AUX
eurjchem-2084	22	3	the	the	DET
eurjchem-2084	22	4	seventh	seventh	ADJ
eurjchem-2084	22	5	virus	virus	NOUN
eurjchem-2084	22	6	in	in	ADP
eurjchem-2084	22	7	the	the	DET
eurjchem-2084	22	8	family	family	NOUN
eurjchem-2084	22	9	of	of	ADP
eurjchem-2084	22	10	coronavirus	coronavirus	NOUN
eurjchem-2084	22	11	and	and	CCONJ
eurjchem-2084	22	12	attacks	attack	NOUN
eurjchem-2084	22	13	mainly	mainly	ADV
eurjchem-2084	22	14	human	human	ADJ
eurjchem-2084	22	15	respiratory	respiratory	ADJ
eurjchem-2084	22	16	systems	system	NOUN
eurjchem-2084	22	17	.	.	PUNCT
eurjchem-2084	23	1	who	who	PRON
eurjchem-2084	23	2	declared	declare	VERB
eurjchem-2084	23	3	covid-19	covid-19	PROPN
eurjchem-2084	23	4	as	as	ADP
eurjchem-2084	23	5	worldwide	worldwide	ADV
eurjchem-2084	23	6	pandemic	pandemic	ADJ
eurjchem-2084	23	7	in	in	ADP
eurjchem-2084	23	8	march	march	PROPN
eurjchem-2084	23	9	2020	2020	NUM
eurjchem-2084	24	1	[	[	X
eurjchem-2084	24	2	3	3	NUM
eurjchem-2084	24	3	]	]	PUNCT
eurjchem-2084	24	4	.	.	PUNCT
eurjchem-2084	25	1	after	after	ADP
eurjchem-2084	25	2	sars	sars	PROPN
eurjchem-2084	25	3	(	(	PUNCT
eurjchem-2084	25	4	severe	severe	ADJ
eurjchem-2084	25	5	acute	acute	ADJ
eurjchem-2084	25	6	respiratory	respiratory	ADJ
eurjchem-2084	25	7	syndrome	syndrome	NOUN
eurjchem-2084	25	8	)	)	PUNCT
eurjchem-2084	25	9	in	in	ADP
eurjchem-2084	25	10	2003	2003	NUM
eurjchem-2084	25	11	and	and	CCONJ
eurjchem-2084	25	12	mers	mer	NOUN
eurjchem-2084	25	13	(	(	PUNCT
eurjchem-2084	25	14	middle	middle	PROPN
eurjchem-2084	25	15	east	east	PROPN
eurjchem-2084	25	16	respiratory	respiratory	ADJ
eurjchem-2084	25	17	syndrome	syndrome	NOUN
eurjchem-2084	25	18	)	)	PUNCT
eurjchem-2084	25	19	in	in	ADP
eurjchem-2084	25	20	2012	2012	NUM
eurjchem-2084	25	21	,	,	PUNCT
eurjchem-2084	25	22	this	this	PRON
eurjchem-2084	25	23	is	be	AUX
eurjchem-2084	25	24	the	the	DET
eurjchem-2084	25	25	third	third	ADJ
eurjchem-2084	25	26	large	large	ADJ
eurjchem-2084	25	27	-	-	PUNCT
eurjchem-2084	25	28	scale	scale	NOUN
eurjchem-2084	25	29	pandemic	pandemic	ADJ
eurjchem-2084	25	30	virus	virus	NOUN
eurjchem-2084	25	31	in	in	ADP
eurjchem-2084	25	32	corona	corona	NOUN
eurjchem-2084	25	33	family	family	NOUN
eurjchem-2084	25	34	.	.	PUNCT
eurjchem-2084	26	1	the	the	DET
eurjchem-2084	26	2	mortality	mortality	NOUN
eurjchem-2084	26	3	rate	rate	NOUN
eurjchem-2084	26	4	of	of	ADP
eurjchem-2084	26	5	sars	sar	NOUN
eurjchem-2084	26	6	-	-	PUNCT
eurjchem-2084	26	7	cov-2	cov-2	NOUN
eurjchem-2084	26	8	in	in	ADP
eurjchem-2084	26	9	humans	human	NOUN
eurjchem-2084	26	10	(	(	PUNCT
eurjchem-2084	26	11	2.9	2.9	NUM
eurjchem-2084	26	12	%	%	NOUN
eurjchem-2084	26	13	)	)	PUNCT
eurjchem-2084	26	14	is	be	AUX
eurjchem-2084	26	15	not	not	PART
eurjchem-2084	26	16	very	very	ADV
eurjchem-2084	26	17	high	high	ADJ
eurjchem-2084	26	18	in	in	ADP
eurjchem-2084	26	19	comparison	comparison	NOUN
eurjchem-2084	26	20	to	to	ADP
eurjchem-2084	26	21	the	the	DET
eurjchem-2084	26	22	previously	previously	ADV
eurjchem-2084	26	23	reported	report	VERB
eurjchem-2084	26	24	sars	sars	PROPN
eurjchem-2084	26	25	-	-	PUNCT
eurjchem-2084	26	26	cov	cov	NOUN
eurjchem-2084	26	27	(	(	PUNCT
eurjchem-2084	26	28	10	10	NUM
eurjchem-2084	26	29	%	%	NOUN
eurjchem-2084	26	30	)	)	PUNCT
eurjchem-2084	26	31	and	and	CCONJ
eurjchem-2084	26	32	mers	mer	NOUN
eurjchem-2084	26	33	-	-	PUNCT
eurjchem-2084	26	34	cov	cov	NOUN
eurjchem-2084	26	35	(	(	PUNCT
eurjchem-2084	26	36	30	30	NUM
eurjchem-2084	26	37	%	%	NOUN
eurjchem-2084	26	38	)	)	PUNCT
eurjchem-2084	26	39	pandemics	pandemic	NOUN
eurjchem-2084	26	40	[	[	X
eurjchem-2084	26	41	4	4	NUM
eurjchem-2084	26	42	]	]	PUNCT
eurjchem-2084	26	43	.	.	PUNCT
eurjchem-2084	27	1	but	but	CCONJ
eurjchem-2084	27	2	the	the	DET
eurjchem-2084	27	3	number	number	NOUN
eurjchem-2084	27	4	of	of	ADP
eurjchem-2084	27	5	infected	infected	ADJ
eurjchem-2084	27	6	people	people	NOUN
eurjchem-2084	27	7	in	in	ADP
eurjchem-2084	27	8	and	and	CCONJ
eurjchem-2084	27	9	outside	outside	ADP
eurjchem-2084	27	10	china	china	PROPN
eurjchem-2084	27	11	just	just	ADV
eurjchem-2084	27	12	after	after	ADP
eurjchem-2084	27	13	two	two	NUM
eurjchem-2084	27	14	months	month	NOUN
eurjchem-2084	27	15	of	of	ADP
eurjchem-2084	27	16	its	its	PRON
eurjchem-2084	27	17	emergence	emergence	NOUN
eurjchem-2084	27	18	,	,	PUNCT
eurjchem-2084	27	19	there	there	PRON
eurjchem-2084	27	20	were	be	VERB
eurjchem-2084	27	21	more	more	ADJ
eurjchem-2084	27	22	than	than	ADP
eurjchem-2084	27	23	3500	3500	NUM
eurjchem-2084	27	24	,	,	PUNCT
eurjchem-2084	27	25	indicating	indicate	VERB
eurjchem-2084	27	26	a	a	DET
eurjchem-2084	27	27	very	very	ADV
eurjchem-2084	27	28	high	high	ADJ
eurjchem-2084	27	29	transmission	transmission	NOUN
eurjchem-2084	27	30	rate	rate	NOUN
eurjchem-2084	27	31	and	and	CCONJ
eurjchem-2084	27	32	rapid	rapid	ADJ
eurjchem-2084	27	33	spread	spread	NOUN
eurjchem-2084	27	34	of	of	ADP
eurjchem-2084	27	35	the	the	DET
eurjchem-2084	27	36	virus	virus	NOUN
eurjchem-2084	27	37	across	across	ADP
eurjchem-2084	27	38	the	the	DET
eurjchem-2084	27	39	continent	continent	NOUN
eurjchem-2084	27	40	.	.	PUNCT
eurjchem-2084	28	1	2	2	X
eurjchem-2084	28	2	.	.	X
eurjchem-2084	28	3	epidemiology	epidemiology	NOUN
eurjchem-2084	28	4	after	after	ADP
eurjchem-2084	28	5	the	the	DET
eurjchem-2084	28	6	emergence	emergence	NOUN
eurjchem-2084	28	7	of	of	ADP
eurjchem-2084	28	8	covid-19	covid-19	PROPN
eurjchem-2084	28	9	in	in	ADP
eurjchem-2084	28	10	china	china	PROPN
eurjchem-2084	28	11	,	,	PUNCT
eurjchem-2084	28	12	the	the	DET
eurjchem-2084	28	13	virus	virus	NOUN
eurjchem-2084	28	14	rapidly	rapidly	ADV
eurjchem-2084	28	15	spread	spread	VERB
eurjchem-2084	28	16	to	to	ADP
eurjchem-2084	28	17	spain	spain	PROPN
eurjchem-2084	28	18	,	,	PUNCT
eurjchem-2084	28	19	france	france	PROPN
eurjchem-2084	28	20	,	,	PUNCT
eurjchem-2084	28	21	italy	italy	PROPN
eurjchem-2084	28	22	and	and	CCONJ
eurjchem-2084	28	23	america	america	PROPN
eurjchem-2084	28	24	.	.	PUNCT
eurjchem-2084	29	1	at	at	ADP
eurjchem-2084	29	2	present	present	ADJ
eurjchem-2084	29	3	,	,	PUNCT
eurjchem-2084	29	4	the	the	DET
eurjchem-2084	29	5	entire	entire	ADJ
eurjchem-2084	29	6	globe	globe	NOUN
eurjchem-2084	29	7	(	(	PUNCT
eurjchem-2084	29	8	except	except	SCONJ
eurjchem-2084	29	9	antarctica	antarctica	PROPN
eurjchem-2084	29	10	)	)	PUNCT
eurjchem-2084	29	11	from	from	ADP
eurjchem-2084	29	12	west	west	PROPN
eurjchem-2084	29	13	to	to	ADP
eurjchem-2084	29	14	the	the	DET
eurjchem-2084	29	15	east	east	NOUN
eurjchem-2084	29	16	is	be	AUX
eurjchem-2084	29	17	infected	infect	VERB
eurjchem-2084	29	18	with	with	ADP
eurjchem-2084	29	19	it	it	PRON
eurjchem-2084	29	20	.	.	PUNCT
eurjchem-2084	30	1	as	as	ADP
eurjchem-2084	30	2	per	per	ADP
eurjchem-2084	30	3	who	who	PRON
eurjchem-2084	30	4	report	report	VERB
eurjchem-2084	30	5	,	,	PUNCT
eurjchem-2084	30	6	globally	globally	ADV
eurjchem-2084	30	7	more	more	ADJ
eurjchem-2084	30	8	than	than	ADP
eurjchem-2084	30	9	88	88	NUM
eurjchem-2084	30	10	million	million	NUM
eurjchem-2084	30	11	confirmed	confirm	VERB
eurjchem-2084	30	12	cases	case	NOUN
eurjchem-2084	30	13	along	along	ADP
eurjchem-2084	30	14	with	with	ADP
eurjchem-2084	30	15	1.9	1.9	NUM
eurjchem-2084	30	16	million	million	NUM
eurjchem-2084	30	17	deaths	death	NOUN
eurjchem-2084	30	18	have	have	AUX
eurjchem-2084	30	19	been	be	AUX
eurjchem-2084	30	20	reported	report	VERB
eurjchem-2084	30	21	tilljanuary10	tilljanuary10	NOUN
eurjchem-2084	30	22	,	,	PUNCT
eurjchem-2084	30	23	2021	2021	NUM
eurjchem-2084	30	24	.	.	PUNCT
eurjchem-2084	31	1	majority	majority	NOUN
eurjchem-2084	31	2	of	of	ADP
eurjchem-2084	31	3	the	the	DET
eurjchem-2084	31	4	deaths	death	NOUN
eurjchem-2084	31	5	have	have	AUX
eurjchem-2084	31	6	been	be	AUX
eurjchem-2084	31	7	reported	report	VERB
eurjchem-2084	31	8	from	from	ADP
eurjchem-2084	31	9	america	america	PROPN
eurjchem-2084	31	10	(	(	PUNCT
eurjchem-2084	31	11	55	55	NUM
eurjchem-2084	31	12	%	%	NOUN
eurjchem-2084	31	13	)	)	PUNCT
eurjchem-2084	31	14	,	,	PUNCT
eurjchem-2084	31	15	europe	europe	PROPN
eurjchem-2084	31	16	(	(	PUNCT
eurjchem-2084	31	17	27	27	NUM
eurjchem-2084	31	18	%	%	NOUN
eurjchem-2084	31	19	)	)	PUNCT
eurjchem-2084	31	20	and	and	CCONJ
eurjchem-2084	31	21	south	south	PROPN
eurjchem-2084	31	22	-	-	PUNCT
eurjchem-2084	31	23	east	east	PROPN
eurjchem-2084	31	24	asia	asia	PROPN
eurjchem-2084	31	25	(	(	PUNCT
eurjchem-2084	31	26	12	12	NUM
eurjchem-2084	31	27	%	%	NOUN
eurjchem-2084	31	28	)	)	PUNCT
eurjchem-2084	31	29	.	.	PUNCT
eurjchem-2084	32	1	epidemiological	epidemiological	ADJ
eurjchem-2084	32	2	data	datum	NOUN
eurjchem-2084	32	3	also	also	ADV
eurjchem-2084	32	4	indicates	indicate	VERB
eurjchem-2084	32	5	that	that	SCONJ
eurjchem-2084	32	6	the	the	DET
eurjchem-2084	32	7	number	number	NOUN
eurjchem-2084	32	8	of	of	ADP
eurjchem-2084	32	9	death	death	NOUN
eurjchem-2084	32	10	cases	case	NOUN
eurjchem-2084	32	11	is	be	AUX
eurjchem-2084	32	12	profoundly	profoundly	ADV
eurjchem-2084	32	13	high	high	ADJ
eurjchem-2084	32	14	in	in	ADP
eurjchem-2084	32	15	central	central	ADJ
eurjchem-2084	32	16	europe	europe	PROPN
eurjchem-2084	32	17	as	as	ADP
eurjchem-2084	32	18	compared	compare	VERB
eurjchem-2084	32	19	to	to	ADP
eurjchem-2084	32	20	south	south	ADJ
eurjchem-2084	32	21	-	-	PUNCT
eurjchem-2084	32	22	east	east	PROPN
eurjchem-2084	32	23	asia	asia	PROPN
eurjchem-2084	32	24	.	.	PUNCT
eurjchem-2084	33	1	the	the	DET
eurjchem-2084	33	2	possible	possible	ADJ
eurjchem-2084	33	3	reason	reason	NOUN
eurjchem-2084	33	4	can	can	AUX
eurjchem-2084	33	5	be	be	AUX
eurjchem-2084	33	6	the	the	DET
eurjchem-2084	33	7	geographical	geographical	ADJ
eurjchem-2084	33	8	,	,	PUNCT
eurjchem-2084	33	9	social	social	ADJ
eurjchem-2084	33	10	,	,	PUNCT
eurjchem-2084	33	11	cultural	cultural	ADJ
eurjchem-2084	33	12	,	,	PUNCT
eurjchem-2084	33	13	and	and	CCONJ
eurjchem-2084	33	14	genetic	genetic	ADJ
eurjchem-2084	33	15	differences	difference	NOUN
eurjchem-2084	33	16	,	,	PUNCT
eurjchem-2084	33	17	and	and	CCONJ
eurjchem-2084	33	18	different	different	ADJ
eurjchem-2084	33	19	viral	viral	ADJ
eurjchem-2084	33	20	strains	strain	NOUN
eurjchem-2084	33	21	between	between	ADP
eurjchem-2084	33	22	the	the	DET
eurjchem-2084	33	23	populations	population	NOUN
eurjchem-2084	33	24	of	of	ADP
eurjchem-2084	33	25	the	the	DET
eurjchem-2084	33	26	two	two	NUM
eurjchem-2084	33	27	regions	region	NOUN
eurjchem-2084	33	28	[	[	X
eurjchem-2084	33	29	5,6	5,6	NUM
eurjchem-2084	33	30	]	]	X
eurjchem-2084	33	31	.	.	PUNCT
eurjchem-2084	34	1	currently	currently	ADV
eurjchem-2084	34	2	,	,	PUNCT
eurjchem-2084	34	3	the	the	DET
eurjchem-2084	34	4	virus	virus	NOUN
eurjchem-2084	34	5	is	be	AUX
eurjchem-2084	34	6	predominant	predominant	ADJ
eurjchem-2084	34	7	in	in	ADP
eurjchem-2084	34	8	the	the	DET
eurjchem-2084	34	9	regions	region	NOUN
eurjchem-2084	34	10	of	of	ADP
eurjchem-2084	34	11	america	america	PROPN
eurjchem-2084	34	12	,	,	PUNCT
eurjchem-2084	34	13	europe	europe	PROPN
eurjchem-2084	34	14	,	,	PUNCT
eurjchem-2084	34	15	and	and	CCONJ
eurjchem-2084	34	16	south	south	ADJ
eurjchem-2084	34	17	-	-	PUNCT
eurjchem-2084	34	18	east	east	PROPN
eurjchem-2084	34	19	asia	asia	PROPN
eurjchem-2084	34	20	.	.	PUNCT
eurjchem-2084	35	1	the	the	DET
eurjchem-2084	35	2	highest	high	ADJ
eurjchem-2084	35	3	occurrence	occurrence	NOUN
eurjchem-2084	35	4	of	of	ADP
eurjchem-2084	35	5	cases	case	NOUN
eurjchem-2084	35	6	has	have	AUX
eurjchem-2084	35	7	been	be	AUX
eurjchem-2084	35	8	reported	report	VERB
eurjchem-2084	35	9	from	from	ADP
eurjchem-2084	35	10	united	united	PROPN
eurjchem-2084	35	11	states	states	PROPN
eurjchem-2084	35	12	of	of	ADP
eurjchem-2084	35	13	america	america	PROPN
eurjchem-2084	35	14	(	(	PUNCT
eurjchem-2084	35	15	37,538,493	37,538,493	NUM
eurjchem-2084	35	16	)	)	PUNCT
eurjchem-2084	35	17	,	,	PUNCT
eurjchem-2084	35	18	india	india	PROPN
eurjchem-2084	35	19	(	(	PUNCT
eurjchem-2084	35	20	10,395,278	10,395,278	NUM
eurjchem-2084	35	21	)	)	PUNCT
eurjchem-2084	35	22	,	,	PUNCT
eurjchem-2084	35	23	brazil	brazil	PROPN
eurjchem-2084	35	24	(	(	PUNCT
eurjchem-2084	35	25	7,8,10,400	7,8,10,400	NOUN
eurjchem-2084	35	26	)	)	PUNCT
eurjchem-2084	35	27	russia	russia	NOUN
eurjchem-2084	35	28	(	(	PUNCT
eurjchem-2084	35	29	3,332,142	3,332,142	NUM
eurjchem-2084	35	30	)	)	PUNCT
eurjchem-2084	35	31	,	,	PUNCT
eurjchem-2084	35	32	and	and	CCONJ
eurjchem-2084	35	33	france	france	PROPN
eurjchem-2084	35	34	(	(	PUNCT
eurjchem-2084	35	35	2,660,740	2,660,740	NUM
eurjchem-2084	35	36	)	)	PUNCT
eurjchem-2084	36	1	[	[	X
eurjchem-2084	36	2	7	7	NUM
eurjchem-2084	36	3	]	]	PUNCT
eurjchem-2084	36	4	.	.	PUNCT
eurjchem-2084	37	1	abstract	abstract	ADJ
eurjchem-2084	37	2	review	review	NOUN
eurjchem-2084	37	3	article	article	NOUN
eurjchem-2084	37	4	keywords	keyword	VERB
eurjchem-2084	37	5	https://dx.doi.org/10.5155/eurjchem.12.2.222-234.2084	https://dx.doi.org/10.5155/eurjchem.12.2.222-234.2084	PROPN
eurjchem-2084	37	6	https://www.eurjchem.com/	https://www.eurjchem.com/	PROPN
eurjchem-2084	37	7	https://dx.doi.org/10.5155/eurjchem.12.2.222-234.2084	https://dx.doi.org/10.5155/eurjchem.12.2.222-234.2084	PROPN
eurjchem-2084	37	8	mailto:zubi.yazdani@gmail.com	mailto:zubi.yazdani@gmail.com	X
eurjchem-2084	38	1	mailto:tryambak@bhu.ac.in	mailto:tryambak@bhu.ac.in	PROPN
eurjchem-2084	38	2	mailto:meenakshisingh@bhu.ac.in	mailto:meenakshisingh@bhu.ac.in	VERB
eurjchem-2084	38	3	mailto:sksingh.phe@iitbhu.ac.in	mailto:sksingh.phe@iitbhu.ac.in	PROPN
eurjchem-2084	38	4	mailto:tryambak@bhu.ac.in	mailto:tryambak@bhu.ac.in	X
eurjchem-2084	38	5	mailto:meenakshisingh@bhu.ac.in	mailto:meenakshisingh@bhu.ac.in	VERB
eurjchem-2084	38	6	http://www.eurjchem.com/	http://www.eurjchem.com/	PROPN
eurjchem-2084	38	7	https://crossmark.crossref.org/dialog/?doi=10.5155/eurjchem.12.2.222-234.2084&domain=pdf&date_stamp=2021-06-30	https://crossmark.crossref.org/dialog/?doi=10.5155/eurjchem.12.2.222-234.2084&domain=pdf&date_stamp=2021-06-30	PROPN
eurjchem-2084	38	8	firdaus	firdaus	PROPN
eurjchem-2084	38	9	et	et	PROPN
eurjchem-2084	38	10	al	al	PROPN
eurjchem-2084	38	11	.	.	PUNCT
eurjchem-2084	38	12	/	/	SYM
eurjchem-2084	38	13	european	european	PROPN
eurjchem-2084	38	14	journal	journal	PROPN
eurjchem-2084	38	15	of	of	ADP
eurjchem-2084	38	16	chemistry	chemistry	NOUN
eurjchem-2084	38	17	12	12	NUM
eurjchem-2084	38	18	(	(	PUNCT
eurjchem-2084	38	19	2	2	NUM
eurjchem-2084	38	20	)	)	PUNCT
eurjchem-2084	38	21	(	(	PUNCT
eurjchem-2084	38	22	2021	2021	NUM
eurjchem-2084	38	23	)	)	PUNCT
eurjchem-2084	38	24	222	222	NUM
eurjchem-2084	38	25	-	-	SYM
eurjchem-2084	38	26	234	234	NUM
eurjchem-2084	38	27	223	223	NUM
eurjchem-2084	38	28	2021	2021	NUM
eurjchem-2084	38	29	–	–	PUNCT
eurjchem-2084	38	30	european	european	ADJ
eurjchem-2084	38	31	journal	journal	NOUN
eurjchem-2084	38	32	of	of	ADP
eurjchem-2084	38	33	chemistry	chemistry	NOUN
eurjchem-2084	38	34	–	–	PUNCT
eurjchem-2084	38	35	cc	cc	NOUN
eurjchem-2084	38	36	by	by	ADP
eurjchem-2084	38	37	nc	nc	PROPN
eurjchem-2084	38	38	–	–	PUNCT
eurjchem-2084	38	39	doi	doi	NOUN
eurjchem-2084	38	40	:	:	PUNCT
eurjchem-2084	38	41	10.5155	10.5155	NUM
eurjchem-2084	38	42	/	/	SYM
eurjchem-2084	38	43	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	38	44	-	-	PUNCT
eurjchem-2084	38	45	234.2084	234.2084	NUM
eurjchem-2084	38	46	figure	figure	NOUN
eurjchem-2084	38	47	1	1	NUM
eurjchem-2084	38	48	.	.	PUNCT
eurjchem-2084	38	49	classification	classification	NOUN
eurjchem-2084	38	50	of	of	ADP
eurjchem-2084	38	51	coronaviruses	coronaviruse	NOUN
eurjchem-2084	38	52	.	.	PUNCT
eurjchem-2084	39	1	3	3	X
eurjchem-2084	39	2	.	.	X
eurjchem-2084	39	3	methodology	methodology	NOUN
eurjchem-2084	39	4	a	a	DET
eurjchem-2084	39	5	systematic	systematic	ADJ
eurjchem-2084	39	6	literature	literature	NOUN
eurjchem-2084	39	7	search	search	NOUN
eurjchem-2084	39	8	was	be	AUX
eurjchem-2084	39	9	performed	perform	VERB
eurjchem-2084	39	10	using	use	VERB
eurjchem-2084	39	11	pubmed	pubmed	PROPN
eurjchem-2084	39	12	,	,	PUNCT
eurjchem-2084	39	13	google	google	NOUN
eurjchem-2084	39	14	scholar	scholar	NOUN
eurjchem-2084	39	15	,	,	PUNCT
eurjchem-2084	39	16	and	and	CCONJ
eurjchem-2084	39	17	web	web	NOUN
eurjchem-2084	39	18	of	of	ADP
eurjchem-2084	39	19	science	science	NOUN
eurjchem-2084	39	20	to	to	PART
eurjchem-2084	39	21	access	access	VERB
eurjchem-2084	39	22	the	the	DET
eurjchem-2084	39	23	articles	article	NOUN
eurjchem-2084	39	24	published	publish	VERB
eurjchem-2084	39	25	from	from	ADP
eurjchem-2084	39	26	december	december	PROPN
eurjchem-2084	39	27	2019	2019	NUM
eurjchem-2084	39	28	to	to	ADP
eurjchem-2084	39	29	december	december	PROPN
eurjchem-2084	39	30	2020	2020	NUM
eurjchem-2084	39	31	.	.	PUNCT
eurjchem-2084	40	1	the	the	DET
eurjchem-2084	40	2	search	search	NOUN
eurjchem-2084	40	3	terms	term	NOUN
eurjchem-2084	40	4	/	/	SYM
eurjchem-2084	40	5	key	key	ADJ
eurjchem-2084	40	6	words	word	NOUN
eurjchem-2084	40	7	included	include	VERB
eurjchem-2084	40	8	‘	'	PUNCT
eurjchem-2084	40	9	novel	novel	ADJ
eurjchem-2084	40	10	coronavirus	coronavirus	NOUN
eurjchem-2084	40	11	’	'	PUNCT
eurjchem-2084	40	12	,	,	PUNCT
eurjchem-2084	40	13	‘	'	PUNCT
eurjchem-2084	40	14	sarscov-2	sarscov-2	NUM
eurjchem-2084	40	15	’	'	PUNCT
eurjchem-2084	40	16	,	,	PUNCT
eurjchem-2084	40	17	‘	'	PUNCT
eurjchem-2084	40	18	covid-19	covid-19	PROPN
eurjchem-2084	40	19	’	'	PUNCT
eurjchem-2084	40	20	,	,	PUNCT
eurjchem-2084	40	21	‘	'	PUNCT
eurjchem-2084	40	22	pandemic-2019	pandemic-2019	X
eurjchem-2084	40	23	’	'	PUNCT
eurjchem-2084	40	24	,	,	PUNCT
eurjchem-2084	40	25	‘	'	PUNCT
eurjchem-2084	40	26	transmission	transmission	NOUN
eurjchem-2084	40	27	’	'	PUNCT
eurjchem-2084	40	28	,	,	PUNCT
eurjchem-2084	40	29	‘	'	PUNCT
eurjchem-2084	40	30	symptoms	symptom	NOUN
eurjchem-2084	40	31	’	'	PUNCT
eurjchem-2084	40	32	,	,	PUNCT
eurjchem-2084	40	33	‘	'	PUNCT
eurjchem-2084	40	34	treatment	treatment	NOUN
eurjchem-2084	40	35	’	'	PUNCT
eurjchem-2084	40	36	,	,	PUNCT
eurjchem-2084	40	37	‘	'	PUNCT
eurjchem-2084	40	38	vaccine	vaccine	NOUN
eurjchem-2084	40	39	development	development	NOUN
eurjchem-2084	40	40	’	'	PUNCT
eurjchem-2084	40	41	,	,	PUNCT
eurjchem-2084	40	42	and	and	CCONJ
eurjchem-2084	40	43	‘	'	PUNCT
eurjchem-2084	40	44	clinical	clinical	ADJ
eurjchem-2084	40	45	management	management	NOUN
eurjchem-2084	40	46	.	.	PUNCT
eurjchem-2084	41	1	the	the	DET
eurjchem-2084	41	2	appropriate	appropriate	ADJ
eurjchem-2084	41	3	literature	literature	NOUN
eurjchem-2084	41	4	reports	report	NOUN
eurjchem-2084	41	5	,	,	PUNCT
eurjchem-2084	41	6	260	260	NUM
eurjchem-2084	41	7	in	in	ADP
eurjchem-2084	41	8	numbers	number	NOUN
eurjchem-2084	41	9	,	,	PUNCT
eurjchem-2084	41	10	which	which	PRON
eurjchem-2084	41	11	included	include	VERB
eurjchem-2084	41	12	most	most	ADJ
eurjchem-2084	41	13	of	of	ADP
eurjchem-2084	41	14	the	the	DET
eurjchem-2084	41	15	searched	search	VERB
eurjchem-2084	41	16	keywords	keyword	NOUN
eurjchem-2084	41	17	,	,	PUNCT
eurjchem-2084	41	18	were	be	AUX
eurjchem-2084	41	19	imported	import	VERB
eurjchem-2084	41	20	to	to	PART
eurjchem-2084	41	21	endnote	endnote	VERB
eurjchem-2084	41	22	.	.	PUNCT
eurjchem-2084	42	1	the	the	DET
eurjchem-2084	42	2	exclusion	exclusion	NOUN
eurjchem-2084	42	3	and	and	CCONJ
eurjchem-2084	42	4	inclusion	inclusion	NOUN
eurjchem-2084	42	5	criteria	criterion	NOUN
eurjchem-2084	42	6	were	be	AUX
eurjchem-2084	42	7	based	base	VERB
eurjchem-2084	42	8	on	on	ADP
eurjchem-2084	42	9	prisma	prisma	PROPN
eurjchem-2084	42	10	guideline	guideline	NOUN
eurjchem-2084	42	11	(	(	PUNCT
eurjchem-2084	42	12	figure	figure	NOUN
eurjchem-2084	42	13	2	2	NUM
eurjchem-2084	42	14	)	)	PUNCT
eurjchem-2084	43	1	[	[	X
eurjchem-2084	43	2	8	8	NUM
eurjchem-2084	43	3	]	]	PUNCT
eurjchem-2084	43	4	.	.	PUNCT
eurjchem-2084	44	1	4	4	X
eurjchem-2084	44	2	.	.	NOUN
eurjchem-2084	44	3	results	result	VERB
eurjchem-2084	44	4	duplicate	duplicate	ADJ
eurjchem-2084	44	5	articles	article	NOUN
eurjchem-2084	44	6	,	,	PUNCT
eurjchem-2084	44	7	non	non	ADJ
eurjchem-2084	44	8	-	-	ADJ
eurjchem-2084	44	9	focused	focused	ADJ
eurjchem-2084	44	10	articles	article	NOUN
eurjchem-2084	44	11	,	,	PUNCT
eurjchem-2084	44	12	articles	article	NOUN
eurjchem-2084	44	13	showing	show	VERB
eurjchem-2084	44	14	only	only	ADV
eurjchem-2084	44	15	abstract	abstract	ADJ
eurjchem-2084	44	16	,	,	PUNCT
eurjchem-2084	44	17	and	and	CCONJ
eurjchem-2084	44	18	articles	article	NOUN
eurjchem-2084	44	19	published	publish	VERB
eurjchem-2084	44	20	in	in	ADP
eurjchem-2084	44	21	non	non	ADJ
eurjchem-2084	44	22	-	-	ADJ
eurjchem-2084	44	23	english	english	ADJ
eurjchem-2084	44	24	languages	language	NOUN
eurjchem-2084	44	25	were	be	AUX
eurjchem-2084	44	26	screened	screen	VERB
eurjchem-2084	44	27	out	out	ADP
eurjchem-2084	44	28	.	.	PUNCT
eurjchem-2084	45	1	finally	finally	ADV
eurjchem-2084	45	2	,	,	PUNCT
eurjchem-2084	45	3	30	30	NUM
eurjchem-2084	45	4	studies	study	NOUN
eurjchem-2084	45	5	were	be	AUX
eurjchem-2084	45	6	chosen	choose	VERB
eurjchem-2084	45	7	for	for	ADP
eurjchem-2084	45	8	quantitative	quantitative	ADJ
eurjchem-2084	45	9	analysis	analysis	NOUN
eurjchem-2084	45	10	.	.	PUNCT
eurjchem-2084	46	1	information	information	NOUN
eurjchem-2084	46	2	available	available	ADJ
eurjchem-2084	46	3	at	at	ADP
eurjchem-2084	46	4	the	the	DET
eurjchem-2084	46	5	who	who	PRON
eurjchem-2084	46	6	website	website	NOUN
eurjchem-2084	46	7	[	[	X
eurjchem-2084	46	8	7	7	NUM
eurjchem-2084	46	9	]	]	PUNCT
eurjchem-2084	46	10	and	and	CCONJ
eurjchem-2084	46	11	studies	study	NOUN
eurjchem-2084	46	12	which	which	PRON
eurjchem-2084	46	13	came	come	VERB
eurjchem-2084	46	14	up	up	ADP
eurjchem-2084	46	15	during	during	ADP
eurjchem-2084	46	16	the	the	DET
eurjchem-2084	46	17	reference	reference	NOUN
eurjchem-2084	46	18	cross	cross	NOUN
eurjchem-2084	46	19	check	check	NOUN
eurjchem-2084	46	20	were	be	AUX
eurjchem-2084	46	21	also	also	ADV
eurjchem-2084	46	22	used	use	VERB
eurjchem-2084	46	23	in	in	ADP
eurjchem-2084	46	24	this	this	DET
eurjchem-2084	46	25	study	study	NOUN
eurjchem-2084	46	26	.	.	PUNCT
eurjchem-2084	47	1	all	all	DET
eurjchem-2084	47	2	data	datum	NOUN
eurjchem-2084	47	3	were	be	AUX
eurjchem-2084	47	4	last	last	ADV
eurjchem-2084	47	5	updated	update	VERB
eurjchem-2084	47	6	on	on	ADP
eurjchem-2084	47	7	december	december	PROPN
eurjchem-2084	47	8	2020	2020	NUM
eurjchem-2084	47	9	before	before	ADP
eurjchem-2084	47	10	the	the	DET
eurjchem-2084	47	11	submission	submission	NOUN
eurjchem-2084	47	12	.	.	PUNCT
eurjchem-2084	48	1	5	5	X
eurjchem-2084	48	2	.	.	X
eurjchem-2084	48	3	the	the	DET
eurjchem-2084	48	4	2019	2019	NUM
eurjchem-2084	48	5	pandemic	pandemic	ADJ
eurjchem-2084	48	6	virus	virus	NOUN
eurjchem-2084	48	7	coronaviruses	coronaviruse	NOUN
eurjchem-2084	48	8	are	be	AUX
eurjchem-2084	48	9	single	single	ADJ
eurjchem-2084	48	10	-	-	PUNCT
eurjchem-2084	48	11	stranded	strand	VERB
eurjchem-2084	48	12	rna	rna	NOUN
eurjchem-2084	48	13	virus	virus	NOUN
eurjchem-2084	48	14	ranging	range	VERB
eurjchem-2084	48	15	from	from	ADP
eurjchem-2084	48	16	27	27	NUM
eurjchem-2084	48	17	-	-	SYM
eurjchem-2084	48	18	34	34	NUM
eurjchem-2084	48	19	kb	kb	PROPN
eurjchem-2084	48	20	in	in	ADP
eurjchem-2084	48	21	length	length	NOUN
eurjchem-2084	48	22	,	,	PUNCT
eurjchem-2084	48	23	80	80	NUM
eurjchem-2084	48	24	-	-	SYM
eurjchem-2084	48	25	120	120	NUM
eurjchem-2084	48	26	nm	nm	NOUN
eurjchem-2084	48	27	in	in	ADP
eurjchem-2084	48	28	diameter	diameter	NOUN
eurjchem-2084	48	29	,	,	PUNCT
eurjchem-2084	48	30	and	and	CCONJ
eurjchem-2084	48	31	encircled	encircle	VERB
eurjchem-2084	48	32	with	with	ADP
eurjchem-2084	48	33	a	a	DET
eurjchem-2084	48	34	nucleocapsid	nucleocapsid	NOUN
eurjchem-2084	48	35	.	.	PUNCT
eurjchem-2084	49	1	four	four	NUM
eurjchem-2084	49	2	known	know	VERB
eurjchem-2084	49	3	types	type	NOUN
eurjchem-2084	49	4	of	of	ADP
eurjchem-2084	49	5	coronaviruses	coronaviruse	NOUN
eurjchem-2084	49	6	are	be	AUX
eurjchem-2084	49	7	αcoronavirus	αcoronavirus	NOUN
eurjchem-2084	49	8	,	,	PUNCT
eurjchem-2084	49	9	β	β	NOUN
eurjchem-2084	49	10	-	-	NOUN
eurjchem-2084	49	11	coronavirus	coronavirus	NOUN
eurjchem-2084	49	12	,	,	PUNCT
eurjchem-2084	49	13	δ	δ	PROPN
eurjchem-2084	49	14	-	-	NOUN
eurjchem-2084	49	15	coronavirus	coronavirus	NOUN
eurjchem-2084	49	16	,	,	PUNCT
eurjchem-2084	49	17	and	and	CCONJ
eurjchem-2084	49	18	γ	γ	NOUN
eurjchem-2084	49	19	-	-	NOUN
eurjchem-2084	49	20	coronavirus	coronavirus	NOUN
eurjchem-2084	49	21	[	[	X
eurjchem-2084	49	22	9	9	NUM
eurjchem-2084	49	23	]	]	PUNCT
eurjchem-2084	49	24	.	.	PUNCT
eurjchem-2084	50	1	sars	sar	NOUN
eurjchem-2084	50	2	-	-	PUNCT
eurjchem-2084	50	3	cov-2	cov-2	NOUN
eurjchem-2084	50	4	,	,	PUNCT
eurjchem-2084	50	5	which	which	PRON
eurjchem-2084	50	6	is	be	AUX
eurjchem-2084	50	7	similar	similar	ADJ
eurjchem-2084	50	8	to	to	ADP
eurjchem-2084	50	9	sars	sar	NOUN
eurjchem-2084	50	10	-	-	PUNCT
eurjchem-2084	50	11	cov	cov	PROPN
eurjchem-2084	50	12	and	and	CCONJ
eurjchem-2084	50	13	merscov	merscov	PROPN
eurjchem-2084	50	14	,	,	PUNCT
eurjchem-2084	50	15	is	be	AUX
eurjchem-2084	50	16	also	also	ADV
eurjchem-2084	50	17	a	a	DET
eurjchem-2084	50	18	β	β	ADJ
eurjchem-2084	50	19	-	-	PUNCT
eurjchem-2084	50	20	coronavirus	coronavirus	NOUN
eurjchem-2084	50	21	comprising	comprising	NOUN
eurjchem-2084	50	22	of	of	ADP
eurjchem-2084	50	23	positive	positive	ADJ
eurjchem-2084	50	24	sense	sense	NOUN
eurjchem-2084	50	25	singlestranded	singlestrande	VERB
eurjchem-2084	50	26	rna	rna	NOUN
eurjchem-2084	50	27	of	of	ADP
eurjchem-2084	50	28	29.9	29.9	NUM
eurjchem-2084	50	29	kb	kb	PROPN
eurjchem-2084	50	30	length	length	NOUN
eurjchem-2084	51	1	[	[	X
eurjchem-2084	51	2	10	10	NUM
eurjchem-2084	51	3	]	]	PUNCT
eurjchem-2084	51	4	.	.	PUNCT
eurjchem-2084	52	1	the	the	DET
eurjchem-2084	52	2	genome	genome	NOUN
eurjchem-2084	52	3	sequence	sequence	NOUN
eurjchem-2084	52	4	similarity	similarity	NOUN
eurjchem-2084	52	5	of	of	ADP
eurjchem-2084	52	6	sars	sar	NOUN
eurjchem-2084	52	7	-	-	PUNCT
eurjchem-2084	52	8	cov-2	cov-2	PART
eurjchem-2084	52	9	and	and	CCONJ
eurjchem-2084	52	10	sars	sar	NOUN
eurjchem-2084	52	11	-	-	PUNCT
eurjchem-2084	52	12	cov	cov	PROPN
eurjchem-2084	52	13	is	be	AUX
eurjchem-2084	52	14	almost	almost	ADV
eurjchem-2084	52	15	79	79	NUM
eurjchem-2084	52	16	%	%	NOUN
eurjchem-2084	52	17	[	[	X
eurjchem-2084	52	18	11	11	NUM
eurjchem-2084	52	19	]	]	PUNCT
eurjchem-2084	52	20	.	.	PUNCT
eurjchem-2084	53	1	study	study	NOUN
eurjchem-2084	53	2	revealed	reveal	VERB
eurjchem-2084	53	3	that	that	SCONJ
eurjchem-2084	53	4	the	the	DET
eurjchem-2084	53	5	spike	spike	ADJ
eurjchem-2084	53	6	glycoprotein	glycoprotein	NOUN
eurjchem-2084	53	7	of	of	ADP
eurjchem-2084	53	8	the	the	DET
eurjchem-2084	53	9	sars	sar	NOUN
eurjchem-2084	53	10	-	-	PUNCT
eurjchem-2084	53	11	cov-2is	cov-2is	VERB
eurjchem-2084	53	12	the	the	DET
eurjchem-2084	53	13	combination	combination	NOUN
eurjchem-2084	53	14	of	of	ADP
eurjchem-2084	53	15	bat	bat	NOUN
eurjchem-2084	53	16	sars	sar	NOUN
eurjchem-2084	53	17	-	-	PUNCT
eurjchem-2084	53	18	cov	cov	PROPN
eurjchem-2084	53	19	and	and	CCONJ
eurjchem-2084	53	20	a	a	DET
eurjchem-2084	53	21	mysterious	mysterious	ADJ
eurjchem-2084	53	22	beta	beta	NOUN
eurjchem-2084	53	23	-	-	PUNCT
eurjchem-2084	53	24	cov	cov	NOUN
eurjchem-2084	53	25	,	,	PUNCT
eurjchem-2084	53	26	thus	thus	ADV
eurjchem-2084	53	27	suggesting	suggest	VERB
eurjchem-2084	53	28	zoonotic	zoonotic	ADJ
eurjchem-2084	53	29	origin	origin	NOUN
eurjchem-2084	53	30	of	of	ADP
eurjchem-2084	53	31	the	the	DET
eurjchem-2084	53	32	virus	virus	NOUN
eurjchem-2084	53	33	[	[	X
eurjchem-2084	53	34	12	12	NUM
eurjchem-2084	53	35	]	]	PUNCT
eurjchem-2084	53	36	.	.	PUNCT
eurjchem-2084	54	1	two	two	NUM
eurjchem-2084	54	2	species	specie	NOUN
eurjchem-2084	54	3	of	of	ADP
eurjchem-2084	54	4	snakes	snake	NOUN
eurjchem-2084	54	5	have	have	AUX
eurjchem-2084	54	6	been	be	AUX
eurjchem-2084	54	7	recognized	recognize	VERB
eurjchem-2084	54	8	as	as	ADP
eurjchem-2084	54	9	an	an	DET
eurjchem-2084	54	10	intermediate	intermediate	ADJ
eurjchem-2084	54	11	host	host	NOUN
eurjchem-2084	54	12	of	of	ADP
eurjchem-2084	54	13	sarscov-2	sarscov-2	PROPN
eurjchem-2084	54	14	;	;	PUNCT
eurjchem-2084	54	15	however	however	ADV
eurjchem-2084	54	16	,	,	PUNCT
eurjchem-2084	54	17	no	no	DET
eurjchem-2084	54	18	authoritative	authoritative	ADJ
eurjchem-2084	54	19	evidence	evidence	NOUN
eurjchem-2084	54	20	has	have	AUX
eurjchem-2084	54	21	emerged	emerge	VERB
eurjchem-2084	54	22	so	so	ADV
eurjchem-2084	54	23	far	far	ADV
eurjchem-2084	54	24	to	to	PART
eurjchem-2084	54	25	support	support	VERB
eurjchem-2084	54	26	this	this	DET
eurjchem-2084	54	27	view	view	NOUN
eurjchem-2084	54	28	[	[	X
eurjchem-2084	54	29	13	13	NUM
eurjchem-2084	54	30	]	]	PUNCT
eurjchem-2084	54	31	.	.	PUNCT
eurjchem-2084	55	1	like	like	ADP
eurjchem-2084	55	2	typical	typical	ADJ
eurjchem-2084	55	3	coronaviruses	coronaviruse	NOUN
eurjchem-2084	55	4	,	,	PUNCT
eurjchem-2084	55	5	the	the	DET
eurjchem-2084	55	6	structural	structural	ADJ
eurjchem-2084	55	7	entity	entity	NOUN
eurjchem-2084	55	8	of	of	ADP
eurjchem-2084	55	9	sarscov-2	sarscov-2	NUM
eurjchem-2084	55	10	also	also	ADV
eurjchem-2084	55	11	contains	contain	VERB
eurjchem-2084	55	12	spike	spike	ADJ
eurjchem-2084	55	13	glycoprotein	glycoprotein	NOUN
eurjchem-2084	55	14	(	(	PUNCT
eurjchem-2084	55	15	s	s	NOUN
eurjchem-2084	55	16	)	)	PUNCT
eurjchem-2084	55	17	,	,	PUNCT
eurjchem-2084	55	18	membrane	membrane	NOUN
eurjchem-2084	55	19	glycolproteins	glycolprotein	NOUN
eurjchem-2084	55	20	(	(	PUNCT
eurjchem-2084	55	21	m	m	NOUN
eurjchem-2084	55	22	)	)	PUNCT
eurjchem-2084	55	23	,	,	PUNCT
eurjchem-2084	55	24	envelope	envelope	NOUN
eurjchem-2084	55	25	glycoprotein	glycoprotein	NOUN
eurjchem-2084	55	26	(	(	PUNCT
eurjchem-2084	55	27	e	e	NOUN
eurjchem-2084	55	28	)	)	PUNCT
eurjchem-2084	55	29	,	,	PUNCT
eurjchem-2084	55	30	and	and	CCONJ
eurjchem-2084	55	31	nucleocapsid	nucleocapsid	ADJ
eurjchem-2084	55	32	protein	protein	NOUN
eurjchem-2084	55	33	(	(	PUNCT
eurjchem-2084	55	34	n	n	CCONJ
eurjchem-2084	55	35	)	)	PUNCT
eurjchem-2084	55	36	along	along	ADP
eurjchem-2084	55	37	with	with	ADP
eurjchem-2084	55	38	other	other	ADJ
eurjchem-2084	55	39	non	non	ADJ
eurjchem-2084	55	40	-	-	ADJ
eurjchem-2084	55	41	structural	structural	ADJ
eurjchem-2084	55	42	and	and	CCONJ
eurjchem-2084	55	43	accessory	accessory	ADJ
eurjchem-2084	55	44	proteins	protein	NOUN
eurjchem-2084	55	45	[	[	X
eurjchem-2084	55	46	10	10	NUM
eurjchem-2084	55	47	]	]	PUNCT
eurjchem-2084	55	48	.	.	PUNCT
eurjchem-2084	56	1	s	s	X
eurjchem-2084	56	2	,	,	PUNCT
eurjchem-2084	56	3	e	e	NOUN
eurjchem-2084	56	4	and	and	CCONJ
eurjchem-2084	56	5	m	m	PROPN
eurjchem-2084	56	6	proteins	protein	NOUN
eurjchem-2084	56	7	jointly	jointly	ADV
eurjchem-2084	56	8	form	form	VERB
eurjchem-2084	56	9	the	the	DET
eurjchem-2084	56	10	viral	viral	ADJ
eurjchem-2084	56	11	envelope	envelope	NOUN
eurjchem-2084	56	12	and	and	CCONJ
eurjchem-2084	56	13	the	the	DET
eurjchem-2084	56	14	n	n	DET
eurjchem-2084	56	15	protein	protein	NOUN
eurjchem-2084	56	16	contains	contain	VERB
eurjchem-2084	56	17	rna	rna	NOUN
eurjchem-2084	56	18	genome	genome	NOUN
eurjchem-2084	57	1	[	[	X
eurjchem-2084	57	2	14	14	NUM
eurjchem-2084	57	3	]	]	PUNCT
eurjchem-2084	57	4	.	.	PUNCT
eurjchem-2084	58	1	the	the	DET
eurjchem-2084	58	2	s	s	NOUN
eurjchem-2084	58	3	protein	protein	NOUN
eurjchem-2084	58	4	is	be	AUX
eurjchem-2084	58	5	a	a	DET
eurjchem-2084	58	6	transmembrane	transmembrane	ADJ
eurjchem-2084	58	7	protein	protein	NOUN
eurjchem-2084	58	8	,	,	PUNCT
eurjchem-2084	58	9	forms	form	VERB
eurjchem-2084	58	10	homotrimers	homotrimer	NOUN
eurjchem-2084	58	11	,	,	PUNCT
eurjchem-2084	58	12	and	and	CCONJ
eurjchem-2084	58	13	enables	enable	VERB
eurjchem-2084	58	14	viral	viral	ADJ
eurjchem-2084	58	15	binding	binding	NOUN
eurjchem-2084	58	16	and	and	CCONJ
eurjchem-2084	58	17	entry	entry	NOUN
eurjchem-2084	58	18	into	into	ADP
eurjchem-2084	58	19	the	the	DET
eurjchem-2084	58	20	host	host	NOUN
eurjchem-2084	58	21	cell	cell	NOUN
eurjchem-2084	58	22	.	.	PUNCT
eurjchem-2084	59	1	the	the	DET
eurjchem-2084	59	2	m	m	PROPN
eurjchem-2084	59	3	protein	protein	NOUN
eurjchem-2084	59	4	imparts	impart	VERB
eurjchem-2084	59	5	shape	shape	NOUN
eurjchem-2084	59	6	to	to	ADP
eurjchem-2084	59	7	the	the	DET
eurjchem-2084	59	8	virus	virus	NOUN
eurjchem-2084	59	9	and	and	CCONJ
eurjchem-2084	59	10	is	be	AUX
eurjchem-2084	59	11	responsible	responsible	ADJ
eurjchem-2084	59	12	for	for	ADP
eurjchem-2084	59	13	membrane	membrane	NOUN
eurjchem-2084	59	14	flexibility	flexibility	NOUN
eurjchem-2084	59	15	and	and	CCONJ
eurjchem-2084	59	16	curvature	curvature	NOUN
eurjchem-2084	59	17	.	.	PUNCT
eurjchem-2084	60	1	the	the	DET
eurjchem-2084	60	2	e	e	PROPN
eurjchem-2084	60	3	protein	protein	NOUN
eurjchem-2084	60	4	participates	participate	VERB
eurjchem-2084	60	5	in	in	ADP
eurjchem-2084	60	6	the	the	DET
eurjchem-2084	60	7	assembly	assembly	NOUN
eurjchem-2084	60	8	and	and	CCONJ
eurjchem-2084	60	9	release	release	NOUN
eurjchem-2084	60	10	of	of	ADP
eurjchem-2084	60	11	the	the	DET
eurjchem-2084	60	12	virus	virus	NOUN
eurjchem-2084	60	13	and	and	CCONJ
eurjchem-2084	60	14	assists	assist	NOUN
eurjchem-2084	60	15	in	in	ADP
eurjchem-2084	60	16	viral	viral	ADJ
eurjchem-2084	60	17	pathogenesis	pathogenesis	NOUN
eurjchem-2084	60	18	[	[	X
eurjchem-2084	60	19	15	15	NUM
eurjchem-2084	60	20	]	]	PUNCT
eurjchem-2084	60	21	.	.	PUNCT
eurjchem-2084	61	1	nonstructural	nonstructural	ADJ
eurjchem-2084	61	2	proteins	protein	NOUN
eurjchem-2084	61	3	are	be	AUX
eurjchem-2084	61	4	involved	involve	VERB
eurjchem-2084	61	5	in	in	ADP
eurjchem-2084	61	6	viral	viral	ADJ
eurjchem-2084	61	7	replication	replication	NOUN
eurjchem-2084	61	8	and	and	CCONJ
eurjchem-2084	61	9	host	host	NOUN
eurjchem-2084	61	10	cell	cell	NOUN
eurjchem-2084	61	11	infection	infection	NOUN
eurjchem-2084	61	12	by	by	ADP
eurjchem-2084	61	13	attenuating	attenuate	VERB
eurjchem-2084	61	14	the	the	DET
eurjchem-2084	61	15	host	host	NOUN
eurjchem-2084	61	16	defense	defense	NOUN
eurjchem-2084	61	17	mechanism	mechanism	NOUN
eurjchem-2084	61	18	[	[	X
eurjchem-2084	61	19	16	16	NUM
eurjchem-2084	61	20	]	]	PUNCT
eurjchem-2084	61	21	.	.	PUNCT
eurjchem-2084	62	1	5.1	5.1	NUM
eurjchem-2084	62	2	.	.	PUNCT
eurjchem-2084	63	1	genomic	genomic	ADJ
eurjchem-2084	63	2	divergence	divergence	NOUN
eurjchem-2084	63	3	of	of	ADP
eurjchem-2084	63	4	viruses	virus	NOUN
eurjchem-2084	63	5	(	(	PUNCT
eurjchem-2084	63	6	difference	difference	NOUN
eurjchem-2084	63	7	in	in	ADP
eurjchem-2084	63	8	existing	exist	VERB
eurjchem-2084	63	9	and	and	CCONJ
eurjchem-2084	63	10	original	original	ADJ
eurjchem-2084	63	11	strains	strain	NOUN
eurjchem-2084	63	12	)	)	PUNCT
eurjchem-2084	63	13	sars	sar	NOUN
eurjchem-2084	63	14	-	-	PUNCT
eurjchem-2084	63	15	cov-2	cov-2	NOUN
eurjchem-2084	63	16	genome	genome	NOUN
eurjchem-2084	63	17	possesses	possess	VERB
eurjchem-2084	63	18	14	14	NUM
eurjchem-2084	63	19	different	different	ADJ
eurjchem-2084	63	20	orf	orf	PROPN
eurjchem-2084	63	21	(	(	PUNCT
eurjchem-2084	63	22	open	open	ADJ
eurjchem-2084	63	23	reading	reading	NOUN
eurjchem-2084	63	24	frame	frame	NOUN
eurjchem-2084	63	25	)	)	PUNCT
eurjchem-2084	63	26	encoding	encode	VERB
eurjchem-2084	63	27	27	27	NUM
eurjchem-2084	63	28	proteins	protein	NOUN
eurjchem-2084	63	29	(	(	PUNCT
eurjchem-2084	63	30	figure	figure	NOUN
eurjchem-2084	63	31	3	3	NUM
eurjchem-2084	63	32	)	)	PUNCT
eurjchem-2084	64	1	[	[	X
eurjchem-2084	64	2	11	11	NUM
eurjchem-2084	64	3	]	]	PUNCT
eurjchem-2084	64	4	.	.	PUNCT
eurjchem-2084	65	1	first	first	ADV
eurjchem-2084	65	2	,	,	PUNCT
eurjchem-2084	65	3	orf	orf	PROPN
eurjchem-2084	65	4	at	at	ADP
eurjchem-2084	65	5	the	the	DET
eurjchem-2084	65	6	5	5	NUM
eurjchem-2084	65	7	’	'	PUNCT
eurjchem-2084	65	8	terminus	terminus	NOUN
eurjchem-2084	65	9	covers	cover	VERB
eurjchem-2084	65	10	two	two	NUM
eurjchem-2084	65	11	-	-	PUNCT
eurjchem-2084	65	12	thirds	third	NOUN
eurjchem-2084	65	13	of	of	ADP
eurjchem-2084	65	14	the	the	DET
eurjchem-2084	65	15	whole	whole	ADJ
eurjchem-2084	65	16	genome	genome	NOUN
eurjchem-2084	65	17	and	and	CCONJ
eurjchem-2084	65	18	codes	code	NOUN
eurjchem-2084	65	19	for	for	ADP
eurjchem-2084	65	20	two	two	NUM
eurjchem-2084	65	21	polypeptides	polypeptide	NOUN
eurjchem-2084	65	22	,	,	PUNCT
eurjchem-2084	65	23	i.e.	i.e.	X
eurjchem-2084	65	24	,	,	PUNCT
eurjchem-2084	65	25	pp1ab	pp1ab	NOUN
eurjchem-2084	65	26	and	and	CCONJ
eurjchem-2084	65	27	pp1a	pp1a	PROPN
eurjchem-2084	65	28	,	,	PUNCT
eurjchem-2084	65	29	which	which	PRON
eurjchem-2084	65	30	collectively	collectively	ADV
eurjchem-2084	65	31	translate	translate	VERB
eurjchem-2084	65	32	15	15	NUM
eurjchem-2084	65	33	non	non	ADJ
eurjchem-2084	65	34	-	-	ADJ
eurjchem-2084	65	35	structural	structural	ADJ
eurjchem-2084	65	36	proteins	protein	NOUN
eurjchem-2084	65	37	.	.	PUNCT
eurjchem-2084	66	1	different	different	ADJ
eurjchem-2084	66	2	orfs	orf	NOUN
eurjchem-2084	66	3	at	at	ADP
eurjchem-2084	66	4	3	3	NUM
eurjchem-2084	66	5	’	'	PUNCT
eurjchem-2084	66	6	terminus	terminus	NOUN
eurjchem-2084	66	7	code	code	NOUN
eurjchem-2084	66	8	for	for	ADP
eurjchem-2084	66	9	the	the	DET
eurjchem-2084	66	10	four	four	NUM
eurjchem-2084	66	11	structural	structural	ADJ
eurjchem-2084	66	12	proteins	protein	NOUN
eurjchem-2084	66	13	(	(	PUNCT
eurjchem-2084	66	14	s	s	X
eurjchem-2084	66	15	,	,	PUNCT
eurjchem-2084	66	16	m	m	PROPN
eurjchem-2084	66	17	,	,	PUNCT
eurjchem-2084	66	18	e	e	NOUN
eurjchem-2084	66	19	,	,	PUNCT
eurjchem-2084	66	20	and	and	CCONJ
eurjchem-2084	66	21	n	n	CCONJ
eurjchem-2084	66	22	)	)	PUNCT
eurjchem-2084	66	23	and	and	CCONJ
eurjchem-2084	66	24	eight	eight	NUM
eurjchem-2084	66	25	accessory	accessory	ADJ
eurjchem-2084	66	26	proteins	protein	NOUN
eurjchem-2084	66	27	(	(	PUNCT
eurjchem-2084	66	28	3a	3a	NUM
eurjchem-2084	66	29	,	,	PUNCT
eurjchem-2084	66	30	3b	3b	NUM
eurjchem-2084	66	31	,	,	PUNCT
eurjchem-2084	66	32	p6	p6	PROPN
eurjchem-2084	66	33	,	,	PUNCT
eurjchem-2084	66	34	7a	7a	NUM
eurjchem-2084	66	35	,	,	PUNCT
eurjchem-2084	66	36	7b	7b	NUM
eurjchem-2084	66	37	,	,	PUNCT
eurjchem-2084	66	38	8b	8b	NUM
eurjchem-2084	66	39	,	,	PUNCT
eurjchem-2084	66	40	9b	9b	NOUN
eurjchem-2084	66	41	and	and	CCONJ
eurjchem-2084	66	42	orf14	orf14	ADJ
eurjchem-2084	66	43	)	)	PUNCT
eurjchem-2084	67	1	[	[	X
eurjchem-2084	67	2	11	11	NUM
eurjchem-2084	67	3	]	]	PUNCT
eurjchem-2084	67	4	.	.	PUNCT
eurjchem-2084	68	1	a	a	DET
eurjchem-2084	68	2	single	single	ADJ
eurjchem-2084	68	3	mutation	mutation	NOUN
eurjchem-2084	68	4	(	(	PUNCT
eurjchem-2084	68	5	n501	n501	PROPN
eurjchem-2084	68	6	t	t	NOUN
eurjchem-2084	68	7	)	)	PUNCT
eurjchem-2084	68	8	in	in	ADP
eurjchem-2084	68	9	spike	spike	ADJ
eurjchem-2084	68	10	protein	protein	NOUN
eurjchem-2084	68	11	of	of	ADP
eurjchem-2084	68	12	sars	sar	NOUN
eurjchem-2084	68	13	-	-	PUNCT
eurjchem-2084	68	14	cov-2	cov-2	PART
eurjchem-2084	68	15	significantly	significantly	ADV
eurjchem-2084	68	16	boosted	boost	VERB
eurjchem-2084	68	17	its	its	PRON
eurjchem-2084	68	18	binding	bind	VERB
eurjchem-2084	68	19	affinity	affinity	NOUN
eurjchem-2084	68	20	with	with	ADP
eurjchem-2084	68	21	host	host	NOUN
eurjchem-2084	68	22	cell	cell	NOUN
eurjchem-2084	68	23	angiotensin	angiotensin	NOUN
eurjchem-2084	68	24	-	-	PUNCT
eurjchem-2084	68	25	converting	convert	VERB
eurjchem-2084	68	26	enzyme	enzyme	NOUN
eurjchem-2084	68	27	2	2	NUM
eurjchem-2084	68	28	(	(	PUNCT
eurjchem-2084	68	29	ace-2	ace-2	NUM
eurjchem-2084	68	30	)	)	PUNCT
eurjchem-2084	68	31	as	as	SCONJ
eurjchem-2084	68	32	compared	compare	VERB
eurjchem-2084	68	33	with	with	ADP
eurjchem-2084	68	34	sars	sar	NOUN
eurjchem-2084	68	35	-	-	PUNCT
eurjchem-2084	68	36	cov	cov	NOUN
eurjchem-2084	68	37	indicating	indicate	VERB
eurjchem-2084	68	38	that	that	SCONJ
eurjchem-2084	68	39	the	the	DET
eurjchem-2084	68	40	genomic	genomic	ADJ
eurjchem-2084	68	41	variation	variation	NOUN
eurjchem-2084	68	42	affected	affect	VERB
eurjchem-2084	68	43	the	the	DET
eurjchem-2084	68	44	functionality	functionality	NOUN
eurjchem-2084	68	45	of	of	ADP
eurjchem-2084	68	46	the	the	DET
eurjchem-2084	68	47	virus	virus	NOUN
eurjchem-2084	68	48	[	[	X
eurjchem-2084	68	49	17	17	NUM
eurjchem-2084	68	50	]	]	PUNCT
eurjchem-2084	68	51	.	.	PUNCT
eurjchem-2084	69	1	a	a	DET
eurjchem-2084	69	2	genomic	genomic	ADJ
eurjchem-2084	69	3	divergence	divergence	NOUN
eurjchem-2084	69	4	study	study	NOUN
eurjchem-2084	69	5	published	publish	VERB
eurjchem-2084	69	6	in	in	ADP
eurjchem-2084	69	7	march	march	PROPN
eurjchem-2084	69	8	2020	2020	NUM
eurjchem-2084	69	9	reported	report	VERB
eurjchem-2084	69	10	a	a	DET
eurjchem-2084	69	11	few	few	ADJ
eurjchem-2084	69	12	notable	notable	ADJ
eurjchem-2084	69	13	variations	variation	NOUN
eurjchem-2084	69	14	in	in	ADP
eurjchem-2084	69	15	the	the	DET
eurjchem-2084	69	16	proteins	protein	NOUN
eurjchem-2084	69	17	of	of	ADP
eurjchem-2084	69	18	sars	sar	NOUN
eurjchem-2084	69	19	-	-	PUNCT
eurjchem-2084	69	20	cov	cov	PROPN
eurjchem-2084	69	21	and	and	CCONJ
eurjchem-2084	69	22	sars	sar	NOUN
eurjchem-2084	69	23	-	-	PUNCT
eurjchem-2084	69	24	cov-2	cov-2	NOUN
eurjchem-2084	69	25	,	,	PUNCT
eurjchem-2084	69	26	including	include	VERB
eurjchem-2084	69	27	the	the	DET
eurjchem-2084	69	28	absence	absence	NOUN
eurjchem-2084	69	29	of	of	ADP
eurjchem-2084	69	30	8a	8a	NUM
eurjchem-2084	69	31	protein	protein	NOUN
eurjchem-2084	69	32	and	and	CCONJ
eurjchem-2084	69	33	fluctuation	fluctuation	NOUN
eurjchem-2084	69	34	in	in	ADP
eurjchem-2084	69	35	the	the	DET
eurjchem-2084	69	36	number	number	NOUN
eurjchem-2084	69	37	of	of	ADP
eurjchem-2084	69	38	amino	amino	ADJ
eurjchem-2084	69	39	acids	acid	NOUN
eurjchem-2084	69	40	in	in	ADP
eurjchem-2084	69	41	8b	8b	NUM
eurjchem-2084	69	42	and	and	CCONJ
eurjchem-2084	69	43	3c	3c	NUM
eurjchem-2084	69	44	proteins	protein	NOUN
eurjchem-2084	69	45	in	in	ADP
eurjchem-2084	69	46	sars	sar	NOUN
eurjchem-2084	69	47	-	-	PUNCT
eurjchem-2084	69	48	cov-2	cov-2	NOUN
eurjchem-2084	69	49	.	.	PUNCT
eurjchem-2084	70	1	but	but	CCONJ
eurjchem-2084	70	2	,	,	PUNCT
eurjchem-2084	70	3	the	the	DET
eurjchem-2084	70	4	effect	effect	NOUN
eurjchem-2084	70	5	of	of	ADP
eurjchem-2084	70	6	these	these	DET
eurjchem-2084	70	7	genomic	genomic	ADJ
eurjchem-2084	70	8	differences	difference	NOUN
eurjchem-2084	70	9	in	in	ADP
eurjchem-2084	70	10	viral	viral	ADJ
eurjchem-2084	70	11	behavior	behavior	NOUN
eurjchem-2084	70	12	and	and	CCONJ
eurjchem-2084	70	13	function	function	NOUN
eurjchem-2084	70	14	is	be	AUX
eurjchem-2084	70	15	not	not	PART
eurjchem-2084	70	16	explained	explain	VERB
eurjchem-2084	70	17	[	[	PUNCT
eurjchem-2084	70	18	11	11	NUM
eurjchem-2084	70	19	]	]	PUNCT
eurjchem-2084	70	20	.	.	PUNCT
eurjchem-2084	71	1	in	in	ADP
eurjchem-2084	71	2	early	early	ADJ
eurjchem-2084	71	3	2020	2020	NUM
eurjchem-2084	71	4	,	,	PUNCT
eurjchem-2084	71	5	researchers	researcher	NOUN
eurjchem-2084	71	6	identified	identify	VERB
eurjchem-2084	71	7	two	two	NUM
eurjchem-2084	71	8	deletions	deletion	NOUN
eurjchem-2084	71	9	orf7b	orf7b	X
eurjchem-2084	71	10	and	and	CCONJ
eurjchem-2084	71	11	orf8	orf8	NOUN
eurjchem-2084	71	12	in	in	ADP
eurjchem-2084	71	13	sars	sar	NOUN
eurjchem-2084	71	14	-	-	PUNCT
eurjchem-2084	71	15	cov-2	cov-2	NOUN
eurjchem-2084	71	16	genome	genome	NOUN
eurjchem-2084	71	17	and	and	CCONJ
eurjchem-2084	71	18	it	it	PRON
eurjchem-2084	71	19	was	be	AUX
eurjchem-2084	71	20	noted	note	VERB
eurjchem-2084	71	21	that	that	SCONJ
eurjchem-2084	71	22	people	people	NOUN
eurjchem-2084	71	23	infected	infect	VERB
eurjchem-2084	71	24	with	with	ADP
eurjchem-2084	71	25	these	these	DET
eurjchem-2084	71	26	viruses	virus	NOUN
eurjchem-2084	71	27	did	do	AUX
eurjchem-2084	71	28	not	not	PART
eurjchem-2084	71	29	need	need	VERB
eurjchem-2084	71	30	supplemental	supplemental	ADJ
eurjchem-2084	71	31	oxygen	oxygen	NOUN
eurjchem-2084	71	32	whereas	whereas	SCONJ
eurjchem-2084	71	33	,	,	PUNCT
eurjchem-2084	71	34	people	people	NOUN
eurjchem-2084	71	35	infected	infect	VERB
eurjchem-2084	71	36	with	with	ADP
eurjchem-2084	71	37	normal	normal	ADJ
eurjchem-2084	71	38	viruses	virus	NOUN
eurjchem-2084	71	39	needed	need	VERB
eurjchem-2084	71	40	supplemental	supplemental	ADJ
eurjchem-2084	71	41	oxygen	oxygen	NOUN
eurjchem-2084	71	42	,	,	PUNCT
eurjchem-2084	71	43	suggesting	suggest	VERB
eurjchem-2084	71	44	that	that	SCONJ
eurjchem-2084	71	45	this	this	PRON
eurjchem-2084	71	46	might	might	AUX
eurjchem-2084	71	47	be	be	AUX
eurjchem-2084	71	48	an	an	DET
eurjchem-2084	71	49	important	important	ADJ
eurjchem-2084	71	50	adaption	adaption	NOUN
eurjchem-2084	71	51	to	to	ADP
eurjchem-2084	71	52	infecting	infect	VERB
eurjchem-2084	71	53	humans	human	NOUN
eurjchem-2084	71	54	[	[	X
eurjchem-2084	71	55	18	18	NUM
eurjchem-2084	71	56	]	]	PUNCT
eurjchem-2084	71	57	.	.	PUNCT
eurjchem-2084	72	1	the	the	DET
eurjchem-2084	72	2	virus	virus	NOUN
eurjchem-2084	72	3	undergoes	undergo	VERB
eurjchem-2084	72	4	mutation	mutation	NOUN
eurjchem-2084	72	5	during	during	ADP
eurjchem-2084	72	6	its	its	PRON
eurjchem-2084	72	7	overseas	overseas	ADJ
eurjchem-2084	72	8	journey	journey	NOUN
eurjchem-2084	72	9	and	and	CCONJ
eurjchem-2084	72	10	at	at	ADP
eurjchem-2084	72	11	present	present	ADJ
eurjchem-2084	72	12	,	,	PUNCT
eurjchem-2084	72	13	there	there	PRON
eurjchem-2084	72	14	are	be	VERB
eurjchem-2084	72	15	at	at	ADV
eurjchem-2084	72	16	least	least	ADJ
eurjchem-2084	72	17	six	six	NUM
eurjchem-2084	72	18	available	available	ADJ
eurjchem-2084	72	19	strains	strain	NOUN
eurjchem-2084	72	20	of	of	ADP
eurjchem-2084	72	21	the	the	DET
eurjchem-2084	72	22	sars	sar	NOUN
eurjchem-2084	72	23	-	-	PUNCT
eurjchem-2084	72	24	cov-2[19	cov-2[19	NOUN
eurjchem-2084	72	25	]	]	X
eurjchem-2084	72	26	.	.	PUNCT
eurjchem-2084	73	1	the	the	DET
eurjchem-2084	73	2	original	original	ADJ
eurjchem-2084	73	3	l	l	NOUN
eurjchem-2084	73	4	strain	strain	NOUN
eurjchem-2084	73	5	appeared	appear	VERB
eurjchem-2084	73	6	in	in	ADP
eurjchem-2084	73	7	wuhan	wuhan	PROPN
eurjchem-2084	73	8	in	in	ADP
eurjchem-2084	73	9	december	december	PROPN
eurjchem-2084	73	10	2019	2019	NUM
eurjchem-2084	73	11	;	;	PUNCT
eurjchem-2084	73	12	its	its	PRON
eurjchem-2084	73	13	first	first	ADJ
eurjchem-2084	73	14	mutated	mutate	VERB
eurjchem-2084	73	15	s	s	PART
eurjchem-2084	73	16	strain	strain	NOUN
eurjchem-2084	73	17	appeared	appear	VERB
eurjchem-2084	73	18	at	at	ADP
eurjchem-2084	73	19	the	the	DET
eurjchem-2084	73	20	beginning	beginning	NOUN
eurjchem-2084	73	21	of	of	ADP
eurjchem-2084	73	22	2020	2020	NUM
eurjchem-2084	73	23	and	and	CCONJ
eurjchem-2084	73	24	was	be	AUX
eurjchem-2084	73	25	followed	follow	VERB
eurjchem-2084	73	26	by	by	ADP
eurjchem-2084	73	27	v	v	NOUN
eurjchem-2084	73	28	and	and	CCONJ
eurjchem-2084	73	29	g	g	NOUN
eurjchem-2084	73	30	strains	strain	NOUN
eurjchem-2084	73	31	by	by	ADP
eurjchem-2084	73	32	mid	mid	NOUN
eurjchem-2084	73	33	-	-	PROPN
eurjchem-2084	73	34	january	january	ADJ
eurjchem-2084	73	35	2020	2020	NUM
eurjchem-2084	73	36	.	.	PUNCT
eurjchem-2084	74	1	224	224	NUM
eurjchem-2084	74	2	firdaus	firdaus	PROPN
eurjchem-2084	74	3	et	et	PROPN
eurjchem-2084	74	4	al	al	PROPN
eurjchem-2084	74	5	.	.	PUNCT
eurjchem-2084	74	6	/	/	SYM
eurjchem-2084	74	7	european	european	PROPN
eurjchem-2084	74	8	journal	journal	PROPN
eurjchem-2084	74	9	of	of	ADP
eurjchem-2084	74	10	chemistry	chemistry	NOUN
eurjchem-2084	74	11	12	12	NUM
eurjchem-2084	74	12	(	(	PUNCT
eurjchem-2084	74	13	2	2	NUM
eurjchem-2084	74	14	)	)	PUNCT
eurjchem-2084	74	15	(	(	PUNCT
eurjchem-2084	74	16	2021	2021	NUM
eurjchem-2084	74	17	)	)	PUNCT
eurjchem-2084	74	18	222	222	NUM
eurjchem-2084	74	19	-	-	SYM
eurjchem-2084	74	20	234	234	NUM
eurjchem-2084	74	21	2021	2021	NUM
eurjchem-2084	74	22	–	–	PUNCT
eurjchem-2084	74	23	european	european	ADJ
eurjchem-2084	74	24	journal	journal	NOUN
eurjchem-2084	74	25	of	of	ADP
eurjchem-2084	74	26	chemistry	chemistry	NOUN
eurjchem-2084	74	27	–	–	PUNCT
eurjchem-2084	74	28	cc	cc	NOUN
eurjchem-2084	74	29	by	by	ADP
eurjchem-2084	74	30	nc	nc	PROPN
eurjchem-2084	74	31	–	–	PUNCT
eurjchem-2084	74	32	doi	doi	NOUN
eurjchem-2084	74	33	:	:	PUNCT
eurjchem-2084	74	34	10.5155	10.5155	NUM
eurjchem-2084	74	35	/	/	SYM
eurjchem-2084	74	36	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	74	37	-	-	PUNCT
eurjchem-2084	74	38	234.2084	234.2084	NUM
eurjchem-2084	74	39	figure	figure	NOUN
eurjchem-2084	74	40	2	2	NUM
eurjchem-2084	74	41	.	.	PUNCT
eurjchem-2084	74	42	prisma	prisma	PROPN
eurjchem-2084	74	43	flow	flow	PROPN
eurjchem-2084	74	44	chart	chart	NOUN
eurjchem-2084	74	45	of	of	ADP
eurjchem-2084	74	46	literature	literature	NOUN
eurjchem-2084	74	47	survey	survey	NOUN
eurjchem-2084	74	48	and	and	CCONJ
eurjchem-2084	74	49	screening	screening	NOUN
eurjchem-2084	74	50	process	process	NOUN
eurjchem-2084	74	51	.	.	PUNCT
eurjchem-2084	75	1	figure	figure	NOUN
eurjchem-2084	75	2	3	3	NUM
eurjchem-2084	75	3	.	.	PUNCT
eurjchem-2084	76	1	genomic	genomic	ADJ
eurjchem-2084	76	2	structure	structure	NOUN
eurjchem-2084	76	3	of	of	ADP
eurjchem-2084	76	4	human	human	ADJ
eurjchem-2084	76	5	coronaviruses	coronaviruse	NOUN
eurjchem-2084	76	6	;	;	PUNCT
eurjchem-2084	76	7	sars	sar	NOUN
eurjchem-2084	76	8	-	-	PUNCT
eurjchem-2084	76	9	cov	cov	PROPN
eurjchem-2084	76	10	,	,	PUNCT
eurjchem-2084	76	11	mers	mer	NOUN
eurjchem-2084	76	12	-	-	PUNCT
eurjchem-2084	76	13	cov	cov	NOUN
eurjchem-2084	76	14	and	and	CCONJ
eurjchem-2084	76	15	sars	sar	NOUN
eurjchem-2084	76	16	-	-	PUNCT
eurjchem-2084	76	17	cov-2	cov-2	NOUN
eurjchem-2084	76	18	.	.	PUNCT
eurjchem-2084	77	1	strain	strain	PROPN
eurjchem-2084	77	2	g	g	PROPN
eurjchem-2084	77	3	was	be	AUX
eurjchem-2084	77	4	further	far	ADV
eurjchem-2084	77	5	mutated	mutate	VERB
eurjchem-2084	77	6	to	to	ADP
eurjchem-2084	77	7	strains	strain	NOUN
eurjchem-2084	77	8	gr	gr	NOUN
eurjchem-2084	77	9	and	and	CCONJ
eurjchem-2084	77	10	gh	gh	PROPN
eurjchem-2084	77	11	at	at	ADP
eurjchem-2084	77	12	the	the	DET
eurjchem-2084	77	13	end	end	NOUN
eurjchem-2084	77	14	of	of	ADP
eurjchem-2084	77	15	february	february	PROPN
eurjchem-2084	77	16	2020	2020	NUM
eurjchem-2084	77	17	.	.	PUNCT
eurjchem-2084	78	1	mercatelli	mercatelli	PROPN
eurjchem-2084	78	2	et	et	PROPN
eurjchem-2084	78	3	al	al	PROPN
eurjchem-2084	78	4	.	.	PROPN
eurjchem-2084	78	5	reported	report	VERB
eurjchem-2084	78	6	that	that	SCONJ
eurjchem-2084	78	7	strain	strain	NOUN
eurjchem-2084	78	8	g	g	NOUN
eurjchem-2084	78	9	and	and	CCONJ
eurjchem-2084	78	10	its	its	PRON
eurjchem-2084	78	11	related	relate	VERB
eurjchem-2084	78	12	strains	strain	NOUN
eurjchem-2084	78	13	gr	gr	NOUN
eurjchem-2084	78	14	and	and	CCONJ
eurjchem-2084	78	15	gh	gh	PROPN
eurjchem-2084	78	16	are	be	AUX
eurjchem-2084	78	17	the	the	DET
eurjchem-2084	78	18	most	most	ADV
eurjchem-2084	78	19	dominant	dominant	ADJ
eurjchem-2084	78	20	,	,	PUNCT
eurjchem-2084	78	21	representing	represent	VERB
eurjchem-2084	78	22	74	74	NUM
eurjchem-2084	78	23	%	%	NOUN
eurjchem-2084	78	24	of	of	ADP
eurjchem-2084	78	25	all	all	DET
eurjchem-2084	78	26	gene	gene	NOUN
eurjchem-2084	78	27	sequences	sequence	NOUN
eurjchem-2084	78	28	analyzed	analyze	VERB
eurjchem-2084	78	29	till	till	SCONJ
eurjchem-2084	78	30	date	date	NOUN
eurjchem-2084	78	31	[	[	X
eurjchem-2084	78	32	19	19	NUM
eurjchem-2084	78	33	]	]	PUNCT
eurjchem-2084	78	34	.	.	PUNCT
eurjchem-2084	79	1	fortunately	fortunately	ADV
eurjchem-2084	79	2	,	,	PUNCT
eurjchem-2084	79	3	the	the	DET
eurjchem-2084	79	4	virus	virus	NOUN
eurjchem-2084	79	5	shows	show	VERB
eurjchem-2084	79	6	limited	limited	ADJ
eurjchem-2084	79	7	diversity	diversity	NOUN
eurjchem-2084	79	8	in	in	ADP
eurjchem-2084	79	9	spite	spite	NOUN
eurjchem-2084	79	10	of	of	ADP
eurjchem-2084	79	11	its	its	PRON
eurjchem-2084	79	12	mutations	mutation	NOUN
eurjchem-2084	79	13	.	.	PUNCT
eurjchem-2084	80	1	two	two	NUM
eurjchem-2084	80	2	widespread	widespread	ADJ
eurjchem-2084	80	3	mutations	mutation	NOUN
eurjchem-2084	80	4	,	,	PUNCT
eurjchem-2084	80	5	p4715l	p4715l	PROPN
eurjchem-2084	80	6	in	in	ADP
eurjchem-2084	80	7	orf1ab	orf1ab	PROPN
eurjchem-2084	80	8	and	and	CCONJ
eurjchem-2084	80	9	d614	d614	PROPN
eurjchem-2084	80	10	g	g	PROPN
eurjchem-2084	80	11	in	in	ADP
eurjchem-2084	80	12	spike	spike	NOUN
eurjchem-2084	80	13	,	,	PUNCT
eurjchem-2084	80	14	have	have	AUX
eurjchem-2084	80	15	already	already	ADV
eurjchem-2084	80	16	become	become	VERB
eurjchem-2084	80	17	consensus	consensus	NOUN
eurjchem-2084	80	18	[	[	X
eurjchem-2084	80	19	20	20	NUM
eurjchem-2084	80	20	]	]	PUNCT
eurjchem-2084	80	21	.	.	PUNCT
eurjchem-2084	81	1	how	how	SCONJ
eurjchem-2084	81	2	this	this	DET
eurjchem-2084	81	3	widespread	widespread	ADJ
eurjchem-2084	81	4	d614	d614	PROPN
eurjchem-2084	81	5	g	g	NOUN
eurjchem-2084	81	6	mutation	mutation	NOUN
eurjchem-2084	81	7	affects	affect	VERB
eurjchem-2084	81	8	the	the	DET
eurjchem-2084	81	9	virus	virus	NOUN
eurjchem-2084	81	10	or	or	CCONJ
eurjchem-2084	81	11	human	human	NOUN
eurjchem-2084	81	12	is	be	AUX
eurjchem-2084	81	13	not	not	PART
eurjchem-2084	81	14	clear	clear	ADJ
eurjchem-2084	81	15	yet	yet	ADV
eurjchem-2084	81	16	.	.	PUNCT
eurjchem-2084	82	1	d614	d614	NUM
eurjchem-2084	82	2	g	g	NOUN
eurjchem-2084	82	3	mutation	mutation	NOUN
eurjchem-2084	82	4	is	be	AUX
eurjchem-2084	82	5	in	in	ADP
eurjchem-2084	82	6	the	the	DET
eurjchem-2084	82	7	interface	interface	NOUN
eurjchem-2084	82	8	between	between	ADP
eurjchem-2084	82	9	the	the	DET
eurjchem-2084	82	10	individual	individual	ADJ
eurjchem-2084	82	11	spike	spike	ADJ
eurjchem-2084	82	12	protomers	protomer	NOUN
eurjchem-2084	82	13	and	and	CCONJ
eurjchem-2084	82	14	is	be	AUX
eurjchem-2084	82	15	therefore	therefore	ADV
eurjchem-2084	82	16	unlikely	unlikely	ADJ
eurjchem-2084	82	17	to	to	PART
eurjchem-2084	82	18	have	have	VERB
eurjchem-2084	82	19	a	a	DET
eurjchem-2084	82	20	major	major	ADJ
eurjchem-2084	82	21	impact	impact	NOUN
eurjchem-2084	82	22	on	on	ADP
eurjchem-2084	82	23	the	the	DET
eurjchem-2084	82	24	efficacy	efficacy	NOUN
eurjchem-2084	82	25	of	of	ADP
eurjchem-2084	82	26	vaccines	vaccine	NOUN
eurjchem-2084	82	27	currently	currently	ADV
eurjchem-2084	82	28	underway	underway	ADJ
eurjchem-2084	82	29	for	for	ADP
eurjchem-2084	82	30	restricted	restricted	ADJ
eurjchem-2084	82	31	use	use	NOUN
eurjchem-2084	82	32	in	in	ADP
eurjchem-2084	82	33	the	the	DET
eurjchem-2084	82	34	world	world	NOUN
eurjchem-2084	82	35	.	.	PUNCT
eurjchem-2084	83	1	the	the	DET
eurjchem-2084	83	2	receptor	receptor	NOUN
eurjchem-2084	83	3	binding	bind	VERB
eurjchem-2084	83	4	domain	domain	NOUN
eurjchem-2084	83	5	(	(	PUNCT
eurjchem-2084	83	6	rbd	rbd	NOUN
eurjchem-2084	83	7	)	)	PUNCT
eurjchem-2084	83	8	of	of	ADP
eurjchem-2084	83	9	spike	spike	ADJ
eurjchem-2084	83	10	protein	protein	NOUN
eurjchem-2084	83	11	is	be	AUX
eurjchem-2084	83	12	crucial	crucial	ADJ
eurjchem-2084	83	13	in	in	ADP
eurjchem-2084	83	14	vaccine	vaccine	NOUN
eurjchem-2084	83	15	development	development	NOUN
eurjchem-2084	83	16	as	as	SCONJ
eurjchem-2084	83	17	some	some	PRON
eurjchem-2084	83	18	of	of	ADP
eurjchem-2084	83	19	which	which	PRON
eurjchem-2084	83	20	exclusively	exclusively	ADV
eurjchem-2084	83	21	target	target	VERB
eurjchem-2084	83	22	the	the	DET
eurjchem-2084	83	23	rbd	rbd	NOUN
eurjchem-2084	84	1	[	[	X
eurjchem-2084	84	2	21	21	NUM
eurjchem-2084	84	3	]	]	PUNCT
eurjchem-2084	84	4	.	.	PUNCT
eurjchem-2084	85	1	the	the	DET
eurjchem-2084	85	2	spike	spike	ADJ
eurjchem-2084	85	3	glycoprotein	glycoprotein	NOUN
eurjchem-2084	85	4	receptor	receptor	NOUN
eurjchem-2084	85	5	-	-	PUNCT
eurjchem-2084	85	6	binding	bind	VERB
eurjchem-2084	85	7	domain	domain	NOUN
eurjchem-2084	85	8	(	(	PUNCT
eurjchem-2084	85	9	rbd	rbd	NOUN
eurjchem-2084	85	10	)	)	PUNCT
eurjchem-2084	85	11	of	of	ADP
eurjchem-2084	85	12	sars	sar	NOUN
eurjchem-2084	85	13	-	-	PUNCT
eurjchem-2084	85	14	cov-2	cov-2	NOUN
eurjchem-2084	85	15	mediates	mediate	VERB
eurjchem-2084	85	16	the	the	DET
eurjchem-2084	85	17	viral	viral	ADJ
eurjchem-2084	85	18	particle	particle	NOUN
eurjchem-2084	85	19	’s	’s	PART
eurjchem-2084	85	20	binding	bind	VERB
eurjchem-2084	85	21	to	to	ADP
eurjchem-2084	85	22	the	the	DET
eurjchem-2084	85	23	angiotensin	angiotensin	NOUN
eurjchem-2084	85	24	-	-	PUNCT
eurjchem-2084	85	25	converting	convert	VERB
eurjchem-2084	85	26	enzyme	enzyme	NOUN
eurjchem-2084	85	27	2	2	NUM
eurjchem-2084	85	28	(	(	PUNCT
eurjchem-2084	85	29	ace2	ace2	NOUN
eurjchem-2084	85	30	)	)	PUNCT
eurjchem-2084	85	31	receptor	receptor	NOUN
eurjchem-2084	85	32	on	on	ADP
eurjchem-2084	85	33	the	the	DET
eurjchem-2084	85	34	surface	surface	NOUN
eurjchem-2084	85	35	of	of	ADP
eurjchem-2084	85	36	human	human	ADJ
eurjchem-2084	85	37	cells	cell	NOUN
eurjchem-2084	85	38	.	.	PUNCT
eurjchem-2084	86	1	recently	recently	ADV
eurjchem-2084	86	2	,	,	PUNCT
eurjchem-2084	86	3	a	a	DET
eurjchem-2084	86	4	new	new	ADJ
eurjchem-2084	86	5	strain	strain	NOUN
eurjchem-2084	86	6	of	of	ADP
eurjchem-2084	86	7	the	the	DET
eurjchem-2084	86	8	sars	sar	NOUN
eurjchem-2084	86	9	-	-	PUNCT
eurjchem-2084	86	10	cov-2	cov-2	PART
eurjchem-2084	86	11	virus	virus	NOUN
eurjchem-2084	86	12	known	know	VERB
eurjchem-2084	86	13	as	as	ADP
eurjchem-2084	86	14	vui	vui	NOUN
eurjchem-2084	86	15	202012/01	202012/01	NUM
eurjchem-2084	86	16	or	or	CCONJ
eurjchem-2084	86	17	the	the	DET
eurjchem-2084	86	18	lineage	lineage	NOUN
eurjchem-2084	86	19	b.1.1.7	b.1.1.7	PROPN
eurjchem-2084	86	20	.	.	PUNCT
eurjchem-2084	86	21	has	have	AUX
eurjchem-2084	86	22	been	be	AUX
eurjchem-2084	86	23	identified	identify	VERB
eurjchem-2084	86	24	in	in	ADP
eurjchem-2084	86	25	the	the	DET
eurjchem-2084	86	26	covid-19	covid-19	PROPN
eurjchem-2084	86	27	genomics	genomics	NOUN
eurjchem-2084	86	28	uk	uk	PROPN
eurjchem-2084	86	29	consortium	consortium	NOUN
eurjchem-2084	86	30	dataset	dataset	NOUN
eurjchem-2084	86	31	(	(	PUNCT
eurjchem-2084	86	32	under	under	ADP
eurjchem-2084	86	33	investigation	investigation	NOUN
eurjchem-2084	86	34	in	in	ADP
eurjchem-2084	86	35	december	december	PROPN
eurjchem-2084	86	36	2020	2020	NUM
eurjchem-2084	86	37	)	)	PUNCT
eurjchem-2084	86	38	,	,	PUNCT
eurjchem-2084	86	39	which	which	PRON
eurjchem-2084	86	40	features	feature	VERB
eurjchem-2084	86	41	an	an	DET
eurjchem-2084	86	42	amino	amino	NOUN
eurjchem-2084	86	43	acid	acid	NOUN
eurjchem-2084	86	44	substitution	substitution	NOUN
eurjchem-2084	86	45	in	in	ADP
eurjchem-2084	86	46	the	the	DET
eurjchem-2084	86	47	spike	spike	ADJ
eurjchem-2084	86	48	rbd	rbd	NOUN
eurjchem-2084	86	49	(	(	PUNCT
eurjchem-2084	86	50	n501y	n501y	PROPN
eurjchem-2084	86	51	mutation	mutation	NOUN
eurjchem-2084	86	52	)	)	PUNCT
eurjchem-2084	86	53	.	.	PUNCT
eurjchem-2084	87	1	the	the	DET
eurjchem-2084	87	2	new	new	ADJ
eurjchem-2084	87	3	strain	strain	NOUN
eurjchem-2084	87	4	,	,	PUNCT
eurjchem-2084	87	5	b.1.1.7	b.1.1.7	PROPN
eurjchem-2084	87	6	,	,	PUNCT
eurjchem-2084	87	7	is	be	AUX
eurjchem-2084	87	8	not	not	PART
eurjchem-2084	87	9	so	so	ADV
eurjchem-2084	87	10	dead	dead	ADJ
eurjchem-2084	87	11	but	but	CCONJ
eurjchem-2084	87	12	is	be	AUX
eurjchem-2084	87	13	70	70	NUM
eurjchem-2084	87	14	%	%	NOUN
eurjchem-2084	87	15	more	more	ADV
eurjchem-2084	87	16	transmissible	transmissible	ADJ
eurjchem-2084	87	17	and	and	CCONJ
eurjchem-2084	87	18	contagious	contagious	ADJ
eurjchem-2084	87	19	compared	compare	VERB
eurjchem-2084	87	20	to	to	ADP
eurjchem-2084	87	21	the	the	DET
eurjchem-2084	87	22	previous	previous	ADJ
eurjchem-2084	87	23	mutated	mutate	VERB
eurjchem-2084	87	24	versions	version	NOUN
eurjchem-2084	87	25	.	.	PUNCT
eurjchem-2084	88	1	this	this	DET
eurjchem-2084	88	2	new	new	ADJ
eurjchem-2084	88	3	phylogenetic	phylogenetic	ADJ
eurjchem-2084	88	4	group	group	NOUN
eurjchem-2084	88	5	of	of	ADP
eurjchem-2084	88	6	sars	sar	NOUN
eurjchem-2084	88	7	-	-	PUNCT
eurjchem-2084	88	8	cov-2	cov-2	PART
eurjchem-2084	88	9	variant	variant	NOUN
eurjchem-2084	88	10	has	have	AUX
eurjchem-2084	88	11	undergone	undergo	VERB
eurjchem-2084	88	12	23	23	NUM
eurjchem-2084	88	13	non	non	ADJ
eurjchem-2084	88	14	-	-	ADJ
eurjchem-2084	88	15	synonymous	synonymous	ADJ
eurjchem-2084	88	16	mutations	mutation	NOUN
eurjchem-2084	88	17	and	and	CCONJ
eurjchem-2084	88	18	deletions	deletion	NOUN
eurjchem-2084	88	19	.	.	PUNCT
eurjchem-2084	89	1	findings	finding	NOUN
eurjchem-2084	89	2	showed	show	VERB
eurjchem-2084	89	3	that	that	SCONJ
eurjchem-2084	89	4	the	the	DET
eurjchem-2084	89	5	increased	increase	VERB
eurjchem-2084	89	6	infectivity	infectivity	NOUN
eurjchem-2084	89	7	of	of	ADP
eurjchem-2084	89	8	sars	sar	NOUN
eurjchem-2084	89	9	-	-	PUNCT
eurjchem-2084	89	10	cov-2	cov-2	NOUN
eurjchem-2084	89	11	lineage	lineage	NOUN
eurjchem-2084	89	12	b.1.1.7	b.1.1.7	PROPN
eurjchem-2084	89	13	is	be	AUX
eurjchem-2084	89	14	associated	associate	VERB
eurjchem-2084	89	15	with	with	ADP
eurjchem-2084	89	16	the	the	DET
eurjchem-2084	89	17	increase	increase	NOUN
eurjchem-2084	89	18	in	in	ADP
eurjchem-2084	89	19	the	the	DET
eurjchem-2084	89	20	interaction	interaction	NOUN
eurjchem-2084	89	21	force	force	NOUN
eurjchem-2084	89	22	affinity	affinity	NOUN
eurjchem-2084	89	23	between	between	ADP
eurjchem-2084	89	24	the	the	DET
eurjchem-2084	89	25	spike	spike	ADJ
eurjchem-2084	89	26	rbd	rbd	NOUN
eurjchem-2084	89	27	y501	y501	NUM
eurjchem-2084	89	28	mutant	mutant	ADJ
eurjchem-2084	89	29	residue	residue	NOUN
eurjchem-2084	89	30	with	with	ADP
eurjchem-2084	89	31	the	the	DET
eurjchem-2084	89	32	ace2	ace2	NOUN
eurjchem-2084	89	33	receptor	receptor	NOUN
eurjchem-2084	90	1	[	[	X
eurjchem-2084	90	2	22	22	NUM
eurjchem-2084	90	3	]	]	PUNCT
eurjchem-2084	90	4	.	.	PUNCT
eurjchem-2084	91	1	the	the	DET
eurjchem-2084	91	2	genomic	genomic	ADJ
eurjchem-2084	91	3	characterization	characterization	NOUN
eurjchem-2084	91	4	of	of	ADP
eurjchem-2084	91	5	an	an	DET
eurjchem-2084	91	6	emergent	emergent	ADJ
eurjchem-2084	91	7	sars	sar	NOUN
eurjchem-2084	91	8	-	-	PUNCT
eurjchem-2084	91	9	cov-2	cov-2	NOUN
eurjchem-2084	91	10	lineage	lineage	NOUN
eurjchem-2084	91	11	underwent	undergo	VERB
eurjchem-2084	91	12	an	an	DET
eurjchem-2084	91	13	unexpectedly	unexpectedly	ADV
eurjchem-2084	91	14	large	large	ADJ
eurjchem-2084	91	15	number	number	NOUN
eurjchem-2084	91	16	of	of	ADP
eurjchem-2084	91	17	genetic	genetic	ADJ
eurjchem-2084	91	18	changes	change	NOUN
eurjchem-2084	91	19	including	include	VERB
eurjchem-2084	91	20	in	in	ADP
eurjchem-2084	91	21	the	the	DET
eurjchem-2084	91	22	receptor	receptor	NOUN
eurjchem-2084	91	23	-	-	PUNCT
eurjchem-2084	91	24	binding	bind	VERB
eurjchem-2084	91	25	domain	domain	NOUN
eurjchem-2084	91	26	and	and	CCONJ
eurjchem-2084	91	27	associated	associate	VERB
eurjchem-2084	91	28	with	with	ADP
eurjchem-2084	91	29	the	the	DET
eurjchem-2084	91	30	furin	furin	NOUN
eurjchem-2084	91	31	cleavage	cleavage	NOUN
eurjchem-2084	91	32	site	site	NOUN
eurjchem-2084	91	33	[	[	X
eurjchem-2084	91	34	23,24	23,24	X
eurjchem-2084	91	35	]	]	X
eurjchem-2084	91	36	.	.	PUNCT
eurjchem-2084	92	1	5.2	5.2	NUM
eurjchem-2084	92	2	.	.	PUNCT
eurjchem-2084	93	1	infection	infection	NOUN
eurjchem-2084	93	2	mechanism	mechanism	NOUN
eurjchem-2084	93	3	of	of	ADP
eurjchem-2084	93	4	virus	virus	NOUN
eurjchem-2084	93	5	sars	sar	NOUN
eurjchem-2084	93	6	-	-	PUNCT
eurjchem-2084	93	7	cov-2	cov-2	NUM
eurjchem-2084	93	8	also	also	ADV
eurjchem-2084	93	9	uses	use	VERB
eurjchem-2084	93	10	ace-2	ace-2	NUM
eurjchem-2084	93	11	receptor	receptor	NOUN
eurjchem-2084	93	12	for	for	ADP
eurjchem-2084	93	13	the	the	DET
eurjchem-2084	93	14	entry	entry	NOUN
eurjchem-2084	93	15	to	to	ADP
eurjchem-2084	93	16	the	the	DET
eurjchem-2084	93	17	host	host	NOUN
eurjchem-2084	93	18	epithelial	epithelial	ADJ
eurjchem-2084	93	19	cell	cell	NOUN
eurjchem-2084	93	20	to	to	PART
eurjchem-2084	93	21	cause	cause	VERB
eurjchem-2084	93	22	infection	infection	NOUN
eurjchem-2084	93	23	,	,	PUNCT
eurjchem-2084	93	24	similar	similar	ADJ
eurjchem-2084	93	25	to	to	ADP
eurjchem-2084	93	26	sars	sars	PROPN
eurjchem-2084	93	27	-	-	PUNCT
eurjchem-2084	93	28	cov	cov	PROPN
eurjchem-2084	93	29	(	(	PUNCT
eurjchem-2084	93	30	figure	figure	NOUN
eurjchem-2084	93	31	4	4	NUM
eurjchem-2084	93	32	)	)	PUNCT
eurjchem-2084	94	1	[	[	X
eurjchem-2084	94	2	25,26	25,26	X
eurjchem-2084	94	3	]	]	ADJ
eurjchem-2084	94	4	.	.	PUNCT
eurjchem-2084	95	1	s	s	PART
eurjchem-2084	95	2	protein	protein	NOUN
eurjchem-2084	95	3	present	present	ADJ
eurjchem-2084	95	4	on	on	ADP
eurjchem-2084	95	5	the	the	DET
eurjchem-2084	95	6	external	external	ADJ
eurjchem-2084	95	7	surface	surface	NOUN
eurjchem-2084	95	8	of	of	ADP
eurjchem-2084	95	9	sars	sar	NOUN
eurjchem-2084	95	10	-	-	PUNCT
eurjchem-2084	95	11	cov-2	cov-2	PART
eurjchem-2084	95	12	is	be	AUX
eurjchem-2084	95	13	comprised	comprise	VERB
eurjchem-2084	95	14	of	of	ADP
eurjchem-2084	95	15	two	two	NUM
eurjchem-2084	95	16	functional	functional	ADJ
eurjchem-2084	95	17	domains	domain	NOUN
eurjchem-2084	95	18	s1	s1	NOUN
eurjchem-2084	95	19	and	and	CCONJ
eurjchem-2084	95	20	s2	s2	PROPN
eurjchem-2084	95	21	.	.	PUNCT
eurjchem-2084	96	1	firdaus	firdaus	PROPN
eurjchem-2084	96	2	et	et	PROPN
eurjchem-2084	96	3	al	al	PROPN
eurjchem-2084	96	4	.	.	PUNCT
eurjchem-2084	96	5	/	/	SYM
eurjchem-2084	96	6	european	european	PROPN
eurjchem-2084	96	7	journal	journal	PROPN
eurjchem-2084	96	8	of	of	ADP
eurjchem-2084	96	9	chemistry	chemistry	NOUN
eurjchem-2084	96	10	12	12	NUM
eurjchem-2084	96	11	(	(	PUNCT
eurjchem-2084	96	12	2	2	NUM
eurjchem-2084	96	13	)	)	PUNCT
eurjchem-2084	96	14	(	(	PUNCT
eurjchem-2084	96	15	2021	2021	NUM
eurjchem-2084	96	16	)	)	PUNCT
eurjchem-2084	96	17	222	222	NUM
eurjchem-2084	96	18	-	-	SYM
eurjchem-2084	96	19	234	234	NUM
eurjchem-2084	96	20	225	225	NUM
eurjchem-2084	96	21	2021	2021	NUM
eurjchem-2084	96	22	–	–	PUNCT
eurjchem-2084	96	23	european	european	ADJ
eurjchem-2084	96	24	journal	journal	NOUN
eurjchem-2084	96	25	of	of	ADP
eurjchem-2084	96	26	chemistry	chemistry	NOUN
eurjchem-2084	96	27	–	–	PUNCT
eurjchem-2084	96	28	cc	cc	NOUN
eurjchem-2084	96	29	by	by	ADP
eurjchem-2084	96	30	nc	nc	PROPN
eurjchem-2084	96	31	–	–	PUNCT
eurjchem-2084	96	32	doi	doi	NOUN
eurjchem-2084	96	33	:	:	PUNCT
eurjchem-2084	96	34	10.5155	10.5155	NUM
eurjchem-2084	96	35	/	/	SYM
eurjchem-2084	96	36	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	96	37	-	-	PUNCT
eurjchem-2084	96	38	234.2084	234.2084	NUM
eurjchem-2084	96	39	figure	figure	NOUN
eurjchem-2084	96	40	4	4	NUM
eurjchem-2084	96	41	.	.	PUNCT
eurjchem-2084	96	42	infection	infection	NOUN
eurjchem-2084	96	43	and	and	CCONJ
eurjchem-2084	96	44	life	life	NOUN
eurjchem-2084	96	45	cycle	cycle	NOUN
eurjchem-2084	96	46	of	of	ADP
eurjchem-2084	96	47	sars	sar	NOUN
eurjchem-2084	96	48	-	-	PUNCT
eurjchem-2084	96	49	cov-2	cov-2	NOUN
eurjchem-2084	96	50	into	into	ADP
eurjchem-2084	96	51	human	human	ADJ
eurjchem-2084	96	52	epithelial	epithelial	ADJ
eurjchem-2084	96	53	cell	cell	NOUN
eurjchem-2084	96	54	.	.	PUNCT
eurjchem-2084	97	1	the	the	DET
eurjchem-2084	97	2	virus	virus	NOUN
eurjchem-2084	97	3	enters	enter	VERB
eurjchem-2084	97	4	into	into	ADP
eurjchem-2084	97	5	the	the	DET
eurjchem-2084	97	6	nasal	nasal	ADJ
eurjchem-2084	97	7	cavity	cavity	NOUN
eurjchem-2084	97	8	during	during	ADP
eurjchem-2084	97	9	inhalation	inhalation	NOUN
eurjchem-2084	97	10	and	and	CCONJ
eurjchem-2084	97	11	the	the	DET
eurjchem-2084	97	12	rbd	rbd	NOUN
eurjchem-2084	97	13	region	region	NOUN
eurjchem-2084	97	14	of	of	ADP
eurjchem-2084	97	15	s	s	NOUN
eurjchem-2084	97	16	protein	protein	NOUN
eurjchem-2084	97	17	binds	bind	VERB
eurjchem-2084	97	18	with	with	ADP
eurjchem-2084	97	19	ace-2	ace-2	PUNCT
eurjchem-2084	97	20	receptor	receptor	NOUN
eurjchem-2084	97	21	present	present	ADJ
eurjchem-2084	97	22	on	on	ADP
eurjchem-2084	97	23	the	the	DET
eurjchem-2084	97	24	epithelial	epithelial	ADJ
eurjchem-2084	97	25	cell	cell	NOUN
eurjchem-2084	97	26	.	.	PUNCT
eurjchem-2084	98	1	s	s	VERB
eurjchem-2084	98	2	protein	protein	NOUN
eurjchem-2084	98	3	of	of	ADP
eurjchem-2084	98	4	s	s	NOUN
eurjchem-2084	98	5	/	/	SYM
eurjchem-2084	98	6	ace-2	ace-2	NUM
eurjchem-2084	98	7	complex	complex	NOUN
eurjchem-2084	98	8	is	be	AUX
eurjchem-2084	98	9	cleaved	cleave	VERB
eurjchem-2084	98	10	at	at	ADP
eurjchem-2084	98	11	s1	s1	NOUN
eurjchem-2084	98	12	/	/	SYM
eurjchem-2084	98	13	s2	s2	NOUN
eurjchem-2084	98	14	cleavage	cleavage	NOUN
eurjchem-2084	98	15	site	site	NOUN
eurjchem-2084	98	16	by	by	ADP
eurjchem-2084	98	17	tmprss2	tmprss2	PROPN
eurjchem-2084	98	18	.	.	PUNCT
eurjchem-2084	99	1	the	the	DET
eurjchem-2084	99	2	s2	s2	PROPN
eurjchem-2084	99	3	domain	domain	NOUN
eurjchem-2084	99	4	interacts	interact	VERB
eurjchem-2084	99	5	with	with	ADP
eurjchem-2084	99	6	host	host	NOUN
eurjchem-2084	99	7	cell	cell	NOUN
eurjchem-2084	99	8	membrane	membrane	NOUN
eurjchem-2084	99	9	to	to	PART
eurjchem-2084	99	10	facilitate	facilitate	VERB
eurjchem-2084	99	11	endocytosis	endocytosis	NOUN
eurjchem-2084	99	12	,	,	PUNCT
eurjchem-2084	99	13	followed	follow	VERB
eurjchem-2084	99	14	by	by	ADP
eurjchem-2084	99	15	the	the	DET
eurjchem-2084	99	16	entry	entry	NOUN
eurjchem-2084	99	17	of	of	ADP
eurjchem-2084	99	18	viral	viral	ADJ
eurjchem-2084	99	19	rna	rna	NOUN
eurjchem-2084	99	20	in	in	ADP
eurjchem-2084	99	21	to	to	ADP
eurjchem-2084	99	22	the	the	DET
eurjchem-2084	99	23	host	host	NOUN
eurjchem-2084	99	24	cell	cell	NOUN
eurjchem-2084	99	25	.	.	PUNCT
eurjchem-2084	100	1	the	the	DET
eurjchem-2084	100	2	viral	viral	ADJ
eurjchem-2084	100	3	rna	rna	NOUN
eurjchem-2084	100	4	translates	translate	VERB
eurjchem-2084	100	5	into	into	ADP
eurjchem-2084	100	6	two	two	NUM
eurjchem-2084	100	7	large	large	ADJ
eurjchem-2084	100	8	polypeptide	polypeptide	ADJ
eurjchem-2084	100	9	chains	chain	NOUN
eurjchem-2084	100	10	,	,	PUNCT
eurjchem-2084	100	11	which	which	PRON
eurjchem-2084	100	12	later	later	ADV
eurjchem-2084	100	13	cleaved	cleave	VERB
eurjchem-2084	100	14	into	into	ADP
eurjchem-2084	100	15	nonstructural	nonstructural	ADJ
eurjchem-2084	100	16	proteins	protein	NOUN
eurjchem-2084	100	17	.	.	PUNCT
eurjchem-2084	101	1	meanwhile	meanwhile	ADV
eurjchem-2084	101	2	,	,	PUNCT
eurjchem-2084	101	3	a	a	DET
eurjchem-2084	101	4	replicase	replicase	NOUN
eurjchem-2084	101	5	-	-	PUNCT
eurjchem-2084	101	6	transcriptase	transcriptase	NOUN
eurjchem-2084	101	7	-	-	PUNCT
eurjchem-2084	101	8	complex	complex	NOUN
eurjchem-2084	101	9	of	of	ADP
eurjchem-2084	101	10	viral	viral	ADJ
eurjchem-2084	101	11	and	and	CCONJ
eurjchem-2084	101	12	host	host	NOUN
eurjchem-2084	101	13	proteins	protein	NOUN
eurjchem-2084	101	14	is	be	AUX
eurjchem-2084	101	15	formed	form	VERB
eurjchem-2084	101	16	which	which	PRON
eurjchem-2084	101	17	enables	enable	VERB
eurjchem-2084	101	18	the	the	DET
eurjchem-2084	101	19	synthesis	synthesis	NOUN
eurjchem-2084	101	20	of	of	ADP
eurjchem-2084	101	21	rna	rna	NOUN
eurjchem-2084	101	22	and	and	CCONJ
eurjchem-2084	101	23	structural	structural	ADJ
eurjchem-2084	101	24	proteins	protein	NOUN
eurjchem-2084	101	25	of	of	ADP
eurjchem-2084	101	26	the	the	DET
eurjchem-2084	101	27	virus	virus	NOUN
eurjchem-2084	101	28	.	.	PUNCT
eurjchem-2084	102	1	the	the	DET
eurjchem-2084	102	2	newly	newly	ADV
eurjchem-2084	102	3	formed	form	VERB
eurjchem-2084	102	4	viral	viral	ADJ
eurjchem-2084	102	5	rna	rna	NOUN
eurjchem-2084	102	6	and	and	CCONJ
eurjchem-2084	102	7	structural	structural	ADJ
eurjchem-2084	102	8	proteins	protein	NOUN
eurjchem-2084	102	9	accumulate	accumulate	VERB
eurjchem-2084	102	10	at	at	ADP
eurjchem-2084	102	11	the	the	DET
eurjchem-2084	102	12	er	er	INTJ
eurjchem-2084	102	13	-	-	PUNCT
eurjchem-2084	102	14	golgi	golgi	NOUN
eurjchem-2084	102	15	system	system	NOUN
eurjchem-2084	102	16	and	and	CCONJ
eurjchem-2084	102	17	assembled	assemble	VERB
eurjchem-2084	102	18	to	to	PART
eurjchem-2084	102	19	form	form	VERB
eurjchem-2084	102	20	new	new	ADJ
eurjchem-2084	102	21	viruses	virus	NOUN
eurjchem-2084	102	22	,	,	PUNCT
eurjchem-2084	102	23	which	which	PRON
eurjchem-2084	102	24	are	be	AUX
eurjchem-2084	102	25	then	then	ADV
eurjchem-2084	102	26	exported	export	VERB
eurjchem-2084	102	27	from	from	ADP
eurjchem-2084	102	28	the	the	DET
eurjchem-2084	102	29	host	host	NOUN
eurjchem-2084	102	30	cell	cell	NOUN
eurjchem-2084	102	31	through	through	ADP
eurjchem-2084	102	32	exocytosis	exocytosis	NOUN
eurjchem-2084	102	33	.	.	PUNCT
eurjchem-2084	103	1	the	the	DET
eurjchem-2084	103	2	rbd	rbd	NOUN
eurjchem-2084	103	3	is	be	AUX
eurjchem-2084	103	4	present	present	ADJ
eurjchem-2084	103	5	in	in	ADP
eurjchem-2084	103	6	the	the	DET
eurjchem-2084	103	7	s1subunit	s1subunit	NOUN
eurjchem-2084	103	8	of	of	ADP
eurjchem-2084	103	9	s	s	NOUN
eurjchem-2084	103	10	protein	protein	NOUN
eurjchem-2084	103	11	and	and	CCONJ
eurjchem-2084	103	12	contains	contain	VERB
eurjchem-2084	103	13	a	a	DET
eurjchem-2084	103	14	3	3	NUM
eurjchem-2084	103	15	-	-	PUNCT
eurjchem-2084	103	16	d	d	NOUN
eurjchem-2084	103	17	structure	structure	NOUN
eurjchem-2084	103	18	to	to	PART
eurjchem-2084	103	19	maintain	maintain	VERB
eurjchem-2084	103	20	the	the	DET
eurjchem-2084	103	21	vander	vander	NOUN
eurjchem-2084	103	22	waals	waal	NOUN
eurjchem-2084	103	23	forces	force	NOUN
eurjchem-2084	103	24	[	[	X
eurjchem-2084	103	25	27	27	NUM
eurjchem-2084	103	26	]	]	PUNCT
eurjchem-2084	103	27	.	.	PUNCT
eurjchem-2084	104	1	the	the	DET
eurjchem-2084	104	2	virus	virus	NOUN
eurjchem-2084	104	3	enters	enter	VERB
eurjchem-2084	104	4	into	into	ADP
eurjchem-2084	104	5	the	the	DET
eurjchem-2084	104	6	nasal	nasal	ADJ
eurjchem-2084	104	7	cavity	cavity	NOUN
eurjchem-2084	104	8	during	during	ADP
eurjchem-2084	104	9	inhalation	inhalation	NOUN
eurjchem-2084	104	10	and	and	CCONJ
eurjchem-2084	104	11	the	the	DET
eurjchem-2084	104	12	rbd	rbd	NOUN
eurjchem-2084	104	13	region	region	NOUN
eurjchem-2084	104	14	of	of	ADP
eurjchem-2084	104	15	s	s	NOUN
eurjchem-2084	104	16	protein	protein	NOUN
eurjchem-2084	104	17	binds	bind	VERB
eurjchem-2084	104	18	to	to	ADP
eurjchem-2084	104	19	ace-2	ace-2	PUNCT
eurjchem-2084	104	20	receptors	receptor	NOUN
eurjchem-2084	104	21	present	present	ADJ
eurjchem-2084	104	22	on	on	ADP
eurjchem-2084	104	23	the	the	DET
eurjchem-2084	104	24	epithelial	epithelial	ADJ
eurjchem-2084	104	25	cells	cell	NOUN
eurjchem-2084	104	26	of	of	ADP
eurjchem-2084	104	27	the	the	DET
eurjchem-2084	104	28	nasal	nasal	ADJ
eurjchem-2084	104	29	cavity	cavity	NOUN
eurjchem-2084	104	30	.	.	PUNCT
eurjchem-2084	105	1	the	the	DET
eurjchem-2084	105	2	glutamine-394	glutamine-394	NOUN
eurjchem-2084	105	3	residue	residue	NOUN
eurjchem-2084	105	4	in	in	ADP
eurjchem-2084	105	5	the	the	DET
eurjchem-2084	105	6	rbd	rbd	NOUN
eurjchem-2084	105	7	region	region	NOUN
eurjchem-2084	105	8	of	of	ADP
eurjchem-2084	105	9	sars	sars	PROPN
eurjchem-2084	105	10	-	-	PUNCT
eurjchem-2084	105	11	cov-2	cov-2	PART
eurjchem-2084	105	12	interacts	interact	VERB
eurjchem-2084	105	13	with	with	ADP
eurjchem-2084	105	14	the	the	DET
eurjchem-2084	105	15	critical	critical	ADJ
eurjchem-2084	105	16	lysine-31	lysine-31	ADJ
eurjchem-2084	105	17	residue	residue	NOUN
eurjchem-2084	105	18	of	of	ADP
eurjchem-2084	105	19	ace-2	ace-2	PUNCT
eurjchem-2084	105	20	receptor	receptor	NOUN
eurjchem-2084	105	21	present	present	ADJ
eurjchem-2084	105	22	on	on	ADP
eurjchem-2084	105	23	the	the	DET
eurjchem-2084	105	24	human	human	ADJ
eurjchem-2084	105	25	cell	cell	NOUN
eurjchem-2084	105	26	surface	surface	NOUN
eurjchem-2084	105	27	and	and	CCONJ
eurjchem-2084	105	28	enables	enable	VERB
eurjchem-2084	105	29	the	the	DET
eurjchem-2084	105	30	entry	entry	NOUN
eurjchem-2084	105	31	of	of	ADP
eurjchem-2084	105	32	virus	virus	NOUN
eurjchem-2084	105	33	to	to	ADP
eurjchem-2084	105	34	the	the	DET
eurjchem-2084	105	35	host	host	NOUN
eurjchem-2084	105	36	cell	cell	NOUN
eurjchem-2084	106	1	[	[	X
eurjchem-2084	106	2	17	17	NUM
eurjchem-2084	106	3	]	]	PUNCT
eurjchem-2084	106	4	.	.	PUNCT
eurjchem-2084	107	1	rbd	rbd	PROPN
eurjchem-2084	107	2	region	region	NOUN
eurjchem-2084	107	3	is	be	AUX
eurjchem-2084	107	4	loosely	loosely	ADV
eurjchem-2084	107	5	attached	attach	VERB
eurjchem-2084	107	6	among	among	ADP
eurjchem-2084	107	7	the	the	DET
eurjchem-2084	107	8	virus	virus	NOUN
eurjchem-2084	107	9	that	that	PRON
eurjchem-2084	107	10	encourages	encourage	VERB
eurjchem-2084	107	11	the	the	DET
eurjchem-2084	107	12	virus	virus	NOUN
eurjchem-2084	107	13	to	to	PART
eurjchem-2084	107	14	infect	infect	VERB
eurjchem-2084	107	15	multiple	multiple	ADJ
eurjchem-2084	107	16	hosts	host	NOUN
eurjchem-2084	107	17	[	[	X
eurjchem-2084	107	18	28	28	NUM
eurjchem-2084	107	19	]	]	PUNCT
eurjchem-2084	107	20	.	.	PUNCT
eurjchem-2084	108	1	s	s	VERB
eurjchem-2084	108	2	protein	protein	NOUN
eurjchem-2084	108	3	of	of	ADP
eurjchem-2084	108	4	s	s	NOUN
eurjchem-2084	108	5	/	/	SYM
eurjchem-2084	108	6	ace-2	ace-2	NUM
eurjchem-2084	108	7	complex	complex	NOUN
eurjchem-2084	108	8	is	be	AUX
eurjchem-2084	108	9	cleaved	cleave	VERB
eurjchem-2084	108	10	at	at	ADP
eurjchem-2084	108	11	s1	s1	NOUN
eurjchem-2084	108	12	/	/	SYM
eurjchem-2084	108	13	s2	s2	NOUN
eurjchem-2084	108	14	cleavage	cleavage	NOUN
eurjchem-2084	108	15	site	site	NOUN
eurjchem-2084	108	16	by	by	ADP
eurjchem-2084	108	17	the	the	DET
eurjchem-2084	108	18	serine	serine	NOUN
eurjchem-2084	108	19	protease	protease	NOUN
eurjchem-2084	108	20	tmprss2	tmprss2	NOUN
eurjchem-2084	108	21	,	,	PUNCT
eurjchem-2084	108	22	cathepsin	cathepsin	NOUN
eurjchem-2084	108	23	l	l	NOUN
eurjchem-2084	108	24	,	,	PUNCT
eurjchem-2084	108	25	and	and	CCONJ
eurjchem-2084	108	26	furin	furin	NOUN
eurjchem-2084	108	27	to	to	PART
eurjchem-2084	108	28	permit	permit	VERB
eurjchem-2084	108	29	the	the	DET
eurjchem-2084	108	30	entry	entry	NOUN
eurjchem-2084	108	31	of	of	ADP
eurjchem-2084	108	32	virus	virus	NOUN
eurjchem-2084	108	33	in	in	ADP
eurjchem-2084	108	34	to	to	ADP
eurjchem-2084	108	35	host	host	NOUN
eurjchem-2084	108	36	cells	cell	NOUN
eurjchem-2084	108	37	[	[	X
eurjchem-2084	108	38	29	29	NUM
eurjchem-2084	108	39	]	]	PUNCT
eurjchem-2084	108	40	.	.	PUNCT
eurjchem-2084	109	1	subsequently	subsequently	ADV
eurjchem-2084	109	2	,	,	PUNCT
eurjchem-2084	109	3	the	the	DET
eurjchem-2084	109	4	s2	s2	NOUN
eurjchem-2084	109	5	domain	domain	NOUN
eurjchem-2084	109	6	interacts	interact	VERB
eurjchem-2084	109	7	with	with	ADP
eurjchem-2084	109	8	the	the	DET
eurjchem-2084	109	9	host	host	NOUN
eurjchem-2084	109	10	cell	cell	NOUN
eurjchem-2084	109	11	membrane	membrane	NOUN
eurjchem-2084	109	12	to	to	PART
eurjchem-2084	109	13	facilitate	facilitate	VERB
eurjchem-2084	109	14	endocytosis	endocytosis	NOUN
eurjchem-2084	109	15	,	,	PUNCT
eurjchem-2084	109	16	followed	follow	VERB
eurjchem-2084	109	17	by	by	ADP
eurjchem-2084	109	18	the	the	DET
eurjchem-2084	109	19	entry	entry	NOUN
eurjchem-2084	109	20	of	of	ADP
eurjchem-2084	109	21	viral	viral	ADJ
eurjchem-2084	109	22	rna	rna	NOUN
eurjchem-2084	109	23	in	in	ADP
eurjchem-2084	109	24	to	to	ADP
eurjchem-2084	109	25	the	the	DET
eurjchem-2084	109	26	host	host	NOUN
eurjchem-2084	109	27	cell	cell	NOUN
eurjchem-2084	109	28	.	.	PUNCT
eurjchem-2084	110	1	the	the	DET
eurjchem-2084	110	2	exact	exact	ADJ
eurjchem-2084	110	3	endocytosis	endocytosis	NOUN
eurjchem-2084	110	4	pathway	pathway	NOUN
eurjchem-2084	110	5	used	use	VERB
eurjchem-2084	110	6	by	by	ADP
eurjchem-2084	110	7	the	the	DET
eurjchem-2084	110	8	virus	virus	NOUN
eurjchem-2084	110	9	is	be	AUX
eurjchem-2084	110	10	still	still	ADV
eurjchem-2084	110	11	not	not	PART
eurjchem-2084	110	12	clear	clear	ADJ
eurjchem-2084	110	13	and	and	CCONJ
eurjchem-2084	110	14	depends	depend	VERB
eurjchem-2084	110	15	on	on	ADP
eurjchem-2084	110	16	the	the	DET
eurjchem-2084	110	17	nature	nature	NOUN
eurjchem-2084	110	18	of	of	ADP
eurjchem-2084	110	19	the	the	DET
eurjchem-2084	110	20	cell	cell	NOUN
eurjchem-2084	111	1	[	[	X
eurjchem-2084	111	2	16	16	NUM
eurjchem-2084	111	3	]	]	PUNCT
eurjchem-2084	111	4	.	.	PUNCT
eurjchem-2084	112	1	once	once	ADV
eurjchem-2084	112	2	the	the	DET
eurjchem-2084	112	3	viral	viral	ADJ
eurjchem-2084	112	4	rna	rna	NOUN
eurjchem-2084	112	5	enters	enter	VERB
eurjchem-2084	112	6	into	into	ADP
eurjchem-2084	112	7	the	the	DET
eurjchem-2084	112	8	host	host	NOUN
eurjchem-2084	112	9	cytoplasm	cytoplasm	NOUN
eurjchem-2084	112	10	,	,	PUNCT
eurjchem-2084	112	11	it	it	PRON
eurjchem-2084	112	12	hijacks	hijack	VERB
eurjchem-2084	112	13	the	the	DET
eurjchem-2084	112	14	host	host	NOUN
eurjchem-2084	112	15	translational	translational	ADJ
eurjchem-2084	112	16	machinery	machinery	NOUN
eurjchem-2084	112	17	to	to	PART
eurjchem-2084	112	18	synthesize	synthesize	VERB
eurjchem-2084	112	19	different	different	ADJ
eurjchem-2084	112	20	proteins	protein	NOUN
eurjchem-2084	112	21	needed	need	VERB
eurjchem-2084	112	22	for	for	ADP
eurjchem-2084	112	23	its	its	PRON
eurjchem-2084	112	24	own	own	ADJ
eurjchem-2084	112	25	replication	replication	NOUN
eurjchem-2084	112	26	.	.	PUNCT
eurjchem-2084	113	1	the	the	DET
eurjchem-2084	113	2	viral	viral	ADJ
eurjchem-2084	113	3	rna	rna	NOUN
eurjchem-2084	113	4	translates	translate	VERB
eurjchem-2084	113	5	into	into	ADP
eurjchem-2084	113	6	two	two	NUM
eurjchem-2084	113	7	large	large	ADJ
eurjchem-2084	113	8	polypeptide	polypeptide	ADJ
eurjchem-2084	113	9	chains	chain	NOUN
eurjchem-2084	113	10	,	,	PUNCT
eurjchem-2084	113	11	which	which	PRON
eurjchem-2084	113	12	later	later	ADV
eurjchem-2084	113	13	cleaved	cleave	VERB
eurjchem-2084	113	14	into	into	ADP
eurjchem-2084	113	15	nsps	nsps	NOUN
eurjchem-2084	113	16	.	.	PUNCT
eurjchem-2084	114	1	meanwhile	meanwhile	ADV
eurjchem-2084	114	2	,	,	PUNCT
eurjchem-2084	114	3	a	a	DET
eurjchem-2084	114	4	replicase	replicase	NOUN
eurjchem-2084	114	5	-	-	PUNCT
eurjchem-2084	114	6	transcriptase	transcriptase	NOUN
eurjchem-2084	114	7	-	-	PUNCT
eurjchem-2084	114	8	complex	complex	NOUN
eurjchem-2084	114	9	of	of	ADP
eurjchem-2084	114	10	viral	viral	ADJ
eurjchem-2084	114	11	and	and	CCONJ
eurjchem-2084	114	12	host	host	NOUN
eurjchem-2084	114	13	proteins	protein	NOUN
eurjchem-2084	114	14	is	be	AUX
eurjchem-2084	114	15	formed	form	VERB
eurjchem-2084	114	16	which	which	PRON
eurjchem-2084	114	17	enables	enable	VERB
eurjchem-2084	114	18	the	the	DET
eurjchem-2084	114	19	synthesis	synthesis	NOUN
eurjchem-2084	114	20	of	of	ADP
eurjchem-2084	114	21	rna	rna	NOUN
eurjchem-2084	114	22	and	and	CCONJ
eurjchem-2084	114	23	structural	structural	ADJ
eurjchem-2084	114	24	proteins	protein	NOUN
eurjchem-2084	114	25	of	of	ADP
eurjchem-2084	114	26	the	the	DET
eurjchem-2084	114	27	virus	virus	NOUN
eurjchem-2084	114	28	.	.	PUNCT
eurjchem-2084	115	1	the	the	DET
eurjchem-2084	115	2	newly	newly	ADV
eurjchem-2084	115	3	formed	form	VERB
eurjchem-2084	115	4	viral	viral	ADJ
eurjchem-2084	115	5	rna	rna	NOUN
eurjchem-2084	115	6	and	and	CCONJ
eurjchem-2084	115	7	structural	structural	ADJ
eurjchem-2084	115	8	proteins	protein	NOUN
eurjchem-2084	115	9	accumulate	accumulate	VERB
eurjchem-2084	115	10	at	at	ADP
eurjchem-2084	115	11	the	the	DET
eurjchem-2084	115	12	er	er	INTJ
eurjchem-2084	115	13	-	-	PUNCT
eurjchem-2084	115	14	golgi	golgi	NOUN
eurjchem-2084	115	15	system	system	NOUN
eurjchem-2084	115	16	and	and	CCONJ
eurjchem-2084	115	17	assemble	assemble	VERB
eurjchem-2084	115	18	to	to	PART
eurjchem-2084	115	19	form	form	VERB
eurjchem-2084	115	20	new	new	ADJ
eurjchem-2084	115	21	viruses	virus	NOUN
eurjchem-2084	115	22	,	,	PUNCT
eurjchem-2084	115	23	which	which	PRON
eurjchem-2084	115	24	are	be	AUX
eurjchem-2084	115	25	then	then	ADV
eurjchem-2084	115	26	exported	export	VERB
eurjchem-2084	115	27	from	from	ADP
eurjchem-2084	115	28	the	the	DET
eurjchem-2084	115	29	host	host	NOUN
eurjchem-2084	115	30	cell	cell	NOUN
eurjchem-2084	115	31	through	through	ADP
eurjchem-2084	115	32	exocytosis	exocytosis	NOUN
eurjchem-2084	115	33	[	[	X
eurjchem-2084	115	34	16	16	NUM
eurjchem-2084	115	35	]	]	PUNCT
eurjchem-2084	115	36	.	.	PUNCT
eurjchem-2084	116	1	the	the	DET
eurjchem-2084	116	2	expression	expression	NOUN
eurjchem-2084	116	3	of	of	ADP
eurjchem-2084	116	4	ace-2	ace-2	PUNCT
eurjchem-2084	116	5	is	be	AUX
eurjchem-2084	116	6	abundant	abundant	ADJ
eurjchem-2084	116	7	in	in	ADP
eurjchem-2084	116	8	the	the	DET
eurjchem-2084	116	9	respiratory	respiratory	ADJ
eurjchem-2084	116	10	tract	tract	NOUN
eurjchem-2084	116	11	including	include	VERB
eurjchem-2084	116	12	nasal	nasal	ADJ
eurjchem-2084	116	13	,	,	PUNCT
eurjchem-2084	116	14	bronchial	bronchial	ADJ
eurjchem-2084	116	15	,	,	PUNCT
eurjchem-2084	116	16	and	and	CCONJ
eurjchem-2084	116	17	alveolar	alveolar	ADJ
eurjchem-2084	116	18	cells	cell	NOUN
eurjchem-2084	116	19	of	of	ADP
eurjchem-2084	116	20	the	the	DET
eurjchem-2084	116	21	lungs	lung	NOUN
eurjchem-2084	116	22	and	and	CCONJ
eurjchem-2084	116	23	also	also	ADV
eurjchem-2084	116	24	in	in	ADP
eurjchem-2084	116	25	the	the	DET
eurjchem-2084	116	26	epithelial	epithelial	ADJ
eurjchem-2084	116	27	cells	cell	NOUN
eurjchem-2084	116	28	of	of	ADP
eurjchem-2084	116	29	the	the	DET
eurjchem-2084	116	30	gastrointestinal	gastrointestinal	ADJ
eurjchem-2084	116	31	(	(	PUNCT
eurjchem-2084	116	32	gi	gi	INTJ
eurjchem-2084	116	33	)	)	PUNCT
eurjchem-2084	116	34	tract	tract	NOUN
eurjchem-2084	116	35	.	.	PUNCT
eurjchem-2084	117	1	tmprss2	tmprss2	PRON
eurjchem-2084	117	2	is	be	AUX
eurjchem-2084	117	3	present	present	ADJ
eurjchem-2084	117	4	in	in	ADP
eurjchem-2084	117	5	alveolar	alveolar	ADJ
eurjchem-2084	117	6	cells	cell	NOUN
eurjchem-2084	117	7	and	and	CCONJ
eurjchem-2084	117	8	gi	gi	ADP
eurjchem-2084	117	9	tract	tract	NOUN
eurjchem-2084	117	10	.	.	PUNCT
eurjchem-2084	118	1	the	the	DET
eurjchem-2084	118	2	coexistence	coexistence	NOUN
eurjchem-2084	118	3	of	of	ADP
eurjchem-2084	118	4	ace-2	ace-2	PUNCT
eurjchem-2084	118	5	and	and	CCONJ
eurjchem-2084	118	6	tmprss2	tmprss2	ADP
eurjchem-2084	118	7	in	in	ADP
eurjchem-2084	118	8	the	the	DET
eurjchem-2084	118	9	respiratory	respiratory	ADJ
eurjchem-2084	118	10	tract	tract	NOUN
eurjchem-2084	118	11	as	as	ADV
eurjchem-2084	118	12	well	well	ADV
eurjchem-2084	118	13	as	as	ADP
eurjchem-2084	118	14	its	its	PRON
eurjchem-2084	118	15	direct	direct	ADJ
eurjchem-2084	118	16	participation	participation	NOUN
eurjchem-2084	118	17	in	in	ADP
eurjchem-2084	118	18	the	the	DET
eurjchem-2084	118	19	inhalation	inhalation	NOUN
eurjchem-2084	118	20	accounts	account	NOUN
eurjchem-2084	118	21	for	for	ADP
eurjchem-2084	118	22	the	the	DET
eurjchem-2084	118	23	predominant	predominant	ADJ
eurjchem-2084	118	24	role	role	NOUN
eurjchem-2084	118	25	of	of	ADP
eurjchem-2084	118	26	the	the	DET
eurjchem-2084	118	27	respiratory	respiratory	ADJ
eurjchem-2084	118	28	system	system	NOUN
eurjchem-2084	118	29	in	in	ADP
eurjchem-2084	118	30	covid-19	covid-19	PROPN
eurjchem-2084	118	31	[	[	X
eurjchem-2084	118	32	30	30	NUM
eurjchem-2084	118	33	]	]	PUNCT
eurjchem-2084	118	34	.	.	PUNCT
eurjchem-2084	119	1	5.3	5.3	NUM
eurjchem-2084	119	2	.	.	PUNCT
eurjchem-2084	119	3	pathogenicity	pathogenicity	NOUN
eurjchem-2084	119	4	of	of	ADP
eurjchem-2084	119	5	virus	virus	NOUN
eurjchem-2084	119	6	virus	virus	NOUN
eurjchem-2084	119	7	initiates	initiate	VERB
eurjchem-2084	119	8	replication	replication	NOUN
eurjchem-2084	119	9	and	and	CCONJ
eurjchem-2084	119	10	moves	move	NOUN
eurjchem-2084	119	11	downward	downward	ADV
eurjchem-2084	119	12	in	in	ADV
eurjchem-2084	119	13	to	to	ADP
eurjchem-2084	119	14	the	the	DET
eurjchem-2084	119	15	alveolar	alveolar	ADJ
eurjchem-2084	119	16	cells	cell	NOUN
eurjchem-2084	119	17	after	after	ADP
eurjchem-2084	119	18	successful	successful	ADJ
eurjchem-2084	119	19	entry	entry	NOUN
eurjchem-2084	119	20	into	into	ADP
eurjchem-2084	119	21	the	the	DET
eurjchem-2084	119	22	host	host	NOUN
eurjchem-2084	119	23	cell	cell	NOUN
eurjchem-2084	119	24	.	.	PUNCT
eurjchem-2084	120	1	simultaneously	simultaneously	ADV
eurjchem-2084	120	2	,	,	PUNCT
eurjchem-2084	120	3	it	it	PRON
eurjchem-2084	120	4	also	also	ADV
eurjchem-2084	120	5	tries	try	VERB
eurjchem-2084	120	6	to	to	PART
eurjchem-2084	120	7	escape	escape	VERB
eurjchem-2084	120	8	encounter	encounter	NOUN
eurjchem-2084	120	9	from	from	ADP
eurjchem-2084	120	10	the	the	DET
eurjchem-2084	120	11	host	host	NOUN
eurjchem-2084	120	12	immune	immune	ADJ
eurjchem-2084	120	13	response	response	NOUN
eurjchem-2084	120	14	,	,	PUNCT
eurjchem-2084	120	15	but	but	CCONJ
eurjchem-2084	120	16	macrophages	macrophage	NOUN
eurjchem-2084	120	17	and	and	CCONJ
eurjchem-2084	120	18	dendritic	dendritic	ADJ
eurjchem-2084	120	19	cells	cell	NOUN
eurjchem-2084	120	20	detect	detect	VERB
eurjchem-2084	120	21	the	the	DET
eurjchem-2084	120	22	virus	virus	NOUN
eurjchem-2084	120	23	particle	particle	NOUN
eurjchem-2084	120	24	and	and	CCONJ
eurjchem-2084	120	25	trigger	trigger	VERB
eurjchem-2084	120	26	a	a	DET
eurjchem-2084	120	27	strong	strong	ADJ
eurjchem-2084	120	28	immune	immune	ADJ
eurjchem-2084	120	29	response	response	NOUN
eurjchem-2084	120	30	(	(	PUNCT
eurjchem-2084	120	31	figure	figure	NOUN
eurjchem-2084	120	32	5	5	NUM
eurjchem-2084	120	33	)	)	PUNCT
eurjchem-2084	120	34	.	.	PUNCT
eurjchem-2084	121	1	to	to	PART
eurjchem-2084	121	2	overcome	overcome	VERB
eurjchem-2084	121	3	the	the	DET
eurjchem-2084	121	4	rapidly	rapidly	ADV
eurjchem-2084	121	5	increasing	increase	VERB
eurjchem-2084	121	6	virus	virus	NOUN
eurjchem-2084	121	7	progeny	progeny	VERB
eurjchem-2084	121	8	in	in	ADP
eurjchem-2084	121	9	the	the	DET
eurjchem-2084	121	10	lungs	lung	NOUN
eurjchem-2084	121	11	,	,	PUNCT
eurjchem-2084	121	12	the	the	DET
eurjchem-2084	121	13	immune	immune	ADJ
eurjchem-2084	121	14	cells	cell	NOUN
eurjchem-2084	121	15	get	get	VERB
eurjchem-2084	121	16	hyper	hyper	ADJ
eurjchem-2084	121	17	activated	activate	VERB
eurjchem-2084	121	18	and	and	CCONJ
eurjchem-2084	121	19	an	an	DET
eurjchem-2084	121	20	imbalance	imbalance	NOUN
eurjchem-2084	121	21	occurs	occur	VERB
eurjchem-2084	121	22	in	in	ADP
eurjchem-2084	121	23	immune	immune	ADJ
eurjchem-2084	121	24	regulation	regulation	NOUN
eurjchem-2084	121	25	leading	lead	VERB
eurjchem-2084	121	26	to	to	ADP
eurjchem-2084	121	27	excess	excess	ADJ
eurjchem-2084	121	28	inflammatory	inflammatory	ADJ
eurjchem-2084	121	29	secretion	secretion	NOUN
eurjchem-2084	121	30	termed	term	VERB
eurjchem-2084	121	31	as	as	ADP
eurjchem-2084	121	32	cytokine	cytokine	ADJ
eurjchem-2084	121	33	storm	storm	NOUN
eurjchem-2084	121	34	[	[	X
eurjchem-2084	121	35	31	31	NUM
eurjchem-2084	121	36	]	]	PUNCT
eurjchem-2084	121	37	.	.	PUNCT
eurjchem-2084	122	1	the	the	DET
eurjchem-2084	122	2	storm	storm	NOUN
eurjchem-2084	122	3	includes	include	VERB
eurjchem-2084	122	4	inflammatory	inflammatory	ADJ
eurjchem-2084	122	5	cytokines	cytokine	NOUN
eurjchem-2084	122	6	viz	viz	PROPN
eurjchem-2084	122	7	.	.	PUNCT
eurjchem-2084	123	1	il-6	il-6	NOUN
eurjchem-2084	123	2	,	,	PUNCT
eurjchem-2084	123	3	il-12	il-12	NOUN
eurjchem-2084	123	4	,	,	PUNCT
eurjchem-2084	123	5	il-18	il-18	ADP
eurjchem-2084	123	6	,	,	PUNCT
eurjchem-2084	123	7	crp	crp	PROPN
eurjchem-2084	123	8	,	,	PUNCT
eurjchem-2084	123	9	and	and	CCONJ
eurjchem-2084	124	1	d	d	X
eurjchem-2084	124	2	-	-	PUNCT
eurjchem-2084	124	3	dimer	dimer	NOUN
eurjchem-2084	124	4	which	which	PRON
eurjchem-2084	124	5	causes	cause	VERB
eurjchem-2084	124	6	acute	acute	ADJ
eurjchem-2084	124	7	respiratory	respiratory	ADJ
eurjchem-2084	124	8	distress	distress	NOUN
eurjchem-2084	124	9	syndrome	syndrome	NOUN
eurjchem-2084	124	10	(	(	PUNCT
eurjchem-2084	124	11	ards	ard	NOUN
eurjchem-2084	124	12	)	)	PUNCT
eurjchem-2084	124	13	in	in	ADP
eurjchem-2084	124	14	the	the	DET
eurjchem-2084	124	15	lungs	lung	NOUN
eurjchem-2084	124	16	leading	lead	VERB
eurjchem-2084	124	17	to	to	ADP
eurjchem-2084	124	18	respiratory	respiratory	ADJ
eurjchem-2084	124	19	failure	failure	NOUN
eurjchem-2084	124	20	and	and	CCONJ
eurjchem-2084	124	21	is	be	AUX
eurjchem-2084	124	22	presumably	presumably	ADV
eurjchem-2084	124	23	the	the	DET
eurjchem-2084	124	24	primary	primary	ADJ
eurjchem-2084	124	25	cause	cause	NOUN
eurjchem-2084	124	26	of	of	ADP
eurjchem-2084	124	27	death	death	NOUN
eurjchem-2084	124	28	in	in	ADP
eurjchem-2084	124	29	sars	sar	NOUN
eurjchem-2084	124	30	-	-	PUNCT
eurjchem-2084	124	31	cov-2	cov-2	PART
eurjchem-2084	124	32	infections	infection	NOUN
eurjchem-2084	124	33	[	[	X
eurjchem-2084	124	34	32	32	NUM
eurjchem-2084	124	35	]	]	PUNCT
eurjchem-2084	124	36	.	.	PUNCT
eurjchem-2084	125	1	the	the	DET
eurjchem-2084	125	2	cytokines	cytokine	NOUN
eurjchem-2084	125	3	and	and	CCONJ
eurjchem-2084	125	4	chemokine	chemokine	ADJ
eurjchem-2084	125	5	storm	storm	NOUN
eurjchem-2084	125	6	mainly	mainly	ADV
eurjchem-2084	125	7	occur	occur	VERB
eurjchem-2084	125	8	in	in	ADP
eurjchem-2084	125	9	lung	lung	NOUN
eurjchem-2084	125	10	but	but	CCONJ
eurjchem-2084	125	11	due	due	ADP
eurjchem-2084	125	12	to	to	ADP
eurjchem-2084	125	13	the	the	DET
eurjchem-2084	125	14	systematic	systematic	ADJ
eurjchem-2084	125	15	inflammation	inflammation	ADJ
eurjchem-2084	125	16	cardiovascular	cardiovascular	ADJ
eurjchem-2084	125	17	system	system	NOUN
eurjchem-2084	125	18	is	be	AUX
eurjchem-2084	125	19	also	also	ADV
eurjchem-2084	125	20	affected	affect	VERB
eurjchem-2084	125	21	and	and	CCONJ
eurjchem-2084	125	22	leads	lead	VERB
eurjchem-2084	125	23	to	to	ADP
eurjchem-2084	125	24	cardiac	cardiac	ADJ
eurjchem-2084	125	25	arrhythmias	arrhythmia	NOUN
eurjchem-2084	125	26	,	,	PUNCT
eurjchem-2084	125	27	intravascular	intravascular	ADJ
eurjchem-2084	125	28	thrombosis	thrombosis	NOUN
eurjchem-2084	125	29	,	,	PUNCT
eurjchem-2084	125	30	heart	heart	NOUN
eurjchem-2084	125	31	failure	failure	NOUN
eurjchem-2084	125	32	and	and	CCONJ
eurjchem-2084	125	33	finally	finally	ADV
eurjchem-2084	125	34	death	death	NOUN
eurjchem-2084	126	1	[	[	X
eurjchem-2084	126	2	33	33	NUM
eurjchem-2084	126	3	]	]	PUNCT
eurjchem-2084	126	4	.	.	PUNCT
eurjchem-2084	127	1	coagulopathy	coagulopathy	ADJ
eurjchem-2084	127	2	is	be	AUX
eurjchem-2084	127	3	also	also	ADV
eurjchem-2084	127	4	a	a	DET
eurjchem-2084	127	5	common	common	ADJ
eurjchem-2084	127	6	comorbid	comorbid	NOUN
eurjchem-2084	127	7	and	and	CCONJ
eurjchem-2084	127	8	often	often	ADV
eurjchem-2084	127	9	found	find	VERB
eurjchem-2084	127	10	in	in	ADP
eurjchem-2084	127	11	hospitalized	hospitalize	VERB
eurjchem-2084	127	12	covid-19	covid-19	PROPN
eurjchem-2084	127	13	patients	patient	NOUN
eurjchem-2084	127	14	.	.	PUNCT
eurjchem-2084	128	1	the	the	DET
eurjchem-2084	128	2	increased	increase	VERB
eurjchem-2084	128	3	cytokine	cytokine	NOUN
eurjchem-2084	128	4	production	production	NOUN
eurjchem-2084	128	5	and	and	CCONJ
eurjchem-2084	128	6	prothrombotic	prothrombotic	ADJ
eurjchem-2084	128	7	factors	factor	NOUN
eurjchem-2084	128	8	play	play	VERB
eurjchem-2084	128	9	a	a	DET
eurjchem-2084	128	10	prominent	prominent	ADJ
eurjchem-2084	128	11	role	role	NOUN
eurjchem-2084	128	12	in	in	ADP
eurjchem-2084	128	13	increasing	increase	VERB
eurjchem-2084	128	14	the	the	DET
eurjchem-2084	128	15	severity	severity	NOUN
eurjchem-2084	128	16	of	of	ADP
eurjchem-2084	128	17	coagulopathy	coagulopathy	ADJ
eurjchem-2084	128	18	.	.	PUNCT
eurjchem-2084	129	1	the	the	DET
eurjchem-2084	129	2	markers	marker	NOUN
eurjchem-2084	129	3	of	of	ADP
eurjchem-2084	129	4	coagulopathy	coagulopathy	ADJ
eurjchem-2084	129	5	include	include	AUX
eurjchem-2084	129	6	increased	increase	VERB
eurjchem-2084	129	7	d	d	ADJ
eurjchem-2084	129	8	-	-	PUNCT
eurjchem-2084	129	9	dimer	dimer	ADJ
eurjchem-2084	129	10	levels	level	NOUN
eurjchem-2084	129	11	,	,	PUNCT
eurjchem-2084	129	12	disseminated	disseminate	VERB
eurjchem-2084	129	13	intravascular	intravascular	ADJ
eurjchem-2084	129	14	coagulation	coagulation	NOUN
eurjchem-2084	129	15	,	,	PUNCT
eurjchem-2084	129	16	and	and	CCONJ
eurjchem-2084	129	17	thrombocytopenia	thrombocytopenia	NOUN
eurjchem-2084	130	1	[	[	X
eurjchem-2084	130	2	34	34	NUM
eurjchem-2084	130	3	]	]	PUNCT
eurjchem-2084	130	4	.	.	PUNCT
eurjchem-2084	131	1	striking	strike	VERB
eurjchem-2084	131	2	evidence	evidence	NOUN
eurjchem-2084	131	3	exhibited	exhibit	VERB
eurjchem-2084	131	4	that	that	SCONJ
eurjchem-2084	131	5	in	in	ADP
eurjchem-2084	131	6	covid-19	covid-19	PROPN
eurjchem-2084	131	7	,	,	PUNCT
eurjchem-2084	131	8	the	the	DET
eurjchem-2084	131	9	virus	virus	NOUN
eurjchem-2084	131	10	also	also	ADV
eurjchem-2084	131	11	affects	affect	VERB
eurjchem-2084	131	12	the	the	DET
eurjchem-2084	131	13	central	central	ADJ
eurjchem-2084	131	14	nervous	nervous	ADJ
eurjchem-2084	131	15	system	system	NOUN
eurjchem-2084	131	16	(	(	PUNCT
eurjchem-2084	131	17	cns	cns	NOUN
eurjchem-2084	131	18	)	)	PUNCT
eurjchem-2084	131	19	,	,	PUNCT
eurjchem-2084	131	20	cerebrovascular	cerebrovascular	ADJ
eurjchem-2084	131	21	events	event	NOUN
eurjchem-2084	131	22	(	(	PUNCT
eurjchem-2084	131	23	cves	cf	NOUN
eurjchem-2084	131	24	)	)	PUNCT
eurjchem-2084	131	25	and	and	CCONJ
eurjchem-2084	131	26	intracranial	intracranial	ADJ
eurjchem-2084	131	27	hemorrhage	hemorrhage	NOUN
eurjchem-2084	131	28	[	[	X
eurjchem-2084	131	29	35	35	NUM
eurjchem-2084	131	30	]	]	PUNCT
eurjchem-2084	131	31	.	.	PUNCT
eurjchem-2084	132	1	furthermore	furthermore	ADV
eurjchem-2084	132	2	,	,	PUNCT
eurjchem-2084	132	3	sars	sar	NOUN
eurjchem-2084	132	4	-	-	PUNCT
eurjchem-2084	132	5	cov-2	cov-2	NUM
eurjchem-2084	132	6	can	can	AUX
eurjchem-2084	132	7	enter	enter	VERB
eurjchem-2084	132	8	in	in	ADV
eurjchem-2084	132	9	to	to	ADP
eurjchem-2084	132	10	the	the	DET
eurjchem-2084	132	11	cns	cns	NOUN
eurjchem-2084	132	12	either	either	CCONJ
eurjchem-2084	132	13	by	by	ADP
eurjchem-2084	132	14	blood	blood	NOUN
eurjchem-2084	132	15	stream	stream	NOUN
eurjchem-2084	132	16	or	or	CCONJ
eurjchem-2084	132	17	by	by	ADP
eurjchem-2084	132	18	retrograde	retrograde	ADJ
eurjchem-2084	132	19	neuronal	neuronal	ADJ
eurjchem-2084	132	20	transport	transport	NOUN
eurjchem-2084	132	21	and	and	CCONJ
eurjchem-2084	132	22	can	can	AUX
eurjchem-2084	132	23	cause	cause	VERB
eurjchem-2084	132	24	neurological	neurological	ADJ
eurjchem-2084	132	25	abnormalities	abnormality	NOUN
eurjchem-2084	132	26	[	[	X
eurjchem-2084	132	27	36	36	NUM
eurjchem-2084	132	28	]	]	PUNCT
eurjchem-2084	132	29	.	.	PUNCT
eurjchem-2084	133	1	the	the	DET
eurjchem-2084	133	2	expression	expression	NOUN
eurjchem-2084	133	3	of	of	ADP
eurjchem-2084	133	4	ace-2	ace-2	PUNCT
eurjchem-2084	133	5	in	in	ADP
eurjchem-2084	133	6	the	the	DET
eurjchem-2084	133	7	cns	cns	NOUN
eurjchem-2084	133	8	encourages	encourage	VERB
eurjchem-2084	133	9	viral	viral	ADJ
eurjchem-2084	133	10	entry	entry	NOUN
eurjchem-2084	133	11	to	to	ADP
eurjchem-2084	133	12	the	the	DET
eurjchem-2084	133	13	brain	brain	NOUN
eurjchem-2084	133	14	[	[	X
eurjchem-2084	133	15	37	37	NUM
eurjchem-2084	133	16	]	]	PUNCT
eurjchem-2084	133	17	.	.	PUNCT
eurjchem-2084	134	1	the	the	DET
eurjchem-2084	134	2	direct	direct	ADJ
eurjchem-2084	134	3	pathology	pathology	NOUN
eurjchem-2084	134	4	of	of	ADP
eurjchem-2084	134	5	neuro	neuro	NOUN
eurjchem-2084	134	6	-	-	PUNCT
eurjchem-2084	134	7	invasion	invasion	NOUN
eurjchem-2084	134	8	has	have	AUX
eurjchem-2084	134	9	not	not	PART
eurjchem-2084	134	10	yet	yet	ADV
eurjchem-2084	134	11	been	be	AUX
eurjchem-2084	134	12	identified	identify	VERB
eurjchem-2084	134	13	for	for	ADP
eurjchem-2084	134	14	sars	sar	NOUN
eurjchem-2084	134	15	-	-	PUNCT
eurjchem-2084	134	16	cov-2	cov-2	NOUN
eurjchem-2084	134	17	,	,	PUNCT
eurjchem-2084	134	18	but	but	CCONJ
eurjchem-2084	134	19	virus	virus	NOUN
eurjchem-2084	134	20	particles	particle	NOUN
eurjchem-2084	134	21	have	have	AUX
eurjchem-2084	134	22	been	be	AUX
eurjchem-2084	134	23	detected	detect	VERB
eurjchem-2084	134	24	in	in	ADP
eurjchem-2084	134	25	brain	brain	NOUN
eurjchem-2084	134	26	autopsy	autopsy	ADJ
eurjchem-2084	134	27	samples	sample	NOUN
eurjchem-2084	134	28	[	[	X
eurjchem-2084	134	29	38	38	NUM
eurjchem-2084	134	30	]	]	PUNCT
eurjchem-2084	134	31	.	.	PUNCT
eurjchem-2084	135	1	in	in	ADP
eurjchem-2084	135	2	a	a	DET
eurjchem-2084	135	3	clinical	clinical	ADJ
eurjchem-2084	135	4	study	study	NOUN
eurjchem-2084	135	5	based	base	VERB
eurjchem-2084	135	6	on	on	ADP
eurjchem-2084	135	7	214	214	NUM
eurjchem-2084	135	8	covid-19	covid-19	PROPN
eurjchem-2084	135	9	patients	patient	NOUN
eurjchem-2084	135	10	,	,	PUNCT
eurjchem-2084	135	11	78	78	NUM
eurjchem-2084	135	12	(	(	PUNCT
eurjchem-2084	135	13	36.4	36.4	NUM
eurjchem-2084	135	14	%	%	NOUN
eurjchem-2084	135	15	)	)	PUNCT
eurjchem-2084	135	16	cases	case	NOUN
eurjchem-2084	135	17	of	of	ADP
eurjchem-2084	135	18	neurological	neurological	ADJ
eurjchem-2084	135	19	disorders	disorder	NOUN
eurjchem-2084	135	20	revealed	reveal	VERB
eurjchem-2084	135	21	a	a	DET
eurjchem-2084	135	22	high	high	ADJ
eurjchem-2084	135	23	prevalence	prevalence	NOUN
eurjchem-2084	135	24	of	of	ADP
eurjchem-2084	135	25	neurological	neurological	ADJ
eurjchem-2084	135	26	symptoms	symptom	NOUN
eurjchem-2084	135	27	in	in	ADP
eurjchem-2084	135	28	covid-19	covid-19	PROPN
eurjchem-2084	135	29	patients	patient	NOUN
eurjchem-2084	135	30	[	[	X
eurjchem-2084	135	31	39	39	NUM
eurjchem-2084	135	32	]	]	PUNCT
eurjchem-2084	135	33	.	.	PUNCT
eurjchem-2084	136	1	5.4	5.4	NUM
eurjchem-2084	136	2	.	.	PUNCT
eurjchem-2084	137	1	how	how	SCONJ
eurjchem-2084	137	2	does	do	AUX
eurjchem-2084	137	3	the	the	DET
eurjchem-2084	137	4	immune	immune	ADJ
eurjchem-2084	137	5	system	system	NOUN
eurjchem-2084	137	6	respond	respond	VERB
eurjchem-2084	137	7	to	to	ADP
eurjchem-2084	137	8	the	the	DET
eurjchem-2084	137	9	virus	virus	NOUN
eurjchem-2084	137	10	?	?	PUNCT
eurjchem-2084	138	1	the	the	DET
eurjchem-2084	138	2	cellular	cellular	ADJ
eurjchem-2084	138	3	immune	immune	ADJ
eurjchem-2084	138	4	response	response	NOUN
eurjchem-2084	138	5	involves	involve	VERB
eurjchem-2084	138	6	activation	activation	NOUN
eurjchem-2084	138	7	of	of	ADP
eurjchem-2084	138	8	cd4	cd4	PROPN
eurjchem-2084	138	9	+	+	PROPN
eurjchem-2084	138	10	and	and	CCONJ
eurjchem-2084	138	11	cd8	cd8	PROPN
eurjchem-2084	138	12	+	+	PROPN
eurjchem-2084	138	13	t	t	PROPN
eurjchem-2084	138	14	-	-	PUNCT
eurjchem-2084	138	15	cells	cell	NOUN
eurjchem-2084	138	16	.	.	PUNCT
eurjchem-2084	139	1	the	the	DET
eurjchem-2084	139	2	functions	function	NOUN
eurjchem-2084	139	3	of	of	ADP
eurjchem-2084	139	4	cd4	cd4	PROPN
eurjchem-2084	139	5	+	+	PROPN
eurjchem-2084	139	6	t	t	PROPN
eurjchem-2084	139	7	-	-	PUNCT
eurjchem-2084	139	8	cells	cell	NOUN
eurjchem-2084	139	9	include	include	VERB
eurjchem-2084	139	10	the	the	DET
eurjchem-2084	139	11	production	production	NOUN
eurjchem-2084	139	12	of	of	ADP
eurjchem-2084	139	13	antibodies	antibody	NOUN
eurjchem-2084	139	14	(	(	PUNCT
eurjchem-2084	139	15	abs	ab	NOUN
eurjchem-2084	139	16	)	)	PUNCT
eurjchem-2084	139	17	(	(	PUNCT
eurjchem-2084	139	18	igm	igm	PROPN
eurjchem-2084	139	19	,	,	PUNCT
eurjchem-2084	139	20	iga	iga	PROPN
eurjchem-2084	139	21	&	&	CCONJ
eurjchem-2084	139	22	igg	igg	PROPN
eurjchem-2084	139	23	)	)	PUNCT
eurjchem-2084	139	24	against	against	ADP
eurjchem-2084	139	25	s	s	PROPN
eurjchem-2084	139	26	,	,	PUNCT
eurjchem-2084	139	27	rbd	rbd	NOUN
eurjchem-2084	139	28	,	,	PUNCT
eurjchem-2084	139	29	and	and	CCONJ
eurjchem-2084	139	30	n	n	NUM
eurjchem-2084	139	31	proteins	protein	NOUN
eurjchem-2084	139	32	of	of	ADP
eurjchem-2084	139	33	the	the	DET
eurjchem-2084	139	34	virus	virus	NOUN
eurjchem-2084	139	35	and	and	CCONJ
eurjchem-2084	139	36	cd8	cd8	PROPN
eurjchem-2084	139	37	+	+	PROPN
eurjchem-2084	139	38	t	t	PROPN
eurjchem-2084	139	39	-	-	PUNCT
eurjchem-2084	139	40	cells	cell	NOUN
eurjchem-2084	139	41	clear	clear	VERB
eurjchem-2084	139	42	the	the	DET
eurjchem-2084	139	43	infected	infected	ADJ
eurjchem-2084	139	44	cells	cell	NOUN
eurjchem-2084	139	45	of	of	ADP
eurjchem-2084	139	46	the	the	DET
eurjchem-2084	139	47	host	host	NOUN
eurjchem-2084	139	48	[	[	X
eurjchem-2084	139	49	40	40	NUM
eurjchem-2084	139	50	]	]	PUNCT
eurjchem-2084	139	51	.	.	PUNCT
eurjchem-2084	140	1	the	the	DET
eurjchem-2084	140	2	formation	formation	NOUN
eurjchem-2084	140	3	of	of	ADP
eurjchem-2084	140	4	antibodies	antibody	NOUN
eurjchem-2084	140	5	against	against	ADP
eurjchem-2084	140	6	viral	viral	ADJ
eurjchem-2084	140	7	proteins	protein	NOUN
eurjchem-2084	140	8	confers	confer	NOUN
eurjchem-2084	140	9	the	the	DET
eurjchem-2084	140	10	development	development	NOUN
eurjchem-2084	140	11	of	of	ADP
eurjchem-2084	140	12	many	many	ADJ
eurjchem-2084	140	13	vaccines	vaccine	NOUN
eurjchem-2084	140	14	under	under	ADP
eurjchem-2084	140	15	clinical	clinical	ADJ
eurjchem-2084	140	16	trials	trial	NOUN
eurjchem-2084	140	17	.	.	PUNCT
eurjchem-2084	141	1	moreover	moreover	ADV
eurjchem-2084	141	2	,	,	PUNCT
eurjchem-2084	141	3	the	the	DET
eurjchem-2084	141	4	presence	presence	NOUN
eurjchem-2084	141	5	of	of	ADP
eurjchem-2084	141	6	abs	ab	NOUN
eurjchem-2084	141	7	in	in	ADP
eurjchem-2084	141	8	the	the	DET
eurjchem-2084	141	9	serum	serum	NOUN
eurjchem-2084	141	10	sample	sample	NOUN
eurjchem-2084	141	11	of	of	ADP
eurjchem-2084	141	12	sars	sar	NOUN
eurjchem-2084	141	13	-	-	PUNCT
eurjchem-2084	141	14	cov-2	cov-2	NOUN
eurjchem-2084	141	15	infected	infected	ADJ
eurjchem-2084	141	16	patients	patient	NOUN
eurjchem-2084	141	17	was	be	AUX
eurjchem-2084	141	18	considered	consider	VERB
eurjchem-2084	141	19	beneficial	beneficial	ADJ
eurjchem-2084	141	20	for	for	ADP
eurjchem-2084	141	21	the	the	DET
eurjchem-2084	141	22	formation	formation	NOUN
eurjchem-2084	141	23	of	of	ADP
eurjchem-2084	141	24	protective	protective	ADJ
eurjchem-2084	141	25	immunity	immunity	NOUN
eurjchem-2084	141	26	.	.	PUNCT
eurjchem-2084	142	1	the	the	DET
eurjchem-2084	142	2	available	available	ADJ
eurjchem-2084	142	3	data	datum	NOUN
eurjchem-2084	142	4	suggested	suggest	VERB
eurjchem-2084	142	5	that	that	SCONJ
eurjchem-2084	142	6	in	in	ADP
eurjchem-2084	142	7	most	most	ADJ
eurjchem-2084	142	8	cases	case	NOUN
eurjchem-2084	142	9	of	of	ADP
eurjchem-2084	142	10	sarscov-2	sarscov-2	NUM
eurjchem-2084	142	11	infection	infection	NOUN
eurjchem-2084	142	12	,	,	PUNCT
eurjchem-2084	142	13	the	the	DET
eurjchem-2084	142	14	immune	immune	ADJ
eurjchem-2084	142	15	response	response	NOUN
eurjchem-2084	142	16	was	be	AUX
eurjchem-2084	142	17	displayed	display	VERB
eurjchem-2084	142	18	during	during	ADP
eurjchem-2084	142	19	710	710	NUM
eurjchem-2084	142	20	days	day	NOUN
eurjchem-2084	142	21	after	after	ADP
eurjchem-2084	142	22	infection	infection	NOUN
eurjchem-2084	142	23	.	.	PUNCT
eurjchem-2084	143	1	226	226	NUM
eurjchem-2084	143	2	firdaus	firdaus	PROPN
eurjchem-2084	143	3	et	et	PROPN
eurjchem-2084	143	4	al	al	PROPN
eurjchem-2084	143	5	.	.	PUNCT
eurjchem-2084	143	6	/	/	SYM
eurjchem-2084	143	7	european	european	PROPN
eurjchem-2084	143	8	journal	journal	PROPN
eurjchem-2084	143	9	of	of	ADP
eurjchem-2084	143	10	chemistry	chemistry	NOUN
eurjchem-2084	143	11	12	12	NUM
eurjchem-2084	143	12	(	(	PUNCT
eurjchem-2084	143	13	2	2	NUM
eurjchem-2084	143	14	)	)	PUNCT
eurjchem-2084	143	15	(	(	PUNCT
eurjchem-2084	143	16	2021	2021	NUM
eurjchem-2084	143	17	)	)	PUNCT
eurjchem-2084	143	18	222	222	NUM
eurjchem-2084	143	19	-	-	SYM
eurjchem-2084	143	20	234	234	NUM
eurjchem-2084	143	21	2021	2021	NUM
eurjchem-2084	143	22	–	–	PUNCT
eurjchem-2084	143	23	european	european	ADJ
eurjchem-2084	143	24	journal	journal	NOUN
eurjchem-2084	143	25	of	of	ADP
eurjchem-2084	143	26	chemistry	chemistry	NOUN
eurjchem-2084	143	27	–	–	PUNCT
eurjchem-2084	143	28	cc	cc	NOUN
eurjchem-2084	143	29	by	by	ADP
eurjchem-2084	143	30	nc	nc	PROPN
eurjchem-2084	143	31	–	–	PUNCT
eurjchem-2084	143	32	doi	doi	NOUN
eurjchem-2084	143	33	:	:	PUNCT
eurjchem-2084	143	34	10.5155	10.5155	NUM
eurjchem-2084	143	35	/	/	SYM
eurjchem-2084	143	36	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	143	37	-	-	PUNCT
eurjchem-2084	143	38	234.2084	234.2084	NUM
eurjchem-2084	143	39	figure	figure	NOUN
eurjchem-2084	143	40	5	5	NUM
eurjchem-2084	143	41	.	.	PUNCT
eurjchem-2084	143	42	schematic	schematic	ADJ
eurjchem-2084	143	43	presentation	presentation	NOUN
eurjchem-2084	143	44	of	of	ADP
eurjchem-2084	143	45	pathogenicity	pathogenicity	NOUN
eurjchem-2084	143	46	caused	cause	VERB
eurjchem-2084	143	47	by	by	ADP
eurjchem-2084	143	48	sars	sar	NOUN
eurjchem-2084	143	49	-	-	PUNCT
eurjchem-2084	143	50	cov-2	cov-2	PART
eurjchem-2084	143	51	infection	infection	NOUN
eurjchem-2084	143	52	.	.	PUNCT
eurjchem-2084	144	1	the	the	DET
eurjchem-2084	144	2	rapidly	rapidly	ADV
eurjchem-2084	144	3	proliferating	proliferate	VERB
eurjchem-2084	144	4	viral	viral	ADJ
eurjchem-2084	144	5	population	population	NOUN
eurjchem-2084	144	6	leads	lead	VERB
eurjchem-2084	144	7	to	to	PART
eurjchem-2084	144	8	cytokine	cytokine	VERB
eurjchem-2084	144	9	production	production	NOUN
eurjchem-2084	144	10	inside	inside	ADP
eurjchem-2084	144	11	the	the	DET
eurjchem-2084	144	12	epithelial	epithelial	ADJ
eurjchem-2084	144	13	cell	cell	NOUN
eurjchem-2084	144	14	.	.	PUNCT
eurjchem-2084	145	1	the	the	DET
eurjchem-2084	145	2	cytokine	cytokine	NOUN
eurjchem-2084	145	3	storm	storm	NOUN
eurjchem-2084	145	4	includes	include	VERB
eurjchem-2084	145	5	il-6	il-6	PRON
eurjchem-2084	145	6	,	,	PUNCT
eurjchem-2084	145	7	il-12	il-12	NOUN
eurjchem-2084	145	8	,	,	PUNCT
eurjchem-2084	145	9	il-18	il-18	ADP
eurjchem-2084	145	10	,	,	PUNCT
eurjchem-2084	145	11	crp	crp	PROPN
eurjchem-2084	145	12	,	,	PUNCT
eurjchem-2084	145	13	and	and	CCONJ
eurjchem-2084	145	14	d	d	X
eurjchem-2084	145	15	-	-	PUNCT
eurjchem-2084	145	16	dimer	dimer	NOUN
eurjchem-2084	145	17	which	which	PRON
eurjchem-2084	145	18	causes	cause	VERB
eurjchem-2084	145	19	acute	acute	ADJ
eurjchem-2084	145	20	respiratory	respiratory	ADJ
eurjchem-2084	145	21	distress	distress	NOUN
eurjchem-2084	145	22	syndrome	syndrome	NOUN
eurjchem-2084	145	23	(	(	PUNCT
eurjchem-2084	145	24	ards	ard	NOUN
eurjchem-2084	145	25	)	)	PUNCT
eurjchem-2084	145	26	in	in	ADP
eurjchem-2084	145	27	lungs	lung	NOUN
eurjchem-2084	145	28	leading	lead	VERB
eurjchem-2084	145	29	to	to	ADP
eurjchem-2084	145	30	respiratory	respiratory	ADJ
eurjchem-2084	145	31	failure	failure	NOUN
eurjchem-2084	145	32	and	and	CCONJ
eurjchem-2084	145	33	death	death	NOUN
eurjchem-2084	145	34	.	.	PUNCT
eurjchem-2084	146	1	the	the	DET
eurjchem-2084	146	2	cytokine	cytokine	NOUN
eurjchem-2084	146	3	storm	storm	NOUN
eurjchem-2084	146	4	also	also	ADV
eurjchem-2084	146	5	affects	affect	VERB
eurjchem-2084	146	6	the	the	DET
eurjchem-2084	146	7	cardiovascular	cardiovascular	ADJ
eurjchem-2084	146	8	system	system	NOUN
eurjchem-2084	146	9	and	and	CCONJ
eurjchem-2084	146	10	cns	cns	NOUN
eurjchem-2084	146	11	by	by	ADP
eurjchem-2084	146	12	systematic	systematic	ADJ
eurjchem-2084	146	13	inflammation	inflammation	NOUN
eurjchem-2084	146	14	and	and	CCONJ
eurjchem-2084	146	15	leads	lead	VERB
eurjchem-2084	146	16	to	to	ADP
eurjchem-2084	146	17	cardiac	cardiac	ADJ
eurjchem-2084	146	18	arrhythmias	arrhythmia	NOUN
eurjchem-2084	146	19	,	,	PUNCT
eurjchem-2084	146	20	intravascular	intravascular	ADJ
eurjchem-2084	146	21	thrombosis	thrombosis	NOUN
eurjchem-2084	146	22	,	,	PUNCT
eurjchem-2084	146	23	intracranial	intracranial	ADJ
eurjchem-2084	146	24	hemorrhage	hemorrhage	NOUN
eurjchem-2084	146	25	,	,	PUNCT
eurjchem-2084	146	26	heart	heart	NOUN
eurjchem-2084	146	27	failure	failure	NOUN
eurjchem-2084	146	28	and	and	CCONJ
eurjchem-2084	146	29	death	death	NOUN
eurjchem-2084	146	30	.	.	PUNCT
eurjchem-2084	147	1	the	the	DET
eurjchem-2084	147	2	presence	presence	NOUN
eurjchem-2084	147	3	of	of	ADP
eurjchem-2084	147	4	igm	igm	PROPN
eurjchem-2084	147	5	and	and	CCONJ
eurjchem-2084	147	6	iga	iga	PROPN
eurjchem-2084	147	7	was	be	AUX
eurjchem-2084	147	8	detected	detect	VERB
eurjchem-2084	147	9	in	in	ADP
eurjchem-2084	147	10	5	5	NUM
eurjchem-2084	147	11	-	-	SYM
eurjchem-2084	147	12	7	7	NUM
eurjchem-2084	147	13	days	day	NOUN
eurjchem-2084	147	14	and	and	CCONJ
eurjchem-2084	147	15	igg	igg	PROPN
eurjchem-2084	147	16	was	be	AUX
eurjchem-2084	147	17	detected	detect	VERB
eurjchem-2084	147	18	in	in	ADP
eurjchem-2084	147	19	between	between	ADP
eurjchem-2084	147	20	7	7	NUM
eurjchem-2084	147	21	-	-	SYM
eurjchem-2084	147	22	10	10	NUM
eurjchem-2084	147	23	days	day	NOUN
eurjchem-2084	147	24	of	of	ADP
eurjchem-2084	147	25	onset	onset	NOUN
eurjchem-2084	147	26	of	of	ADP
eurjchem-2084	147	27	disease	disease	NOUN
eurjchem-2084	147	28	[	[	X
eurjchem-2084	147	29	41	41	NUM
eurjchem-2084	147	30	]	]	PUNCT
eurjchem-2084	147	31	.	.	PUNCT
eurjchem-2084	148	1	the	the	DET
eurjchem-2084	148	2	longevity	longevity	NOUN
eurjchem-2084	148	3	of	of	ADP
eurjchem-2084	148	4	abs	ab	NOUN
eurjchem-2084	148	5	is	be	AUX
eurjchem-2084	148	6	also	also	ADV
eurjchem-2084	148	7	not	not	PART
eurjchem-2084	148	8	ascertained	ascertain	VERB
eurjchem-2084	148	9	in	in	ADP
eurjchem-2084	148	10	sars	sar	NOUN
eurjchem-2084	148	11	-	-	PUNCT
eurjchem-2084	148	12	cov-2	cov-2	PART
eurjchem-2084	148	13	infection	infection	NOUN
eurjchem-2084	148	14	,	,	PUNCT
eurjchem-2084	148	15	but	but	CCONJ
eurjchem-2084	148	16	seasonal	seasonal	ADJ
eurjchem-2084	148	17	coronaviruses	coronaviruse	NOUN
eurjchem-2084	148	18	impart	impart	VERB
eurjchem-2084	148	19	protection	protection	NOUN
eurjchem-2084	148	20	for	for	ADP
eurjchem-2084	148	21	short	short	ADJ
eurjchem-2084	148	22	duration	duration	NOUN
eurjchem-2084	148	23	.	.	PUNCT
eurjchem-2084	149	1	in	in	ADP
eurjchem-2084	149	2	earlier	early	ADJ
eurjchem-2084	149	3	sars	sars	PROPN
eurjchem-2084	149	4	infections	infection	NOUN
eurjchem-2084	149	5	,	,	PUNCT
eurjchem-2084	149	6	ab	ab	PROPN
eurjchem-2084	149	7	was	be	AUX
eurjchem-2084	149	8	found	find	VERB
eurjchem-2084	149	9	to	to	PART
eurjchem-2084	149	10	diminish	diminish	VERB
eurjchem-2084	149	11	by	by	ADP
eurjchem-2084	149	12	12	12	NUM
eurjchem-2084	149	13	-	-	SYM
eurjchem-2084	149	14	52	52	NUM
eurjchem-2084	149	15	weeks	week	NOUN
eurjchem-2084	149	16	of	of	ADP
eurjchem-2084	149	17	onset	onset	NOUN
eurjchem-2084	149	18	of	of	ADP
eurjchem-2084	149	19	symptoms	symptom	NOUN
eurjchem-2084	149	20	.	.	PUNCT
eurjchem-2084	150	1	similarly	similarly	ADV
eurjchem-2084	150	2	,	,	PUNCT
eurjchem-2084	150	3	in	in	ADP
eurjchem-2084	150	4	sars	sar	NOUN
eurjchem-2084	150	5	-	-	PUNCT
eurjchem-2084	150	6	cov-2	cov-2	PART
eurjchem-2084	150	7	infection	infection	NOUN
eurjchem-2084	150	8	,	,	PUNCT
eurjchem-2084	150	9	a	a	DET
eurjchem-2084	150	10	decline	decline	NOUN
eurjchem-2084	150	11	in	in	ADP
eurjchem-2084	150	12	serum	serum	NOUN
eurjchem-2084	150	13	igm	igm	PROPN
eurjchem-2084	150	14	and	and	CCONJ
eurjchem-2084	150	15	iga	iga	PROPN
eurjchem-2084	150	16	titers	titer	NOUN
eurjchem-2084	150	17	was	be	AUX
eurjchem-2084	150	18	found	find	VERB
eurjchem-2084	150	19	after	after	ADP
eurjchem-2084	150	20	4	4	NUM
eurjchem-2084	150	21	weeks	week	NOUN
eurjchem-2084	150	22	of	of	ADP
eurjchem-2084	150	23	onset	onset	NOUN
eurjchem-2084	150	24	of	of	ADP
eurjchem-2084	150	25	symptoms	symptom	NOUN
eurjchem-2084	150	26	,	,	PUNCT
eurjchem-2084	150	27	whereas	whereas	SCONJ
eurjchem-2084	150	28	the	the	DET
eurjchem-2084	150	29	igg	igg	NOUN
eurjchem-2084	150	30	remained	remain	VERB
eurjchem-2084	150	31	at	at	ADP
eurjchem-2084	150	32	peak	peak	NOUN
eurjchem-2084	150	33	for	for	ADP
eurjchem-2084	150	34	at	at	ADV
eurjchem-2084	150	35	least	least	ADV
eurjchem-2084	150	36	7	7	NUM
eurjchem-2084	150	37	weeks	week	NOUN
eurjchem-2084	151	1	[	[	X
eurjchem-2084	151	2	42	42	NUM
eurjchem-2084	151	3	]	]	PUNCT
eurjchem-2084	151	4	.	.	PUNCT
eurjchem-2084	152	1	a	a	DET
eurjchem-2084	152	2	group	group	NOUN
eurjchem-2084	152	3	of	of	ADP
eurjchem-2084	152	4	122	122	NUM
eurjchem-2084	152	5	people	people	NOUN
eurjchem-2084	152	6	on	on	ADP
eurjchem-2084	152	7	an	an	DET
eurjchem-2084	152	8	us	us	PROPN
eurjchem-2084	152	9	fishing	fishing	NOUN
eurjchem-2084	152	10	boat	boat	NOUN
eurjchem-2084	152	11	were	be	AUX
eurjchem-2084	152	12	tested	test	VERB
eurjchem-2084	152	13	for	for	ADP
eurjchem-2084	152	14	sars	sar	NOUN
eurjchem-2084	152	15	-	-	PUNCT
eurjchem-2084	152	16	cov-2	cov-2	NOUN
eurjchem-2084	152	17	and	and	CCONJ
eurjchem-2084	152	18	its	its	PRON
eurjchem-2084	152	19	antibodies	antibody	NOUN
eurjchem-2084	152	20	before	before	ADV
eurjchem-2084	152	21	and	and	CCONJ
eurjchem-2084	152	22	after	after	ADP
eurjchem-2084	152	23	viral	viral	ADJ
eurjchem-2084	152	24	exposure	exposure	NOUN
eurjchem-2084	152	25	.	.	PUNCT
eurjchem-2084	153	1	it	it	PRON
eurjchem-2084	153	2	was	be	AUX
eurjchem-2084	153	3	reported	report	VERB
eurjchem-2084	153	4	that	that	SCONJ
eurjchem-2084	153	5	104	104	NUM
eurjchem-2084	153	6	members	member	NOUN
eurjchem-2084	153	7	tested	test	VERB
eurjchem-2084	153	8	covid-19	covid-19	PROPN
eurjchem-2084	153	9	positive	positive	ADJ
eurjchem-2084	153	10	,	,	PUNCT
eurjchem-2084	153	11	but	but	CCONJ
eurjchem-2084	153	12	3	3	NUM
eurjchem-2084	153	13	people	people	NOUN
eurjchem-2084	153	14	who	who	PRON
eurjchem-2084	153	15	showed	show	VERB
eurjchem-2084	153	16	antibodies	antibody	NOUN
eurjchem-2084	153	17	before	before	SCONJ
eurjchem-2084	153	18	exposure	exposure	NOUN
eurjchem-2084	153	19	escaped	escape	VERB
eurjchem-2084	153	20	the	the	DET
eurjchem-2084	153	21	infection	infection	NOUN
eurjchem-2084	153	22	.	.	PUNCT
eurjchem-2084	154	1	the	the	DET
eurjchem-2084	154	2	study	study	NOUN
eurjchem-2084	154	3	,	,	PUNCT
eurjchem-2084	154	4	therefore	therefore	ADV
eurjchem-2084	154	5	,	,	PUNCT
eurjchem-2084	154	6	provided	provide	VERB
eurjchem-2084	154	7	statistically	statistically	ADV
eurjchem-2084	154	8	significant	significant	ADJ
eurjchem-2084	154	9	data	datum	NOUN
eurjchem-2084	154	10	to	to	PART
eurjchem-2084	154	11	support	support	VERB
eurjchem-2084	154	12	the	the	DET
eurjchem-2084	154	13	hypothesis	hypothesis	NOUN
eurjchem-2084	154	14	of	of	ADP
eurjchem-2084	154	15	acquired	acquire	VERB
eurjchem-2084	154	16	immunity	immunity	NOUN
eurjchem-2084	154	17	in	in	ADP
eurjchem-2084	154	18	case	case	NOUN
eurjchem-2084	154	19	of	of	ADP
eurjchem-2084	154	20	sarscov-2	sarscov-2	NUM
eurjchem-2084	154	21	infection	infection	NOUN
eurjchem-2084	155	1	[	[	X
eurjchem-2084	155	2	43	43	NUM
eurjchem-2084	155	3	]	]	PUNCT
eurjchem-2084	155	4	.	.	PUNCT
eurjchem-2084	156	1	however	however	ADV
eurjchem-2084	156	2	,	,	PUNCT
eurjchem-2084	156	3	gradually	gradually	ADV
eurjchem-2084	156	4	,	,	PUNCT
eurjchem-2084	156	5	cases	case	NOUN
eurjchem-2084	156	6	from	from	ADP
eurjchem-2084	156	7	many	many	ADJ
eurjchem-2084	156	8	countries	country	NOUN
eurjchem-2084	156	9	have	have	AUX
eurjchem-2084	156	10	been	be	AUX
eurjchem-2084	156	11	reported	report	VERB
eurjchem-2084	156	12	claiming	claim	VERB
eurjchem-2084	156	13	the	the	DET
eurjchem-2084	156	14	reinfection	reinfection	NOUN
eurjchem-2084	156	15	of	of	ADP
eurjchem-2084	156	16	sarscov-2	sarscov-2	NUM
eurjchem-2084	157	1	[	[	X
eurjchem-2084	157	2	44	44	NUM
eurjchem-2084	157	3	]	]	PUNCT
eurjchem-2084	157	4	.	.	PUNCT
eurjchem-2084	158	1	the	the	DET
eurjchem-2084	158	2	duration	duration	NOUN
eurjchem-2084	158	3	of	of	ADP
eurjchem-2084	158	4	protection	protection	NOUN
eurjchem-2084	158	5	of	of	ADP
eurjchem-2084	158	6	host	host	NOUN
eurjchem-2084	158	7	cells	cell	NOUN
eurjchem-2084	158	8	by	by	ADP
eurjchem-2084	158	9	antibodies	antibody	NOUN
eurjchem-2084	158	10	against	against	ADP
eurjchem-2084	158	11	reinfection	reinfection	NOUN
eurjchem-2084	158	12	is	be	AUX
eurjchem-2084	158	13	still	still	ADV
eurjchem-2084	158	14	uncertain	uncertain	ADJ
eurjchem-2084	158	15	.	.	PUNCT
eurjchem-2084	159	1	all	all	DET
eurjchem-2084	159	2	available	available	ADJ
eurjchem-2084	159	3	reports	report	NOUN
eurjchem-2084	159	4	on	on	ADP
eurjchem-2084	159	5	the	the	DET
eurjchem-2084	159	6	formation	formation	NOUN
eurjchem-2084	159	7	of	of	ADP
eurjchem-2084	159	8	protective	protective	ADJ
eurjchem-2084	159	9	immunity	immunity	NOUN
eurjchem-2084	159	10	due	due	ADP
eurjchem-2084	159	11	to	to	ADP
eurjchem-2084	159	12	sarscov-2	sarscov-2	NUM
eurjchem-2084	159	13	infection	infection	NOUN
eurjchem-2084	159	14	include	include	VERB
eurjchem-2084	159	15	data	datum	NOUN
eurjchem-2084	159	16	analysis	analysis	NOUN
eurjchem-2084	159	17	of	of	ADP
eurjchem-2084	159	18	short	short	ADJ
eurjchem-2084	159	19	duration	duration	NOUN
eurjchem-2084	159	20	.	.	PUNCT
eurjchem-2084	160	1	therefore	therefore	ADV
eurjchem-2084	160	2	,	,	PUNCT
eurjchem-2084	160	3	longer	long	ADJ
eurjchem-2084	160	4	duration	duration	NOUN
eurjchem-2084	160	5	data	datum	NOUN
eurjchem-2084	160	6	analysis	analysis	NOUN
eurjchem-2084	160	7	is	be	AUX
eurjchem-2084	160	8	needed	need	VERB
eurjchem-2084	160	9	to	to	PART
eurjchem-2084	160	10	understand	understand	VERB
eurjchem-2084	160	11	the	the	DET
eurjchem-2084	160	12	longevity	longevity	NOUN
eurjchem-2084	160	13	of	of	ADP
eurjchem-2084	160	14	memory	memory	NOUN
eurjchem-2084	160	15	and	and	CCONJ
eurjchem-2084	160	16	host	host	NOUN
eurjchem-2084	160	17	cell	cell	NOUN
eurjchem-2084	160	18	protection	protection	NOUN
eurjchem-2084	160	19	.	.	PUNCT
eurjchem-2084	161	1	6	6	NUM
eurjchem-2084	161	2	.	.	X
eurjchem-2084	161	3	viral	viral	ADJ
eurjchem-2084	161	4	infection	infection	NOUN
eurjchem-2084	161	5	into	into	ADP
eurjchem-2084	161	6	global	global	ADJ
eurjchem-2084	161	7	pandemic	pandemic	NOUN
eurjchem-2084	161	8	the	the	DET
eurjchem-2084	161	9	first	first	ADJ
eurjchem-2084	161	10	case	case	NOUN
eurjchem-2084	161	11	of	of	ADP
eurjchem-2084	161	12	sars	sar	NOUN
eurjchem-2084	161	13	-	-	PUNCT
eurjchem-2084	161	14	cov-2	cov-2	NOUN
eurjchem-2084	161	15	transfer	transfer	NOUN
eurjchem-2084	161	16	from	from	ADP
eurjchem-2084	161	17	bat	bat	NOUN
eurjchem-2084	161	18	to	to	ADP
eurjchem-2084	161	19	human	human	NOUN
eurjchem-2084	161	20	was	be	AUX
eurjchem-2084	161	21	reported	report	VERB
eurjchem-2084	161	22	at	at	ADP
eurjchem-2084	161	23	wuhan	wuhan	PROPN
eurjchem-2084	161	24	seafood	seafood	PROPN
eurjchem-2084	161	25	market	market	NOUN
eurjchem-2084	161	26	in	in	ADP
eurjchem-2084	161	27	china	china	PROPN
eurjchem-2084	161	28	,	,	PUNCT
eurjchem-2084	161	29	where	where	SCONJ
eurjchem-2084	161	30	live	live	ADJ
eurjchem-2084	161	31	animals	animal	NOUN
eurjchem-2084	161	32	are	be	AUX
eurjchem-2084	161	33	sold	sell	VERB
eurjchem-2084	161	34	regularly	regularly	ADV
eurjchem-2084	161	35	.	.	PUNCT
eurjchem-2084	162	1	since	since	SCONJ
eurjchem-2084	162	2	the	the	DET
eurjchem-2084	162	3	first	first	ADJ
eurjchem-2084	162	4	incident	incident	NOUN
eurjchem-2084	162	5	,	,	PUNCT
eurjchem-2084	162	6	the	the	DET
eurjchem-2084	162	7	number	number	NOUN
eurjchem-2084	162	8	of	of	ADP
eurjchem-2084	162	9	infected	infected	ADJ
eurjchem-2084	162	10	people	people	NOUN
eurjchem-2084	162	11	has	have	AUX
eurjchem-2084	162	12	gone	go	VERB
eurjchem-2084	162	13	up	up	ADP
eurjchem-2084	162	14	exponentially	exponentially	ADV
eurjchem-2084	162	15	.	.	PUNCT
eurjchem-2084	163	1	although	although	SCONJ
eurjchem-2084	163	2	,	,	PUNCT
eurjchem-2084	163	3	several	several	ADJ
eurjchem-2084	163	4	victims	victim	NOUN
eurjchem-2084	163	5	did	do	AUX
eurjchem-2084	163	6	not	not	PART
eurjchem-2084	163	7	have	have	VERB
eurjchem-2084	163	8	direct	direct	ADJ
eurjchem-2084	163	9	contact	contact	NOUN
eurjchem-2084	163	10	with	with	ADP
eurjchem-2084	163	11	the	the	DET
eurjchem-2084	163	12	market	market	NOUN
eurjchem-2084	163	13	thus	thus	ADV
eurjchem-2084	163	14	suggesting	suggest	VERB
eurjchem-2084	163	15	local	local	ADJ
eurjchem-2084	163	16	human	human	NOUN
eurjchem-2084	163	17	-	-	PUNCT
eurjchem-2084	163	18	to	to	PART
eurjchem-2084	163	19	--	--	PUNCT
eurjchem-2084	163	20	to	to	ADP
eurjchem-2084	163	21	-	-	PUNCT
eurjchem-2084	163	22	human	human	ADJ
eurjchem-2084	163	23	transmission	transmission	NOUN
eurjchem-2084	163	24	and	and	CCONJ
eurjchem-2084	163	25	even	even	ADV
eurjchem-2084	163	26	more	more	ADV
eurjchem-2084	163	27	dangerous	dangerous	ADJ
eurjchem-2084	163	28	community	community	NOUN
eurjchem-2084	163	29	transmission	transmission	NOUN
eurjchem-2084	163	30	which	which	PRON
eurjchem-2084	163	31	led	lead	VERB
eurjchem-2084	163	32	to	to	ADP
eurjchem-2084	163	33	the	the	DET
eurjchem-2084	163	34	pandemic	pandemic	ADJ
eurjchem-2084	163	35	status	status	NOUN
eurjchem-2084	163	36	[	[	X
eurjchem-2084	163	37	45	45	NUM
eurjchem-2084	163	38	]	]	PUNCT
eurjchem-2084	163	39	.	.	PUNCT
eurjchem-2084	164	1	the	the	DET
eurjchem-2084	164	2	virus	virus	NOUN
eurjchem-2084	164	3	reportedly	reportedly	ADV
eurjchem-2084	164	4	stays	stay	VERB
eurjchem-2084	164	5	in	in	ADP
eurjchem-2084	164	6	the	the	DET
eurjchem-2084	164	7	air	air	NOUN
eurjchem-2084	164	8	for	for	ADP
eurjchem-2084	164	9	a	a	DET
eurjchem-2084	164	10	prolonged	prolonged	ADJ
eurjchem-2084	164	11	time	time	NOUN
eurjchem-2084	164	12	and	and	CCONJ
eurjchem-2084	164	13	can	can	AUX
eurjchem-2084	164	14	survive	survive	VERB
eurjchem-2084	164	15	for	for	ADP
eurjchem-2084	164	16	hours	hour	NOUN
eurjchem-2084	164	17	on	on	ADP
eurjchem-2084	164	18	contaminated	contaminate	VERB
eurjchem-2084	164	19	metal	metal	NOUN
eurjchem-2084	164	20	surfaces	surface	NOUN
eurjchem-2084	164	21	,	,	PUNCT
eurjchem-2084	164	22	latex	latex	NOUN
eurjchem-2084	164	23	surgical	surgical	ADJ
eurjchem-2084	164	24	gloves	glove	NOUN
eurjchem-2084	164	25	,	,	PUNCT
eurjchem-2084	164	26	and	and	CCONJ
eurjchem-2084	164	27	sterile	sterile	ADJ
eurjchem-2084	164	28	sponges	sponge	NOUN
eurjchem-2084	164	29	.	.	PUNCT
eurjchem-2084	165	1	transmission	transmission	NOUN
eurjchem-2084	165	2	occurs	occur	VERB
eurjchem-2084	165	3	by	by	ADP
eurjchem-2084	165	4	coming	come	VERB
eurjchem-2084	165	5	in	in	ADP
eurjchem-2084	165	6	close	close	ADJ
eurjchem-2084	165	7	contact	contact	NOUN
eurjchem-2084	165	8	with	with	ADP
eurjchem-2084	165	9	an	an	DET
eurjchem-2084	165	10	infected	infected	ADJ
eurjchem-2084	165	11	person	person	NOUN
eurjchem-2084	165	12	(	(	PUNCT
eurjchem-2084	165	13	within	within	ADP
eurjchem-2084	165	14	1	1	NUM
eurjchem-2084	165	15	m	m	NOUN
eurjchem-2084	165	16	)	)	PUNCT
eurjchem-2084	165	17	,	,	PUNCT
eurjchem-2084	165	18	either	either	CCONJ
eurjchem-2084	165	19	by	by	ADP
eurjchem-2084	165	20	inhalation	inhalation	NOUN
eurjchem-2084	165	21	of	of	ADP
eurjchem-2084	165	22	respiratory	respiratory	ADJ
eurjchem-2084	165	23	droplets	droplet	NOUN
eurjchem-2084	165	24	(	(	PUNCT
eurjchem-2084	165	25	>	>	X
eurjchem-2084	165	26	10	10	NUM
eurjchem-2084	165	27	µm	µm	NOUN
eurjchem-2084	165	28	)	)	PUNCT
eurjchem-2084	165	29	or	or	CCONJ
eurjchem-2084	165	30	skin	skin	NOUN
eurjchem-2084	165	31	-	-	PUNCT
eurjchem-2084	165	32	to	to	ADP
eurjchem-2084	165	33	-	-	PUNCT
eurjchem-2084	165	34	skin	skin	NOUN
eurjchem-2084	165	35	contact	contact	NOUN
eurjchem-2084	165	36	and	and	CCONJ
eurjchem-2084	165	37	by	by	ADP
eurjchem-2084	165	38	touching	touch	VERB
eurjchem-2084	165	39	the	the	DET
eurjchem-2084	165	40	contaminated	contaminate	VERB
eurjchem-2084	165	41	surface	surface	NOUN
eurjchem-2084	165	42	[	[	X
eurjchem-2084	165	43	46	46	NUM
eurjchem-2084	165	44	]	]	PUNCT
eurjchem-2084	165	45	.	.	PUNCT
eurjchem-2084	166	1	furthermore	furthermore	ADV
eurjchem-2084	166	2	,	,	PUNCT
eurjchem-2084	166	3	reports	report	NOUN
eurjchem-2084	166	4	suggest	suggest	VERB
eurjchem-2084	166	5	that	that	SCONJ
eurjchem-2084	166	6	sars	sar	NOUN
eurjchem-2084	166	7	-	-	PUNCT
eurjchem-2084	166	8	cov	cov	PROPN
eurjchem-2084	166	9	can	can	AUX
eurjchem-2084	166	10	survive	survive	VERB
eurjchem-2084	166	11	in	in	ADP
eurjchem-2084	166	12	stool	stool	NOUN
eurjchem-2084	166	13	samples	sample	NOUN
eurjchem-2084	166	14	up	up	ADP
eurjchem-2084	166	15	to	to	PART
eurjchem-2084	166	16	4	4	NUM
eurjchem-2084	166	17	days	day	NOUN
eurjchem-2084	166	18	[	[	X
eurjchem-2084	166	19	47	47	NUM
eurjchem-2084	166	20	]	]	PUNCT
eurjchem-2084	166	21	.	.	PUNCT
eurjchem-2084	167	1	the	the	DET
eurjchem-2084	167	2	presence	presence	NOUN
eurjchem-2084	167	3	of	of	ADP
eurjchem-2084	167	4	sars	sar	NOUN
eurjchem-2084	167	5	-	-	PUNCT
eurjchem-2084	167	6	cov-2	cov-2	PART
eurjchem-2084	167	7	has	have	AUX
eurjchem-2084	167	8	also	also	ADV
eurjchem-2084	167	9	been	be	AUX
eurjchem-2084	167	10	spotted	spot	VERB
eurjchem-2084	167	11	in	in	ADP
eurjchem-2084	167	12	fecal	fecal	ADJ
eurjchem-2084	167	13	samples	sample	NOUN
eurjchem-2084	167	14	of	of	ADP
eurjchem-2084	167	15	infected	infected	ADJ
eurjchem-2084	167	16	patients	patient	NOUN
eurjchem-2084	167	17	,	,	PUNCT
eurjchem-2084	167	18	so	so	CCONJ
eurjchem-2084	167	19	the	the	DET
eurjchem-2084	167	20	fecal	fecal	ADJ
eurjchem-2084	167	21	route	route	NOUN
eurjchem-2084	167	22	of	of	ADP
eurjchem-2084	167	23	transmission	transmission	NOUN
eurjchem-2084	167	24	should	should	AUX
eurjchem-2084	167	25	not	not	PART
eurjchem-2084	167	26	be	be	AUX
eurjchem-2084	167	27	ruled	rule	VERB
eurjchem-2084	167	28	out	out	ADP
eurjchem-2084	167	29	[	[	X
eurjchem-2084	167	30	48	48	NUM
eurjchem-2084	167	31	]	]	PUNCT
eurjchem-2084	167	32	.	.	PUNCT
eurjchem-2084	168	1	the	the	DET
eurjchem-2084	168	2	presence	presence	NOUN
eurjchem-2084	168	3	of	of	ADP
eurjchem-2084	168	4	stool	stool	NOUN
eurjchem-2084	168	5	,	,	PUNCT
eurjchem-2084	168	6	from	from	ADP
eurjchem-2084	168	7	an	an	DET
eurjchem-2084	168	8	infected	infected	ADJ
eurjchem-2084	168	9	patient	patient	NOUN
eurjchem-2084	168	10	in	in	ADP
eurjchem-2084	168	11	wastewater	wastewater	NOUN
eurjchem-2084	168	12	may	may	AUX
eurjchem-2084	168	13	generate	generate	VERB
eurjchem-2084	168	14	a	a	DET
eurjchem-2084	168	15	further	further	ADJ
eurjchem-2084	168	16	route	route	NOUN
eurjchem-2084	168	17	of	of	ADP
eurjchem-2084	168	18	transmission	transmission	NOUN
eurjchem-2084	168	19	via	via	ADP
eurjchem-2084	168	20	the	the	DET
eurjchem-2084	168	21	generation	generation	NOUN
eurjchem-2084	168	22	of	of	ADP
eurjchem-2084	168	23	virus	virus	NOUN
eurjchem-2084	168	24	-	-	PUNCT
eurjchem-2084	168	25	laden	laden	ADJ
eurjchem-2084	168	26	aerosols	aerosol	NOUN
eurjchem-2084	168	27	during	during	ADP
eurjchem-2084	168	28	wastewater	wastewater	NOUN
eurjchem-2084	168	29	treatment	treatment	NOUN
eurjchem-2084	168	30	as	as	SCONJ
eurjchem-2084	168	31	reported	report	VERB
eurjchem-2084	168	32	in	in	ADP
eurjchem-2084	168	33	hong	hong	PROPN
eurjchem-2084	168	34	kong	kong	PROPN
eurjchem-2084	168	35	in	in	ADP
eurjchem-2084	168	36	2003	2003	NUM
eurjchem-2084	168	37	during	during	ADP
eurjchem-2084	168	38	sars	sars	PROPN
eurjchem-2084	168	39	-	-	PUNCT
eurjchem-2084	168	40	cov	cov	NOUN
eurjchem-2084	168	41	outbreak	outbreak	NOUN
eurjchem-2084	168	42	[	[	X
eurjchem-2084	168	43	49	49	NUM
eurjchem-2084	168	44	]	]	PUNCT
eurjchem-2084	168	45	.	.	PUNCT
eurjchem-2084	169	1	the	the	DET
eurjchem-2084	169	2	presence	presence	NOUN
eurjchem-2084	169	3	of	of	ADP
eurjchem-2084	169	4	coronaviruses	coronaviruse	NOUN
eurjchem-2084	169	5	has	have	AUX
eurjchem-2084	169	6	been	be	AUX
eurjchem-2084	169	7	reported	report	VERB
eurjchem-2084	169	8	in	in	ADP
eurjchem-2084	169	9	water	water	NOUN
eurjchem-2084	169	10	,	,	PUNCT
eurjchem-2084	169	11	sewage	sewage	NOUN
eurjchem-2084	169	12	,	,	PUNCT
eurjchem-2084	169	13	and	and	CCONJ
eurjchem-2084	169	14	pure	pure	ADJ
eurjchem-2084	169	15	or	or	CCONJ
eurjchem-2084	169	16	pasteurized	pasteurize	VERB
eurjchem-2084	169	17	settled	settle	VERB
eurjchem-2084	169	18	sewage	sewage	NOUN
eurjchem-2084	169	19	,	,	PUNCT
eurjchem-2084	169	20	and	and	CCONJ
eurjchem-2084	169	21	the	the	DET
eurjchem-2084	169	22	viruses	virus	NOUN
eurjchem-2084	169	23	can	can	AUX
eurjchem-2084	169	24	remain	remain	VERB
eurjchem-2084	169	25	infectious	infectious	ADJ
eurjchem-2084	169	26	for	for	ADP
eurjchem-2084	169	27	3	3	NUM
eurjchem-2084	169	28	days	day	NOUN
eurjchem-2084	169	29	to	to	ADP
eurjchem-2084	169	30	3	3	NUM
eurjchem-2084	169	31	weeks	week	NOUN
eurjchem-2084	170	1	[	[	X
eurjchem-2084	170	2	50	50	NUM
eurjchem-2084	170	3	]	]	PUNCT
eurjchem-2084	170	4	.	.	PUNCT
eurjchem-2084	171	1	therefore	therefore	ADV
eurjchem-2084	171	2	,	,	PUNCT
eurjchem-2084	171	3	the	the	DET
eurjchem-2084	171	4	contaminated	contaminate	VERB
eurjchem-2084	171	5	sewage	sewage	NOUN
eurjchem-2084	171	6	-	-	PUNCT
eurjchem-2084	171	7	borne	bear	VERB
eurjchem-2084	171	8	aerosols	aerosol	NOUN
eurjchem-2084	171	9	also	also	ADV
eurjchem-2084	171	10	pose	pose	VERB
eurjchem-2084	171	11	a	a	DET
eurjchem-2084	171	12	possible	possible	ADJ
eurjchem-2084	171	13	source	source	NOUN
eurjchem-2084	171	14	of	of	ADP
eurjchem-2084	171	15	sars	sar	NOUN
eurjchem-2084	171	16	-	-	PUNCT
eurjchem-2084	171	17	cov-2	cov-2	NOUN
eurjchem-2084	171	18	transmission	transmission	NOUN
eurjchem-2084	171	19	and	and	CCONJ
eurjchem-2084	171	20	needs	need	VERB
eurjchem-2084	171	21	further	further	ADJ
eurjchem-2084	171	22	study	study	NOUN
eurjchem-2084	171	23	.	.	PUNCT
eurjchem-2084	172	1	earlier	early	ADV
eurjchem-2084	172	2	,	,	PUNCT
eurjchem-2084	172	3	the	the	DET
eurjchem-2084	172	4	transmission	transmission	NOUN
eurjchem-2084	172	5	of	of	ADP
eurjchem-2084	172	6	infectious	infectious	ADJ
eurjchem-2084	172	7	diseases	disease	NOUN
eurjchem-2084	172	8	was	be	AUX
eurjchem-2084	172	9	linked	link	VERB
eurjchem-2084	172	10	to	to	ADP
eurjchem-2084	172	11	the	the	DET
eurjchem-2084	172	12	presence	presence	NOUN
eurjchem-2084	172	13	of	of	ADP
eurjchem-2084	172	14	microorganisms	microorganism	NOUN
eurjchem-2084	172	15	in	in	ADP
eurjchem-2084	172	16	airborne	airborne	ADJ
eurjchem-2084	172	17	particulate	particulate	NOUN
eurjchem-2084	172	18	matter	matter	NOUN
eurjchem-2084	172	19	(	(	PUNCT
eurjchem-2084	172	20	pm)/airborne	pm)/airborne	ADP
eurjchem-2084	172	21	dust	dust	NOUN
eurjchem-2084	172	22	[	[	X
eurjchem-2084	172	23	51	51	NUM
eurjchem-2084	172	24	]	]	PUNCT
eurjchem-2084	172	25	.	.	PUNCT
eurjchem-2084	173	1	air	air	NOUN
eurjchem-2084	173	2	pollution	pollution	NOUN
eurjchem-2084	173	3	is	be	AUX
eurjchem-2084	173	4	common	common	ADJ
eurjchem-2084	173	5	in	in	ADP
eurjchem-2084	173	6	many	many	ADJ
eurjchem-2084	173	7	countries	country	NOUN
eurjchem-2084	173	8	and	and	CCONJ
eurjchem-2084	173	9	surface	surface	NOUN
eurjchem-2084	173	10	adsorption	adsorption	NOUN
eurjchem-2084	173	11	of	of	ADP
eurjchem-2084	173	12	sars	sar	NOUN
eurjchem-2084	173	13	-	-	PUNCT
eurjchem-2084	173	14	cov-2	cov-2	NOUN
eurjchem-2084	173	15	on	on	ADP
eurjchem-2084	173	16	airborne	airborne	ADJ
eurjchem-2084	173	17	pm	pm	NOUN
eurjchem-2084	173	18	or	or	CCONJ
eurjchem-2084	173	19	dust	dust	NOUN
eurjchem-2084	173	20	may	may	AUX
eurjchem-2084	173	21	contribute	contribute	VERB
eurjchem-2084	173	22	the	the	DET
eurjchem-2084	173	23	long	long	ADJ
eurjchem-2084	173	24	range	range	NOUN
eurjchem-2084	173	25	transmission	transmission	NOUN
eurjchem-2084	173	26	of	of	ADP
eurjchem-2084	173	27	viral	viral	ADJ
eurjchem-2084	173	28	infections	infection	NOUN
eurjchem-2084	173	29	.	.	PUNCT
eurjchem-2084	174	1	inhalation	inhalation	NOUN
eurjchem-2084	174	2	of	of	ADP
eurjchem-2084	174	3	virus	virus	NOUN
eurjchem-2084	174	4	-	-	PUNCT
eurjchem-2084	174	5	laden	laden	ADJ
eurjchem-2084	174	6	fine	fine	ADJ
eurjchem-2084	174	7	pm	pm	NOUN
eurjchem-2084	174	8	could	could	AUX
eurjchem-2084	174	9	transport	transport	VERB
eurjchem-2084	174	10	the	the	DET
eurjchem-2084	174	11	virus	virus	NOUN
eurjchem-2084	174	12	into	into	ADP
eurjchem-2084	174	13	deep	deep	ADJ
eurjchem-2084	174	14	alveolar	alveolar	ADJ
eurjchem-2084	174	15	tissues	tissue	NOUN
eurjchem-2084	174	16	,	,	PUNCT
eurjchem-2084	174	17	tracheobronchial	tracheobronchial	ADJ
eurjchem-2084	174	18	regions	region	NOUN
eurjchem-2084	174	19	and	and	CCONJ
eurjchem-2084	174	20	increase	increase	VERB
eurjchem-2084	174	21	the	the	DET
eurjchem-2084	174	22	chance	chance	NOUN
eurjchem-2084	174	23	of	of	ADP
eurjchem-2084	174	24	infection	infection	NOUN
eurjchem-2084	174	25	[	[	X
eurjchem-2084	174	26	46	46	NUM
eurjchem-2084	174	27	]	]	PUNCT
eurjchem-2084	174	28	.	.	PUNCT
eurjchem-2084	175	1	further	further	ADJ
eurjchem-2084	175	2	investigation	investigation	NOUN
eurjchem-2084	175	3	on	on	ADP
eurjchem-2084	175	4	the	the	DET
eurjchem-2084	175	5	survival	survival	NOUN
eurjchem-2084	175	6	of	of	ADP
eurjchem-2084	175	7	sarscov-2	sarscov-2	NUM
eurjchem-2084	175	8	in	in	ADP
eurjchem-2084	175	9	airborne	airborne	ADJ
eurjchem-2084	175	10	pm	pm	NOUN
eurjchem-2084	175	11	/	/	SYM
eurjchem-2084	175	12	dust	dust	NOUN
eurjchem-2084	175	13	will	will	AUX
eurjchem-2084	175	14	explain	explain	VERB
eurjchem-2084	175	15	their	their	PRON
eurjchem-2084	175	16	role	role	NOUN
eurjchem-2084	175	17	in	in	ADP
eurjchem-2084	175	18	transmission	transmission	NOUN
eurjchem-2084	175	19	.	.	PUNCT
eurjchem-2084	176	1	6.1	6.1	NUM
eurjchem-2084	176	2	.	.	PUNCT
eurjchem-2084	176	3	virus	virus	NOUN
eurjchem-2084	176	4	and	and	CCONJ
eurjchem-2084	176	5	demography	demography	NOUN
eurjchem-2084	176	6	:	:	PUNCT
eurjchem-2084	176	7	who	who	PRON
eurjchem-2084	176	8	are	be	AUX
eurjchem-2084	176	9	at	at	ADP
eurjchem-2084	176	10	risk	risk	NOUN
eurjchem-2084	176	11	?	?	PUNCT
eurjchem-2084	177	1	although	although	SCONJ
eurjchem-2084	177	2	,	,	PUNCT
eurjchem-2084	177	3	sars	sar	NOUN
eurjchem-2084	177	4	-	-	PUNCT
eurjchem-2084	177	5	cov-2	cov-2	NUM
eurjchem-2084	177	6	can	can	AUX
eurjchem-2084	177	7	infect	infect	VERB
eurjchem-2084	177	8	persons	person	NOUN
eurjchem-2084	177	9	of	of	ADP
eurjchem-2084	177	10	any	any	DET
eurjchem-2084	177	11	age	age	NOUN
eurjchem-2084	177	12	,	,	PUNCT
eurjchem-2084	177	13	but	but	CCONJ
eurjchem-2084	177	14	middle	middle	ADJ
eurjchem-2084	177	15	and	and	CCONJ
eurjchem-2084	177	16	old	old	ADJ
eurjchem-2084	177	17	age	age	NOUN
eurjchem-2084	177	18	people	people	NOUN
eurjchem-2084	177	19	are	be	AUX
eurjchem-2084	177	20	generally	generally	ADV
eurjchem-2084	177	21	more	more	ADV
eurjchem-2084	177	22	susceptible	susceptible	ADJ
eurjchem-2084	177	23	;	;	PUNCT
eurjchem-2084	177	24	most	most	ADJ
eurjchem-2084	177	25	of	of	ADP
eurjchem-2084	177	26	the	the	DET
eurjchem-2084	177	27	covid-19	covid-19	PROPN
eurjchem-2084	177	28	patients	patient	NOUN
eurjchem-2084	177	29	are	be	AUX
eurjchem-2084	177	30	in	in	ADP
eurjchem-2084	177	31	between	between	ADP
eurjchem-2084	177	32	48	48	NUM
eurjchem-2084	177	33	to	to	PART
eurjchem-2084	177	34	58	58	NUM
eurjchem-2084	177	35	years	year	NOUN
eurjchem-2084	177	36	.	.	PUNCT
eurjchem-2084	178	1	[	[	X
eurjchem-2084	178	2	52	52	NUM
eurjchem-2084	178	3	]	]	PUNCT
eurjchem-2084	178	4	.	.	PUNCT
eurjchem-2084	179	1	the	the	DET
eurjchem-2084	179	2	chinese	chinese	ADJ
eurjchem-2084	179	3	center	center	NOUN
eurjchem-2084	179	4	for	for	ADP
eurjchem-2084	179	5	disease	disease	NOUN
eurjchem-2084	179	6	control	control	NOUN
eurjchem-2084	179	7	and	and	CCONJ
eurjchem-2084	179	8	prevention	prevention	NOUN
eurjchem-2084	179	9	(	(	PUNCT
eurjchem-2084	179	10	ccdc	ccdc	PROPN
eurjchem-2084	179	11	)	)	PUNCT
eurjchem-2084	179	12	case	case	NOUN
eurjchem-2084	179	13	report	report	NOUN
eurjchem-2084	179	14	of	of	ADP
eurjchem-2084	179	15	44,500	44,500	NUM
eurjchem-2084	179	16	confirmed	confirm	VERB
eurjchem-2084	179	17	cases	case	NOUN
eurjchem-2084	179	18	of	of	ADP
eurjchem-2084	179	19	sars	sar	NOUN
eurjchem-2084	179	20	-	-	PUNCT
eurjchem-2084	179	21	cov-2	cov-2	NOUN
eurjchem-2084	179	22	infections	infection	NOUN
eurjchem-2084	179	23	,	,	PUNCT
eurjchem-2084	179	24	87	87	NUM
eurjchem-2084	179	25	%	%	NOUN
eurjchem-2084	179	26	of	of	ADP
eurjchem-2084	179	27	patients	patient	NOUN
eurjchem-2084	179	28	were	be	AUX
eurjchem-2084	179	29	in	in	ADP
eurjchem-2084	179	30	the	the	DET
eurjchem-2084	179	31	age	age	NOUN
eurjchem-2084	179	32	group	group	NOUN
eurjchem-2084	179	33	of	of	ADP
eurjchem-2084	179	34	30	30	NUM
eurjchem-2084	179	35	-	-	SYM
eurjchem-2084	179	36	79	79	NUM
eurjchem-2084	179	37	years	year	NOUN
eurjchem-2084	179	38	.	.	PUNCT
eurjchem-2084	180	1	in	in	ADP
eurjchem-2084	180	2	70	70	NUM
eurjchem-2084	180	3	-	-	SYM
eurjchem-2084	180	4	80	80	NUM
eurjchem-2084	180	5	years	year	NOUN
eurjchem-2084	180	6	age	age	NOUN
eurjchem-2084	180	7	group	group	NOUN
eurjchem-2084	180	8	,	,	PUNCT
eurjchem-2084	180	9	the	the	DET
eurjchem-2084	180	10	sars	sar	NOUN
eurjchem-2084	180	11	-	-	PUNCT
eurjchem-2084	180	12	cov-2	cov-2	PART
eurjchem-2084	180	13	infection	infection	NOUN
eurjchem-2084	180	14	comes	come	VERB
eurjchem-2084	180	15	in	in	ADP
eurjchem-2084	180	16	comorbidity	comorbidity	NOUN
eurjchem-2084	180	17	with	with	ADP
eurjchem-2084	180	18	some	some	DET
eurjchem-2084	180	19	previous	previous	ADJ
eurjchem-2084	180	20	disease	disease	NOUN
eurjchem-2084	180	21	which	which	PRON
eurjchem-2084	180	22	increases	increase	VERB
eurjchem-2084	180	23	the	the	DET
eurjchem-2084	180	24	chances	chance	NOUN
eurjchem-2084	180	25	of	of	ADP
eurjchem-2084	180	26	death	death	NOUN
eurjchem-2084	180	27	(	(	PUNCT
eurjchem-2084	180	28	8–15	8–15	PROPN
eurjchem-2084	180	29	%	%	NOUN
eurjchem-2084	180	30	)	)	PUNCT
eurjchem-2084	180	31	in	in	ADP
eurjchem-2084	180	32	this	this	DET
eurjchem-2084	180	33	age	age	NOUN
eurjchem-2084	180	34	group	group	NOUN
eurjchem-2084	180	35	[	[	X
eurjchem-2084	180	36	53	53	NUM
eurjchem-2084	180	37	]	]	PUNCT
eurjchem-2084	180	38	.	.	PUNCT
eurjchem-2084	181	1	the	the	DET
eurjchem-2084	181	2	prevalence	prevalence	NOUN
eurjchem-2084	181	3	of	of	ADP
eurjchem-2084	181	4	sars	sar	NOUN
eurjchem-2084	181	5	-	-	PUNCT
eurjchem-2084	181	6	cov-2	cov-2	PART
eurjchem-2084	181	7	infection	infection	NOUN
eurjchem-2084	181	8	was	be	AUX
eurjchem-2084	181	9	found	find	VERB
eurjchem-2084	181	10	to	to	PART
eurjchem-2084	181	11	be	be	AUX
eurjchem-2084	181	12	same	same	ADJ
eurjchem-2084	181	13	in	in	ADP
eurjchem-2084	181	14	both	both	DET
eurjchem-2084	181	15	males	male	NOUN
eurjchem-2084	181	16	and	and	CCONJ
eurjchem-2084	181	17	females	female	NOUN
eurjchem-2084	181	18	,	,	PUNCT
eurjchem-2084	181	19	but	but	CCONJ
eurjchem-2084	181	20	a	a	DET
eurjchem-2084	181	21	gender	gender	NOUN
eurjchem-2084	181	22	-	-	PUNCT
eurjchem-2084	181	23	based	base	VERB
eurjchem-2084	181	24	difference	difference	NOUN
eurjchem-2084	181	25	in	in	ADP
eurjchem-2084	181	26	the	the	DET
eurjchem-2084	181	27	mortality	mortality	NOUN
eurjchem-2084	181	28	rate	rate	NOUN
eurjchem-2084	181	29	was	be	AUX
eurjchem-2084	181	30	observed	observe	VERB
eurjchem-2084	181	31	.	.	PUNCT
eurjchem-2084	182	1	firdaus	firdaus	PROPN
eurjchem-2084	182	2	et	et	PROPN
eurjchem-2084	182	3	al	al	PROPN
eurjchem-2084	182	4	.	.	PUNCT
eurjchem-2084	182	5	/	/	SYM
eurjchem-2084	182	6	european	european	PROPN
eurjchem-2084	182	7	journal	journal	PROPN
eurjchem-2084	182	8	of	of	ADP
eurjchem-2084	182	9	chemistry	chemistry	NOUN
eurjchem-2084	182	10	12	12	NUM
eurjchem-2084	182	11	(	(	PUNCT
eurjchem-2084	182	12	2	2	NUM
eurjchem-2084	182	13	)	)	PUNCT
eurjchem-2084	182	14	(	(	PUNCT
eurjchem-2084	182	15	2021	2021	NUM
eurjchem-2084	182	16	)	)	PUNCT
eurjchem-2084	182	17	222	222	NUM
eurjchem-2084	182	18	-	-	SYM
eurjchem-2084	182	19	234	234	NUM
eurjchem-2084	182	20	227	227	NUM
eurjchem-2084	182	21	2021	2021	NUM
eurjchem-2084	182	22	–	–	PUNCT
eurjchem-2084	182	23	european	european	ADJ
eurjchem-2084	182	24	journal	journal	NOUN
eurjchem-2084	182	25	of	of	ADP
eurjchem-2084	182	26	chemistry	chemistry	NOUN
eurjchem-2084	182	27	–	–	PUNCT
eurjchem-2084	182	28	cc	cc	NOUN
eurjchem-2084	182	29	by	by	ADP
eurjchem-2084	182	30	nc	nc	PROPN
eurjchem-2084	182	31	–	–	PUNCT
eurjchem-2084	182	32	doi	doi	NOUN
eurjchem-2084	182	33	:	:	PUNCT
eurjchem-2084	182	34	10.5155	10.5155	NUM
eurjchem-2084	182	35	/	/	SYM
eurjchem-2084	182	36	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	182	37	-	-	PUNCT
eurjchem-2084	182	38	234.2084	234.2084	NUM
eurjchem-2084	182	39	table	table	NOUN
eurjchem-2084	182	40	1	1	NUM
eurjchem-2084	182	41	.	.	PUNCT
eurjchem-2084	182	42	list	list	NOUN
eurjchem-2084	182	43	of	of	ADP
eurjchem-2084	182	44	available	available	ADJ
eurjchem-2084	182	45	drugs	drug	NOUN
eurjchem-2084	182	46	to	to	PART
eurjchem-2084	182	47	manage	manage	VERB
eurjchem-2084	182	48	covid-19	covid-19	PROPN
eurjchem-2084	182	49	symptoms	symptom	NOUN
eurjchem-2084	182	50	with	with	ADP
eurjchem-2084	182	51	the	the	DET
eurjchem-2084	182	52	result	result	NOUN
eurjchem-2084	182	53	of	of	ADP
eurjchem-2084	182	54	clinical	clinical	ADJ
eurjchem-2084	182	55	trials	trial	NOUN
eurjchem-2084	182	56	.	.	PUNCT
eurjchem-2084	183	1	table	table	NOUN
eurjchem-2084	183	2	abbreviation	abbreviation	NOUN
eurjchem-2084	183	3	:	:	PUNCT
eurjchem-2084	183	4	fpv	fpv	NOUN
eurjchem-2084	183	5	:	:	PUNCT
eurjchem-2084	183	6	favipiravir	favipiravir	PROPN
eurjchem-2084	183	7	;	;	PUNCT
eurjchem-2084	183	8	arb	arb	PROPN
eurjchem-2084	183	9	:	:	PUNCT
eurjchem-2084	183	10	arbidol	arbidol	ADJ
eurjchem-2084	183	11	;	;	PUNCT
eurjchem-2084	183	12	ifn	ifn	PROPN
eurjchem-2084	183	13	:	:	PUNCT
eurjchem-2084	183	14	interferon	interferon	ADJ
eurjchem-2084	183	15	;	;	PUNCT
eurjchem-2084	183	16	lpv	lpv	PROPN
eurjchem-2084	183	17	/	/	SYM
eurjchem-2084	183	18	rtv	rtv	PROPN
eurjchem-2084	183	19	:	:	PUNCT
eurjchem-2084	183	20	lopinavir	lopinavir	PROPN
eurjchem-2084	183	21	and	and	CCONJ
eurjchem-2084	183	22	ritonavir	ritonavir	PRON
eurjchem-2084	183	23	;	;	PUNCT
eurjchem-2084	183	24	rbv	rbv	NOUN
eurjchem-2084	183	25	:	:	PUNCT
eurjchem-2084	183	26	ribavirin	ribavirin	NOUN
eurjchem-2084	183	27	;	;	PUNCT
eurjchem-2084	183	28	hcq	hcq	NOUN
eurjchem-2084	183	29	:	:	PUNCT
eurjchem-2084	183	30	hydroxychloroquine	hydroxychloroquine	PROPN
eurjchem-2084	183	31	;	;	PUNCT
eurjchem-2084	183	32	azt	azt	PROPN
eurjchem-2084	183	33	:	:	PUNCT
eurjchem-2084	183	34	azithromycin	azithromycin	PROPN
eurjchem-2084	183	35	;	;	PUNCT
eurjchem-2084	183	36	cp	cp	NUM
eurjchem-2084	183	37	:	:	PUNCT
eurjchem-2084	183	38	convalescent	convalescent	NOUN
eurjchem-2084	183	39	plasma	plasma	NOUN
eurjchem-2084	183	40	.	.	PUNCT
eurjchem-2084	184	1	no	no	DET
eurjchem-2084	184	2	drug	drug	NOUN
eurjchem-2084	184	3	clinical	clinical	ADJ
eurjchem-2084	184	4	trial	trial	NOUN
eurjchem-2084	184	5	sample	sample	NOUN
eurjchem-2084	184	6	size	size	NOUN
eurjchem-2084	184	7	groups	group	NOUN
eurjchem-2084	184	8	result	result	VERB
eurjchem-2084	184	9	1	1	NUM
eurjchem-2084	184	10	favipiravir	favipiravir	NOUN
eurjchem-2084	184	11	(	(	PUNCT
eurjchem-2084	184	12	fpv	fpv	PROPN
eurjchem-2084	184	13	)	)	PUNCT
eurjchem-2084	184	14	multicenter	multicenter	NOUN
eurjchem-2084	184	15	,	,	PUNCT
eurjchem-2084	184	16	controlled	control	VERB
eurjchem-2084	184	17	,	,	PUNCT
eurjchem-2084	184	18	open	open	ADJ
eurjchem-2084	184	19	-	-	PUNCT
eurjchem-2084	184	20	label	label	NOUN
eurjchem-2084	184	21	,	,	PUNCT
eurjchem-2084	184	22	randomized	randomize	VERB
eurjchem-2084	184	23	superiority	superiority	NOUN
eurjchem-2084	184	24	trial	trial	NOUN
eurjchem-2084	184	25	240	240	NUM
eurjchem-2084	184	26	grp1	grp1	NOUN
eurjchem-2084	184	27	.	.	PUNCT
eurjchem-2084	185	1	fpv	fpv	NOUN
eurjchem-2084	185	2	(	(	PUNCT
eurjchem-2084	185	3	120	120	NUM
eurjchem-2084	185	4	)	)	PUNCT
eurjchem-2084	185	5	grp	grp	NOUN
eurjchem-2084	185	6	2	2	NUM
eurjchem-2084	185	7	.	.	PUNCT
eurjchem-2084	185	8	arb	arb	PROPN
eurjchem-2084	185	9	(	(	PUNCT
eurjchem-2084	185	10	120	120	NUM
eurjchem-2084	185	11	)	)	PUNCT
eurjchem-2084	185	12	symptom	symptom	NOUN
eurjchem-2084	185	13	improvement	improvement	NOUN
eurjchem-2084	185	14	was	be	AUX
eurjchem-2084	185	15	markedly	markedly	ADV
eurjchem-2084	185	16	low	low	ADJ
eurjchem-2084	185	17	in	in	ADP
eurjchem-2084	185	18	fpv	fpv	PROPN
eurjchem-2084	185	19	group	group	NOUN
eurjchem-2084	185	20	as	as	SCONJ
eurjchem-2084	185	21	compared	compare	VERB
eurjchem-2084	185	22	with	with	ADP
eurjchem-2084	185	23	arb	arb	PROPN
eurjchem-2084	185	24	group	group	NOUN
eurjchem-2084	185	25	(	(	PUNCT
eurjchem-2084	185	26	chictr200030254	chictr200030254	PROPN
eurjchem-2084	185	27	)	)	PUNCT
eurjchem-2084	186	1	[	[	X
eurjchem-2084	186	2	111	111	NUM
eurjchem-2084	186	3	]	]	SYM
eurjchem-2084	186	4	2	2	NUM
eurjchem-2084	186	5	remdesivir	remdesivir	NOUN
eurjchem-2084	186	6	randomized	randomize	VERB
eurjchem-2084	186	7	,	,	PUNCT
eurjchem-2084	186	8	doubleblind	doubleblind	NOUN
eurjchem-2084	186	9	,	,	PUNCT
eurjchem-2084	186	10	placebo	placebo	NOUN
eurjchem-2084	186	11	-	-	PUNCT
eurjchem-2084	186	12	controlled	control	VERB
eurjchem-2084	186	13	,	,	PUNCT
eurjchem-2084	186	14	multicenter	multicenter	ADJ
eurjchem-2084	186	15	trial	trial	NOUN
eurjchem-2084	186	16	237	237	NUM
eurjchem-2084	186	17	grp	grp	NOUN
eurjchem-2084	186	18	1	1	NUM
eurjchem-2084	186	19	.	.	PUNCT
eurjchem-2084	187	1	remdesivir	remdesivir	NOUN
eurjchem-2084	187	2	(	(	PUNCT
eurjchem-2084	187	3	158	158	X
eurjchem-2084	187	4	)	)	PUNCT
eurjchem-2084	187	5	grp	grp	NOUN
eurjchem-2084	187	6	2	2	NUM
eurjchem-2084	187	7	.	.	PUNCT
eurjchem-2084	187	8	placebo	placebo	NOUN
eurjchem-2084	187	9	(	(	PUNCT
eurjchem-2084	187	10	79	79	NUM
eurjchem-2084	187	11	)	)	PUNCT
eurjchem-2084	187	12	rapid	rapid	ADJ
eurjchem-2084	187	13	improvement	improvement	NOUN
eurjchem-2084	187	14	in	in	ADP
eurjchem-2084	187	15	remdesivir	remdesivir	NOUN
eurjchem-2084	187	16	injected	inject	VERB
eurjchem-2084	187	17	group	group	NOUN
eurjchem-2084	187	18	[	[	X
eurjchem-2084	187	19	112	112	NUM
eurjchem-2084	187	20	]	]	PUNCT
eurjchem-2084	187	21	double	double	ADJ
eurjchem-2084	187	22	-	-	PUNCT
eurjchem-2084	187	23	blinded	blinded	ADJ
eurjchem-2084	187	24	,	,	PUNCT
eurjchem-2084	187	25	randomized	randomize	VERB
eurjchem-2084	187	26	,	,	PUNCT
eurjchem-2084	187	27	placebocontrolled	placebocontrolle	VERB
eurjchem-2084	187	28	trial	trial	NOUN
eurjchem-2084	187	29	1063	1063	NUM
eurjchem-2084	187	30	grp	grp	PROPN
eurjchem-2084	187	31	1	1	NUM
eurjchem-2084	187	32	.	.	PUNCT
eurjchem-2084	188	1	remdesivir	remdesivir	NOUN
eurjchem-2084	188	2	(	(	PUNCT
eurjchem-2084	188	3	538	538	NUM
eurjchem-2084	188	4	)	)	PUNCT
eurjchem-2084	188	5	grp	grp	NOUN
eurjchem-2084	188	6	2	2	NUM
eurjchem-2084	188	7	.	.	PUNCT
eurjchem-2084	188	8	placebo	placebo	NOUN
eurjchem-2084	188	9	(	(	PUNCT
eurjchem-2084	188	10	521	521	NUM
eurjchem-2084	188	11	)	)	PUNCT
eurjchem-2084	188	12	recovery	recovery	NOUN
eurjchem-2084	188	13	time	time	NOUN
eurjchem-2084	188	14	was	be	AUX
eurjchem-2084	188	15	reduced	reduce	VERB
eurjchem-2084	188	16	in	in	ADP
eurjchem-2084	188	17	remdesivir	remdesivir	PROPN
eurjchem-2084	188	18	group	group	NOUN
eurjchem-2084	188	19	(	(	PUNCT
eurjchem-2084	188	20	11	11	NUM
eurjchem-2084	188	21	days	day	NOUN
eurjchem-2084	188	22	)	)	PUNCT
eurjchem-2084	188	23	than	than	ADP
eurjchem-2084	188	24	placebo	placebo	NOUN
eurjchem-2084	188	25	(	(	PUNCT
eurjchem-2084	188	26	15	15	NUM
eurjchem-2084	188	27	days	day	NOUN
eurjchem-2084	188	28	)	)	PUNCT
eurjchem-2084	188	29	and	and	CCONJ
eurjchem-2084	188	30	the	the	DET
eurjchem-2084	188	31	mortality	mortality	NOUN
eurjchem-2084	188	32	rate	rate	NOUN
eurjchem-2084	188	33	were	be	AUX
eurjchem-2084	188	34	also	also	ADV
eurjchem-2084	188	35	reduced	reduce	VERB
eurjchem-2084	188	36	(	(	PUNCT
eurjchem-2084	188	37	nct04280705	nct04280705	NOUN
eurjchem-2084	188	38	)	)	PUNCT
eurjchem-2084	189	1	[	[	X
eurjchem-2084	189	2	68	68	NUM
eurjchem-2084	189	3	]	]	SYM
eurjchem-2084	189	4	3	3	NUM
eurjchem-2084	189	5	(	(	PUNCT
eurjchem-2084	189	6	fpv)/lpv+rtv	fpv)/lpv+rtv	VERB
eurjchem-2084	189	7	open	open	ADJ
eurjchem-2084	189	8	-	-	PUNCT
eurjchem-2084	189	9	label	label	NOUN
eurjchem-2084	189	10	,	,	PUNCT
eurjchem-2084	189	11	nonrandomized	nonrandomize	VERB
eurjchem-2084	189	12	,	,	PUNCT
eurjchem-2084	189	13	before	before	ADP
eurjchem-2084	189	14	-	-	PUNCT
eurjchem-2084	189	15	after	after	ADV
eurjchem-2084	189	16	controlled	control	VERB
eurjchem-2084	189	17	study	study	NOUN
eurjchem-2084	189	18	80	80	NUM
eurjchem-2084	189	19	grp	grp	NOUN
eurjchem-2084	189	20	1	1	NUM
eurjchem-2084	189	21	(	(	PUNCT
eurjchem-2084	189	22	35	35	NUM
eurjchem-2084	189	23	)	)	PUNCT
eurjchem-2084	189	24	fpv	fpv	NOUN
eurjchem-2084	189	25	(	(	PUNCT
eurjchem-2084	189	26	oral)+ifn	oral)+ifn	NUM
eurjchem-2084	189	27	-	-	SYM
eurjchem-2084	189	28	α	α	NOUN
eurjchem-2084	189	29	(	(	PUNCT
eurjchem-2084	189	30	aerosol	aerosol	NOUN
eurjchem-2084	189	31	inhalation	inhalation	NOUN
eurjchem-2084	189	32	)	)	PUNCT
eurjchem-2084	189	33	grp	grp	NOUN
eurjchem-2084	189	34	2	2	NUM
eurjchem-2084	189	35	.	.	PUNCT
eurjchem-2084	189	36	control	control	NOUN
eurjchem-2084	189	37	(	(	PUNCT
eurjchem-2084	189	38	45	45	NUM
eurjchem-2084	189	39	)	)	PUNCT
eurjchem-2084	189	40	(	(	PUNCT
eurjchem-2084	189	41	lpv	lpv	NOUN
eurjchem-2084	189	42	/	/	SYM
eurjchem-2084	189	43	rtv+	rtv+	VERB
eurjchem-2084	189	44	ifn	ifn	PROPN
eurjchem-2084	189	45	α	α	NUM
eurjchem-2084	189	46	)	)	PUNCT
eurjchem-2084	189	47	fpv	fpv	PROPN
eurjchem-2084	189	48	treatment	treatment	NOUN
eurjchem-2084	189	49	was	be	AUX
eurjchem-2084	189	50	useful	useful	ADJ
eurjchem-2084	189	51	and	and	CCONJ
eurjchem-2084	189	52	exhibited	exhibit	VERB
eurjchem-2084	189	53	notable	notable	ADJ
eurjchem-2084	189	54	improvement	improvement	NOUN
eurjchem-2084	189	55	(	(	PUNCT
eurjchem-2084	189	56	91.43	91.43	NUM
eurjchem-2084	189	57	%	%	NOUN
eurjchem-2084	189	58	)	)	PUNCT
eurjchem-2084	189	59	in	in	ADP
eurjchem-2084	189	60	chest	chest	NOUN
eurjchem-2084	189	61	imaging	imaging	NOUN
eurjchem-2084	189	62	compared	compare	VERB
eurjchem-2084	189	63	with	with	ADP
eurjchem-2084	189	64	the	the	DET
eurjchem-2084	189	65	control	control	NOUN
eurjchem-2084	189	66	(	(	PUNCT
eurjchem-2084	189	67	62.22	62.22	NUM
eurjchem-2084	189	68	%	%	NOUN
eurjchem-2084	189	69	)	)	PUNCT
eurjchem-2084	189	70	treatment	treatment	NOUN
eurjchem-2084	189	71	[	[	X
eurjchem-2084	189	72	65	65	NUM
eurjchem-2084	189	73	]	]	SYM
eurjchem-2084	189	74	4	4	NUM
eurjchem-2084	189	75	lpv	lpv	NOUN
eurjchem-2084	189	76	/	/	SYM
eurjchem-2084	189	77	rtv+	rtv+	ADJ
eurjchem-2084	189	78	ifnβ-1b	ifnβ-1b	NOUN
eurjchem-2084	189	79	multicenter	multicenter	NOUN
eurjchem-2084	189	80	,	,	PUNCT
eurjchem-2084	189	81	prospective	prospective	ADJ
eurjchem-2084	189	82	,	,	PUNCT
eurjchem-2084	189	83	open	open	ADJ
eurjchem-2084	189	84	-	-	PUNCT
eurjchem-2084	189	85	label	label	NOUN
eurjchem-2084	189	86	,	,	PUNCT
eurjchem-2084	189	87	randomized	randomize	VERB
eurjchem-2084	189	88	,	,	PUNCT
eurjchem-2084	189	89	phase	phase	NOUN
eurjchem-2084	189	90	2	2	NUM
eurjchem-2084	189	91	trial	trial	NOUN
eurjchem-2084	189	92	127	127	NUM
eurjchem-2084	189	93	grp	grp	NOUN
eurjchem-2084	189	94	1(86	1(86	NUM
eurjchem-2084	189	95	)	)	PUNCT
eurjchem-2084	189	96	lpv+rtv+rbv+	lpv+rtv+rbv+	NOUN
eurjchem-2084	189	97	ifnβ-1b	ifnβ-1b	NOUN
eurjchem-2084	189	98	grp	grp	PROPN
eurjchem-2084	189	99	2	2	X
eurjchem-2084	189	100	.	.	PUNCT
eurjchem-2084	190	1	(	(	PUNCT
eurjchem-2084	190	2	41)control	41)control	PROPN
eurjchem-2084	190	3	(	(	PUNCT
eurjchem-2084	190	4	lpv	lpv	PROPN
eurjchem-2084	190	5	/	/	SYM
eurjchem-2084	190	6	rtv	rtv	PROPN
eurjchem-2084	190	7	)	)	PUNCT
eurjchem-2084	190	8	for	for	ADP
eurjchem-2084	190	9	14	14	NUM
eurjchem-2084	190	10	days	day	NOUN
eurjchem-2084	190	11	the	the	DET
eurjchem-2084	190	12	combined	combined	ADJ
eurjchem-2084	190	13	treatment	treatment	NOUN
eurjchem-2084	190	14	(	(	PUNCT
eurjchem-2084	190	15	grp	grp	NOUN
eurjchem-2084	190	16	1	1	NUM
eurjchem-2084	190	17	)	)	PUNCT
eurjchem-2084	190	18	was	be	AUX
eurjchem-2084	190	19	better	well	ADJ
eurjchem-2084	190	20	and	and	CCONJ
eurjchem-2084	190	21	safe	safe	ADJ
eurjchem-2084	190	22	in	in	ADP
eurjchem-2084	190	23	improving	improve	VERB
eurjchem-2084	190	24	the	the	DET
eurjchem-2084	190	25	symptoms	symptom	NOUN
eurjchem-2084	190	26	and	and	CCONJ
eurjchem-2084	190	27	attenuating	attenuate	VERB
eurjchem-2084	190	28	viral	viral	ADJ
eurjchem-2084	190	29	load	load	NOUN
eurjchem-2084	190	30	in	in	ADP
eurjchem-2084	190	31	the	the	DET
eurjchem-2084	190	32	nasopharynx	nasopharynx	NOUN
eurjchem-2084	190	33	nct04276688	nct04276688	NOUN
eurjchem-2084	191	1	[	[	X
eurjchem-2084	191	2	71	71	NUM
eurjchem-2084	191	3	]	]	SYM
eurjchem-2084	191	4	5	5	NUM
eurjchem-2084	191	5	ifn	ifn	NOUN
eurjchem-2084	191	6	-	-	PUNCT
eurjchem-2084	191	7	α2b	α2b	NOUN
eurjchem-2084	191	8	an	an	DET
eurjchem-2084	191	9	uncontrolled	uncontrolled	ADJ
eurjchem-2084	191	10	,	,	PUNCT
eurjchem-2084	191	11	exploratory	exploratory	ADJ
eurjchem-2084	191	12	case	case	NOUN
eurjchem-2084	191	13	study	study	NOUN
eurjchem-2084	191	14	77	77	NUM
eurjchem-2084	191	15	grp	grp	NOUN
eurjchem-2084	191	16	1	1	NUM
eurjchem-2084	191	17	.	.	PUNCT
eurjchem-2084	192	1	ifn	ifn	PROPN
eurjchem-2084	192	2	-	-	PUNCT
eurjchem-2084	192	3	α2b	α2b	NOUN
eurjchem-2084	192	4	(	(	PUNCT
eurjchem-2084	192	5	7	7	NUM
eurjchem-2084	192	6	)	)	PUNCT
eurjchem-2084	192	7	grp	grp	NOUN
eurjchem-2084	192	8	2	2	NUM
eurjchem-2084	192	9	.	.	PUNCT
eurjchem-2084	193	1	arb	arb	PROPN
eurjchem-2084	193	2	(	(	PUNCT
eurjchem-2084	193	3	24	24	NUM
eurjchem-2084	193	4	)	)	PUNCT
eurjchem-2084	193	5	grp	grp	NOUN
eurjchem-2084	193	6	3	3	X
eurjchem-2084	193	7	.	.	PUNCT
eurjchem-2084	194	1	ifn	ifn	PROPN
eurjchem-2084	194	2	-	-	PUNCT
eurjchem-2084	194	3	α2b	α2b	NOUN
eurjchem-2084	194	4	+	+	CCONJ
eurjchem-2084	194	5	arb	arb	NOUN
eurjchem-2084	194	6	(	(	PUNCT
eurjchem-2084	194	7	46	46	NUM
eurjchem-2084	194	8	)	)	PUNCT
eurjchem-2084	194	9	ifn	ifn	PROPN
eurjchem-2084	194	10	-	-	PUNCT
eurjchem-2084	194	11	α2	α2	NOUN
eurjchem-2084	194	12	b	b	PROPN
eurjchem-2084	194	13	alone	alone	ADJ
eurjchem-2084	194	14	or	or	CCONJ
eurjchem-2084	194	15	with	with	ADP
eurjchem-2084	194	16	arb	arb	PROPN
eurjchem-2084	194	17	reduced	reduce	VERB
eurjchem-2084	194	18	the	the	DET
eurjchem-2084	194	19	duration	duration	NOUN
eurjchem-2084	194	20	of	of	ADP
eurjchem-2084	194	21	detectable	detectable	ADJ
eurjchem-2084	194	22	virus	virus	NOUN
eurjchem-2084	194	23	in	in	ADP
eurjchem-2084	194	24	nasopharynx	nasopharynx	NOUN
eurjchem-2084	194	25	and	and	CCONJ
eurjchem-2084	194	26	also	also	ADV
eurjchem-2084	194	27	the	the	DET
eurjchem-2084	194	28	duration	duration	NOUN
eurjchem-2084	194	29	of	of	ADP
eurjchem-2084	194	30	inflammatory	inflammatory	ADJ
eurjchem-2084	194	31	response	response	NOUN
eurjchem-2084	194	32	[	[	X
eurjchem-2084	194	33	75	75	NUM
eurjchem-2084	194	34	]	]	SYM
eurjchem-2084	194	35	6	6	NUM
eurjchem-2084	194	36	hcq	hcq	NOUN
eurjchem-2084	194	37	open	open	ADJ
eurjchem-2084	194	38	labeled	label	VERB
eurjchem-2084	194	39	nonrandomized	nonrandomize	VERB
eurjchem-2084	194	40	clinical	clinical	ADJ
eurjchem-2084	194	41	trial	trial	NOUN
eurjchem-2084	194	42	42	42	NUM
eurjchem-2084	194	43	grp	grp	NOUN
eurjchem-2084	194	44	1	1	NUM
eurjchem-2084	194	45	.	.	PUNCT
eurjchem-2084	195	1	hcq	hcq	NOUN
eurjchem-2084	195	2	(	(	PUNCT
eurjchem-2084	195	3	20	20	NUM
eurjchem-2084	195	4	)	)	PUNCT
eurjchem-2084	195	5	grp	grp	NOUN
eurjchem-2084	195	6	2	2	NUM
eurjchem-2084	195	7	.	.	PUNCT
eurjchem-2084	196	1	hcq+azt	hcq+azt	NOUN
eurjchem-2084	196	2	(	(	PUNCT
eurjchem-2084	196	3	6	6	NUM
eurjchem-2084	196	4	)	)	PUNCT
eurjchem-2084	196	5	grp	grp	NOUN
eurjchem-2084	196	6	3	3	X
eurjchem-2084	196	7	.	.	PUNCT
eurjchem-2084	196	8	control	control	NOUN
eurjchem-2084	196	9	(	(	PUNCT
eurjchem-2084	196	10	16	16	NUM
eurjchem-2084	196	11	)	)	PUNCT
eurjchem-2084	196	12	significant	significant	ADJ
eurjchem-2084	196	13	reduction	reduction	NOUN
eurjchem-2084	196	14	of	of	ADP
eurjchem-2084	196	15	viral	viral	ADJ
eurjchem-2084	196	16	load	load	NOUN
eurjchem-2084	196	17	in	in	ADP
eurjchem-2084	196	18	patients	patient	NOUN
eurjchem-2084	196	19	with	with	ADP
eurjchem-2084	196	20	hcq	hcq	NOUN
eurjchem-2084	196	21	treatment	treatment	NOUN
eurjchem-2084	196	22	;	;	PUNCT
eurjchem-2084	196	23	effect	effect	NOUN
eurjchem-2084	196	24	was	be	AUX
eurjchem-2084	196	25	augmented	augment	VERB
eurjchem-2084	196	26	by	by	ADP
eurjchem-2084	196	27	azt	azt	PROPN
eurjchem-2084	196	28	[	[	X
eurjchem-2084	196	29	113	113	NUM
eurjchem-2084	196	30	]	]	PUNCT
eurjchem-2084	196	31	uncontrolled	uncontrolled	ADJ
eurjchem-2084	196	32	,	,	PUNCT
eurjchem-2084	196	33	noncomparative	noncomparative	ADJ
eurjchem-2084	196	34	,	,	PUNCT
eurjchem-2084	196	35	observational	observational	ADJ
eurjchem-2084	196	36	study	study	NOUN
eurjchem-2084	196	37	80	80	NUM
eurjchem-2084	196	38	79	79	NUM
eurjchem-2084	196	39	hcq+azt	hcq+azt	ADJ
eurjchem-2084	196	40	significant	significant	ADJ
eurjchem-2084	196	41	clinical	clinical	ADJ
eurjchem-2084	196	42	recovery	recovery	NOUN
eurjchem-2084	196	43	and	and	CCONJ
eurjchem-2084	196	44	rapid	rapid	ADJ
eurjchem-2084	196	45	reduction	reduction	NOUN
eurjchem-2084	196	46	of	of	ADP
eurjchem-2084	196	47	viral	viral	ADJ
eurjchem-2084	196	48	congestion	congestion	NOUN
eurjchem-2084	196	49	in	in	ADP
eurjchem-2084	196	50	nasopharynx	nasopharynx	NOUN
eurjchem-2084	196	51	except	except	SCONJ
eurjchem-2084	196	52	two	two	NUM
eurjchem-2084	196	53	deaths	death	NOUN
eurjchem-2084	196	54	[	[	X
eurjchem-2084	196	55	79	79	NUM
eurjchem-2084	196	56	]	]	SYM
eurjchem-2084	196	57	7	7	NUM
eurjchem-2084	196	58	tocilizumab	tocilizumab	NOUN
eurjchem-2084	196	59	retrospective	retrospective	ADJ
eurjchem-2084	196	60	,	,	PUNCT
eurjchem-2084	196	61	observational	observational	ADJ
eurjchem-2084	196	62	,	,	PUNCT
eurjchem-2084	196	63	multicenter	multicenter	ADJ
eurjchem-2084	196	64	cohort	cohort	NOUN
eurjchem-2084	196	65	study	study	NOUN
eurjchem-2084	196	66	764	764	NUM
eurjchem-2084	196	67	icu	icu	PROPN
eurjchem-2084	196	68	patients	patient	NOUN
eurjchem-2084	196	69	grp	grp	VERB
eurjchem-2084	196	70	1	1	X
eurjchem-2084	196	71	.	.	PUNCT
eurjchem-2084	197	1	(	(	PUNCT
eurjchem-2084	197	2	210	210	NUM
eurjchem-2084	197	3	)	)	PUNCT
eurjchem-2084	197	4	tocilizumab	tocilizumab	NOUN
eurjchem-2084	197	5	grp	grp	NOUN
eurjchem-2084	197	6	2	2	X
eurjchem-2084	197	7	.	.	PUNCT
eurjchem-2084	198	1	(	(	PUNCT
eurjchem-2084	198	2	554	554	NUM
eurjchem-2084	198	3	)	)	PUNCT
eurjchem-2084	198	4	no	no	DET
eurjchem-2084	198	5	tocilizumab	tocilizumab	NOUN
eurjchem-2084	198	6	tocilizumab	tocilizumab	NOUN
eurjchem-2084	198	7	treatment	treatment	NOUN
eurjchem-2084	198	8	reduces	reduce	VERB
eurjchem-2084	198	9	mortality	mortality	NOUN
eurjchem-2084	198	10	in	in	ADP
eurjchem-2084	198	11	hospitalized	hospitalize	VERB
eurjchem-2084	198	12	patients	patient	NOUN
eurjchem-2084	198	13	requiring	require	VERB
eurjchem-2084	198	14	icu	icu	PROPN
eurjchem-2084	198	15	support	support	NOUN
eurjchem-2084	198	16	[	[	X
eurjchem-2084	198	17	114	114	NUM
eurjchem-2084	198	18	]	]	SYM
eurjchem-2084	198	19	8	8	NUM
eurjchem-2084	198	20	cpt	cpt	PROPN
eurjchem-2084	198	21	retrospective	retrospective	NOUN
eurjchem-2084	198	22	,	,	PUNCT
eurjchem-2084	198	23	randomized	randomize	VERB
eurjchem-2084	198	24	blinded	blind	VERB
eurjchem-2084	198	25	,	,	PUNCT
eurjchem-2084	198	26	single	single	ADJ
eurjchem-2084	198	27	center	center	NOUN
eurjchem-2084	198	28	clinical	clinical	ADJ
eurjchem-2084	198	29	trial	trial	NOUN
eurjchem-2084	198	30	1568	1568	NUM
eurjchem-2084	198	31	grp1	grp1	NOUN
eurjchem-2084	198	32	.	.	PUNCT
eurjchem-2084	199	1	(	(	PUNCT
eurjchem-2084	199	2	1430	1430	NUM
eurjchem-2084	199	3	)	)	PUNCT
eurjchem-2084	199	4	standard	standard	ADJ
eurjchem-2084	199	5	treatment	treatment	NOUN
eurjchem-2084	199	6	grp	grp	NOUN
eurjchem-2084	199	7	2	2	X
eurjchem-2084	199	8	.	.	PUNCT
eurjchem-2084	199	9	(	(	PUNCT
eurjchem-2084	199	10	168	168	NUM
eurjchem-2084	199	11	)	)	PUNCT
eurjchem-2084	199	12	(	(	PUNCT
eurjchem-2084	199	13	abo	abo	NOUN
eurjchem-2084	199	14	-	-	PUNCT
eurjchem-2084	199	15	compatible	compatible	ADJ
eurjchem-2084	199	16	cp	cp	NOUN
eurjchem-2084	199	17	)	)	PUNCT
eurjchem-2084	199	18	50	50	NUM
eurjchem-2084	199	19	%	%	NOUN
eurjchem-2084	199	20	reduction	reduction	NOUN
eurjchem-2084	199	21	in	in	ADP
eurjchem-2084	199	22	death	death	NOUN
eurjchem-2084	199	23	and	and	CCONJ
eurjchem-2084	199	24	intensive	intensive	ADJ
eurjchem-2084	199	25	care	care	NOUN
eurjchem-2084	199	26	unit	unit	NOUN
eurjchem-2084	199	27	(	(	PUNCT
eurjchem-2084	199	28	icu	icu	PROPN
eurjchem-2084	199	29	)	)	PUNCT
eurjchem-2084	199	30	admission	admission	NOUN
eurjchem-2084	199	31	rates	rate	NOUN
eurjchem-2084	199	32	as	as	SCONJ
eurjchem-2084	199	33	compared	compare	VERB
eurjchem-2084	199	34	with	with	ADP
eurjchem-2084	199	35	standard	standard	ADJ
eurjchem-2084	199	36	treatment	treatment	NOUN
eurjchem-2084	199	37	[	[	X
eurjchem-2084	199	38	92	92	NUM
eurjchem-2084	199	39	]	]	SYM
eurjchem-2084	199	40	retrospective	retrospective	ADJ
eurjchem-2084	199	41	,	,	PUNCT
eurjchem-2084	199	42	propensity	propensity	NOUN
eurjchem-2084	199	43	score	score	NOUN
eurjchem-2084	199	44	–	–	PUNCT
eurjchem-2084	199	45	matched	match	VERB
eurjchem-2084	199	46	case	case	NOUN
eurjchem-2084	199	47	–	–	PUNCT
eurjchem-2084	199	48	control	control	NOUN
eurjchem-2084	199	49	study	study	NOUN
eurjchem-2084	199	50	195	195	NUM
eurjchem-2084	199	51	grp1	grp1	NOUN
eurjchem-2084	199	52	.	.	PUNCT
eurjchem-2084	200	1	plasma	plasma	NOUN
eurjchem-2084	200	2	treatment	treatment	NOUN
eurjchem-2084	200	3	(	(	PUNCT
eurjchem-2084	200	4	39	39	NUM
eurjchem-2084	200	5	)	)	PUNCT
eurjchem-2084	200	6	grp	grp	NOUN
eurjchem-2084	200	7	2	2	NUM
eurjchem-2084	200	8	.	.	PUNCT
eurjchem-2084	200	9	control	control	NOUN
eurjchem-2084	200	10	(	(	PUNCT
eurjchem-2084	200	11	156	156	NUM
eurjchem-2084	200	12	)	)	PUNCT
eurjchem-2084	200	13	cp	cp	PROPN
eurjchem-2084	200	14	recipients	recipient	NOUN
eurjchem-2084	200	15	needs	need	VERB
eurjchem-2084	200	16	less	less	ADV
eurjchem-2084	200	17	supplemental	supplemental	ADJ
eurjchem-2084	200	18	oxygen	oxygen	NOUN
eurjchem-2084	200	19	than	than	ADP
eurjchem-2084	200	20	control	control	NOUN
eurjchem-2084	200	21	group	group	NOUN
eurjchem-2084	200	22	by	by	ADP
eurjchem-2084	200	23	14th	14th	ADJ
eurjchem-2084	200	24	day	day	NOUN
eurjchem-2084	200	25	of	of	ADP
eurjchem-2084	200	26	posttransfusion	posttransfusion	NOUN
eurjchem-2084	200	27	[	[	X
eurjchem-2084	200	28	115	115	NUM
eurjchem-2084	200	29	]	]	PUNCT
eurjchem-2084	200	30	study	study	NOUN
eurjchem-2084	200	31	conducted	conduct	VERB
eurjchem-2084	200	32	on	on	ADP
eurjchem-2084	200	33	a	a	DET
eurjchem-2084	200	34	very	very	ADV
eurjchem-2084	200	35	large	large	ADJ
eurjchem-2084	200	36	sample	sample	NOUN
eurjchem-2084	200	37	from	from	ADP
eurjchem-2084	200	38	9	9	NUM
eurjchem-2084	200	39	countries	country	NOUN
eurjchem-2084	200	40	including	include	VERB
eurjchem-2084	200	41	194,349,591	194,349,591	NUM
eurjchem-2084	200	42	men	man	NOUN
eurjchem-2084	200	43	and	and	CCONJ
eurjchem-2084	200	44	201,715,364	201,715,364	NUM
eurjchem-2084	200	45	women	woman	NOUN
eurjchem-2084	200	46	reported	report	VERB
eurjchem-2084	200	47	the	the	DET
eurjchem-2084	200	48	men	man	NOUN
eurjchem-2084	200	49	to	to	ADP
eurjchem-2084	200	50	women	woman	NOUN
eurjchem-2084	200	51	mortality	mortality	NOUN
eurjchem-2084	200	52	ratio	ratio	NOUN
eurjchem-2084	200	53	of	of	ADP
eurjchem-2084	200	54	1.4	1.4	NUM
eurjchem-2084	200	55	:	:	SYM
eurjchem-2084	200	56	1	1	NUM
eurjchem-2084	200	57	per	per	ADP
eurjchem-2084	200	58	100,000	100,000	NUM
eurjchem-2084	200	59	population	population	NOUN
eurjchem-2084	201	1	[	[	X
eurjchem-2084	201	2	54	54	NUM
eurjchem-2084	201	3	]	]	PUNCT
eurjchem-2084	201	4	.	.	PUNCT
eurjchem-2084	201	5	life	life	NOUN
eurjchem-2084	201	6	style	style	NOUN
eurjchem-2084	201	7	and	and	CCONJ
eurjchem-2084	201	8	chromosomal	chromosomal	ADJ
eurjchem-2084	201	9	differences	difference	NOUN
eurjchem-2084	201	10	were	be	AUX
eurjchem-2084	201	11	considered	consider	VERB
eurjchem-2084	201	12	the	the	DET
eurjchem-2084	201	13	most	most	ADV
eurjchem-2084	201	14	suitable	suitable	ADJ
eurjchem-2084	201	15	explanation	explanation	NOUN
eurjchem-2084	201	16	for	for	ADP
eurjchem-2084	201	17	the	the	DET
eurjchem-2084	201	18	death	death	NOUN
eurjchem-2084	201	19	due	due	ADP
eurjchem-2084	201	20	to	to	ADP
eurjchem-2084	201	21	gender	gender	NOUN
eurjchem-2084	201	22	difference	difference	NOUN
eurjchem-2084	201	23	,	,	PUNCT
eurjchem-2084	201	24	the	the	DET
eurjchem-2084	201	25	author	author	NOUN
eurjchem-2084	201	26	added	add	VERB
eurjchem-2084	201	27	.	.	PUNCT
eurjchem-2084	202	1	initially	initially	ADV
eurjchem-2084	202	2	during	during	ADP
eurjchem-2084	202	3	the	the	DET
eurjchem-2084	202	4	spread	spread	NOUN
eurjchem-2084	202	5	of	of	ADP
eurjchem-2084	202	6	the	the	DET
eurjchem-2084	202	7	virus	virus	NOUN
eurjchem-2084	202	8	,	,	PUNCT
eurjchem-2084	202	9	age	age	NOUN
eurjchem-2084	202	10	was	be	AUX
eurjchem-2084	202	11	considered	consider	VERB
eurjchem-2084	202	12	as	as	ADP
eurjchem-2084	202	13	one	one	NUM
eurjchem-2084	202	14	of	of	ADP
eurjchem-2084	202	15	the	the	DET
eurjchem-2084	202	16	prominent	prominent	ADJ
eurjchem-2084	202	17	risk	risk	NOUN
eurjchem-2084	202	18	factors	factor	NOUN
eurjchem-2084	202	19	,	,	PUNCT
eurjchem-2084	202	20	but	but	CCONJ
eurjchem-2084	202	21	with	with	ADP
eurjchem-2084	202	22	the	the	DET
eurjchem-2084	202	23	progression	progression	NOUN
eurjchem-2084	202	24	of	of	ADP
eurjchem-2084	202	25	pandemic	pandemic	ADJ
eurjchem-2084	202	26	,	,	PUNCT
eurjchem-2084	202	27	both	both	CCONJ
eurjchem-2084	202	28	sex	sex	NOUN
eurjchem-2084	202	29	and	and	CCONJ
eurjchem-2084	202	30	age	age	NOUN
eurjchem-2084	202	31	are	be	AUX
eurjchem-2084	202	32	considered	consider	VERB
eurjchem-2084	202	33	as	as	ADP
eurjchem-2084	202	34	prominent	prominent	ADJ
eurjchem-2084	202	35	risk	risk	NOUN
eurjchem-2084	202	36	factors	factor	NOUN
eurjchem-2084	202	37	.	.	PUNCT
eurjchem-2084	203	1	pregnant	pregnant	ADJ
eurjchem-2084	203	2	women	woman	NOUN
eurjchem-2084	203	3	are	be	AUX
eurjchem-2084	203	4	at	at	ADP
eurjchem-2084	203	5	higher	high	ADJ
eurjchem-2084	203	6	risk	risk	NOUN
eurjchem-2084	203	7	for	for	ADP
eurjchem-2084	203	8	respiratory	respiratory	ADJ
eurjchem-2084	203	9	pathogens	pathogen	NOUN
eurjchem-2084	203	10	and	and	CCONJ
eurjchem-2084	203	11	acute	acute	ADJ
eurjchem-2084	203	12	pneumonia	pneumonia	NOUN
eurjchem-2084	203	13	infections	infection	NOUN
eurjchem-2084	203	14	therefore	therefore	ADV
eurjchem-2084	203	15	it	it	PRON
eurjchem-2084	203	16	is	be	AUX
eurjchem-2084	203	17	important	important	ADJ
eurjchem-2084	203	18	to	to	PART
eurjchem-2084	203	19	understand	understand	VERB
eurjchem-2084	203	20	the	the	DET
eurjchem-2084	203	21	mother	mother	NOUN
eurjchem-2084	203	22	to	to	ADP
eurjchem-2084	203	23	neonatal	neonatal	ADJ
eurjchem-2084	203	24	transfer	transfer	NOUN
eurjchem-2084	203	25	of	of	ADP
eurjchem-2084	203	26	sars	sar	NOUN
eurjchem-2084	203	27	-	-	PUNCT
eurjchem-2084	203	28	cov-2	cov-2	NOUN
eurjchem-2084	203	29	.	.	PUNCT
eurjchem-2084	204	1	recently	recently	ADV
eurjchem-2084	204	2	,	,	PUNCT
eurjchem-2084	204	3	a	a	DET
eurjchem-2084	204	4	small	small	ADJ
eurjchem-2084	204	5	study	study	NOUN
eurjchem-2084	204	6	was	be	AUX
eurjchem-2084	204	7	conducted	conduct	VERB
eurjchem-2084	204	8	on	on	ADP
eurjchem-2084	204	9	covid19	covid19	NOUN
eurjchem-2084	204	10	positive	positive	ADJ
eurjchem-2084	204	11	pregnant	pregnant	ADJ
eurjchem-2084	204	12	women	woman	NOUN
eurjchem-2084	204	13	to	to	PART
eurjchem-2084	204	14	see	see	VERB
eurjchem-2084	204	15	the	the	DET
eurjchem-2084	204	16	neonatal	neonatal	ADJ
eurjchem-2084	204	17	transfer	transfer	NOUN
eurjchem-2084	204	18	of	of	ADP
eurjchem-2084	204	19	sars	sar	NOUN
eurjchem-2084	204	20	-	-	PUNCT
eurjchem-2084	204	21	cov-2	cov-2	NOUN
eurjchem-2084	204	22	and	and	CCONJ
eurjchem-2084	204	23	the	the	DET
eurjchem-2084	204	24	results	result	NOUN
eurjchem-2084	204	25	exhibited	exhibit	VERB
eurjchem-2084	204	26	that	that	SCONJ
eurjchem-2084	204	27	all	all	DET
eurjchem-2084	204	28	babies	baby	NOUN
eurjchem-2084	204	29	were	be	AUX
eurjchem-2084	204	30	born	bear	VERB
eurjchem-2084	204	31	healthy	healthy	ADJ
eurjchem-2084	204	32	indicating	indicate	VERB
eurjchem-2084	204	33	a	a	DET
eurjchem-2084	204	34	zero	zero	NUM
eurjchem-2084	204	35	case	case	NOUN
eurjchem-2084	204	36	of	of	ADP
eurjchem-2084	204	37	neonatal	neonatal	ADJ
eurjchem-2084	204	38	transfer	transfer	NOUN
eurjchem-2084	204	39	[	[	X
eurjchem-2084	204	40	55	55	NUM
eurjchem-2084	204	41	]	]	PUNCT
eurjchem-2084	204	42	.	.	PUNCT
eurjchem-2084	205	1	all	all	DET
eurjchem-2084	205	2	the	the	DET
eurjchem-2084	205	3	observations	observation	NOUN
eurjchem-2084	205	4	in	in	ADP
eurjchem-2084	205	5	this	this	DET
eurjchem-2084	205	6	study	study	NOUN
eurjchem-2084	205	7	were	be	AUX
eurjchem-2084	205	8	from	from	ADP
eurjchem-2084	205	9	the	the	DET
eurjchem-2084	205	10	caesarean	caesarean	ADJ
eurjchem-2084	205	11	delivery	delivery	NOUN
eurjchem-2084	205	12	.	.	PUNCT
eurjchem-2084	206	1	to	to	PART
eurjchem-2084	206	2	decide	decide	VERB
eurjchem-2084	206	3	the	the	DET
eurjchem-2084	206	4	pregnancy	pregnancy	NOUN
eurjchem-2084	206	5	and	and	CCONJ
eurjchem-2084	206	6	covid-19	covid-19	PROPN
eurjchem-2084	206	7	associated	associated	ADJ
eurjchem-2084	206	8	risks	risk	NOUN
eurjchem-2084	206	9	,	,	PUNCT
eurjchem-2084	206	10	a	a	DET
eurjchem-2084	206	11	systematic	systematic	ADJ
eurjchem-2084	206	12	review	review	NOUN
eurjchem-2084	206	13	by	by	ADP
eurjchem-2084	206	14	retrieving	retrieve	VERB
eurjchem-2084	206	15	49	49	NUM
eurjchem-2084	206	16	studies	study	NOUN
eurjchem-2084	206	17	found	find	VERB
eurjchem-2084	206	18	that	that	SCONJ
eurjchem-2084	206	19	8	8	NUM
eurjchem-2084	206	20	out	out	ADP
eurjchem-2084	206	21	of	of	ADP
eurjchem-2084	206	22	292	292	NUM
eurjchem-2084	206	23	(	(	PUNCT
eurjchem-2084	206	24	2.7	2.7	NUM
eurjchem-2084	206	25	%	%	NOUN
eurjchem-2084	206	26	)	)	PUNCT
eurjchem-2084	206	27	women	woman	NOUN
eurjchem-2084	206	28	who	who	PRON
eurjchem-2084	206	29	delivered	deliver	VERB
eurjchem-2084	206	30	their	their	PRON
eurjchem-2084	206	31	babies	baby	NOUN
eurjchem-2084	206	32	vaginally	vaginally	ADV
eurjchem-2084	206	33	had	have	VERB
eurjchem-2084	206	34	covid-19	covid-19	PROPN
eurjchem-2084	206	35	confirmed	confirm	VERB
eurjchem-2084	206	36	babies	baby	NOUN
eurjchem-2084	206	37	and	and	CCONJ
eurjchem-2084	206	38	20	20	NUM
eurjchem-2084	206	39	out	out	ADP
eurjchem-2084	206	40	of	of	ADP
eurjchem-2084	206	41	364	364	NUM
eurjchem-2084	206	42	(	(	PUNCT
eurjchem-2084	206	43	5.3	5.3	NUM
eurjchem-2084	206	44	%	%	NOUN
eurjchem-2084	206	45	)	)	PUNCT
eurjchem-2084	206	46	women	woman	NOUN
eurjchem-2084	206	47	who	who	PRON
eurjchem-2084	206	48	had	have	VERB
eurjchem-2084	206	49	caesarean	caesarean	ADJ
eurjchem-2084	206	50	baby	baby	NOUN
eurjchem-2084	206	51	had	have	VERB
eurjchem-2084	206	52	covid-19	covid-19	PROPN
eurjchem-2084	206	53	confirmed	confirm	VERB
eurjchem-2084	206	54	baby	baby	NOUN
eurjchem-2084	206	55	.	.	PUNCT
eurjchem-2084	207	1	therefore	therefore	ADV
eurjchem-2084	207	2	,	,	PUNCT
eurjchem-2084	207	3	the	the	DET
eurjchem-2084	207	4	study	study	NOUN
eurjchem-2084	207	5	concluded	conclude	VERB
eurjchem-2084	207	6	that	that	SCONJ
eurjchem-2084	207	7	neonatal	neonatal	ADJ
eurjchem-2084	207	8	transmission	transmission	NOUN
eurjchem-2084	207	9	of	of	ADP
eurjchem-2084	207	10	covid-19	covid-19	PROPN
eurjchem-2084	207	11	is	be	AUX
eurjchem-2084	207	12	infrequent	infrequent	ADJ
eurjchem-2084	207	13	and	and	CCONJ
eurjchem-2084	207	14	the	the	DET
eurjchem-2084	207	15	infection	infection	NOUN
eurjchem-2084	207	16	rate	rate	NOUN
eurjchem-2084	207	17	is	be	AUX
eurjchem-2084	207	18	independent	independent	ADJ
eurjchem-2084	207	19	of	of	ADP
eurjchem-2084	207	20	the	the	DET
eurjchem-2084	207	21	delivery	delivery	NOUN
eurjchem-2084	207	22	route	route	NOUN
eurjchem-2084	208	1	[	[	X
eurjchem-2084	208	2	56	56	NUM
eurjchem-2084	208	3	]	]	PUNCT
eurjchem-2084	208	4	.	.	PUNCT
eurjchem-2084	209	1	further	far	ADV
eurjchem-2084	209	2	,	,	PUNCT
eurjchem-2084	209	3	most	most	ADJ
eurjchem-2084	209	4	of	of	ADP
eurjchem-2084	209	5	the	the	DET
eurjchem-2084	209	6	infected	infected	ADJ
eurjchem-2084	209	7	newborns	newborn	NOUN
eurjchem-2084	209	8	were	be	AUX
eurjchem-2084	209	9	asymptomatic	asymptomatic	ADJ
eurjchem-2084	209	10	or	or	CCONJ
eurjchem-2084	209	11	exhibited	exhibit	VERB
eurjchem-2084	209	12	mild	mild	ADJ
eurjchem-2084	209	13	symptoms	symptom	NOUN
eurjchem-2084	209	14	[	[	X
eurjchem-2084	209	15	57	57	NUM
eurjchem-2084	209	16	]	]	PUNCT
eurjchem-2084	209	17	.	.	PUNCT
eurjchem-2084	210	1	till	till	SCONJ
eurjchem-2084	210	2	now	now	ADV
eurjchem-2084	210	3	,	,	PUNCT
eurjchem-2084	210	4	very	very	ADV
eurjchem-2084	210	5	few	few	ADJ
eurjchem-2084	210	6	cases	case	NOUN
eurjchem-2084	210	7	of	of	ADP
eurjchem-2084	210	8	sars	sar	NOUN
eurjchem-2084	210	9	-	-	PUNCT
eurjchem-2084	210	10	cov-2	cov-2	PART
eurjchem-2084	210	11	infection	infection	NOUN
eurjchem-2084	210	12	have	have	AUX
eurjchem-2084	210	13	been	be	AUX
eurjchem-2084	210	14	found	find	VERB
eurjchem-2084	210	15	in	in	ADP
eurjchem-2084	210	16	children	child	NOUN
eurjchem-2084	210	17	(	(	PUNCT
eurjchem-2084	210	18	age	age	NOUN
eurjchem-2084	210	19	0	0	NUM
eurjchem-2084	210	20	-	-	SYM
eurjchem-2084	210	21	17	17	NUM
eurjchem-2084	210	22	years	year	NOUN
eurjchem-2084	210	23	)	)	PUNCT
eurjchem-2084	210	24	compared	compare	VERB
eurjchem-2084	210	25	with	with	ADP
eurjchem-2084	210	26	adults	adult	NOUN
eurjchem-2084	210	27	,	,	PUNCT
eurjchem-2084	210	28	therefore	therefore	ADV
eurjchem-2084	210	29	,	,	PUNCT
eurjchem-2084	210	30	the	the	DET
eurjchem-2084	210	31	potential	potential	NOUN
eurjchem-2084	210	32	of	of	ADP
eurjchem-2084	210	33	viral	viral	ADJ
eurjchem-2084	210	34	infection	infection	NOUN
eurjchem-2084	210	35	and	and	CCONJ
eurjchem-2084	210	36	transmission	transmission	NOUN
eurjchem-2084	210	37	in	in	ADP
eurjchem-2084	210	38	children	child	NOUN
eurjchem-2084	210	39	is	be	AUX
eurjchem-2084	210	40	not	not	PART
eurjchem-2084	210	41	much	much	ADV
eurjchem-2084	210	42	clear	clear	ADJ
eurjchem-2084	210	43	[	[	X
eurjchem-2084	210	44	58	58	NUM
eurjchem-2084	210	45	]	]	PUNCT
eurjchem-2084	210	46	.	.	PUNCT
eurjchem-2084	211	1	the	the	DET
eurjchem-2084	211	2	viral	viral	ADJ
eurjchem-2084	211	3	loads	load	NOUN
eurjchem-2084	211	4	in	in	ADP
eurjchem-2084	211	5	the	the	DET
eurjchem-2084	211	6	nasopharynx	nasopharynx	NOUN
eurjchem-2084	211	7	and	and	CCONJ
eurjchem-2084	211	8	the	the	DET
eurjchem-2084	211	9	efficacy	efficacy	NOUN
eurjchem-2084	211	10	of	of	ADP
eurjchem-2084	211	11	viral	viral	ADJ
eurjchem-2084	211	12	transmission	transmission	NOUN
eurjchem-2084	211	13	in	in	ADP
eurjchem-2084	211	14	children	child	NOUN
eurjchem-2084	211	15	are	be	AUX
eurjchem-2084	211	16	almost	almost	ADV
eurjchem-2084	211	17	the	the	DET
eurjchem-2084	211	18	same	same	ADJ
eurjchem-2084	211	19	as	as	ADP
eurjchem-2084	211	20	in	in	ADP
eurjchem-2084	211	21	adults	adult	NOUN
eurjchem-2084	211	22	[	[	X
eurjchem-2084	211	23	59	59	NUM
eurjchem-2084	211	24	]	]	PUNCT
eurjchem-2084	211	25	.	.	PUNCT
eurjchem-2084	212	1	the	the	DET
eurjchem-2084	212	2	comparison	comparison	NOUN
eurjchem-2084	212	3	of	of	ADP
eurjchem-2084	212	4	the	the	DET
eurjchem-2084	212	5	incidence	incidence	NOUN
eurjchem-2084	212	6	of	of	ADP
eurjchem-2084	212	7	infection	infection	NOUN
eurjchem-2084	212	8	in	in	ADP
eurjchem-2084	212	9	children	child	NOUN
eurjchem-2084	212	10	before	before	ADP
eurjchem-2084	212	11	and	and	CCONJ
eurjchem-2084	212	12	after	after	ADP
eurjchem-2084	212	13	opening	opening	NOUN
eurjchem-2084	212	14	of	of	ADP
eurjchem-2084	212	15	schools	school	NOUN
eurjchem-2084	212	16	and	and	CCONJ
eurjchem-2084	212	17	other	other	ADJ
eurjchem-2084	212	18	activities	activity	NOUN
eurjchem-2084	212	19	can	can	AUX
eurjchem-2084	212	20	provide	provide	VERB
eurjchem-2084	212	21	additional	additional	ADJ
eurjchem-2084	212	22	insight	insight	NOUN
eurjchem-2084	212	23	into	into	ADP
eurjchem-2084	212	24	the	the	DET
eurjchem-2084	212	25	pediatric	pediatric	ADJ
eurjchem-2084	212	26	infection	infection	NOUN
eurjchem-2084	212	27	.	.	PUNCT
eurjchem-2084	213	1	6.2	6.2	NUM
eurjchem-2084	213	2	.	.	PUNCT
eurjchem-2084	214	1	strive	strive	ADJ
eurjchem-2084	214	2	of	of	ADP
eurjchem-2084	214	3	the	the	DET
eurjchem-2084	214	4	scientific	scientific	ADJ
eurjchem-2084	214	5	community	community	NOUN
eurjchem-2084	214	6	against	against	ADP
eurjchem-2084	214	7	pandemic	pandemic	ADJ
eurjchem-2084	214	8	viruses	virus	NOUN
eurjchem-2084	214	9	the	the	DET
eurjchem-2084	214	10	cases	case	NOUN
eurjchem-2084	214	11	of	of	ADP
eurjchem-2084	214	12	covid-19	covid-19	PROPN
eurjchem-2084	214	13	infections	infection	NOUN
eurjchem-2084	214	14	are	be	AUX
eurjchem-2084	214	15	continuously	continuously	ADV
eurjchem-2084	214	16	increasing	increase	VERB
eurjchem-2084	214	17	,	,	PUNCT
eurjchem-2084	214	18	unfortunately	unfortunately	ADV
eurjchem-2084	214	19	no	no	DET
eurjchem-2084	214	20	medicine/	medicine/	NUM
eurjchem-2084	214	21	vaccine	vaccine	NOUN
eurjchem-2084	214	22	has	have	AUX
eurjchem-2084	214	23	been	be	AUX
eurjchem-2084	214	24	officially	officially	ADV
eurjchem-2084	214	25	approved	approve	VERB
eurjchem-2084	214	26	to	to	PART
eurjchem-2084	214	27	treat	treat	VERB
eurjchem-2084	214	28	covid-19	covid-19	PROPN
eurjchem-2084	214	29	patients	patient	NOUN
eurjchem-2084	214	30	until	until	ADP
eurjchem-2084	214	31	earlier	early	ADV
eurjchem-2084	214	32	in	in	ADP
eurjchem-2084	214	33	the	the	DET
eurjchem-2084	214	34	last	last	ADJ
eurjchem-2084	214	35	year	year	NOUN
eurjchem-2084	214	36	2020	2020	NUM
eurjchem-2084	214	37	.	.	PUNCT
eurjchem-2084	215	1	therefore	therefore	ADV
eurjchem-2084	215	2	,	,	PUNCT
eurjchem-2084	215	3	at	at	ADP
eurjchem-2084	215	4	that	that	DET
eurjchem-2084	215	5	time	time	NOUN
eurjchem-2084	215	6	,	,	PUNCT
eurjchem-2084	215	7	clinical	clinical	ADJ
eurjchem-2084	215	8	management	management	NOUN
eurjchem-2084	215	9	involves	involve	VERB
eurjchem-2084	215	10	protective	protective	ADJ
eurjchem-2084	215	11	and	and	CCONJ
eurjchem-2084	215	12	control	control	NOUN
eurjchem-2084	215	13	measures	measure	NOUN
eurjchem-2084	215	14	along	along	ADP
eurjchem-2084	215	15	with	with	ADP
eurjchem-2084	215	16	supplemental	supplemental	ADJ
eurjchem-2084	215	17	oxygen	oxygen	NOUN
eurjchem-2084	215	18	and	and	CCONJ
eurjchem-2084	215	19	ventilation	ventilation	NOUN
eurjchem-2084	215	20	to	to	PART
eurjchem-2084	215	21	prevent	prevent	VERB
eurjchem-2084	215	22	the	the	DET
eurjchem-2084	215	23	rapid	rapid	ADJ
eurjchem-2084	215	24	spread	spread	NOUN
eurjchem-2084	215	25	of	of	ADP
eurjchem-2084	215	26	the	the	DET
eurjchem-2084	215	27	virus	virus	NOUN
eurjchem-2084	215	28	and	and	CCONJ
eurjchem-2084	215	29	to	to	PART
eurjchem-2084	215	30	manage	manage	VERB
eurjchem-2084	215	31	the	the	DET
eurjchem-2084	215	32	disease	disease	NOUN
eurjchem-2084	215	33	symptoms	symptom	NOUN
eurjchem-2084	215	34	.	.	PUNCT
eurjchem-2084	216	1	therefore	therefore	ADV
eurjchem-2084	216	2	,	,	PUNCT
eurjchem-2084	216	3	there	there	PRON
eurjchem-2084	216	4	is	be	VERB
eurjchem-2084	216	5	a	a	DET
eurjchem-2084	216	6	pressure	pressure	NOUN
eurjchem-2084	216	7	on	on	ADP
eurjchem-2084	216	8	the	the	DET
eurjchem-2084	216	9	scientific	scientific	ADJ
eurjchem-2084	216	10	community	community	NOUN
eurjchem-2084	216	11	to	to	PART
eurjchem-2084	216	12	find	find	VERB
eurjchem-2084	216	13	some	some	DET
eurjchem-2084	216	14	alternative	alternative	ADJ
eurjchem-2084	216	15	medicine	medicine	NOUN
eurjchem-2084	216	16	to	to	PART
eurjchem-2084	216	17	tackle	tackle	VERB
eurjchem-2084	216	18	/	/	SYM
eurjchem-2084	216	19	combat	combat	VERB
eurjchem-2084	216	20	the	the	DET
eurjchem-2084	216	21	virus	virus	NOUN
eurjchem-2084	216	22	effectively	effectively	ADV
eurjchem-2084	216	23	.	.	PUNCT
eurjchem-2084	217	1	to	to	PART
eurjchem-2084	217	2	overcome	overcome	VERB
eurjchem-2084	217	3	this	this	DET
eurjchem-2084	217	4	issue	issue	NOUN
eurjchem-2084	217	5	,	,	PUNCT
eurjchem-2084	217	6	scientists	scientist	NOUN
eurjchem-2084	217	7	are	be	AUX
eurjchem-2084	217	8	trying	try	VERB
eurjchem-2084	217	9	the	the	DET
eurjchem-2084	217	10	repurposing	repurposing	NOUN
eurjchem-2084	217	11	of	of	ADP
eurjchem-2084	217	12	the	the	DET
eurjchem-2084	217	13	available	available	ADJ
eurjchem-2084	217	14	drugs	drug	NOUN
eurjchem-2084	217	15	.	.	PUNCT
eurjchem-2084	218	1	who	who	PRON
eurjchem-2084	218	2	has	have	AUX
eurjchem-2084	218	3	announced	announce	VERB
eurjchem-2084	218	4	a	a	DET
eurjchem-2084	218	5	number	number	NOUN
eurjchem-2084	218	6	of	of	ADP
eurjchem-2084	218	7	drugs	drug	NOUN
eurjchem-2084	218	8	that	that	PRON
eurjchem-2084	218	9	showed	show	VERB
eurjchem-2084	218	10	efficacy	efficacy	NOUN
eurjchem-2084	218	11	against	against	ADP
eurjchem-2084	218	12	sars	sar	NOUN
eurjchem-2084	218	13	-	-	PUNCT
eurjchem-2084	218	14	cov-2	cov-2	PART
eurjchem-2084	218	15	infection	infection	NOUN
eurjchem-2084	218	16	.	.	PUNCT
eurjchem-2084	219	1	until	until	ADP
eurjchem-2084	219	2	now	now	ADV
eurjchem-2084	219	3	,	,	PUNCT
eurjchem-2084	219	4	antivirals	antiviral	NOUN
eurjchem-2084	219	5	have	have	AUX
eurjchem-2084	219	6	found	find	VERB
eurjchem-2084	219	7	the	the	DET
eurjchem-2084	219	8	most	most	ADV
eurjchem-2084	219	9	effective	effective	ADJ
eurjchem-2084	219	10	use	use	NOUN
eurjchem-2084	219	11	against	against	ADP
eurjchem-2084	219	12	the	the	DET
eurjchem-2084	219	13	virus	virus	NOUN
eurjchem-2084	219	14	,	,	PUNCT
eurjchem-2084	219	15	which	which	PRON
eurjchem-2084	219	16	lowers	lower	VERB
eurjchem-2084	219	17	the	the	DET
eurjchem-2084	219	18	ability	ability	NOUN
eurjchem-2084	219	19	of	of	ADP
eurjchem-2084	219	20	the	the	DET
eurjchem-2084	219	21	viruses	virus	NOUN
eurjchem-2084	219	22	to	to	PART
eurjchem-2084	219	23	invade	invade	VERB
eurjchem-2084	219	24	the	the	DET
eurjchem-2084	219	25	cells	cell	NOUN
eurjchem-2084	219	26	and	and	CCONJ
eurjchem-2084	219	27	arrest	arrest	VERB
eurjchem-2084	219	28	their	their	PRON
eurjchem-2084	219	29	multiplication	multiplication	NOUN
eurjchem-2084	219	30	process	process	NOUN
eurjchem-2084	219	31	.	.	PUNCT
eurjchem-2084	220	1	we	we	PRON
eurjchem-2084	220	2	have	have	AUX
eurjchem-2084	220	3	discussed	discuss	VERB
eurjchem-2084	220	4	the	the	DET
eurjchem-2084	220	5	usage	usage	NOUN
eurjchem-2084	220	6	and	and	CCONJ
eurjchem-2084	220	7	clinical	clinical	ADJ
eurjchem-2084	220	8	trial	trial	NOUN
eurjchem-2084	220	9	reports	report	NOUN
eurjchem-2084	220	10	(	(	PUNCT
eurjchem-2084	220	11	table	table	NOUN
eurjchem-2084	220	12	1	1	NUM
eurjchem-2084	220	13	)	)	PUNCT
eurjchem-2084	220	14	of	of	ADP
eurjchem-2084	220	15	the	the	DET
eurjchem-2084	220	16	drugs	drug	NOUN
eurjchem-2084	220	17	currently	currently	ADV
eurjchem-2084	220	18	being	be	AUX
eurjchem-2084	220	19	used	use	VERB
eurjchem-2084	220	20	to	to	PART
eurjchem-2084	220	21	manage	manage	VERB
eurjchem-2084	220	22	sars	sar	NOUN
eurjchem-2084	220	23	-	-	PUNCT
eurjchem-2084	220	24	cov-2	cov-2	NOUN
eurjchem-2084	220	25	infection	infection	NOUN
eurjchem-2084	220	26	in	in	ADP
eurjchem-2084	220	27	the	the	DET
eurjchem-2084	220	28	following	follow	VERB
eurjchem-2084	220	29	section	section	NOUN
eurjchem-2084	220	30	.	.	PUNCT
eurjchem-2084	221	1	vaccines	vaccine	NOUN
eurjchem-2084	221	2	typically	typically	ADV
eurjchem-2084	221	3	require	require	VERB
eurjchem-2084	221	4	years	year	NOUN
eurjchem-2084	221	5	of	of	ADP
eurjchem-2084	221	6	research	research	NOUN
eurjchem-2084	221	7	and	and	CCONJ
eurjchem-2084	221	8	testing	testing	NOUN
eurjchem-2084	221	9	before	before	ADP
eurjchem-2084	221	10	reaching	reach	VERB
eurjchem-2084	221	11	the	the	DET
eurjchem-2084	221	12	clinic	clinic	NOUN
eurjchem-2084	221	13	,	,	PUNCT
eurjchem-2084	221	14	and	and	CCONJ
eurjchem-2084	221	15	although	although	SCONJ
eurjchem-2084	221	16	scientists	scientist	NOUN
eurjchem-2084	221	17	have	have	AUX
eurjchem-2084	221	18	been	be	AUX
eurjchem-2084	221	19	working	work	VERB
eurjchem-2084	221	20	tirelessly	tirelessly	ADV
eurjchem-2084	221	21	for	for	ADP
eurjchem-2084	221	22	vaccine	vaccine	NOUN
eurjchem-2084	221	23	development	development	NOUN
eurjchem-2084	221	24	in	in	ADP
eurjchem-2084	221	25	2020	2020	NUM
eurjchem-2084	221	26	.	.	PUNCT
eurjchem-2084	222	1	it	it	PRON
eurjchem-2084	222	2	is	be	AUX
eurjchem-2084	222	3	now	now	ADV
eurjchem-2084	222	4	certain	certain	ADJ
eurjchem-2084	222	5	that	that	SCONJ
eurjchem-2084	222	6	the	the	DET
eurjchem-2084	222	7	vaccine	vaccine	NOUN
eurjchem-2084	222	8	appears	appear	VERB
eurjchem-2084	222	9	at	at	ADP
eurjchem-2084	222	10	the	the	DET
eurjchem-2084	222	11	earliest	early	ADJ
eurjchem-2084	222	12	as	as	SCONJ
eurjchem-2084	222	13	scientists	scientist	NOUN
eurjchem-2084	222	14	embarked	embark	VERB
eurjchem-2084	222	15	on	on	ADP
eurjchem-2084	222	16	a	a	DET
eurjchem-2084	222	17	race	race	NOUN
eurjchem-2084	222	18	to	to	PART
eurjchem-2084	222	19	produce	produce	VERB
eurjchem-2084	222	20	safe	safe	ADJ
eurjchem-2084	222	21	and	and	CCONJ
eurjchem-2084	222	22	effective	effective	ADJ
eurjchem-2084	222	23	corona	corona	NOUN
eurjchem-2084	222	24	virus	virus	NOUN
eurjchem-2084	222	25	vaccines	vaccine	NOUN
eurjchem-2084	222	26	in	in	ADP
eurjchem-2084	222	27	record	record	NOUN
eurjchem-2084	222	28	time	time	NOUN
eurjchem-2084	222	29	.	.	PUNCT
eurjchem-2084	223	1	researchers	researcher	NOUN
eurjchem-2084	223	2	are	be	AUX
eurjchem-2084	223	3	currently	currently	ADV
eurjchem-2084	223	4	testing	test	VERB
eurjchem-2084	223	5	64	64	NUM
eurjchem-2084	223	6	vaccines	vaccine	NOUN
eurjchem-2084	223	7	in	in	ADP
eurjchem-2084	223	8	clinical	clinical	ADJ
eurjchem-2084	223	9	trials	trial	NOUN
eurjchem-2084	223	10	on	on	ADP
eurjchem-2084	223	11	humans	human	NOUN
eurjchem-2084	223	12	,	,	PUNCT
eurjchem-2084	223	13	and	and	CCONJ
eurjchem-2084	223	14	20	20	NUM
eurjchem-2084	223	15	have	have	AUX
eurjchem-2084	223	16	reached	reach	VERB
eurjchem-2084	223	17	the	the	DET
eurjchem-2084	223	18	final	final	ADJ
eurjchem-2084	223	19	stages	stage	NOUN
eurjchem-2084	223	20	of	of	ADP
eurjchem-2084	223	21	testing	testing	NOUN
eurjchem-2084	223	22	.	.	PUNCT
eurjchem-2084	224	1	at	at	ADP
eurjchem-2084	224	2	least	least	ADJ
eurjchem-2084	224	3	85	85	NUM
eurjchem-2084	224	4	preclinical	preclinical	ADJ
eurjchem-2084	224	5	vaccines	vaccine	NOUN
eurjchem-2084	224	6	are	be	AUX
eurjchem-2084	224	7	under	under	ADP
eurjchem-2084	224	8	active	active	ADJ
eurjchem-2084	224	9	investigation	investigation	NOUN
eurjchem-2084	224	10	in	in	ADP
eurjchem-2084	224	11	animals	animal	NOUN
eurjchem-2084	224	12	.	.	PUNCT
eurjchem-2084	225	1	228	228	NUM
eurjchem-2084	225	2	firdaus	firdaus	PROPN
eurjchem-2084	225	3	et	et	PROPN
eurjchem-2084	225	4	al	al	PROPN
eurjchem-2084	225	5	.	.	PUNCT
eurjchem-2084	225	6	/	/	SYM
eurjchem-2084	225	7	european	european	PROPN
eurjchem-2084	225	8	journal	journal	PROPN
eurjchem-2084	225	9	of	of	ADP
eurjchem-2084	225	10	chemistry	chemistry	NOUN
eurjchem-2084	225	11	12	12	NUM
eurjchem-2084	225	12	(	(	PUNCT
eurjchem-2084	225	13	2	2	NUM
eurjchem-2084	225	14	)	)	PUNCT
eurjchem-2084	225	15	(	(	PUNCT
eurjchem-2084	225	16	2021	2021	NUM
eurjchem-2084	225	17	)	)	PUNCT
eurjchem-2084	225	18	222	222	NUM
eurjchem-2084	225	19	-	-	SYM
eurjchem-2084	225	20	234	234	NUM
eurjchem-2084	225	21	2021	2021	NUM
eurjchem-2084	225	22	–	–	PUNCT
eurjchem-2084	225	23	european	european	ADJ
eurjchem-2084	225	24	journal	journal	NOUN
eurjchem-2084	225	25	of	of	ADP
eurjchem-2084	225	26	chemistry	chemistry	NOUN
eurjchem-2084	225	27	–	–	PUNCT
eurjchem-2084	225	28	cc	cc	NOUN
eurjchem-2084	225	29	by	by	ADP
eurjchem-2084	225	30	nc	nc	PROPN
eurjchem-2084	225	31	–	–	PUNCT
eurjchem-2084	225	32	doi	doi	NOUN
eurjchem-2084	225	33	:	:	PUNCT
eurjchem-2084	225	34	10.5155	10.5155	NUM
eurjchem-2084	225	35	/	/	SYM
eurjchem-2084	225	36	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	225	37	-	-	PUNCT
eurjchem-2084	225	38	234.2084	234.2084	NUM
eurjchem-2084	225	39	table	table	NOUN
eurjchem-2084	225	40	2	2	NUM
eurjchem-2084	225	41	.	.	X
eurjchem-2084	225	42	list	list	NOUN
eurjchem-2084	225	43	of	of	ADP
eurjchem-2084	225	44	all	all	DET
eurjchem-2084	225	45	vaccines	vaccine	NOUN
eurjchem-2084	225	46	that	that	PRON
eurjchem-2084	225	47	have	have	AUX
eurjchem-2084	225	48	been	be	AUX
eurjchem-2084	225	49	approved	approve	VERB
eurjchem-2084	225	50	and	and	CCONJ
eurjchem-2084	225	51	set	set	VERB
eurjchem-2084	225	52	for	for	ADP
eurjchem-2084	225	53	emergency	emergency	NOUN
eurjchem-2084	225	54	use	use	NOUN
eurjchem-2084	225	55	in	in	ADP
eurjchem-2084	225	56	certain	certain	ADJ
eurjchem-2084	225	57	countries	country	NOUN
eurjchem-2084	225	58	.	.	PUNCT
eurjchem-2084	226	1	no	no	DET
eurjchem-2084	226	2	vaccine	vaccine	NOUN
eurjchem-2084	226	3	developer	developer	NOUN
eurjchem-2084	226	4	type	type	NOUN
eurjchem-2084	226	5	phase	phase	NOUN
eurjchem-2084	226	6	status	status	NOUN
eurjchem-2084	226	7	1	1	NUM
eurjchem-2084	226	8	pfizer	pfizer	NOUN
eurjchem-2084	226	9	-	-	PUNCT
eurjchem-2084	226	10	biontech	biontech	NOUN
eurjchem-2084	226	11	mrna	mrna	PROPN
eurjchem-2084	226	12	2	2	NUM
eurjchem-2084	226	13	,	,	PUNCT
eurjchem-2084	226	14	3	3	NUM
eurjchem-2084	226	15	approved	approve	VERB
eurjchem-2084	226	16	in	in	ADP
eurjchem-2084	226	17	canada	canada	PROPN
eurjchem-2084	226	18	,	,	PUNCT
eurjchem-2084	226	19	other	other	ADJ
eurjchem-2084	226	20	countries	country	NOUN
eurjchem-2084	226	21	.	.	PUNCT
eurjchem-2084	227	1	emergency	emergency	NOUN
eurjchem-2084	227	2	use	use	NOUN
eurjchem-2084	227	3	in	in	ADP
eurjchem-2084	227	4	u.s	u.s	PROPN
eurjchem-2084	227	5	.	.	PROPN
eurjchem-2084	227	6	,	,	PUNCT
eurjchem-2084	227	7	other	other	ADJ
eurjchem-2084	227	8	countries	country	NOUN
eurjchem-2084	227	9	.	.	PUNCT
eurjchem-2084	228	1	2	2	NUM
eurjchem-2084	228	2	moderna	moderna	PROPN
eurjchem-2084	228	3	mrna	mrna	PROPN
eurjchem-2084	228	4	3	3	NUM
eurjchem-2084	228	5	approved	approve	VERB
eurjchem-2084	228	6	in	in	ADP
eurjchem-2084	228	7	canada	canada	PROPN
eurjchem-2084	228	8	.	.	PUNCT
eurjchem-2084	229	1	emergency	emergency	NOUN
eurjchem-2084	229	2	use	use	NOUN
eurjchem-2084	229	3	in	in	ADP
eurjchem-2084	229	4	u.s	u.s	PROPN
eurjchem-2084	229	5	.	.	PROPN
eurjchem-2084	229	6	3	3	NUM
eurjchem-2084	229	7	gamaleya	gamaleya	NOUN
eurjchem-2084	229	8	adenovirus	adenovirus	VERB
eurjchem-2084	229	9	3	3	NUM
eurjchem-2084	229	10	early	early	ADJ
eurjchem-2084	229	11	use	use	NOUN
eurjchem-2084	229	12	in	in	ADP
eurjchem-2084	229	13	russia	russia	PROPN
eurjchem-2084	229	14	.	.	PUNCT
eurjchem-2084	230	1	emergency	emergency	NOUN
eurjchem-2084	230	2	use	use	NOUN
eurjchem-2084	230	3	in	in	ADP
eurjchem-2084	230	4	belarus	belarus	PROPN
eurjchem-2084	230	5	,	,	PUNCT
eurjchem-2084	230	6	argentina	argentina	PROPN
eurjchem-2084	230	7	.	.	PUNCT
eurjchem-2084	231	1	4	4	NUM
eurjchem-2084	231	2	oxford	oxford	PROPN
eurjchem-2084	231	3	-	-	PUNCT
eurjchem-2084	231	4	astrazeneca	astrazeneca	NOUN
eurjchem-2084	231	5	adenovirus	adenovirus	NOUN
eurjchem-2084	231	6	2	2	NUM
eurjchem-2084	231	7	,	,	PUNCT
eurjchem-2084	231	8	3	3	NUM
eurjchem-2084	231	9	emergency	emergency	NOUN
eurjchem-2084	231	10	use	use	NOUN
eurjchem-2084	231	11	in	in	ADP
eurjchem-2084	231	12	britain	britain	PROPN
eurjchem-2084	231	13	,	,	PUNCT
eurjchem-2084	231	14	india	india	PROPN
eurjchem-2084	231	15	,	,	PUNCT
eurjchem-2084	231	16	argentina	argentina	PROPN
eurjchem-2084	231	17	.	.	PUNCT
eurjchem-2084	232	1	5	5	NUM
eurjchem-2084	232	2	cansino	cansino	NOUN
eurjchem-2084	232	3	adenovirus	adenovirus	NOUN
eurjchem-2084	232	4	3	3	NUM
eurjchem-2084	232	5	limited	limited	ADJ
eurjchem-2084	232	6	use	use	NOUN
eurjchem-2084	232	7	in	in	ADP
eurjchem-2084	232	8	china	china	PROPN
eurjchem-2084	232	9	.	.	PUNCT
eurjchem-2084	233	1	6	6	NUM
eurjchem-2084	233	2	johnson	johnson	PROPN
eurjchem-2084	233	3	&	&	CCONJ
eurjchem-2084	233	4	johnson	johnson	PROPN
eurjchem-2084	233	5	adenovirus	adenovirus	VERB
eurjchem-2084	233	6	3	3	NUM
eurjchem-2084	233	7	7	7	NUM
eurjchem-2084	233	8	vector	vector	NOUN
eurjchem-2084	233	9	institute	institute	NOUN
eurjchem-2084	233	10	protein	protein	NOUN
eurjchem-2084	233	11	3	3	NUM
eurjchem-2084	233	12	early	early	ADJ
eurjchem-2084	233	13	use	use	NOUN
eurjchem-2084	233	14	in	in	ADP
eurjchem-2084	233	15	russia	russia	PROPN
eurjchem-2084	233	16	.	.	PUNCT
eurjchem-2084	234	1	8	8	NUM
eurjchem-2084	234	2	novavax	novavax	NOUN
eurjchem-2084	234	3	protein	protein	NOUN
eurjchem-2084	234	4	3	3	NUM
eurjchem-2084	234	5	9	9	NUM
eurjchem-2084	234	6	sinopharm	sinopharm	NOUN
eurjchem-2084	234	7	inactivated	inactivated	ADJ
eurjchem-2084	234	8	3	3	NUM
eurjchem-2084	234	9	approved	approve	VERB
eurjchem-2084	234	10	in	in	ADP
eurjchem-2084	234	11	china	china	PROPN
eurjchem-2084	234	12	,	,	PUNCT
eurjchem-2084	234	13	u.a.e	u.a.e	PROPN
eurjchem-2084	234	14	.	.	PROPN
eurjchem-2084	234	15	,	,	PUNCT
eurjchem-2084	234	16	bahrain	bahrain	NOUN
eurjchem-2084	234	17	.	.	PUNCT
eurjchem-2084	235	1	emergency	emergency	NOUN
eurjchem-2084	235	2	use	use	NOUN
eurjchem-2084	235	3	in	in	ADP
eurjchem-2084	235	4	egypt	egypt	PROPN
eurjchem-2084	235	5	.	.	PUNCT
eurjchem-2084	236	1	10	10	NUM
eurjchem-2084	236	2	sinovac	sinovac	NOUN
eurjchem-2084	236	3	inactivated	inactivated	ADJ
eurjchem-2084	236	4	3	3	NUM
eurjchem-2084	236	5	limited	limited	ADJ
eurjchem-2084	236	6	use	use	NOUN
eurjchem-2084	236	7	in	in	ADP
eurjchem-2084	236	8	china	china	PROPN
eurjchem-2084	236	9	.	.	PUNCT
eurjchem-2084	237	1	11	11	NUM
eurjchem-2084	237	2	sinopharm	sinopharm	NOUN
eurjchem-2084	237	3	-	-	PUNCT
eurjchem-2084	237	4	wuhan	wuhan	PROPN
eurjchem-2084	237	5	inactivated	inactivate	VERB
eurjchem-2084	237	6	3	3	NUM
eurjchem-2084	237	7	limited	limited	ADJ
eurjchem-2084	237	8	use	use	NOUN
eurjchem-2084	237	9	in	in	ADP
eurjchem-2084	237	10	china	china	PROPN
eurjchem-2084	237	11	,	,	PUNCT
eurjchem-2084	237	12	u.a.e	u.a.e	PROPN
eurjchem-2084	237	13	.	.	PROPN
eurjchem-2084	237	14	12	12	NUM
eurjchem-2084	237	15	bharat	bharat	PROPN
eurjchem-2084	237	16	biotech	biotech	NOUN
eurjchem-2084	237	17	inactivated	inactivate	VERB
eurjchem-2084	237	18	3	3	NUM
eurjchem-2084	237	19	emergency	emergency	NOUN
eurjchem-2084	237	20	use	use	NOUN
eurjchem-2084	237	21	in	in	ADP
eurjchem-2084	237	22	india	india	PROPN
eurjchem-2084	237	23	.	.	PUNCT
eurjchem-2084	238	1	the	the	DET
eurjchem-2084	238	2	food	food	NOUN
eurjchem-2084	238	3	and	and	CCONJ
eurjchem-2084	238	4	drug	drug	PROPN
eurjchem-2084	238	5	administration	administration	NOUN
eurjchem-2084	238	6	(	(	PUNCT
eurjchem-2084	238	7	fda	fda	PROPN
eurjchem-2084	238	8	’s	’s	PART
eurjchem-2084	238	9	)	)	PUNCT
eurjchem-2084	238	10	authorization	authorization	NOUN
eurjchem-2084	238	11	for	for	ADP
eurjchem-2084	238	12	emergency	emergency	NOUN
eurjchem-2084	238	13	use	use	NOUN
eurjchem-2084	238	14	of	of	ADP
eurjchem-2084	238	15	the	the	DET
eurjchem-2084	238	16	first	first	ADJ
eurjchem-2084	238	17	covid-19	covid-19	PROPN
eurjchem-2084	238	18	vaccine	vaccine	NOUN
eurjchem-2084	238	19	is	be	AUX
eurjchem-2084	238	20	a	a	DET
eurjchem-2084	238	21	significant	significant	ADJ
eurjchem-2084	238	22	milestone	milestone	NOUN
eurjchem-2084	238	23	in	in	ADP
eurjchem-2084	238	24	battling	battle	VERB
eurjchem-2084	238	25	this	this	DET
eurjchem-2084	238	26	devastating	devastating	ADJ
eurjchem-2084	238	27	pandemic	pandemic	NOUN
eurjchem-2084	238	28	that	that	PRON
eurjchem-2084	238	29	has	have	AUX
eurjchem-2084	238	30	affected	affect	VERB
eurjchem-2084	238	31	so	so	ADV
eurjchem-2084	238	32	many	many	ADJ
eurjchem-2084	238	33	families	family	NOUN
eurjchem-2084	238	34	in	in	ADP
eurjchem-2084	238	35	the	the	DET
eurjchem-2084	238	36	united	united	PROPN
eurjchem-2084	238	37	states	states	PROPN
eurjchem-2084	238	38	and	and	CCONJ
eurjchem-2084	238	39	around	around	ADP
eurjchem-2084	238	40	the	the	DET
eurjchem-2084	238	41	world	world	NOUN
eurjchem-2084	238	42	.	.	PUNCT
eurjchem-2084	239	1	the	the	DET
eurjchem-2084	239	2	fda	fda	PROPN
eurjchem-2084	239	3	granted	grant	VERB
eurjchem-2084	239	4	the	the	DET
eurjchem-2084	239	5	first	first	ADJ
eurjchem-2084	239	6	emergency	emergency	NOUN
eurjchem-2084	239	7	use	use	NOUN
eurjchem-2084	239	8	authorization	authorization	NOUN
eurjchem-2084	239	9	(	(	PUNCT
eurjchem-2084	239	10	eua	eua	PROPN
eurjchem-2084	239	11	)	)	PUNCT
eurjchem-2084	239	12	to	to	ADP
eurjchem-2084	239	13	a	a	DET
eurjchem-2084	239	14	coronavirus	coronavirus	NOUN
eurjchem-2084	239	15	vaccine	vaccine	NOUN
eurjchem-2084	239	16	on	on	ADP
eurjchem-2084	239	17	dec	dec	PROPN
eurjchem-2084	239	18	.	.	PROPN
eurjchem-2084	239	19	11	11	NUM
eurjchem-2084	239	20	,	,	PUNCT
eurjchem-2084	239	21	developed	develop	VERB
eurjchem-2084	239	22	by	by	ADP
eurjchem-2084	239	23	new	new	PROPN
eurjchem-2084	239	24	york	york	PROPN
eurjchem-2084	239	25	-	-	PUNCT
eurjchem-2084	239	26	based	base	VERB
eurjchem-2084	239	27	pfizer	pfizer	NOUN
eurjchem-2084	239	28	and	and	CCONJ
eurjchem-2084	239	29	the	the	DET
eurjchem-2084	239	30	german	german	ADJ
eurjchem-2084	239	31	company	company	NOUN
eurjchem-2084	239	32	biontech	biontech	NOUN
eurjchem-2084	239	33	and	and	CCONJ
eurjchem-2084	239	34	is	be	AUX
eurjchem-2084	239	35	over	over	ADV
eurjchem-2084	239	36	90	90	NUM
eurjchem-2084	239	37	percent	percent	NOUN
eurjchem-2084	239	38	effective	effective	ADJ
eurjchem-2084	239	39	.	.	PUNCT
eurjchem-2084	240	1	the	the	DET
eurjchem-2084	240	2	oxford	oxford	PROPN
eurjchem-2084	240	3	-	-	PUNCT
eurjchem-2084	240	4	astrazeneca	astrazeneca	NOUN
eurjchem-2084	240	5	vaccine	vaccine	NOUN
eurjchem-2084	240	6	has	have	AUX
eurjchem-2084	240	7	been	be	AUX
eurjchem-2084	240	8	approved	approve	VERB
eurjchem-2084	240	9	for	for	ADP
eurjchem-2084	240	10	emergency	emergency	NOUN
eurjchem-2084	240	11	use	use	NOUN
eurjchem-2084	240	12	in	in	ADP
eurjchem-2084	240	13	the	the	DET
eurjchem-2084	240	14	uk	uk	PROPN
eurjchem-2084	240	15	on	on	ADP
eurjchem-2084	240	16	30	30	NUM
eurjchem-2084	240	17	december	december	NOUN
eurjchem-2084	240	18	.	.	PUNCT
eurjchem-2084	241	1	in	in	ADP
eurjchem-2084	241	2	india	india	PROPN
eurjchem-2084	241	3	,	,	PUNCT
eurjchem-2084	241	4	the	the	DET
eurjchem-2084	241	5	drugs	drug	NOUN
eurjchem-2084	241	6	controller	controller	NOUN
eurjchem-2084	241	7	general	general	ADJ
eurjchem-2084	241	8	of	of	ADP
eurjchem-2084	241	9	india	india	PROPN
eurjchem-2084	241	10	(	(	PUNCT
eurjchem-2084	241	11	dcgi	dcgi	PROPN
eurjchem-2084	241	12	)	)	PUNCT
eurjchem-2084	241	13	on	on	ADP
eurjchem-2084	241	14	3rd	3rd	ADJ
eurjchem-2084	241	15	january	january	PROPN
eurjchem-2084	241	16	2021	2021	NUM
eurjchem-2084	241	17	formally	formally	ADV
eurjchem-2084	241	18	announced	announce	VERB
eurjchem-2084	241	19	the	the	DET
eurjchem-2084	241	20	approval	approval	NOUN
eurjchem-2084	241	21	of	of	ADP
eurjchem-2084	241	22	india	india	PROPN
eurjchem-2084	241	23	's	's	PART
eurjchem-2084	241	24	1st	1st	ADJ
eurjchem-2084	241	25	covid-19	covid-19	PROPN
eurjchem-2084	241	26	vaccine	vaccine	NOUN
eurjchem-2084	241	27	,	,	PUNCT
eurjchem-2084	241	28	bharat	bharat	PROPN
eurjchem-2084	241	29	biotech	biotech	NOUN
eurjchem-2084	241	30	's	's	PART
eurjchem-2084	241	31	covaxin	covaxin	NOUN
eurjchem-2084	241	32	and	and	CCONJ
eurjchem-2084	241	33	the	the	DET
eurjchem-2084	241	34	serum	serum	PROPN
eurjchem-2084	241	35	institute	institute	PROPN
eurjchem-2084	241	36	of	of	ADP
eurjchem-2084	241	37	india	india	PROPN
eurjchem-2084	241	38	's	's	PART
eurjchem-2084	241	39	covishield	covishield	NOUN
eurjchem-2084	241	40	for	for	ADP
eurjchem-2084	241	41	'	'	PUNCT
eurjchem-2084	241	42	restricted	restricted	ADJ
eurjchem-2084	241	43	use	use	NOUN
eurjchem-2084	241	44	'	'	PUNCT
eurjchem-2084	241	45	in	in	ADP
eurjchem-2084	241	46	the	the	DET
eurjchem-2084	241	47	country	country	NOUN
eurjchem-2084	241	48	[	[	X
eurjchem-2084	241	49	60	60	NUM
eurjchem-2084	241	50	]	]	PUNCT
eurjchem-2084	241	51	.	.	PUNCT
eurjchem-2084	242	1	table	table	NOUN
eurjchem-2084	242	2	2	2	NUM
eurjchem-2084	242	3	is	be	AUX
eurjchem-2084	242	4	a	a	DET
eurjchem-2084	242	5	list	list	NOUN
eurjchem-2084	242	6	of	of	ADP
eurjchem-2084	242	7	all	all	DET
eurjchem-2084	242	8	vaccines	vaccine	NOUN
eurjchem-2084	242	9	that	that	PRON
eurjchem-2084	242	10	have	have	AUX
eurjchem-2084	242	11	been	be	AUX
eurjchem-2084	242	12	approved	approve	VERB
eurjchem-2084	242	13	and	and	CCONJ
eurjchem-2084	242	14	set	set	VERB
eurjchem-2084	242	15	for	for	ADP
eurjchem-2084	242	16	emergency	emergency	NOUN
eurjchem-2084	242	17	use	use	NOUN
eurjchem-2084	242	18	in	in	ADP
eurjchem-2084	242	19	certain	certain	ADJ
eurjchem-2084	242	20	countries	country	NOUN
eurjchem-2084	242	21	.	.	PUNCT
eurjchem-2084	243	1	6.2.1	6.2.1	X
eurjchem-2084	243	2	.	.	PUNCT
eurjchem-2084	244	1	antivirals	antiviral	NOUN
eurjchem-2084	244	2	in	in	ADP
eurjchem-2084	244	3	the	the	DET
eurjchem-2084	244	4	treatment	treatment	NOUN
eurjchem-2084	244	5	of	of	ADP
eurjchem-2084	244	6	covid-19	covid-19	PROPN
eurjchem-2084	244	7	favipiravir	favipiravir	PROPN
eurjchem-2084	244	8	(	(	PUNCT
eurjchem-2084	244	9	fpv	fpv	PROPN
eurjchem-2084	244	10	)	)	PUNCT
eurjchem-2084	244	11	was	be	AUX
eurjchem-2084	244	12	approved	approve	VERB
eurjchem-2084	244	13	in	in	ADP
eurjchem-2084	244	14	2014	2014	NUM
eurjchem-2084	244	15	against	against	ADP
eurjchem-2084	244	16	influenza	influenza	NOUN
eurjchem-2084	244	17	virus	virus	NOUN
eurjchem-2084	244	18	in	in	ADP
eurjchem-2084	244	19	japan	japan	PROPN
eurjchem-2084	244	20	.	.	PUNCT
eurjchem-2084	245	1	it	it	PRON
eurjchem-2084	245	2	inhibits	inhibit	VERB
eurjchem-2084	245	3	the	the	DET
eurjchem-2084	245	4	replication	replication	NOUN
eurjchem-2084	245	5	enzyme	enzyme	NOUN
eurjchem-2084	245	6	,	,	PUNCT
eurjchem-2084	245	7	rna	rna	NOUN
eurjchem-2084	245	8	dependent	dependent	ADJ
eurjchem-2084	245	9	rna	rna	NOUN
eurjchem-2084	245	10	polymerase	polymerase	NOUN
eurjchem-2084	245	11	(	(	PUNCT
eurjchem-2084	245	12	rdrp	rdrp	PROPN
eurjchem-2084	245	13	)	)	PUNCT
eurjchem-2084	245	14	,	,	PUNCT
eurjchem-2084	245	15	and	and	CCONJ
eurjchem-2084	245	16	arrests	arrest	VERB
eurjchem-2084	245	17	the	the	DET
eurjchem-2084	245	18	replication	replication	NOUN
eurjchem-2084	245	19	process	process	NOUN
eurjchem-2084	245	20	of	of	ADP
eurjchem-2084	245	21	the	the	DET
eurjchem-2084	245	22	virus	virus	NOUN
eurjchem-2084	245	23	.	.	PUNCT
eurjchem-2084	246	1	it	it	PRON
eurjchem-2084	246	2	has	have	AUX
eurjchem-2084	246	3	been	be	AUX
eurjchem-2084	246	4	permitted	permit	VERB
eurjchem-2084	246	5	in	in	ADP
eurjchem-2084	246	6	many	many	ADJ
eurjchem-2084	246	7	countries	country	NOUN
eurjchem-2084	246	8	to	to	PART
eurjchem-2084	246	9	treat	treat	VERB
eurjchem-2084	246	10	covid-19	covid-19	PROPN
eurjchem-2084	247	1	[	[	X
eurjchem-2084	247	2	61	61	NUM
eurjchem-2084	247	3	]	]	PUNCT
eurjchem-2084	247	4	.	.	PUNCT
eurjchem-2084	248	1	however	however	ADV
eurjchem-2084	248	2	,	,	PUNCT
eurjchem-2084	248	3	fpv	fpv	PROPN
eurjchem-2084	248	4	has	have	AUX
eurjchem-2084	248	5	not	not	PART
eurjchem-2084	248	6	yet	yet	ADV
eurjchem-2084	248	7	been	be	AUX
eurjchem-2084	248	8	approved	approve	VERB
eurjchem-2084	248	9	by	by	ADP
eurjchem-2084	248	10	the	the	DET
eurjchem-2084	248	11	u.s	u.s	PROPN
eurjchem-2084	248	12	.	.	PROPN
eurjchem-2084	248	13	fda	fda	PROPN
eurjchem-2084	249	1	[	[	X
eurjchem-2084	249	2	62	62	NUM
eurjchem-2084	249	3	]	]	PUNCT
eurjchem-2084	249	4	but	but	CCONJ
eurjchem-2084	249	5	eua	eua	PROPN
eurjchem-2084	249	6	has	have	AUX
eurjchem-2084	249	7	been	be	AUX
eurjchem-2084	249	8	allowed	allow	VERB
eurjchem-2084	249	9	in	in	ADP
eurjchem-2084	249	10	many	many	ADJ
eurjchem-2084	249	11	countries	country	NOUN
eurjchem-2084	249	12	based	base	VERB
eurjchem-2084	249	13	on	on	ADP
eurjchem-2084	249	14	statistically	statistically	ADV
eurjchem-2084	249	15	significant	significant	ADJ
eurjchem-2084	249	16	positive	positive	ADJ
eurjchem-2084	249	17	results	result	NOUN
eurjchem-2084	249	18	[	[	X
eurjchem-2084	249	19	63,64	63,64	NOUN
eurjchem-2084	249	20	]	]	X
eurjchem-2084	249	21	.	.	PUNCT
eurjchem-2084	250	1	the	the	DET
eurjchem-2084	250	2	idea	idea	NOUN
eurjchem-2084	250	3	of	of	ADP
eurjchem-2084	250	4	combined	combined	ADJ
eurjchem-2084	250	5	treatment	treatment	NOUN
eurjchem-2084	250	6	of	of	ADP
eurjchem-2084	250	7	fpv	fpv	PROPN
eurjchem-2084	250	8	with	with	ADP
eurjchem-2084	250	9	interferonα(ifnα	interferonα(ifnα	PROPN
eurjchem-2084	250	10	)	)	PUNCT
eurjchem-2084	250	11	was	be	AUX
eurjchem-2084	250	12	found	find	VERB
eurjchem-2084	250	13	effective[65	effective[65	PROPN
eurjchem-2084	250	14	]	]	PUNCT
eurjchem-2084	250	15	.	.	PUNCT
eurjchem-2084	251	1	remdesivir	remdesivir	PROPN
eurjchem-2084	251	2	(	(	PUNCT
eurjchem-2084	251	3	gs-5734	gs-5734	NOUN
eurjchem-2084	251	4	)	)	PUNCT
eurjchem-2084	251	5	is	be	AUX
eurjchem-2084	251	6	a	a	DET
eurjchem-2084	251	7	widely	widely	ADV
eurjchem-2084	251	8	known	know	VERB
eurjchem-2084	251	9	antiviral	antiviral	ADJ
eurjchem-2084	251	10	drug	drug	NOUN
eurjchem-2084	251	11	formerly	formerly	ADV
eurjchem-2084	251	12	designed	design	VERB
eurjchem-2084	251	13	to	to	PART
eurjchem-2084	251	14	target	target	VERB
eurjchem-2084	251	15	ebola	ebola	PROPN
eurjchem-2084	251	16	virus	virus	NOUN
eurjchem-2084	251	17	.	.	PUNCT
eurjchem-2084	252	1	it	it	PRON
eurjchem-2084	252	2	also	also	ADV
eurjchem-2084	252	3	inhibits	inhibit	VERB
eurjchem-2084	252	4	viral	viral	ADJ
eurjchem-2084	252	5	replication	replication	NOUN
eurjchem-2084	252	6	by	by	ADP
eurjchem-2084	252	7	attenuation	attenuation	NOUN
eurjchem-2084	252	8	of	of	ADP
eurjchem-2084	252	9	rna	rna	NOUN
eurjchem-2084	252	10	transcription	transcription	NOUN
eurjchem-2084	252	11	,	,	PUNCT
eurjchem-2084	252	12	which	which	PRON
eurjchem-2084	252	13	arrests	arrest	VERB
eurjchem-2084	252	14	the	the	DET
eurjchem-2084	252	15	virus	virus	NOUN
eurjchem-2084	252	16	's	's	PART
eurjchem-2084	252	17	ability	ability	NOUN
eurjchem-2084	252	18	to	to	PART
eurjchem-2084	252	19	multiply	multiply	VERB
eurjchem-2084	252	20	[	[	X
eurjchem-2084	252	21	66	66	NUM
eurjchem-2084	252	22	]	]	PUNCT
eurjchem-2084	252	23	.	.	PUNCT
eurjchem-2084	253	1	the	the	DET
eurjchem-2084	253	2	first	first	ADJ
eurjchem-2084	253	3	case	case	NOUN
eurjchem-2084	253	4	of	of	ADP
eurjchem-2084	253	5	sars	sar	NOUN
eurjchem-2084	253	6	-	-	PUNCT
eurjchem-2084	253	7	cov-2	cov-2	PART
eurjchem-2084	253	8	infection	infection	NOUN
eurjchem-2084	253	9	in	in	ADP
eurjchem-2084	253	10	washington	washington	PROPN
eurjchem-2084	253	11	state	state	NOUN
eurjchem-2084	253	12	was	be	AUX
eurjchem-2084	253	13	reported	report	VERB
eurjchem-2084	253	14	on	on	ADP
eurjchem-2084	253	15	january	january	PROPN
eurjchem-2084	253	16	19	19	NUM
eurjchem-2084	253	17	,	,	PUNCT
eurjchem-2084	253	18	2020	2020	NUM
eurjchem-2084	253	19	in	in	ADP
eurjchem-2084	253	20	a	a	DET
eurjchem-2084	253	21	35	35	NUM
eurjchem-2084	253	22	-	-	PUNCT
eurjchem-2084	253	23	year	year	NOUN
eurjchem-2084	253	24	-	-	PUNCT
eurjchem-2084	253	25	old	old	ADJ
eurjchem-2084	253	26	man	man	NOUN
eurjchem-2084	253	27	who	who	PRON
eurjchem-2084	253	28	successfully	successfully	ADV
eurjchem-2084	253	29	recovered	recover	VERB
eurjchem-2084	253	30	after	after	ADP
eurjchem-2084	253	31	remdesivir	remdesivir	X
eurjchem-2084	253	32	treatment	treatment	NOUN
eurjchem-2084	253	33	[	[	X
eurjchem-2084	253	34	67	67	NUM
eurjchem-2084	253	35	]	]	PUNCT
eurjchem-2084	253	36	.	.	PUNCT
eurjchem-2084	254	1	however	however	ADV
eurjchem-2084	254	2	,	,	PUNCT
eurjchem-2084	254	3	the	the	DET
eurjchem-2084	254	4	efficacy	efficacy	NOUN
eurjchem-2084	254	5	and	and	CCONJ
eurjchem-2084	254	6	safety	safety	NOUN
eurjchem-2084	254	7	of	of	ADP
eurjchem-2084	254	8	remdesivir	remdesivir	NOUN
eurjchem-2084	254	9	in	in	ADP
eurjchem-2084	254	10	patients	patient	NOUN
eurjchem-2084	254	11	with	with	ADP
eurjchem-2084	254	12	sars	sar	NOUN
eurjchem-2084	254	13	-	-	PUNCT
eurjchem-2084	254	14	cov-2	cov-2	PART
eurjchem-2084	254	15	infection	infection	NOUN
eurjchem-2084	254	16	still	still	ADV
eurjchem-2084	254	17	needs	need	VERB
eurjchem-2084	254	18	to	to	PART
eurjchem-2084	254	19	be	be	AUX
eurjchem-2084	254	20	established	establish	VERB
eurjchem-2084	254	21	by	by	ADP
eurjchem-2084	254	22	clinical	clinical	ADJ
eurjchem-2084	254	23	studies	study	NOUN
eurjchem-2084	254	24	.	.	PUNCT
eurjchem-2084	255	1	ongoing	ongoing	ADJ
eurjchem-2084	255	2	studies	study	NOUN
eurjchem-2084	255	3	with	with	ADP
eurjchem-2084	255	4	larger	large	ADJ
eurjchem-2084	255	5	sample	sample	NOUN
eurjchem-2084	255	6	sizes	size	NOUN
eurjchem-2084	255	7	will	will	AUX
eurjchem-2084	255	8	continue	continue	VERB
eurjchem-2084	255	9	to	to	PART
eurjchem-2084	255	10	update	update	VERB
eurjchem-2084	255	11	our	our	PRON
eurjchem-2084	255	12	understanding	understanding	NOUN
eurjchem-2084	255	13	of	of	ADP
eurjchem-2084	255	14	the	the	DET
eurjchem-2084	255	15	effect	effect	NOUN
eurjchem-2084	255	16	of	of	ADP
eurjchem-2084	255	17	remdesivir	remdesivir	NOUN
eurjchem-2084	255	18	on	on	ADP
eurjchem-2084	255	19	covid-19[68	covid-19[68	NOUN
eurjchem-2084	255	20	]	]	PUNCT
eurjchem-2084	255	21	.	.	PUNCT
eurjchem-2084	256	1	in	in	ADP
eurjchem-2084	256	2	continuation	continuation	NOUN
eurjchem-2084	256	3	to	to	ADP
eurjchem-2084	256	4	the	the	DET
eurjchem-2084	256	5	further	further	ADJ
eurjchem-2084	256	6	studies	study	NOUN
eurjchem-2084	256	7	on	on	ADP
eurjchem-2084	256	8	remdesivir	remdesivir	NOUN
eurjchem-2084	256	9	,	,	PUNCT
eurjchem-2084	256	10	a	a	DET
eurjchem-2084	256	11	phase	phase	NOUN
eurjchem-2084	256	12	3	3	NUM
eurjchem-2084	256	13	randomized	randomize	VERB
eurjchem-2084	256	14	,	,	PUNCT
eurjchem-2084	256	15	open	open	ADJ
eurjchem-2084	256	16	label	label	NOUN
eurjchem-2084	256	17	trial	trial	NOUN
eurjchem-2084	256	18	is	be	AUX
eurjchem-2084	256	19	under	under	ADP
eurjchem-2084	256	20	progress	progress	NOUN
eurjchem-2084	256	21	to	to	PART
eurjchem-2084	256	22	evaluate	evaluate	VERB
eurjchem-2084	256	23	the	the	DET
eurjchem-2084	256	24	safety	safety	NOUN
eurjchem-2084	256	25	and	and	CCONJ
eurjchem-2084	256	26	antiviral	antiviral	ADJ
eurjchem-2084	256	27	activity	activity	NOUN
eurjchem-2084	256	28	of	of	ADP
eurjchem-2084	256	29	the	the	DET
eurjchem-2084	256	30	drug	drug	NOUN
eurjchem-2084	256	31	(	(	PUNCT
eurjchem-2084	256	32	gs-5734	gs-5734	PROPN
eurjchem-2084	256	33	™	™	PROPN
eurjchem-2084	256	34	)	)	PUNCT
eurjchem-2084	256	35	in	in	ADP
eurjchem-2084	256	36	1113	1113	NUM
eurjchem-2084	256	37	participants	participant	NOUN
eurjchem-2084	256	38	with	with	ADP
eurjchem-2084	256	39	moderate	moderate	ADJ
eurjchem-2084	256	40	sars	sar	NOUN
eurjchem-2084	256	41	-	-	PUNCT
eurjchem-2084	256	42	cov-2	cov-2	PART
eurjchem-2084	256	43	infection	infection	NOUN
eurjchem-2084	256	44	compared	compare	VERB
eurjchem-2084	256	45	to	to	ADP
eurjchem-2084	256	46	standard	standard	ADJ
eurjchem-2084	256	47	care	care	NOUN
eurjchem-2084	256	48	treatment	treatment	NOUN
eurjchem-2084	256	49	(	(	PUNCT
eurjchem-2084	256	50	nct04292730	nct04292730	X
eurjchem-2084	256	51	)	)	PUNCT
eurjchem-2084	257	1	[	[	X
eurjchem-2084	257	2	69	69	NUM
eurjchem-2084	257	3	]	]	PUNCT
eurjchem-2084	257	4	.	.	PUNCT
eurjchem-2084	258	1	lopinavir	lopinavir	PROPN
eurjchem-2084	258	2	and	and	CCONJ
eurjchem-2084	258	3	ritonavir	ritonavir	PROPN
eurjchem-2084	258	4	(	(	PUNCT
eurjchem-2084	258	5	lpv	lpv	PROPN
eurjchem-2084	258	6	/	/	SYM
eurjchem-2084	258	7	rtv	rtv	PROPN
eurjchem-2084	258	8	)	)	PUNCT
eurjchem-2084	258	9	are	be	AUX
eurjchem-2084	258	10	protease	protease	NOUN
eurjchem-2084	258	11	inhibitors	inhibitor	NOUN
eurjchem-2084	258	12	which	which	PRON
eurjchem-2084	258	13	are	be	AUX
eurjchem-2084	258	14	used	use	VERB
eurjchem-2084	258	15	against	against	ADP
eurjchem-2084	258	16	hiv	hiv	PROPN
eurjchem-2084	258	17	infection	infection	NOUN
eurjchem-2084	258	18	and	and	CCONJ
eurjchem-2084	258	19	inhibit	inhibit	VERB
eurjchem-2084	258	20	viral	viral	ADJ
eurjchem-2084	258	21	replication	replication	NOUN
eurjchem-2084	258	22	.	.	PUNCT
eurjchem-2084	259	1	a	a	DET
eurjchem-2084	259	2	study	study	NOUN
eurjchem-2084	259	3	published	publish	VERB
eurjchem-2084	259	4	in	in	ADP
eurjchem-2084	259	5	march	march	PROPN
eurjchem-2084	259	6	2020	2020	NUM
eurjchem-2084	259	7	in	in	ADP
eurjchem-2084	259	8	the	the	DET
eurjchem-2084	259	9	new	new	PROPN
eurjchem-2084	259	10	england	england	PROPN
eurjchem-2084	259	11	journal	journal	PROPN
eurjchem-2084	259	12	of	of	ADP
eurjchem-2084	259	13	medicine	medicine	NOUN
eurjchem-2084	259	14	concluded	conclude	VERB
eurjchem-2084	259	15	that	that	SCONJ
eurjchem-2084	259	16	treating	treat	VERB
eurjchem-2084	259	17	covid-19	covid-19	PROPN
eurjchem-2084	259	18	patients	patient	NOUN
eurjchem-2084	259	19	with	with	ADP
eurjchem-2084	259	20	lpv	lpv	PROPN
eurjchem-2084	259	21	/	/	SYM
eurjchem-2084	259	22	rtv	rtv	PROPN
eurjchem-2084	259	23	added	add	VERB
eurjchem-2084	259	24	no	no	DET
eurjchem-2084	259	25	clinical	clinical	ADJ
eurjchem-2084	259	26	advantage	advantage	NOUN
eurjchem-2084	259	27	in	in	ADP
eurjchem-2084	259	28	comparison	comparison	NOUN
eurjchem-2084	259	29	with	with	ADP
eurjchem-2084	259	30	standard	standard	ADJ
eurjchem-2084	259	31	supportive	supportive	ADJ
eurjchem-2084	259	32	care	care	NOUN
eurjchem-2084	259	33	[	[	X
eurjchem-2084	259	34	70	70	NUM
eurjchem-2084	259	35	]	]	PUNCT
eurjchem-2084	259	36	.	.	PUNCT
eurjchem-2084	260	1	however	however	ADV
eurjchem-2084	260	2	satisfactory	satisfactory	ADJ
eurjchem-2084	260	3	results	result	NOUN
eurjchem-2084	260	4	were	be	AUX
eurjchem-2084	260	5	reported	report	VERB
eurjchem-2084	260	6	when	when	SCONJ
eurjchem-2084	260	7	lpv	lpv	PROPN
eurjchem-2084	260	8	/	/	SYM
eurjchem-2084	260	9	rtv	rtv	PROPN
eurjchem-2084	260	10	were	be	AUX
eurjchem-2084	260	11	given	give	VERB
eurjchem-2084	260	12	in	in	ADP
eurjchem-2084	260	13	combination	combination	NOUN
eurjchem-2084	260	14	with	with	ADP
eurjchem-2084	260	15	ifns	ifns	NOUN
eurjchem-2084	261	1	[	[	X
eurjchem-2084	261	2	71	71	NUM
eurjchem-2084	261	3	]	]	PUNCT
eurjchem-2084	261	4	.	.	PUNCT
eurjchem-2084	262	1	a	a	DET
eurjchem-2084	262	2	double	double	ADJ
eurjchem-2084	262	3	-	-	PUNCT
eurjchem-2084	262	4	blind	blind	ADJ
eurjchem-2084	262	5	,	,	PUNCT
eurjchem-2084	262	6	randomized	randomize	VERB
eurjchem-2084	262	7	,	,	PUNCT
eurjchem-2084	262	8	placebo	placebo	NOUN
eurjchem-2084	262	9	-	-	PUNCT
eurjchem-2084	262	10	controlled	control	VERB
eurjchem-2084	262	11	phase	phase	NOUN
eurjchem-2084	262	12	ii	ii	NOUN
eurjchem-2084	262	13	clinical	clinical	ADJ
eurjchem-2084	262	14	trial	trial	NOUN
eurjchem-2084	262	15	of	of	ADP
eurjchem-2084	262	16	lpv	lpv	PROPN
eurjchem-2084	262	17	/	/	SYM
eurjchem-2084	262	18	rtv	rtv	PROPN
eurjchem-2084	262	19	is	be	AUX
eurjchem-2084	262	20	under	under	ADP
eurjchem-2084	262	21	progress	progress	NOUN
eurjchem-2084	262	22	in	in	ADP
eurjchem-2084	262	23	covid-19	covid-19	PROPN
eurjchem-2084	262	24	patients	patient	NOUN
eurjchem-2084	262	25	with	with	ADP
eurjchem-2084	262	26	cancer	cancer	NOUN
eurjchem-2084	262	27	and	and	CCONJ
eurjchem-2084	262	28	immune	immune	ADJ
eurjchem-2084	262	29	suppression	suppression	NOUN
eurjchem-2084	262	30	[	[	X
eurjchem-2084	262	31	72	72	NUM
eurjchem-2084	262	32	]	]	X
eurjchem-2084	262	33	type	type	NOUN
eurjchem-2084	262	34	1	1	NUM
eurjchem-2084	262	35	ifns	ifns	NOUN
eurjchem-2084	262	36	are	be	AUX
eurjchem-2084	262	37	a	a	DET
eurjchem-2084	262	38	large	large	ADJ
eurjchem-2084	262	39	subgroup	subgroup	NOUN
eurjchem-2084	262	40	of	of	ADP
eurjchem-2084	262	41	ifns	ifns	NOUN
eurjchem-2084	262	42	including	include	VERB
eurjchem-2084	262	43	ifn	ifn	PROPN
eurjchem-2084	262	44	-	-	PUNCT
eurjchem-2084	262	45	α	α	NOUN
eurjchem-2084	262	46	and	and	CCONJ
eurjchem-2084	262	47	ifn	ifn	PROPN
eurjchem-2084	262	48	-	-	PUNCT
eurjchem-2084	262	49	β	β	NOUN
eurjchem-2084	262	50	.	.	PUNCT
eurjchem-2084	263	1	ifn	ifn	PROPN
eurjchem-2084	263	2	-	-	PUNCT
eurjchem-2084	263	3	α	α	PROPN
eurjchem-2084	263	4	is	be	AUX
eurjchem-2084	263	5	a	a	DET
eurjchem-2084	263	6	broad	broad	ADJ
eurjchem-2084	263	7	-	-	PUNCT
eurjchem-2084	263	8	spectrum	spectrum	NOUN
eurjchem-2084	263	9	antiviral	antiviral	ADJ
eurjchem-2084	263	10	drug	drug	NOUN
eurjchem-2084	263	11	commonly	commonly	ADV
eurjchem-2084	263	12	used	use	VERB
eurjchem-2084	263	13	to	to	PART
eurjchem-2084	263	14	treat	treat	VERB
eurjchem-2084	263	15	hepatitis	hepatitis	NOUN
eurjchem-2084	263	16	,	,	PUNCT
eurjchem-2084	263	17	whereas	whereas	SCONJ
eurjchem-2084	263	18	ifn	ifn	PROPN
eurjchem-2084	263	19	-	-	PUNCT
eurjchem-2084	263	20	β	β	PROPN
eurjchem-2084	263	21	is	be	AUX
eurjchem-2084	263	22	usually	usually	ADV
eurjchem-2084	263	23	given	give	VERB
eurjchem-2084	263	24	in	in	ADP
eurjchem-2084	263	25	multiple	multiple	ADJ
eurjchem-2084	263	26	sclerosis	sclerosis	NOUN
eurjchem-2084	263	27	.	.	PUNCT
eurjchem-2084	264	1	who	who	PRON
eurjchem-2084	264	2	has	have	AUX
eurjchem-2084	264	3	recommended	recommend	VERB
eurjchem-2084	264	4	the	the	DET
eurjchem-2084	264	5	use	use	NOUN
eurjchem-2084	264	6	of	of	ADP
eurjchem-2084	264	7	ifnαagainst	ifnαagainst	ADJ
eurjchem-2084	264	8	sars	sar	NOUN
eurjchem-2084	264	9	-	-	PUNCT
eurjchem-2084	264	10	cov-2	cov-2	PART
eurjchem-2084	264	11	infection	infection	NOUN
eurjchem-2084	264	12	[	[	X
eurjchem-2084	264	13	73	73	NUM
eurjchem-2084	264	14	]	]	PUNCT
eurjchem-2084	264	15	.	.	PUNCT
eurjchem-2084	265	1	a	a	DET
eurjchem-2084	265	2	review	review	NOUN
eurjchem-2084	265	3	published	publish	VERB
eurjchem-2084	265	4	in	in	ADP
eurjchem-2084	265	5	nature	nature	NOUN
eurjchem-2084	265	6	[	[	X
eurjchem-2084	265	7	74	74	NUM
eurjchem-2084	265	8	]	]	PUNCT
eurjchem-2084	265	9	claimed	claim	VERB
eurjchem-2084	265	10	that	that	SCONJ
eurjchem-2084	265	11	severe	severe	ADJ
eurjchem-2084	265	12	covid-19	covid-19	PROPN
eurjchem-2084	265	13	patients	patient	NOUN
eurjchem-2084	265	14	showed	show	VERB
eurjchem-2084	265	15	strong	strong	ADJ
eurjchem-2084	265	16	response	response	NOUN
eurjchem-2084	265	17	to	to	PART
eurjchem-2084	265	18	type	type	VERB
eurjchem-2084	265	19	i	i	PRON
eurjchem-2084	265	20	ifn	ifn	NOUN
eurjchem-2084	265	21	,	,	PUNCT
eurjchem-2084	265	22	which	which	PRON
eurjchem-2084	265	23	was	be	AUX
eurjchem-2084	265	24	contradictory	contradictory	ADJ
eurjchem-2084	265	25	to	to	ADP
eurjchem-2084	265	26	previous	previous	ADJ
eurjchem-2084	265	27	reports	report	NOUN
eurjchem-2084	265	28	[	[	X
eurjchem-2084	265	29	71,75	71,75	NOUN
eurjchem-2084	265	30	]	]	X
eurjchem-2084	265	31	.	.	PUNCT
eurjchem-2084	266	1	this	this	DET
eurjchem-2084	266	2	study	study	NOUN
eurjchem-2084	266	3	further	far	ADV
eurjchem-2084	266	4	suggested	suggest	VERB
eurjchem-2084	266	5	that	that	SCONJ
eurjchem-2084	266	6	understanding	understand	VERB
eurjchem-2084	266	7	the	the	DET
eurjchem-2084	266	8	dynamics	dynamic	NOUN
eurjchem-2084	266	9	of	of	ADP
eurjchem-2084	266	10	type	type	NOUN
eurjchem-2084	266	11	i	i	PRON
eurjchem-2084	266	12	ifn	ifn	VERB
eurjchem-2084	266	13	at	at	ADP
eurjchem-2084	266	14	different	different	ADJ
eurjchem-2084	266	15	stages	stage	NOUN
eurjchem-2084	266	16	of	of	ADP
eurjchem-2084	266	17	infection	infection	NOUN
eurjchem-2084	266	18	might	might	AUX
eurjchem-2084	266	19	help	help	VERB
eurjchem-2084	266	20	in	in	ADP
eurjchem-2084	266	21	understanding	understand	VERB
eurjchem-2084	266	22	the	the	DET
eurjchem-2084	266	23	therapeutic	therapeutic	ADJ
eurjchem-2084	266	24	use	use	NOUN
eurjchem-2084	266	25	in	in	ADP
eurjchem-2084	266	26	covid-19	covid-19	PROPN
eurjchem-2084	266	27	patients	patient	NOUN
eurjchem-2084	266	28	[	[	X
eurjchem-2084	266	29	74	74	NUM
eurjchem-2084	266	30	]	]	PUNCT
eurjchem-2084	266	31	.	.	PUNCT
eurjchem-2084	267	1	6.2.2	6.2.2	X
eurjchem-2084	267	2	.	.	PUNCT
eurjchem-2084	267	3	anti	anti	ADJ
eurjchem-2084	267	4	-	-	ADJ
eurjchem-2084	267	5	malarial	malarial	ADJ
eurjchem-2084	267	6	in	in	ADP
eurjchem-2084	267	7	the	the	DET
eurjchem-2084	267	8	treatment	treatment	NOUN
eurjchem-2084	267	9	of	of	ADP
eurjchem-2084	267	10	covid-19	covid-19	PROPN
eurjchem-2084	267	11	:	:	PUNCT
eurjchem-2084	267	12	expectations	expectation	NOUN
eurjchem-2084	267	13	and	and	CCONJ
eurjchem-2084	267	14	reality	reality	NOUN
eurjchem-2084	267	15	chloroquine	chloroquine	NOUN
eurjchem-2084	267	16	(	(	PUNCT
eurjchem-2084	267	17	cq	cq	NOUN
eurjchem-2084	267	18	)	)	PUNCT
eurjchem-2084	267	19	and	and	CCONJ
eurjchem-2084	267	20	hydroxychloroquine	hydroxychloroquine	PROPN
eurjchem-2084	267	21	(	(	PUNCT
eurjchem-2084	267	22	hcq	hcq	NOUN
eurjchem-2084	267	23	)	)	PUNCT
eurjchem-2084	267	24	are	be	AUX
eurjchem-2084	267	25	antimalarial	antimalarial	ADJ
eurjchem-2084	267	26	drugs	drug	NOUN
eurjchem-2084	267	27	and	and	CCONJ
eurjchem-2084	267	28	are	be	AUX
eurjchem-2084	267	29	also	also	ADV
eurjchem-2084	267	30	used	use	VERB
eurjchem-2084	267	31	in	in	ADP
eurjchem-2084	267	32	the	the	DET
eurjchem-2084	267	33	treatment	treatment	NOUN
eurjchem-2084	267	34	of	of	ADP
eurjchem-2084	267	35	inflammation	inflammation	NOUN
eurjchem-2084	267	36	.	.	PUNCT
eurjchem-2084	268	1	these	these	DET
eurjchem-2084	268	2	drugs	drug	NOUN
eurjchem-2084	268	3	alter	alter	VERB
eurjchem-2084	268	4	the	the	DET
eurjchem-2084	268	5	working	work	VERB
eurjchem-2084	268	6	environment	environment	NOUN
eurjchem-2084	268	7	of	of	ADP
eurjchem-2084	268	8	the	the	DET
eurjchem-2084	268	9	virus	virus	NOUN
eurjchem-2084	268	10	by	by	ADP
eurjchem-2084	268	11	altering	alter	VERB
eurjchem-2084	268	12	the	the	DET
eurjchem-2084	268	13	optimum	optimum	ADJ
eurjchem-2084	268	14	ph	ph	NOUN
eurjchem-2084	268	15	inside	inside	ADP
eurjchem-2084	268	16	the	the	DET
eurjchem-2084	268	17	cells	cell	NOUN
eurjchem-2084	268	18	to	to	PART
eurjchem-2084	268	19	arrest	arrest	VERB
eurjchem-2084	268	20	the	the	DET
eurjchem-2084	268	21	viral	viral	ADJ
eurjchem-2084	268	22	activity	activity	NOUN
eurjchem-2084	268	23	.	.	PUNCT
eurjchem-2084	269	1	clinical	clinical	ADJ
eurjchem-2084	269	2	trials	trial	NOUN
eurjchem-2084	269	3	of	of	ADP
eurjchem-2084	269	4	both	both	DET
eurjchem-2084	269	5	drugs	drug	NOUN
eurjchem-2084	269	6	against	against	ADP
eurjchem-2084	269	7	covid-19	covid-19	PROPN
eurjchem-2084	269	8	have	have	AUX
eurjchem-2084	269	9	been	be	AUX
eurjchem-2084	269	10	approved	approve	VERB
eurjchem-2084	269	11	by	by	ADP
eurjchem-2084	269	12	fda	fda	PROPN
eurjchem-2084	269	13	[	[	X
eurjchem-2084	269	14	73	73	NUM
eurjchem-2084	269	15	]	]	PUNCT
eurjchem-2084	269	16	as	as	SCONJ
eurjchem-2084	269	17	both	both	DET
eurjchem-2084	269	18	drugs	drug	NOUN
eurjchem-2084	269	19	reduced	reduce	VERB
eurjchem-2084	269	20	the	the	DET
eurjchem-2084	269	21	transmission	transmission	NOUN
eurjchem-2084	269	22	of	of	ADP
eurjchem-2084	269	23	sars	sars	PROPN
eurjchem-2084	269	24	-	-	PUNCT
eurjchem-2084	269	25	cov	cov	PROPN
eurjchem-2084	269	26	and	and	CCONJ
eurjchem-2084	269	27	sars	sar	NOUN
eurjchem-2084	269	28	-	-	PUNCT
eurjchem-2084	269	29	cov-2	cov-2	NOUN
eurjchem-2084	269	30	in	in	ADP
eurjchem-2084	269	31	vitro	vitro	X
eurjchem-2084	269	32	experiments	experiment	NOUN
eurjchem-2084	269	33	[	[	X
eurjchem-2084	269	34	76	76	NUM
eurjchem-2084	269	35	]	]	PUNCT
eurjchem-2084	269	36	.	.	PUNCT
eurjchem-2084	270	1	based	base	VERB
eurjchem-2084	270	2	on	on	ADP
eurjchem-2084	270	3	these	these	DET
eurjchem-2084	270	4	findings	finding	NOUN
eurjchem-2084	270	5	,	,	PUNCT
eurjchem-2084	270	6	cq	cq	PROPN
eurjchem-2084	270	7	and	and	CCONJ
eurjchem-2084	270	8	hcq	hcq	NOUN
eurjchem-2084	270	9	were	be	AUX
eurjchem-2084	270	10	suggested	suggest	VERB
eurjchem-2084	270	11	to	to	PART
eurjchem-2084	270	12	treat	treat	AUX
eurjchem-2084	270	13	hospitalized	hospitalize	VERB
eurjchem-2084	270	14	covid-19	covid-19	PROPN
eurjchem-2084	270	15	patients	patient	NOUN
eurjchem-2084	270	16	in	in	ADP
eurjchem-2084	270	17	several	several	ADJ
eurjchem-2084	270	18	countries	country	NOUN
eurjchem-2084	270	19	.	.	PUNCT
eurjchem-2084	271	1	studies	study	NOUN
eurjchem-2084	271	2	conducted	conduct	VERB
eurjchem-2084	271	3	on	on	ADP
eurjchem-2084	271	4	covid-19	covid-19	PROPN
eurjchem-2084	271	5	patients	patient	NOUN
eurjchem-2084	271	6	to	to	PART
eurjchem-2084	271	7	evaluate	evaluate	VERB
eurjchem-2084	271	8	the	the	DET
eurjchem-2084	271	9	efficacy	efficacy	NOUN
eurjchem-2084	271	10	of	of	ADP
eurjchem-2084	271	11	cq	cq	PROPN
eurjchem-2084	271	12	reported	report	VERB
eurjchem-2084	271	13	a	a	DET
eurjchem-2084	271	14	significant	significant	ADJ
eurjchem-2084	271	15	reduction	reduction	NOUN
eurjchem-2084	271	16	in	in	ADP
eurjchem-2084	271	17	disease	disease	NOUN
eurjchem-2084	271	18	symptoms	symptom	NOUN
eurjchem-2084	271	19	and	and	CCONJ
eurjchem-2084	271	20	in	in	ADP
eurjchem-2084	271	21	viral	viral	ADJ
eurjchem-2084	271	22	congestion	congestion	NOUN
eurjchem-2084	271	23	in	in	ADP
eurjchem-2084	271	24	lungs	lung	NOUN
eurjchem-2084	271	25	much	much	ADV
eurjchem-2084	271	26	earlier	early	ADV
eurjchem-2084	271	27	than	than	ADP
eurjchem-2084	271	28	controls	control	NOUN
eurjchem-2084	271	29	[	[	X
eurjchem-2084	271	30	77,78	77,78	PROPN
eurjchem-2084	271	31	]	]	PUNCT
eurjchem-2084	271	32	.	.	PUNCT
eurjchem-2084	272	1	gautret	gautret	PROPN
eurjchem-2084	272	2	,	,	PUNCT
eurjchem-2084	272	3	et	et	PROPN
eurjchem-2084	272	4	al	al	PROPN
eurjchem-2084	272	5	.	.	PROPN
eurjchem-2084	272	6	found	find	VERB
eurjchem-2084	272	7	that	that	SCONJ
eurjchem-2084	272	8	the	the	DET
eurjchem-2084	272	9	combined	combined	ADJ
eurjchem-2084	272	10	treatment	treatment	NOUN
eurjchem-2084	272	11	of	of	ADP
eurjchem-2084	272	12	hcq	hcq	NOUN
eurjchem-2084	272	13	and	and	CCONJ
eurjchem-2084	272	14	azithromycin	azithromycin	PROPN
eurjchem-2084	272	15	could	could	AUX
eurjchem-2084	272	16	be	be	AUX
eurjchem-2084	272	17	more	more	ADV
eurjchem-2084	272	18	effective	effective	ADJ
eurjchem-2084	272	19	against	against	ADP
eurjchem-2084	272	20	sars	sar	NOUN
eurjchem-2084	272	21	-	-	PUNCT
eurjchem-2084	272	22	cov-2	cov-2	PART
eurjchem-2084	272	23	infection	infection	NOUN
eurjchem-2084	272	24	[	[	X
eurjchem-2084	272	25	79	79	NUM
eurjchem-2084	272	26	]	]	PUNCT
eurjchem-2084	272	27	.	.	PUNCT
eurjchem-2084	273	1	based	base	VERB
eurjchem-2084	273	2	on	on	ADP
eurjchem-2084	273	3	the	the	DET
eurjchem-2084	273	4	results	result	NOUN
eurjchem-2084	273	5	of	of	ADP
eurjchem-2084	273	6	these	these	DET
eurjchem-2084	273	7	studies	study	NOUN
eurjchem-2084	273	8	,	,	PUNCT
eurjchem-2084	273	9	the	the	DET
eurjchem-2084	273	10	usfda	usfda	NOUN
eurjchem-2084	273	11	issued	issue	VERB
eurjchem-2084	273	12	an	an	DET
eurjchem-2084	273	13	eua	eua	PROPN
eurjchem-2084	273	14	on	on	ADP
eurjchem-2084	273	15	march	march	PROPN
eurjchem-2084	273	16	28	28	NUM
eurjchem-2084	273	17	,	,	PUNCT
eurjchem-2084	273	18	2020	2020	NUM
eurjchem-2084	273	19	,	,	PUNCT
eurjchem-2084	273	20	to	to	PART
eurjchem-2084	273	21	permit	permit	VERB
eurjchem-2084	273	22	the	the	DET
eurjchem-2084	273	23	use	use	NOUN
eurjchem-2084	273	24	of	of	ADP
eurjchem-2084	273	25	cq	cq	NOUN
eurjchem-2084	273	26	and	and	CCONJ
eurjchem-2084	273	27	hcq	hcq	NOUN
eurjchem-2084	273	28	for	for	ADP
eurjchem-2084	273	29	the	the	DET
eurjchem-2084	273	30	treatment	treatment	NOUN
eurjchem-2084	273	31	of	of	ADP
eurjchem-2084	273	32	covid-19	covid-19	PROPN
eurjchem-2084	273	33	hospitalized	hospitalize	VERB
eurjchem-2084	273	34	patients	patient	NOUN
eurjchem-2084	273	35	.	.	PUNCT
eurjchem-2084	274	1	6.2.3	6.2.3	X
eurjchem-2084	274	2	.	.	X
eurjchem-2084	274	3	hydroxychloroquine	hydroxychloroquine	PROPN
eurjchem-2084	274	4	in	in	ADP
eurjchem-2084	274	5	treatment	treatment	NOUN
eurjchem-2084	274	6	of	of	ADP
eurjchem-2084	274	7	covid-19	covid-19	PROPN
eurjchem-2084	274	8	a	a	DET
eurjchem-2084	274	9	number	number	NOUN
eurjchem-2084	274	10	of	of	ADP
eurjchem-2084	274	11	large	large	ADJ
eurjchem-2084	274	12	clinical	clinical	ADJ
eurjchem-2084	274	13	trials	trial	NOUN
eurjchem-2084	274	14	were	be	AUX
eurjchem-2084	274	15	initiated	initiate	VERB
eurjchem-2084	274	16	to	to	PART
eurjchem-2084	274	17	assess	assess	VERB
eurjchem-2084	274	18	the	the	DET
eurjchem-2084	274	19	effectiveness	effectiveness	NOUN
eurjchem-2084	274	20	of	of	ADP
eurjchem-2084	274	21	hcq	hcq	NOUN
eurjchem-2084	274	22	,	,	PUNCT
eurjchem-2084	274	23	as	as	ADV
eurjchem-2084	274	24	well	well	ADV
eurjchem-2084	274	25	as	as	ADP
eurjchem-2084	274	26	other	other	ADJ
eurjchem-2084	274	27	potent	potent	ADJ
eurjchem-2084	274	28	drugs	drug	NOUN
eurjchem-2084	274	29	against	against	ADP
eurjchem-2084	274	30	covid-19	covid-19	PROPN
eurjchem-2084	274	31	worldwide	worldwide	ADV
eurjchem-2084	274	32	.	.	PUNCT
eurjchem-2084	275	1	the	the	DET
eurjchem-2084	275	2	solidarity	solidarity	NOUN
eurjchem-2084	275	3	trial	trial	NOUN
eurjchem-2084	275	4	,	,	PUNCT
eurjchem-2084	275	5	to	to	PART
eurjchem-2084	275	6	compare	compare	VERB
eurjchem-2084	275	7	four	four	NUM
eurjchem-2084	275	8	treatments	treatment	NOUN
eurjchem-2084	275	9	including	include	VERB
eurjchem-2084	275	10	hcq	hcq	NOUN
eurjchem-2084	275	11	against	against	ADP
eurjchem-2084	275	12	standard	standard	ADJ
eurjchem-2084	275	13	care	care	NOUN
eurjchem-2084	275	14	,	,	PUNCT
eurjchem-2084	275	15	was	be	AUX
eurjchem-2084	275	16	started	start	VERB
eurjchem-2084	275	17	by	by	ADP
eurjchem-2084	275	18	who	who	PRON
eurjchem-2084	275	19	in	in	ADP
eurjchem-2084	275	20	march	march	PROPN
eurjchem-2084	275	21	2020	2020	NUM
eurjchem-2084	275	22	.	.	PUNCT
eurjchem-2084	276	1	it	it	PRON
eurjchem-2084	276	2	recruited	recruit	VERB
eurjchem-2084	276	3	over	over	ADP
eurjchem-2084	276	4	3500	3500	NUM
eurjchem-2084	276	5	patients	patient	NOUN
eurjchem-2084	276	6	from	from	ADP
eurjchem-2084	276	7	400	400	NUM
eurjchem-2084	276	8	hospitals	hospital	NOUN
eurjchem-2084	276	9	in	in	ADP
eurjchem-2084	276	10	35	35	NUM
eurjchem-2084	276	11	countries	country	NOUN
eurjchem-2084	276	12	(	(	PUNCT
eurjchem-2084	276	13	“	"	PUNCT
eurjchem-2084	276	14	solidarity	solidarity	NOUN
eurjchem-2084	276	15	”	"	PUNCT
eurjchem-2084	276	16	clinical	clinical	ADJ
eurjchem-2084	276	17	trial	trial	NOUN
eurjchem-2084	276	18	for	for	ADP
eurjchem-2084	276	19	covid-19	covid-19	PROPN
eurjchem-2084	276	20	treatment	treatment	NOUN
eurjchem-2084	276	21	[	[	X
eurjchem-2084	276	22	80	80	NUM
eurjchem-2084	276	23	]	]	PUNCT
eurjchem-2084	276	24	.	.	PUNCT
eurjchem-2084	277	1	a	a	DET
eurjchem-2084	277	2	similar	similar	ADJ
eurjchem-2084	277	3	trial	trial	NOUN
eurjchem-2084	277	4	was	be	AUX
eurjchem-2084	277	5	started	start	VERB
eurjchem-2084	277	6	at	at	ADP
eurjchem-2084	277	7	the	the	DET
eurjchem-2084	277	8	university	university	NOUN
eurjchem-2084	277	9	of	of	ADP
eurjchem-2084	277	10	oxford	oxford	PROPN
eurjchem-2084	277	11	,	,	PUNCT
eurjchem-2084	277	12	the	the	DET
eurjchem-2084	277	13	recovery	recovery	NOUN
eurjchem-2084	277	14	trial	trial	NOUN
eurjchem-2084	277	15	,	,	PUNCT
eurjchem-2084	277	16	and	and	CCONJ
eurjchem-2084	277	17	recruited	recruit	VERB
eurjchem-2084	277	18	more	more	ADJ
eurjchem-2084	277	19	than	than	ADP
eurjchem-2084	277	20	11,000	11,000	NUM
eurjchem-2084	277	21	patients	patient	NOUN
eurjchem-2084	277	22	from	from	ADP
eurjchem-2084	277	23	175	175	NUM
eurjchem-2084	277	24	nhs	nhs	NOUN
eurjchem-2084	277	25	hospitals	hospital	NOUN
eurjchem-2084	277	26	to	to	PART
eurjchem-2084	277	27	evaluate	evaluate	VERB
eurjchem-2084	277	28	six	six	NUM
eurjchem-2084	277	29	different	different	ADJ
eurjchem-2084	277	30	therapies	therapy	NOUN
eurjchem-2084	277	31	including	include	VERB
eurjchem-2084	277	32	hcq	hcq	NOUN
eurjchem-2084	277	33	[	[	X
eurjchem-2084	277	34	81	81	NUM
eurjchem-2084	277	35	]	]	PUNCT
eurjchem-2084	277	36	.	.	PUNCT
eurjchem-2084	278	1	on	on	ADP
eurjchem-2084	278	2	may	may	PROPN
eurjchem-2084	278	3	22,2020	22,2020	NUM
eurjchem-2084	278	4	,	,	PUNCT
eurjchem-2084	278	5	lancet	lancet	PROPN
eurjchem-2084	278	6	published	publish	VERB
eurjchem-2084	278	7	a	a	DET
eurjchem-2084	278	8	case	case	NOUN
eurjchem-2084	278	9	study	study	NOUN
eurjchem-2084	278	10	involving	involve	VERB
eurjchem-2084	278	11	more	more	ADJ
eurjchem-2084	278	12	than	than	ADP
eurjchem-2084	278	13	96,000	96,000	NUM
eurjchem-2084	278	14	patients	patient	NOUN
eurjchem-2084	278	15	from	from	ADP
eurjchem-2084	278	16	six	six	NUM
eurjchem-2084	278	17	continents	continent	NOUN
eurjchem-2084	278	18	.	.	PUNCT
eurjchem-2084	279	1	the	the	DET
eurjchem-2084	279	2	study	study	NOUN
eurjchem-2084	279	3	conducted	conduct	VERB
eurjchem-2084	279	4	during	during	ADP
eurjchem-2084	279	5	december	december	PROPN
eurjchem-2084	279	6	2019	2019	NUM
eurjchem-2084	279	7	to	to	ADP
eurjchem-2084	279	8	april	april	PROPN
eurjchem-2084	279	9	2020	2020	NUM
eurjchem-2084	279	10	reported	report	VERB
eurjchem-2084	279	11	a	a	DET
eurjchem-2084	279	12	high	high	ADJ
eurjchem-2084	279	13	risk	risk	NOUN
eurjchem-2084	279	14	of	of	ADP
eurjchem-2084	279	15	ventricular	ventricular	ADJ
eurjchem-2084	279	16	arrhythmia	arrhythmia	NOUN
eurjchem-2084	279	17	/	/	SYM
eurjchem-2084	279	18	heart	heart	NOUN
eurjchem-2084	279	19	disease	disease	NOUN
eurjchem-2084	279	20	and	and	CCONJ
eurjchem-2084	279	21	death	death	NOUN
eurjchem-2084	279	22	in	in	ADP
eurjchem-2084	279	23	cq	cq	NOUN
eurjchem-2084	279	24	or	or	CCONJ
eurjchem-2084	279	25	hcq	hcq	PROPN
eurjchem-2084	279	26	treated	treat	VERB
eurjchem-2084	279	27	sars	sar	NOUN
eurjchem-2084	279	28	-	-	PUNCT
eurjchem-2084	279	29	cov-2	cov-2	PART
eurjchem-2084	279	30	patients	patient	NOUN
eurjchem-2084	279	31	than	than	ADP
eurjchem-2084	279	32	control	control	NOUN
eurjchem-2084	279	33	group	group	NOUN
eurjchem-2084	279	34	[	[	X
eurjchem-2084	279	35	82	82	NUM
eurjchem-2084	279	36	]	]	PUNCT
eurjchem-2084	279	37	.	.	PUNCT
eurjchem-2084	280	1	after	after	ADP
eurjchem-2084	280	2	this	this	DET
eurjchem-2084	280	3	study	study	NOUN
eurjchem-2084	280	4	,	,	PUNCT
eurjchem-2084	280	5	who	who	PRON
eurjchem-2084	280	6	paused	pause	VERB
eurjchem-2084	280	7	the	the	DET
eurjchem-2084	280	8	hcq	hcq	NOUN
eurjchem-2084	280	9	arm	arm	NOUN
eurjchem-2084	280	10	of	of	ADP
eurjchem-2084	280	11	its	its	PRON
eurjchem-2084	280	12	solidarity	solidarity	NOUN
eurjchem-2084	280	13	trial	trial	NOUN
eurjchem-2084	280	14	,	,	PUNCT
eurjchem-2084	280	15	but	but	CCONJ
eurjchem-2084	280	16	later	later	ADV
eurjchem-2084	280	17	the	the	DET
eurjchem-2084	280	18	paper	paper	NOUN
eurjchem-2084	280	19	was	be	AUX
eurjchem-2084	280	20	retracted	retract	VERB
eurjchem-2084	280	21	due	due	ADJ
eurjchem-2084	280	22	to	to	ADP
eurjchem-2084	280	23	objections	objection	NOUN
eurjchem-2084	280	24	raised	raise	VERB
eurjchem-2084	280	25	by	by	ADP
eurjchem-2084	280	26	the	the	DET
eurjchem-2084	280	27	scientific	scientific	ADJ
eurjchem-2084	280	28	community	community	NOUN
eurjchem-2084	280	29	and	and	CCONJ
eurjchem-2084	280	30	the	the	DET
eurjchem-2084	280	31	solidarity	solidarity	NOUN
eurjchem-2084	280	32	trial	trial	NOUN
eurjchem-2084	280	33	was	be	AUX
eurjchem-2084	280	34	restarted	restart	VERB
eurjchem-2084	280	35	on	on	ADP
eurjchem-2084	280	36	june	june	PROPN
eurjchem-2084	280	37	4	4	NUM
eurjchem-2084	280	38	,	,	PUNCT
eurjchem-2084	280	39	2020	2020	NUM
eurjchem-2084	280	40	.	.	PUNCT
eurjchem-2084	281	1	meanwhile	meanwhile	ADV
eurjchem-2084	281	2	,	,	PUNCT
eurjchem-2084	281	3	the	the	DET
eurjchem-2084	281	4	team	team	NOUN
eurjchem-2084	281	5	leading	lead	VERB
eurjchem-2084	281	6	the	the	DET
eurjchem-2084	281	7	recovery	recovery	NOUN
eurjchem-2084	281	8	trial	trial	NOUN
eurjchem-2084	281	9	claimed	claim	VERB
eurjchem-2084	281	10	that	that	SCONJ
eurjchem-2084	281	11	hcq	hcq	PROPN
eurjchem-2084	281	12	had	have	VERB
eurjchem-2084	281	13	no	no	DET
eurjchem-2084	281	14	clinical	clinical	ADJ
eurjchem-2084	281	15	advantage	advantage	NOUN
eurjchem-2084	281	16	for	for	ADP
eurjchem-2084	281	17	patients	patient	NOUN
eurjchem-2084	281	18	with	with	ADP
eurjchem-2084	281	19	covid-19and	covid-19and	NOUN
eurjchem-2084	281	20	closed	close	VERB
eurjchem-2084	281	21	hcq	hcq	NOUN
eurjchem-2084	281	22	arm	arm	NOUN
eurjchem-2084	281	23	activity	activity	NOUN
eurjchem-2084	281	24	[	[	X
eurjchem-2084	281	25	83	83	NUM
eurjchem-2084	281	26	]	]	PUNCT
eurjchem-2084	281	27	.	.	PUNCT
eurjchem-2084	282	1	finally	finally	ADV
eurjchem-2084	282	2	,	,	PUNCT
eurjchem-2084	282	3	on	on	ADP
eurjchem-2084	282	4	june	june	PROPN
eurjchem-2084	282	5	17	17	NUM
eurjchem-2084	282	6	,	,	PUNCT
eurjchem-2084	282	7	2020	2020	NUM
eurjchem-2084	282	8	,	,	PUNCT
eurjchem-2084	282	9	who	who	PRON
eurjchem-2084	282	10	also	also	ADV
eurjchem-2084	282	11	announced	announce	VERB
eurjchem-2084	282	12	to	to	PART
eurjchem-2084	282	13	stop	stop	VERB
eurjchem-2084	282	14	the	the	DET
eurjchem-2084	282	15	hcq	hcq	NOUN
eurjchem-2084	282	16	arm	arm	NOUN
eurjchem-2084	282	17	of	of	ADP
eurjchem-2084	282	18	the	the	DET
eurjchem-2084	282	19	solidarity	solidarity	NOUN
eurjchem-2084	282	20	trial	trial	NOUN
eurjchem-2084	282	21	.	.	PUNCT
eurjchem-2084	283	1	strategies	strategy	NOUN
eurjchem-2084	283	2	are	be	AUX
eurjchem-2084	283	3	being	be	AUX
eurjchem-2084	283	4	developed	develop	VERB
eurjchem-2084	283	5	continuously	continuously	ADV
eurjchem-2084	283	6	to	to	ADP
eurjchem-2084	283	7	firdaus	firdaus	PROPN
eurjchem-2084	283	8	et	et	PROPN
eurjchem-2084	283	9	al	al	PROPN
eurjchem-2084	283	10	.	.	PUNCT
eurjchem-2084	283	11	/	/	SYM
eurjchem-2084	283	12	european	european	PROPN
eurjchem-2084	283	13	journal	journal	PROPN
eurjchem-2084	283	14	of	of	ADP
eurjchem-2084	283	15	chemistry	chemistry	NOUN
eurjchem-2084	283	16	12	12	NUM
eurjchem-2084	283	17	(	(	PUNCT
eurjchem-2084	283	18	2	2	NUM
eurjchem-2084	283	19	)	)	PUNCT
eurjchem-2084	283	20	(	(	PUNCT
eurjchem-2084	283	21	2021	2021	NUM
eurjchem-2084	283	22	)	)	PUNCT
eurjchem-2084	283	23	222	222	NUM
eurjchem-2084	283	24	-	-	SYM
eurjchem-2084	283	25	234	234	NUM
eurjchem-2084	283	26	229	229	NUM
eurjchem-2084	283	27	2021	2021	NUM
eurjchem-2084	283	28	–	–	PUNCT
eurjchem-2084	283	29	european	european	ADJ
eurjchem-2084	283	30	journal	journal	NOUN
eurjchem-2084	283	31	of	of	ADP
eurjchem-2084	283	32	chemistry	chemistry	NOUN
eurjchem-2084	283	33	–	–	PUNCT
eurjchem-2084	283	34	cc	cc	NOUN
eurjchem-2084	283	35	by	by	ADP
eurjchem-2084	283	36	nc	nc	PROPN
eurjchem-2084	283	37	–	–	PUNCT
eurjchem-2084	283	38	doi	doi	NOUN
eurjchem-2084	283	39	:	:	PUNCT
eurjchem-2084	283	40	10.5155	10.5155	NUM
eurjchem-2084	283	41	/	/	SYM
eurjchem-2084	283	42	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	283	43	-	-	PUNCT
eurjchem-2084	283	44	234.2084	234.2084	NUM
eurjchem-2084	283	45	make	make	VERB
eurjchem-2084	283	46	hcq	hcq	NOUN
eurjchem-2084	283	47	potent	potent	NOUN
eurjchem-2084	283	48	and	and	CCONJ
eurjchem-2084	283	49	,	,	PUNCT
eurjchem-2084	283	50	nih	nih	PROPN
eurjchem-2084	283	51	has	have	AUX
eurjchem-2084	283	52	begun	begin	VERB
eurjchem-2084	283	53	a	a	DET
eurjchem-2084	283	54	phase	phase	NOUN
eurjchem-2084	283	55	2b	2b	NUM
eurjchem-2084	283	56	clinical	clinical	ADJ
eurjchem-2084	283	57	trial	trial	NOUN
eurjchem-2084	283	58	of	of	ADP
eurjchem-2084	283	59	hcq	hcq	PROPN
eurjchem-2084	283	60	together	together	ADV
eurjchem-2084	283	61	with	with	ADP
eurjchem-2084	283	62	azithromycin	azithromycin	PROPN
eurjchem-2084	283	63	to	to	PART
eurjchem-2084	283	64	evaluate	evaluate	VERB
eurjchem-2084	283	65	their	their	PRON
eurjchem-2084	283	66	efficacy	efficacy	NOUN
eurjchem-2084	283	67	in	in	ADP
eurjchem-2084	283	68	hospitalization	hospitalization	NOUN
eurjchem-2084	283	69	and	and	CCONJ
eurjchem-2084	283	70	death	death	NOUN
eurjchem-2084	283	71	in	in	ADP
eurjchem-2084	283	72	sars	sar	NOUN
eurjchem-2084	283	73	-	-	PUNCT
eurjchem-2084	283	74	cov-2	cov-2	NOUN
eurjchem-2084	283	75	infected	infected	ADJ
eurjchem-2084	283	76	patients	patient	NOUN
eurjchem-2084	283	77	[	[	X
eurjchem-2084	283	78	84	84	NUM
eurjchem-2084	283	79	]	]	PUNCT
eurjchem-2084	283	80	.	.	PUNCT
eurjchem-2084	284	1	however	however	ADV
eurjchem-2084	284	2	,	,	PUNCT
eurjchem-2084	284	3	the	the	DET
eurjchem-2084	284	4	prophylactic	prophylactic	ADJ
eurjchem-2084	284	5	use	use	NOUN
eurjchem-2084	284	6	of	of	ADP
eurjchem-2084	284	7	cq	cq	NOUN
eurjchem-2084	284	8	and	and	CCONJ
eurjchem-2084	284	9	hcq	hcq	NOUN
eurjchem-2084	284	10	is	be	AUX
eurjchem-2084	284	11	discouraged	discourage	VERB
eurjchem-2084	284	12	now	now	ADV
eurjchem-2084	284	13	because	because	SCONJ
eurjchem-2084	284	14	of	of	ADP
eurjchem-2084	284	15	their	their	PRON
eurjchem-2084	284	16	acute	acute	ADJ
eurjchem-2084	284	17	side	side	NOUN
eurjchem-2084	284	18	effects	effect	NOUN
eurjchem-2084	284	19	(	(	PUNCT
eurjchem-2084	284	20	worsening	worsen	VERB
eurjchem-2084	284	21	vision	vision	NOUN
eurjchem-2084	284	22	,	,	PUNCT
eurjchem-2084	284	23	nausea	nausea	NOUN
eurjchem-2084	284	24	,	,	PUNCT
eurjchem-2084	284	25	digestive	digestive	ADJ
eurjchem-2084	284	26	disorders	disorder	NOUN
eurjchem-2084	284	27	and	and	CCONJ
eurjchem-2084	284	28	heart	heart	NOUN
eurjchem-2084	284	29	failure	failure	NOUN
eurjchem-2084	284	30	)	)	PUNCT
eurjchem-2084	284	31	.	.	PUNCT
eurjchem-2084	285	1	a	a	DET
eurjchem-2084	285	2	case	case	NOUN
eurjchem-2084	285	3	study	study	NOUN
eurjchem-2084	285	4	in	in	ADP
eurjchem-2084	285	5	arizona	arizona	PROPN
eurjchem-2084	285	6	reported	report	VERB
eurjchem-2084	285	7	the	the	DET
eurjchem-2084	285	8	death	death	NOUN
eurjchem-2084	285	9	of	of	ADP
eurjchem-2084	285	10	a	a	DET
eurjchem-2084	285	11	husband	husband	NOUN
eurjchem-2084	285	12	and	and	CCONJ
eurjchem-2084	285	13	critical	critical	ADJ
eurjchem-2084	285	14	condition	condition	NOUN
eurjchem-2084	285	15	of	of	ADP
eurjchem-2084	285	16	wife	wife	NOUN
eurjchem-2084	285	17	after	after	ADP
eurjchem-2084	285	18	taking	take	VERB
eurjchem-2084	285	19	cq	cq	NOUN
eurjchem-2084	285	20	to	to	PART
eurjchem-2084	285	21	protect	protect	VERB
eurjchem-2084	285	22	themselves	themselves	PRON
eurjchem-2084	285	23	from	from	ADP
eurjchem-2084	285	24	sars	sar	NOUN
eurjchem-2084	285	25	-	-	PUNCT
eurjchem-2084	285	26	cov-2	cov-2	PART
eurjchem-2084	285	27	infection	infection	NOUN
eurjchem-2084	285	28	[	[	X
eurjchem-2084	285	29	85	85	NUM
eurjchem-2084	285	30	]	]	PUNCT
eurjchem-2084	285	31	.	.	PUNCT
eurjchem-2084	286	1	6.2.4	6.2.4	X
eurjchem-2084	286	2	.	.	PUNCT
eurjchem-2084	286	3	tocilizumab	tocilizumab	NOUN
eurjchem-2084	286	4	mystery	mystery	NOUN
eurjchem-2084	286	5	in	in	ADP
eurjchem-2084	286	6	covid-19	covid-19	PROPN
eurjchem-2084	286	7	tocilizumab	tocilizumab	NOUN
eurjchem-2084	286	8	is	be	AUX
eurjchem-2084	286	9	a	a	DET
eurjchem-2084	286	10	recombinant	recombinant	ADJ
eurjchem-2084	286	11	humanized	humanize	VERB
eurjchem-2084	286	12	monoclonal	monoclonal	NOUN
eurjchem-2084	286	13	antibody	antibody	NOUN
eurjchem-2084	286	14	of	of	ADP
eurjchem-2084	286	15	igg1	igg1	NOUN
eurjchem-2084	286	16	class	class	NOUN
eurjchem-2084	286	17	,	,	PUNCT
eurjchem-2084	286	18	which	which	PRON
eurjchem-2084	286	19	is	be	AUX
eurjchem-2084	286	20	directed	direct	VERB
eurjchem-2084	286	21	against	against	ADP
eurjchem-2084	286	22	both	both	CCONJ
eurjchem-2084	286	23	soluble	soluble	ADJ
eurjchem-2084	286	24	and	and	CCONJ
eurjchem-2084	286	25	membrane	membrane	NOUN
eurjchem-2084	286	26	-	-	PUNCT
eurjchem-2084	286	27	bound	bind	VERB
eurjchem-2084	286	28	forms	form	NOUN
eurjchem-2084	286	29	of	of	ADP
eurjchem-2084	286	30	the	the	DET
eurjchem-2084	286	31	interleukin-6	interleukin-6	PROPN
eurjchem-2084	286	32	(	(	PUNCT
eurjchem-2084	286	33	il-6	il-6	NOUN
eurjchem-2084	286	34	)	)	PUNCT
eurjchem-2084	286	35	receptor	receptor	NOUN
eurjchem-2084	286	36	[	[	X
eurjchem-2084	286	37	86	86	NUM
eurjchem-2084	286	38	]	]	PUNCT
eurjchem-2084	286	39	.	.	PUNCT
eurjchem-2084	287	1	it	it	PRON
eurjchem-2084	287	2	is	be	AUX
eurjchem-2084	287	3	an	an	DET
eurjchem-2084	287	4	immunosuppressive	immunosuppressive	ADJ
eurjchem-2084	287	5	drug	drug	NOUN
eurjchem-2084	287	6	available	available	ADJ
eurjchem-2084	287	7	under	under	ADP
eurjchem-2084	287	8	the	the	DET
eurjchem-2084	287	9	name	name	NOUN
eurjchem-2084	287	10	actemra	actemra	NOUN
eurjchem-2084	287	11	and	and	CCONJ
eurjchem-2084	287	12	has	have	AUX
eurjchem-2084	287	13	been	be	AUX
eurjchem-2084	287	14	used	use	VERB
eurjchem-2084	287	15	for	for	ADP
eurjchem-2084	287	16	the	the	DET
eurjchem-2084	287	17	treatment	treatment	NOUN
eurjchem-2084	287	18	of	of	ADP
eurjchem-2084	287	19	rheumatoid	rheumatoid	NOUN
eurjchem-2084	287	20	arthritis	arthritis	NOUN
eurjchem-2084	287	21	and	and	CCONJ
eurjchem-2084	287	22	to	to	PART
eurjchem-2084	287	23	reduce	reduce	VERB
eurjchem-2084	287	24	inflammation	inflammation	NOUN
eurjchem-2084	287	25	.	.	PUNCT
eurjchem-2084	288	1	an	an	DET
eurjchem-2084	288	2	initial	initial	ADJ
eurjchem-2084	288	3	clinical	clinical	ADJ
eurjchem-2084	288	4	trial	trial	NOUN
eurjchem-2084	288	5	of	of	ADP
eurjchem-2084	288	6	tocilizumab	tocilizumab	NOUN
eurjchem-2084	288	7	on	on	ADP
eurjchem-2084	288	8	20	20	NUM
eurjchem-2084	288	9	acute	acute	NOUN
eurjchem-2084	288	10	covid-19	covid-19	PROPN
eurjchem-2084	288	11	patients	patient	NOUN
eurjchem-2084	288	12	reported	report	VERB
eurjchem-2084	288	13	95	95	NUM
eurjchem-2084	288	14	%	%	NOUN
eurjchem-2084	288	15	recovery	recovery	NOUN
eurjchem-2084	288	16	within	within	ADP
eurjchem-2084	288	17	two	two	NUM
eurjchem-2084	288	18	weeks	week	NOUN
eurjchem-2084	289	1	[	[	X
eurjchem-2084	289	2	1	1	NUM
eurjchem-2084	289	3	]	]	PUNCT
eurjchem-2084	289	4	.	.	PUNCT
eurjchem-2084	290	1	fda	fda	PROPN
eurjchem-2084	290	2	approved	approve	VERB
eurjchem-2084	290	3	a	a	DET
eurjchem-2084	290	4	phase	phase	NOUN
eurjchem-2084	290	5	3	3	NUM
eurjchem-2084	290	6	trial	trial	NOUN
eurjchem-2084	290	7	of	of	ADP
eurjchem-2084	290	8	actemrain	actemrain	ADJ
eurjchem-2084	290	9	severe	severe	ADJ
eurjchem-2084	290	10	sars	sar	NOUN
eurjchem-2084	290	11	-	-	PUNCT
eurjchem-2084	290	12	cov-2infections	cov-2infection	NOUN
eurjchem-2084	290	13	.	.	PUNCT
eurjchem-2084	291	1	further	far	ADV
eurjchem-2084	291	2	,	,	PUNCT
eurjchem-2084	291	3	roche	roche	PROPN
eurjchem-2084	291	4	announced	announce	VERB
eurjchem-2084	291	5	that	that	SCONJ
eurjchem-2084	291	6	in	in	ADP
eurjchem-2084	291	7	the	the	DET
eurjchem-2084	291	8	phase3	phase3	NOUN
eurjchem-2084	291	9	covacta	covacta	NOUN
eurjchem-2084	291	10	trial	trial	NOUN
eurjchem-2084	291	11	,	,	PUNCT
eurjchem-2084	291	12	actemra	actemra	PROPN
eurjchem-2084	291	13	®	®	PROPN
eurjchem-2084	291	14	/roactemra	/roactemra	NOUN
eurjchem-2084	291	15	®	®	NOUN
eurjchem-2084	291	16	(	(	PUNCT
eurjchem-2084	291	17	tocilizumab	tocilizumab	NOUN
eurjchem-2084	291	18	)	)	PUNCT
eurjchem-2084	291	19	did	do	AUX
eurjchem-2084	291	20	not	not	PART
eurjchem-2084	291	21	improve	improve	VERB
eurjchem-2084	291	22	the	the	DET
eurjchem-2084	291	23	clinical	clinical	ADJ
eurjchem-2084	291	24	status	status	NOUN
eurjchem-2084	291	25	of	of	ADP
eurjchem-2084	291	26	the	the	DET
eurjchem-2084	291	27	patients	patient	NOUN
eurjchem-2084	291	28	and	and	CCONJ
eurjchem-2084	291	29	death	death	NOUN
eurjchem-2084	291	30	occurred	occur	VERB
eurjchem-2084	291	31	in	in	ADP
eurjchem-2084	291	32	hospitalized	hospitalize	VERB
eurjchem-2084	291	33	adult	adult	NOUN
eurjchem-2084	291	34	patients	patient	NOUN
eurjchem-2084	291	35	with	with	ADP
eurjchem-2084	291	36	severe	severe	ADJ
eurjchem-2084	291	37	covid-19	covid-19	PROPN
eurjchem-2084	291	38	associated	associated	ADJ
eurjchem-2084	291	39	pneumonia	pneumonia	NOUN
eurjchem-2084	291	40	[	[	X
eurjchem-2084	291	41	87	87	NUM
eurjchem-2084	291	42	]	]	PUNCT
eurjchem-2084	291	43	.	.	PUNCT
eurjchem-2084	292	1	in	in	ADP
eurjchem-2084	292	2	another	another	DET
eurjchem-2084	292	3	attempt	attempt	NOUN
eurjchem-2084	292	4	to	to	PART
eurjchem-2084	292	5	establish	establish	VERB
eurjchem-2084	292	6	the	the	DET
eurjchem-2084	292	7	efficacy	efficacy	NOUN
eurjchem-2084	292	8	of	of	ADP
eurjchem-2084	292	9	the	the	DET
eurjchem-2084	292	10	drug	drug	NOUN
eurjchem-2084	292	11	,	,	PUNCT
eurjchem-2084	292	12	all	all	DET
eurjchem-2084	292	13	available	available	ADJ
eurjchem-2084	292	14	data	datum	NOUN
eurjchem-2084	292	15	from	from	ADP
eurjchem-2084	292	16	13	13	NUM
eurjchem-2084	292	17	published	publish	VERB
eurjchem-2084	292	18	,	,	PUNCT
eurjchem-2084	292	19	15	15	NUM
eurjchem-2084	292	20	pre	pre	ADJ
eurjchem-2084	292	21	-	-	ADJ
eurjchem-2084	292	22	print	print	ADJ
eurjchem-2084	292	23	clinical	clinical	ADJ
eurjchem-2084	292	24	studies	study	NOUN
eurjchem-2084	292	25	and	and	CCONJ
eurjchem-2084	292	26	5776	5776	NUM
eurjchem-2084	292	27	patients	patient	NOUN
eurjchem-2084	292	28	were	be	AUX
eurjchem-2084	292	29	further	far	ADV
eurjchem-2084	292	30	evaluated	evaluate	VERB
eurjchem-2084	292	31	.	.	PUNCT
eurjchem-2084	293	1	the	the	DET
eurjchem-2084	293	2	study	study	NOUN
eurjchem-2084	293	3	concluded	conclude	VERB
eurjchem-2084	293	4	that	that	SCONJ
eurjchem-2084	293	5	there	there	PRON
eurjchem-2084	293	6	were	be	VERB
eurjchem-2084	293	7	insufficient	insufficient	ADJ
eurjchem-2084	293	8	data	datum	NOUN
eurjchem-2084	293	9	regarding	regard	VERB
eurjchem-2084	293	10	the	the	DET
eurjchem-2084	293	11	safety	safety	NOUN
eurjchem-2084	293	12	and	and	CCONJ
eurjchem-2084	293	13	efficacy	efficacy	NOUN
eurjchem-2084	293	14	of	of	ADP
eurjchem-2084	293	15	the	the	DET
eurjchem-2084	293	16	drug	drug	NOUN
eurjchem-2084	293	17	,	,	PUNCT
eurjchem-2084	293	18	as	as	SCONJ
eurjchem-2084	293	19	only	only	ADV
eurjchem-2084	293	20	a	a	DET
eurjchem-2084	293	21	few	few	ADJ
eurjchem-2084	293	22	trials	trial	NOUN
eurjchem-2084	293	23	were	be	AUX
eurjchem-2084	293	24	multicenter	multicenter	ADJ
eurjchem-2084	293	25	,	,	PUNCT
eurjchem-2084	293	26	the	the	DET
eurjchem-2084	293	27	sample	sample	NOUN
eurjchem-2084	293	28	size	size	NOUN
eurjchem-2084	293	29	receiving	receive	VERB
eurjchem-2084	293	30	tocilizumab	tocilizumab	NOUN
eurjchem-2084	293	31	was	be	AUX
eurjchem-2084	293	32	not	not	PART
eurjchem-2084	293	33	large	large	ADJ
eurjchem-2084	293	34	and	and	CCONJ
eurjchem-2084	293	35	most	most	ADJ
eurjchem-2084	293	36	studies	study	NOUN
eurjchem-2084	293	37	were	be	AUX
eurjchem-2084	293	38	without	without	ADP
eurjchem-2084	293	39	control	control	NOUN
eurjchem-2084	293	40	[	[	X
eurjchem-2084	293	41	88	88	NUM
eurjchem-2084	293	42	]	]	PUNCT
eurjchem-2084	293	43	.	.	PUNCT
eurjchem-2084	294	1	who	who	PRON
eurjchem-2084	294	2	has	have	AUX
eurjchem-2084	294	3	recommended	recommend	VERB
eurjchem-2084	294	4	the	the	DET
eurjchem-2084	294	5	use	use	NOUN
eurjchem-2084	294	6	of	of	ADP
eurjchem-2084	294	7	tocilizumab	tocilizumab	NOUN
eurjchem-2084	294	8	only	only	ADV
eurjchem-2084	294	9	in	in	ADP
eurjchem-2084	294	10	severe	severe	ADJ
eurjchem-2084	294	11	clinical	clinical	ADJ
eurjchem-2084	294	12	conditions	condition	NOUN
eurjchem-2084	294	13	[	[	X
eurjchem-2084	294	14	89	89	NUM
eurjchem-2084	294	15	]	]	SYM
eurjchem-2084	294	16	.	.	PUNCT
eurjchem-2084	295	1	6.2.5	6.2.5	NUM
eurjchem-2084	295	2	.	.	PUNCT
eurjchem-2084	295	3	potential	potential	ADJ
eurjchem-2084	295	4	role	role	NOUN
eurjchem-2084	295	5	of	of	ADP
eurjchem-2084	295	6	convalescent	convalescent	NOUN
eurjchem-2084	295	7	plasma	plasma	NOUN
eurjchem-2084	295	8	therapy	therapy	NOUN
eurjchem-2084	295	9	in	in	ADP
eurjchem-2084	295	10	covid-19	covid-19	PROPN
eurjchem-2084	295	11	convalescent	convalescent	NOUN
eurjchem-2084	295	12	plasma	plasma	NOUN
eurjchem-2084	295	13	(	(	PUNCT
eurjchem-2084	295	14	cp	cp	NOUN
eurjchem-2084	295	15	)	)	PUNCT
eurjchem-2084	295	16	therapy	therapy	NOUN
eurjchem-2084	295	17	is	be	AUX
eurjchem-2084	295	18	a	a	DET
eurjchem-2084	295	19	classic	classic	ADJ
eurjchem-2084	295	20	adaptive	adaptive	ADJ
eurjchem-2084	295	21	immunotherapy	immunotherapy	NOUN
eurjchem-2084	295	22	and	and	CCONJ
eurjchem-2084	295	23	is	be	AUX
eurjchem-2084	295	24	widely	widely	ADV
eurjchem-2084	295	25	used	use	VERB
eurjchem-2084	295	26	for	for	ADP
eurjchem-2084	295	27	the	the	DET
eurjchem-2084	295	28	control	control	NOUN
eurjchem-2084	295	29	and	and	CCONJ
eurjchem-2084	295	30	treatment	treatment	NOUN
eurjchem-2084	295	31	of	of	ADP
eurjchem-2084	295	32	many	many	ADJ
eurjchem-2084	295	33	infectious	infectious	ADJ
eurjchem-2084	295	34	diseases	disease	NOUN
eurjchem-2084	295	35	since	since	SCONJ
eurjchem-2084	295	36	a	a	DET
eurjchem-2084	295	37	long	long	ADJ
eurjchem-2084	295	38	time	time	NOUN
eurjchem-2084	295	39	.	.	PUNCT
eurjchem-2084	296	1	fda	fda	PROPN
eurjchem-2084	296	2	has	have	AUX
eurjchem-2084	296	3	approved	approve	VERB
eurjchem-2084	296	4	the	the	DET
eurjchem-2084	296	5	use	use	NOUN
eurjchem-2084	296	6	of	of	ADP
eurjchem-2084	296	7	blood	blood	NOUN
eurjchem-2084	296	8	plasma	plasma	NOUN
eurjchem-2084	296	9	from	from	ADP
eurjchem-2084	296	10	recovered	recovered	ADJ
eurjchem-2084	296	11	covid19	covid19	NOUN
eurjchem-2084	296	12	patients	patient	NOUN
eurjchem-2084	296	13	having	have	VERB
eurjchem-2084	296	14	high	high	ADJ
eurjchem-2084	296	15	neutralizing	neutralize	VERB
eurjchem-2084	296	16	antibody	antibody	NOUN
eurjchem-2084	296	17	titer	titer	NOUN
eurjchem-2084	296	18	and	and	CCONJ
eurjchem-2084	296	19	also	also	ADV
eurjchem-2084	296	20	use	use	VERB
eurjchem-2084	296	21	of	of	ADP
eurjchem-2084	296	22	such	such	ADJ
eurjchem-2084	296	23	people	people	NOUN
eurjchem-2084	296	24	as	as	ADP
eurjchem-2084	296	25	a	a	DET
eurjchem-2084	296	26	potent	potent	ADJ
eurjchem-2084	296	27	donor	donor	NOUN
eurjchem-2084	296	28	source	source	NOUN
eurjchem-2084	296	29	of	of	ADP
eurjchem-2084	296	30	cp	cp	PROPN
eurjchem-2084	297	1	[	[	X
eurjchem-2084	297	2	90	90	NUM
eurjchem-2084	297	3	]	]	PUNCT
eurjchem-2084	297	4	.	.	PUNCT
eurjchem-2084	298	1	fda	fda	PROPN
eurjchem-2084	298	2	approved	approve	VERB
eurjchem-2084	298	3	a	a	DET
eurjchem-2084	298	4	multicenter	multicenter	NOUN
eurjchem-2084	298	5	,	,	PUNCT
eurjchem-2084	298	6	open	open	ADJ
eurjchem-2084	298	7	label	label	NOUN
eurjchem-2084	298	8	trial	trial	NOUN
eurjchem-2084	298	9	on	on	ADP
eurjchem-2084	298	10	a	a	DET
eurjchem-2084	298	11	hospitalized	hospitalize	VERB
eurjchem-2084	298	12	covid-19	covid-19	PROPN
eurjchem-2084	298	13	patient	patient	NOUN
eurjchem-2084	298	14	using	use	VERB
eurjchem-2084	298	15	cp	cp	PROPN
eurjchem-2084	298	16	and	and	CCONJ
eurjchem-2084	298	17	preliminary	preliminary	ADJ
eurjchem-2084	298	18	data	datum	NOUN
eurjchem-2084	298	19	analysis	analysis	NOUN
eurjchem-2084	298	20	of	of	ADP
eurjchem-2084	298	21	the	the	DET
eurjchem-2084	298	22	first	first	ADJ
eurjchem-2084	298	23	20,000	20,000	NUM
eurjchem-2084	298	24	patients	patient	NOUN
eurjchem-2084	298	25	established	establish	VERB
eurjchem-2084	298	26	the	the	DET
eurjchem-2084	298	27	safety	safety	NOUN
eurjchem-2084	298	28	and	and	CCONJ
eurjchem-2084	298	29	benefit	benefit	NOUN
eurjchem-2084	298	30	of	of	ADP
eurjchem-2084	298	31	cp	cp	NUM
eurjchem-2084	298	32	treatment	treatment	NOUN
eurjchem-2084	298	33	[	[	X
eurjchem-2084	298	34	91	91	NUM
eurjchem-2084	298	35	]	]	PUNCT
eurjchem-2084	298	36	.	.	PUNCT
eurjchem-2084	299	1	cp	cp	NUM
eurjchem-2084	299	2	therapy	therapy	NOUN
eurjchem-2084	299	3	could	could	AUX
eurjchem-2084	299	4	be	be	AUX
eurjchem-2084	299	5	more	more	ADV
eurjchem-2084	299	6	effective	effective	ADJ
eurjchem-2084	299	7	if	if	SCONJ
eurjchem-2084	299	8	it	it	PRON
eurjchem-2084	299	9	is	be	AUX
eurjchem-2084	299	10	administered	administer	VERB
eurjchem-2084	299	11	to	to	ADP
eurjchem-2084	299	12	covid-19	covid-19	PROPN
eurjchem-2084	299	13	patients	patient	NOUN
eurjchem-2084	299	14	before	before	ADP
eurjchem-2084	299	15	the	the	DET
eurjchem-2084	299	16	severe	severe	ADJ
eurjchem-2084	299	17	lung	lung	NOUN
eurjchem-2084	299	18	infections	infection	NOUN
eurjchem-2084	299	19	.	.	PUNCT
eurjchem-2084	300	1	[	[	X
eurjchem-2084	300	2	92	92	NUM
eurjchem-2084	300	3	]	]	SYM
eurjchem-2084	300	4	.	.	PUNCT
eurjchem-2084	301	1	7	7	X
eurjchem-2084	301	2	.	.	X
eurjchem-2084	301	3	vaccines	vaccine	NOUN
eurjchem-2084	301	4	in	in	ADP
eurjchem-2084	301	5	infectious	infectious	ADJ
eurjchem-2084	301	6	diseases	disease	NOUN
eurjchem-2084	301	7	vaccines	vaccine	NOUN
eurjchem-2084	301	8	are	be	AUX
eurjchem-2084	301	9	the	the	DET
eurjchem-2084	301	10	utmost	utmost	ADJ
eurjchem-2084	301	11	reasonable	reasonable	ADJ
eurjchem-2084	301	12	and	and	CCONJ
eurjchem-2084	301	13	effectual	effectual	ADJ
eurjchem-2084	301	14	measures	measure	NOUN
eurjchem-2084	301	15	to	to	PART
eurjchem-2084	301	16	prevent	prevent	VERB
eurjchem-2084	301	17	and	and	CCONJ
eurjchem-2084	301	18	control	control	VERB
eurjchem-2084	301	19	infectious	infectious	ADJ
eurjchem-2084	301	20	diseases	disease	NOUN
eurjchem-2084	301	21	[	[	X
eurjchem-2084	301	22	93	93	NUM
eurjchem-2084	301	23	]	]	PUNCT
eurjchem-2084	301	24	.	.	PUNCT
eurjchem-2084	302	1	it	it	PRON
eurjchem-2084	302	2	is	be	AUX
eurjchem-2084	302	3	dire	dire	ADJ
eurjchem-2084	302	4	need	need	NOUN
eurjchem-2084	302	5	to	to	PART
eurjchem-2084	302	6	develop	develop	VERB
eurjchem-2084	302	7	an	an	DET
eurjchem-2084	302	8	effective	effective	ADJ
eurjchem-2084	302	9	vaccine	vaccine	NOUN
eurjchem-2084	302	10	against	against	ADP
eurjchem-2084	302	11	sars	sar	NOUN
eurjchem-2084	302	12	-	-	PUNCT
eurjchem-2084	302	13	cov-2	cov-2	PART
eurjchem-2084	302	14	infection	infection	NOUN
eurjchem-2084	302	15	.	.	PUNCT
eurjchem-2084	303	1	the	the	DET
eurjchem-2084	303	2	identification	identification	NOUN
eurjchem-2084	303	3	of	of	ADP
eurjchem-2084	303	4	sars	sar	NOUN
eurjchem-2084	303	5	-	-	PUNCT
eurjchem-2084	303	6	cov-2	cov-2	PART
eurjchem-2084	303	7	was	be	AUX
eurjchem-2084	303	8	achieved	achieve	VERB
eurjchem-2084	303	9	within	within	ADP
eurjchem-2084	303	10	3	3	NUM
eurjchem-2084	303	11	months	month	NOUN
eurjchem-2084	303	12	of	of	ADP
eurjchem-2084	303	13	its	its	PRON
eurjchem-2084	303	14	spread	spread	NOUN
eurjchem-2084	303	15	.	.	PUNCT
eurjchem-2084	304	1	the	the	DET
eurjchem-2084	304	2	studies	study	NOUN
eurjchem-2084	304	3	on	on	ADP
eurjchem-2084	304	4	its	its	PRON
eurjchem-2084	304	5	other	other	ADJ
eurjchem-2084	304	6	biological	biological	ADJ
eurjchem-2084	304	7	characteristics	characteristic	NOUN
eurjchem-2084	304	8	are	be	AUX
eurjchem-2084	304	9	undergoing	undergo	VERB
eurjchem-2084	304	10	vigorously	vigorously	ADV
eurjchem-2084	304	11	to	to	PART
eurjchem-2084	304	12	facilitate	facilitate	VERB
eurjchem-2084	304	13	the	the	DET
eurjchem-2084	304	14	rapid	rapid	ADJ
eurjchem-2084	304	15	development	development	NOUN
eurjchem-2084	304	16	of	of	ADP
eurjchem-2084	304	17	vaccine	vaccine	NOUN
eurjchem-2084	304	18	.	.	PUNCT
eurjchem-2084	305	1	globally	globally	ADV
eurjchem-2084	305	2	,	,	PUNCT
eurjchem-2084	305	3	confirmed	confirm	VERB
eurjchem-2084	305	4	covid-19	covid-19	PROPN
eurjchem-2084	305	5	cases	case	NOUN
eurjchem-2084	305	6	are	be	AUX
eurjchem-2084	305	7	still	still	ADV
eurjchem-2084	305	8	increasing	increase	VERB
eurjchem-2084	305	9	at	at	ADP
eurjchem-2084	305	10	an	an	DET
eurjchem-2084	305	11	alarming	alarming	ADJ
eurjchem-2084	305	12	rate	rate	NOUN
eurjchem-2084	305	13	and	and	CCONJ
eurjchem-2084	305	14	it	it	PRON
eurjchem-2084	305	15	may	may	AUX
eurjchem-2084	305	16	become	become	VERB
eurjchem-2084	305	17	a	a	DET
eurjchem-2084	305	18	flu	flu	NOUN
eurjchem-2084	305	19	-	-	PUNCT
eurjchem-2084	305	20	like	like	ADJ
eurjchem-2084	305	21	seasonal	seasonal	ADJ
eurjchem-2084	305	22	disease	disease	NOUN
eurjchem-2084	305	23	and	and	CCONJ
eurjchem-2084	305	24	remain	remain	VERB
eurjchem-2084	305	25	in	in	ADP
eurjchem-2084	305	26	coexistence	coexistence	NOUN
eurjchem-2084	305	27	with	with	ADP
eurjchem-2084	305	28	human	human	ADJ
eurjchem-2084	305	29	beings	being	NOUN
eurjchem-2084	305	30	for	for	ADP
eurjchem-2084	305	31	a	a	DET
eurjchem-2084	305	32	long	long	ADJ
eurjchem-2084	305	33	time	time	NOUN
eurjchem-2084	305	34	[	[	X
eurjchem-2084	305	35	94	94	NUM
eurjchem-2084	305	36	]	]	PUNCT
eurjchem-2084	305	37	.	.	PUNCT
eurjchem-2084	306	1	thus	thus	ADV
eurjchem-2084	306	2	,	,	PUNCT
eurjchem-2084	306	3	vaccine	vaccine	NOUN
eurjchem-2084	306	4	development	development	NOUN
eurjchem-2084	306	5	is	be	AUX
eurjchem-2084	306	6	necessary	necessary	ADJ
eurjchem-2084	306	7	even	even	ADV
eurjchem-2084	306	8	if	if	SCONJ
eurjchem-2084	306	9	it	it	PRON
eurjchem-2084	306	10	is	be	AUX
eurjchem-2084	306	11	occurring	occur	VERB
eurjchem-2084	306	12	at	at	ADP
eurjchem-2084	306	13	a	a	DET
eurjchem-2084	306	14	slower	slow	ADJ
eurjchem-2084	306	15	pace	pace	NOUN
eurjchem-2084	306	16	than	than	ADP
eurjchem-2084	306	17	the	the	DET
eurjchem-2084	306	18	spreading	spreading	NOUN
eurjchem-2084	306	19	of	of	ADP
eurjchem-2084	306	20	covid-19	covid-19	PROPN
eurjchem-2084	306	21	pandemic	pandemic	NOUN
eurjchem-2084	306	22	.	.	PUNCT
eurjchem-2084	307	1	to	to	ADP
eurjchem-2084	307	2	date	date	NOUN
eurjchem-2084	307	3	,	,	PUNCT
eurjchem-2084	307	4	nearly	nearly	ADV
eurjchem-2084	307	5	forty	forty	NUM
eurjchem-2084	307	6	pharmaceutical	pharmaceutical	ADJ
eurjchem-2084	307	7	firms	firm	NOUN
eurjchem-2084	307	8	and	and	CCONJ
eurjchem-2084	307	9	academic	academic	ADJ
eurjchem-2084	307	10	institutions	institution	NOUN
eurjchem-2084	307	11	have	have	AUX
eurjchem-2084	307	12	launched	launch	VERB
eurjchem-2084	307	13	their	their	PRON
eurjchem-2084	307	14	vaccine	vaccine	NOUN
eurjchem-2084	307	15	development	development	NOUN
eurjchem-2084	307	16	programs	program	NOUN
eurjchem-2084	307	17	against	against	ADP
eurjchem-2084	307	18	sars	sar	NOUN
eurjchem-2084	307	19	-	-	PUNCT
eurjchem-2084	307	20	cov-2	cov-2	PART
eurjchem-2084	307	21	infection	infection	NOUN
eurjchem-2084	307	22	globally	globally	ADV
eurjchem-2084	307	23	.	.	PUNCT
eurjchem-2084	308	1	however	however	ADV
eurjchem-2084	308	2	,	,	PUNCT
eurjchem-2084	308	3	the	the	DET
eurjchem-2084	308	4	course	course	NOUN
eurjchem-2084	308	5	of	of	ADP
eurjchem-2084	308	6	vaccine	vaccine	NOUN
eurjchem-2084	308	7	production	production	NOUN
eurjchem-2084	308	8	has	have	VERB
eurjchem-2084	308	9	to	to	PART
eurjchem-2084	308	10	follow	follow	VERB
eurjchem-2084	308	11	the	the	DET
eurjchem-2084	308	12	strict	strict	ADJ
eurjchem-2084	308	13	rules	rule	NOUN
eurjchem-2084	308	14	set	set	VERB
eurjchem-2084	308	15	by	by	ADP
eurjchem-2084	308	16	various	various	ADJ
eurjchem-2084	308	17	regulatory	regulatory	ADJ
eurjchem-2084	308	18	agencies	agency	NOUN
eurjchem-2084	308	19	and	and	CCONJ
eurjchem-2084	308	20	is	be	AUX
eurjchem-2084	308	21	not	not	PART
eurjchem-2084	308	22	an	an	DET
eurjchem-2084	308	23	overnight	overnight	ADJ
eurjchem-2084	308	24	task	task	NOUN
eurjchem-2084	308	25	.	.	PUNCT
eurjchem-2084	309	1	broadly	broadly	ADV
eurjchem-2084	309	2	the	the	DET
eurjchem-2084	309	3	vaccine	vaccine	NOUN
eurjchem-2084	309	4	production	production	NOUN
eurjchem-2084	309	5	process	process	NOUN
eurjchem-2084	309	6	can	can	AUX
eurjchem-2084	309	7	be	be	AUX
eurjchem-2084	309	8	classified	classify	VERB
eurjchem-2084	309	9	as	as	ADP
eurjchem-2084	309	10	:	:	PUNCT
eurjchem-2084	309	11	(	(	PUNCT
eurjchem-2084	309	12	a	a	X
eurjchem-2084	309	13	)	)	PUNCT
eurjchem-2084	309	14	the	the	DET
eurjchem-2084	309	15	vaccine	vaccine	NOUN
eurjchem-2084	309	16	designing	design	VERB
eurjchem-2084	309	17	process	process	NOUN
eurjchem-2084	309	18	,	,	PUNCT
eurjchem-2084	309	19	(	(	PUNCT
eurjchem-2084	309	20	b	b	X
eurjchem-2084	309	21	)	)	PUNCT
eurjchem-2084	309	22	its	its	PRON
eurjchem-2084	309	23	safety	safety	NOUN
eurjchem-2084	309	24	and	and	CCONJ
eurjchem-2084	309	25	efficacy	efficacy	NOUN
eurjchem-2084	309	26	in	in	ADP
eurjchem-2084	309	27	animal	animal	NOUN
eurjchem-2084	309	28	studies	study	NOUN
eurjchem-2084	309	29	followed	follow	VERB
eurjchem-2084	309	30	by	by	ADP
eurjchem-2084	309	31	(	(	PUNCT
eurjchem-2084	309	32	c	c	NOUN
eurjchem-2084	309	33	)	)	PUNCT
eurjchem-2084	309	34	clinical	clinical	ADJ
eurjchem-2084	309	35	trials	trial	NOUN
eurjchem-2084	309	36	(	(	PUNCT
eurjchem-2084	309	37	phases	phase	NOUN
eurjchem-2084	309	38	1	1	NUM
eurjchem-2084	309	39	,	,	PUNCT
eurjchem-2084	309	40	2	2	NUM
eurjchem-2084	309	41	,	,	PUNCT
eurjchem-2084	309	42	and	and	CCONJ
eurjchem-2084	309	43	3	3	NUM
eurjchem-2084	309	44	)	)	PUNCT
eurjchem-2084	309	45	,	,	PUNCT
eurjchem-2084	309	46	and	and	CCONJ
eurjchem-2084	309	47	(	(	PUNCT
eurjchem-2084	309	48	d	d	X
eurjchem-2084	309	49	)	)	PUNCT
eurjchem-2084	309	50	regulatory	regulatory	ADJ
eurjchem-2084	309	51	approval	approval	NOUN
eurjchem-2084	309	52	.	.	PUNCT
eurjchem-2084	310	1	generally	generally	ADV
eurjchem-2084	310	2	,	,	PUNCT
eurjchem-2084	310	3	it	it	PRON
eurjchem-2084	310	4	takes	take	VERB
eurjchem-2084	310	5	a	a	DET
eurjchem-2084	310	6	decade	decade	NOUN
eurjchem-2084	310	7	or	or	CCONJ
eurjchem-2084	310	8	two	two	NUM
eurjchem-2084	310	9	for	for	SCONJ
eurjchem-2084	310	10	a	a	DET
eurjchem-2084	310	11	new	new	ADJ
eurjchem-2084	310	12	vaccine	vaccine	NOUN
eurjchem-2084	310	13	to	to	PART
eurjchem-2084	310	14	go	go	VERB
eurjchem-2084	310	15	from	from	ADP
eurjchem-2084	310	16	the	the	DET
eurjchem-2084	310	17	design	design	NOUN
eurjchem-2084	310	18	to	to	ADP
eurjchem-2084	310	19	approval	approval	NOUN
eurjchem-2084	310	20	stage	stage	NOUN
eurjchem-2084	310	21	[	[	X
eurjchem-2084	310	22	95	95	NUM
eurjchem-2084	310	23	]	]	PUNCT
eurjchem-2084	310	24	.	.	PUNCT
eurjchem-2084	311	1	however	however	ADV
eurjchem-2084	311	2	,	,	PUNCT
eurjchem-2084	311	3	the	the	DET
eurjchem-2084	311	4	process	process	NOUN
eurjchem-2084	311	5	of	of	ADP
eurjchem-2084	311	6	vaccine	vaccine	NOUN
eurjchem-2084	311	7	development	development	NOUN
eurjchem-2084	311	8	against	against	ADP
eurjchem-2084	311	9	covid19	covid19	NOUN
eurjchem-2084	311	10	has	have	AUX
eurjchem-2084	311	11	briskly	briskly	ADV
eurjchem-2084	311	12	reached	reach	VERB
eurjchem-2084	311	13	the	the	DET
eurjchem-2084	311	14	phase	phase	NOUN
eurjchem-2084	311	15	3	3	NUM
eurjchem-2084	311	16	clinical	clinical	ADJ
eurjchem-2084	311	17	trial	trial	NOUN
eurjchem-2084	311	18	(	(	PUNCT
eurjchem-2084	311	19	table	table	NOUN
eurjchem-2084	311	20	3	3	NUM
eurjchem-2084	311	21	)	)	PUNCT
eurjchem-2084	311	22	at	at	ADP
eurjchem-2084	311	23	various	various	ADJ
eurjchem-2084	311	24	places	place	NOUN
eurjchem-2084	311	25	worldwide	worldwide	ADV
eurjchem-2084	311	26	and	and	CCONJ
eurjchem-2084	311	27	it	it	PRON
eurjchem-2084	311	28	is	be	AUX
eurjchem-2084	311	29	expected	expect	VERB
eurjchem-2084	311	30	to	to	PART
eurjchem-2084	311	31	be	be	AUX
eurjchem-2084	311	32	the	the	DET
eurjchem-2084	311	33	fastest	fast	ADJ
eurjchem-2084	311	34	vaccine	vaccine	NOUN
eurjchem-2084	311	35	ever	ever	ADV
eurjchem-2084	311	36	produced	produce	VERB
eurjchem-2084	311	37	in	in	ADP
eurjchem-2084	311	38	human	human	ADJ
eurjchem-2084	311	39	history	history	NOUN
eurjchem-2084	311	40	.	.	PUNCT
eurjchem-2084	312	1	viral	viral	ADJ
eurjchem-2084	312	2	diversity	diversity	NOUN
eurjchem-2084	312	3	has	have	AUX
eurjchem-2084	312	4	challenged	challenge	VERB
eurjchem-2084	312	5	vaccine	vaccine	NOUN
eurjchem-2084	312	6	development	development	NOUN
eurjchem-2084	312	7	efforts	effort	NOUN
eurjchem-2084	312	8	for	for	ADP
eurjchem-2084	312	9	other	other	ADJ
eurjchem-2084	312	10	viruses	virus	NOUN
eurjchem-2084	312	11	such	such	ADJ
eurjchem-2084	312	12	as	as	ADP
eurjchem-2084	312	13	hiv-1	hiv-1	ADJ
eurjchem-2084	312	14	,	,	PUNCT
eurjchem-2084	312	15	influenza	influenza	NOUN
eurjchem-2084	312	16	,	,	PUNCT
eurjchem-2084	312	17	or	or	CCONJ
eurjchem-2084	312	18	dengue	dengue	NOUN
eurjchem-2084	312	19	,	,	PUNCT
eurjchem-2084	312	20	as	as	SCONJ
eurjchem-2084	312	21	these	these	DET
eurjchem-2084	312	22	viruses	virus	NOUN
eurjchem-2084	312	23	constitute	constitute	VERB
eurjchem-2084	312	24	a	a	DET
eurjchem-2084	312	25	more	more	ADV
eurjchem-2084	312	26	diverse	diverse	ADJ
eurjchem-2084	312	27	population	population	NOUN
eurjchem-2084	312	28	than	than	ADP
eurjchem-2084	312	29	sars	sar	NOUN
eurjchem-2084	312	30	-	-	PUNCT
eurjchem-2084	312	31	cov-2	cov-2	PART
eurjchem-2084	312	32	virus	virus	NOUN
eurjchem-2084	312	33	.	.	PUNCT
eurjchem-2084	313	1	currently	currently	ADV
eurjchem-2084	313	2	,	,	PUNCT
eurjchem-2084	313	3	circulating	circulate	VERB
eurjchem-2084	313	4	sars	sar	NOUN
eurjchem-2084	313	5	-	-	PUNCT
eurjchem-2084	313	6	cov-2	cov-2	PART
eurjchem-2084	313	7	constitutes	constitute	VERB
eurjchem-2084	313	8	a	a	DET
eurjchem-2084	313	9	comparatively	comparatively	ADV
eurjchem-2084	313	10	homogeneous	homogeneous	ADJ
eurjchem-2084	313	11	population	population	NOUN
eurjchem-2084	313	12	and	and	CCONJ
eurjchem-2084	313	13	there	there	PRON
eurjchem-2084	313	14	is	be	VERB
eurjchem-2084	313	15	indication	indication	NOUN
eurjchem-2084	313	16	of	of	ADP
eurjchem-2084	313	17	purifying	purify	VERB
eurjchem-2084	313	18	selection	selection	NOUN
eurjchem-2084	313	19	but	but	CCONJ
eurjchem-2084	313	20	little	little	ADJ
eurjchem-2084	313	21	sign	sign	NOUN
eurjchem-2084	313	22	of	of	ADP
eurjchem-2084	313	23	diversifying	diversify	VERB
eurjchem-2084	313	24	selection	selection	NOUN
eurjchem-2084	313	25	[	[	X
eurjchem-2084	313	26	96	96	NUM
eurjchem-2084	313	27	]	]	PUNCT
eurjchem-2084	313	28	.	.	PUNCT
eurjchem-2084	314	1	therefore	therefore	ADV
eurjchem-2084	314	2	,	,	PUNCT
eurjchem-2084	314	3	we	we	PRON
eurjchem-2084	314	4	can	can	AUX
eurjchem-2084	314	5	be	be	AUX
eurjchem-2084	314	6	cautiously	cautiously	ADV
eurjchem-2084	314	7	optimistic	optimistic	ADJ
eurjchem-2084	314	8	that	that	SCONJ
eurjchem-2084	314	9	viral	viral	ADJ
eurjchem-2084	314	10	diversity	diversity	NOUN
eurjchem-2084	314	11	should	should	AUX
eurjchem-2084	314	12	not	not	PART
eurjchem-2084	314	13	be	be	AUX
eurjchem-2084	314	14	an	an	DET
eurjchem-2084	314	15	obstacle	obstacle	NOUN
eurjchem-2084	314	16	for	for	ADP
eurjchem-2084	314	17	the	the	DET
eurjchem-2084	314	18	development	development	NOUN
eurjchem-2084	314	19	of	of	ADP
eurjchem-2084	314	20	a	a	DET
eurjchem-2084	314	21	sars	sar	NOUN
eurjchem-2084	314	22	-	-	PUNCT
eurjchem-2084	314	23	cov-2	cov-2	PART
eurjchem-2084	314	24	broad	broad	ADJ
eurjchem-2084	314	25	spectrum	spectrum	NOUN
eurjchem-2084	314	26	vaccine	vaccine	NOUN
eurjchem-2084	314	27	.	.	PUNCT
eurjchem-2084	315	1	the	the	DET
eurjchem-2084	315	2	various	various	ADJ
eurjchem-2084	315	3	vaccines	vaccine	NOUN
eurjchem-2084	315	4	that	that	PRON
eurjchem-2084	315	5	are	be	AUX
eurjchem-2084	315	6	being	be	AUX
eurjchem-2084	315	7	currently	currently	ADV
eurjchem-2084	315	8	developed	develop	VERB
eurjchem-2084	315	9	(	(	PUNCT
eurjchem-2084	315	10	table	table	NOUN
eurjchem-2084	315	11	3	3	NUM
eurjchem-2084	315	12	)	)	PUNCT
eurjchem-2084	315	13	should	should	AUX
eurjchem-2084	315	14	elicit	elicit	VERB
eurjchem-2084	315	15	reactive	reactive	ADJ
eurjchem-2084	315	16	responses	response	NOUN
eurjchem-2084	315	17	against	against	ADP
eurjchem-2084	315	18	circulating	circulate	VERB
eurjchem-2084	315	19	variants	variant	NOUN
eurjchem-2084	315	20	of	of	ADP
eurjchem-2084	315	21	sars	sar	NOUN
eurjchem-2084	315	22	-	-	PUNCT
eurjchem-2084	315	23	cov-2	cov-2	NOUN
eurjchem-2084	315	24	.	.	PUNCT
eurjchem-2084	316	1	7.1	7.1	NUM
eurjchem-2084	316	2	.	.	PUNCT
eurjchem-2084	316	3	types	type	NOUN
eurjchem-2084	316	4	of	of	ADP
eurjchem-2084	316	5	vaccines	vaccine	NOUN
eurjchem-2084	316	6	whole	whole	ADJ
eurjchem-2084	316	7	-	-	PUNCT
eurjchem-2084	316	8	cell	cell	NOUN
eurjchem-2084	316	9	killed	kill	VERB
eurjchem-2084	316	10	or	or	CCONJ
eurjchem-2084	316	11	live	live	ADV
eurjchem-2084	316	12	-	-	PUNCT
eurjchem-2084	316	13	attenuated	attenuate	VERB
eurjchem-2084	316	14	vaccines	vaccine	NOUN
eurjchem-2084	316	15	possess	possess	VERB
eurjchem-2084	316	16	multiple	multiple	ADJ
eurjchem-2084	316	17	epitopes	epitope	NOUN
eurjchem-2084	316	18	to	to	ADP
eurjchem-2084	316	19	the	the	DET
eurjchem-2084	316	20	host	host	NOUN
eurjchem-2084	316	21	and	and	CCONJ
eurjchem-2084	316	22	therefore	therefore	ADV
eurjchem-2084	316	23	,	,	PUNCT
eurjchem-2084	316	24	can	can	AUX
eurjchem-2084	316	25	potentially	potentially	ADV
eurjchem-2084	316	26	induce	induce	VERB
eurjchem-2084	316	27	a	a	DET
eurjchem-2084	316	28	robust	robust	ADJ
eurjchem-2084	316	29	immunologic	immunologic	ADJ
eurjchem-2084	316	30	response	response	NOUN
eurjchem-2084	316	31	against	against	ADP
eurjchem-2084	316	32	pathogen	pathogen	NOUN
eurjchem-2084	316	33	[	[	X
eurjchem-2084	316	34	97	97	NUM
eurjchem-2084	316	35	]	]	PUNCT
eurjchem-2084	316	36	.	.	PUNCT
eurjchem-2084	317	1	they	they	PRON
eurjchem-2084	317	2	are	be	AUX
eurjchem-2084	317	3	traditionally	traditionally	ADV
eurjchem-2084	317	4	developed	develop	VERB
eurjchem-2084	317	5	vaccines	vaccine	NOUN
eurjchem-2084	317	6	with	with	ADP
eurjchem-2084	317	7	advanced	advanced	ADJ
eurjchem-2084	317	8	technology	technology	NOUN
eurjchem-2084	317	9	and	and	CCONJ
eurjchem-2084	317	10	may	may	AUX
eurjchem-2084	317	11	become	become	VERB
eurjchem-2084	317	12	the	the	DET
eurjchem-2084	317	13	leading	lead	VERB
eurjchem-2084	317	14	candidates	candidate	NOUN
eurjchem-2084	317	15	to	to	PART
eurjchem-2084	317	16	put	put	VERB
eurjchem-2084	317	17	into	into	ADP
eurjchem-2084	317	18	a	a	DET
eurjchem-2084	317	19	clinical	clinical	ADJ
eurjchem-2084	317	20	trial	trial	NOUN
eurjchem-2084	317	21	against	against	ADP
eurjchem-2084	317	22	sars	sar	NOUN
eurjchem-2084	317	23	-	-	PUNCT
eurjchem-2084	317	24	cov-2	cov-2	PART
eurjchem-2084	317	25	infection	infection	NOUN
eurjchem-2084	317	26	.	.	PUNCT
eurjchem-2084	318	1	subunit	subunit	NOUN
eurjchem-2084	318	2	vaccines	vaccine	NOUN
eurjchem-2084	318	3	contain	contain	VERB
eurjchem-2084	318	4	one	one	NUM
eurjchem-2084	318	5	or	or	CCONJ
eurjchem-2084	318	6	more	more	ADJ
eurjchem-2084	318	7	antigens	antigen	NOUN
eurjchem-2084	318	8	with	with	ADP
eurjchem-2084	318	9	strong	strong	ADJ
eurjchem-2084	318	10	immunogenicity	immunogenicity	NOUN
eurjchem-2084	318	11	capable	capable	ADJ
eurjchem-2084	318	12	of	of	ADP
eurjchem-2084	318	13	efficiently	efficiently	ADV
eurjchem-2084	318	14	activating	activate	VERB
eurjchem-2084	318	15	the	the	DET
eurjchem-2084	318	16	host	host	NOUN
eurjchem-2084	318	17	immune	immune	ADJ
eurjchem-2084	318	18	system	system	NOUN
eurjchem-2084	318	19	.	.	PUNCT
eurjchem-2084	319	1	usually	usually	ADV
eurjchem-2084	319	2	,	,	PUNCT
eurjchem-2084	319	3	these	these	PRON
eurjchem-2084	319	4	require	require	VERB
eurjchem-2084	319	5	the	the	DET
eurjchem-2084	319	6	addition	addition	NOUN
eurjchem-2084	319	7	of	of	ADP
eurjchem-2084	319	8	adjuvants	adjuvant	NOUN
eurjchem-2084	319	9	to	to	PART
eurjchem-2084	319	10	elicit	elicit	VERB
eurjchem-2084	319	11	a	a	DET
eurjchem-2084	319	12	prompt	prompt	ADJ
eurjchem-2084	319	13	and	and	CCONJ
eurjchem-2084	319	14	strong	strong	ADJ
eurjchem-2084	319	15	immune	immune	ADJ
eurjchem-2084	319	16	response	response	NOUN
eurjchem-2084	319	17	.	.	PUNCT
eurjchem-2084	320	1	the	the	DET
eurjchem-2084	320	2	earlier	early	ADJ
eurjchem-2084	320	3	research	research	NOUN
eurjchem-2084	320	4	on	on	ADP
eurjchem-2084	320	5	coronavirus	coronavirus	NOUN
eurjchem-2084	320	6	indicated	indicate	VERB
eurjchem-2084	320	7	that	that	SCONJ
eurjchem-2084	320	8	n	n	CCONJ
eurjchem-2084	320	9	,	,	PUNCT
eurjchem-2084	320	10	e	e	NOUN
eurjchem-2084	320	11	,	,	PUNCT
eurjchem-2084	320	12	and	and	CCONJ
eurjchem-2084	320	13	m	m	PROPN
eurjchem-2084	320	14	proteins	protein	NOUN
eurjchem-2084	320	15	are	be	AUX
eurjchem-2084	320	16	not	not	PART
eurjchem-2084	320	17	suitable	suitable	ADJ
eurjchem-2084	320	18	antigens	antigen	NOUN
eurjchem-2084	320	19	for	for	ADP
eurjchem-2084	320	20	vaccine	vaccine	NOUN
eurjchem-2084	320	21	development	development	NOUN
eurjchem-2084	320	22	because	because	SCONJ
eurjchem-2084	320	23	of	of	ADP
eurjchem-2084	320	24	the	the	DET
eurjchem-2084	320	25	highly	highly	ADV
eurjchem-2084	320	26	conserved	conserved	ADJ
eurjchem-2084	320	27	region	region	NOUN
eurjchem-2084	320	28	in	in	ADP
eurjchem-2084	320	29	the	the	DET
eurjchem-2084	320	30	coronavirus	coronavirus	NOUN
eurjchem-2084	320	31	and	and	CCONJ
eurjchem-2084	320	32	the	the	DET
eurjchem-2084	320	33	weak	weak	ADJ
eurjchem-2084	320	34	immune	immune	ADJ
eurjchem-2084	320	35	response	response	NOUN
eurjchem-2084	320	36	produced	produce	VERB
eurjchem-2084	320	37	by	by	ADP
eurjchem-2084	320	38	n	n	CCONJ
eurjchem-2084	320	39	,	,	PUNCT
eurjchem-2084	320	40	e	e	NOUN
eurjchem-2084	320	41	and	and	CCONJ
eurjchem-2084	320	42	m.	m.	NOUN
eurjchem-2084	320	43	furthermore	furthermore	ADV
eurjchem-2084	320	44	,	,	PUNCT
eurjchem-2084	320	45	it	it	PRON
eurjchem-2084	320	46	was	be	AUX
eurjchem-2084	320	47	established	establish	VERB
eurjchem-2084	320	48	that	that	SCONJ
eurjchem-2084	320	49	out	out	ADP
eurjchem-2084	320	50	of	of	ADP
eurjchem-2084	320	51	the	the	DET
eurjchem-2084	320	52	two	two	NUM
eurjchem-2084	320	53	subunits	subunit	NOUN
eurjchem-2084	320	54	of	of	ADP
eurjchem-2084	320	55	s	s	PRON
eurjchem-2084	320	56	protein	protein	NOUN
eurjchem-2084	320	57	,	,	PUNCT
eurjchem-2084	320	58	s2	s2	PROPN
eurjchem-2084	320	59	is	be	AUX
eurjchem-2084	320	60	99	99	NUM
eurjchem-2084	320	61	%	%	NOUN
eurjchem-2084	320	62	conserved	conserved	ADJ
eurjchem-2084	320	63	and	and	CCONJ
eurjchem-2084	320	64	the	the	DET
eurjchem-2084	320	65	variation	variation	NOUN
eurjchem-2084	320	66	resides	reside	VERB
eurjchem-2084	320	67	in	in	ADP
eurjchem-2084	320	68	the	the	DET
eurjchem-2084	320	69	rbd	rbd	NOUN
eurjchem-2084	320	70	region	region	NOUN
eurjchem-2084	320	71	of	of	ADP
eurjchem-2084	320	72	s1	s1	PROPN
eurjchem-2084	320	73	subunit	subunit	NOUN
eurjchem-2084	320	74	which	which	PRON
eurjchem-2084	320	75	is	be	AUX
eurjchem-2084	320	76	used	use	VERB
eurjchem-2084	320	77	in	in	ADP
eurjchem-2084	320	78	ace-2	ace-2	PUNCT
eurjchem-2084	320	79	interaction	interaction	NOUN
eurjchem-2084	320	80	and	and	CCONJ
eurjchem-2084	320	81	virus	virus	NOUN
eurjchem-2084	320	82	entry	entry	NOUN
eurjchem-2084	320	83	into	into	ADP
eurjchem-2084	320	84	host	host	NOUN
eurjchem-2084	320	85	cell	cell	NOUN
eurjchem-2084	321	1	[	[	X
eurjchem-2084	321	2	17	17	NUM
eurjchem-2084	321	3	]	]	PUNCT
eurjchem-2084	321	4	.	.	PUNCT
eurjchem-2084	322	1	therefore	therefore	ADV
eurjchem-2084	322	2	,	,	PUNCT
eurjchem-2084	322	3	inhibiting	inhibit	VERB
eurjchem-2084	322	4	virus	virus	NOUN
eurjchem-2084	322	5	entry	entry	NOUN
eurjchem-2084	322	6	is	be	AUX
eurjchem-2084	322	7	a	a	DET
eurjchem-2084	322	8	prime	prime	ADJ
eurjchem-2084	322	9	strategy	strategy	NOUN
eurjchem-2084	322	10	to	to	PART
eurjchem-2084	322	11	prevent	prevent	VERB
eurjchem-2084	322	12	viral	viral	ADJ
eurjchem-2084	322	13	infection	infection	NOUN
eurjchem-2084	322	14	.	.	PUNCT
eurjchem-2084	323	1	so	so	ADV
eurjchem-2084	323	2	far	far	ADV
eurjchem-2084	323	3	,	,	PUNCT
eurjchem-2084	323	4	a	a	DET
eurjchem-2084	323	5	number	number	NOUN
eurjchem-2084	323	6	of	of	ADP
eurjchem-2084	323	7	sars	sar	NOUN
eurjchem-2084	323	8	-	-	PUNCT
eurjchem-2084	323	9	cov-2	cov-2	NOUN
eurjchem-2084	323	10	subunit	subunit	NOUN
eurjchem-2084	323	11	vaccines	vaccine	NOUN
eurjchem-2084	323	12	are	be	AUX
eurjchem-2084	323	13	under	under	ADP
eurjchem-2084	323	14	the	the	DET
eurjchem-2084	323	15	process	process	NOUN
eurjchem-2084	323	16	of	of	ADP
eurjchem-2084	323	17	development	development	NOUN
eurjchem-2084	323	18	and	and	CCONJ
eurjchem-2084	323	19	the	the	DET
eurjchem-2084	323	20	majority	majority	NOUN
eurjchem-2084	323	21	of	of	ADP
eurjchem-2084	323	22	them	they	PRON
eurjchem-2084	323	23	uses	use	VERB
eurjchem-2084	323	24	the	the	DET
eurjchem-2084	323	25	s	s	NOUN
eurjchem-2084	323	26	protein	protein	NOUN
eurjchem-2084	323	27	as	as	ADP
eurjchem-2084	323	28	antigen	antigen	ADV
eurjchem-2084	323	29	.	.	PUNCT
eurjchem-2084	324	1	with	with	ADP
eurjchem-2084	324	2	the	the	DET
eurjchem-2084	324	3	advancements	advancement	NOUN
eurjchem-2084	324	4	in	in	ADP
eurjchem-2084	324	5	mrna	mrna	PROPN
eurjchem-2084	324	6	synthesis	synthesis	NOUN
eurjchem-2084	324	7	,	,	PUNCT
eurjchem-2084	324	8	modification	modification	NOUN
eurjchem-2084	324	9	,	,	PUNCT
eurjchem-2084	324	10	and	and	CCONJ
eurjchem-2084	324	11	delivery	delivery	NOUN
eurjchem-2084	324	12	technology	technology	NOUN
eurjchem-2084	324	13	,	,	PUNCT
eurjchem-2084	324	14	the	the	DET
eurjchem-2084	324	15	development	development	NOUN
eurjchem-2084	324	16	of	of	ADP
eurjchem-2084	324	17	mrna	mrna	PROPN
eurjchem-2084	324	18	vaccines	vaccine	NOUN
eurjchem-2084	324	19	has	have	AUX
eurjchem-2084	324	20	regained	regain	VERB
eurjchem-2084	324	21	attention	attention	NOUN
eurjchem-2084	324	22	in	in	ADP
eurjchem-2084	324	23	the	the	DET
eurjchem-2084	324	24	recent	recent	ADJ
eurjchem-2084	324	25	past	past	NOUN
eurjchem-2084	324	26	.	.	PUNCT
eurjchem-2084	325	1	furthermore	furthermore	ADV
eurjchem-2084	325	2	,	,	PUNCT
eurjchem-2084	325	3	mrna	mrna	PROPN
eurjchem-2084	325	4	vaccines	vaccine	NOUN
eurjchem-2084	325	5	could	could	AUX
eurjchem-2084	325	6	be	be	AUX
eurjchem-2084	325	7	a	a	DET
eurjchem-2084	325	8	better	well	ADJ
eurjchem-2084	325	9	alternative	alternative	NOUN
eurjchem-2084	325	10	to	to	ADP
eurjchem-2084	325	11	traditional	traditional	ADJ
eurjchem-2084	325	12	vaccines	vaccine	NOUN
eurjchem-2084	325	13	;	;	PUNCT
eurjchem-2084	325	14	they	they	PRON
eurjchem-2084	325	15	are	be	AUX
eurjchem-2084	325	16	highly	highly	ADV
eurjchem-2084	325	17	potent	potent	ADJ
eurjchem-2084	325	18	,	,	PUNCT
eurjchem-2084	325	19	can	can	AUX
eurjchem-2084	325	20	be	be	AUX
eurjchem-2084	325	21	easily	easily	ADV
eurjchem-2084	325	22	produced	produce	VERB
eurjchem-2084	325	23	,	,	PUNCT
eurjchem-2084	325	24	cost	cost	NOUN
eurjchem-2084	325	25	-	-	PUNCT
eurjchem-2084	325	26	effective	effective	ADJ
eurjchem-2084	325	27	,	,	PUNCT
eurjchem-2084	325	28	and	and	CCONJ
eurjchem-2084	325	29	safe	safe	ADJ
eurjchem-2084	325	30	[	[	X
eurjchem-2084	325	31	98	98	NUM
eurjchem-2084	325	32	]	]	PUNCT
eurjchem-2084	325	33	.	.	PUNCT
eurjchem-2084	326	1	the	the	DET
eurjchem-2084	326	2	mrna	mrna	PROPN
eurjchem-2084	326	3	vaccine	vaccine	NOUN
eurjchem-2084	326	4	production	production	NOUN
eurjchem-2084	326	5	includes	include	VERB
eurjchem-2084	326	6	antigen	antigen	ADJ
eurjchem-2084	326	7	selection	selection	NOUN
eurjchem-2084	326	8	,	,	PUNCT
eurjchem-2084	326	9	sequence	sequence	NOUN
eurjchem-2084	326	10	optimization	optimization	NOUN
eurjchem-2084	326	11	,	,	PUNCT
eurjchem-2084	326	12	altered	alter	VERB
eurjchem-2084	326	13	nucleotide	nucleotide	NOUN
eurjchem-2084	326	14	screening	screening	NOUN
eurjchem-2084	326	15	,	,	PUNCT
eurjchem-2084	326	16	delivery	delivery	NOUN
eurjchem-2084	326	17	system	system	NOUN
eurjchem-2084	326	18	optimization	optimization	NOUN
eurjchem-2084	326	19	,	,	PUNCT
eurjchem-2084	326	20	immune	immune	ADJ
eurjchem-2084	326	21	response	response	NOUN
eurjchem-2084	326	22	and	and	CCONJ
eurjchem-2084	326	23	safety	safety	NOUN
eurjchem-2084	326	24	evaluation	evaluation	NOUN
eurjchem-2084	326	25	[	[	X
eurjchem-2084	326	26	99	99	NUM
eurjchem-2084	326	27	]	]	PUNCT
eurjchem-2084	326	28	.	.	PUNCT
eurjchem-2084	327	1	one	one	NUM
eurjchem-2084	327	2	of	of	ADP
eurjchem-2084	327	3	the	the	DET
eurjchem-2084	327	4	plausible	plausible	ADJ
eurjchem-2084	327	5	short	short	ADJ
eurjchem-2084	327	6	coming	coming	NOUN
eurjchem-2084	327	7	of	of	ADP
eurjchem-2084	327	8	mrnabased	mrnabase	VERB
eurjchem-2084	327	9	vaccine	vaccine	NOUN
eurjchem-2084	327	10	could	could	AUX
eurjchem-2084	327	11	be	be	AUX
eurjchem-2084	327	12	the	the	DET
eurjchem-2084	327	13	storage	storage	NOUN
eurjchem-2084	327	14	and	and	CCONJ
eurjchem-2084	327	15	transportation	transportation	NOUN
eurjchem-2084	327	16	in	in	ADP
eurjchem-2084	327	17	developing	develop	VERB
eurjchem-2084	327	18	and	and	CCONJ
eurjchem-2084	327	19	under	under	ADV
eurjchem-2084	327	20	-	-	PUNCT
eurjchem-2084	327	21	developed	develop	VERB
eurjchem-2084	327	22	countries	country	NOUN
eurjchem-2084	327	23	due	due	ADJ
eurjchem-2084	327	24	the	the	DET
eurjchem-2084	327	25	stability	stability	NOUN
eurjchem-2084	327	26	of	of	ADP
eurjchem-2084	327	27	mrna	mrna	PROPN
eurjchem-2084	327	28	vaccine	vaccine	NOUN
eurjchem-2084	327	29	in	in	ADP
eurjchem-2084	327	30	deep	deep	ADJ
eurjchem-2084	327	31	freezer	freezer	NOUN
eurjchem-2084	327	32	at	at	ADP
eurjchem-2084	327	33	-70	-70	PROPN
eurjchem-2084	327	34	to	to	ADP
eurjchem-2084	327	35	80	80	NUM
eurjchem-2084	327	36	°	°	NOUN
eurjchem-2084	327	37	c	c	NOUN
eurjchem-2084	327	38	.	.	PUNCT
eurjchem-2084	328	1	on	on	ADP
eurjchem-2084	328	2	november	november	PROPN
eurjchem-2084	328	3	9	9	NUM
eurjchem-2084	328	4	,	,	PUNCT
eurjchem-2084	328	5	pfizer	pfizer	NOUN
eurjchem-2084	328	6	and	and	CCONJ
eurjchem-2084	328	7	biontech	biontech	NOUN
eurjchem-2084	328	8	announced	announce	VERB
eurjchem-2084	328	9	the	the	DET
eurjchem-2084	328	10	successful	successful	ADJ
eurjchem-2084	328	11	completion	completion	NOUN
eurjchem-2084	328	12	of	of	ADP
eurjchem-2084	328	13	a	a	DET
eurjchem-2084	328	14	phase	phase	NOUN
eurjchem-2084	328	15	3	3	NUM
eurjchem-2084	328	16	clinical	clinical	ADJ
eurjchem-2084	328	17	trial	trial	NOUN
eurjchem-2084	328	18	of	of	ADP
eurjchem-2084	328	19	their	their	PRON
eurjchem-2084	328	20	mrna	mrna	NOUN
eurjchem-2084	328	21	vaccine	vaccine	NOUN
eurjchem-2084	328	22	candidate	candidate	NOUN
eurjchem-2084	328	23	bnt162b2	bnt162b2	PROPN
eurjchem-2084	328	24	,	,	PUNCT
eurjchem-2084	328	25	and	and	CCONJ
eurjchem-2084	328	26	reported	report	VERB
eurjchem-2084	328	27	that	that	SCONJ
eurjchem-2084	328	28	the	the	DET
eurjchem-2084	328	29	vaccine	vaccine	NOUN
eurjchem-2084	328	30	was	be	AUX
eurjchem-2084	328	31	found	find	VERB
eurjchem-2084	328	32	more	more	ADJ
eurjchem-2084	328	33	than	than	ADP
eurjchem-2084	328	34	90	90	NUM
eurjchem-2084	328	35	percent	percent	NOUN
eurjchem-2084	328	36	effective	effective	ADJ
eurjchem-2084	328	37	after	after	ADP
eurjchem-2084	328	38	first	first	ADJ
eurjchem-2084	328	39	dose	dose	NOUN
eurjchem-2084	328	40	and	and	CCONJ
eurjchem-2084	328	41	three	three	NUM
eurjchem-2084	328	42	weeks	week	NOUN
eurjchem-2084	328	43	later	later	ADV
eurjchem-2084	328	44	after	after	ADP
eurjchem-2084	328	45	the	the	DET
eurjchem-2084	328	46	second	second	ADJ
eurjchem-2084	328	47	dose	dose	NOUN
eurjchem-2084	328	48	and	and	CCONJ
eurjchem-2084	328	49	95	95	NUM
eurjchem-2084	328	50	%	%	NOUN
eurjchem-2084	328	51	effective	effective	ADJ
eurjchem-2084	328	52	irrespective	irrespective	ADV
eurjchem-2084	328	53	of	of	ADP
eurjchem-2084	328	54	age	age	NOUN
eurjchem-2084	328	55	,	,	PUNCT
eurjchem-2084	328	56	gender	gender	NOUN
eurjchem-2084	328	57	,	,	PUNCT
eurjchem-2084	328	58	race	race	NOUN
eurjchem-2084	328	59	and	and	CCONJ
eurjchem-2084	328	60	demographics	demographic	NOUN
eurjchem-2084	329	1	[	[	X
eurjchem-2084	329	2	100	100	NUM
eurjchem-2084	329	3	]	]	PUNCT
eurjchem-2084	329	4	.	.	PUNCT
eurjchem-2084	330	1	just	just	ADV
eurjchem-2084	330	2	a	a	DET
eurjchem-2084	330	3	week	week	NOUN
eurjchem-2084	330	4	later	later	ADV
eurjchem-2084	330	5	,	,	PUNCT
eurjchem-2084	330	6	moderna	moderna	PROPN
eurjchem-2084	330	7	has	have	AUX
eurjchem-2084	330	8	announced	announce	VERB
eurjchem-2084	330	9	94.5	94.5	NUM
eurjchem-2084	330	10	%	%	NOUN
eurjchem-2084	330	11	efficacy	efficacy	NOUN
eurjchem-2084	330	12	of	of	ADP
eurjchem-2084	330	13	its	its	PRON
eurjchem-2084	330	14	vaccine	vaccine	NOUN
eurjchem-2084	330	15	candidate	candidate	NOUN
eurjchem-2084	330	16	mrna-1273	mrna-1273	ADV
eurjchem-2084	330	17	against	against	ADP
eurjchem-2084	330	18	covid-19	covid-19	PROPN
eurjchem-2084	330	19	infection	infection	NOUN
eurjchem-2084	330	20	[	[	X
eurjchem-2084	330	21	101	101	NUM
eurjchem-2084	330	22	]	]	PUNCT
eurjchem-2084	330	23	.	.	PUNCT
eurjchem-2084	331	1	on	on	ADP
eurjchem-2084	331	2	december	december	PROPN
eurjchem-2084	331	3	9	9	NUM
eurjchem-2084	331	4	,	,	PUNCT
eurjchem-2084	331	5	2020	2020	NUM
eurjchem-2084	331	6	pfizer	pfizer	NOUN
eurjchem-2084	331	7	/	/	SYM
eurjchem-2084	331	8	biontech	biontech	NOUN
eurjchem-2084	331	9	vaccine	vaccine	NOUN
eurjchem-2084	331	10	got	get	VERB
eurjchem-2084	331	11	approval	approval	NOUN
eurjchem-2084	331	12	from	from	ADP
eurjchem-2084	331	13	fda	fda	PROPN
eurjchem-2084	332	1	[	[	X
eurjchem-2084	332	2	102	102	NUM
eurjchem-2084	332	3	]	]	PUNCT
eurjchem-2084	332	4	.	.	PUNCT
eurjchem-2084	333	1	later	later	ADV
eurjchem-2084	333	2	on	on	ADP
eurjchem-2084	333	3	december	december	PROPN
eurjchem-2084	333	4	30	30	NUM
eurjchem-2084	333	5	,	,	PUNCT
eurjchem-2084	333	6	the	the	DET
eurjchem-2084	333	7	oxford	oxford	PROPN
eurjchem-2084	333	8	-	-	PUNCT
eurjchem-2084	333	9	astrazeneca	astrazeneca	NOUN
eurjchem-2084	333	10	vaccine	vaccine	NOUN
eurjchem-2084	333	11	has	have	AUX
eurjchem-2084	333	12	been	be	AUX
eurjchem-2084	333	13	approved	approve	VERB
eurjchem-2084	333	14	for	for	ADP
eurjchem-2084	333	15	emergency	emergency	NOUN
eurjchem-2084	333	16	use	use	NOUN
eurjchem-2084	333	17	in	in	ADP
eurjchem-2084	333	18	the	the	DET
eurjchem-2084	333	19	uk	uk	PROPN
eurjchem-2084	333	20	[	[	X
eurjchem-2084	333	21	103	103	NUM
eurjchem-2084	333	22	]	]	PUNCT
eurjchem-2084	333	23	dna	dna	PROPN
eurjchem-2084	333	24	vaccines	vaccine	NOUN
eurjchem-2084	333	25	are	be	AUX
eurjchem-2084	333	26	usually	usually	ADV
eurjchem-2084	333	27	comprised	comprise	VERB
eurjchem-2084	333	28	of	of	ADP
eurjchem-2084	333	29	plasmid	plasmid	ADJ
eurjchem-2084	333	30	dna	dna	NOUN
eurjchem-2084	333	31	molecules	molecule	NOUN
eurjchem-2084	333	32	encoding	encode	VERB
eurjchem-2084	333	33	one	one	NUM
eurjchem-2084	333	34	or	or	CCONJ
eurjchem-2084	333	35	more	more	ADJ
eurjchem-2084	333	36	antigens	antigen	NOUN
eurjchem-2084	333	37	.	.	PUNCT
eurjchem-2084	334	1	they	they	PRON
eurjchem-2084	334	2	are	be	AUX
eurjchem-2084	334	3	considered	consider	VERB
eurjchem-2084	334	4	better	well	ADJ
eurjchem-2084	334	5	than	than	ADP
eurjchem-2084	334	6	mrna	mrna	PROPN
eurjchem-2084	334	7	vaccines	vaccine	NOUN
eurjchem-2084	334	8	in	in	ADP
eurjchem-2084	334	9	terms	term	NOUN
eurjchem-2084	334	10	of	of	ADP
eurjchem-2084	334	11	stability	stability	NOUN
eurjchem-2084	334	12	and	and	CCONJ
eurjchem-2084	334	13	delivery	delivery	NOUN
eurjchem-2084	334	14	efficiency	efficiency	NOUN
eurjchem-2084	334	15	.	.	PUNCT
eurjchem-2084	335	1	however	however	ADV
eurjchem-2084	335	2	,	,	PUNCT
eurjchem-2084	335	3	dna	dna	PROPN
eurjchem-2084	335	4	vaccines	vaccine	NOUN
eurjchem-2084	335	5	have	have	VERB
eurjchem-2084	335	6	an	an	DET
eurjchem-2084	335	7	associated	associated	ADJ
eurjchem-2084	335	8	risk	risk	NOUN
eurjchem-2084	335	9	of	of	ADP
eurjchem-2084	335	10	vector	vector	NOUN
eurjchem-2084	335	11	integration	integration	NOUN
eurjchem-2084	335	12	and	and	CCONJ
eurjchem-2084	335	13	mutations	mutation	NOUN
eurjchem-2084	335	14	in	in	ADP
eurjchem-2084	335	15	the	the	DET
eurjchem-2084	335	16	host	host	NOUN
eurjchem-2084	335	17	genome	genome	NOUN
eurjchem-2084	336	1	[	[	X
eurjchem-2084	336	2	104	104	NUM
eurjchem-2084	336	3	]	]	PUNCT
eurjchem-2084	336	4	.	.	PUNCT
eurjchem-2084	337	1	230	230	NUM
eurjchem-2084	337	2	firdaus	firdaus	PROPN
eurjchem-2084	337	3	et	et	PROPN
eurjchem-2084	337	4	al	al	PROPN
eurjchem-2084	337	5	.	.	PUNCT
eurjchem-2084	337	6	/	/	SYM
eurjchem-2084	337	7	european	european	PROPN
eurjchem-2084	337	8	journal	journal	PROPN
eurjchem-2084	337	9	of	of	ADP
eurjchem-2084	337	10	chemistry	chemistry	NOUN
eurjchem-2084	337	11	12	12	NUM
eurjchem-2084	337	12	(	(	PUNCT
eurjchem-2084	337	13	2	2	NUM
eurjchem-2084	337	14	)	)	PUNCT
eurjchem-2084	337	15	(	(	PUNCT
eurjchem-2084	337	16	2021	2021	NUM
eurjchem-2084	337	17	)	)	PUNCT
eurjchem-2084	337	18	222	222	NUM
eurjchem-2084	337	19	-	-	SYM
eurjchem-2084	337	20	234	234	NUM
eurjchem-2084	337	21	2021	2021	NUM
eurjchem-2084	337	22	–	–	PUNCT
eurjchem-2084	337	23	european	european	ADJ
eurjchem-2084	337	24	journal	journal	NOUN
eurjchem-2084	337	25	of	of	ADP
eurjchem-2084	337	26	chemistry	chemistry	NOUN
eurjchem-2084	337	27	–	–	PUNCT
eurjchem-2084	337	28	cc	cc	NOUN
eurjchem-2084	337	29	by	by	ADP
eurjchem-2084	337	30	nc	nc	PROPN
eurjchem-2084	337	31	–	–	PUNCT
eurjchem-2084	337	32	doi	doi	NOUN
eurjchem-2084	337	33	:	:	PUNCT
eurjchem-2084	337	34	10.5155	10.5155	NUM
eurjchem-2084	337	35	/	/	SYM
eurjchem-2084	337	36	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	337	37	-	-	PUNCT
eurjchem-2084	337	38	234.2084	234.2084	NUM
eurjchem-2084	337	39	table	table	NOUN
eurjchem-2084	337	40	3	3	NUM
eurjchem-2084	337	41	.	.	X
eurjchem-2084	337	42	list	list	NOUN
eurjchem-2084	337	43	of	of	ADP
eurjchem-2084	337	44	candidate	candidate	NOUN
eurjchem-2084	337	45	vaccine	vaccine	NOUN
eurjchem-2084	337	46	(	(	PUNCT
eurjchem-2084	337	47	under	under	ADP
eurjchem-2084	337	48	progress	progress	NOUN
eurjchem-2084	337	49	)	)	PUNCT
eurjchem-2084	337	50	with	with	ADP
eurjchem-2084	337	51	the	the	DET
eurjchem-2084	337	52	description	description	NOUN
eurjchem-2084	337	53	of	of	ADP
eurjchem-2084	337	54	type	type	NOUN
eurjchem-2084	337	55	,	,	PUNCT
eurjchem-2084	337	56	developer	developer	NOUN
eurjchem-2084	337	57	and	and	CCONJ
eurjchem-2084	337	58	phases	phase	NOUN
eurjchem-2084	337	59	of	of	ADP
eurjchem-2084	337	60	clinical	clinical	ADJ
eurjchem-2084	337	61	trials	trial	NOUN
eurjchem-2084	337	62	.	.	PUNCT
eurjchem-2084	338	1	details	detail	NOUN
eurjchem-2084	338	2	of	of	ADP
eurjchem-2084	338	3	the	the	DET
eurjchem-2084	338	4	vaccine	vaccine	NOUN
eurjchem-2084	338	5	clinical	clinical	ADJ
eurjchem-2084	338	6	trial	trial	NOUN
eurjchem-2084	338	7	status	status	NOUN
eurjchem-2084	338	8	no	no	DET
eurjchem-2084	338	9	candidate	candidate	NOUN
eurjchem-2084	338	10	name	name	NOUN
eurjchem-2084	338	11	type	type	NOUN
eurjchem-2084	338	12	of	of	ADP
eurjchem-2084	338	13	vaccine	vaccine	NOUN
eurjchem-2084	338	14	developer	developer	NOUN
eurjchem-2084	338	15	phase	phase	NOUN
eurjchem-2084	338	16	doses	dose	NOUN
eurjchem-2084	338	17	(	(	PUNCT
eurjchem-2084	338	18	days	day	NOUN
eurjchem-2084	338	19	)	)	PUNCT
eurjchem-2084	338	20	sample	sample	NOUN
eurjchem-2084	338	21	size	size	NOUN
eurjchem-2084	338	22	&	&	CCONJ
eurjchem-2084	338	23	age	age	NOUN
eurjchem-2084	338	24	description	description	NOUN
eurjchem-2084	338	25	1	1	NUM
eurjchem-2084	338	26	bbv152	bbv152	PROPN
eurjchem-2084	338	27	whole	whole	ADJ
eurjchem-2084	338	28	-	-	PUNCT
eurjchem-2084	338	29	virion	virion	NOUN
eurjchem-2084	338	30	inactivated	inactivated	ADJ
eurjchem-2084	338	31	bharat	bharat	NOUN
eurjchem-2084	338	32	biotech	biotech	ADJ
eurjchem-2084	338	33	phase	phase	NOUN
eurjchem-2084	338	34	2	2	NUM
eurjchem-2084	338	35	completed	complete	VERB
eurjchem-2084	338	36	2	2	NUM
eurjchem-2084	338	37	(	(	PUNCT
eurjchem-2084	338	38	0	0	NUM
eurjchem-2084	338	39	,	,	PUNCT
eurjchem-2084	338	40	28	28	NUM
eurjchem-2084	338	41	)	)	PUNCT
eurjchem-2084	338	42	755	755	NUM
eurjchem-2084	338	43	p	p	NOUN
eurjchem-2084	338	44	,	,	PUNCT
eurjchem-2084	338	45	≥	≥	NUM
eurjchem-2084	338	46	18	18	NUM
eurjchem-2084	338	47	years	year	NOUN
eurjchem-2084	338	48	adaptive	adaptive	ADJ
eurjchem-2084	338	49	randomized	randomize	VERB
eurjchem-2084	338	50	,	,	PUNCT
eurjchem-2084	338	51	double	double	ADJ
eurjchem-2084	338	52	-	-	PUNCT
eurjchem-2084	338	53	blind	blind	ADJ
eurjchem-2084	338	54	,	,	PUNCT
eurjchem-2084	338	55	multicenter	multicenter	NOUN
eurjchem-2084	338	56	[	[	X
eurjchem-2084	338	57	116	116	NUM
eurjchem-2084	338	58	]	]	SYM
eurjchem-2084	338	59	2	2	NUM
eurjchem-2084	338	60	coronavac	coronavac	NOUN
eurjchem-2084	338	61	whole	whole	ADJ
eurjchem-2084	338	62	-	-	PUNCT
eurjchem-2084	338	63	virion	virion	NOUN
eurjchem-2084	338	64	inactivated	inactivate	VERB
eurjchem-2084	338	65	sinovac	sinovac	NOUN
eurjchem-2084	338	66	phase	phase	NOUN
eurjchem-2084	338	67	3	3	NUM
eurjchem-2084	338	68	2	2	NUM
eurjchem-2084	338	69	(	(	PUNCT
eurjchem-2084	338	70	0	0	NUM
eurjchem-2084	338	71	,	,	PUNCT
eurjchem-2084	338	72	14	14	NUM
eurjchem-2084	338	73	)	)	PUNCT
eurjchem-2084	338	74	13060	13060	NUM
eurjchem-2084	338	75	p	p	NOUN
eurjchem-2084	338	76	,	,	PUNCT
eurjchem-2084	338	77	18	18	NUM
eurjchem-2084	338	78	-	-	SYM
eurjchem-2084	338	79	59	59	NUM
eurjchem-2084	338	80	≥	≥	NOUN
eurjchem-2084	338	81	60	60	NUM
eurjchem-2084	338	82	years	year	NOUN
eurjchem-2084	338	83	randomized	randomize	VERB
eurjchem-2084	338	84	,	,	PUNCT
eurjchem-2084	338	85	double	double	ADJ
eurjchem-2084	338	86	-	-	PUNCT
eurjchem-2084	338	87	blind	blind	ADJ
eurjchem-2084	338	88	,	,	PUNCT
eurjchem-2084	338	89	placebo	placebo	NOUN
eurjchem-2084	338	90	controlled	control	VERB
eurjchem-2084	339	1	[	[	X
eurjchem-2084	339	2	117	117	NUM
eurjchem-2084	339	3	]	]	SYM
eurjchem-2084	339	4	3	3	NUM
eurjchem-2084	339	5	inactivated	inactivated	ADJ
eurjchem-2084	339	6	sarscov-2	sarscov-2	NUM
eurjchem-2084	339	7	vaccine	vaccine	NOUN
eurjchem-2084	339	8	(	(	PUNCT
eurjchem-2084	339	9	vero	vero	PROPN
eurjchem-2084	339	10	cell	cell	NOUN
eurjchem-2084	339	11	)	)	PUNCT
eurjchem-2084	339	12	whole	whole	ADJ
eurjchem-2084	339	13	-	-	PUNCT
eurjchem-2084	339	14	virion	virion	NOUN
eurjchem-2084	339	15	inactivated	inactivate	VERB
eurjchem-2084	339	16	beijing	beijing	PROPN
eurjchem-2084	339	17	institute	institute	PROPN
eurjchem-2084	339	18	of	of	ADP
eurjchem-2084	339	19	biological	biological	ADJ
eurjchem-2084	339	20	products	product	NOUN
eurjchem-2084	339	21	/	/	SYM
eurjchem-2084	339	22	sinophar	sinophar	ADJ
eurjchem-2084	339	23	m	m	NOUN
eurjchem-2084	339	24	phase	phase	NOUN
eurjchem-2084	339	25	3	3	NUM
eurjchem-2084	339	26	2	2	NUM
eurjchem-2084	339	27	(	(	PUNCT
eurjchem-2084	339	28	0	0	NUM
eurjchem-2084	339	29	,	,	PUNCT
eurjchem-2084	339	30	21	21	NUM
eurjchem-2084	339	31	)	)	PUNCT
eurjchem-2084	339	32	45000	45000	NUM
eurjchem-2084	339	33	p	p	NOUN
eurjchem-2084	339	34	,	,	PUNCT
eurjchem-2084	339	35	≥	≥	NUM
eurjchem-2084	339	36	18	18	NUM
eurjchem-2084	339	37	years	year	NOUN
eurjchem-2084	339	38	multicenter	multicenter	NOUN
eurjchem-2084	339	39	,	,	PUNCT
eurjchem-2084	339	40	randomized	randomize	VERB
eurjchem-2084	339	41	,	,	PUNCT
eurjchem-2084	339	42	double	double	ADV
eurjchem-2084	339	43	blind	blind	ADJ
eurjchem-2084	339	44	,	,	PUNCT
eurjchem-2084	339	45	parallel	parallel	ADJ
eurjchem-2084	339	46	placebo	placebo	NOUN
eurjchem-2084	339	47	controlled	control	VERB
eurjchem-2084	339	48	[	[	X
eurjchem-2084	339	49	118	118	NUM
eurjchem-2084	339	50	]	]	SYM
eurjchem-2084	339	51	4	4	NUM
eurjchem-2084	339	52	azd1222	azd1222	NOUN
eurjchem-2084	339	53	non	non	ADJ
eurjchem-2084	339	54	-	-	ADJ
eurjchem-2084	339	55	replicating	replicate	VERB
eurjchem-2084	339	56	viral	viral	ADJ
eurjchem-2084	339	57	vector	vector	NOUN
eurjchem-2084	339	58	(	(	PUNCT
eurjchem-2084	339	59	chadox1	chadox1	ADJ
eurjchem-2084	339	60	-	-	PUNCT
eurjchem-2084	339	61	s	s	NOUN
eurjchem-2084	339	62	)	)	PUNCT
eurjchem-2084	339	63	university	university	NOUN
eurjchem-2084	339	64	of	of	ADP
eurjchem-2084	339	65	oxford	oxford	PROPN
eurjchem-2084	339	66	/	/	SYM
eurjchem-2084	339	67	astrazeneca	astrazeneca	PROPN
eurjchem-2084	339	68	phase	phase	NOUN
eurjchem-2084	339	69	3	3	NUM
eurjchem-2084	339	70	completed	complete	VERB
eurjchem-2084	339	71	2	2	NUM
eurjchem-2084	339	72	(	(	PUNCT
eurjchem-2084	339	73	0	0	NUM
eurjchem-2084	339	74	,	,	PUNCT
eurjchem-2084	339	75	28	28	NUM
eurjchem-2084	339	76	)	)	PUNCT
eurjchem-2084	339	77	40,000	40,000	NUM
eurjchem-2084	339	78	p	p	NOUN
eurjchem-2084	339	79	,	,	PUNCT
eurjchem-2084	339	80	≥	≥	NUM
eurjchem-2084	339	81	18	18	NUM
eurjchem-2084	339	82	years	year	NOUN
eurjchem-2084	339	83	randomized	randomize	VERB
eurjchem-2084	339	84	,	,	PUNCT
eurjchem-2084	339	85	double	double	ADJ
eurjchem-2084	339	86	-	-	PUNCT
eurjchem-2084	339	87	blind	blind	ADJ
eurjchem-2084	339	88	,	,	PUNCT
eurjchem-2084	339	89	placebo	placebo	NOUN
eurjchem-2084	339	90	controlled	control	VERB
eurjchem-2084	339	91	,	,	PUNCT
eurjchem-2084	339	92	multicenter	multicenter	NOUN
eurjchem-2084	339	93	[	[	X
eurjchem-2084	339	94	119	119	NUM
eurjchem-2084	339	95	]	]	SYM
eurjchem-2084	339	96	5	5	NUM
eurjchem-2084	339	97	ad5	ad5	VERB
eurjchem-2084	339	98	-	-	PUNCT
eurjchem-2084	339	99	ncov	ncov	ADV
eurjchem-2084	339	100	non	non	ADJ
eurjchem-2084	339	101	-	-	ADJ
eurjchem-2084	339	102	replicating	replicate	VERB
eurjchem-2084	339	103	viral	viral	ADJ
eurjchem-2084	339	104	vector	vector	NOUN
eurjchem-2084	339	105	(	(	PUNCT
eurjchem-2084	339	106	adenovirus	adenovirus	NOUN
eurjchem-2084	339	107	type	type	NOUN
eurjchem-2084	339	108	5	5	NUM
eurjchem-2084	339	109	)	)	PUNCT
eurjchem-2084	339	110	cansino	cansino	NOUN
eurjchem-2084	339	111	biological	biological	PROPN
eurjchem-2084	339	112	inc	inc	PROPN
eurjchem-2084	339	113	phase	phase	NOUN
eurjchem-2084	339	114	3	3	NUM
eurjchem-2084	339	115	1	1	NUM
eurjchem-2084	339	116	40,000p	40,000p	NOUN
eurjchem-2084	339	117	,	,	PUNCT
eurjchem-2084	339	118	≥	≥	NUM
eurjchem-2084	339	119	18	18	NUM
eurjchem-2084	339	120	years	year	NOUN
eurjchem-2084	339	121	randomized	randomize	VERB
eurjchem-2084	339	122	,	,	PUNCT
eurjchem-2084	339	123	double	double	ADJ
eurjchem-2084	339	124	-	-	PUNCT
eurjchem-2084	339	125	blind	blind	ADJ
eurjchem-2084	339	126	,	,	PUNCT
eurjchem-2084	339	127	placebo	placebo	NOUN
eurjchem-2084	339	128	-	-	PUNCT
eurjchem-2084	339	129	controlled	control	VERB
eurjchem-2084	339	130	[	[	X
eurjchem-2084	339	131	120	120	NUM
eurjchem-2084	339	132	]	]	SYM
eurjchem-2084	339	133	6	6	NUM
eurjchem-2084	339	134	ad26.cov2.s	ad26.cov2.s	X
eurjchem-2084	339	135	non	non	ADJ
eurjchem-2084	339	136	-	-	ADJ
eurjchem-2084	339	137	replicating	replicate	VERB
eurjchem-2084	339	138	viral	viral	ADJ
eurjchem-2084	339	139	vector	vector	NOUN
eurjchem-2084	339	140	janssen	janssen	PROPN
eurjchem-2084	339	141	pharmaceutical	pharmaceutical	NOUN
eurjchem-2084	339	142	companies	company	NOUN
eurjchem-2084	339	143	phase	phase	VERB
eurjchem-2084	339	144	3	3	NUM
eurjchem-2084	339	145	2	2	NUM
eurjchem-2084	339	146	(	(	PUNCT
eurjchem-2084	339	147	0	0	NUM
eurjchem-2084	339	148	,	,	PUNCT
eurjchem-2084	339	149	21	21	NUM
eurjchem-2084	339	150	)	)	PUNCT
eurjchem-2084	339	151	30,000	30,000	NUM
eurjchem-2084	339	152	p	p	NOUN
eurjchem-2084	339	153	,	,	PUNCT
eurjchem-2084	339	154	(	(	PUNCT
eurjchem-2084	339	155	18	18	NUM
eurjchem-2084	339	156	-	-	SYM
eurjchem-2084	339	157	55	55	NUM
eurjchem-2084	339	158	)	)	PUNCT
eurjchem-2084	339	159	years	year	NOUN
eurjchem-2084	339	160	randomized	randomize	VERB
eurjchem-2084	339	161	,	,	PUNCT
eurjchem-2084	339	162	double	double	ADJ
eurjchem-2084	339	163	-	-	PUNCT
eurjchem-2084	339	164	blind	blind	ADJ
eurjchem-2084	339	165	,	,	PUNCT
eurjchem-2084	339	166	placebo	placebo	NOUN
eurjchem-2084	339	167	-	-	PUNCT
eurjchem-2084	339	168	controlled	control	VERB
eurjchem-2084	339	169	[	[	X
eurjchem-2084	339	170	121	121	NUM
eurjchem-2084	339	171	]	]	SYM
eurjchem-2084	339	172	7	7	NUM
eurjchem-2084	339	173	tmv-083	tmv-083	NOUN
eurjchem-2084	339	174	replicating	replicate	VERB
eurjchem-2084	339	175	viral	viral	ADJ
eurjchem-2084	339	176	vector	vector	NOUN
eurjchem-2084	339	177	institute	institute	NOUN
eurjchem-2084	339	178	pasteur	pasteur	PROPN
eurjchem-2084	339	179	phase	phase	NOUN
eurjchem-2084	339	180	1	1	NUM
eurjchem-2084	339	181	2	2	NUM
eurjchem-2084	339	182	(	(	PUNCT
eurjchem-2084	339	183	0	0	NUM
eurjchem-2084	339	184	,	,	PUNCT
eurjchem-2084	339	185	28	28	NUM
eurjchem-2084	339	186	)	)	PUNCT
eurjchem-2084	339	187	90	90	NUM
eurjchem-2084	339	188	p	p	NOUN
eurjchem-2084	339	189	,	,	PUNCT
eurjchem-2084	339	190	≥	≥	NUM
eurjchem-2084	339	191	18	18	NUM
eurjchem-2084	339	192	years	year	NOUN
eurjchem-2084	339	193	randomized	randomize	VERB
eurjchem-2084	339	194	,	,	PUNCT
eurjchem-2084	339	195	two	two	NUM
eurjchem-2084	339	196	center	center	NOUN
eurjchem-2084	339	197	,	,	PUNCT
eurjchem-2084	339	198	placebo	placebo	NOUN
eurjchem-2084	339	199	-	-	PUNCT
eurjchem-2084	339	200	controlled	control	VERB
eurjchem-2084	339	201	trial	trial	NOUN
eurjchem-2084	339	202	[	[	X
eurjchem-2084	339	203	122	122	NUM
eurjchem-2084	339	204	]	]	SYM
eurjchem-2084	339	205	8	8	NUM
eurjchem-2084	339	206	gam	gam	NOUN
eurjchem-2084	339	207	-	-	PUNCT
eurjchem-2084	339	208	covid	covid	NOUN
eurjchem-2084	339	209	-	-	ADJ
eurjchem-2084	339	210	vaclyo	vaclyo	PROPN
eurjchem-2084	339	211	(	(	PUNCT
eurjchem-2084	339	212	sputnik	sputnik	X
eurjchem-2084	339	213	v	v	NOUN
eurjchem-2084	339	214	)	)	PUNCT
eurjchem-2084	339	215	non	non	ADJ
eurjchem-2084	339	216	-	-	ADJ
eurjchem-2084	339	217	replicating	replicate	VERB
eurjchem-2084	339	218	viral	viral	ADJ
eurjchem-2084	339	219	vector	vector	NOUN
eurjchem-2084	339	220	gamaleya	gamaleya	PROPN
eurjchem-2084	339	221	research	research	PROPN
eurjchem-2084	339	222	institute	institute	PROPN
eurjchem-2084	339	223	phase	phase	NOUN
eurjchem-2084	339	224	3	3	NUM
eurjchem-2084	339	225	2	2	NUM
eurjchem-2084	339	226	(	(	PUNCT
eurjchem-2084	339	227	0	0	NUM
eurjchem-2084	339	228	,	,	PUNCT
eurjchem-2084	339	229	21	21	NUM
eurjchem-2084	339	230	)	)	PUNCT
eurjchem-2084	339	231	40,000	40,000	NUM
eurjchem-2084	339	232	p	p	NOUN
eurjchem-2084	339	233	,	,	PUNCT
eurjchem-2084	339	234	≥	≥	NUM
eurjchem-2084	339	235	18	18	NUM
eurjchem-2084	339	236	years	year	NOUN
eurjchem-2084	339	237	open	open	ADJ
eurjchem-2084	339	238	-	-	PUNCT
eurjchem-2084	339	239	label	label	NOUN
eurjchem-2084	339	240	,	,	PUNCT
eurjchem-2084	339	241	nonrandomized	nonrandomize	VERB
eurjchem-2084	339	242	,	,	PUNCT
eurjchem-2084	339	243	parallel	parallel	ADJ
eurjchem-2084	339	244	assignment	assignment	NOUN
eurjchem-2084	339	245	,	,	PUNCT
eurjchem-2084	339	246	two	two	NUM
eurjchem-2084	339	247	-	-	PUNCT
eurjchem-2084	339	248	stage	stage	NOUN
eurjchem-2084	339	249	study	study	NOUN
eurjchem-2084	339	250	[	[	X
eurjchem-2084	339	251	123	123	NUM
eurjchem-2084	339	252	]	]	SYM
eurjchem-2084	339	253	9	9	NUM
eurjchem-2084	339	254	m	m	PROPN
eurjchem-2084	339	255	-	-	PUNCT
eurjchem-2084	339	256	rna	rna	ADJ
eurjchem-2084	339	257	1273	1273	NUM
eurjchem-2084	339	258	lnp	lnp	PROPN
eurjchem-2084	339	259	-	-	PUNCT
eurjchem-2084	339	260	encapsulated	encapsulate	VERB
eurjchem-2084	339	261	m	m	NOUN
eurjchem-2084	339	262	-	-	PUNCT
eurjchem-2084	339	263	rna	rna	ADJ
eurjchem-2084	339	264	moderna	moderna	PROPN
eurjchem-2084	339	265	/	/	SYM
eurjchem-2084	339	266	niaid	niaid	PROPN
eurjchem-2084	339	267	phase	phase	NOUN
eurjchem-2084	339	268	3	3	NUM
eurjchem-2084	339	269	2	2	NUM
eurjchem-2084	339	270	(	(	PUNCT
eurjchem-2084	339	271	0	0	NUM
eurjchem-2084	339	272	,	,	PUNCT
eurjchem-2084	339	273	28	28	NUM
eurjchem-2084	339	274	)	)	PUNCT
eurjchem-2084	339	275	30000	30000	NUM
eurjchem-2084	339	276	p	p	NOUN
eurjchem-2084	339	277	,	,	PUNCT
eurjchem-2084	339	278	≥	≥	NUM
eurjchem-2084	339	279	18	18	NUM
eurjchem-2084	339	280	years	year	NOUN
eurjchem-2084	339	281	randomized	randomize	VERB
eurjchem-2084	339	282	,	,	PUNCT
eurjchem-2084	339	283	observer	observer	NOUN
eurjchem-2084	339	284	blind	blind	ADJ
eurjchem-2084	339	285	,	,	PUNCT
eurjchem-2084	339	286	placebo	placebo	NOUN
eurjchem-2084	339	287	-	-	PUNCT
eurjchem-2084	339	288	controlled	control	VERB
eurjchem-2084	339	289	[	[	X
eurjchem-2084	339	290	124	124	NUM
eurjchem-2084	339	291	]	]	SYM
eurjchem-2084	339	292	10	10	NUM
eurjchem-2084	339	293	bnt162b1	bnt162b1	NOUN
eurjchem-2084	339	294	bnt162b2	bnt162b2	NOUN
eurjchem-2084	339	295	lnp	lnp	PROPN
eurjchem-2084	339	296	m	m	PROPN
eurjchem-2084	339	297	-	-	PUNCT
eurjchem-2084	339	298	rnas	rnas	ADJ
eurjchem-2084	339	299	biontech/	biontech/	NUM
eurjchem-2084	339	300	pfizer	pfizer	NOUN
eurjchem-2084	339	301	phase	phase	NOUN
eurjchem-2084	339	302	3	3	NUM
eurjchem-2084	339	303	completed	complete	VERB
eurjchem-2084	339	304	2	2	NUM
eurjchem-2084	339	305	(	(	PUNCT
eurjchem-2084	339	306	0	0	NUM
eurjchem-2084	339	307	,	,	PUNCT
eurjchem-2084	339	308	28	28	NUM
eurjchem-2084	339	309	)	)	PUNCT
eurjchem-2084	339	310	43998	43998	NUM
eurjchem-2084	339	311	p	p	NOUN
eurjchem-2084	339	312	,	,	PUNCT
eurjchem-2084	339	313	18	18	NUM
eurjchem-2084	339	314	-	-	SYM
eurjchem-2084	339	315	85	85	NUM
eurjchem-2084	339	316	years	year	NOUN
eurjchem-2084	339	317	randomized	randomize	VERB
eurjchem-2084	339	318	,	,	PUNCT
eurjchem-2084	339	319	observer	observer	NOUN
eurjchem-2084	339	320	blind	blind	ADJ
eurjchem-2084	339	321	,	,	PUNCT
eurjchem-2084	339	322	placebo	placebo	NOUN
eurjchem-2084	339	323	-	-	PUNCT
eurjchem-2084	339	324	controlled	control	VERB
eurjchem-2084	339	325	study	study	NOUN
eurjchem-2084	339	326	[	[	X
eurjchem-2084	339	327	125	125	NUM
eurjchem-2084	339	328	]	]	SYM
eurjchem-2084	339	329	11	11	NUM
eurjchem-2084	339	330	cvncov	cvncov	ADP
eurjchem-2084	339	331	mrna	mrna	PROPN
eurjchem-2084	339	332	curevac	curevac	NOUN
eurjchem-2084	339	333	phase	phase	NOUN
eurjchem-2084	339	334	2a	2a	NUM
eurjchem-2084	339	335	2	2	NUM
eurjchem-2084	339	336	(	(	PUNCT
eurjchem-2084	339	337	0	0	NUM
eurjchem-2084	339	338	,	,	PUNCT
eurjchem-2084	339	339	28	28	NUM
eurjchem-2084	339	340	)	)	PUNCT
eurjchem-2084	340	1	691	691	NUM
eurjchem-2084	340	2	p	p	NOUN
eurjchem-2084	340	3	,	,	PUNCT
eurjchem-2084	340	4	18	18	NUM
eurjchem-2084	340	5	-	-	SYM
eurjchem-2084	340	6	60	60	NUM
eurjchem-2084	340	7	)	)	PUNCT
eurjchem-2084	340	8	years	year	NOUN
eurjchem-2084	340	9	randomized	randomize	VERB
eurjchem-2084	340	10	,	,	PUNCT
eurjchem-2084	340	11	observerblind	observerblind	NOUN
eurjchem-2084	340	12	,	,	PUNCT
eurjchem-2084	340	13	multicenter	multicenter	NOUN
eurjchem-2084	340	14	,	,	PUNCT
eurjchem-2084	340	15	controlled	control	VERB
eurjchem-2084	340	16	,	,	PUNCT
eurjchem-2084	340	17	[	[	X
eurjchem-2084	340	18	126	126	NUM
eurjchem-2084	340	19	]	]	SYM
eurjchem-2084	340	20	12	12	NUM
eurjchem-2084	340	21	arct-021	arct-021	PROPN
eurjchem-2084	340	22	mrna	mrna	PROPN
eurjchem-2084	340	23	arcturus	arcturus	PROPN
eurjchem-2084	340	24	/	/	SYM
eurjchem-2084	340	25	duke	duke	PROPN
eurjchem-2084	340	26	-	-	PUNCT
eurjchem-2084	340	27	nus	nus	NOUN
eurjchem-2084	340	28	phase	phase	NOUN
eurjchem-2084	340	29	1/2	1/2	NUM
eurjchem-2084	340	30	1	1	NUM
eurjchem-2084	340	31	92	92	NUM
eurjchem-2084	340	32	p	p	NOUN
eurjchem-2084	340	33	,	,	PUNCT
eurjchem-2084	340	34	2155	2155	NUM
eurjchem-2084	340	35	&	&	CCONJ
eurjchem-2084	340	36	56	56	NUM
eurjchem-2084	340	37	-	-	SYM
eurjchem-2084	340	38	80	80	NUM
eurjchem-2084	340	39	years	year	NOUN
eurjchem-2084	340	40	a	a	DET
eurjchem-2084	340	41	randomised	randomised	ADJ
eurjchem-2084	340	42	,	,	PUNCT
eurjchem-2084	340	43	double	double	ADJ
eurjchem-2084	340	44	blinded	blind	VERB
eurjchem-2084	340	45	,	,	PUNCT
eurjchem-2084	340	46	placebo	placebo	NOUN
eurjchem-2084	340	47	controlled	control	VERB
eurjchem-2084	340	48	,	,	PUNCT
eurjchem-2084	340	49	participants	participant	NOUN
eurjchem-2084	340	50	in	in	ADP
eurjchem-2084	340	51	two	two	NUM
eurjchem-2084	340	52	age	age	NOUN
eurjchem-2084	340	53	group	group	NOUN
eurjchem-2084	341	1	[	[	X
eurjchem-2084	341	2	127	127	NUM
eurjchem-2084	341	3	]	]	SYM
eurjchem-2084	341	4	13	13	NUM
eurjchem-2084	341	5	lnp	lnp	PROPN
eurjchem-2084	341	6	-	-	PUNCT
eurjchem-2084	341	7	ncovsarna	ncovsarna	NOUN
eurjchem-2084	341	8	rna	rna	PROPN
eurjchem-2084	341	9	imperial	imperial	PROPN
eurjchem-2084	341	10	college	college	PROPN
eurjchem-2084	341	11	london	london	PROPN
eurjchem-2084	341	12	phase	phase	NOUN
eurjchem-2084	341	13	1	1	NUM
eurjchem-2084	341	14	1	1	NUM
eurjchem-2084	341	15	320	320	NUM
eurjchem-2084	341	16	p	p	NOUN
eurjchem-2084	341	17	,	,	PUNCT
eurjchem-2084	341	18	18	18	NUM
eurjchem-2084	341	19	-	-	SYM
eurjchem-2084	341	20	45	45	NUM
eurjchem-2084	341	21	&	&	CCONJ
eurjchem-2084	341	22	18	18	NUM
eurjchem-2084	341	23	-	-	SYM
eurjchem-2084	341	24	75	75	NUM
eurjchem-2084	341	25	years	year	NOUN
eurjchem-2084	341	26	open	open	ADJ
eurjchem-2084	341	27	label	label	NOUN
eurjchem-2084	341	28	,	,	PUNCT
eurjchem-2084	341	29	nonrandomized	nonrandomize	VERB
eurjchem-2084	341	30	,	,	PUNCT
eurjchem-2084	341	31	phase	phase	NOUN
eurjchem-2084	341	32	participants	participant	NOUN
eurjchem-2084	341	33	,	,	PUNCT
eurjchem-2084	341	34	two	two	NUM
eurjchem-2084	341	35	age	age	NOUN
eurjchem-2084	341	36	group	group	NOUN
eurjchem-2084	341	37	[	[	X
eurjchem-2084	341	38	128	128	NUM
eurjchem-2084	341	39	]	]	SYM
eurjchem-2084	341	40	14	14	NUM
eurjchem-2084	341	41	ncov	ncov	ADP
eurjchem-2084	341	42	vaccine	vaccine	NOUN
eurjchem-2084	341	43	dna	dna	VERB
eurjchem-2084	341	44	plasmid	plasmid	ADJ
eurjchem-2084	341	45	vaccine	vaccine	NOUN
eurjchem-2084	341	46	cadila	cadila	PROPN
eurjchem-2084	341	47	healthcare	healthcare	PROPN
eurjchem-2084	341	48	limited	limit	VERB
eurjchem-2084	341	49	phase	phase	NOUN
eurjchem-2084	341	50	1/2	1/2	NUM
eurjchem-2084	341	51	3	3	NUM
eurjchem-2084	341	52	(	(	PUNCT
eurjchem-2084	341	53	0	0	NUM
eurjchem-2084	341	54	,	,	PUNCT
eurjchem-2084	341	55	28	28	NUM
eurjchem-2084	341	56	,	,	PUNCT
eurjchem-2084	341	57	56	56	NUM
eurjchem-2084	341	58	)	)	PUNCT
eurjchem-2084	341	59	1048	1048	NUM
eurjchem-2084	341	60	p	p	NOUN
eurjchem-2084	341	61	,	,	PUNCT
eurjchem-2084	341	62	18	18	NUM
eurjchem-2084	341	63	-	-	SYM
eurjchem-2084	341	64	55	55	NUM
eurjchem-2084	341	65	years	year	NOUN
eurjchem-2084	341	66	prospective	prospective	ADJ
eurjchem-2084	341	67	,	,	PUNCT
eurjchem-2084	341	68	randomized	randomize	VERB
eurjchem-2084	341	69	,	,	PUNCT
eurjchem-2084	341	70	adaptive	adaptive	ADJ
eurjchem-2084	341	71	,	,	PUNCT
eurjchem-2084	341	72	clinical	clinical	ADJ
eurjchem-2084	341	73	study	study	NOUN
eurjchem-2084	341	74	[	[	X
eurjchem-2084	341	75	129	129	NUM
eurjchem-2084	341	76	]	]	SYM
eurjchem-2084	341	77	15	15	NUM
eurjchem-2084	341	78	gx-19	gx-19	ADJ
eurjchem-2084	341	79	dna	dna	PROPN
eurjchem-2084	341	80	vaccine	vaccine	PROPN
eurjchem-2084	341	81	genexine	genexine	PROPN
eurjchem-2084	341	82	consortium	consortium	NOUN
eurjchem-2084	341	83	phase	phase	NOUN
eurjchem-2084	341	84	1/2a	1/2a	NUM
eurjchem-2084	341	85	2	2	NUM
eurjchem-2084	341	86	(	(	PUNCT
eurjchem-2084	341	87	0	0	NUM
eurjchem-2084	341	88	,	,	PUNCT
eurjchem-2084	341	89	28	28	NUM
eurjchem-2084	341	90	)	)	PUNCT
eurjchem-2084	341	91	210	210	NUM
eurjchem-2084	341	92	p	p	NOUN
eurjchem-2084	341	93	,	,	PUNCT
eurjchem-2084	341	94	≥	≥	NUM
eurjchem-2084	341	95	18	18	NUM
eurjchem-2084	341	96	years	year	NOUN
eurjchem-2084	341	97	multi	multi	ADJ
eurjchem-2084	341	98	-	-	ADJ
eurjchem-2084	341	99	center	center	ADJ
eurjchem-2084	341	100	,	,	PUNCT
eurjchem-2084	341	101	randomized	randomize	VERB
eurjchem-2084	341	102	,	,	PUNCT
eurjchem-2084	341	103	double	double	ADJ
eurjchem-2084	341	104	-	-	PUNCT
eurjchem-2084	341	105	blind	blind	ADJ
eurjchem-2084	341	106	,	,	PUNCT
eurjchem-2084	341	107	placebocontrolled	placebocontrolle	VERB
eurjchem-2084	341	108	study	study	NOUN
eurjchem-2084	341	109	participants	participant	NOUN
eurjchem-2084	341	110	in	in	ADP
eurjchem-2084	341	111	healthy	healthy	ADJ
eurjchem-2084	341	112	adult	adult	NOUN
eurjchem-2084	342	1	[	[	X
eurjchem-2084	342	2	130	130	NUM
eurjchem-2084	342	3	]	]	SYM
eurjchem-2084	342	4	16	16	NUM
eurjchem-2084	342	5	ino-4800	ino-4800	VERB
eurjchem-2084	342	6	dna	dna	PROPN
eurjchem-2084	342	7	plasmid	plasmid	ADJ
eurjchem-2084	342	8	vaccine	vaccine	NOUN
eurjchem-2084	342	9	with	with	ADP
eurjchem-2084	342	10	electroporation	electroporation	NOUN
eurjchem-2084	342	11	inovio	inovio	NOUN
eurjchem-2084	342	12	pharmaceuticals	pharmaceutical	NOUN
eurjchem-2084	342	13	phase	phase	NOUN
eurjchem-2084	342	14	1/2a	1/2a	NUM
eurjchem-2084	342	15	2	2	NUM
eurjchem-2084	342	16	(	(	PUNCT
eurjchem-2084	342	17	0	0	NUM
eurjchem-2084	342	18	,	,	PUNCT
eurjchem-2084	342	19	28	28	NUM
eurjchem-2084	342	20	)	)	PUNCT
eurjchem-2084	342	21	160	160	NUM
eurjchem-2084	342	22	p	p	NOUN
eurjchem-2084	342	23	,	,	PUNCT
eurjchem-2084	342	24	19	19	NUM
eurjchem-2084	342	25	-	-	SYM
eurjchem-2084	342	26	64	64	NUM
eurjchem-2084	342	27	years	year	NOUN
eurjchem-2084	342	28	randomized	randomize	VERB
eurjchem-2084	342	29	,	,	PUNCT
eurjchem-2084	342	30	open	open	ADJ
eurjchem-2084	342	31	label	label	NOUN
eurjchem-2084	342	32	and	and	CCONJ
eurjchem-2084	342	33	double	double	ADJ
eurjchem-2084	342	34	-	-	PUNCT
eurjchem-2084	342	35	blind	blind	ADJ
eurjchem-2084	342	36	study	study	NOUN
eurjchem-2084	342	37	[	[	X
eurjchem-2084	342	38	131	131	NUM
eurjchem-2084	342	39	]	]	SYM
eurjchem-2084	342	40	17	17	NUM
eurjchem-2084	342	41	ag0301	ag0301	PROPN
eurjchem-2084	342	42	-	-	PUNCT
eurjchem-2084	342	43	covid19	covid19	NOUN
eurjchem-2084	342	44	dna	dna	NOUN
eurjchem-2084	342	45	plasmid	plasmid	ADJ
eurjchem-2084	342	46	vaccine	vaccine	NOUN
eurjchem-2084	342	47	+	+	CCONJ
eurjchem-2084	342	48	adjuvant	adjuvant	ADJ
eurjchem-2084	342	49	osaka	osaka	PROPN
eurjchem-2084	342	50	university/	university/	NUM
eurjchem-2084	342	51	anges/	anges/	NUM
eurjchem-2084	342	52	takara	takara	PROPN
eurjchem-2084	342	53	bio	bio	PROPN
eurjchem-2084	342	54	phase	phase	NOUN
eurjchem-2084	342	55	1/2	1/2	NUM
eurjchem-2084	342	56	2	2	NUM
eurjchem-2084	342	57	(	(	PUNCT
eurjchem-2084	342	58	0	0	NUM
eurjchem-2084	342	59	,	,	PUNCT
eurjchem-2084	342	60	14	14	NUM
eurjchem-2084	342	61	)	)	PUNCT
eurjchem-2084	342	62	30	30	NUM
eurjchem-2084	342	63	p	p	NOUN
eurjchem-2084	342	64	,	,	PUNCT
eurjchem-2084	342	65	20	20	NUM
eurjchem-2084	342	66	-	-	SYM
eurjchem-2084	342	67	65	65	NUM
eurjchem-2084	342	68	years	year	NOUN
eurjchem-2084	342	69	non	non	ADJ
eurjchem-2084	342	70	-	-	ADJ
eurjchem-2084	342	71	randomized	randomized	ADJ
eurjchem-2084	342	72	,	,	PUNCT
eurjchem-2084	342	73	openlabel	openlabel	NOUN
eurjchem-2084	342	74	,	,	PUNCT
eurjchem-2084	342	75	non	non	ADJ
eurjchem-2084	342	76	-	-	ADJ
eurjchem-2084	342	77	controlled	control	VERB
eurjchem-2084	342	78	[	[	X
eurjchem-2084	342	79	132	132	NUM
eurjchem-2084	342	80	]	]	SYM
eurjchem-2084	342	81	18	18	NUM
eurjchem-2084	342	82	sars	sar	NOUN
eurjchem-2084	342	83	-	-	PUNCT
eurjchem-2084	342	84	cov-2	cov-2	NOUN
eurjchem-2084	342	85	rs	rs	ADJ
eurjchem-2084	342	86	protein	protein	NOUN
eurjchem-2084	342	87	subunit	subunit	NOUN
eurjchem-2084	342	88	(	(	PUNCT
eurjchem-2084	342	89	full	full	ADJ
eurjchem-2084	342	90	length	length	NOUN
eurjchem-2084	342	91	recombinant	recombinant	ADJ
eurjchem-2084	342	92	sars	sar	NOUN
eurjchem-2084	342	93	cov-2	cov-2	PART
eurjchem-2084	342	94	glycoprotein	glycoprotein	NOUN
eurjchem-2084	342	95	nanoparticle	nanoparticle	NOUN
eurjchem-2084	342	96	vaccine	vaccine	NOUN
eurjchem-2084	342	97	adjuvanted	adjuvante	VERB
eurjchem-2084	342	98	with	with	ADP
eurjchem-2084	342	99	matrix	matrix	NOUN
eurjchem-2084	342	100	m	m	VERB
eurjchem-2084	342	101	novavax	novavax	NOUN
eurjchem-2084	342	102	phase	phase	NOUN
eurjchem-2084	342	103	1/2	1/2	NUM
eurjchem-2084	342	104	2	2	NUM
eurjchem-2084	342	105	(	(	PUNCT
eurjchem-2084	342	106	0	0	NUM
eurjchem-2084	342	107	,	,	PUNCT
eurjchem-2084	342	108	21	21	NUM
eurjchem-2084	342	109	)	)	PUNCT
eurjchem-2084	342	110	1419	1419	NUM
eurjchem-2084	342	111	p	p	NOUN
eurjchem-2084	342	112	,	,	PUNCT
eurjchem-2084	342	113	18	18	NUM
eurjchem-2084	342	114	-	-	SYM
eurjchem-2084	342	115	59	59	NUM
eurjchem-2084	342	116	years	year	NOUN
eurjchem-2084	342	117	randomized	randomize	VERB
eurjchem-2084	342	118	,	,	PUNCT
eurjchem-2084	342	119	observerblinded	observerblinde	VERB
eurjchem-2084	342	120	[	[	X
eurjchem-2084	342	121	133	133	NUM
eurjchem-2084	342	122	]	]	SYM
eurjchem-2084	342	123	19	19	NUM
eurjchem-2084	342	124	kbp	kbp	PROPN
eurjchem-2084	342	125	-	-	PUNCT
eurjchem-2084	342	126	covid-19	covid-19	PROPN
eurjchem-2084	342	127	protein	protein	NOUN
eurjchem-2084	342	128	subunit	subunit	NOUN
eurjchem-2084	342	129	(	(	PUNCT
eurjchem-2084	342	130	rbd	rbd	NOUN
eurjchem-2084	342	131	based	base	VERB
eurjchem-2084	342	132	)	)	PUNCT
eurjchem-2084	342	133	kentucky	kentucky	PROPN
eurjchem-2084	342	134	bioprocessing	bioprocessing	PROPN
eurjchem-2084	342	135	,	,	PUNCT
eurjchem-2084	342	136	inc	inc	PROPN
eurjchem-2084	342	137	phase	phase	NOUN
eurjchem-2084	342	138	1/2	1/2	NUM
eurjchem-2084	342	139	2	2	NUM
eurjchem-2084	342	140	(	(	PUNCT
eurjchem-2084	342	141	0	0	NUM
eurjchem-2084	342	142	,	,	PUNCT
eurjchem-2084	342	143	21	21	NUM
eurjchem-2084	342	144	)	)	PUNCT
eurjchem-2084	342	145	180	180	NUM
eurjchem-2084	342	146	p	p	NOUN
eurjchem-2084	342	147	,	,	PUNCT
eurjchem-2084	342	148	18	18	NUM
eurjchem-2084	342	149	-	-	SYM
eurjchem-2084	342	150	49	49	NUM
eurjchem-2084	342	151	&	&	CCONJ
eurjchem-2084	342	152	50	50	NUM
eurjchem-2084	342	153	-	-	SYM
eurjchem-2084	342	154	70	70	NUM
eurjchem-2084	342	155	years	year	NOUN
eurjchem-2084	342	156	first	first	ADJ
eurjchem-2084	342	157	-	-	PUNCT
eurjchem-2084	342	158	in	in	ADP
eurjchem-2084	342	159	-	-	PUNCT
eurjchem-2084	342	160	human	human	NOUN
eurjchem-2084	342	161	,	,	PUNCT
eurjchem-2084	342	162	observerblinded	observerblinded	ADJ
eurjchem-2084	342	163	,	,	PUNCT
eurjchem-2084	342	164	randomized	randomize	VERB
eurjchem-2084	342	165	,	,	PUNCT
eurjchem-2084	342	166	placebo	placebo	NOUN
eurjchem-2084	342	167	-	-	PUNCT
eurjchem-2084	342	168	controlled	control	VERB
eurjchem-2084	342	169	,	,	PUNCT
eurjchem-2084	342	170	parallel	parallel	ADJ
eurjchem-2084	342	171	group	group	NOUN
eurjchem-2084	342	172	study	study	NOUN
eurjchem-2084	342	173	in	in	ADP
eurjchem-2084	342	174	two	two	NUM
eurjchem-2084	342	175	age	age	NOUN
eurjchem-2084	342	176	group	group	NOUN
eurjchem-2084	342	177	,	,	PUNCT
eurjchem-2084	342	178	[	[	X
eurjchem-2084	342	179	134	134	NUM
eurjchem-2084	342	180	]	]	SYM
eurjchem-2084	342	181	20	20	NUM
eurjchem-2084	342	182	recombinant	recombinant	ADJ
eurjchem-2084	342	183	new	new	ADJ
eurjchem-2084	342	184	corona	corona	NOUN
eurjchem-2084	342	185	vaccine	vaccine	NOUN
eurjchem-2084	342	186	protein	protein	NOUN
eurjchem-2084	342	187	subunit	subunit	NOUN
eurjchem-2084	342	188	(	(	PUNCT
eurjchem-2084	342	189	adjuvanted	adjuvante	VERB
eurjchem-2084	342	190	recombinant	recombinant	ADJ
eurjchem-2084	342	191	protein	protein	NOUN
eurjchem-2084	342	192	(	(	PUNCT
eurjchem-2084	342	193	rbd	rbd	NOUN
eurjchem-2084	342	194	-	-	PUNCT
eurjchem-2084	342	195	dimer	dimer	NOUN
eurjchem-2084	342	196	)	)	PUNCT
eurjchem-2084	343	1	anhui	anhui	PROPN
eurjchem-2084	343	2	zhifei	zhifei	PROPN
eurjchem-2084	343	3	longcom	longcom	PROPN
eurjchem-2084	343	4	biopharmaceutical	biopharmaceutical	PROPN
eurjchem-2084	343	5	/	/	SYM
eurjchem-2084	343	6	i	i	PRON
eurjchem-2084	343	7	nstitute	nstitute	VERB
eurjchem-2084	343	8	of	of	ADP
eurjchem-2084	343	9	microbiology	microbiology	NOUN
eurjchem-2084	343	10	,	,	PUNCT
eurjchem-2084	343	11	chinese	chinese	PROPN
eurjchem-2084	343	12	academy	academy	PROPN
eurjchem-2084	343	13	of	of	ADP
eurjchem-2084	343	14	sciences	sciences	PROPN
eurjchem-2084	343	15	phase	phase	NOUN
eurjchem-2084	343	16	3	3	NUM
eurjchem-2084	343	17	3	3	NUM
eurjchem-2084	343	18	(	(	PUNCT
eurjchem-2084	343	19	0	0	NUM
eurjchem-2084	343	20	,	,	PUNCT
eurjchem-2084	343	21	30	30	NUM
eurjchem-2084	343	22	,	,	PUNCT
eurjchem-2084	343	23	60	60	NUM
eurjchem-2084	343	24	)	)	PUNCT
eurjchem-2084	343	25	29000	29000	NUM
eurjchem-2084	343	26	p	p	NOUN
eurjchem-2084	343	27	,	,	PUNCT
eurjchem-2084	343	28	18	18	NUM
eurjchem-2084	343	29	-	-	SYM
eurjchem-2084	343	30	59	59	NUM
eurjchem-2084	343	31	years	year	NOUN
eurjchem-2084	343	32	randomized	randomize	VERB
eurjchem-2084	343	33	,	,	PUNCT
eurjchem-2084	343	34	blinded	blind	VERB
eurjchem-2084	343	35	,	,	PUNCT
eurjchem-2084	343	36	placebo	placebo	NOUN
eurjchem-2084	343	37	-	-	PUNCT
eurjchem-2084	343	38	controlled	control	VERB
eurjchem-2084	344	1	[	[	X
eurjchem-2084	344	2	135	135	NUM
eurjchem-2084	344	3	]	]	SYM
eurjchem-2084	344	4	21	21	NUM
eurjchem-2084	344	5	covax-19	covax-19	PROPN
eurjchem-2084	344	6	recombinant	recombinant	ADJ
eurjchem-2084	344	7	spike	spike	ADJ
eurjchem-2084	344	8	protein	protein	NOUN
eurjchem-2084	344	9	with	with	ADP
eurjchem-2084	344	10	advax	advax	ADJ
eurjchem-2084	344	11	™	™	PROPN
eurjchem-2084	344	12	adjuvant	adjuvant	ADJ
eurjchem-2084	344	13	vaxine	vaxine	PROPN
eurjchem-2084	344	14	pty	pty	PROPN
eurjchem-2084	344	15	ltd	ltd	PROPN
eurjchem-2084	344	16	/	/	SYM
eurjchem-2084	344	17	medytox	medytox	ADJ
eurjchem-2084	344	18	phase	phase	NOUN
eurjchem-2084	344	19	1	1	NUM
eurjchem-2084	344	20	1	1	NUM
eurjchem-2084	344	21	40	40	NUM
eurjchem-2084	344	22	p	p	NOUN
eurjchem-2084	344	23	,	,	PUNCT
eurjchem-2084	344	24	18	18	NUM
eurjchem-2084	344	25	-	-	SYM
eurjchem-2084	344	26	65	65	NUM
eurjchem-2084	344	27	years	year	NOUN
eurjchem-2084	344	28	randomized	randomize	VERB
eurjchem-2084	344	29	,	,	PUNCT
eurjchem-2084	344	30	controlled	control	VERB
eurjchem-2084	344	31	study	study	NOUN
eurjchem-2084	344	32	[	[	X
eurjchem-2084	344	33	136	136	NUM
eurjchem-2084	344	34	]	]	SYM
eurjchem-2084	344	35	22	22	NUM
eurjchem-2084	344	36	coronavirus	coronavirus	NOUN
eurjchem-2084	344	37	-	-	PUNCT
eurjchem-2084	344	38	like	like	ADJ
eurjchem-2084	344	39	particle	particle	NOUN
eurjchem-2084	344	40	covid19	covid19	NOUN
eurjchem-2084	344	41	vaccine	vaccine	NOUN
eurjchem-2084	344	42	plant	plant	NOUN
eurjchem-2084	344	43	-	-	PUNCT
eurjchem-2084	344	44	derived	derive	VERB
eurjchem-2084	344	45	vlp	vlp	PROPN
eurjchem-2084	344	46	adjuvanted	adjuvante	VERB
eurjchem-2084	344	47	with	with	ADP
eurjchem-2084	344	48	cpg	cpg	PROPN
eurjchem-2084	344	49	1018	1018	NUM
eurjchem-2084	344	50	or	or	CCONJ
eurjchem-2084	344	51	as03	as03	PROPN
eurjchem-2084	344	52	medicago	medicago	PROPN
eurjchem-2084	344	53	inc	inc	PROPN
eurjchem-2084	344	54	.	.	PROPN
eurjchem-2084	344	55	phase	phase	NOUN
eurjchem-2084	344	56	2/3	2/3	NUM
eurjchem-2084	344	57	2	2	NUM
eurjchem-2084	344	58	(	(	PUNCT
eurjchem-2084	344	59	0	0	NUM
eurjchem-2084	344	60	,	,	PUNCT
eurjchem-2084	344	61	21	21	NUM
eurjchem-2084	344	62	)	)	PUNCT
eurjchem-2084	344	63	30612	30612	NUM
eurjchem-2084	344	64	p	p	NOUN
eurjchem-2084	344	65	,	,	PUNCT
eurjchem-2084	344	66	18	18	NUM
eurjchem-2084	344	67	-	-	SYM
eurjchem-2084	344	68	55	55	NUM
eurjchem-2084	344	69	years	year	NOUN
eurjchem-2084	344	70	randomized	randomize	VERB
eurjchem-2084	344	71	,	,	PUNCT
eurjchem-2084	344	72	partiallyblinded	partiallyblinde	VERB
eurjchem-2084	344	73	,	,	PUNCT
eurjchem-2084	344	74	dose	dose	NOUN
eurjchem-2084	344	75	-	-	PUNCT
eurjchem-2084	344	76	ranging	range	VERB
eurjchem-2084	344	77	study	study	NOUN
eurjchem-2084	344	78	in	in	ADP
eurjchem-2084	344	79	[	[	X
eurjchem-2084	344	80	137	137	NUM
eurjchem-2084	344	81	]	]	X
eurjchem-2084	344	82	firdaus	firdaus	PROPN
eurjchem-2084	344	83	et	et	PROPN
eurjchem-2084	344	84	al	al	PROPN
eurjchem-2084	344	85	.	.	PUNCT
eurjchem-2084	344	86	/	/	SYM
eurjchem-2084	344	87	european	european	PROPN
eurjchem-2084	344	88	journal	journal	PROPN
eurjchem-2084	344	89	of	of	ADP
eurjchem-2084	344	90	chemistry	chemistry	NOUN
eurjchem-2084	344	91	12	12	NUM
eurjchem-2084	344	92	(	(	PUNCT
eurjchem-2084	344	93	2	2	NUM
eurjchem-2084	344	94	)	)	PUNCT
eurjchem-2084	344	95	(	(	PUNCT
eurjchem-2084	344	96	2021	2021	NUM
eurjchem-2084	344	97	)	)	PUNCT
eurjchem-2084	344	98	222	222	NUM
eurjchem-2084	344	99	-	-	SYM
eurjchem-2084	344	100	234	234	NUM
eurjchem-2084	344	101	231	231	NUM
eurjchem-2084	344	102	2021	2021	NUM
eurjchem-2084	344	103	–	–	PUNCT
eurjchem-2084	344	104	european	european	ADJ
eurjchem-2084	344	105	journal	journal	NOUN
eurjchem-2084	344	106	of	of	ADP
eurjchem-2084	344	107	chemistry	chemistry	NOUN
eurjchem-2084	344	108	–	–	PUNCT
eurjchem-2084	344	109	cc	cc	NOUN
eurjchem-2084	344	110	by	by	ADP
eurjchem-2084	344	111	nc	nc	PROPN
eurjchem-2084	344	112	–	–	PUNCT
eurjchem-2084	344	113	doi	doi	NOUN
eurjchem-2084	344	114	:	:	PUNCT
eurjchem-2084	344	115	10.5155	10.5155	NUM
eurjchem-2084	344	116	/	/	SYM
eurjchem-2084	344	117	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	344	118	-	-	PUNCT
eurjchem-2084	344	119	234.2084	234.2084	NUM
eurjchem-2084	344	120	live	live	ADJ
eurjchem-2084	344	121	vector	vector	NOUN
eurjchem-2084	344	122	vaccines	vaccine	NOUN
eurjchem-2084	344	123	are	be	AUX
eurjchem-2084	344	124	live	live	ADJ
eurjchem-2084	344	125	viruses	virus	NOUN
eurjchem-2084	344	126	(	(	PUNCT
eurjchem-2084	344	127	the	the	DET
eurjchem-2084	344	128	vector	vector	NOUN
eurjchem-2084	344	129	)	)	PUNCT
eurjchem-2084	344	130	that	that	PRON
eurjchem-2084	344	131	possess	possess	VERB
eurjchem-2084	344	132	miscellaneous	miscellaneous	ADJ
eurjchem-2084	344	133	antigen(s	antigen(s	NOUN
eurjchem-2084	344	134	)	)	PUNCT
eurjchem-2084	344	135	.	.	PUNCT
eurjchem-2084	345	1	the	the	DET
eurjchem-2084	345	2	vaccines	vaccine	NOUN
eurjchem-2084	345	3	show	show	VERB
eurjchem-2084	345	4	strong	strong	ADJ
eurjchem-2084	345	5	immunogenicity	immunogenicity	NOUN
eurjchem-2084	345	6	and	and	CCONJ
eurjchem-2084	345	7	safety	safety	NOUN
eurjchem-2084	345	8	like	like	ADP
eurjchem-2084	345	9	live	live	ADJ
eurjchem-2084	345	10	attenuated	attenuated	ADJ
eurjchem-2084	345	11	vaccines	vaccine	NOUN
eurjchem-2084	345	12	and	and	CCONJ
eurjchem-2084	345	13	subunit	subunit	NOUN
eurjchem-2084	345	14	vaccines	vaccine	NOUN
eurjchem-2084	345	15	respectively	respectively	ADV
eurjchem-2084	345	16	and	and	CCONJ
eurjchem-2084	345	17	are	be	AUX
eurjchem-2084	345	18	widely	widely	ADV
eurjchem-2084	345	19	used	use	VERB
eurjchem-2084	345	20	to	to	PART
eurjchem-2084	345	21	induce	induce	VERB
eurjchem-2084	345	22	cellular	cellular	ADJ
eurjchem-2084	345	23	immunity	immunity	NOUN
eurjchem-2084	345	24	.	.	PUNCT
eurjchem-2084	346	1	synthetic	synthetic	ADJ
eurjchem-2084	346	2	peptide	peptide	NOUN
eurjchem-2084	346	3	/	/	SYM
eurjchem-2084	346	4	epitope	epitope	NOUN
eurjchem-2084	346	5	vaccines	vaccine	NOUN
eurjchem-2084	346	6	carry	carry	VERB
eurjchem-2084	346	7	only	only	ADV
eurjchem-2084	346	8	certain	certain	ADJ
eurjchem-2084	346	9	shreds	shred	NOUN
eurjchem-2084	346	10	of	of	ADP
eurjchem-2084	346	11	intact	intact	ADJ
eurjchem-2084	346	12	antigens	antigen	NOUN
eurjchem-2084	346	13	and	and	CCONJ
eurjchem-2084	346	14	are	be	AUX
eurjchem-2084	346	15	generally	generally	ADV
eurjchem-2084	346	16	prepared	prepare	VERB
eurjchem-2084	346	17	by	by	ADP
eurjchem-2084	346	18	chemical	chemical	ADJ
eurjchem-2084	346	19	synthesis	synthesis	NOUN
eurjchem-2084	346	20	technique	technique	NOUN
eurjchem-2084	346	21	.	.	PUNCT
eurjchem-2084	347	1	although	although	SCONJ
eurjchem-2084	347	2	the	the	DET
eurjchem-2084	347	3	preparation	preparation	NOUN
eurjchem-2084	347	4	and	and	CCONJ
eurjchem-2084	347	5	quality	quality	NOUN
eurjchem-2084	347	6	control	control	NOUN
eurjchem-2084	347	7	processes	process	NOUN
eurjchem-2084	347	8	are	be	AUX
eurjchem-2084	347	9	simple	simple	ADJ
eurjchem-2084	347	10	,	,	PUNCT
eurjchem-2084	347	11	vaccines	vaccine	NOUN
eurjchem-2084	347	12	impart	impart	VERB
eurjchem-2084	347	13	low	low	ADJ
eurjchem-2084	347	14	immunogenicity	immunogenicity	NOUN
eurjchem-2084	347	15	due	due	ADP
eurjchem-2084	347	16	to	to	ADP
eurjchem-2084	347	17	the	the	DET
eurjchem-2084	347	18	low	low	ADJ
eurjchem-2084	347	19	molecular	molecular	ADJ
eurjchem-2084	347	20	weight	weight	NOUN
eurjchem-2084	347	21	and	and	CCONJ
eurjchem-2084	347	22	structural	structural	ADJ
eurjchem-2084	347	23	complexity	complexity	NOUN
eurjchem-2084	347	24	.	.	PUNCT
eurjchem-2084	348	1	therefore	therefore	ADV
eurjchem-2084	348	2	,	,	PUNCT
eurjchem-2084	348	3	structural	structural	ADJ
eurjchem-2084	348	4	alterations	alteration	NOUN
eurjchem-2084	348	5	,	,	PUNCT
eurjchem-2084	348	6	delivery	delivery	NOUN
eurjchem-2084	348	7	systems	system	NOUN
eurjchem-2084	348	8	,	,	PUNCT
eurjchem-2084	348	9	and	and	CCONJ
eurjchem-2084	348	10	adjuvants	adjuvant	NOUN
eurjchem-2084	348	11	are	be	AUX
eurjchem-2084	348	12	prerequisite	prerequisite	ADJ
eurjchem-2084	348	13	in	in	ADP
eurjchem-2084	348	14	their	their	PRON
eurjchem-2084	348	15	formulation	formulation	NOUN
eurjchem-2084	348	16	[	[	X
eurjchem-2084	348	17	105	105	NUM
eurjchem-2084	348	18	]	]	PUNCT
eurjchem-2084	348	19	.	.	PUNCT
eurjchem-2084	349	1	david	david	PROPN
eurjchem-2084	349	2	curiel	curiel	PROPN
eurjchem-2084	349	3	and	and	CCONJ
eurjchem-2084	349	4	their	their	PRON
eurjchem-2084	349	5	colleagues	colleague	NOUN
eurjchem-2084	349	6	created	create	VERB
eurjchem-2084	349	7	a	a	DET
eurjchem-2084	349	8	chimpanzee	chimpanzee	NOUN
eurjchem-2084	349	9	adenovirus	adenovirus	NOUN
eurjchem-2084	349	10	vectored	vectore	VERB
eurjchem-2084	349	11	vaccine	vaccine	NOUN
eurjchem-2084	349	12	encoding	encode	VERB
eurjchem-2084	349	13	a	a	DET
eurjchem-2084	349	14	prefusion	prefusion	NOUN
eurjchem-2084	349	15	stabilized	stabilize	VERB
eurjchem-2084	349	16	spike	spike	ADJ
eurjchem-2084	349	17	protein	protein	NOUN
eurjchem-2084	349	18	(	(	PUNCT
eurjchem-2084	349	19	chad	chad	NOUN
eurjchem-2084	349	20	-	-	PUNCT
eurjchem-2084	349	21	sars	sar	NOUN
eurjchem-2084	349	22	-	-	PUNCT
eurjchem-2084	349	23	cov-2	cov-2	NOUN
eurjchem-2084	349	24	-	-	PUNCT
eurjchem-2084	349	25	s	s	NOUN
eurjchem-2084	349	26	)	)	PUNCT
eurjchem-2084	349	27	and	and	CCONJ
eurjchem-2084	349	28	evaluated	evaluate	VERB
eurjchem-2084	349	29	the	the	DET
eurjchem-2084	349	30	efficacy	efficacy	NOUN
eurjchem-2084	349	31	in	in	ADP
eurjchem-2084	349	32	sars	sars	PROPN
eurjchem-2084	349	33	-	-	PUNCT
eurjchem-2084	349	34	cov-2	cov-2	NOUN
eurjchem-2084	349	35	infected	infected	ADJ
eurjchem-2084	349	36	bioengineered	bioengineere	VERB
eurjchem-2084	349	37	mice	mouse	NOUN
eurjchem-2084	349	38	expressing	express	VERB
eurjchem-2084	349	39	the	the	DET
eurjchem-2084	349	40	human	human	ADJ
eurjchem-2084	349	41	ace-2	ace-2	PUNCT
eurjchem-2084	349	42	receptor	receptor	NOUN
eurjchem-2084	349	43	[	[	X
eurjchem-2084	349	44	106	106	NUM
eurjchem-2084	349	45	]	]	PUNCT
eurjchem-2084	349	46	.	.	PUNCT
eurjchem-2084	350	1	the	the	DET
eurjchem-2084	350	2	study	study	NOUN
eurjchem-2084	350	3	reported	report	VERB
eurjchem-2084	350	4	that	that	SCONJ
eurjchem-2084	350	5	intranasal	intranasal	ADJ
eurjchem-2084	350	6	administration	administration	NOUN
eurjchem-2084	350	7	of	of	ADP
eurjchem-2084	350	8	chad	chad	PROPN
eurjchem-2084	350	9	-	-	PUNCT
eurjchem-2084	350	10	sars	sars	PROPN
eurjchem-2084	350	11	-	-	PUNCT
eurjchem-2084	350	12	cov-2	cov-2	NOUN
eurjchem-2084	350	13	-	-	PUNCT
eurjchem-2084	350	14	s	s	NOUN
eurjchem-2084	350	15	induced	induce	VERB
eurjchem-2084	350	16	a	a	DET
eurjchem-2084	350	17	strong	strong	ADJ
eurjchem-2084	350	18	and	and	CCONJ
eurjchem-2084	350	19	better	well	ADJ
eurjchem-2084	350	20	immune	immune	ADJ
eurjchem-2084	350	21	response	response	NOUN
eurjchem-2084	350	22	to	to	ADP
eurjchem-2084	350	23	those	those	PRON
eurjchem-2084	350	24	receiving	receive	VERB
eurjchem-2084	350	25	intramuscular	intramuscular	ADJ
eurjchem-2084	350	26	injection	injection	NOUN
eurjchem-2084	350	27	.	.	PUNCT
eurjchem-2084	351	1	furthermore	furthermore	ADV
eurjchem-2084	351	2	,	,	PUNCT
eurjchem-2084	351	3	no	no	DET
eurjchem-2084	351	4	remnants	remnant	NOUN
eurjchem-2084	351	5	of	of	ADP
eurjchem-2084	351	6	the	the	DET
eurjchem-2084	351	7	virus	virus	NOUN
eurjchem-2084	351	8	were	be	AUX
eurjchem-2084	351	9	found	find	VERB
eurjchem-2084	351	10	in	in	ADP
eurjchem-2084	351	11	nasopharyngeal	nasopharyngeal	ADJ
eurjchem-2084	351	12	tracts	tract	NOUN
eurjchem-2084	351	13	in	in	ADP
eurjchem-2084	351	14	intranasal	intranasal	ADJ
eurjchem-2084	351	15	dosing	dosing	NOUN
eurjchem-2084	351	16	,	,	PUNCT
eurjchem-2084	351	17	whereas	whereas	SCONJ
eurjchem-2084	351	18	traces	trace	NOUN
eurjchem-2084	351	19	of	of	ADP
eurjchem-2084	351	20	viral	viral	ADJ
eurjchem-2084	351	21	rna	rna	NOUN
eurjchem-2084	351	22	were	be	AUX
eurjchem-2084	351	23	present	present	ADJ
eurjchem-2084	351	24	in	in	ADP
eurjchem-2084	351	25	the	the	DET
eurjchem-2084	351	26	lungs	lung	NOUN
eurjchem-2084	351	27	of	of	ADP
eurjchem-2084	351	28	mice	mouse	NOUN
eurjchem-2084	351	29	in	in	ADP
eurjchem-2084	351	30	intramuscular	intramuscular	ADV
eurjchem-2084	351	31	dosing	dose	VERB
eurjchem-2084	352	1	[	[	X
eurjchem-2084	352	2	96	96	NUM
eurjchem-2084	352	3	]	]	PUNCT
eurjchem-2084	352	4	.	.	PUNCT
eurjchem-2084	353	1	in	in	ADP
eurjchem-2084	353	2	parallel	parallel	NOUN
eurjchem-2084	353	3	,	,	PUNCT
eurjchem-2084	353	4	another	another	DET
eurjchem-2084	353	5	team	team	NOUN
eurjchem-2084	353	6	reported	report	VERB
eurjchem-2084	353	7	the	the	DET
eurjchem-2084	353	8	genesis	genesis	NOUN
eurjchem-2084	353	9	of	of	ADP
eurjchem-2084	353	10	a	a	DET
eurjchem-2084	353	11	candidate	candidate	NOUN
eurjchem-2084	353	12	vaccine	vaccine	NOUN
eurjchem-2084	353	13	having	have	VERB
eurjchem-2084	353	14	a	a	DET
eurjchem-2084	353	15	replicationincompetent	replicationincompetent	NOUN
eurjchem-2084	353	16	recombinant	recombinant	ADJ
eurjchem-2084	353	17	serotype	serotype	ADJ
eurjchem-2084	353	18	5	5	NUM
eurjchem-2084	353	19	adenovirus	adenovirus	NOUN
eurjchem-2084	353	20	,	,	PUNCT
eurjchem-2084	353	21	ad5	ad5	PROPN
eurjchem-2084	353	22	-	-	PUNCT
eurjchem-2084	353	23	s	s	NOUN
eurjchem-2084	353	24	-	-	PUNCT
eurjchem-2084	353	25	nb2	nb2	NOUN
eurjchem-2084	353	26	,	,	PUNCT
eurjchem-2084	353	27	carrying	carry	VERB
eurjchem-2084	353	28	a	a	DET
eurjchem-2084	353	29	codon	codon	NOUN
eurjchem-2084	353	30	-	-	PUNCT
eurjchem-2084	353	31	optimized	optimize	VERB
eurjchem-2084	353	32	gene	gene	NOUN
eurjchem-2084	353	33	encoding	encode	VERB
eurjchem-2084	353	34	spike	spike	ADJ
eurjchem-2084	353	35	protein	protein	NOUN
eurjchem-2084	353	36	(	(	PUNCT
eurjchem-2084	353	37	s	s	NOUN
eurjchem-2084	353	38	)	)	PUNCT
eurjchem-2084	353	39	and	and	CCONJ
eurjchem-2084	353	40	evaluated	evaluate	VERB
eurjchem-2084	353	41	the	the	DET
eurjchem-2084	353	42	potency	potency	NOUN
eurjchem-2084	353	43	in	in	ADP
eurjchem-2084	353	44	mice	mouse	NOUN
eurjchem-2084	353	45	and	and	CCONJ
eurjchem-2084	353	46	rhesus	rhesus	NOUN
eurjchem-2084	353	47	macaques	macaque	NOUN
eurjchem-2084	353	48	.	.	PUNCT
eurjchem-2084	354	1	the	the	DET
eurjchem-2084	354	2	team	team	NOUN
eurjchem-2084	354	3	considered	consider	VERB
eurjchem-2084	354	4	the	the	DET
eurjchem-2084	354	5	time	time	NOUN
eurjchem-2084	354	6	interval	interval	NOUN
eurjchem-2084	354	7	as	as	ADP
eurjchem-2084	354	8	an	an	DET
eurjchem-2084	354	9	important	important	ADJ
eurjchem-2084	354	10	factor	factor	NOUN
eurjchem-2084	354	11	and	and	CCONJ
eurjchem-2084	354	12	reported	report	VERB
eurjchem-2084	354	13	that	that	SCONJ
eurjchem-2084	354	14	a	a	DET
eurjchem-2084	354	15	single	single	ADJ
eurjchem-2084	354	16	dose	dose	NOUN
eurjchem-2084	354	17	intramuscular	intramuscular	ADJ
eurjchem-2084	354	18	or	or	CCONJ
eurjchem-2084	354	19	intranasal	intranasal	ADJ
eurjchem-2084	354	20	administration	administration	NOUN
eurjchem-2084	354	21	of	of	ADP
eurjchem-2084	354	22	the	the	DET
eurjchem-2084	354	23	vaccine	vaccine	NOUN
eurjchem-2084	354	24	produced	produce	VERB
eurjchem-2084	354	25	immunity	immunity	NOUN
eurjchem-2084	354	26	against	against	ADP
eurjchem-2084	354	27	sarscov-2	sarscov-2	NUM
eurjchem-2084	354	28	after	after	ADP
eurjchem-2084	354	29	30	30	NUM
eurjchem-2084	354	30	days	day	NOUN
eurjchem-2084	354	31	of	of	ADP
eurjchem-2084	354	32	the	the	DET
eurjchem-2084	354	33	first	first	ADJ
eurjchem-2084	354	34	vaccination	vaccination	NOUN
eurjchem-2084	354	35	[	[	X
eurjchem-2084	354	36	107	107	NUM
eurjchem-2084	354	37	]	]	PUNCT
eurjchem-2084	354	38	.	.	PUNCT
eurjchem-2084	355	1	plant	plant	NOUN
eurjchem-2084	355	2	based	base	VERB
eurjchem-2084	355	3	biomolecules	biomolecule	NOUN
eurjchem-2084	355	4	were	be	AUX
eurjchem-2084	355	5	found	find	VERB
eurjchem-2084	355	6	successful	successful	ADJ
eurjchem-2084	355	7	in	in	ADP
eurjchem-2084	355	8	boosting	boost	VERB
eurjchem-2084	355	9	the	the	DET
eurjchem-2084	355	10	immune	immune	ADJ
eurjchem-2084	355	11	response	response	NOUN
eurjchem-2084	355	12	and	and	CCONJ
eurjchem-2084	355	13	giving	give	VERB
eurjchem-2084	355	14	tolerance	tolerance	NOUN
eurjchem-2084	355	15	to	to	ADP
eurjchem-2084	355	16	viral	viral	ADJ
eurjchem-2084	355	17	infections	infection	NOUN
eurjchem-2084	355	18	.	.	PUNCT
eurjchem-2084	356	1	however	however	ADV
eurjchem-2084	356	2	,	,	PUNCT
eurjchem-2084	356	3	the	the	DET
eurjchem-2084	356	4	use	use	NOUN
eurjchem-2084	356	5	of	of	ADP
eurjchem-2084	356	6	plants	plant	NOUN
eurjchem-2084	356	7	for	for	ADP
eurjchem-2084	356	8	the	the	DET
eurjchem-2084	356	9	development	development	NOUN
eurjchem-2084	356	10	of	of	ADP
eurjchem-2084	356	11	vaccines	vaccine	NOUN
eurjchem-2084	356	12	,	,	PUNCT
eurjchem-2084	356	13	and	and	CCONJ
eurjchem-2084	356	14	antiviral	antiviral	ADJ
eurjchem-2084	356	15	agents	agent	NOUN
eurjchem-2084	356	16	are	be	AUX
eurjchem-2084	356	17	of	of	ADP
eurjchem-2084	356	18	limited	limited	ADJ
eurjchem-2084	356	19	use	use	NOUN
eurjchem-2084	356	20	[	[	X
eurjchem-2084	356	21	108	108	NUM
eurjchem-2084	356	22	]	]	PUNCT
eurjchem-2084	356	23	.	.	PUNCT
eurjchem-2084	357	1	on	on	ADP
eurjchem-2084	357	2	a	a	DET
eurjchem-2084	357	3	different	different	ADJ
eurjchem-2084	357	4	track	track	NOUN
eurjchem-2084	357	5	from	from	ADP
eurjchem-2084	357	6	traditional	traditional	ADJ
eurjchem-2084	357	7	vaccine	vaccine	NOUN
eurjchem-2084	357	8	development	development	NOUN
eurjchem-2084	357	9	methods	method	NOUN
eurjchem-2084	357	10	of	of	ADP
eurjchem-2084	357	11	using	use	VERB
eurjchem-2084	357	12	killed	kill	VERB
eurjchem-2084	357	13	or	or	CCONJ
eurjchem-2084	357	14	attenuated	attenuate	VERB
eurjchem-2084	357	15	viruses	virus	NOUN
eurjchem-2084	357	16	,	,	PUNCT
eurjchem-2084	357	17	medicago	medicago	PROPN
eurjchem-2084	357	18	proposed	propose	VERB
eurjchem-2084	357	19	a	a	DET
eurjchem-2084	357	20	plant	plant	NOUN
eurjchem-2084	357	21	-	-	PUNCT
eurjchem-2084	357	22	based	base	VERB
eurjchem-2084	357	23	vaccine	vaccine	NOUN
eurjchem-2084	357	24	.	.	PUNCT
eurjchem-2084	358	1	although	although	SCONJ
eurjchem-2084	358	2	,	,	PUNCT
eurjchem-2084	358	3	the	the	DET
eurjchem-2084	358	4	details	detail	NOUN
eurjchem-2084	358	5	are	be	AUX
eurjchem-2084	358	6	confidential	confidential	ADJ
eurjchem-2084	358	7	,	,	PUNCT
eurjchem-2084	358	8	the	the	DET
eurjchem-2084	358	9	basic	basic	ADJ
eurjchem-2084	358	10	idea	idea	NOUN
eurjchem-2084	358	11	is	be	AUX
eurjchem-2084	358	12	to	to	PART
eurjchem-2084	358	13	develop	develop	VERB
eurjchem-2084	358	14	a	a	DET
eurjchem-2084	358	15	virus	virus	NOUN
eurjchem-2084	358	16	-	-	PUNCT
eurjchem-2084	358	17	like	like	ADJ
eurjchem-2084	358	18	particle	particle	NOUN
eurjchem-2084	358	19	(	(	PUNCT
eurjchem-2084	358	20	vlp	vlp	PROPN
eurjchem-2084	358	21	)	)	PUNCT
eurjchem-2084	358	22	that	that	PRON
eurjchem-2084	358	23	mimics	mimic	VERB
eurjchem-2084	358	24	the	the	DET
eurjchem-2084	358	25	appearance	appearance	NOUN
eurjchem-2084	358	26	and	and	CCONJ
eurjchem-2084	358	27	conformation	conformation	NOUN
eurjchem-2084	358	28	of	of	ADP
eurjchem-2084	358	29	sarscov-2	sarscov-2	PROPN
eurjchem-2084	358	30	,	,	PUNCT
eurjchem-2084	358	31	and	and	CCONJ
eurjchem-2084	358	32	its	its	PRON
eurjchem-2084	358	33	subsequent	subsequent	ADJ
eurjchem-2084	358	34	expression	expression	NOUN
eurjchem-2084	358	35	in	in	ADP
eurjchem-2084	358	36	tobacco	tobacco	NOUN
eurjchem-2084	358	37	plant	plant	NOUN
eurjchem-2084	358	38	to	to	PART
eurjchem-2084	358	39	form	form	VERB
eurjchem-2084	358	40	subunit	subunit	NOUN
eurjchem-2084	358	41	proteins	protein	NOUN
eurjchem-2084	358	42	.	.	PUNCT
eurjchem-2084	359	1	for	for	ADP
eurjchem-2084	359	2	large	large	ADJ
eurjchem-2084	359	3	scale	scale	NOUN
eurjchem-2084	359	4	production	production	NOUN
eurjchem-2084	359	5	of	of	ADP
eurjchem-2084	359	6	vaccine	vaccine	NOUN
eurjchem-2084	359	7	doses	dose	NOUN
eurjchem-2084	359	8	,	,	PUNCT
eurjchem-2084	359	9	the	the	DET
eurjchem-2084	359	10	company	company	NOUN
eurjchem-2084	359	11	also	also	ADV
eurjchem-2084	359	12	plans	plan	VERB
eurjchem-2084	359	13	to	to	PART
eurjchem-2084	359	14	use	use	VERB
eurjchem-2084	359	15	adjuvant	adjuvant	NOUN
eurjchem-2084	359	16	with	with	ADP
eurjchem-2084	359	17	vlp	vlp	PROPN
eurjchem-2084	360	1	[	[	X
eurjchem-2084	360	2	109	109	NUM
eurjchem-2084	360	3	]	]	PUNCT
eurjchem-2084	360	4	a	a	DET
eurjchem-2084	360	5	recent	recent	ADJ
eurjchem-2084	360	6	study	study	NOUN
eurjchem-2084	360	7	by	by	ADP
eurjchem-2084	360	8	rajapaksha	rajapaksha	PROPN
eurjchem-2084	360	9	et	et	PROPN
eurjchem-2084	360	10	.	.	PUNCT
eurjchem-2084	361	1	al	al	PROPN
eurjchem-2084	361	2	.	.	PROPN
eurjchem-2084	361	3	showed	show	VERB
eurjchem-2084	361	4	that	that	SCONJ
eurjchem-2084	361	5	the	the	DET
eurjchem-2084	361	6	phytochemicals	phytochemical	NOUN
eurjchem-2084	361	7	(	(	PUNCT
eurjchem-2084	361	8	taepeenin	taepeenin	INTJ
eurjchem-2084	361	9	j	j	PROPN
eurjchem-2084	361	10	and	and	CCONJ
eurjchem-2084	361	11	nortaepeenin	nortaepeenin	PROPN
eurjchem-2084	361	12	b	b	X
eurjchem-2084	361	13	)	)	PUNCT
eurjchem-2084	361	14	found	find	VERB
eurjchem-2084	361	15	in	in	ADP
eurjchem-2084	361	16	existing	exist	VERB
eurjchem-2084	361	17	ayurveda	ayurveda	NOUN
eurjchem-2084	361	18	drugs	drug	NOUN
eurjchem-2084	361	19	have	have	VERB
eurjchem-2084	361	20	the	the	DET
eurjchem-2084	361	21	ability	ability	NOUN
eurjchem-2084	361	22	to	to	PART
eurjchem-2084	361	23	inhibit	inhibit	VERB
eurjchem-2084	361	24	the	the	DET
eurjchem-2084	361	25	interleukin	interleukin	NOUN
eurjchem-2084	361	26	6	6	NUM
eurjchem-2084	361	27	(	(	PUNCT
eurjchem-2084	361	28	il-6r	il-6r	VERB
eurjchem-2084	361	29	)	)	PUNCT
eurjchem-2084	361	30	and	and	CCONJ
eurjchem-2084	361	31	interleukin	interleukin	NOUN
eurjchem-2084	361	32	1	1	NUM
eurjchem-2084	361	33	(	(	PUNCT
eurjchem-2084	361	34	il-1r	il-1r	NOUN
eurjchem-2084	361	35	)	)	PUNCT
eurjchem-2084	361	36	receptors	receptor	NOUN
eurjchem-2084	361	37	and	and	CCONJ
eurjchem-2084	361	38	are	be	AUX
eurjchem-2084	361	39	the	the	DET
eurjchem-2084	361	40	potential	potential	ADJ
eurjchem-2084	361	41	candidates	candidate	NOUN
eurjchem-2084	361	42	for	for	ADP
eurjchem-2084	361	43	further	far	ADV
eurjchem-2084	361	44	in	in	ADP
eurjchem-2084	361	45	vitro	vitro	X
eurjchem-2084	361	46	studies	study	NOUN
eurjchem-2084	361	47	for	for	ADP
eurjchem-2084	361	48	the	the	DET
eurjchem-2084	361	49	development	development	NOUN
eurjchem-2084	361	50	of	of	ADP
eurjchem-2084	361	51	medicine	medicine	NOUN
eurjchem-2084	361	52	against	against	ADP
eurjchem-2084	361	53	cytokine	cytokine	NOUN
eurjchem-2084	361	54	storm	storm	NOUN
eurjchem-2084	361	55	on	on	ADP
eurjchem-2084	361	56	behalf	behalf	NOUN
eurjchem-2084	361	57	of	of	ADP
eurjchem-2084	361	58	sars	sar	NOUN
eurjchem-2084	361	59	-	-	PUNCT
eurjchem-2084	361	60	cov-2	cov-2	NOUN
eurjchem-2084	361	61	infected	infected	ADJ
eurjchem-2084	361	62	patients	patient	NOUN
eurjchem-2084	361	63	.	.	PUNCT
eurjchem-2084	362	1	the	the	DET
eurjchem-2084	362	2	study	study	NOUN
eurjchem-2084	362	3	was	be	AUX
eurjchem-2084	362	4	proved	prove	VERB
eurjchem-2084	362	5	through	through	ADP
eurjchem-2084	362	6	computational	computational	ADJ
eurjchem-2084	362	7	investigation	investigation	NOUN
eurjchem-2084	362	8	of	of	ADP
eurjchem-2084	362	9	possible	possible	ADJ
eurjchem-2084	362	10	allosteric	allosteric	ADJ
eurjchem-2084	362	11	inhibitory	inhibitory	ADJ
eurjchem-2084	362	12	actions	action	NOUN
eurjchem-2084	362	13	on	on	ADP
eurjchem-2084	362	14	il-6r	il-6r	VERB
eurjchem-2084	362	15	and	and	CCONJ
eurjchem-2084	362	16	il-1r	il-1r	NOUN
eurjchem-2084	362	17	using	use	VERB
eurjchem-2084	362	18	selected	select	VERB
eurjchem-2084	362	19	phytochemicals	phytochemical	NOUN
eurjchem-2084	362	20	[	[	X
eurjchem-2084	362	21	110	110	NUM
eurjchem-2084	362	22	]	]	SYM
eurjchem-2084	362	23	.	.	PUNCT
eurjchem-2084	363	1	8	8	X
eurjchem-2084	363	2	.	.	X
eurjchem-2084	364	1	conclusion	conclusion	NOUN
eurjchem-2084	364	2	covid-19	covid-19	PROPN
eurjchem-2084	364	3	is	be	AUX
eurjchem-2084	364	4	not	not	PART
eurjchem-2084	364	5	only	only	ADV
eurjchem-2084	364	6	a	a	DET
eurjchem-2084	364	7	massive	massive	ADJ
eurjchem-2084	364	8	health	health	NOUN
eurjchem-2084	364	9	crisis	crisis	NOUN
eurjchem-2084	364	10	but	but	CCONJ
eurjchem-2084	364	11	also	also	ADV
eurjchem-2084	364	12	a	a	DET
eurjchem-2084	364	13	threat	threat	NOUN
eurjchem-2084	364	14	to	to	ADP
eurjchem-2084	364	15	human	human	ADJ
eurjchem-2084	364	16	life	life	NOUN
eurjchem-2084	364	17	and	and	CCONJ
eurjchem-2084	364	18	development	development	NOUN
eurjchem-2084	364	19	globally	globally	ADV
eurjchem-2084	364	20	.	.	PUNCT
eurjchem-2084	365	1	the	the	DET
eurjchem-2084	365	2	pandemic	pandemic	NOUN
eurjchem-2084	365	3	is	be	AUX
eurjchem-2084	365	4	moving	move	VERB
eurjchem-2084	365	5	like	like	ADP
eurjchem-2084	365	6	a	a	DET
eurjchem-2084	365	7	wave	wave	NOUN
eurjchem-2084	365	8	leaving	leave	VERB
eurjchem-2084	365	9	in	in	ADP
eurjchem-2084	365	10	deaths	death	NOUN
eurjchem-2084	365	11	,	,	PUNCT
eurjchem-2084	365	12	damaging	damaging	ADJ
eurjchem-2084	365	13	immune	immune	ADJ
eurjchem-2084	365	14	systems	system	NOUN
eurjchem-2084	365	15	,	,	PUNCT
eurjchem-2084	365	16	and	and	CCONJ
eurjchem-2084	365	17	weakening	weaken	VERB
eurjchem-2084	365	18	economies	economy	NOUN
eurjchem-2084	365	19	globally	globally	ADV
eurjchem-2084	365	20	.	.	PUNCT
eurjchem-2084	366	1	though	though	ADV
eurjchem-2084	366	2	,	,	PUNCT
eurjchem-2084	366	3	the	the	DET
eurjchem-2084	366	4	virus	virus	NOUN
eurjchem-2084	366	5	went	go	VERB
eurjchem-2084	366	6	with	with	ADP
eurjchem-2084	366	7	some	some	DET
eurjchem-2084	366	8	mutations	mutation	NOUN
eurjchem-2084	366	9	and	and	CCONJ
eurjchem-2084	366	10	its	its	PRON
eurjchem-2084	366	11	severity	severity	NOUN
eurjchem-2084	366	12	is	be	AUX
eurjchem-2084	366	13	weakening	weaken	VERB
eurjchem-2084	366	14	,	,	PUNCT
eurjchem-2084	366	15	the	the	DET
eurjchem-2084	366	16	transmission	transmission	NOUN
eurjchem-2084	366	17	is	be	AUX
eurjchem-2084	366	18	still	still	ADV
eurjchem-2084	366	19	very	very	ADV
eurjchem-2084	366	20	high	high	ADJ
eurjchem-2084	366	21	.	.	PUNCT
eurjchem-2084	367	1	currently	currently	ADV
eurjchem-2084	367	2	,	,	PUNCT
eurjchem-2084	367	3	the	the	DET
eurjchem-2084	367	4	world	world	NOUN
eurjchem-2084	367	5	is	be	AUX
eurjchem-2084	367	6	reopening	reopen	VERB
eurjchem-2084	367	7	but	but	CCONJ
eurjchem-2084	367	8	the	the	DET
eurjchem-2084	367	9	healing	healing	NOUN
eurjchem-2084	367	10	is	be	AUX
eurjchem-2084	367	11	uncertain	uncertain	ADJ
eurjchem-2084	367	12	as	as	SCONJ
eurjchem-2084	367	13	the	the	DET
eurjchem-2084	367	14	incidence	incidence	NOUN
eurjchem-2084	367	15	of	of	ADP
eurjchem-2084	367	16	new	new	ADJ
eurjchem-2084	367	17	cases	case	NOUN
eurjchem-2084	367	18	is	be	AUX
eurjchem-2084	367	19	constantly	constantly	ADV
eurjchem-2084	367	20	increasing	increase	VERB
eurjchem-2084	367	21	and	and	CCONJ
eurjchem-2084	367	22	some	some	DET
eurjchem-2084	367	23	countries	country	NOUN
eurjchem-2084	367	24	are	be	AUX
eurjchem-2084	367	25	going	go	VERB
eurjchem-2084	367	26	on	on	ADP
eurjchem-2084	367	27	lockdown	lockdown	NOUN
eurjchem-2084	367	28	again	again	ADV
eurjchem-2084	367	29	.	.	PUNCT
eurjchem-2084	368	1	to	to	PART
eurjchem-2084	368	2	treat	treat	VERB
eurjchem-2084	368	3	a	a	DET
eurjchem-2084	368	4	viral	viral	ADJ
eurjchem-2084	368	5	disease	disease	NOUN
eurjchem-2084	368	6	,	,	PUNCT
eurjchem-2084	368	7	vaccination	vaccination	NOUN
eurjchem-2084	368	8	and	and	CCONJ
eurjchem-2084	368	9	use	use	NOUN
eurjchem-2084	368	10	of	of	ADP
eurjchem-2084	368	11	antivirals	antiviral	NOUN
eurjchem-2084	368	12	are	be	AUX
eurjchem-2084	368	13	the	the	DET
eurjchem-2084	368	14	available	available	ADJ
eurjchem-2084	368	15	way	way	NOUN
eurjchem-2084	368	16	outs	out	NOUN
eurjchem-2084	368	17	.	.	PUNCT
eurjchem-2084	369	1	the	the	DET
eurjchem-2084	369	2	vaccine	vaccine	NOUN
eurjchem-2084	369	3	development	development	NOUN
eurjchem-2084	369	4	is	be	AUX
eurjchem-2084	369	5	a	a	DET
eurjchem-2084	369	6	tedious	tedious	ADJ
eurjchem-2084	369	7	and	and	CCONJ
eurjchem-2084	369	8	lengthy	lengthy	ADJ
eurjchem-2084	369	9	process	process	NOUN
eurjchem-2084	369	10	and	and	CCONJ
eurjchem-2084	369	11	some	some	PRON
eurjchem-2084	369	12	of	of	ADP
eurjchem-2084	369	13	the	the	DET
eurjchem-2084	369	14	approved	approve	VERB
eurjchem-2084	369	15	vaccines	vaccine	NOUN
eurjchem-2084	369	16	for	for	ADP
eurjchem-2084	369	17	emergency	emergency	NOUN
eurjchem-2084	369	18	use	use	NOUN
eurjchem-2084	369	19	arrived	arrive	VERB
eurjchem-2084	369	20	very	very	ADV
eurjchem-2084	369	21	recently	recently	ADV
eurjchem-2084	369	22	came	come	VERB
eurjchem-2084	369	23	in	in	ADP
eurjchem-2084	369	24	the	the	DET
eurjchem-2084	369	25	year	year	NOUN
eurjchem-2084	369	26	2020	2020	NUM
eurjchem-2084	369	27	-	-	SYM
eurjchem-2084	369	28	21	21	NUM
eurjchem-2084	369	29	.	.	PUNCT
eurjchem-2084	370	1	therefore	therefore	ADV
eurjchem-2084	370	2	,	,	PUNCT
eurjchem-2084	370	3	taking	take	VERB
eurjchem-2084	370	4	the	the	DET
eurjchem-2084	370	5	second	second	ADJ
eurjchem-2084	370	6	option	option	NOUN
eurjchem-2084	370	7	of	of	ADP
eurjchem-2084	370	8	using	use	VERB
eurjchem-2084	370	9	antivirals	antiviral	NOUN
eurjchem-2084	370	10	,	,	PUNCT
eurjchem-2084	370	11	scientists	scientist	NOUN
eurjchem-2084	370	12	started	start	VERB
eurjchem-2084	370	13	the	the	DET
eurjchem-2084	370	14	repurposing	repurposing	NOUN
eurjchem-2084	370	15	of	of	ADP
eurjchem-2084	370	16	existing	exist	VERB
eurjchem-2084	370	17	drugs	drug	NOUN
eurjchem-2084	370	18	to	to	PART
eurjchem-2084	370	19	treat	treat	VERB
eurjchem-2084	370	20	covid-19	covid-19	PROPN
eurjchem-2084	370	21	patients	patient	NOUN
eurjchem-2084	370	22	.	.	PUNCT
eurjchem-2084	371	1	however	however	ADV
eurjchem-2084	371	2	,	,	PUNCT
eurjchem-2084	371	3	in	in	ADP
eurjchem-2084	371	4	various	various	ADJ
eurjchem-2084	371	5	clinical	clinical	ADJ
eurjchem-2084	371	6	trials	trial	NOUN
eurjchem-2084	371	7	,	,	PUNCT
eurjchem-2084	371	8	the	the	DET
eurjchem-2084	371	9	drugs	drug	NOUN
eurjchem-2084	371	10	did	do	AUX
eurjchem-2084	371	11	not	not	PART
eurjchem-2084	371	12	show	show	VERB
eurjchem-2084	371	13	efficacy	efficacy	NOUN
eurjchem-2084	371	14	and	and	CCONJ
eurjchem-2084	371	15	in	in	ADP
eurjchem-2084	371	16	some	some	DET
eurjchem-2084	371	17	cases	case	NOUN
eurjchem-2084	371	18	produced	produce	VERB
eurjchem-2084	371	19	many	many	ADJ
eurjchem-2084	371	20	side	side	NOUN
eurjchem-2084	371	21	effects	effect	NOUN
eurjchem-2084	371	22	.	.	PUNCT
eurjchem-2084	372	1	to	to	PART
eurjchem-2084	372	2	overcome	overcome	VERB
eurjchem-2084	372	3	the	the	DET
eurjchem-2084	372	4	limitations	limitation	NOUN
eurjchem-2084	372	5	,	,	PUNCT
eurjchem-2084	372	6	combination	combination	NOUN
eurjchem-2084	372	7	of	of	ADP
eurjchem-2084	372	8	drugs	drug	NOUN
eurjchem-2084	372	9	/	/	SYM
eurjchem-2084	372	10	multidrug	multidrug	NOUN
eurjchem-2084	372	11	is	be	AUX
eurjchem-2084	372	12	being	be	AUX
eurjchem-2084	372	13	evaluated	evaluate	VERB
eurjchem-2084	372	14	and	and	CCONJ
eurjchem-2084	372	15	positive	positive	ADJ
eurjchem-2084	372	16	results	result	NOUN
eurjchem-2084	372	17	have	have	AUX
eurjchem-2084	372	18	come	come	VERB
eurjchem-2084	372	19	forth	forth	ADV
eurjchem-2084	372	20	in	in	ADP
eurjchem-2084	372	21	few	few	ADJ
eurjchem-2084	372	22	studies	study	NOUN
eurjchem-2084	372	23	.	.	PUNCT
eurjchem-2084	373	1	the	the	DET
eurjchem-2084	373	2	nature	nature	NOUN
eurjchem-2084	373	3	of	of	ADP
eurjchem-2084	373	4	virus	virus	NOUN
eurjchem-2084	373	5	is	be	AUX
eurjchem-2084	373	6	very	very	ADV
eurjchem-2084	373	7	unpredictable	unpredictable	ADJ
eurjchem-2084	373	8	,	,	PUNCT
eurjchem-2084	373	9	specifically	specifically	ADV
eurjchem-2084	373	10	,	,	PUNCT
eurjchem-2084	373	11	its	its	PRON
eurjchem-2084	373	12	new	new	ADJ
eurjchem-2084	373	13	variants	variant	NOUN
eurjchem-2084	373	14	due	due	ADP
eurjchem-2084	373	15	to	to	ADP
eurjchem-2084	373	16	the	the	DET
eurjchem-2084	373	17	mutations	mutation	NOUN
eurjchem-2084	373	18	in	in	ADP
eurjchem-2084	373	19	the	the	DET
eurjchem-2084	373	20	spike	spike	ADJ
eurjchem-2084	373	21	rbd	rbd	NOUN
eurjchem-2084	373	22	region	region	NOUN
eurjchem-2084	373	23	,	,	PUNCT
eurjchem-2084	373	24	but	but	CCONJ
eurjchem-2084	373	25	novel	novel	ADJ
eurjchem-2084	373	26	information	information	NOUN
eurjchem-2084	373	27	is	be	AUX
eurjchem-2084	373	28	continuously	continuously	ADV
eurjchem-2084	373	29	being	be	AUX
eurjchem-2084	373	30	added	add	VERB
eurjchem-2084	373	31	about	about	ADP
eurjchem-2084	373	32	the	the	DET
eurjchem-2084	373	33	nature	nature	NOUN
eurjchem-2084	373	34	and	and	CCONJ
eurjchem-2084	373	35	mechanism	mechanism	NOUN
eurjchem-2084	373	36	of	of	ADP
eurjchem-2084	373	37	viral	viral	ADJ
eurjchem-2084	373	38	action	action	NOUN
eurjchem-2084	373	39	.	.	PUNCT
eurjchem-2084	374	1	therefore	therefore	ADV
eurjchem-2084	374	2	,	,	PUNCT
eurjchem-2084	374	3	the	the	DET
eurjchem-2084	374	4	longevity	longevity	NOUN
eurjchem-2084	374	5	of	of	ADP
eurjchem-2084	374	6	any	any	DET
eurjchem-2084	374	7	existing	exist	VERB
eurjchem-2084	374	8	drug	drug	NOUN
eurjchem-2084	374	9	could	could	AUX
eurjchem-2084	374	10	not	not	PART
eurjchem-2084	374	11	be	be	AUX
eurjchem-2084	374	12	ascertained	ascertain	VERB
eurjchem-2084	374	13	.	.	PUNCT
eurjchem-2084	375	1	moreover	moreover	ADV
eurjchem-2084	375	2	,	,	PUNCT
eurjchem-2084	375	3	looking	look	VERB
eurjchem-2084	375	4	at	at	ADP
eurjchem-2084	375	5	the	the	DET
eurjchem-2084	375	6	past	past	ADJ
eurjchem-2084	375	7	pandemics	pandemic	NOUN
eurjchem-2084	375	8	,	,	PUNCT
eurjchem-2084	375	9	the	the	DET
eurjchem-2084	375	10	arrival	arrival	NOUN
eurjchem-2084	375	11	of	of	ADP
eurjchem-2084	375	12	another	another	DET
eurjchem-2084	375	13	pandemic	pandemic	ADJ
eurjchem-2084	375	14	era	era	NOUN
eurjchem-2084	375	15	can	can	AUX
eurjchem-2084	375	16	not	not	PART
eurjchem-2084	375	17	be	be	AUX
eurjchem-2084	375	18	ruled	rule	VERB
eurjchem-2084	375	19	out	out	ADP
eurjchem-2084	375	20	.	.	PUNCT
eurjchem-2084	376	1	new	new	ADJ
eurjchem-2084	376	2	approaches	approach	NOUN
eurjchem-2084	376	3	to	to	PART
eurjchem-2084	376	4	treat	treat	VERB
eurjchem-2084	376	5	/	/	SYM
eurjchem-2084	376	6	manage	manage	VERB
eurjchem-2084	376	7	coronaviruses	coronaviruse	NOUN
eurjchem-2084	376	8	infections	infection	NOUN
eurjchem-2084	376	9	are	be	AUX
eurjchem-2084	376	10	the	the	DET
eurjchem-2084	376	11	need	need	NOUN
eurjchem-2084	376	12	of	of	ADP
eurjchem-2084	376	13	the	the	DET
eurjchem-2084	376	14	hour	hour	NOUN
eurjchem-2084	376	15	considering	consider	VERB
eurjchem-2084	376	16	the	the	DET
eurjchem-2084	376	17	overall	overall	ADJ
eurjchem-2084	376	18	global	global	ADJ
eurjchem-2084	376	19	scenario	scenario	NOUN
eurjchem-2084	376	20	.	.	PUNCT
eurjchem-2084	377	1	plant	plant	NOUN
eurjchem-2084	377	2	based	base	VERB
eurjchem-2084	377	3	products	product	NOUN
eurjchem-2084	377	4	are	be	AUX
eurjchem-2084	377	5	being	be	AUX
eurjchem-2084	377	6	used	use	VERB
eurjchem-2084	377	7	since	since	SCONJ
eurjchem-2084	377	8	ancient	ancient	ADJ
eurjchem-2084	377	9	times	time	NOUN
eurjchem-2084	377	10	against	against	ADP
eurjchem-2084	377	11	infectious	infectious	ADJ
eurjchem-2084	377	12	diseases	disease	NOUN
eurjchem-2084	377	13	.	.	PUNCT
eurjchem-2084	378	1	plant	plant	NOUN
eurjchem-2084	378	2	based	base	VERB
eurjchem-2084	378	3	vaccines	vaccine	NOUN
eurjchem-2084	378	4	have	have	AUX
eurjchem-2084	378	5	also	also	ADV
eurjchem-2084	378	6	passed	pass	VERB
eurjchem-2084	378	7	the	the	DET
eurjchem-2084	378	8	phase	phase	NOUN
eurjchem-2084	378	9	1	1	NUM
eurjchem-2084	378	10	clinical	clinical	ADJ
eurjchem-2084	378	11	trial	trial	NOUN
eurjchem-2084	378	12	and	and	CCONJ
eurjchem-2084	378	13	have	have	AUX
eurjchem-2084	378	14	entered	enter	VERB
eurjchem-2084	378	15	in	in	ADP
eurjchem-2084	378	16	phase	phase	NOUN
eurjchem-2084	378	17	2/3	2/3	NUM
eurjchem-2084	378	18	.	.	PUNCT
eurjchem-2084	379	1	phytochemicals	phytochemical	NOUN
eurjchem-2084	379	2	like	like	ADP
eurjchem-2084	379	3	alkaloids	alkaloid	NOUN
eurjchem-2084	379	4	,	,	PUNCT
eurjchem-2084	379	5	flavonoids	flavonoid	NOUN
eurjchem-2084	379	6	,	,	PUNCT
eurjchem-2084	379	7	saponins	saponin	NOUN
eurjchem-2084	379	8	,	,	PUNCT
eurjchem-2084	379	9	terpenoids	terpenoid	NOUN
eurjchem-2084	379	10	,	,	PUNCT
eurjchem-2084	379	11	and	and	CCONJ
eurjchem-2084	379	12	essential	essential	ADJ
eurjchem-2084	379	13	oils	oil	NOUN
eurjchem-2084	379	14	possess	possess	VERB
eurjchem-2084	379	15	strong	strong	ADJ
eurjchem-2084	379	16	antioxidant	antioxidant	ADJ
eurjchem-2084	379	17	properties	property	NOUN
eurjchem-2084	379	18	and	and	CCONJ
eurjchem-2084	379	19	could	could	AUX
eurjchem-2084	379	20	give	give	VERB
eurjchem-2084	379	21	promising	promising	ADJ
eurjchem-2084	379	22	results	result	NOUN
eurjchem-2084	379	23	in	in	ADP
eurjchem-2084	379	24	developing	develop	VERB
eurjchem-2084	379	25	antivirals	antiviral	NOUN
eurjchem-2084	379	26	and	and	CCONJ
eurjchem-2084	379	27	managing	manage	VERB
eurjchem-2084	379	28	the	the	DET
eurjchem-2084	379	29	severity	severity	NOUN
eurjchem-2084	379	30	of	of	ADP
eurjchem-2084	379	31	disease	disease	NOUN
eurjchem-2084	379	32	.	.	PUNCT
eurjchem-2084	380	1	structural	structural	ADJ
eurjchem-2084	380	2	modifications	modification	NOUN
eurjchem-2084	380	3	in	in	ADP
eurjchem-2084	380	4	existing	exist	VERB
eurjchem-2084	380	5	drugs	drug	NOUN
eurjchem-2084	380	6	by	by	ADP
eurjchem-2084	380	7	reducing	reduce	VERB
eurjchem-2084	380	8	the	the	DET
eurjchem-2084	380	9	toxicity	toxicity	NOUN
eurjchem-2084	380	10	and	and	CCONJ
eurjchem-2084	380	11	improving	improve	VERB
eurjchem-2084	380	12	efficacy	efficacy	NOUN
eurjchem-2084	380	13	may	may	AUX
eurjchem-2084	380	14	also	also	ADV
eurjchem-2084	380	15	be	be	AUX
eurjchem-2084	380	16	useful	useful	ADJ
eurjchem-2084	380	17	in	in	ADP
eurjchem-2084	380	18	disease	disease	NOUN
eurjchem-2084	380	19	control	control	NOUN
eurjchem-2084	380	20	.	.	PUNCT
eurjchem-2084	381	1	acknowledgements	acknowledgement	NOUN
eurjchem-2084	381	2	zeba	zeba	PROPN
eurjchem-2084	381	3	firdaus	firdaus	PROPN
eurjchem-2084	381	4	is	be	AUX
eurjchem-2084	381	5	thankful	thankful	ADJ
eurjchem-2084	381	6	to	to	ADP
eurjchem-2084	381	7	council	council	PROPN
eurjchem-2084	381	8	of	of	ADP
eurjchem-2084	381	9	scientific	scientific	ADJ
eurjchem-2084	381	10	and	and	CCONJ
eurjchem-2084	381	11	industrial	industrial	ADJ
eurjchem-2084	381	12	research	research	NOUN
eurjchem-2084	381	13	(	(	PUNCT
eurjchem-2084	381	14	csir	csir	PROPN
eurjchem-2084	381	15	)	)	PUNCT
eurjchem-2084	381	16	,	,	PUNCT
eurjchem-2084	381	17	india	india	PROPN
eurjchem-2084	381	18	for	for	ADP
eurjchem-2084	381	19	providing	provide	VERB
eurjchem-2084	381	20	a	a	DET
eurjchem-2084	381	21	fellowship	fellowship	NOUN
eurjchem-2084	381	22	grant	grant	NOUN
eurjchem-2084	381	23	.	.	PUNCT
eurjchem-2084	382	1	disclosure	disclosure	NOUN
eurjchem-2084	382	2	statement	statement	NOUN
eurjchem-2084	382	3	conflict	conflict	NOUN
eurjchem-2084	382	4	of	of	ADP
eurjchem-2084	382	5	interests	interest	NOUN
eurjchem-2084	382	6	:	:	PUNCT
eurjchem-2084	382	7	the	the	DET
eurjchem-2084	382	8	authors	author	NOUN
eurjchem-2084	382	9	declare	declare	VERB
eurjchem-2084	382	10	that	that	SCONJ
eurjchem-2084	382	11	they	they	PRON
eurjchem-2084	382	12	have	have	VERB
eurjchem-2084	382	13	no	no	DET
eurjchem-2084	382	14	conflict	conflict	NOUN
eurjchem-2084	382	15	of	of	ADP
eurjchem-2084	382	16	interest	interest	NOUN
eurjchem-2084	382	17	.	.	PUNCT
eurjchem-2084	383	1	author	author	NOUN
eurjchem-2084	383	2	contributions	contribution	NOUN
eurjchem-2084	383	3	:	:	PUNCT
eurjchem-2084	383	4	all	all	DET
eurjchem-2084	383	5	authors	author	NOUN
eurjchem-2084	383	6	contributed	contribute	VERB
eurjchem-2084	383	7	equally	equally	ADV
eurjchem-2084	383	8	to	to	ADP
eurjchem-2084	383	9	this	this	DET
eurjchem-2084	383	10	work	work	NOUN
eurjchem-2084	383	11	.	.	PUNCT
eurjchem-2084	384	1	ethical	ethical	ADJ
eurjchem-2084	384	2	approval	approval	NOUN
eurjchem-2084	384	3	:	:	PUNCT
eurjchem-2084	385	1	all	all	DET
eurjchem-2084	385	2	ethical	ethical	ADJ
eurjchem-2084	385	3	guidelines	guideline	NOUN
eurjchem-2084	385	4	have	have	AUX
eurjchem-2084	385	5	been	be	AUX
eurjchem-2084	385	6	adhered	adhere	VERB
eurjchem-2084	385	7	.	.	PUNCT
eurjchem-2084	386	1	orcid	orcid	PROPN
eurjchem-2084	386	2	zeba	zeba	PROPN
eurjchem-2084	386	3	firdaus	firdaus	PROPN
eurjchem-2084	386	4	https://orcid.org/0000-0003-1169-9390	https://orcid.org/0000-0003-1169-9390	PROPN
eurjchem-2084	386	5	sushil	sushil	PROPN
eurjchem-2084	386	6	kumar	kumar	PROPN
eurjchem-2084	386	7	singh	singh	PROPN
eurjchem-2084	386	8	https://orcid.org/0000-0003-0473-5824	https://orcid.org/0000-0003-0473-5824	PROPN
eurjchem-2084	386	9	tryambak	tryambak	VERB
eurjchem-2084	386	10	deo	deo	NOUN
eurjchem-2084	386	11	singh	singh	PROPN
eurjchem-2084	386	12	https://orcid.org/0000-0001-7935-0457	https://orcid.org/0000-0001-7935-0457	PROPN
eurjchem-2084	386	13	meenakshi	meenakshi	PROPN
eurjchem-2084	386	14	singh	singh	PROPN
eurjchem-2084	386	15	https://orcid.org/0000-0002-6247-5242	https://orcid.org/0000-0002-6247-5242	PROPN
eurjchem-2084	386	16	references	reference	NOUN
eurjchem-2084	386	17	[	[	X
eurjchem-2084	386	18	1	1	NUM
eurjchem-2084	386	19	]	]	PUNCT
eurjchem-2084	386	20	.	.	PUNCT
eurjchem-2084	387	1	zhang	zhang	PROPN
eurjchem-2084	387	2	,	,	PUNCT
eurjchem-2084	387	3	q.	q.	PROPN
eurjchem-2084	387	4	;	;	PUNCT
eurjchem-2084	387	5	wang	wang	PROPN
eurjchem-2084	387	6	,	,	PUNCT
eurjchem-2084	387	7	y.	y.	PROPN
eurjchem-2084	387	8	;	;	PUNCT
eurjchem-2084	387	9	qi	qi	PROPN
eurjchem-2084	387	10	,	,	PUNCT
eurjchem-2084	387	11	c.	c.	PROPN
eurjchem-2084	387	12	;	;	PUNCT
eurjchem-2084	387	13	shen	shen	PROPN
eurjchem-2084	387	14	,	,	PUNCT
eurjchem-2084	387	15	l.	l.	PROPN
eurjchem-2084	387	16	;	;	PUNCT
eurjchem-2084	387	17	li	li	PROPN
eurjchem-2084	387	18	,	,	PUNCT
eurjchem-2084	387	19	j.	j.	PROPN
eurjchem-2084	387	20	j.	j.	PROPN
eurjchem-2084	387	21	med	med	PROPN
eurjchem-2084	387	22	.	.	PUNCT
eurjchem-2084	387	23	virol	virol	PROPN
eurjchem-2084	387	24	.	.	PUNCT
eurjchem-2084	388	1	2020	2020	NUM
eurjchem-2084	388	2	,	,	PUNCT
eurjchem-2084	388	3	92	92	NUM
eurjchem-2084	388	4	(	(	PUNCT
eurjchem-2084	388	5	6	6	NUM
eurjchem-2084	388	6	)	)	PUNCT
eurjchem-2084	388	7	,	,	PUNCT
eurjchem-2084	388	8	540	540	NUM
eurjchem-2084	388	9	–	–	PUNCT
eurjchem-2084	388	10	545	545	NUM
eurjchem-2084	388	11	.	.	PUNCT
eurjchem-2084	389	1	[	[	X
eurjchem-2084	389	2	2	2	NUM
eurjchem-2084	389	3	]	]	PUNCT
eurjchem-2084	389	4	.	.	PUNCT
eurjchem-2084	390	1	lai	lai	PROPN
eurjchem-2084	390	2	,	,	PUNCT
eurjchem-2084	390	3	c.-c	c.-c	PROPN
eurjchem-2084	390	4	.	.	PUNCT
eurjchem-2084	390	5	;	;	PUNCT
eurjchem-2084	390	6	shih	shih	NOUN
eurjchem-2084	390	7	,	,	PUNCT
eurjchem-2084	390	8	t.-p	t.-p	PROPN
eurjchem-2084	390	9	.	.	PUNCT
eurjchem-2084	390	10	;	;	PUNCT
eurjchem-2084	390	11	ko	ko	PROPN
eurjchem-2084	390	12	,	,	PUNCT
eurjchem-2084	390	13	w.-c	w.-c	PROPN
eurjchem-2084	390	14	.	.	PUNCT
eurjchem-2084	390	15	;	;	PUNCT
eurjchem-2084	390	16	tang	tang	PROPN
eurjchem-2084	390	17	,	,	PUNCT
eurjchem-2084	390	18	h.-j	h.-j	PROPN
eurjchem-2084	390	19	.	.	PROPN
eurjchem-2084	390	20	;	;	PUNCT
eurjchem-2084	390	21	hsueh	hsueh	PROPN
eurjchem-2084	390	22	,	,	PUNCT
eurjchem-2084	390	23	p.-r	p.-r	PROPN
eurjchem-2084	390	24	.	.	PUNCT
eurjchem-2084	391	1	int	int	NOUN
eurjchem-2084	391	2	.	.	PUNCT
eurjchem-2084	392	1	j.	j.	PROPN
eurjchem-2084	392	2	antimicrob	antimicrob	PROPN
eurjchem-2084	392	3	.	.	PUNCT
eurjchem-2084	393	1	agents	agent	NOUN
eurjchem-2084	393	2	2020	2020	NUM
eurjchem-2084	393	3	,	,	PUNCT
eurjchem-2084	393	4	55	55	NUM
eurjchem-2084	393	5	(	(	PUNCT
eurjchem-2084	393	6	3	3	NUM
eurjchem-2084	393	7	)	)	PUNCT
eurjchem-2084	393	8	,	,	PUNCT
eurjchem-2084	393	9	105924	105924	NUM
eurjchem-2084	393	10	.	.	PUNCT
eurjchem-2084	394	1	[	[	X
eurjchem-2084	394	2	3	3	NUM
eurjchem-2084	394	3	]	]	PUNCT
eurjchem-2084	394	4	.	.	PUNCT
eurjchem-2084	395	1	zhang	zhang	PROPN
eurjchem-2084	395	2	,	,	PUNCT
eurjchem-2084	395	3	c.	c.	PROPN
eurjchem-2084	395	4	;	;	PUNCT
eurjchem-2084	395	5	zheng	zheng	PROPN
eurjchem-2084	395	6	,	,	PUNCT
eurjchem-2084	395	7	w.	w.	PROPN
eurjchem-2084	395	8	;	;	PUNCT
eurjchem-2084	395	9	huang	huang	PROPN
eurjchem-2084	395	10	,	,	PUNCT
eurjchem-2084	395	11	x.	x.	PROPN
eurjchem-2084	395	12	;	;	PUNCT
eurjchem-2084	395	13	bell	bell	PROPN
eurjchem-2084	395	14	,	,	PUNCT
eurjchem-2084	395	15	e.	e.	PROPN
eurjchem-2084	395	16	w.	w.	PROPN
eurjchem-2084	395	17	;	;	PUNCT
eurjchem-2084	395	18	zhou	zhou	PROPN
eurjchem-2084	395	19	,	,	PUNCT
eurjchem-2084	395	20	x.	x.	PROPN
eurjchem-2084	395	21	;	;	PUNCT
eurjchem-2084	395	22	zhang	zhang	PROPN
eurjchem-2084	395	23	,	,	PUNCT
eurjchem-2084	395	24	y.	y.	PROPN
eurjchem-2084	395	25	j.	j.	PROPN
eurjchem-2084	395	26	proteome	proteome	PROPN
eurjchem-2084	395	27	res	re	NOUN
eurjchem-2084	395	28	.	.	PUNCT
eurjchem-2084	395	29	2020	2020	NUM
eurjchem-2084	395	30	,	,	PUNCT
eurjchem-2084	395	31	19	19	NUM
eurjchem-2084	395	32	(	(	PUNCT
eurjchem-2084	395	33	4	4	NUM
eurjchem-2084	395	34	)	)	PUNCT
eurjchem-2084	395	35	,	,	PUNCT
eurjchem-2084	395	36	1351–1360	1351–1360	NUM
eurjchem-2084	395	37	.	.	PUNCT
eurjchem-2084	396	1	[	[	X
eurjchem-2084	396	2	4	4	NUM
eurjchem-2084	396	3	]	]	PUNCT
eurjchem-2084	396	4	.	.	PUNCT
eurjchem-2084	397	1	rohde	rohde	PROPN
eurjchem-2084	397	2	,	,	PUNCT
eurjchem-2084	397	3	r.	r.	PROPN
eurjchem-2084	397	4	,	,	PUNCT
eurjchem-2084	397	5	novel	novel	ADJ
eurjchem-2084	397	6	coronavirus	coronavirus	NOUN
eurjchem-2084	397	7	(	(	PUNCT
eurjchem-2084	397	8	2019	2019	NUM
eurjchem-2084	397	9	-	-	PUNCT
eurjchem-2084	397	10	ncov	ncov	NOUN
eurjchem-2084	397	11	)	)	PUNCT
eurjchem-2084	397	12	update	update	NOUN
eurjchem-2084	397	13	:	:	PUNCT
eurjchem-2084	397	14	uncoating	uncoate	VERB
eurjchem-2084	397	15	the	the	DET
eurjchem-2084	397	16	virus	virus	NOUN
eurjchem-2084	397	17	https://asm.org/articles/2020/january/2019-novel-corona	https://asm.org/articles/2020/january/2019-novel-corona	ADP
eurjchem-2084	397	18	virus-2019	virus-2019	NOUN
eurjchem-2084	397	19	-	-	PUNCT
eurjchem-2084	397	20	ncov	ncov	ADP
eurjchem-2084	397	21	-	-	PUNCT
eurjchem-2084	397	22	update	update	NOUN
eurjchem-2084	397	23	-	-	PUNCT
eurjchem-2084	397	24	uncoating	uncoating	NOUN
eurjchem-2084	397	25	(	(	PUNCT
eurjchem-2084	397	26	accessed	access	VERB
eurjchem-2084	397	27	december	december	PROPN
eurjchem-2084	397	28	9	9	NUM
eurjchem-2084	397	29	,	,	PUNCT
eurjchem-2084	397	30	2020	2020	NUM
eurjchem-2084	397	31	)	)	PUNCT
eurjchem-2084	397	32	.	.	PUNCT
eurjchem-2084	398	1	[	[	X
eurjchem-2084	398	2	5	5	NUM
eurjchem-2084	398	3	]	]	PUNCT
eurjchem-2084	398	4	.	.	PUNCT
eurjchem-2084	399	1	yamamoto	yamamoto	PROPN
eurjchem-2084	399	2	,	,	PUNCT
eurjchem-2084	399	3	n.	n.	PROPN
eurjchem-2084	399	4	;	;	PUNCT
eurjchem-2084	399	5	bauer	bauer	PROPN
eurjchem-2084	399	6	,	,	PUNCT
eurjchem-2084	399	7	g.	g.	PROPN
eurjchem-2084	399	8	med	med	PROPN
eurjchem-2084	399	9	.	.	PUNCT
eurjchem-2084	400	1	hypotheses	hypothesis	NOUN
eurjchem-2084	400	2	2020	2020	NUM
eurjchem-2084	400	3	,	,	PUNCT
eurjchem-2084	400	4	144	144	NUM
eurjchem-2084	400	5	(	(	PUNCT
eurjchem-2084	400	6	110160	110160	NUM
eurjchem-2084	400	7	)	)	PUNCT
eurjchem-2084	400	8	,	,	PUNCT
eurjchem-2084	400	9	110160	110160	NUM
eurjchem-2084	400	10	.	.	PUNCT
eurjchem-2084	401	1	[	[	X
eurjchem-2084	401	2	6	6	NUM
eurjchem-2084	401	3	]	]	PUNCT
eurjchem-2084	401	4	.	.	PUNCT
eurjchem-2084	402	1	toyoshima	toyoshima	PROPN
eurjchem-2084	402	2	,	,	PUNCT
eurjchem-2084	402	3	y.	y.	PROPN
eurjchem-2084	402	4	;	;	PUNCT
eurjchem-2084	402	5	nemoto	nemoto	NOUN
eurjchem-2084	402	6	,	,	PUNCT
eurjchem-2084	402	7	k.	k.	PROPN
eurjchem-2084	402	8	;	;	PUNCT
eurjchem-2084	402	9	matsumoto	matsumoto	PROPN
eurjchem-2084	402	10	,	,	PUNCT
eurjchem-2084	402	11	s.	s.	PROPN
eurjchem-2084	402	12	;	;	PUNCT
eurjchem-2084	402	13	nakamura	nakamura	PROPN
eurjchem-2084	402	14	,	,	PUNCT
eurjchem-2084	402	15	y.	y.	PROPN
eurjchem-2084	402	16	;	;	PUNCT
eurjchem-2084	402	17	kiyotani	kiyotani	PROPN
eurjchem-2084	402	18	,	,	PUNCT
eurjchem-2084	402	19	k.	k.	PROPN
eurjchem-2084	402	20	j.	j.	PROPN
eurjchem-2084	402	21	hum	hum	PROPN
eurjchem-2084	402	22	.	.	PUNCT
eurjchem-2084	403	1	genet	genet	NOUN
eurjchem-2084	403	2	.	.	PUNCT
eurjchem-2084	404	1	2020	2020	NUM
eurjchem-2084	404	2	,	,	PUNCT
eurjchem-2084	404	3	65	65	NUM
eurjchem-2084	404	4	(	(	PUNCT
eurjchem-2084	404	5	12	12	NUM
eurjchem-2084	404	6	)	)	PUNCT
eurjchem-2084	404	7	,	,	PUNCT
eurjchem-2084	404	8	1075–1082	1075–1082	NUM
eurjchem-2084	404	9	.	.	PUNCT
eurjchem-2084	405	1	[	[	X
eurjchem-2084	405	2	7	7	NUM
eurjchem-2084	405	3	]	]	PUNCT
eurjchem-2084	405	4	.	.	PUNCT
eurjchem-2084	406	1	who	who	PRON
eurjchem-2084	406	2	coronavirus	coronavirus	PROPN
eurjchem-2084	406	3	(	(	PUNCT
eurjchem-2084	406	4	covid-19	covid-19	PROPN
eurjchem-2084	406	5	)	)	PUNCT
eurjchem-2084	406	6	dashboard	dashboard	NOUN
eurjchem-2084	406	7	https://covid19.who.int/	https://covid19.who.int/	PROPN
eurjchem-2084	406	8	(	(	PUNCT
eurjchem-2084	406	9	accessed	access	VERB
eurjchem-2084	406	10	december	december	PROPN
eurjchem-2084	406	11	9	9	NUM
eurjchem-2084	406	12	,	,	PUNCT
eurjchem-2084	406	13	2020	2020	NUM
eurjchem-2084	406	14	)	)	PUNCT
eurjchem-2084	406	15	.	.	PUNCT
eurjchem-2084	407	1	[	[	X
eurjchem-2084	407	2	8	8	NUM
eurjchem-2084	407	3	]	]	PUNCT
eurjchem-2084	407	4	.	.	PUNCT
eurjchem-2084	408	1	moher	moher	PROPN
eurjchem-2084	408	2	,	,	PUNCT
eurjchem-2084	408	3	d.	d.	PROPN
eurjchem-2084	408	4	;	;	PUNCT
eurjchem-2084	408	5	liberati	liberati	PROPN
eurjchem-2084	408	6	,	,	PUNCT
eurjchem-2084	408	7	a.	a.	NOUN
eurjchem-2084	408	8	;	;	PUNCT
eurjchem-2084	408	9	tetzlaff	tetzlaff	NUM
eurjchem-2084	408	10	,	,	PUNCT
eurjchem-2084	408	11	j.	j.	PROPN
eurjchem-2084	408	12	;	;	PUNCT
eurjchem-2084	408	13	altman	altman	PROPN
eurjchem-2084	408	14	,	,	PUNCT
eurjchem-2084	408	15	d.	d.	PROPN
eurjchem-2084	408	16	g.	g.	PROPN
eurjchem-2084	408	17	plos	plos	PROPN
eurjchem-2084	408	18	med	med	PROPN
eurjchem-2084	408	19	.	.	PROPN
eurjchem-2084	408	20	2009	2009	NUM
eurjchem-2084	408	21	,	,	PUNCT
eurjchem-2084	408	22	6	6	NUM
eurjchem-2084	408	23	(	(	PUNCT
eurjchem-2084	408	24	7	7	NUM
eurjchem-2084	408	25	)	)	PUNCT
eurjchem-2084	408	26	,	,	PUNCT
eurjchem-2084	408	27	e1000097	e1000097	PROPN
eurjchem-2084	408	28	.	.	PUNCT
eurjchem-2084	409	1	[	[	X
eurjchem-2084	409	2	9	9	NUM
eurjchem-2084	409	3	]	]	PUNCT
eurjchem-2084	409	4	.	.	PUNCT
eurjchem-2084	410	1	chan	chan	PROPN
eurjchem-2084	410	2	,	,	PUNCT
eurjchem-2084	410	3	j.	j.	PROPN
eurjchem-2084	410	4	f.-w	f.-w	PROPN
eurjchem-2084	410	5	.	.	PROPN
eurjchem-2084	410	6	;	;	PUNCT
eurjchem-2084	410	7	to	to	PART
eurjchem-2084	410	8	,	,	PUNCT
eurjchem-2084	410	9	k.	k.	PROPN
eurjchem-2084	410	10	k.-w	k.-w	PROPN
eurjchem-2084	410	11	.	.	PUNCT
eurjchem-2084	410	12	;	;	PUNCT
eurjchem-2084	410	13	tse	tse	PROPN
eurjchem-2084	410	14	,	,	PUNCT
eurjchem-2084	410	15	h.	h.	PROPN
eurjchem-2084	410	16	;	;	PUNCT
eurjchem-2084	410	17	jin	jin	NOUN
eurjchem-2084	410	18	,	,	PUNCT
eurjchem-2084	410	19	d.-y	d.-y	PROPN
eurjchem-2084	410	20	.	.	PUNCT
eurjchem-2084	410	21	;	;	PUNCT
eurjchem-2084	410	22	yuen	yuen	PROPN
eurjchem-2084	410	23	,	,	PUNCT
eurjchem-2084	410	24	k.-y	k.-y	NOUN
eurjchem-2084	410	25	.	.	PUNCT
eurjchem-2084	411	1	trends	trend	NOUN
eurjchem-2084	411	2	microbiol	microbiol	PROPN
eurjchem-2084	411	3	.	.	PUNCT
eurjchem-2084	412	1	2013	2013	NUM
eurjchem-2084	412	2	,	,	PUNCT
eurjchem-2084	412	3	21	21	NUM
eurjchem-2084	412	4	(	(	PUNCT
eurjchem-2084	412	5	10	10	NUM
eurjchem-2084	412	6	)	)	PUNCT
eurjchem-2084	412	7	,	,	PUNCT
eurjchem-2084	412	8	544–555	544–555	NUM
eurjchem-2084	412	9	.	.	PUNCT
eurjchem-2084	413	1	[	[	X
eurjchem-2084	413	2	10	10	NUM
eurjchem-2084	413	3	]	]	PUNCT
eurjchem-2084	413	4	.	.	PUNCT
eurjchem-2084	414	1	wu	wu	PROPN
eurjchem-2084	414	2	,	,	PUNCT
eurjchem-2084	414	3	f.	f.	PROPN
eurjchem-2084	414	4	;	;	PUNCT
eurjchem-2084	414	5	zhao	zhao	PROPN
eurjchem-2084	414	6	,	,	PUNCT
eurjchem-2084	414	7	s.	s.	PROPN
eurjchem-2084	414	8	;	;	PUNCT
eurjchem-2084	414	9	yu	yu	PROPN
eurjchem-2084	414	10	,	,	PUNCT
eurjchem-2084	414	11	b.	b.	PROPN
eurjchem-2084	414	12	;	;	PUNCT
eurjchem-2084	414	13	chen	chen	PROPN
eurjchem-2084	414	14	,	,	PUNCT
eurjchem-2084	414	15	y.-m	y.-m	PROPN
eurjchem-2084	414	16	.	.	PUNCT
eurjchem-2084	414	17	;	;	PUNCT
eurjchem-2084	414	18	wang	wang	PROPN
eurjchem-2084	414	19	,	,	PUNCT
eurjchem-2084	414	20	w.	w.	PROPN
eurjchem-2084	414	21	;	;	PUNCT
eurjchem-2084	414	22	song	song	NOUN
eurjchem-2084	414	23	,	,	PUNCT
eurjchem-2084	414	24	z.-g	z.-g	PROPN
eurjchem-2084	414	25	.	.	PUNCT
eurjchem-2084	414	26	;	;	PUNCT
eurjchem-2084	414	27	hu	hu	PROPN
eurjchem-2084	414	28	,	,	PUNCT
eurjchem-2084	414	29	y.	y.	PROPN
eurjchem-2084	414	30	;	;	PUNCT
eurjchem-2084	414	31	tao	tao	PROPN
eurjchem-2084	414	32	,	,	PUNCT
eurjchem-2084	414	33	z.-w	z.-w	PROPN
eurjchem-2084	414	34	.	.	PUNCT
eurjchem-2084	414	35	;	;	PUNCT
eurjchem-2084	414	36	tian	tian	ADJ
eurjchem-2084	414	37	,	,	PUNCT
eurjchem-2084	414	38	j.-h	j.-h	PROPN
eurjchem-2084	414	39	.	.	PUNCT
eurjchem-2084	414	40	;	;	PUNCT
eurjchem-2084	414	41	pei	pei	PROPN
eurjchem-2084	414	42	,	,	PUNCT
eurjchem-2084	414	43	y.-y	y.-y	PROPN
eurjchem-2084	414	44	.	.	PUNCT
eurjchem-2084	414	45	;	;	PUNCT
eurjchem-2084	415	1	yuan	yuan	NOUN
eurjchem-2084	415	2	,	,	PUNCT
eurjchem-2084	415	3	m.-l	m.-l	PROPN
eurjchem-2084	415	4	.	.	PUNCT
eurjchem-2084	415	5	;	;	PUNCT
eurjchem-2084	415	6	zhang	zhang	PROPN
eurjchem-2084	415	7	,	,	PUNCT
eurjchem-2084	415	8	y.-l	y.-l	NOUN
eurjchem-2084	415	9	.	.	PUNCT
eurjchem-2084	415	10	;	;	PUNCT
eurjchem-2084	415	11	dai	dai	PROPN
eurjchem-2084	415	12	,	,	PUNCT
eurjchem-2084	415	13	f.-h	f.-h	PROPN
eurjchem-2084	415	14	.	.	PUNCT
eurjchem-2084	415	15	;	;	PUNCT
eurjchem-2084	416	1	liu	liu	PROPN
eurjchem-2084	416	2	,	,	PUNCT
eurjchem-2084	416	3	y.	y.	PROPN
eurjchem-2084	416	4	;	;	PUNCT
eurjchem-2084	416	5	https://orcid.org/0000-0003-1169-9390	https://orcid.org/0000-0003-1169-9390	PROPN
eurjchem-2084	416	6	https://orcid.org/0000-0003-0473-5824	https://orcid.org/0000-0003-0473-5824	VERB
eurjchem-2084	416	7	https://orcid.org/0000-0001-7935-0457	https://orcid.org/0000-0001-7935-0457	PROPN
eurjchem-2084	416	8	https://orcid.org/0000-0002-6247-5242	https://orcid.org/0000-0002-6247-5242	PROPN
eurjchem-2084	416	9	https://asm.org/articles/2020/january/2019-novel-corona%20virus-2019-ncov-update-uncoating	https://asm.org/articles/2020/january/2019-novel-corona%20virus-2019-ncov-update-uncoate	VERB
eurjchem-2084	416	10	https://asm.org/articles/2020/january/2019-novel-corona%20virus-2019-ncov-update-uncoating	https://asm.org/articles/2020/january/2019-novel-corona%20virus-2019-ncov-update-uncoate	VERB
eurjchem-2084	416	11	https://covid19.who.int/	https://covid19.who.int/	PROPN
eurjchem-2084	416	12	232	232	NUM
eurjchem-2084	417	1	firdaus	firdaus	PROPN
eurjchem-2084	417	2	et	et	PROPN
eurjchem-2084	417	3	al	al	PROPN
eurjchem-2084	417	4	.	.	PUNCT
eurjchem-2084	417	5	/	/	SYM
eurjchem-2084	417	6	european	european	PROPN
eurjchem-2084	417	7	journal	journal	PROPN
eurjchem-2084	417	8	of	of	ADP
eurjchem-2084	417	9	chemistry	chemistry	NOUN
eurjchem-2084	417	10	12	12	NUM
eurjchem-2084	417	11	(	(	PUNCT
eurjchem-2084	417	12	2	2	NUM
eurjchem-2084	417	13	)	)	PUNCT
eurjchem-2084	417	14	(	(	PUNCT
eurjchem-2084	417	15	2021	2021	NUM
eurjchem-2084	417	16	)	)	PUNCT
eurjchem-2084	417	17	222	222	NUM
eurjchem-2084	417	18	-	-	SYM
eurjchem-2084	417	19	234	234	NUM
eurjchem-2084	417	20	2021	2021	NUM
eurjchem-2084	417	21	–	–	PUNCT
eurjchem-2084	417	22	european	european	ADJ
eurjchem-2084	417	23	journal	journal	NOUN
eurjchem-2084	417	24	of	of	ADP
eurjchem-2084	417	25	chemistry	chemistry	NOUN
eurjchem-2084	417	26	–	–	PUNCT
eurjchem-2084	417	27	cc	cc	NOUN
eurjchem-2084	417	28	by	by	ADP
eurjchem-2084	417	29	nc	nc	PROPN
eurjchem-2084	417	30	–	–	PUNCT
eurjchem-2084	417	31	doi	doi	NOUN
eurjchem-2084	417	32	:	:	PUNCT
eurjchem-2084	417	33	10.5155	10.5155	NUM
eurjchem-2084	417	34	/	/	SYM
eurjchem-2084	417	35	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	417	36	-	-	PUNCT
eurjchem-2084	417	37	234.2084	234.2084	NUM
eurjchem-2084	417	38	wang	wang	NOUN
eurjchem-2084	417	39	,	,	PUNCT
eurjchem-2084	417	40	q.-m	q.-m	NOUN
eurjchem-2084	417	41	.	.	PUNCT
eurjchem-2084	417	42	;	;	PUNCT
eurjchem-2084	418	1	zheng	zheng	PROPN
eurjchem-2084	418	2	,	,	PUNCT
eurjchem-2084	418	3	j.-j	j.-j	PROPN
eurjchem-2084	418	4	.	.	PUNCT
eurjchem-2084	418	5	;	;	PUNCT
eurjchem-2084	418	6	xu	xu	PROPN
eurjchem-2084	418	7	,	,	PUNCT
eurjchem-2084	418	8	l.	l.	PROPN
eurjchem-2084	418	9	;	;	PUNCT
eurjchem-2084	418	10	holmes	holmes	PROPN
eurjchem-2084	418	11	,	,	PUNCT
eurjchem-2084	418	12	e.	e.	PROPN
eurjchem-2084	418	13	c.	c.	PROPN
eurjchem-2084	418	14	;	;	PUNCT
eurjchem-2084	418	15	zhang	zhang	PROPN
eurjchem-2084	418	16	,	,	PUNCT
eurjchem-2084	418	17	y.-z	y.-z	PROPN
eurjchem-2084	418	18	.	.	PUNCT
eurjchem-2084	419	1	nature	nature	NOUN
eurjchem-2084	419	2	2020	2020	NUM
eurjchem-2084	419	3	,	,	PUNCT
eurjchem-2084	419	4	579	579	NUM
eurjchem-2084	419	5	(	(	PUNCT
eurjchem-2084	419	6	7798	7798	NUM
eurjchem-2084	419	7	)	)	PUNCT
eurjchem-2084	419	8	,	,	PUNCT
eurjchem-2084	419	9	265–269	265–269	NUM
eurjchem-2084	419	10	.	.	PUNCT
eurjchem-2084	420	1	[	[	X
eurjchem-2084	420	2	11	11	NUM
eurjchem-2084	420	3	]	]	PUNCT
eurjchem-2084	420	4	.	.	PUNCT
eurjchem-2084	421	1	wu	wu	PROPN
eurjchem-2084	421	2	,	,	PUNCT
eurjchem-2084	421	3	a.	a.	PROPN
eurjchem-2084	421	4	;	;	PUNCT
eurjchem-2084	421	5	peng	peng	PROPN
eurjchem-2084	421	6	,	,	PUNCT
eurjchem-2084	421	7	y.	y.	PROPN
eurjchem-2084	421	8	;	;	PUNCT
eurjchem-2084	421	9	huang	huang	PROPN
eurjchem-2084	421	10	,	,	PUNCT
eurjchem-2084	421	11	b.	b.	PROPN
eurjchem-2084	421	12	;	;	PUNCT
eurjchem-2084	421	13	ding	ding	NOUN
eurjchem-2084	421	14	,	,	PUNCT
eurjchem-2084	421	15	x.	x.	PROPN
eurjchem-2084	421	16	;	;	PUNCT
eurjchem-2084	421	17	wang	wang	PROPN
eurjchem-2084	421	18	,	,	PUNCT
eurjchem-2084	421	19	x.	x.	PROPN
eurjchem-2084	421	20	;	;	PUNCT
eurjchem-2084	421	21	niu	niu	PROPN
eurjchem-2084	421	22	,	,	PUNCT
eurjchem-2084	421	23	p.	p.	NOUN
eurjchem-2084	421	24	;	;	PUNCT
eurjchem-2084	421	25	meng	meng	PROPN
eurjchem-2084	421	26	,	,	PUNCT
eurjchem-2084	421	27	j.	j.	PROPN
eurjchem-2084	421	28	;	;	PUNCT
eurjchem-2084	421	29	zhu	zhu	PROPN
eurjchem-2084	421	30	,	,	PUNCT
eurjchem-2084	421	31	z.	z.	PROPN
eurjchem-2084	421	32	;	;	PUNCT
eurjchem-2084	421	33	zhang	zhang	PROPN
eurjchem-2084	421	34	,	,	PUNCT
eurjchem-2084	421	35	z.	z.	PROPN
eurjchem-2084	421	36	;	;	PUNCT
eurjchem-2084	421	37	wang	wang	PROPN
eurjchem-2084	421	38	,	,	PUNCT
eurjchem-2084	421	39	j.	j.	PROPN
eurjchem-2084	421	40	;	;	PUNCT
eurjchem-2084	421	41	sheng	sheng	PROPN
eurjchem-2084	421	42	,	,	PUNCT
eurjchem-2084	421	43	j.	j.	PROPN
eurjchem-2084	421	44	;	;	PUNCT
eurjchem-2084	421	45	quan	quan	PROPN
eurjchem-2084	421	46	,	,	PUNCT
eurjchem-2084	421	47	l.	l.	PROPN
eurjchem-2084	421	48	;	;	PUNCT
eurjchem-2084	421	49	xia	xia	PROPN
eurjchem-2084	421	50	,	,	PUNCT
eurjchem-2084	421	51	z.	z.	PROPN
eurjchem-2084	421	52	;	;	PUNCT
eurjchem-2084	421	53	tan	tan	PROPN
eurjchem-2084	421	54	,	,	PUNCT
eurjchem-2084	421	55	w.	w.	PROPN
eurjchem-2084	421	56	;	;	PUNCT
eurjchem-2084	421	57	cheng	cheng	PROPN
eurjchem-2084	421	58	,	,	PUNCT
eurjchem-2084	421	59	g.	g.	PROPN
eurjchem-2084	421	60	;	;	PUNCT
eurjchem-2084	421	61	jiang	jiang	PROPN
eurjchem-2084	421	62	,	,	PUNCT
eurjchem-2084	421	63	t.	t.	PROPN
eurjchem-2084	421	64	cell	cell	NOUN
eurjchem-2084	421	65	host	host	NOUN
eurjchem-2084	421	66	microbe	microbe	PROPN
eurjchem-2084	421	67	2020	2020	NUM
eurjchem-2084	421	68	,	,	PUNCT
eurjchem-2084	421	69	27	27	NUM
eurjchem-2084	421	70	(	(	PUNCT
eurjchem-2084	421	71	3	3	NUM
eurjchem-2084	421	72	)	)	PUNCT
eurjchem-2084	421	73	,	,	PUNCT
eurjchem-2084	421	74	325–328	325–328	NUM
eurjchem-2084	421	75	.	.	PUNCT
eurjchem-2084	422	1	[	[	X
eurjchem-2084	422	2	12	12	NUM
eurjchem-2084	422	3	]	]	PUNCT
eurjchem-2084	422	4	.	.	PUNCT
eurjchem-2084	423	1	li	li	PROPN
eurjchem-2084	423	2	,	,	PUNCT
eurjchem-2084	423	3	b.	b.	PROPN
eurjchem-2084	423	4	;	;	PUNCT
eurjchem-2084	423	5	si	si	PROPN
eurjchem-2084	423	6	,	,	PUNCT
eurjchem-2084	423	7	h.-r	h.-r	PROPN
eurjchem-2084	423	8	.	.	PUNCT
eurjchem-2084	423	9	;	;	PUNCT
eurjchem-2084	424	1	zhu	zhu	PROPN
eurjchem-2084	424	2	,	,	PUNCT
eurjchem-2084	424	3	y.	y.	PROPN
eurjchem-2084	424	4	;	;	PUNCT
eurjchem-2084	424	5	yang	yang	PROPN
eurjchem-2084	424	6	,	,	PUNCT
eurjchem-2084	424	7	x.-l	x.-l	PROPN
eurjchem-2084	424	8	.	.	PUNCT
eurjchem-2084	424	9	;	;	PUNCT
eurjchem-2084	424	10	anderson	anderson	PROPN
eurjchem-2084	424	11	,	,	PUNCT
eurjchem-2084	424	12	d.	d.	PROPN
eurjchem-2084	424	13	e.	e.	PROPN
eurjchem-2084	424	14	;	;	PUNCT
eurjchem-2084	424	15	shi	shi	PROPN
eurjchem-2084	424	16	,	,	PUNCT
eurjchem-2084	424	17	z.-l	z.-l	PROPN
eurjchem-2084	424	18	.	.	PUNCT
eurjchem-2084	424	19	;	;	PUNCT
eurjchem-2084	424	20	wang	wang	PROPN
eurjchem-2084	424	21	,	,	PUNCT
eurjchem-2084	424	22	l.f	l.f	PROPN
eurjchem-2084	424	23	.	.	PROPN
eurjchem-2084	424	24	;	;	PUNCT
eurjchem-2084	424	25	zhou	zhou	PROPN
eurjchem-2084	424	26	,	,	PUNCT
eurjchem-2084	424	27	p.	p.	PROPN
eurjchem-2084	424	28	d.	d.	PROPN
eurjchem-2084	424	29	msphere	msphere	PROPN
eurjchem-2084	424	30	2020	2020	NUM
eurjchem-2084	424	31	,	,	PUNCT
eurjchem-2084	424	32	5	5	NUM
eurjchem-2084	424	33	(	(	PUNCT
eurjchem-2084	424	34	1	1	NUM
eurjchem-2084	424	35	)	)	PUNCT
eurjchem-2084	424	36	.	.	PUNCT
eurjchem-2084	425	1	https://doi.org/10.1128/	https://doi.org/10.1128/	PROPN
eurjchem-2084	425	2	msphere.00807	msphere.00807	PROPN
eurjchem-2084	425	3	-	-	PUNCT
eurjchem-2084	425	4	19	19	NUM
eurjchem-2084	425	5	.	.	PUNCT
eurjchem-2084	426	1	[	[	X
eurjchem-2084	426	2	13	13	NUM
eurjchem-2084	426	3	]	]	PUNCT
eurjchem-2084	426	4	.	.	PUNCT
eurjchem-2084	427	1	rothan	rothan	PROPN
eurjchem-2084	427	2	,	,	PUNCT
eurjchem-2084	427	3	h.	h.	PROPN
eurjchem-2084	427	4	a.	a.	PROPN
eurjchem-2084	427	5	;	;	PUNCT
eurjchem-2084	427	6	byrareddy	byrareddy	PROPN
eurjchem-2084	427	7	,	,	PUNCT
eurjchem-2084	427	8	s.	s.	PROPN
eurjchem-2084	427	9	n.	n.	PROPN
eurjchem-2084	427	10	j.	j.	PROPN
eurjchem-2084	427	11	autoimmun	autoimmun	PROPN
eurjchem-2084	427	12	.	.	PUNCT
eurjchem-2084	428	1	2020	2020	NUM
eurjchem-2084	428	2	,	,	PUNCT
eurjchem-2084	428	3	109	109	NUM
eurjchem-2084	428	4	(	(	PUNCT
eurjchem-2084	428	5	102433	102433	NUM
eurjchem-2084	428	6	)	)	PUNCT
eurjchem-2084	428	7	,	,	PUNCT
eurjchem-2084	428	8	102433	102433	NUM
eurjchem-2084	428	9	.	.	PUNCT
eurjchem-2084	429	1	[	[	X
eurjchem-2084	429	2	14	14	NUM
eurjchem-2084	429	3	]	]	SYM
eurjchem-2084	429	4	.	.	PUNCT
eurjchem-2084	430	1	wu	wu	PROPN
eurjchem-2084	430	2	,	,	PUNCT
eurjchem-2084	430	3	c.	c.	PROPN
eurjchem-2084	430	4	;	;	PUNCT
eurjchem-2084	430	5	liu	liu	PROPN
eurjchem-2084	430	6	,	,	PUNCT
eurjchem-2084	430	7	y.	y.	PROPN
eurjchem-2084	430	8	;	;	PUNCT
eurjchem-2084	430	9	yang	yang	PROPN
eurjchem-2084	430	10	,	,	PUNCT
eurjchem-2084	430	11	y.	y.	PROPN
eurjchem-2084	430	12	;	;	PUNCT
eurjchem-2084	430	13	zhang	zhang	PROPN
eurjchem-2084	430	14	,	,	PUNCT
eurjchem-2084	430	15	p.	p.	PROPN
eurjchem-2084	430	16	;	;	PUNCT
eurjchem-2084	430	17	zhong	zhong	PROPN
eurjchem-2084	430	18	,	,	PUNCT
eurjchem-2084	430	19	w.	w.	PROPN
eurjchem-2084	430	20	;	;	PUNCT
eurjchem-2084	430	21	wang	wang	PROPN
eurjchem-2084	430	22	,	,	PUNCT
eurjchem-2084	430	23	y.	y.	PROPN
eurjchem-2084	430	24	;	;	PUNCT
eurjchem-2084	430	25	wang	wang	PROPN
eurjchem-2084	430	26	,	,	PUNCT
eurjchem-2084	430	27	q.	q.	PROPN
eurjchem-2084	430	28	;	;	PUNCT
eurjchem-2084	430	29	xu	xu	PROPN
eurjchem-2084	430	30	,	,	PUNCT
eurjchem-2084	430	31	y.	y.	PROPN
eurjchem-2084	430	32	;	;	PUNCT
eurjchem-2084	430	33	li	li	PROPN
eurjchem-2084	430	34	,	,	PUNCT
eurjchem-2084	430	35	m.	m.	NOUN
eurjchem-2084	430	36	;	;	PUNCT
eurjchem-2084	430	37	li	li	PROPN
eurjchem-2084	430	38	,	,	PUNCT
eurjchem-2084	430	39	x.	x.	PROPN
eurjchem-2084	430	40	;	;	PUNCT
eurjchem-2084	430	41	zheng	zheng	PROPN
eurjchem-2084	430	42	,	,	PUNCT
eurjchem-2084	430	43	m.	m.	NOUN
eurjchem-2084	430	44	;	;	PUNCT
eurjchem-2084	430	45	chen	chen	PROPN
eurjchem-2084	430	46	,	,	PUNCT
eurjchem-2084	430	47	l.	l.	PROPN
eurjchem-2084	430	48	;	;	PUNCT
eurjchem-2084	430	49	li	li	PROPN
eurjchem-2084	430	50	,	,	PUNCT
eurjchem-2084	430	51	h.	h.	PROPN
eurjchem-2084	430	52	acta	acta	PROPN
eurjchem-2084	430	53	pharm	pharm	PROPN
eurjchem-2084	430	54	.	.	PUNCT
eurjchem-2084	431	1	sin	sin	PROPN
eurjchem-2084	431	2	.	.	PUNCT
eurjchem-2084	432	1	b.	b.	PROPN
eurjchem-2084	432	2	2020	2020	NUM
eurjchem-2084	432	3	,	,	PUNCT
eurjchem-2084	432	4	10	10	NUM
eurjchem-2084	432	5	(	(	PUNCT
eurjchem-2084	432	6	5	5	NUM
eurjchem-2084	432	7	)	)	PUNCT
eurjchem-2084	432	8	,	,	PUNCT
eurjchem-2084	432	9	766–788	766–788	NUM
eurjchem-2084	432	10	.	.	PUNCT
eurjchem-2084	433	1	[	[	X
eurjchem-2084	433	2	15	15	NUM
eurjchem-2084	433	3	]	]	PUNCT
eurjchem-2084	433	4	.	.	PUNCT
eurjchem-2084	434	1	chen	chen	PROPN
eurjchem-2084	434	2	,	,	PUNCT
eurjchem-2084	434	3	y.	y.	PROPN
eurjchem-2084	434	4	;	;	PUNCT
eurjchem-2084	434	5	liu	liu	PROPN
eurjchem-2084	434	6	,	,	PUNCT
eurjchem-2084	434	7	q.	q.	PROPN
eurjchem-2084	434	8	;	;	PUNCT
eurjchem-2084	434	9	guo	guo	PROPN
eurjchem-2084	434	10	,	,	PUNCT
eurjchem-2084	434	11	d.	d.	PROPN
eurjchem-2084	434	12	j.	j.	PROPN
eurjchem-2084	434	13	med	med	PROPN
eurjchem-2084	434	14	.	.	PUNCT
eurjchem-2084	434	15	virol	virol	PROPN
eurjchem-2084	434	16	.	.	PUNCT
eurjchem-2084	435	1	2020	2020	NUM
eurjchem-2084	435	2	,	,	PUNCT
eurjchem-2084	435	3	92	92	NUM
eurjchem-2084	435	4	(	(	PUNCT
eurjchem-2084	435	5	4	4	NUM
eurjchem-2084	435	6	)	)	PUNCT
eurjchem-2084	435	7	,	,	PUNCT
eurjchem-2084	435	8	418–423	418–423	NUM
eurjchem-2084	435	9	.	.	PUNCT
eurjchem-2084	436	1	[	[	X
eurjchem-2084	436	2	16	16	NUM
eurjchem-2084	436	3	]	]	PUNCT
eurjchem-2084	436	4	.	.	PUNCT
eurjchem-2084	437	1	marian	marian	PROPN
eurjchem-2084	437	2	,	,	PUNCT
eurjchem-2084	437	3	a.	a.	PROPN
eurjchem-2084	437	4	j.	j.	PROPN
eurjchem-2084	437	5	cardiovasc	cardiovasc	PROPN
eurjchem-2084	437	6	.	.	PUNCT
eurjchem-2084	437	7	pathol	pathol	PROPN
eurjchem-2084	437	8	.	.	PUNCT
eurjchem-2084	438	1	2021	2021	NUM
eurjchem-2084	438	2	,	,	PUNCT
eurjchem-2084	438	3	50	50	NUM
eurjchem-2084	438	4	(	(	PUNCT
eurjchem-2084	438	5	107278	107278	NUM
eurjchem-2084	438	6	)	)	PUNCT
eurjchem-2084	438	7	,	,	PUNCT
eurjchem-2084	438	8	107278	107278	NUM
eurjchem-2084	438	9	.	.	PUNCT
eurjchem-2084	439	1	[	[	X
eurjchem-2084	439	2	17	17	NUM
eurjchem-2084	439	3	]	]	PUNCT
eurjchem-2084	439	4	.	.	PUNCT
eurjchem-2084	440	1	wan	wan	PROPN
eurjchem-2084	440	2	,	,	PUNCT
eurjchem-2084	440	3	y.	y.	PROPN
eurjchem-2084	440	4	;	;	PUNCT
eurjchem-2084	440	5	shang	shang	PROPN
eurjchem-2084	440	6	,	,	PUNCT
eurjchem-2084	440	7	j.	j.	PROPN
eurjchem-2084	440	8	;	;	PUNCT
eurjchem-2084	440	9	graham	graham	PROPN
eurjchem-2084	440	10	,	,	PUNCT
eurjchem-2084	440	11	r.	r.	PROPN
eurjchem-2084	440	12	;	;	PUNCT
eurjchem-2084	440	13	baric	baric	ADJ
eurjchem-2084	440	14	,	,	PUNCT
eurjchem-2084	440	15	r.	r.	PROPN
eurjchem-2084	440	16	s.	s.	PROPN
eurjchem-2084	440	17	;	;	PUNCT
eurjchem-2084	440	18	li	li	PROPN
eurjchem-2084	440	19	,	,	PUNCT
eurjchem-2084	440	20	f.	f.	PROPN
eurjchem-2084	440	21	j.	j.	PROPN
eurjchem-2084	440	22	virol	virol	PROPN
eurjchem-2084	440	23	.	.	PUNCT
eurjchem-2084	441	1	2020	2020	NUM
eurjchem-2084	441	2	,	,	PUNCT
eurjchem-2084	441	3	94	94	NUM
eurjchem-2084	441	4	(	(	PUNCT
eurjchem-2084	441	5	7	7	NUM
eurjchem-2084	441	6	)	)	PUNCT
eurjchem-2084	441	7	.	.	PUNCT
eurjchem-2084	442	1	https://doi.org/10.1128/jvi.00127-20	https://doi.org/10.1128/jvi.00127-20	PROPN
eurjchem-2084	442	2	.	.	PUNCT
eurjchem-2084	443	1	[	[	X
eurjchem-2084	443	2	18	18	NUM
eurjchem-2084	443	3	]	]	PUNCT
eurjchem-2084	443	4	.	.	PUNCT
eurjchem-2084	444	1	young	young	PROPN
eurjchem-2084	444	2	,	,	PUNCT
eurjchem-2084	444	3	b.	b.	PROPN
eurjchem-2084	444	4	e.	e.	PROPN
eurjchem-2084	444	5	;	;	PUNCT
eurjchem-2084	444	6	fong	fong	PROPN
eurjchem-2084	444	7	,	,	PUNCT
eurjchem-2084	444	8	s.-w	s.-w	PROPN
eurjchem-2084	444	9	.	.	PUNCT
eurjchem-2084	444	10	;	;	PUNCT
eurjchem-2084	444	11	chan	chan	PROPN
eurjchem-2084	444	12	,	,	PUNCT
eurjchem-2084	444	13	y.-h	y.-h	PROPN
eurjchem-2084	444	14	.	.	PUNCT
eurjchem-2084	444	15	;	;	PUNCT
eurjchem-2084	444	16	mak	mak	PROPN
eurjchem-2084	444	17	,	,	PUNCT
eurjchem-2084	444	18	t.-m	t.-m	NOUN
eurjchem-2084	444	19	.	.	PUNCT
eurjchem-2084	444	20	;	;	PUNCT
eurjchem-2084	445	1	ang	ang	PROPN
eurjchem-2084	445	2	,	,	PUNCT
eurjchem-2084	445	3	l.	l.	PROPN
eurjchem-2084	445	4	w.	w.	PROPN
eurjchem-2084	445	5	;	;	PUNCT
eurjchem-2084	445	6	anderson	anderson	PROPN
eurjchem-2084	445	7	,	,	PUNCT
eurjchem-2084	445	8	d.	d.	PROPN
eurjchem-2084	445	9	e.	e.	PROPN
eurjchem-2084	445	10	;	;	PUNCT
eurjchem-2084	445	11	lee	lee	PROPN
eurjchem-2084	445	12	,	,	PUNCT
eurjchem-2084	445	13	c.	c.	PROPN
eurjchem-2084	445	14	y.-p	y.-p	PROPN
eurjchem-2084	445	15	.	.	PUNCT
eurjchem-2084	445	16	;	;	PUNCT
eurjchem-2084	445	17	amrun	amrun	PROPN
eurjchem-2084	445	18	,	,	PUNCT
eurjchem-2084	445	19	s.	s.	PROPN
eurjchem-2084	445	20	n.	n.	PROPN
eurjchem-2084	445	21	;	;	PUNCT
eurjchem-2084	445	22	lee	lee	PROPN
eurjchem-2084	445	23	,	,	PUNCT
eurjchem-2084	445	24	b.	b.	PROPN
eurjchem-2084	445	25	;	;	PUNCT
eurjchem-2084	445	26	goh	goh	PROPN
eurjchem-2084	445	27	,	,	PUNCT
eurjchem-2084	445	28	y.	y.	PROPN
eurjchem-2084	445	29	s.	s.	PROPN
eurjchem-2084	445	30	;	;	PUNCT
eurjchem-2084	445	31	su	su	PROPN
eurjchem-2084	445	32	,	,	PUNCT
eurjchem-2084	445	33	y.	y.	PROPN
eurjchem-2084	445	34	c.	c.	PROPN
eurjchem-2084	445	35	f.	f.	PROPN
eurjchem-2084	445	36	;	;	PUNCT
eurjchem-2084	445	37	wei	wei	PROPN
eurjchem-2084	445	38	,	,	PUNCT
eurjchem-2084	445	39	w.	w.	PROPN
eurjchem-2084	445	40	e.	e.	PROPN
eurjchem-2084	445	41	;	;	PUNCT
eurjchem-2084	445	42	kalimuddin	kalimuddin	PROPN
eurjchem-2084	445	43	,	,	PUNCT
eurjchem-2084	445	44	s.	s.	PROPN
eurjchem-2084	445	45	;	;	PUNCT
eurjchem-2084	445	46	chai	chai	NOUN
eurjchem-2084	445	47	,	,	PUNCT
eurjchem-2084	445	48	l.	l.	PROPN
eurjchem-2084	445	49	y.	y.	PROPN
eurjchem-2084	445	50	a.	a.	PROPN
eurjchem-2084	445	51	;	;	PUNCT
eurjchem-2084	445	52	pada	pada	PROPN
eurjchem-2084	445	53	,	,	PUNCT
eurjchem-2084	445	54	s.	s.	PROPN
eurjchem-2084	445	55	;	;	PUNCT
eurjchem-2084	445	56	tan	tan	PROPN
eurjchem-2084	445	57	,	,	PUNCT
eurjchem-2084	445	58	s.	s.	PROPN
eurjchem-2084	445	59	y.	y.	PROPN
eurjchem-2084	445	60	;	;	PUNCT
eurjchem-2084	445	61	sun	sun	PROPN
eurjchem-2084	445	62	,	,	PUNCT
eurjchem-2084	445	63	l.	l.	PROPN
eurjchem-2084	445	64	;	;	PUNCT
eurjchem-2084	445	65	parthasarathy	parthasarathy	PROPN
eurjchem-2084	445	66	,	,	PUNCT
eurjchem-2084	445	67	p.	p.	PROPN
eurjchem-2084	445	68	;	;	PUNCT
eurjchem-2084	445	69	chen	chen	PROPN
eurjchem-2084	445	70	,	,	PUNCT
eurjchem-2084	445	71	y.	y.	PROPN
eurjchem-2084	445	72	y.	y.	PROPN
eurjchem-2084	445	73	c.	c.	PROPN
eurjchem-2084	445	74	;	;	PUNCT
eurjchem-2084	445	75	barkham	barkham	PROPN
eurjchem-2084	445	76	,	,	PUNCT
eurjchem-2084	445	77	t.	t.	PROPN
eurjchem-2084	445	78	;	;	PUNCT
eurjchem-2084	445	79	lin	lin	PROPN
eurjchem-2084	445	80	,	,	PUNCT
eurjchem-2084	445	81	r.	r.	PROPN
eurjchem-2084	445	82	t.	t.	PROPN
eurjchem-2084	445	83	p.	p.	PROPN
eurjchem-2084	445	84	;	;	PUNCT
eurjchem-2084	445	85	maurerstroh	maurerstroh	PROPN
eurjchem-2084	445	86	,	,	PUNCT
eurjchem-2084	445	87	s.	s.	PROPN
eurjchem-2084	445	88	;	;	PUNCT
eurjchem-2084	445	89	leo	leo	PROPN
eurjchem-2084	445	90	,	,	PUNCT
eurjchem-2084	445	91	y.-s	y.-	NOUN
eurjchem-2084	445	92	.	.	PUNCT
eurjchem-2084	445	93	;	;	PUNCT
eurjchem-2084	445	94	wang	wang	PROPN
eurjchem-2084	445	95	,	,	PUNCT
eurjchem-2084	445	96	l.-f	l.-f	NOUN
eurjchem-2084	445	97	.	.	PUNCT
eurjchem-2084	445	98	;	;	PUNCT
eurjchem-2084	445	99	renia	renia	PROPN
eurjchem-2084	445	100	,	,	PUNCT
eurjchem-2084	445	101	l.	l.	PROPN
eurjchem-2084	445	102	;	;	PUNCT
eurjchem-2084	445	103	lee	lee	PROPN
eurjchem-2084	445	104	,	,	PUNCT
eurjchem-2084	445	105	v.	v.	PROPN
eurjchem-2084	445	106	j.	j.	PROPN
eurjchem-2084	445	107	;	;	PUNCT
eurjchem-2084	445	108	smith	smith	PROPN
eurjchem-2084	445	109	,	,	PUNCT
eurjchem-2084	445	110	g.	g.	PROPN
eurjchem-2084	445	111	j.	j.	PROPN
eurjchem-2084	445	112	d.	d.	PROPN
eurjchem-2084	445	113	;	;	PUNCT
eurjchem-2084	445	114	lye	lye	PROPN
eurjchem-2084	445	115	,	,	PUNCT
eurjchem-2084	445	116	d.	d.	PROPN
eurjchem-2084	445	117	c.	c.	PROPN
eurjchem-2084	445	118	;	;	PUNCT
eurjchem-2084	445	119	ng	ng	PROPN
eurjchem-2084	445	120	,	,	PUNCT
eurjchem-2084	445	121	l.	l.	PROPN
eurjchem-2084	445	122	f.	f.	PROPN
eurjchem-2084	446	1	p.	p.	PROPN
eurjchem-2084	446	2	lancet	lancet	PROPN
eurjchem-2084	446	3	2020	2020	NUM
eurjchem-2084	446	4	,	,	PUNCT
eurjchem-2084	446	5	396	396	NUM
eurjchem-2084	446	6	(	(	PUNCT
eurjchem-2084	446	7	10251	10251	NUM
eurjchem-2084	446	8	)	)	PUNCT
eurjchem-2084	446	9	,	,	PUNCT
eurjchem-2084	446	10	603–611	603–611	NUM
eurjchem-2084	446	11	.	.	PUNCT
eurjchem-2084	447	1	[	[	X
eurjchem-2084	447	2	19	19	NUM
eurjchem-2084	447	3	]	]	PUNCT
eurjchem-2084	447	4	.	.	PUNCT
eurjchem-2084	448	1	mercatelli	mercatelli	PROPN
eurjchem-2084	448	2	,	,	PUNCT
eurjchem-2084	448	3	d.	d.	PROPN
eurjchem-2084	448	4	;	;	PUNCT
eurjchem-2084	448	5	giorgi	giorgi	PROPN
eurjchem-2084	448	6	,	,	PUNCT
eurjchem-2084	448	7	f.	f.	PROPN
eurjchem-2084	448	8	m.	m.	PROPN
eurjchem-2084	448	9	front	front	PROPN
eurjchem-2084	448	10	.	.	PUNCT
eurjchem-2084	449	1	microbiol	microbiol	PROPN
eurjchem-2084	449	2	.	.	PUNCT
eurjchem-2084	450	1	2020	2020	NUM
eurjchem-2084	450	2	,	,	PUNCT
eurjchem-2084	450	3	11	11	NUM
eurjchem-2084	450	4	.	.	PUNCT
eurjchem-2084	450	5	https://doi.org/	https://doi.org/	NOUN
eurjchem-2084	450	6	10.3389	10.3389	NUM
eurjchem-2084	450	7	/	/	SYM
eurjchem-2084	450	8	fmicb.2020.01800	fmicb.2020.01800	NOUN
eurjchem-2084	450	9	.	.	PUNCT
eurjchem-2084	451	1	[	[	X
eurjchem-2084	451	2	20	20	NUM
eurjchem-2084	451	3	]	]	PUNCT
eurjchem-2084	451	4	.	.	PUNCT
eurjchem-2084	452	1	dearlove	dearlove	PROPN
eurjchem-2084	452	2	,	,	PUNCT
eurjchem-2084	452	3	b.	b.	PROPN
eurjchem-2084	452	4	;	;	PUNCT
eurjchem-2084	452	5	lewitus	lewitus	PROPN
eurjchem-2084	452	6	,	,	PUNCT
eurjchem-2084	452	7	e.	e.	PROPN
eurjchem-2084	452	8	;	;	PUNCT
eurjchem-2084	452	9	bai	bai	PROPN
eurjchem-2084	452	10	,	,	PUNCT
eurjchem-2084	452	11	h.	h.	PROPN
eurjchem-2084	452	12	;	;	PUNCT
eurjchem-2084	452	13	li	li	PROPN
eurjchem-2084	452	14	,	,	PUNCT
eurjchem-2084	452	15	y.	y.	PROPN
eurjchem-2084	452	16	;	;	PUNCT
eurjchem-2084	452	17	reeves	reeves	PROPN
eurjchem-2084	452	18	,	,	PUNCT
eurjchem-2084	452	19	d.	d.	PROPN
eurjchem-2084	452	20	b.	b.	PROPN
eurjchem-2084	452	21	;	;	PUNCT
eurjchem-2084	452	22	joyce	joyce	PROPN
eurjchem-2084	452	23	,	,	PUNCT
eurjchem-2084	452	24	m.	m.	NOUN
eurjchem-2084	452	25	g.	g.	PROPN
eurjchem-2084	452	26	;	;	PUNCT
eurjchem-2084	452	27	scott	scott	PROPN
eurjchem-2084	452	28	,	,	PUNCT
eurjchem-2084	452	29	p.	p.	PROPN
eurjchem-2084	452	30	t.	t.	PROPN
eurjchem-2084	452	31	;	;	PUNCT
eurjchem-2084	452	32	amare	amare	PROPN
eurjchem-2084	452	33	,	,	PUNCT
eurjchem-2084	452	34	m.	m.	PROPN
eurjchem-2084	452	35	f.	f.	PROPN
eurjchem-2084	452	36	;	;	PUNCT
eurjchem-2084	452	37	vasan	vasan	PROPN
eurjchem-2084	452	38	,	,	PUNCT
eurjchem-2084	452	39	s.	s.	PROPN
eurjchem-2084	452	40	;	;	PUNCT
eurjchem-2084	452	41	michael	michael	PROPN
eurjchem-2084	452	42	,	,	PUNCT
eurjchem-2084	452	43	n.	n.	PROPN
eurjchem-2084	452	44	l.	l.	PROPN
eurjchem-2084	452	45	;	;	PUNCT
eurjchem-2084	452	46	modjarrad	modjarrad	PROPN
eurjchem-2084	452	47	,	,	PUNCT
eurjchem-2084	452	48	k.	k.	PROPN
eurjchem-2084	452	49	;	;	PUNCT
eurjchem-2084	452	50	rolland	rolland	PROPN
eurjchem-2084	452	51	,	,	PUNCT
eurjchem-2084	452	52	m.	m.	NOUN
eurjchem-2084	452	53	proc	proc	PROPN
eurjchem-2084	452	54	.	.	PUNCT
eurjchem-2084	453	1	natl	natl	PROPN
eurjchem-2084	453	2	.	.	PUNCT
eurjchem-2084	454	1	acad	acad	PROPN
eurjchem-2084	454	2	.	.	PUNCT
eurjchem-2084	455	1	sci	sci	PROPN
eurjchem-2084	455	2	.	.	PUNCT
eurjchem-2084	455	3	u.	u.	PROPN
eurjchem-2084	455	4	s.	s.	PROPN
eurjchem-2084	455	5	a.	a.	PROPN
eurjchem-2084	455	6	2020	2020	NUM
eurjchem-2084	455	7	,	,	PUNCT
eurjchem-2084	455	8	117	117	NUM
eurjchem-2084	455	9	(	(	PUNCT
eurjchem-2084	455	10	38	38	NUM
eurjchem-2084	455	11	)	)	PUNCT
eurjchem-2084	455	12	,	,	PUNCT
eurjchem-2084	455	13	23652–23662	23652–23662	NUM
eurjchem-2084	455	14	.	.	PUNCT
eurjchem-2084	456	1	[	[	X
eurjchem-2084	456	2	21	21	NUM
eurjchem-2084	456	3	]	]	PUNCT
eurjchem-2084	456	4	.	.	PUNCT
eurjchem-2084	457	1	grubaugh	grubaugh	PROPN
eurjchem-2084	457	2	,	,	PUNCT
eurjchem-2084	457	3	n.	n.	PROPN
eurjchem-2084	457	4	d.	d.	PROPN
eurjchem-2084	457	5	;	;	PUNCT
eurjchem-2084	457	6	hanage	hanage	PROPN
eurjchem-2084	457	7	,	,	PUNCT
eurjchem-2084	457	8	w.	w.	PROPN
eurjchem-2084	457	9	p.	p.	PROPN
eurjchem-2084	457	10	;	;	PUNCT
eurjchem-2084	457	11	rasmussen	rasmussen	PROPN
eurjchem-2084	457	12	,	,	PUNCT
eurjchem-2084	457	13	a.	a.	PROPN
eurjchem-2084	457	14	l.	l.	PROPN
eurjchem-2084	457	15	cell	cell	PROPN
eurjchem-2084	457	16	2020	2020	NUM
eurjchem-2084	457	17	,	,	PUNCT
eurjchem-2084	457	18	182	182	NUM
eurjchem-2084	457	19	(	(	PUNCT
eurjchem-2084	457	20	4	4	NUM
eurjchem-2084	457	21	)	)	PUNCT
eurjchem-2084	457	22	,	,	PUNCT
eurjchem-2084	457	23	794–795	794–795	NUM
eurjchem-2084	457	24	.	.	PUNCT
eurjchem-2084	458	1	[	[	X
eurjchem-2084	458	2	22	22	NUM
eurjchem-2084	458	3	]	]	PUNCT
eurjchem-2084	458	4	.	.	PUNCT
eurjchem-2084	458	5	starr	starr	PROPN
eurjchem-2084	458	6	,	,	PUNCT
eurjchem-2084	458	7	t.	t.	PROPN
eurjchem-2084	458	8	n.	n.	PROPN
eurjchem-2084	458	9	;	;	PUNCT
eurjchem-2084	458	10	greaney	greaney	NOUN
eurjchem-2084	458	11	,	,	PUNCT
eurjchem-2084	458	12	a.	a.	NOUN
eurjchem-2084	458	13	j.	j.	PROPN
eurjchem-2084	458	14	;	;	PUNCT
eurjchem-2084	458	15	hilton	hilton	PROPN
eurjchem-2084	458	16	,	,	PUNCT
eurjchem-2084	458	17	s.	s.	PROPN
eurjchem-2084	458	18	k.	k.	PROPN
eurjchem-2084	458	19	;	;	PUNCT
eurjchem-2084	458	20	ellis	ellis	PROPN
eurjchem-2084	458	21	,	,	PUNCT
eurjchem-2084	458	22	d.	d.	PROPN
eurjchem-2084	458	23	;	;	PUNCT
eurjchem-2084	458	24	crawford	crawford	PROPN
eurjchem-2084	458	25	,	,	PUNCT
eurjchem-2084	458	26	k.	k.	PROPN
eurjchem-2084	458	27	h.	h.	PROPN
eurjchem-2084	458	28	d.	d.	PROPN
eurjchem-2084	458	29	;	;	PUNCT
eurjchem-2084	458	30	dingens	dingen	NOUN
eurjchem-2084	458	31	,	,	PUNCT
eurjchem-2084	458	32	a.	a.	PROPN
eurjchem-2084	458	33	s.	s.	PROPN
eurjchem-2084	458	34	;	;	PUNCT
eurjchem-2084	458	35	navarro	navarro	PROPN
eurjchem-2084	458	36	,	,	PUNCT
eurjchem-2084	458	37	m.	m.	PROPN
eurjchem-2084	458	38	j.	j.	PROPN
eurjchem-2084	458	39	;	;	PUNCT
eurjchem-2084	458	40	bowen	bowen	PROPN
eurjchem-2084	458	41	,	,	PUNCT
eurjchem-2084	458	42	j.	j.	PROPN
eurjchem-2084	458	43	e.	e.	PROPN
eurjchem-2084	458	44	;	;	PUNCT
eurjchem-2084	458	45	tortorici	tortorici	PROPN
eurjchem-2084	458	46	,	,	PUNCT
eurjchem-2084	458	47	m.	m.	NOUN
eurjchem-2084	458	48	a.	a.	PROPN
eurjchem-2084	458	49	;	;	PUNCT
eurjchem-2084	458	50	walls	wall	NOUN
eurjchem-2084	458	51	,	,	PUNCT
eurjchem-2084	458	52	a.	a.	PROPN
eurjchem-2084	458	53	c.	c.	PROPN
eurjchem-2084	458	54	;	;	PUNCT
eurjchem-2084	458	55	king	king	NOUN
eurjchem-2084	458	56	,	,	PUNCT
eurjchem-2084	458	57	n.	n.	PROPN
eurjchem-2084	458	58	p.	p.	PROPN
eurjchem-2084	458	59	;	;	PUNCT
eurjchem-2084	458	60	veesler	veesler	NOUN
eurjchem-2084	458	61	,	,	PUNCT
eurjchem-2084	458	62	d.	d.	PROPN
eurjchem-2084	458	63	;	;	PUNCT
eurjchem-2084	458	64	bloom	bloom	PROPN
eurjchem-2084	458	65	,	,	PUNCT
eurjchem-2084	458	66	j.	j.	PROPN
eurjchem-2084	458	67	d.	d.	PROPN
eurjchem-2084	458	68	cell	cell	PROPN
eurjchem-2084	458	69	2020	2020	NUM
eurjchem-2084	458	70	,	,	PUNCT
eurjchem-2084	458	71	182	182	NUM
eurjchem-2084	458	72	(	(	PUNCT
eurjchem-2084	458	73	5	5	NUM
eurjchem-2084	458	74	)	)	PUNCT
eurjchem-2084	458	75	,	,	PUNCT
eurjchem-2084	458	76	1295	1295	NUM
eurjchem-2084	458	77	-	-	SYM
eurjchem-2084	458	78	1310.e20	1310.e20	NUM
eurjchem-2084	458	79	.	.	PUNCT
eurjchem-2084	459	1	[	[	X
eurjchem-2084	459	2	23	23	NUM
eurjchem-2084	459	3	]	]	PUNCT
eurjchem-2084	459	4	.	.	PUNCT
eurjchem-2084	460	1	rambaut	rambaut	PROPN
eurjchem-2084	460	2	,	,	PUNCT
eurjchem-2084	460	3	a.	a.	NOUN
eurjchem-2084	460	4	;	;	PUNCT
eurjchem-2084	460	5	loman	loman	NOUN
eurjchem-2084	460	6	,	,	PUNCT
eurjchem-2084	460	7	n.	n.	NOUN
eurjchem-2084	460	8	;	;	PUNCT
eurjchem-2084	460	9	pybus	pybus	NOUN
eurjchem-2084	460	10	,	,	PUNCT
eurjchem-2084	460	11	o.	o.	PROPN
eurjchem-2084	460	12	;	;	PUNCT
eurjchem-2084	460	13	barclay	barclay	PROPN
eurjchem-2084	460	14	,	,	PUNCT
eurjchem-2084	460	15	w.	w.	PROPN
eurjchem-2084	460	16	;	;	PUNCT
eurjchem-2084	460	17	barrett	barrett	PROPN
eurjchem-2084	460	18	,	,	PUNCT
eurjchem-2084	460	19	j.	j.	PROPN
eurjchem-2084	460	20	;	;	PUNCT
eurjchem-2084	460	21	carabelli	carabelli	PROPN
eurjchem-2084	460	22	,	,	PUNCT
eurjchem-2084	460	23	a.	a.	NOUN
eurjchem-2084	460	24	;	;	PUNCT
eurjchem-2084	460	25	connor	connor	NOUN
eurjchem-2084	460	26	,	,	PUNCT
eurjchem-2084	460	27	t.	t.	PROPN
eurjchem-2084	460	28	;	;	PUNCT
eurjchem-2084	460	29	peacock	peacock	NOUN
eurjchem-2084	460	30	,	,	PUNCT
eurjchem-2084	460	31	t.	t.	PROPN
eurjchem-2084	460	32	;	;	PUNCT
eurjchem-2084	460	33	robertson	robertson	PROPN
eurjchem-2084	460	34	,	,	PUNCT
eurjchem-2084	460	35	d.	d.	PROPN
eurjchem-2084	460	36	l.	l.	PROPN
eurjchem-2084	460	37	;	;	PUNCT
eurjchem-2084	460	38	volz	volz	PROPN
eurjchem-2084	460	39	,	,	PUNCT
eurjchem-2084	460	40	e.	e.	PROPN
eurjchem-2084	460	41	preliminary	preliminary	ADJ
eurjchem-2084	460	42	genomic	genomic	ADJ
eurjchem-2084	460	43	characterization	characterization	NOUN
eurjchem-2084	460	44	of	of	ADP
eurjchem-2084	460	45	an	an	DET
eurjchem-2084	460	46	emergent	emergent	ADJ
eurjchem-2084	460	47	sars	sar	NOUN
eurjchem-2084	460	48	-	-	PUNCT
eurjchem-2084	460	49	cov-2	cov-2	NOUN
eurjchem-2084	460	50	lineage	lineage	NOUN
eurjchem-2084	460	51	in	in	ADP
eurjchem-2084	460	52	the	the	DET
eurjchem-2084	460	53	uk	uk	PROPN
eurjchem-2084	460	54	defined	define	VERB
eurjchem-2084	460	55	by	by	ADP
eurjchem-2084	460	56	a	a	DET
eurjchem-2084	460	57	novel	novel	ADJ
eurjchem-2084	460	58	set	set	NOUN
eurjchem-2084	460	59	of	of	ADP
eurjchem-2084	460	60	spike	spike	ADJ
eurjchem-2084	460	61	mutations	mutation	NOUN
eurjchem-2084	460	62	https://virological.org/t/	https://virological.org/t/	ADP
eurjchem-2084	460	63	preliminary	preliminary	ADJ
eurjchem-2084	460	64	-	-	ADJ
eurjchem-2084	460	65	genomic	genomic	ADJ
eurjchem-2084	460	66	-	-	PUNCT
eurjchem-2084	460	67	characterisation	characterisation	NOUN
eurjchem-2084	460	68	-	-	PUNCT
eurjchem-2084	460	69	of	of	ADP
eurjchem-2084	460	70	-	-	PUNCT
eurjchem-2084	460	71	an	an	DET
eurjchem-2084	460	72	-	-	PUNCT
eurjchem-2084	460	73	emergent	emergent	NOUN
eurjchem-2084	460	74	-	-	PUNCT
eurjchem-2084	460	75	sars	sars	NOUN
eurjchem-2084	460	76	-	-	PUNCT
eurjchem-2084	460	77	cov-2lineage	cov-2lineage	NOUN
eurjchem-2084	460	78	-	-	PUNCT
eurjchem-2084	460	79	in	in	ADP
eurjchem-2084	460	80	-	-	PUNCT
eurjchem-2084	460	81	the	the	DET
eurjchem-2084	460	82	-	-	PUNCT
eurjchem-2084	460	83	uk	uk	NOUN
eurjchem-2084	460	84	-	-	PUNCT
eurjchem-2084	460	85	defined	define	VERB
eurjchem-2084	460	86	-	-	PUNCT
eurjchem-2084	460	87	by	by	ADP
eurjchem-2084	460	88	-	-	PUNCT
eurjchem-2084	460	89	a	a	DET
eurjchem-2084	460	90	-	-	PUNCT
eurjchem-2084	460	91	novel	novel	NOUN
eurjchem-2084	460	92	-	-	PUNCT
eurjchem-2084	460	93	set	set	NOUN
eurjchem-2084	460	94	-	-	PUNCT
eurjchem-2084	460	95	of	of	ADP
eurjchem-2084	460	96	-	-	PUNCT
eurjchem-2084	460	97	spike	spike	NOUN
eurjchem-2084	460	98	-	-	PUNCT
eurjchem-2084	460	99	mutations/563	mutations/563	NOUN
eurjchem-2084	460	100	(	(	PUNCT
eurjchem-2084	460	101	accessed	access	VERB
eurjchem-2084	460	102	december	december	PROPN
eurjchem-2084	460	103	9	9	NUM
eurjchem-2084	460	104	,	,	PUNCT
eurjchem-2084	460	105	2020	2020	NUM
eurjchem-2084	460	106	)	)	PUNCT
eurjchem-2084	460	107	.	.	PUNCT
eurjchem-2084	461	1	[	[	X
eurjchem-2084	461	2	24	24	NUM
eurjchem-2084	461	3	]	]	PUNCT
eurjchem-2084	461	4	.	.	PUNCT
eurjchem-2084	461	5	santos	santos	PROPN
eurjchem-2084	461	6	,	,	PUNCT
eurjchem-2084	461	7	j.	j.	PROPN
eurjchem-2084	461	8	c.	c.	PROPN
eurjchem-2084	461	9	;	;	PUNCT
eurjchem-2084	461	10	passos	passos	PROPN
eurjchem-2084	461	11	,	,	PUNCT
eurjchem-2084	461	12	g.	g.	PROPN
eurjchem-2084	461	13	a.	a.	NOUN
eurjchem-2084	461	14	biorxiv	biorxiv	PROPN
eurjchem-2084	461	15	,	,	PUNCT
eurjchem-2084	461	16	2021	2021	NUM
eurjchem-2084	461	17	.	.	PUNCT
eurjchem-2084	462	1	https://doi.org/10.1101/	https://doi.org/10.1101/	PROPN
eurjchem-2084	462	2	2020.12.29.424708	2020.12.29.424708	NOUN
eurjchem-2084	462	3	.	.	PUNCT
eurjchem-2084	463	1	[	[	X
eurjchem-2084	463	2	25	25	NUM
eurjchem-2084	463	3	]	]	PUNCT
eurjchem-2084	463	4	.	.	PUNCT
eurjchem-2084	464	1	hoffmann	hoffmann	PROPN
eurjchem-2084	464	2	,	,	PUNCT
eurjchem-2084	464	3	m.	m.	NOUN
eurjchem-2084	464	4	;	;	PUNCT
eurjchem-2084	464	5	kleine	kleine	PROPN
eurjchem-2084	464	6	-	-	PUNCT
eurjchem-2084	464	7	weber	weber	PROPN
eurjchem-2084	464	8	,	,	PUNCT
eurjchem-2084	464	9	h.	h.	PROPN
eurjchem-2084	464	10	;	;	PUNCT
eurjchem-2084	464	11	krüger	krüger	NOUN
eurjchem-2084	464	12	,	,	PUNCT
eurjchem-2084	464	13	n.	n.	NOUN
eurjchem-2084	464	14	;	;	PUNCT
eurjchem-2084	464	15	müller	müller	PROPN
eurjchem-2084	464	16	,	,	PUNCT
eurjchem-2084	464	17	m.	m.	NOUN
eurjchem-2084	464	18	;	;	PUNCT
eurjchem-2084	464	19	drosten	drosten	PROPN
eurjchem-2084	464	20	,	,	PUNCT
eurjchem-2084	464	21	c.	c.	NOUN
eurjchem-2084	464	22	;	;	PUNCT
eurjchem-2084	464	23	pöhlmann	pöhlmann	PROPN
eurjchem-2084	464	24	,	,	PUNCT
eurjchem-2084	464	25	s.	s.	PROPN
eurjchem-2084	464	26	biorxiv	biorxiv	PROPN
eurjchem-2084	464	27	,	,	PUNCT
eurjchem-2084	464	28	2020	2020	NUM
eurjchem-2084	464	29	.	.	PUNCT
eurjchem-2084	465	1	https://doi.org/10.1101/2020.01.31	https://doi.org/10.1101/2020.01.31	NOUN
eurjchem-2084	465	2	.	.	NOUN
eurjchem-2084	465	3	929042	929042	NUM
eurjchem-2084	465	4	.	.	PUNCT
eurjchem-2084	466	1	[	[	X
eurjchem-2084	466	2	26	26	NUM
eurjchem-2084	466	3	]	]	PUNCT
eurjchem-2084	466	4	.	.	PUNCT
eurjchem-2084	467	1	gralinski	gralinski	PROPN
eurjchem-2084	467	2	,	,	PUNCT
eurjchem-2084	467	3	l.	l.	PROPN
eurjchem-2084	467	4	e.	e.	PROPN
eurjchem-2084	467	5	;	;	PUNCT
eurjchem-2084	467	6	menachery	menachery	PROPN
eurjchem-2084	467	7	,	,	PUNCT
eurjchem-2084	467	8	v.	v.	PROPN
eurjchem-2084	467	9	d.	d.	PROPN
eurjchem-2084	467	10	viruses	viruse	VERB
eurjchem-2084	467	11	2020	2020	NUM
eurjchem-2084	467	12	,	,	PUNCT
eurjchem-2084	467	13	12	12	NUM
eurjchem-2084	467	14	(	(	PUNCT
eurjchem-2084	467	15	2	2	NUM
eurjchem-2084	467	16	)	)	PUNCT
eurjchem-2084	467	17	,	,	PUNCT
eurjchem-2084	467	18	135	135	NUM
eurjchem-2084	467	19	.	.	PUNCT
eurjchem-2084	468	1	[	[	X
eurjchem-2084	468	2	27	27	NUM
eurjchem-2084	468	3	]	]	PUNCT
eurjchem-2084	468	4	.	.	PUNCT
eurjchem-2084	469	1	xu	xu	INTJ
eurjchem-2084	469	2	,	,	PUNCT
eurjchem-2084	469	3	x.	x.	PROPN
eurjchem-2084	469	4	;	;	PUNCT
eurjchem-2084	469	5	chen	chen	PROPN
eurjchem-2084	469	6	,	,	PUNCT
eurjchem-2084	469	7	p.	p.	PROPN
eurjchem-2084	469	8	;	;	PUNCT
eurjchem-2084	469	9	wang	wang	PROPN
eurjchem-2084	469	10	,	,	PUNCT
eurjchem-2084	469	11	j.	j.	PROPN
eurjchem-2084	469	12	;	;	PUNCT
eurjchem-2084	469	13	feng	feng	PROPN
eurjchem-2084	469	14	,	,	PUNCT
eurjchem-2084	469	15	j.	j.	PROPN
eurjchem-2084	469	16	;	;	PUNCT
eurjchem-2084	469	17	zhou	zhou	PROPN
eurjchem-2084	469	18	,	,	PUNCT
eurjchem-2084	469	19	h.	h.	PROPN
eurjchem-2084	469	20	;	;	PUNCT
eurjchem-2084	469	21	li	li	PROPN
eurjchem-2084	469	22	,	,	PUNCT
eurjchem-2084	469	23	x.	x.	PROPN
eurjchem-2084	469	24	;	;	PUNCT
eurjchem-2084	469	25	zhong	zhong	PROPN
eurjchem-2084	469	26	,	,	PUNCT
eurjchem-2084	469	27	w.	w.	PROPN
eurjchem-2084	469	28	;	;	PUNCT
eurjchem-2084	469	29	hao	hao	PROPN
eurjchem-2084	469	30	,	,	PUNCT
eurjchem-2084	469	31	p.	p.	PROPN
eurjchem-2084	469	32	sci	sci	PROPN
eurjchem-2084	469	33	.	.	PUNCT
eurjchem-2084	470	1	china	china	PROPN
eurjchem-2084	470	2	life	life	PROPN
eurjchem-2084	470	3	sci	sci	PROPN
eurjchem-2084	470	4	.	.	PROPN
eurjchem-2084	470	5	2020	2020	NUM
eurjchem-2084	470	6	,	,	PUNCT
eurjchem-2084	470	7	63	63	NUM
eurjchem-2084	470	8	(	(	PUNCT
eurjchem-2084	470	9	3	3	NUM
eurjchem-2084	470	10	)	)	PUNCT
eurjchem-2084	470	11	,	,	PUNCT
eurjchem-2084	470	12	457–460	457–460	NUM
eurjchem-2084	470	13	.	.	PUNCT
eurjchem-2084	471	1	[	[	X
eurjchem-2084	471	2	28	28	NUM
eurjchem-2084	471	3	]	]	PUNCT
eurjchem-2084	471	4	.	.	PUNCT
eurjchem-2084	472	1	raj	raj	PROPN
eurjchem-2084	472	2	,	,	PUNCT
eurjchem-2084	472	3	v.	v.	PROPN
eurjchem-2084	472	4	s.	s.	PROPN
eurjchem-2084	472	5	;	;	PUNCT
eurjchem-2084	472	6	mou	mou	PROPN
eurjchem-2084	472	7	,	,	PUNCT
eurjchem-2084	472	8	h.	h.	PROPN
eurjchem-2084	472	9	;	;	PUNCT
eurjchem-2084	472	10	smits	smit	NOUN
eurjchem-2084	472	11	,	,	PUNCT
eurjchem-2084	472	12	s.	s.	PROPN
eurjchem-2084	472	13	l.	l.	PROPN
eurjchem-2084	472	14	;	;	PUNCT
eurjchem-2084	472	15	dekkers	dekkers	PROPN
eurjchem-2084	472	16	,	,	PUNCT
eurjchem-2084	472	17	d.	d.	PROPN
eurjchem-2084	472	18	h.	h.	PROPN
eurjchem-2084	472	19	w.	w.	PROPN
eurjchem-2084	472	20	;	;	PUNCT
eurjchem-2084	472	21	müller	müller	PROPN
eurjchem-2084	472	22	,	,	PUNCT
eurjchem-2084	472	23	m.	m.	NOUN
eurjchem-2084	472	24	a.	a.	PROPN
eurjchem-2084	472	25	;	;	PUNCT
eurjchem-2084	472	26	dijkman	dijkman	PROPN
eurjchem-2084	472	27	,	,	PUNCT
eurjchem-2084	472	28	r.	r.	PROPN
eurjchem-2084	472	29	;	;	PUNCT
eurjchem-2084	472	30	muth	muth	PROPN
eurjchem-2084	472	31	,	,	PUNCT
eurjchem-2084	472	32	d.	d.	PROPN
eurjchem-2084	472	33	;	;	PUNCT
eurjchem-2084	472	34	demmers	demmer	NOUN
eurjchem-2084	472	35	,	,	PUNCT
eurjchem-2084	472	36	j.	j.	PROPN
eurjchem-2084	472	37	a.	a.	PROPN
eurjchem-2084	472	38	a.	a.	PROPN
eurjchem-2084	472	39	;	;	PUNCT
eurjchem-2084	473	1	zaki	zaki	PROPN
eurjchem-2084	473	2	,	,	PUNCT
eurjchem-2084	473	3	a.	a.	NOUN
eurjchem-2084	473	4	;	;	PUNCT
eurjchem-2084	473	5	fouchier	fouchier	PROPN
eurjchem-2084	473	6	,	,	PUNCT
eurjchem-2084	473	7	r.	r.	PROPN
eurjchem-2084	473	8	a.	a.	NOUN
eurjchem-2084	473	9	m.	m.	PROPN
eurjchem-2084	473	10	;	;	PUNCT
eurjchem-2084	473	11	thiel	thiel	PROPN
eurjchem-2084	473	12	,	,	PUNCT
eurjchem-2084	473	13	v.	v.	PROPN
eurjchem-2084	473	14	;	;	PUNCT
eurjchem-2084	473	15	drosten	drosten	PROPN
eurjchem-2084	473	16	,	,	PUNCT
eurjchem-2084	473	17	c.	c.	NOUN
eurjchem-2084	473	18	;	;	PUNCT
eurjchem-2084	473	19	rottier	rottier	NOUN
eurjchem-2084	473	20	,	,	PUNCT
eurjchem-2084	473	21	p.	p.	PROPN
eurjchem-2084	473	22	j.	j.	PROPN
eurjchem-2084	473	23	m.	m.	PROPN
eurjchem-2084	473	24	;	;	PUNCT
eurjchem-2084	473	25	osterhaus	osterhaus	PROPN
eurjchem-2084	473	26	,	,	PUNCT
eurjchem-2084	473	27	a.	a.	PROPN
eurjchem-2084	473	28	d.	d.	PROPN
eurjchem-2084	473	29	m.	m.	PROPN
eurjchem-2084	473	30	e.	e.	PROPN
eurjchem-2084	473	31	;	;	PUNCT
eurjchem-2084	473	32	bosch	bosch	PROPN
eurjchem-2084	473	33	,	,	PUNCT
eurjchem-2084	473	34	b.	b.	PROPN
eurjchem-2084	473	35	j.	j.	PROPN
eurjchem-2084	473	36	;	;	PUNCT
eurjchem-2084	473	37	haagmans	haagmans	PROPN
eurjchem-2084	473	38	,	,	PUNCT
eurjchem-2084	473	39	b.	b.	PROPN
eurjchem-2084	473	40	l.	l.	PROPN
eurjchem-2084	473	41	nature	nature	PROPN
eurjchem-2084	473	42	2013	2013	NUM
eurjchem-2084	473	43	,	,	PUNCT
eurjchem-2084	473	44	495	495	NUM
eurjchem-2084	473	45	(	(	PUNCT
eurjchem-2084	473	46	7440	7440	NUM
eurjchem-2084	473	47	)	)	PUNCT
eurjchem-2084	473	48	,	,	PUNCT
eurjchem-2084	473	49	251–254	251–254	NUM
eurjchem-2084	473	50	.	.	PUNCT
eurjchem-2084	474	1	[	[	X
eurjchem-2084	474	2	29	29	NUM
eurjchem-2084	474	3	]	]	PUNCT
eurjchem-2084	474	4	.	.	PUNCT
eurjchem-2084	475	1	jaimes	jaimes	PROPN
eurjchem-2084	475	2	,	,	PUNCT
eurjchem-2084	475	3	j.	j.	PROPN
eurjchem-2084	475	4	a.	a.	PROPN
eurjchem-2084	475	5	;	;	PUNCT
eurjchem-2084	475	6	millet	millet	PROPN
eurjchem-2084	475	7	,	,	PUNCT
eurjchem-2084	475	8	j.	j.	PROPN
eurjchem-2084	475	9	k.	k.	PROPN
eurjchem-2084	475	10	;	;	PUNCT
eurjchem-2084	475	11	whittaker	whittaker	PROPN
eurjchem-2084	475	12	,	,	PUNCT
eurjchem-2084	475	13	g.	g.	PROPN
eurjchem-2084	475	14	r.	r.	PROPN
eurjchem-2084	475	15	iscience	iscience	PROPN
eurjchem-2084	475	16	2020	2020	NUM
eurjchem-2084	475	17	,	,	PUNCT
eurjchem-2084	475	18	23	23	NUM
eurjchem-2084	475	19	(	(	PUNCT
eurjchem-2084	475	20	6	6	NUM
eurjchem-2084	475	21	)	)	PUNCT
eurjchem-2084	475	22	,	,	PUNCT
eurjchem-2084	475	23	101212	101212	NUM
eurjchem-2084	475	24	.	.	PUNCT
eurjchem-2084	476	1	[	[	X
eurjchem-2084	476	2	30	30	NUM
eurjchem-2084	476	3	]	]	SYM
eurjchem-2084	476	4	.	.	PUNCT
eurjchem-2084	477	1	lukassen	lukassen	ADJ
eurjchem-2084	477	2	,	,	PUNCT
eurjchem-2084	477	3	s.	s.	PROPN
eurjchem-2084	477	4	;	;	PUNCT
eurjchem-2084	477	5	chua	chua	PROPN
eurjchem-2084	477	6	,	,	PUNCT
eurjchem-2084	477	7	r.	r.	PROPN
eurjchem-2084	477	8	l.	l.	PROPN
eurjchem-2084	477	9	;	;	PUNCT
eurjchem-2084	477	10	trefzer	trefzer	NOUN
eurjchem-2084	477	11	,	,	PUNCT
eurjchem-2084	477	12	t.	t.	PROPN
eurjchem-2084	477	13	;	;	PUNCT
eurjchem-2084	477	14	kahn	kahn	PROPN
eurjchem-2084	477	15	,	,	PUNCT
eurjchem-2084	477	16	n.	n.	PROPN
eurjchem-2084	477	17	c.	c.	PROPN
eurjchem-2084	477	18	;	;	PUNCT
eurjchem-2084	477	19	schneider	schneider	NOUN
eurjchem-2084	477	20	,	,	PUNCT
eurjchem-2084	477	21	m.	m.	NOUN
eurjchem-2084	477	22	a.	a.	PROPN
eurjchem-2084	477	23	;	;	PUNCT
eurjchem-2084	477	24	muley	muley	NOUN
eurjchem-2084	477	25	,	,	PUNCT
eurjchem-2084	477	26	t.	t.	PROPN
eurjchem-2084	477	27	;	;	PUNCT
eurjchem-2084	477	28	winter	winter	PROPN
eurjchem-2084	477	29	,	,	PUNCT
eurjchem-2084	477	30	h.	h.	PROPN
eurjchem-2084	477	31	;	;	PUNCT
eurjchem-2084	477	32	meister	meister	PROPN
eurjchem-2084	477	33	,	,	PUNCT
eurjchem-2084	477	34	m.	m.	NOUN
eurjchem-2084	477	35	;	;	PUNCT
eurjchem-2084	477	36	veith	veith	PROPN
eurjchem-2084	477	37	,	,	PUNCT
eurjchem-2084	477	38	c.	c.	PROPN
eurjchem-2084	477	39	;	;	PUNCT
eurjchem-2084	477	40	boots	boot	NOUN
eurjchem-2084	477	41	,	,	PUNCT
eurjchem-2084	477	42	a.	a.	PROPN
eurjchem-2084	477	43	w.	w.	PROPN
eurjchem-2084	477	44	;	;	PUNCT
eurjchem-2084	477	45	hennig	hennig	PROPN
eurjchem-2084	477	46	,	,	PUNCT
eurjchem-2084	477	47	b.	b.	PROPN
eurjchem-2084	477	48	p.	p.	NOUN
eurjchem-2084	477	49	;	;	PUNCT
eurjchem-2084	477	50	kreuter	kreuter	NOUN
eurjchem-2084	477	51	,	,	PUNCT
eurjchem-2084	477	52	m.	m.	NOUN
eurjchem-2084	477	53	;	;	PUNCT
eurjchem-2084	477	54	conrad	conrad	PROPN
eurjchem-2084	477	55	,	,	PUNCT
eurjchem-2084	477	56	c.	c.	PROPN
eurjchem-2084	477	57	;	;	PUNCT
eurjchem-2084	477	58	eils	eil	NOUN
eurjchem-2084	477	59	,	,	PUNCT
eurjchem-2084	477	60	r.	r.	PROPN
eurjchem-2084	477	61	embo	embo	PROPN
eurjchem-2084	477	62	j.	j.	PROPN
eurjchem-2084	477	63	2020	2020	PROPN
eurjchem-2084	477	64	,	,	PUNCT
eurjchem-2084	477	65	39	39	NUM
eurjchem-2084	477	66	(	(	PUNCT
eurjchem-2084	477	67	10	10	NUM
eurjchem-2084	477	68	)	)	PUNCT
eurjchem-2084	477	69	,	,	PUNCT
eurjchem-2084	477	70	e105114	e105114	X
eurjchem-2084	477	71	.	.	PUNCT
eurjchem-2084	478	1	[	[	X
eurjchem-2084	478	2	31	31	NUM
eurjchem-2084	478	3	]	]	PUNCT
eurjchem-2084	478	4	.	.	PUNCT
eurjchem-2084	479	1	melenotte	melenotte	PROPN
eurjchem-2084	479	2	,	,	PUNCT
eurjchem-2084	479	3	c.	c.	PROPN
eurjchem-2084	479	4	;	;	PUNCT
eurjchem-2084	479	5	silvin	silvin	PROPN
eurjchem-2084	479	6	,	,	PUNCT
eurjchem-2084	479	7	a.	a.	NOUN
eurjchem-2084	479	8	;	;	PUNCT
eurjchem-2084	479	9	goubet	goubet	PROPN
eurjchem-2084	479	10	,	,	PUNCT
eurjchem-2084	479	11	a.-g	a.-g	PROPN
eurjchem-2084	479	12	.	.	PUNCT
eurjchem-2084	479	13	;	;	PUNCT
eurjchem-2084	480	1	lahmar	lahmar	PROPN
eurjchem-2084	480	2	,	,	PUNCT
eurjchem-2084	480	3	i.	i.	PROPN
eurjchem-2084	480	4	;	;	PUNCT
eurjchem-2084	480	5	dubuisson	dubuisson	PROPN
eurjchem-2084	480	6	,	,	PUNCT
eurjchem-2084	480	7	a.	a.	NOUN
eurjchem-2084	480	8	;	;	PUNCT
eurjchem-2084	480	9	zumla	zumla	NOUN
eurjchem-2084	480	10	,	,	PUNCT
eurjchem-2084	480	11	a.	a.	NOUN
eurjchem-2084	480	12	;	;	PUNCT
eurjchem-2084	480	13	raoult	raoult	VERB
eurjchem-2084	480	14	,	,	PUNCT
eurjchem-2084	480	15	d.	d.	PROPN
eurjchem-2084	480	16	;	;	PUNCT
eurjchem-2084	480	17	merad	merad	PROPN
eurjchem-2084	480	18	,	,	PUNCT
eurjchem-2084	480	19	m.	m.	NOUN
eurjchem-2084	480	20	;	;	PUNCT
eurjchem-2084	480	21	gachot	gachot	PROPN
eurjchem-2084	480	22	,	,	PUNCT
eurjchem-2084	480	23	b.	b.	PROPN
eurjchem-2084	480	24	;	;	PUNCT
eurjchem-2084	480	25	hénon	hénon	PROPN
eurjchem-2084	480	26	,	,	PUNCT
eurjchem-2084	480	27	c.	c.	PROPN
eurjchem-2084	480	28	;	;	PUNCT
eurjchem-2084	480	29	solary	solary	ADJ
eurjchem-2084	480	30	,	,	PUNCT
eurjchem-2084	480	31	e.	e.	PROPN
eurjchem-2084	480	32	;	;	PUNCT
eurjchem-2084	480	33	fontenay	fontenay	NOUN
eurjchem-2084	480	34	,	,	PUNCT
eurjchem-2084	480	35	m.	m.	NOUN
eurjchem-2084	480	36	;	;	PUNCT
eurjchem-2084	480	37	andré	andré	PROPN
eurjchem-2084	480	38	,	,	PUNCT
eurjchem-2084	480	39	f.	f.	PROPN
eurjchem-2084	480	40	;	;	PUNCT
eurjchem-2084	480	41	maeurer	maeurer	NOUN
eurjchem-2084	480	42	,	,	PUNCT
eurjchem-2084	480	43	m.	m.	NOUN
eurjchem-2084	480	44	;	;	PUNCT
eurjchem-2084	480	45	ippolito	ippolito	PROPN
eurjchem-2084	480	46	,	,	PUNCT
eurjchem-2084	480	47	g.	g.	PROPN
eurjchem-2084	480	48	;	;	PUNCT
eurjchem-2084	480	49	piacentini	piacentini	NOUN
eurjchem-2084	480	50	,	,	PUNCT
eurjchem-2084	480	51	m.	m.	NOUN
eurjchem-2084	480	52	;	;	PUNCT
eurjchem-2084	480	53	wang	wang	PROPN
eurjchem-2084	480	54	,	,	PUNCT
eurjchem-2084	480	55	f.-s	f.-s	PROPN
eurjchem-2084	480	56	.	.	PUNCT
eurjchem-2084	480	57	;	;	PUNCT
eurjchem-2084	480	58	ginhoux	ginhoux	VERB
eurjchem-2084	480	59	,	,	PUNCT
eurjchem-2084	480	60	f.	f.	PROPN
eurjchem-2084	480	61	;	;	PUNCT
eurjchem-2084	480	62	marabelle	marabelle	PROPN
eurjchem-2084	480	63	,	,	PUNCT
eurjchem-2084	480	64	a.	a.	NOUN
eurjchem-2084	480	65	;	;	PUNCT
eurjchem-2084	480	66	kroemer	kroemer	PROPN
eurjchem-2084	480	67	,	,	PUNCT
eurjchem-2084	480	68	g.	g.	PROPN
eurjchem-2084	480	69	;	;	PUNCT
eurjchem-2084	480	70	derosa	derosa	PROPN
eurjchem-2084	480	71	,	,	PUNCT
eurjchem-2084	480	72	l.	l.	PROPN
eurjchem-2084	480	73	;	;	PUNCT
eurjchem-2084	480	74	zitvogel	zitvogel	NOUN
eurjchem-2084	480	75	,	,	PUNCT
eurjchem-2084	480	76	l.	l.	PROPN
eurjchem-2084	480	77	oncoimmunology	oncoimmunology	PROPN
eurjchem-2084	480	78	2020	2020	NUM
eurjchem-2084	480	79	,	,	PUNCT
eurjchem-2084	480	80	9	9	NUM
eurjchem-2084	480	81	(	(	PUNCT
eurjchem-2084	480	82	1	1	NUM
eurjchem-2084	480	83	)	)	PUNCT
eurjchem-2084	480	84	,	,	PUNCT
eurjchem-2084	480	85	1807836	1807836	NUM
eurjchem-2084	480	86	.	.	PUNCT
eurjchem-2084	481	1	[	[	X
eurjchem-2084	481	2	32	32	NUM
eurjchem-2084	481	3	]	]	PUNCT
eurjchem-2084	481	4	.	.	PUNCT
eurjchem-2084	482	1	mehta	mehta	PROPN
eurjchem-2084	482	2	,	,	PUNCT
eurjchem-2084	482	3	p.	p.	PROPN
eurjchem-2084	482	4	;	;	PUNCT
eurjchem-2084	482	5	mcauley	mcauley	PROPN
eurjchem-2084	482	6	,	,	PUNCT
eurjchem-2084	482	7	d.	d.	PROPN
eurjchem-2084	482	8	f.	f.	PROPN
eurjchem-2084	482	9	;	;	PUNCT
eurjchem-2084	482	10	brown	brown	PROPN
eurjchem-2084	482	11	,	,	PUNCT
eurjchem-2084	482	12	m.	m.	NOUN
eurjchem-2084	482	13	;	;	PUNCT
eurjchem-2084	482	14	sanchez	sanchez	PROPN
eurjchem-2084	482	15	,	,	PUNCT
eurjchem-2084	482	16	e.	e.	PROPN
eurjchem-2084	482	17	;	;	PUNCT
eurjchem-2084	482	18	tattersall	tattersall	NOUN
eurjchem-2084	482	19	,	,	PUNCT
eurjchem-2084	482	20	r.	r.	PROPN
eurjchem-2084	482	21	s.	s.	PROPN
eurjchem-2084	482	22	;	;	PUNCT
eurjchem-2084	482	23	manson	manson	PROPN
eurjchem-2084	482	24	,	,	PUNCT
eurjchem-2084	482	25	j.	j.	PROPN
eurjchem-2084	482	26	j.	j.	PROPN
eurjchem-2084	482	27	lancet	lancet	PROPN
eurjchem-2084	482	28	2020	2020	NUM
eurjchem-2084	482	29	,	,	PUNCT
eurjchem-2084	482	30	395	395	NUM
eurjchem-2084	482	31	(	(	PUNCT
eurjchem-2084	482	32	10229	10229	NUM
eurjchem-2084	482	33	)	)	PUNCT
eurjchem-2084	482	34	,	,	PUNCT
eurjchem-2084	482	35	1033–1034	1033–1034	NUM
eurjchem-2084	482	36	.	.	PUNCT
eurjchem-2084	483	1	[	[	X
eurjchem-2084	483	2	33	33	NUM
eurjchem-2084	483	3	]	]	PUNCT
eurjchem-2084	483	4	.	.	PUNCT
eurjchem-2084	484	1	akhmerov	akhmerov	PROPN
eurjchem-2084	484	2	,	,	PUNCT
eurjchem-2084	484	3	a.	a.	NOUN
eurjchem-2084	484	4	;	;	PUNCT
eurjchem-2084	484	5	marbán	marbán	NOUN
eurjchem-2084	484	6	,	,	PUNCT
eurjchem-2084	484	7	e.	e.	PROPN
eurjchem-2084	484	8	circ	circ	PROPN
eurjchem-2084	484	9	.	.	PUNCT
eurjchem-2084	485	1	res	re	NOUN
eurjchem-2084	485	2	.	.	PUNCT
eurjchem-2084	486	1	2020	2020	NUM
eurjchem-2084	486	2	,	,	PUNCT
eurjchem-2084	486	3	126	126	NUM
eurjchem-2084	486	4	(	(	PUNCT
eurjchem-2084	486	5	10	10	NUM
eurjchem-2084	486	6	)	)	PUNCT
eurjchem-2084	486	7	,	,	PUNCT
eurjchem-2084	486	8	1443–1455	1443–1455	X
eurjchem-2084	486	9	.	.	PUNCT
eurjchem-2084	487	1	[	[	X
eurjchem-2084	487	2	34	34	NUM
eurjchem-2084	487	3	]	]	PUNCT
eurjchem-2084	487	4	.	.	PUNCT
eurjchem-2084	488	1	martín	martín	NOUN
eurjchem-2084	488	2	-	-	PUNCT
eurjchem-2084	488	3	rojas	rojas	PROPN
eurjchem-2084	488	4	,	,	PUNCT
eurjchem-2084	488	5	r.	r.	PROPN
eurjchem-2084	488	6	m.	m.	NOUN
eurjchem-2084	488	7	;	;	PUNCT
eurjchem-2084	488	8	pérez	pérez	NOUN
eurjchem-2084	488	9	-	-	PUNCT
eurjchem-2084	488	10	rus	rus	NOUN
eurjchem-2084	488	11	,	,	PUNCT
eurjchem-2084	488	12	g.	g.	PROPN
eurjchem-2084	488	13	;	;	PUNCT
eurjchem-2084	488	14	delgado	delgado	NOUN
eurjchem-2084	488	15	-	-	PUNCT
eurjchem-2084	488	16	pinos	pinos	PROPN
eurjchem-2084	488	17	,	,	PUNCT
eurjchem-2084	488	18	v.	v.	PROPN
eurjchem-2084	488	19	e.	e.	PROPN
eurjchem-2084	488	20	;	;	PUNCT
eurjchem-2084	488	21	domingogonzález	domingogonzález	PROPN
eurjchem-2084	488	22	,	,	PUNCT
eurjchem-2084	488	23	a.	a.	NOUN
eurjchem-2084	488	24	;	;	PUNCT
eurjchem-2084	488	25	regalado	regalado	PROPN
eurjchem-2084	488	26	-	-	PUNCT
eurjchem-2084	488	27	artamendi	artamendi	PROPN
eurjchem-2084	488	28	,	,	PUNCT
eurjchem-2084	488	29	i.	i.	NOUN
eurjchem-2084	488	30	;	;	PUNCT
eurjchem-2084	488	31	alba	alba	NOUN
eurjchem-2084	488	32	-	-	PUNCT
eurjchem-2084	488	33	urdiales	urdiale	NOUN
eurjchem-2084	488	34	,	,	PUNCT
eurjchem-2084	488	35	n.	n.	NOUN
eurjchem-2084	488	36	;	;	PUNCT
eurjchem-2084	488	37	demelorodríguez	demelorodríguez	NOUN
eurjchem-2084	488	38	,	,	PUNCT
eurjchem-2084	488	39	p.	p.	PROPN
eurjchem-2084	488	40	;	;	PUNCT
eurjchem-2084	488	41	monsalvo	monsalvo	PROPN
eurjchem-2084	488	42	,	,	PUNCT
eurjchem-2084	488	43	s.	s.	PROPN
eurjchem-2084	488	44	;	;	PUNCT
eurjchem-2084	488	45	rodríguez	rodríguez	NOUN
eurjchem-2084	488	46	-	-	PUNCT
eurjchem-2084	488	47	macías	macías	PROPN
eurjchem-2084	488	48	,	,	PUNCT
eurjchem-2084	488	49	g.	g.	PROPN
eurjchem-2084	488	50	;	;	PUNCT
eurjchem-2084	488	51	ballesteros	ballesteros	PROPN
eurjchem-2084	488	52	,	,	PUNCT
eurjchem-2084	488	53	m.	m.	NOUN
eurjchem-2084	488	54	;	;	PUNCT
eurjchem-2084	488	55	osorio	osorio	NOUN
eurjchem-2084	488	56	-	-	PUNCT
eurjchem-2084	488	57	prendes	prende	VERB
eurjchem-2084	488	58	,	,	PUNCT
eurjchem-2084	488	59	s.	s.	PROPN
eurjchem-2084	488	60	;	;	PUNCT
eurjchem-2084	488	61	díez	díez	NOUN
eurjchem-2084	488	62	-	-	PUNCT
eurjchem-2084	488	63	martín	martín	PROPN
eurjchem-2084	488	64	,	,	PUNCT
eurjchem-2084	488	65	j.	j.	PROPN
eurjchem-2084	488	66	l.	l.	PROPN
eurjchem-2084	488	67	;	;	PUNCT
eurjchem-2084	488	68	pascual	pascual	ADJ
eurjchem-2084	488	69	izquierdo	izquierdo	PROPN
eurjchem-2084	488	70	,	,	PUNCT
eurjchem-2084	488	71	c.	c.	PROPN
eurjchem-2084	488	72	eur	eur	PROPN
eurjchem-2084	488	73	.	.	PUNCT
eurjchem-2084	489	1	j.	j.	PROPN
eurjchem-2084	489	2	haematol	haematol	PROPN
eurjchem-2084	489	3	.	.	PUNCT
eurjchem-2084	490	1	2020	2020	NUM
eurjchem-2084	490	2	,	,	PUNCT
eurjchem-2084	490	3	105	105	NUM
eurjchem-2084	490	4	(	(	PUNCT
eurjchem-2084	490	5	6	6	NUM
eurjchem-2084	490	6	)	)	PUNCT
eurjchem-2084	490	7	,	,	PUNCT
eurjchem-2084	490	8	741–750	741–750	NUM
eurjchem-2084	490	9	.	.	PUNCT
eurjchem-2084	491	1	[	[	X
eurjchem-2084	491	2	35	35	NUM
eurjchem-2084	491	3	]	]	SYM
eurjchem-2084	491	4	.	.	PUNCT
eurjchem-2084	492	1	reddy	reddy	PROPN
eurjchem-2084	492	2	,	,	PUNCT
eurjchem-2084	492	3	s.	s.	PROPN
eurjchem-2084	492	4	t.	t.	PROPN
eurjchem-2084	492	5	;	;	PUNCT
eurjchem-2084	492	6	garg	garg	NOUN
eurjchem-2084	492	7	,	,	PUNCT
eurjchem-2084	492	8	t.	t.	PROPN
eurjchem-2084	492	9	;	;	PUNCT
eurjchem-2084	492	10	shah	shah	PROPN
eurjchem-2084	492	11	,	,	PUNCT
eurjchem-2084	492	12	c.	c.	PROPN
eurjchem-2084	492	13	;	;	PUNCT
eurjchem-2084	492	14	nascimento	nascimento	PROPN
eurjchem-2084	492	15	,	,	PUNCT
eurjchem-2084	492	16	f.	f.	PROPN
eurjchem-2084	492	17	a.	a.	PROPN
eurjchem-2084	492	18	;	;	PUNCT
eurjchem-2084	492	19	imran	imran	PROPN
eurjchem-2084	492	20	,	,	PUNCT
eurjchem-2084	492	21	r.	r.	PROPN
eurjchem-2084	492	22	;	;	PUNCT
eurjchem-2084	492	23	kan	kan	PROPN
eurjchem-2084	492	24	,	,	PUNCT
eurjchem-2084	492	25	p.	p.	PROPN
eurjchem-2084	492	26	;	;	PUNCT
eurjchem-2084	492	27	bowry	bowry	PROPN
eurjchem-2084	492	28	,	,	PUNCT
eurjchem-2084	492	29	r.	r.	PROPN
eurjchem-2084	492	30	;	;	PUNCT
eurjchem-2084	492	31	gonzales	gonzales	PROPN
eurjchem-2084	492	32	,	,	PUNCT
eurjchem-2084	492	33	n.	n.	PROPN
eurjchem-2084	492	34	;	;	PUNCT
eurjchem-2084	492	35	barreto	barreto	PROPN
eurjchem-2084	492	36	,	,	PUNCT
eurjchem-2084	492	37	a.	a.	PROPN
eurjchem-2084	492	38	;	;	PUNCT
eurjchem-2084	492	39	kumar	kumar	PROPN
eurjchem-2084	492	40	,	,	PUNCT
eurjchem-2084	492	41	a.	a.	NOUN
eurjchem-2084	492	42	;	;	PUNCT
eurjchem-2084	492	43	volpi	volpi	PROPN
eurjchem-2084	492	44	,	,	PUNCT
eurjchem-2084	492	45	j.	j.	PROPN
eurjchem-2084	492	46	;	;	PUNCT
eurjchem-2084	492	47	misra	misra	ADJ
eurjchem-2084	492	48	,	,	PUNCT
eurjchem-2084	492	49	v.	v.	ADP
eurjchem-2084	492	50	;	;	PUNCT
eurjchem-2084	492	51	chiu	chiu	PROPN
eurjchem-2084	492	52	,	,	PUNCT
eurjchem-2084	492	53	d.	d.	PROPN
eurjchem-2084	492	54	;	;	PUNCT
eurjchem-2084	492	55	gadhia	gadhia	PROPN
eurjchem-2084	492	56	,	,	PUNCT
eurjchem-2084	492	57	r.	r.	PROPN
eurjchem-2084	492	58	;	;	PUNCT
eurjchem-2084	492	59	savitz	savitz	PROPN
eurjchem-2084	492	60	,	,	PUNCT
eurjchem-2084	492	61	s.	s.	PROPN
eurjchem-2084	492	62	i.	i.	PROPN
eurjchem-2084	492	63	case	case	PROPN
eurjchem-2084	492	64	rep	rep	PROPN
eurjchem-2084	492	65	.	.	PROPN
eurjchem-2084	492	66	neurol	neurol	PROPN
eurjchem-2084	492	67	.	.	PUNCT
eurjchem-2084	493	1	2020	2020	NUM
eurjchem-2084	493	2	,	,	PUNCT
eurjchem-2084	493	3	12	12	NUM
eurjchem-2084	493	4	(	(	PUNCT
eurjchem-2084	493	5	2	2	NUM
eurjchem-2084	493	6	)	)	PUNCT
eurjchem-2084	493	7	,	,	PUNCT
eurjchem-2084	493	8	199–209	199–209	NUM
eurjchem-2084	493	9	.	.	PUNCT
eurjchem-2084	494	1	[	[	X
eurjchem-2084	494	2	36	36	NUM
eurjchem-2084	494	3	]	]	SYM
eurjchem-2084	494	4	.	.	PUNCT
eurjchem-2084	495	1	baig	baig	PROPN
eurjchem-2084	495	2	,	,	PUNCT
eurjchem-2084	495	3	a.	a.	NOUN
eurjchem-2084	495	4	m.	m.	NOUN
eurjchem-2084	495	5	;	;	PUNCT
eurjchem-2084	495	6	khaleeq	khaleeq	PROPN
eurjchem-2084	495	7	,	,	PUNCT
eurjchem-2084	495	8	a.	a.	PROPN
eurjchem-2084	495	9	;	;	PUNCT
eurjchem-2084	495	10	ali	ali	PROPN
eurjchem-2084	495	11	,	,	PUNCT
eurjchem-2084	495	12	u.	u.	PROPN
eurjchem-2084	495	13	;	;	PUNCT
eurjchem-2084	495	14	syeda	syeda	PROPN
eurjchem-2084	495	15	,	,	PUNCT
eurjchem-2084	495	16	h.	h.	PROPN
eurjchem-2084	495	17	acs	acs	PROPN
eurjchem-2084	495	18	chem	chem	PROPN
eurjchem-2084	495	19	.	.	PUNCT
eurjchem-2084	496	1	neurosci	neurosci	PROPN
eurjchem-2084	496	2	.	.	PUNCT
eurjchem-2084	497	1	2020	2020	NUM
eurjchem-2084	497	2	,	,	PUNCT
eurjchem-2084	497	3	11	11	NUM
eurjchem-2084	497	4	(	(	PUNCT
eurjchem-2084	497	5	7	7	NUM
eurjchem-2084	497	6	)	)	PUNCT
eurjchem-2084	497	7	,	,	PUNCT
eurjchem-2084	497	8	995–998	995–998	NUM
eurjchem-2084	497	9	.	.	PUNCT
eurjchem-2084	498	1	[	[	X
eurjchem-2084	498	2	37	37	NUM
eurjchem-2084	498	3	]	]	SYM
eurjchem-2084	498	4	.	.	PUNCT
eurjchem-2084	498	5	bittmann	bittmann	PROPN
eurjchem-2084	498	6	,	,	PUNCT
eurjchem-2084	498	7	s.	s.	PROPN
eurjchem-2084	498	8	;	;	PUNCT
eurjchem-2084	498	9	weissenstein	weissenstein	X
eurjchem-2084	498	10	,	,	PUNCT
eurjchem-2084	498	11	a.	a.	NOUN
eurjchem-2084	498	12	;	;	PUNCT
eurjchem-2084	498	13	villalon	villalon	PROPN
eurjchem-2084	498	14	,	,	PUNCT
eurjchem-2084	498	15	g.	g.	PROPN
eurjchem-2084	498	16	;	;	PUNCT
eurjchem-2084	498	17	moschuring	moschure	VERB
eurjchem-2084	498	18	-	-	PUNCT
eurjchem-2084	498	19	alieva	alieva	PROPN
eurjchem-2084	498	20	,	,	PUNCT
eurjchem-2084	498	21	e.	e.	PROPN
eurjchem-2084	498	22	;	;	PUNCT
eurjchem-2084	498	23	luchter	luchter	PROPN
eurjchem-2084	498	24	,	,	PUNCT
eurjchem-2084	498	25	e.	e.	PROPN
eurjchem-2084	498	26	j.	j.	PROPN
eurjchem-2084	498	27	clin	clin	PROPN
eurjchem-2084	498	28	.	.	PUNCT
eurjchem-2084	499	1	med	med	PROPN
eurjchem-2084	499	2	.	.	PUNCT
eurjchem-2084	500	1	res	re	NOUN
eurjchem-2084	500	2	.	.	PUNCT
eurjchem-2084	501	1	2020	2020	NUM
eurjchem-2084	501	2	,	,	PUNCT
eurjchem-2084	501	3	12	12	NUM
eurjchem-2084	501	4	(	(	PUNCT
eurjchem-2084	501	5	5	5	NUM
eurjchem-2084	501	6	)	)	PUNCT
eurjchem-2084	501	7	,	,	PUNCT
eurjchem-2084	501	8	320–322	320–322	NUM
eurjchem-2084	501	9	.	.	PUNCT
eurjchem-2084	502	1	[	[	X
eurjchem-2084	502	2	38	38	NUM
eurjchem-2084	502	3	]	]	PUNCT
eurjchem-2084	502	4	.	.	PUNCT
eurjchem-2084	503	1	solomon	solomon	PROPN
eurjchem-2084	503	2	,	,	PUNCT
eurjchem-2084	503	3	i.	i.	PROPN
eurjchem-2084	503	4	h.	h.	PROPN
eurjchem-2084	503	5	;	;	PUNCT
eurjchem-2084	503	6	normandin	normandin	NUM
eurjchem-2084	503	7	,	,	PUNCT
eurjchem-2084	503	8	e.	e.	PROPN
eurjchem-2084	503	9	;	;	PUNCT
eurjchem-2084	503	10	bhattacharyya	bhattacharyya	PROPN
eurjchem-2084	503	11	,	,	PUNCT
eurjchem-2084	503	12	s.	s.	PROPN
eurjchem-2084	503	13	;	;	PUNCT
eurjchem-2084	503	14	mukerji	mukerji	PROPN
eurjchem-2084	503	15	,	,	PUNCT
eurjchem-2084	503	16	s.	s.	PROPN
eurjchem-2084	503	17	s.	s.	PROPN
eurjchem-2084	503	18	;	;	PUNCT
eurjchem-2084	503	19	keller	keller	PROPN
eurjchem-2084	503	20	,	,	PUNCT
eurjchem-2084	503	21	k.	k.	PROPN
eurjchem-2084	503	22	;	;	PUNCT
eurjchem-2084	503	23	ali	ali	PROPN
eurjchem-2084	503	24	,	,	PUNCT
eurjchem-2084	503	25	a.	a.	PROPN
eurjchem-2084	503	26	s.	s.	PROPN
eurjchem-2084	503	27	;	;	PUNCT
eurjchem-2084	503	28	adams	adams	PROPN
eurjchem-2084	503	29	,	,	PUNCT
eurjchem-2084	503	30	g.	g.	PROPN
eurjchem-2084	503	31	;	;	PUNCT
eurjchem-2084	503	32	hornick	hornick	PROPN
eurjchem-2084	503	33	,	,	PUNCT
eurjchem-2084	503	34	j.	j.	PROPN
eurjchem-2084	503	35	l.	l.	PROPN
eurjchem-2084	503	36	;	;	PUNCT
eurjchem-2084	503	37	padera	padera	PROPN
eurjchem-2084	503	38	,	,	PUNCT
eurjchem-2084	503	39	r.	r.	PROPN
eurjchem-2084	503	40	f.	f.	PROPN
eurjchem-2084	503	41	,	,	PUNCT
eurjchem-2084	503	42	jr	jr	PROPN
eurjchem-2084	503	43	;	;	PUNCT
eurjchem-2084	503	44	sabeti	sabeti	NOUN
eurjchem-2084	503	45	,	,	PUNCT
eurjchem-2084	503	46	p.	p.	PROPN
eurjchem-2084	503	47	n.	n.	PROPN
eurjchem-2084	503	48	engl	engl	PROPN
eurjchem-2084	503	49	.	.	PUNCT
eurjchem-2084	504	1	j.	j.	PROPN
eurjchem-2084	504	2	med	med	PROPN
eurjchem-2084	504	3	.	.	PUNCT
eurjchem-2084	505	1	2020	2020	NUM
eurjchem-2084	505	2	,	,	PUNCT
eurjchem-2084	505	3	383	383	NUM
eurjchem-2084	505	4	(	(	PUNCT
eurjchem-2084	505	5	10	10	NUM
eurjchem-2084	505	6	)	)	PUNCT
eurjchem-2084	505	7	,	,	PUNCT
eurjchem-2084	505	8	989–992	989–992	NUM
eurjchem-2084	505	9	.	.	PUNCT
eurjchem-2084	506	1	[	[	X
eurjchem-2084	506	2	39	39	NUM
eurjchem-2084	506	3	]	]	PUNCT
eurjchem-2084	506	4	.	.	PUNCT
eurjchem-2084	507	1	mao	mao	PROPN
eurjchem-2084	507	2	,	,	PUNCT
eurjchem-2084	507	3	l.	l.	PROPN
eurjchem-2084	507	4	;	;	PUNCT
eurjchem-2084	507	5	jin	jin	PROPN
eurjchem-2084	507	6	,	,	PUNCT
eurjchem-2084	507	7	h.	h.	PROPN
eurjchem-2084	507	8	;	;	PUNCT
eurjchem-2084	507	9	wang	wang	PROPN
eurjchem-2084	507	10	,	,	PUNCT
eurjchem-2084	507	11	m.	m.	NOUN
eurjchem-2084	507	12	;	;	PUNCT
eurjchem-2084	507	13	hu	hu	PROPN
eurjchem-2084	507	14	,	,	PUNCT
eurjchem-2084	507	15	y.	y.	PROPN
eurjchem-2084	507	16	;	;	PUNCT
eurjchem-2084	507	17	chen	chen	PROPN
eurjchem-2084	507	18	,	,	PUNCT
eurjchem-2084	507	19	s.	s.	PROPN
eurjchem-2084	507	20	;	;	PUNCT
eurjchem-2084	507	21	he	he	PRON
eurjchem-2084	507	22	,	,	PUNCT
eurjchem-2084	507	23	q.	q.	PROPN
eurjchem-2084	507	24	;	;	PUNCT
eurjchem-2084	507	25	chang	chang	PROPN
eurjchem-2084	507	26	,	,	PUNCT
eurjchem-2084	507	27	j.	j.	PROPN
eurjchem-2084	507	28	;	;	PUNCT
eurjchem-2084	507	29	hong	hong	PROPN
eurjchem-2084	507	30	,	,	PUNCT
eurjchem-2084	507	31	c.	c.	PROPN
eurjchem-2084	507	32	;	;	PUNCT
eurjchem-2084	507	33	zhou	zhou	PROPN
eurjchem-2084	507	34	,	,	PUNCT
eurjchem-2084	507	35	y.	y.	PROPN
eurjchem-2084	507	36	;	;	PUNCT
eurjchem-2084	507	37	wang	wang	PROPN
eurjchem-2084	507	38	,	,	PUNCT
eurjchem-2084	507	39	d.	d.	PROPN
eurjchem-2084	507	40	;	;	PUNCT
eurjchem-2084	507	41	miao	miao	NOUN
eurjchem-2084	507	42	,	,	PUNCT
eurjchem-2084	507	43	x.	x.	NOUN
eurjchem-2084	507	44	;	;	PUNCT
eurjchem-2084	507	45	li	li	PROPN
eurjchem-2084	507	46	,	,	PUNCT
eurjchem-2084	507	47	y.	y.	PROPN
eurjchem-2084	507	48	;	;	PUNCT
eurjchem-2084	507	49	hu	hu	PROPN
eurjchem-2084	507	50	,	,	PUNCT
eurjchem-2084	507	51	b.	b.	PROPN
eurjchem-2084	507	52	jama	jama	PROPN
eurjchem-2084	507	53	neurol	neurol	PROPN
eurjchem-2084	507	54	.	.	PUNCT
eurjchem-2084	508	1	2020	2020	NUM
eurjchem-2084	508	2	,	,	PUNCT
eurjchem-2084	508	3	77	77	NUM
eurjchem-2084	508	4	(	(	PUNCT
eurjchem-2084	508	5	6	6	NUM
eurjchem-2084	508	6	)	)	PUNCT
eurjchem-2084	508	7	,	,	PUNCT
eurjchem-2084	508	8	683–690	683–690	NUM
eurjchem-2084	508	9	.	.	PUNCT
eurjchem-2084	509	1	[	[	X
eurjchem-2084	509	2	40	40	NUM
eurjchem-2084	509	3	]	]	PUNCT
eurjchem-2084	509	4	.	.	PUNCT
eurjchem-2084	510	1	poland	poland	PROPN
eurjchem-2084	510	2	,	,	PUNCT
eurjchem-2084	510	3	g.	g.	PROPN
eurjchem-2084	510	4	a.	a.	PROPN
eurjchem-2084	510	5	;	;	PUNCT
eurjchem-2084	510	6	ovsyannikova	ovsyannikova	PROPN
eurjchem-2084	510	7	,	,	PUNCT
eurjchem-2084	510	8	i.	i.	PROPN
eurjchem-2084	510	9	g.	g.	PROPN
eurjchem-2084	510	10	;	;	PUNCT
eurjchem-2084	510	11	kennedy	kennedy	PROPN
eurjchem-2084	510	12	,	,	PUNCT
eurjchem-2084	510	13	r.	r.	PROPN
eurjchem-2084	510	14	b.	b.	PROPN
eurjchem-2084	510	15	lancet	lancet	PROPN
eurjchem-2084	510	16	2020	2020	NUM
eurjchem-2084	510	17	,	,	PUNCT
eurjchem-2084	510	18	396	396	NUM
eurjchem-2084	510	19	(	(	PUNCT
eurjchem-2084	510	20	10262	10262	NUM
eurjchem-2084	510	21	)	)	PUNCT
eurjchem-2084	510	22	,	,	PUNCT
eurjchem-2084	510	23	1595–1606	1595–1606	NUM
eurjchem-2084	510	24	.	.	PUNCT
eurjchem-2084	511	1	[	[	X
eurjchem-2084	511	2	41	41	NUM
eurjchem-2084	511	3	]	]	PUNCT
eurjchem-2084	511	4	.	.	PUNCT
eurjchem-2084	512	1	stephens	stephens	PROPN
eurjchem-2084	512	2	,	,	PUNCT
eurjchem-2084	512	3	d.	d.	PROPN
eurjchem-2084	512	4	s.	s.	PROPN
eurjchem-2084	512	5	;	;	PUNCT
eurjchem-2084	512	6	mcelrath	mcelrath	PROPN
eurjchem-2084	512	7	,	,	PUNCT
eurjchem-2084	512	8	m.	m.	NOUN
eurjchem-2084	512	9	j.	j.	PROPN
eurjchem-2084	512	10	jama	jama	PROPN
eurjchem-2084	512	11	2020	2020	NUM
eurjchem-2084	512	12	,	,	PUNCT
eurjchem-2084	512	13	324	324	NUM
eurjchem-2084	512	14	(	(	PUNCT
eurjchem-2084	512	15	13	13	NUM
eurjchem-2084	512	16	)	)	PUNCT
eurjchem-2084	512	17	,	,	PUNCT
eurjchem-2084	512	18	1279–1281	1279–1281	NUM
eurjchem-2084	512	19	.	.	PUNCT
eurjchem-2084	513	1	[	[	X
eurjchem-2084	513	2	42	42	NUM
eurjchem-2084	513	3	]	]	PUNCT
eurjchem-2084	513	4	.	.	PUNCT
eurjchem-2084	514	1	zeng	zeng	PROPN
eurjchem-2084	514	2	,	,	PUNCT
eurjchem-2084	514	3	h.	h.	PROPN
eurjchem-2084	514	4	;	;	PUNCT
eurjchem-2084	514	5	xu	xu	PROPN
eurjchem-2084	514	6	,	,	PUNCT
eurjchem-2084	514	7	c.	c.	PROPN
eurjchem-2084	514	8	;	;	PUNCT
eurjchem-2084	514	9	fan	fan	PROPN
eurjchem-2084	514	10	,	,	PUNCT
eurjchem-2084	514	11	j.	j.	PROPN
eurjchem-2084	514	12	;	;	PUNCT
eurjchem-2084	514	13	tang	tang	PROPN
eurjchem-2084	514	14	,	,	PUNCT
eurjchem-2084	514	15	y.	y.	PROPN
eurjchem-2084	514	16	;	;	PUNCT
eurjchem-2084	514	17	deng	deng	PROPN
eurjchem-2084	514	18	,	,	PUNCT
eurjchem-2084	514	19	q.	q.	PROPN
eurjchem-2084	514	20	;	;	PUNCT
eurjchem-2084	514	21	zhang	zhang	PROPN
eurjchem-2084	514	22	,	,	PUNCT
eurjchem-2084	514	23	w.	w.	PROPN
eurjchem-2084	514	24	;	;	PUNCT
eurjchem-2084	514	25	long	long	ADV
eurjchem-2084	514	26	,	,	PUNCT
eurjchem-2084	514	27	x.	x.	NOUN
eurjchem-2084	514	28	jama	jama	PROPN
eurjchem-2084	514	29	2020	2020	NUM
eurjchem-2084	514	30	,	,	PUNCT
eurjchem-2084	514	31	323	323	NUM
eurjchem-2084	514	32	(	(	PUNCT
eurjchem-2084	514	33	18	18	NUM
eurjchem-2084	514	34	)	)	PUNCT
eurjchem-2084	514	35	,	,	PUNCT
eurjchem-2084	514	36	1848–1849	1848–1849	NUM
eurjchem-2084	514	37	.	.	PUNCT
eurjchem-2084	515	1	[	[	X
eurjchem-2084	515	2	43	43	NUM
eurjchem-2084	515	3	]	]	PUNCT
eurjchem-2084	515	4	.	.	PUNCT
eurjchem-2084	515	5	addetia	addetia	PROPN
eurjchem-2084	515	6	,	,	PUNCT
eurjchem-2084	515	7	a.	a.	PROPN
eurjchem-2084	515	8	;	;	PUNCT
eurjchem-2084	515	9	crawford	crawford	PROPN
eurjchem-2084	515	10	,	,	PUNCT
eurjchem-2084	515	11	k.	k.	PROPN
eurjchem-2084	515	12	h.	h.	PROPN
eurjchem-2084	515	13	d.	d.	PROPN
eurjchem-2084	515	14	;	;	PUNCT
eurjchem-2084	515	15	dingens	dingen	NOUN
eurjchem-2084	515	16	,	,	PUNCT
eurjchem-2084	515	17	a.	a.	NOUN
eurjchem-2084	515	18	;	;	PUNCT
eurjchem-2084	515	19	zhu	zhu	PROPN
eurjchem-2084	515	20	,	,	PUNCT
eurjchem-2084	515	21	h.	h.	PROPN
eurjchem-2084	515	22	;	;	PUNCT
eurjchem-2084	515	23	roychoudhury	roychoudhury	NOUN
eurjchem-2084	515	24	,	,	PUNCT
eurjchem-2084	515	25	p.	p.	PROPN
eurjchem-2084	515	26	;	;	PUNCT
eurjchem-2084	515	27	huang	huang	PROPN
eurjchem-2084	515	28	,	,	PUNCT
eurjchem-2084	515	29	m.-l	m.-l	PROPN
eurjchem-2084	515	30	.	.	PUNCT
eurjchem-2084	515	31	;	;	PUNCT
eurjchem-2084	515	32	jerome	jerome	PROPN
eurjchem-2084	515	33	,	,	PUNCT
eurjchem-2084	515	34	k.	k.	PROPN
eurjchem-2084	515	35	r.	r.	PROPN
eurjchem-2084	515	36	;	;	PUNCT
eurjchem-2084	515	37	bloom	bloom	PROPN
eurjchem-2084	515	38	,	,	PUNCT
eurjchem-2084	515	39	j.	j.	PROPN
eurjchem-2084	515	40	d.	d.	PROPN
eurjchem-2084	515	41	;	;	PUNCT
eurjchem-2084	515	42	greninger	greninger	NOUN
eurjchem-2084	515	43	,	,	PUNCT
eurjchem-2084	515	44	a.	a.	PROPN
eurjchem-2084	515	45	l.	l.	PROPN
eurjchem-2084	515	46	j.	j.	PROPN
eurjchem-2084	515	47	clin	clin	PROPN
eurjchem-2084	515	48	.	.	PUNCT
eurjchem-2084	516	1	microbiol	microbiol	PROPN
eurjchem-2084	516	2	.	.	PUNCT
eurjchem-2084	517	1	2020	2020	NUM
eurjchem-2084	517	2	,	,	PUNCT
eurjchem-2084	517	3	58	58	NUM
eurjchem-2084	517	4	(	(	PUNCT
eurjchem-2084	517	5	11	11	NUM
eurjchem-2084	517	6	)	)	PUNCT
eurjchem-2084	517	7	.	.	PUNCT
eurjchem-2084	518	1	https://doi.org/10.1128/jcm.02107-20	https://doi.org/10.1128/jcm.02107-20	NOUN
eurjchem-2084	518	2	.	.	PUNCT
eurjchem-2084	519	1	[	[	X
eurjchem-2084	519	2	44	44	NUM
eurjchem-2084	519	3	]	]	PUNCT
eurjchem-2084	519	4	.	.	PUNCT
eurjchem-2084	519	5	iwasaki	iwasaki	PROPN
eurjchem-2084	519	6	,	,	PUNCT
eurjchem-2084	519	7	a.	a.	PROPN
eurjchem-2084	519	8	lancet	lancet	PROPN
eurjchem-2084	519	9	infect	infect	PROPN
eurjchem-2084	519	10	.	.	PUNCT
eurjchem-2084	520	1	dis	dis	PROPN
eurjchem-2084	520	2	.	.	PROPN
eurjchem-2084	520	3	2021	2021	NUM
eurjchem-2084	520	4	,	,	PUNCT
eurjchem-2084	520	5	21	21	NUM
eurjchem-2084	520	6	(	(	PUNCT
eurjchem-2084	520	7	1	1	NUM
eurjchem-2084	520	8	)	)	PUNCT
eurjchem-2084	520	9	,	,	PUNCT
eurjchem-2084	520	10	3–5	3–5	X
eurjchem-2084	520	11	.	.	PUNCT
eurjchem-2084	521	1	[	[	X
eurjchem-2084	521	2	45	45	NUM
eurjchem-2084	521	3	]	]	PUNCT
eurjchem-2084	521	4	.	.	PUNCT
eurjchem-2084	522	1	organization	organization	PROPN
eurjchem-2084	522	2	,	,	PUNCT
eurjchem-2084	522	3	w.	w.	PROPN
eurjchem-2084	522	4	h.	h.	PROPN
eurjchem-2084	522	5	coronavirus	coronavirus	PROPN
eurjchem-2084	522	6	disease	disease	NOUN
eurjchem-2084	522	7	2019	2019	NUM
eurjchem-2084	522	8	(	(	PUNCT
eurjchem-2084	522	9	covid-19	covid-19	PROPN
eurjchem-2084	522	10	)	)	PUNCT
eurjchem-2084	522	11	situation	situation	NOUN
eurjchem-2084	522	12	report–51	report–51	NOUN
eurjchem-2084	522	13	;	;	PUNCT
eurjchem-2084	522	14	world	world	NOUN
eurjchem-2084	522	15	health	health	NOUN
eurjchem-2084	522	16	organization	organization	PROPN
eurjchem-2084	522	17	:	:	PUNCT
eurjchem-2084	522	18	geneva	geneva	PROPN
eurjchem-2084	522	19	,	,	PUNCT
eurjchem-2084	522	20	switzerland	switzerland	PROPN
eurjchem-2084	522	21	,	,	PUNCT
eurjchem-2084	522	22	2020	2020	NUM
eurjchem-2084	522	23	.	.	PUNCT
eurjchem-2084	523	1	[	[	X
eurjchem-2084	523	2	46	46	NUM
eurjchem-2084	523	3	]	]	PUNCT
eurjchem-2084	523	4	.	.	PUNCT
eurjchem-2084	524	1	qu	qu	PROPN
eurjchem-2084	524	2	,	,	PUNCT
eurjchem-2084	524	3	g.	g.	PROPN
eurjchem-2084	524	4	;	;	PUNCT
eurjchem-2084	524	5	li	li	PROPN
eurjchem-2084	524	6	,	,	PUNCT
eurjchem-2084	524	7	x.	x.	PROPN
eurjchem-2084	524	8	;	;	PUNCT
eurjchem-2084	524	9	hu	hu	PROPN
eurjchem-2084	524	10	,	,	PUNCT
eurjchem-2084	524	11	l.	l.	PROPN
eurjchem-2084	524	12	;	;	PUNCT
eurjchem-2084	524	13	jiang	jiang	PROPN
eurjchem-2084	524	14	,	,	PUNCT
eurjchem-2084	524	15	g.	g.	PROPN
eurjchem-2084	524	16	environ	environ	PROPN
eurjchem-2084	524	17	.	.	PUNCT
eurjchem-2084	525	1	sci	sci	PROPN
eurjchem-2084	525	2	.	.	PROPN
eurjchem-2084	525	3	technol	technol	PROPN
eurjchem-2084	525	4	.	.	PROPN
eurjchem-2084	525	5	2020	2020	NUM
eurjchem-2084	525	6	,	,	PUNCT
eurjchem-2084	525	7	54	54	NUM
eurjchem-2084	525	8	(	(	PUNCT
eurjchem-2084	525	9	7	7	NUM
eurjchem-2084	525	10	)	)	PUNCT
eurjchem-2084	525	11	,	,	PUNCT
eurjchem-2084	525	12	3730	3730	NUM
eurjchem-2084	525	13	–	–	PUNCT
eurjchem-2084	525	14	3732	3732	NUM
eurjchem-2084	525	15	.	.	PUNCT
eurjchem-2084	526	1	[	[	X
eurjchem-2084	526	2	47	47	NUM
eurjchem-2084	526	3	]	]	PUNCT
eurjchem-2084	526	4	.	.	PUNCT
eurjchem-2084	527	1	weber	weber	PROPN
eurjchem-2084	527	2	,	,	PUNCT
eurjchem-2084	527	3	d.	d.	PROPN
eurjchem-2084	527	4	j.	j.	PROPN
eurjchem-2084	527	5	;	;	PUNCT
eurjchem-2084	527	6	rutala	rutala	PROPN
eurjchem-2084	527	7	,	,	PUNCT
eurjchem-2084	527	8	w.	w.	PROPN
eurjchem-2084	527	9	a.	a.	PROPN
eurjchem-2084	527	10	;	;	PUNCT
eurjchem-2084	527	11	fischer	fischer	PROPN
eurjchem-2084	527	12	,	,	PUNCT
eurjchem-2084	527	13	w.	w.	PROPN
eurjchem-2084	527	14	a.	a.	PROPN
eurjchem-2084	527	15	;	;	PUNCT
eurjchem-2084	527	16	kanamori	kanamori	PROPN
eurjchem-2084	527	17	,	,	PUNCT
eurjchem-2084	527	18	h.	h.	PROPN
eurjchem-2084	527	19	;	;	PUNCT
eurjchem-2084	527	20	sickbertbennett	sickbertbennett	PROPN
eurjchem-2084	527	21	,	,	PUNCT
eurjchem-2084	527	22	e.	e.	PROPN
eurjchem-2084	527	23	e.	e.	PROPN
eurjchem-2084	527	24	am	am	PROPN
eurjchem-2084	527	25	.	.	PUNCT
eurjchem-2084	528	1	j.	j.	PROPN
eurjchem-2084	528	2	infect	infect	PROPN
eurjchem-2084	528	3	.	.	PUNCT
eurjchem-2084	529	1	control	control	PROPN
eurjchem-2084	529	2	2016	2016	NUM
eurjchem-2084	529	3	,	,	PUNCT
eurjchem-2084	529	4	44	44	NUM
eurjchem-2084	529	5	(	(	PUNCT
eurjchem-2084	529	6	5	5	NUM
eurjchem-2084	529	7	)	)	PUNCT
eurjchem-2084	529	8	,	,	PUNCT
eurjchem-2084	529	9	e91	e91	PROPN
eurjchem-2084	529	10	–	–	PUNCT
eurjchem-2084	529	11	e100	e100	PROPN
eurjchem-2084	529	12	.	.	PUNCT
eurjchem-2084	530	1	[	[	X
eurjchem-2084	530	2	48	48	NUM
eurjchem-2084	530	3	]	]	PUNCT
eurjchem-2084	530	4	.	.	PUNCT
eurjchem-2084	531	1	wang	wang	PROPN
eurjchem-2084	531	2	,	,	PUNCT
eurjchem-2084	531	3	w.	w.	PROPN
eurjchem-2084	531	4	;	;	PUNCT
eurjchem-2084	531	5	xu	xu	PROPN
eurjchem-2084	531	6	,	,	PUNCT
eurjchem-2084	531	7	y.	y.	PROPN
eurjchem-2084	531	8	;	;	PUNCT
eurjchem-2084	531	9	gao	gao	PROPN
eurjchem-2084	531	10	,	,	PUNCT
eurjchem-2084	531	11	r.	r.	PROPN
eurjchem-2084	531	12	;	;	PUNCT
eurjchem-2084	531	13	lu	lu	PROPN
eurjchem-2084	531	14	,	,	PUNCT
eurjchem-2084	531	15	r.	r.	PROPN
eurjchem-2084	531	16	;	;	PUNCT
eurjchem-2084	531	17	han	han	PROPN
eurjchem-2084	531	18	,	,	PUNCT
eurjchem-2084	531	19	k.	k.	PROPN
eurjchem-2084	531	20	;	;	PUNCT
eurjchem-2084	531	21	wu	wu	PROPN
eurjchem-2084	531	22	,	,	PUNCT
eurjchem-2084	531	23	g.	g.	PROPN
eurjchem-2084	531	24	;	;	PUNCT
eurjchem-2084	531	25	tan	tan	PROPN
eurjchem-2084	531	26	,	,	PUNCT
eurjchem-2084	531	27	w.	w.	PROPN
eurjchem-2084	531	28	jama	jama	PROPN
eurjchem-2084	531	29	2020	2020	NUM
eurjchem-2084	531	30	,	,	PUNCT
eurjchem-2084	531	31	323	323	NUM
eurjchem-2084	531	32	(	(	PUNCT
eurjchem-2084	531	33	18	18	NUM
eurjchem-2084	531	34	)	)	PUNCT
eurjchem-2084	531	35	,	,	PUNCT
eurjchem-2084	531	36	1843–1844	1843–1844	NUM
eurjchem-2084	531	37	.	.	PUNCT
eurjchem-2084	532	1	[	[	X
eurjchem-2084	532	2	49	49	NUM
eurjchem-2084	532	3	]	]	PUNCT
eurjchem-2084	532	4	.	.	PUNCT
eurjchem-2084	532	5	peiris	peiris	PROPN
eurjchem-2084	532	6	,	,	PUNCT
eurjchem-2084	532	7	j.	j.	PROPN
eurjchem-2084	532	8	s.	s.	PROPN
eurjchem-2084	532	9	m.	m.	PROPN
eurjchem-2084	532	10	;	;	PUNCT
eurjchem-2084	532	11	chu	chu	PROPN
eurjchem-2084	532	12	,	,	PUNCT
eurjchem-2084	532	13	c.	c.	PROPN
eurjchem-2084	532	14	m.	m.	NOUN
eurjchem-2084	532	15	;	;	PUNCT
eurjchem-2084	532	16	cheng	cheng	PROPN
eurjchem-2084	532	17	,	,	PUNCT
eurjchem-2084	532	18	v.	v.	PROPN
eurjchem-2084	532	19	c.	c.	PROPN
eurjchem-2084	532	20	c.	c.	PROPN
eurjchem-2084	532	21	;	;	PUNCT
eurjchem-2084	532	22	chan	chan	PROPN
eurjchem-2084	532	23	,	,	PUNCT
eurjchem-2084	532	24	k.	k.	PROPN
eurjchem-2084	532	25	s.	s.	PROPN
eurjchem-2084	532	26	;	;	PUNCT
eurjchem-2084	532	27	hung	hung	PROPN
eurjchem-2084	532	28	,	,	PUNCT
eurjchem-2084	532	29	i.	i.	PROPN
eurjchem-2084	532	30	f.	f.	PROPN
eurjchem-2084	532	31	n.	n.	PROPN
eurjchem-2084	532	32	;	;	PUNCT
eurjchem-2084	532	33	poon	poon	NOUN
eurjchem-2084	532	34	,	,	PUNCT
eurjchem-2084	532	35	l.	l.	PROPN
eurjchem-2084	532	36	l.	l.	PROPN
eurjchem-2084	532	37	m.	m.	PROPN
eurjchem-2084	532	38	;	;	PUNCT
eurjchem-2084	532	39	law	law	NOUN
eurjchem-2084	532	40	,	,	PUNCT
eurjchem-2084	532	41	k.	k.	PROPN
eurjchem-2084	532	42	i.	i.	PROPN
eurjchem-2084	532	43	;	;	PUNCT
eurjchem-2084	532	44	tang	tang	PROPN
eurjchem-2084	532	45	,	,	PUNCT
eurjchem-2084	532	46	b.	b.	PROPN
eurjchem-2084	532	47	s.	s.	PROPN
eurjchem-2084	532	48	f.	f.	PROPN
eurjchem-2084	532	49	;	;	PUNCT
eurjchem-2084	532	50	hon	hon	PROPN
eurjchem-2084	532	51	,	,	PUNCT
eurjchem-2084	532	52	t.	t.	PROPN
eurjchem-2084	532	53	y.	y.	PROPN
eurjchem-2084	532	54	w.	w.	PROPN
eurjchem-2084	532	55	;	;	PUNCT
eurjchem-2084	532	56	chan	chan	PROPN
eurjchem-2084	532	57	,	,	PUNCT
eurjchem-2084	532	58	c.	c.	PROPN
eurjchem-2084	532	59	s.	s.	PROPN
eurjchem-2084	532	60	;	;	PUNCT
eurjchem-2084	532	61	chan	chan	PROPN
eurjchem-2084	532	62	,	,	PUNCT
eurjchem-2084	532	63	k.	k.	PROPN
eurjchem-2084	532	64	h.	h.	PROPN
eurjchem-2084	532	65	;	;	PUNCT
eurjchem-2084	532	66	ng	ng	PROPN
eurjchem-2084	532	67	,	,	PUNCT
eurjchem-2084	532	68	j.	j.	PROPN
eurjchem-2084	532	69	s.	s.	PROPN
eurjchem-2084	532	70	c.	c.	PROPN
eurjchem-2084	532	71	;	;	PUNCT
eurjchem-2084	532	72	zheng	zheng	PROPN
eurjchem-2084	532	73	,	,	PUNCT
eurjchem-2084	532	74	b.	b.	PROPN
eurjchem-2084	532	75	j.	j.	PROPN
eurjchem-2084	532	76	;	;	PUNCT
eurjchem-2084	532	77	ng	ng	PROPN
eurjchem-2084	532	78	,	,	PUNCT
eurjchem-2084	532	79	w.	w.	PROPN
eurjchem-2084	532	80	l.	l.	PROPN
eurjchem-2084	532	81	;	;	PUNCT
eurjchem-2084	532	82	lai	lai	PROPN
eurjchem-2084	532	83	,	,	PUNCT
eurjchem-2084	532	84	r.	r.	PROPN
eurjchem-2084	532	85	w.	w.	PROPN
eurjchem-2084	532	86	m.	m.	PROPN
eurjchem-2084	532	87	;	;	PUNCT
eurjchem-2084	532	88	guan	guan	PROPN
eurjchem-2084	532	89	,	,	PUNCT
eurjchem-2084	532	90	y.	y.	PROPN
eurjchem-2084	532	91	;	;	PUNCT
eurjchem-2084	532	92	yuen	yuen	PROPN
eurjchem-2084	532	93	,	,	PUNCT
eurjchem-2084	532	94	k.	k.	PROPN
eurjchem-2084	532	95	y.	y.	PROPN
eurjchem-2084	532	96	lancet	lancet	PROPN
eurjchem-2084	532	97	2003	2003	NUM
eurjchem-2084	532	98	,	,	PUNCT
eurjchem-2084	532	99	361	361	NUM
eurjchem-2084	532	100	(	(	PUNCT
eurjchem-2084	532	101	9371	9371	NUM
eurjchem-2084	532	102	)	)	PUNCT
eurjchem-2084	532	103	,	,	PUNCT
eurjchem-2084	532	104	1767–1772	1767–1772	NUM
eurjchem-2084	532	105	.	.	PUNCT
eurjchem-2084	533	1	[	[	X
eurjchem-2084	533	2	50	50	NUM
eurjchem-2084	533	3	]	]	PUNCT
eurjchem-2084	533	4	.	.	PUNCT
eurjchem-2084	534	1	casanova	casanova	PROPN
eurjchem-2084	534	2	,	,	PUNCT
eurjchem-2084	534	3	l.	l.	PROPN
eurjchem-2084	534	4	;	;	PUNCT
eurjchem-2084	534	5	rutala	rutala	PROPN
eurjchem-2084	534	6	,	,	PUNCT
eurjchem-2084	534	7	w.	w.	PROPN
eurjchem-2084	534	8	a.	a.	PROPN
eurjchem-2084	534	9	;	;	PUNCT
eurjchem-2084	534	10	weber	weber	PROPN
eurjchem-2084	534	11	,	,	PUNCT
eurjchem-2084	534	12	d.	d.	PROPN
eurjchem-2084	534	13	j.	j.	PROPN
eurjchem-2084	534	14	;	;	PUNCT
eurjchem-2084	534	15	sobsey	sobsey	NOUN
eurjchem-2084	534	16	,	,	PUNCT
eurjchem-2084	534	17	m.	m.	NOUN
eurjchem-2084	534	18	d.	d.	PROPN
eurjchem-2084	534	19	water	water	PROPN
eurjchem-2084	534	20	res	re	NOUN
eurjchem-2084	534	21	.	.	PUNCT
eurjchem-2084	534	22	2009	2009	NUM
eurjchem-2084	534	23	,	,	PUNCT
eurjchem-2084	534	24	43	43	NUM
eurjchem-2084	534	25	(	(	PUNCT
eurjchem-2084	534	26	7	7	NUM
eurjchem-2084	534	27	)	)	PUNCT
eurjchem-2084	534	28	,	,	PUNCT
eurjchem-2084	534	29	1893–1898	1893–1898	NUM
eurjchem-2084	534	30	.	.	PUNCT
eurjchem-2084	535	1	[	[	X
eurjchem-2084	535	2	51	51	NUM
eurjchem-2084	535	3	]	]	PUNCT
eurjchem-2084	535	4	.	.	PUNCT
eurjchem-2084	536	1	yu	yu	PROPN
eurjchem-2084	536	2	,	,	PUNCT
eurjchem-2084	536	3	i.	i.	PROPN
eurjchem-2084	536	4	t.	t.	PROPN
eurjchem-2084	536	5	s.	s.	PROPN
eurjchem-2084	536	6	;	;	PUNCT
eurjchem-2084	536	7	li	li	PROPN
eurjchem-2084	536	8	,	,	PUNCT
eurjchem-2084	536	9	y.	y.	PROPN
eurjchem-2084	536	10	;	;	PUNCT
eurjchem-2084	536	11	wong	wong	PROPN
eurjchem-2084	536	12	,	,	PUNCT
eurjchem-2084	536	13	t.	t.	PROPN
eurjchem-2084	536	14	w.	w.	PROPN
eurjchem-2084	536	15	;	;	PUNCT
eurjchem-2084	536	16	tam	tam	PROPN
eurjchem-2084	536	17	,	,	PUNCT
eurjchem-2084	536	18	w.	w.	PROPN
eurjchem-2084	536	19	;	;	PUNCT
eurjchem-2084	536	20	chan	chan	PROPN
eurjchem-2084	536	21	,	,	PUNCT
eurjchem-2084	536	22	a.	a.	NOUN
eurjchem-2084	536	23	t.	t.	PROPN
eurjchem-2084	536	24	;	;	PUNCT
eurjchem-2084	536	25	lee	lee	PROPN
eurjchem-2084	536	26	,	,	PUNCT
eurjchem-2084	536	27	j.	j.	PROPN
eurjchem-2084	536	28	h.	h.	PROPN
eurjchem-2084	536	29	w.	w.	PROPN
eurjchem-2084	536	30	;	;	PUNCT
eurjchem-2084	536	31	leung	leung	PROPN
eurjchem-2084	536	32	,	,	PUNCT
eurjchem-2084	536	33	d.	d.	PROPN
eurjchem-2084	536	34	y.	y.	PROPN
eurjchem-2084	536	35	c.	c.	PROPN
eurjchem-2084	536	36	;	;	PUNCT
eurjchem-2084	536	37	ho	ho	PROPN
eurjchem-2084	536	38	,	,	PUNCT
eurjchem-2084	536	39	t.	t.	PROPN
eurjchem-2084	536	40	n.	n.	PROPN
eurjchem-2084	536	41	engl	engl	PROPN
eurjchem-2084	536	42	.	.	PUNCT
eurjchem-2084	537	1	j.	j.	PROPN
eurjchem-2084	537	2	med	med	PROPN
eurjchem-2084	537	3	.	.	PUNCT
eurjchem-2084	538	1	2004	2004	NUM
eurjchem-2084	538	2	,	,	PUNCT
eurjchem-2084	538	3	350	350	NUM
eurjchem-2084	538	4	(	(	PUNCT
eurjchem-2084	538	5	17	17	NUM
eurjchem-2084	538	6	)	)	PUNCT
eurjchem-2084	538	7	,	,	PUNCT
eurjchem-2084	538	8	1731–1739	1731–1739	NUM
eurjchem-2084	538	9	.	.	PUNCT
eurjchem-2084	539	1	[	[	X
eurjchem-2084	539	2	52	52	NUM
eurjchem-2084	539	3	]	]	PUNCT
eurjchem-2084	539	4	.	.	PUNCT
eurjchem-2084	540	1	huang	huang	PROPN
eurjchem-2084	540	2	,	,	PUNCT
eurjchem-2084	540	3	c.	c.	PROPN
eurjchem-2084	540	4	;	;	PUNCT
eurjchem-2084	540	5	wang	wang	PROPN
eurjchem-2084	540	6	,	,	PUNCT
eurjchem-2084	540	7	y.	y.	PROPN
eurjchem-2084	540	8	;	;	PUNCT
eurjchem-2084	540	9	li	li	PROPN
eurjchem-2084	540	10	,	,	PUNCT
eurjchem-2084	540	11	x.	x.	PROPN
eurjchem-2084	540	12	;	;	PUNCT
eurjchem-2084	540	13	ren	ren	PROPN
eurjchem-2084	540	14	,	,	PUNCT
eurjchem-2084	540	15	l.	l.	PROPN
eurjchem-2084	540	16	;	;	PUNCT
eurjchem-2084	540	17	zhao	zhao	PROPN
eurjchem-2084	540	18	,	,	PUNCT
eurjchem-2084	540	19	j.	j.	PROPN
eurjchem-2084	540	20	;	;	PUNCT
eurjchem-2084	540	21	hu	hu	PROPN
eurjchem-2084	540	22	,	,	PUNCT
eurjchem-2084	540	23	y.	y.	PROPN
eurjchem-2084	540	24	;	;	PUNCT
eurjchem-2084	540	25	zhang	zhang	PROPN
eurjchem-2084	540	26	,	,	PUNCT
eurjchem-2084	540	27	l.	l.	PROPN
eurjchem-2084	540	28	;	;	PUNCT
eurjchem-2084	540	29	fan	fan	PROPN
eurjchem-2084	540	30	,	,	PUNCT
eurjchem-2084	540	31	g.	g.	PROPN
eurjchem-2084	540	32	;	;	PUNCT
eurjchem-2084	540	33	xu	xu	PROPN
eurjchem-2084	540	34	,	,	PUNCT
eurjchem-2084	540	35	j.	j.	PROPN
eurjchem-2084	540	36	;	;	PUNCT
eurjchem-2084	540	37	gu	gu	PROPN
eurjchem-2084	540	38	,	,	PUNCT
eurjchem-2084	540	39	x.	x.	PROPN
eurjchem-2084	540	40	;	;	PUNCT
eurjchem-2084	540	41	cheng	cheng	PROPN
eurjchem-2084	540	42	,	,	PUNCT
eurjchem-2084	540	43	z.	z.	PROPN
eurjchem-2084	540	44	;	;	PUNCT
eurjchem-2084	540	45	yu	yu	PROPN
eurjchem-2084	540	46	,	,	PUNCT
eurjchem-2084	540	47	t.	t.	PROPN
eurjchem-2084	540	48	;	;	PUNCT
eurjchem-2084	540	49	xia	xia	PROPN
eurjchem-2084	540	50	,	,	PUNCT
eurjchem-2084	540	51	j.	j.	PROPN
eurjchem-2084	540	52	;	;	PUNCT
eurjchem-2084	540	53	wei	wei	PROPN
eurjchem-2084	540	54	,	,	PUNCT
eurjchem-2084	540	55	y.	y.	PROPN
eurjchem-2084	540	56	;	;	PUNCT
eurjchem-2084	540	57	wu	wu	PROPN
eurjchem-2084	540	58	,	,	PUNCT
eurjchem-2084	540	59	w.	w.	PROPN
eurjchem-2084	540	60	;	;	PUNCT
eurjchem-2084	540	61	xie	xie	PROPN
eurjchem-2084	540	62	,	,	PUNCT
eurjchem-2084	540	63	x.	x.	PROPN
eurjchem-2084	540	64	;	;	PUNCT
eurjchem-2084	540	65	yin	yin	PROPN
eurjchem-2084	540	66	,	,	PUNCT
eurjchem-2084	540	67	w.	w.	PROPN
eurjchem-2084	540	68	;	;	PUNCT
eurjchem-2084	540	69	li	li	PROPN
eurjchem-2084	540	70	,	,	PUNCT
eurjchem-2084	540	71	h.	h.	PROPN
eurjchem-2084	540	72	;	;	PUNCT
eurjchem-2084	540	73	liu	liu	PROPN
eurjchem-2084	540	74	,	,	PUNCT
eurjchem-2084	540	75	m.	m.	NOUN
eurjchem-2084	540	76	;	;	PUNCT
eurjchem-2084	540	77	xiao	xiao	PROPN
eurjchem-2084	540	78	,	,	PUNCT
eurjchem-2084	540	79	y.	y.	PROPN
eurjchem-2084	540	80	;	;	PUNCT
eurjchem-2084	540	81	gao	gao	PROPN
eurjchem-2084	540	82	,	,	PUNCT
eurjchem-2084	540	83	h.	h.	PROPN
eurjchem-2084	540	84	;	;	PUNCT
eurjchem-2084	540	85	guo	guo	PROPN
eurjchem-2084	540	86	,	,	PUNCT
eurjchem-2084	540	87	l.	l.	PROPN
eurjchem-2084	540	88	;	;	PUNCT
eurjchem-2084	540	89	xie	xie	PROPN
eurjchem-2084	540	90	,	,	PUNCT
eurjchem-2084	540	91	j.	j.	PROPN
eurjchem-2084	540	92	;	;	PUNCT
eurjchem-2084	540	93	wang	wang	PROPN
eurjchem-2084	540	94	,	,	PUNCT
eurjchem-2084	540	95	g.	g.	PROPN
eurjchem-2084	540	96	;	;	PUNCT
eurjchem-2084	540	97	jiang	jiang	PROPN
eurjchem-2084	540	98	,	,	PUNCT
eurjchem-2084	540	99	r.	r.	PROPN
eurjchem-2084	540	100	;	;	PUNCT
eurjchem-2084	540	101	gao	gao	PROPN
eurjchem-2084	540	102	,	,	PUNCT
eurjchem-2084	540	103	z.	z.	PROPN
eurjchem-2084	540	104	;	;	PUNCT
eurjchem-2084	540	105	jin	jin	PROPN
eurjchem-2084	540	106	,	,	PUNCT
eurjchem-2084	540	107	q.	q.	PROPN
eurjchem-2084	540	108	;	;	PUNCT
eurjchem-2084	540	109	wang	wang	PROPN
eurjchem-2084	540	110	,	,	PUNCT
eurjchem-2084	540	111	j.	j.	PROPN
eurjchem-2084	540	112	;	;	PUNCT
eurjchem-2084	540	113	cao	cao	PROPN
eurjchem-2084	540	114	,	,	PUNCT
eurjchem-2084	540	115	b.	b.	PROPN
eurjchem-2084	540	116	lancet	lancet	PROPN
eurjchem-2084	540	117	2020	2020	NUM
eurjchem-2084	540	118	,	,	PUNCT
eurjchem-2084	540	119	395	395	NUM
eurjchem-2084	540	120	(	(	PUNCT
eurjchem-2084	540	121	10223	10223	NUM
eurjchem-2084	540	122	)	)	PUNCT
eurjchem-2084	540	123	,	,	PUNCT
eurjchem-2084	540	124	497–506	497–506	NUM
eurjchem-2084	540	125	.	.	PUNCT
eurjchem-2084	541	1	[	[	X
eurjchem-2084	541	2	53	53	NUM
eurjchem-2084	541	3	]	]	PUNCT
eurjchem-2084	541	4	.	.	PUNCT
eurjchem-2084	542	1	wu	wu	PROPN
eurjchem-2084	542	2	,	,	PUNCT
eurjchem-2084	542	3	z.	z.	PROPN
eurjchem-2084	542	4	;	;	PUNCT
eurjchem-2084	542	5	mcgoogan	mcgoogan	PROPN
eurjchem-2084	542	6	,	,	PUNCT
eurjchem-2084	542	7	j.	j.	PROPN
eurjchem-2084	542	8	m.	m.	PROPN
eurjchem-2084	542	9	jama	jama	PROPN
eurjchem-2084	542	10	2020	2020	NUM
eurjchem-2084	542	11	,	,	PUNCT
eurjchem-2084	542	12	323	323	NUM
eurjchem-2084	542	13	(	(	PUNCT
eurjchem-2084	542	14	13	13	NUM
eurjchem-2084	542	15	)	)	PUNCT
eurjchem-2084	542	16	,	,	PUNCT
eurjchem-2084	542	17	1239–1242	1239–1242	NUM
eurjchem-2084	542	18	.	.	PUNCT
eurjchem-2084	543	1	[	[	X
eurjchem-2084	543	2	54	54	NUM
eurjchem-2084	543	3	]	]	PUNCT
eurjchem-2084	543	4	.	.	PUNCT
eurjchem-2084	544	1	bhopal	bhopal	PROPN
eurjchem-2084	544	2	,	,	PUNCT
eurjchem-2084	544	3	s.	s.	PROPN
eurjchem-2084	544	4	s.	s.	PROPN
eurjchem-2084	544	5	;	;	PUNCT
eurjchem-2084	544	6	bhopal	bhopal	PROPN
eurjchem-2084	544	7	,	,	PUNCT
eurjchem-2084	544	8	r.	r.	PROPN
eurjchem-2084	544	9	lancet	lancet	PROPN
eurjchem-2084	544	10	2020	2020	NUM
eurjchem-2084	544	11	,	,	PUNCT
eurjchem-2084	544	12	396	396	NUM
eurjchem-2084	544	13	(	(	PUNCT
eurjchem-2084	544	14	10250	10250	NUM
eurjchem-2084	544	15	)	)	PUNCT
eurjchem-2084	544	16	,	,	PUNCT
eurjchem-2084	544	17	532–533	532–533	NUM
eurjchem-2084	544	18	.	.	PUNCT
eurjchem-2084	545	1	[	[	X
eurjchem-2084	545	2	55	55	NUM
eurjchem-2084	545	3	]	]	PUNCT
eurjchem-2084	545	4	.	.	PUNCT
eurjchem-2084	546	1	chen	chen	PROPN
eurjchem-2084	546	2	,	,	PUNCT
eurjchem-2084	546	3	h.	h.	PROPN
eurjchem-2084	546	4	;	;	PUNCT
eurjchem-2084	546	5	guo	guo	PROPN
eurjchem-2084	546	6	,	,	PUNCT
eurjchem-2084	546	7	j.	j.	PROPN
eurjchem-2084	546	8	;	;	PUNCT
eurjchem-2084	546	9	wang	wang	PROPN
eurjchem-2084	546	10	,	,	PUNCT
eurjchem-2084	546	11	c.	c.	PROPN
eurjchem-2084	546	12	;	;	PUNCT
eurjchem-2084	546	13	luo	luo	PROPN
eurjchem-2084	546	14	,	,	PUNCT
eurjchem-2084	546	15	f.	f.	PROPN
eurjchem-2084	546	16	;	;	PUNCT
eurjchem-2084	546	17	yu	yu	PROPN
eurjchem-2084	546	18	,	,	PUNCT
eurjchem-2084	546	19	x.	x.	PROPN
eurjchem-2084	546	20	;	;	PUNCT
eurjchem-2084	546	21	zhang	zhang	PROPN
eurjchem-2084	546	22	,	,	PUNCT
eurjchem-2084	546	23	w.	w.	PROPN
eurjchem-2084	546	24	;	;	PUNCT
eurjchem-2084	546	25	li	li	PROPN
eurjchem-2084	546	26	,	,	PUNCT
eurjchem-2084	546	27	j.	j.	PROPN
eurjchem-2084	546	28	;	;	PUNCT
eurjchem-2084	546	29	zhao	zhao	PROPN
eurjchem-2084	546	30	,	,	PUNCT
eurjchem-2084	546	31	d.	d.	PROPN
eurjchem-2084	546	32	;	;	PUNCT
eurjchem-2084	546	33	xu	xu	PROPN
eurjchem-2084	546	34	,	,	PUNCT
eurjchem-2084	546	35	d.	d.	PROPN
eurjchem-2084	546	36	;	;	PUNCT
eurjchem-2084	546	37	gong	gong	PROPN
eurjchem-2084	546	38	,	,	PUNCT
eurjchem-2084	546	39	q.	q.	PROPN
eurjchem-2084	546	40	;	;	PUNCT
eurjchem-2084	546	41	liao	liao	PROPN
eurjchem-2084	546	42	,	,	PUNCT
eurjchem-2084	546	43	j.	j.	PROPN
eurjchem-2084	546	44	;	;	PUNCT
eurjchem-2084	546	45	yang	yang	PROPN
eurjchem-2084	546	46	,	,	PUNCT
eurjchem-2084	546	47	h.	h.	PROPN
eurjchem-2084	546	48	;	;	PUNCT
eurjchem-2084	546	49	hou	hou	PROPN
eurjchem-2084	546	50	,	,	PUNCT
eurjchem-2084	546	51	w.	w.	PROPN
eurjchem-2084	546	52	;	;	PUNCT
eurjchem-2084	546	53	zhang	zhang	PROPN
eurjchem-2084	546	54	,	,	PUNCT
eurjchem-2084	546	55	y.	y.	PROPN
eurjchem-2084	546	56	lancet	lancet	PROPN
eurjchem-2084	546	57	2020	2020	NUM
eurjchem-2084	546	58	,	,	PUNCT
eurjchem-2084	546	59	395	395	NUM
eurjchem-2084	546	60	(	(	PUNCT
eurjchem-2084	546	61	10226	10226	NUM
eurjchem-2084	546	62	)	)	PUNCT
eurjchem-2084	546	63	,	,	PUNCT
eurjchem-2084	546	64	809–815	809–815	NUM
eurjchem-2084	546	65	.	.	PUNCT
eurjchem-2084	547	1	[	[	X
eurjchem-2084	547	2	56	56	NUM
eurjchem-2084	547	3	]	]	SYM
eurjchem-2084	547	4	.	.	PUNCT
eurjchem-2084	547	5	walker	walker	PROPN
eurjchem-2084	547	6	,	,	PUNCT
eurjchem-2084	547	7	k.	k.	PROPN
eurjchem-2084	547	8	f.	f.	PROPN
eurjchem-2084	547	9	;	;	PUNCT
eurjchem-2084	547	10	o’donoghue	o’donoghue	PROPN
eurjchem-2084	547	11	,	,	PUNCT
eurjchem-2084	547	12	k.	k.	PROPN
eurjchem-2084	547	13	;	;	PUNCT
eurjchem-2084	547	14	grace	grace	NOUN
eurjchem-2084	547	15	,	,	PUNCT
eurjchem-2084	547	16	n.	n.	NOUN
eurjchem-2084	547	17	;	;	PUNCT
eurjchem-2084	547	18	dorling	dorling	PROPN
eurjchem-2084	547	19	,	,	PUNCT
eurjchem-2084	547	20	j.	j.	PROPN
eurjchem-2084	547	21	;	;	PUNCT
eurjchem-2084	547	22	comeau	comeau	PROPN
eurjchem-2084	547	23	,	,	PUNCT
eurjchem-2084	547	24	j.	j.	PROPN
eurjchem-2084	547	25	l.	l.	PROPN
eurjchem-2084	547	26	;	;	PUNCT
eurjchem-2084	547	27	li	li	PROPN
eurjchem-2084	547	28	,	,	PUNCT
eurjchem-2084	547	29	w.	w.	PROPN
eurjchem-2084	547	30	;	;	PUNCT
eurjchem-2084	547	31	thornton	thornton	PROPN
eurjchem-2084	547	32	,	,	PUNCT
eurjchem-2084	547	33	j.	j.	PROPN
eurjchem-2084	547	34	g.	g.	PROPN
eurjchem-2084	547	35	bjog	bjog	PROPN
eurjchem-2084	547	36	2020	2020	NUM
eurjchem-2084	547	37	,	,	PUNCT
eurjchem-2084	547	38	127	127	NUM
eurjchem-2084	547	39	(	(	PUNCT
eurjchem-2084	547	40	11	11	NUM
eurjchem-2084	547	41	)	)	PUNCT
eurjchem-2084	547	42	,	,	PUNCT
eurjchem-2084	547	43	1324–1336	1324–1336	NUM
eurjchem-2084	547	44	.	.	PUNCT
eurjchem-2084	548	1	[	[	X
eurjchem-2084	548	2	57	57	NUM
eurjchem-2084	548	3	]	]	PUNCT
eurjchem-2084	548	4	.	.	PUNCT
eurjchem-2084	549	1	trevisanuto	trevisanuto	PROPN
eurjchem-2084	549	2	,	,	PUNCT
eurjchem-2084	549	3	d.	d.	PROPN
eurjchem-2084	549	4	;	;	PUNCT
eurjchem-2084	549	5	cavallin	cavallin	PROPN
eurjchem-2084	549	6	,	,	PUNCT
eurjchem-2084	549	7	f.	f.	PROPN
eurjchem-2084	549	8	;	;	PUNCT
eurjchem-2084	549	9	cavicchiolo	cavicchiolo	PROPN
eurjchem-2084	549	10	,	,	PUNCT
eurjchem-2084	549	11	m.	m.	PROPN
eurjchem-2084	549	12	e.	e.	PROPN
eurjchem-2084	549	13	;	;	PUNCT
eurjchem-2084	549	14	borellini	borellini	PROPN
eurjchem-2084	549	15	,	,	PUNCT
eurjchem-2084	549	16	m.	m.	NOUN
eurjchem-2084	549	17	;	;	PUNCT
eurjchem-2084	549	18	calgaro	calgaro	NOUN
eurjchem-2084	549	19	,	,	PUNCT
eurjchem-2084	549	20	s.	s.	PROPN
eurjchem-2084	549	21	;	;	PUNCT
eurjchem-2084	549	22	baraldi	baraldi	PROPN
eurjchem-2084	549	23	,	,	PUNCT
eurjchem-2084	549	24	e.	e.	PROPN
eurjchem-2084	549	25	arch	arch	PROPN
eurjchem-2084	549	26	.	.	PUNCT
eurjchem-2084	550	1	dis	dis	PROPN
eurjchem-2084	550	2	.	.	PUNCT
eurjchem-2084	550	3	child	child	NOUN
eurjchem-2084	550	4	.	.	PUNCT
eurjchem-2084	551	1	fetal	fetal	ADJ
eurjchem-2084	551	2	neonatal	neonatal	ADJ
eurjchem-2084	551	3	ed	ed	NOUN
eurjchem-2084	551	4	.	.	PROPN
eurjchem-2084	552	1	2020	2020	NUM
eurjchem-2084	552	2	,	,	PUNCT
eurjchem-2084	552	3	fetalneonatal2020	fetalneonatal2020	NOUN
eurjchem-2084	552	4	-	-	PUNCT
eurjchem-2084	552	5	319837	319837	NUM
eurjchem-2084	552	6	.	.	PUNCT
eurjchem-2084	553	1	[	[	X
eurjchem-2084	553	2	58	58	NUM
eurjchem-2084	553	3	]	]	PUNCT
eurjchem-2084	553	4	.	.	PUNCT
eurjchem-2084	554	1	stokes	stokes	PROPN
eurjchem-2084	554	2	,	,	PUNCT
eurjchem-2084	554	3	e.	e.	PROPN
eurjchem-2084	554	4	k.	k.	PROPN
eurjchem-2084	554	5	;	;	PUNCT
eurjchem-2084	554	6	zambrano	zambrano	PROPN
eurjchem-2084	554	7	,	,	PUNCT
eurjchem-2084	554	8	l.	l.	PROPN
eurjchem-2084	554	9	d.	d.	PROPN
eurjchem-2084	554	10	;	;	PUNCT
eurjchem-2084	554	11	anderson	anderson	PROPN
eurjchem-2084	554	12	,	,	PUNCT
eurjchem-2084	554	13	k.	k.	PROPN
eurjchem-2084	554	14	n.	n.	PROPN
eurjchem-2084	554	15	;	;	PUNCT
eurjchem-2084	554	16	marder	marder	PROPN
eurjchem-2084	554	17	,	,	PUNCT
eurjchem-2084	554	18	e.	e.	PROPN
eurjchem-2084	554	19	p.	p.	PROPN
eurjchem-2084	554	20	;	;	PUNCT
eurjchem-2084	555	1	raz	raz	PROPN
eurjchem-2084	555	2	,	,	PUNCT
eurjchem-2084	555	3	k.	k.	PROPN
eurjchem-2084	555	4	m.	m.	PROPN
eurjchem-2084	555	5	;	;	PUNCT
eurjchem-2084	555	6	el	el	PROPN
eurjchem-2084	555	7	burai	burai	PROPN
eurjchem-2084	555	8	felix	felix	PROPN
eurjchem-2084	555	9	,	,	PUNCT
eurjchem-2084	555	10	s.	s.	PROPN
eurjchem-2084	555	11	;	;	PUNCT
eurjchem-2084	555	12	tie	tie	NOUN
eurjchem-2084	555	13	,	,	PUNCT
eurjchem-2084	555	14	y.	y.	PROPN
eurjchem-2084	555	15	;	;	PUNCT
eurjchem-2084	555	16	fullerton	fullerton	PROPN
eurjchem-2084	555	17	,	,	PUNCT
eurjchem-2084	555	18	k.	k.	PROPN
eurjchem-2084	555	19	e.	e.	PROPN
eurjchem-2084	555	20	mmwr	mmwr	PROPN
eurjchem-2084	555	21	morb	morb	PROPN
eurjchem-2084	555	22	.	.	PUNCT
eurjchem-2084	556	1	mortal	mortal	ADJ
eurjchem-2084	556	2	.	.	PUNCT
eurjchem-2084	557	1	wkly	wkly	PROPN
eurjchem-2084	557	2	.	.	PUNCT
eurjchem-2084	558	1	rep	rep	PROPN
eurjchem-2084	558	2	.	.	PROPN
eurjchem-2084	558	3	2020	2020	NUM
eurjchem-2084	558	4	,	,	PUNCT
eurjchem-2084	558	5	69	69	NUM
eurjchem-2084	558	6	(	(	PUNCT
eurjchem-2084	558	7	24	24	NUM
eurjchem-2084	558	8	)	)	PUNCT
eurjchem-2084	558	9	,	,	PUNCT
eurjchem-2084	558	10	759–765	759–765	NUM
eurjchem-2084	558	11	.	.	PUNCT
eurjchem-2084	559	1	[	[	X
eurjchem-2084	559	2	59	59	NUM
eurjchem-2084	559	3	]	]	PUNCT
eurjchem-2084	559	4	.	.	PUNCT
eurjchem-2084	560	1	heald	heald	PROPN
eurjchem-2084	560	2	-	-	PUNCT
eurjchem-2084	560	3	sargent	sargent	PROPN
eurjchem-2084	560	4	,	,	PUNCT
eurjchem-2084	560	5	t.	t.	PROPN
eurjchem-2084	560	6	;	;	PUNCT
eurjchem-2084	560	7	muller	muller	PROPN
eurjchem-2084	560	8	,	,	PUNCT
eurjchem-2084	560	9	w.	w.	PROPN
eurjchem-2084	560	10	j.	j.	PROPN
eurjchem-2084	560	11	;	;	PUNCT
eurjchem-2084	560	12	zheng	zheng	PROPN
eurjchem-2084	560	13	,	,	PUNCT
eurjchem-2084	560	14	x.	x.	PROPN
eurjchem-2084	560	15	;	;	PUNCT
eurjchem-2084	560	16	rippe	rippe	PROPN
eurjchem-2084	560	17	,	,	PUNCT
eurjchem-2084	560	18	j.	j.	PROPN
eurjchem-2084	560	19	;	;	PUNCT
eurjchem-2084	560	20	patel	patel	PROPN
eurjchem-2084	560	21	,	,	PUNCT
eurjchem-2084	560	22	a.	a.	PROPN
eurjchem-2084	560	23	b.	b.	PROPN
eurjchem-2084	560	24	;	;	PUNCT
eurjchem-2084	560	25	kociolek	kociolek	PROPN
eurjchem-2084	560	26	,	,	PUNCT
eurjchem-2084	560	27	l.	l.	PROPN
eurjchem-2084	560	28	k.	k.	PROPN
eurjchem-2084	560	29	jama	jama	PROPN
eurjchem-2084	560	30	pediatr	pediatr	PROPN
eurjchem-2084	560	31	.	.	PUNCT
eurjchem-2084	560	32	2020	2020	NUM
eurjchem-2084	560	33	,	,	PUNCT
eurjchem-2084	560	34	174	174	NUM
eurjchem-2084	560	35	(	(	PUNCT
eurjchem-2084	560	36	9	9	NUM
eurjchem-2084	560	37	)	)	PUNCT
eurjchem-2084	560	38	,	,	PUNCT
eurjchem-2084	560	39	902–903	902–903	NUM
eurjchem-2084	560	40	.	.	PUNCT
eurjchem-2084	561	1	[	[	X
eurjchem-2084	561	2	60	60	NUM
eurjchem-2084	561	3	]	]	PUNCT
eurjchem-2084	561	4	.	.	PUNCT
eurjchem-2084	562	1	zimmer	zimmer	PROPN
eurjchem-2084	562	2	,	,	PUNCT
eurjchem-2084	562	3	c.	c.	PROPN
eurjchem-2084	562	4	;	;	PUNCT
eurjchem-2084	562	5	corum	corum	PROPN
eurjchem-2084	562	6	,	,	PUNCT
eurjchem-2084	562	7	j.	j.	PROPN
eurjchem-2084	562	8	;	;	PUNCT
eurjchem-2084	562	9	wee	wee	ADJ
eurjchem-2084	562	10	,	,	PUNCT
eurjchem-2084	562	11	s.-l	s.-l	PROPN
eurjchem-2084	562	12	.	.	PUNCT
eurjchem-2084	563	1	coronavirus	coronavirus	NOUN
eurjchem-2084	563	2	vaccine	vaccine	NOUN
eurjchem-2084	563	3	tracker	tracker	PROPN
eurjchem-2084	563	4	.	.	PUNCT
eurjchem-2084	564	1	the	the	DET
eurjchem-2084	564	2	new	new	PROPN
eurjchem-2084	564	3	york	york	PROPN
eurjchem-2084	564	4	times	times	PROPN
eurjchem-2084	564	5	.	.	PUNCT
eurjchem-2084	565	1	the	the	DET
eurjchem-2084	565	2	new	new	PROPN
eurjchem-2084	565	3	york	york	PROPN
eurjchem-2084	565	4	times	times	PROPN
eurjchem-2084	565	5	april	april	PROPN
eurjchem-2084	565	6	1	1	NUM
eurjchem-2084	565	7	,	,	PUNCT
eurjchem-2084	565	8	2021	2021	NUM
eurjchem-2084	565	9	,	,	PUNCT
eurjchem-2084	565	10	https://www.nytimes.com/interactive/2020/science/coronavirusvaccine-tracker.html	https://www.nytimes.com/interactive/2020/science/coronavirusvaccine-tracker.html	PROPN
eurjchem-2084	565	11	(	(	PUNCT
eurjchem-2084	565	12	accessed	access	VERB
eurjchem-2084	565	13	april	april	PROPN
eurjchem-2084	565	14	1	1	NUM
eurjchem-2084	565	15	,	,	PUNCT
eurjchem-2084	565	16	2021	2021	NUM
eurjchem-2084	565	17	)	)	PUNCT
eurjchem-2084	565	18	.	.	PUNCT
eurjchem-2084	566	1	[	[	X
eurjchem-2084	566	2	61	61	NUM
eurjchem-2084	566	3	]	]	PUNCT
eurjchem-2084	566	4	.	.	PUNCT
eurjchem-2084	567	1	elfiky	elfiky	VERB
eurjchem-2084	567	2	,	,	PUNCT
eurjchem-2084	567	3	a.	a.	NOUN
eurjchem-2084	567	4	a.	a.	PROPN
eurjchem-2084	567	5	life	life	PROPN
eurjchem-2084	567	6	sci	sci	PROPN
eurjchem-2084	567	7	.	.	PROPN
eurjchem-2084	567	8	2020	2020	NUM
eurjchem-2084	567	9	,	,	PUNCT
eurjchem-2084	567	10	248	248	NUM
eurjchem-2084	567	11	(	(	PUNCT
eurjchem-2084	567	12	117477	117477	NUM
eurjchem-2084	567	13	)	)	PUNCT
eurjchem-2084	567	14	,	,	PUNCT
eurjchem-2084	567	15	117477	117477	NUM
eurjchem-2084	567	16	.	.	PUNCT
eurjchem-2084	568	1	[	[	X
eurjchem-2084	568	2	62	62	NUM
eurjchem-2084	568	3	]	]	PUNCT
eurjchem-2084	568	4	.	.	PUNCT
eurjchem-2084	569	1	li	li	PROPN
eurjchem-2084	569	2	,	,	PUNCT
eurjchem-2084	569	3	g.	g.	PROPN
eurjchem-2084	569	4	;	;	PUNCT
eurjchem-2084	569	5	de	de	X
eurjchem-2084	569	6	clercq	clercq	PROPN
eurjchem-2084	569	7	,	,	PUNCT
eurjchem-2084	569	8	e.	e.	PROPN
eurjchem-2084	569	9	nat	nat	PROPN
eurjchem-2084	569	10	.	.	PUNCT
eurjchem-2084	570	1	rev	rev	PROPN
eurjchem-2084	570	2	.	.	PROPN
eurjchem-2084	570	3	drug	drug	NOUN
eurjchem-2084	570	4	discov	discov	NOUN
eurjchem-2084	570	5	.	.	PUNCT
eurjchem-2084	571	1	2020	2020	NUM
eurjchem-2084	571	2	,	,	PUNCT
eurjchem-2084	571	3	19	19	NUM
eurjchem-2084	571	4	(	(	PUNCT
eurjchem-2084	571	5	3	3	NUM
eurjchem-2084	571	6	)	)	PUNCT
eurjchem-2084	571	7	,	,	PUNCT
eurjchem-2084	571	8	149–150	149–150	NUM
eurjchem-2084	571	9	.	.	PUNCT
eurjchem-2084	572	1	[	[	X
eurjchem-2084	572	2	63	63	NUM
eurjchem-2084	572	3	]	]	PUNCT
eurjchem-2084	572	4	.	.	PUNCT
eurjchem-2084	573	1	radhakrishnan	radhakrishnan	PROPN
eurjchem-2084	573	2	,	,	PUNCT
eurjchem-2084	573	3	a.	a.	PROPN
eurjchem-2084	573	4	;	;	PUNCT
eurjchem-2084	573	5	arunachalam	arunachalam	PROPN
eurjchem-2084	573	6	,	,	PUNCT
eurjchem-2084	573	7	r.	r.	PROPN
eurjchem-2084	573	8	;	;	PUNCT
eurjchem-2084	573	9	elango	elango	PROPN
eurjchem-2084	573	10	,	,	PUNCT
eurjchem-2084	573	11	a.	a.	PROPN
eurjchem-2084	573	12	ssrn	ssrn	PROPN
eurjchem-2084	573	13	electron	electron	PROPN
eurjchem-2084	573	14	.	.	PUNCT
eurjchem-2084	574	1	j.	j.	PROPN
eurjchem-2084	574	2	2020	2020	PROPN
eurjchem-2084	574	3	.	.	PUNCT
eurjchem-2084	575	1	https://doi.org/10.2139/ssrn.3636958	https://doi.org/10.2139/ssrn.3636958	X
eurjchem-2084	575	2	.	.	PUNCT
eurjchem-2084	576	1	[	[	X
eurjchem-2084	576	2	64	64	NUM
eurjchem-2084	576	3	]	]	PUNCT
eurjchem-2084	576	4	.	.	PUNCT
eurjchem-2084	577	1	agrawal	agrawal	PROPN
eurjchem-2084	577	2	,	,	PUNCT
eurjchem-2084	577	3	u.	u.	PROPN
eurjchem-2084	577	4	;	;	PUNCT
eurjchem-2084	577	5	raju	raju	PROPN
eurjchem-2084	577	6	,	,	PUNCT
eurjchem-2084	577	7	r.	r.	PROPN
eurjchem-2084	577	8	;	;	PUNCT
eurjchem-2084	577	9	udwadia	udwadia	PROPN
eurjchem-2084	577	10	,	,	PUNCT
eurjchem-2084	577	11	z.	z.	PROPN
eurjchem-2084	577	12	f.	f.	PROPN
eurjchem-2084	577	13	med	med	PROPN
eurjchem-2084	577	14	j.	j.	PROPN
eurjchem-2084	577	15	armed	armed	PROPN
eurjchem-2084	577	16	forces	force	NOUN
eurjchem-2084	577	17	india	india	PROPN
eurjchem-2084	577	18	2020	2020	NUM
eurjchem-2084	577	19	,	,	PUNCT
eurjchem-2084	577	20	76	76	NUM
eurjchem-2084	577	21	(	(	PUNCT
eurjchem-2084	577	22	4	4	NUM
eurjchem-2084	577	23	)	)	PUNCT
eurjchem-2084	577	24	,	,	PUNCT
eurjchem-2084	577	25	370–376	370–376	NUM
eurjchem-2084	577	26	.	.	PUNCT
eurjchem-2084	578	1	[	[	X
eurjchem-2084	578	2	65	65	NUM
eurjchem-2084	578	3	]	]	PUNCT
eurjchem-2084	578	4	.	.	PUNCT
eurjchem-2084	579	1	cai	cai	PROPN
eurjchem-2084	579	2	,	,	PUNCT
eurjchem-2084	579	3	q.	q.	PROPN
eurjchem-2084	579	4	;	;	PUNCT
eurjchem-2084	579	5	yang	yang	PROPN
eurjchem-2084	579	6	,	,	PUNCT
eurjchem-2084	579	7	m.	m.	NOUN
eurjchem-2084	579	8	;	;	PUNCT
eurjchem-2084	579	9	liu	liu	PROPN
eurjchem-2084	579	10	,	,	PUNCT
eurjchem-2084	579	11	d.	d.	PROPN
eurjchem-2084	579	12	;	;	PUNCT
eurjchem-2084	579	13	chen	chen	PROPN
eurjchem-2084	579	14	,	,	PUNCT
eurjchem-2084	579	15	j.	j.	PROPN
eurjchem-2084	579	16	;	;	PUNCT
eurjchem-2084	579	17	shu	shu	PROPN
eurjchem-2084	579	18	,	,	PUNCT
eurjchem-2084	579	19	d.	d.	PROPN
eurjchem-2084	579	20	;	;	PUNCT
eurjchem-2084	579	21	xia	xia	PROPN
eurjchem-2084	579	22	,	,	PUNCT
eurjchem-2084	579	23	j.	j.	PROPN
eurjchem-2084	579	24	;	;	PUNCT
eurjchem-2084	579	25	liao	liao	PROPN
eurjchem-2084	579	26	,	,	PUNCT
eurjchem-2084	579	27	x.	x.	NOUN
eurjchem-2084	579	28	;	;	PUNCT
eurjchem-2084	579	29	gu	gu	NOUN
eurjchem-2084	579	30	,	,	PUNCT
eurjchem-2084	579	31	y.	y.	PROPN
eurjchem-2084	579	32	;	;	PUNCT
eurjchem-2084	579	33	cai	cai	PROPN
eurjchem-2084	579	34	,	,	PUNCT
eurjchem-2084	579	35	q.	q.	PROPN
eurjchem-2084	579	36	;	;	PUNCT
eurjchem-2084	579	37	yang	yang	PROPN
eurjchem-2084	579	38	,	,	PUNCT
eurjchem-2084	579	39	y.	y.	PROPN
eurjchem-2084	579	40	;	;	PUNCT
eurjchem-2084	579	41	shen	shen	PROPN
eurjchem-2084	579	42	,	,	PUNCT
eurjchem-2084	579	43	c.	c.	PROPN
eurjchem-2084	579	44	;	;	PUNCT
eurjchem-2084	579	45	li	li	PROPN
eurjchem-2084	579	46	,	,	PUNCT
eurjchem-2084	579	47	x.	x.	PROPN
eurjchem-2084	579	48	;	;	PUNCT
eurjchem-2084	579	49	peng	peng	PROPN
eurjchem-2084	579	50	,	,	PUNCT
eurjchem-2084	579	51	l.	l.	PROPN
eurjchem-2084	579	52	;	;	PUNCT
eurjchem-2084	579	53	huang	huang	PROPN
eurjchem-2084	579	54	,	,	PUNCT
eurjchem-2084	579	55	d.	d.	PROPN
eurjchem-2084	579	56	;	;	PUNCT
eurjchem-2084	579	57	zhang	zhang	PROPN
eurjchem-2084	579	58	,	,	PUNCT
eurjchem-2084	579	59	j.	j.	PROPN
eurjchem-2084	579	60	;	;	PUNCT
eurjchem-2084	579	61	zhang	zhang	PROPN
eurjchem-2084	579	62	,	,	PUNCT
eurjchem-2084	579	63	s.	s.	PROPN
eurjchem-2084	579	64	;	;	PUNCT
eurjchem-2084	579	65	wang	wang	PROPN
eurjchem-2084	579	66	,	,	PUNCT
eurjchem-2084	579	67	f.	f.	PROPN
eurjchem-2084	579	68	;	;	PUNCT
eurjchem-2084	579	69	liu	liu	PROPN
eurjchem-2084	579	70	,	,	PUNCT
eurjchem-2084	579	71	j.	j.	PROPN
eurjchem-2084	579	72	;	;	PUNCT
eurjchem-2084	579	73	chen	chen	PROPN
eurjchem-2084	579	74	,	,	PUNCT
eurjchem-2084	579	75	l.	l.	PROPN
eurjchem-2084	579	76	;	;	PUNCT
eurjchem-2084	579	77	chen	chen	PROPN
eurjchem-2084	579	78	,	,	PUNCT
eurjchem-2084	579	79	s.	s.	PROPN
eurjchem-2084	579	80	;	;	PUNCT
eurjchem-2084	579	81	wang	wang	PROPN
eurjchem-2084	579	82	,	,	PUNCT
eurjchem-2084	579	83	z.	z.	PROPN
eurjchem-2084	579	84	;	;	PUNCT
eurjchem-2084	579	85	zhang	zhang	PROPN
eurjchem-2084	579	86	,	,	PUNCT
eurjchem-2084	579	87	z.	z.	PROPN
eurjchem-2084	579	88	;	;	PUNCT
eurjchem-2084	579	89	cao	cao	PROPN
eurjchem-2084	579	90	,	,	PUNCT
eurjchem-2084	579	91	r.	r.	PROPN
eurjchem-2084	579	92	;	;	PUNCT
eurjchem-2084	579	93	zhong	zhong	PROPN
eurjchem-2084	579	94	,	,	PUNCT
eurjchem-2084	579	95	w.	w.	PROPN
eurjchem-2084	579	96	;	;	PUNCT
eurjchem-2084	579	97	liu	liu	PROPN
eurjchem-2084	579	98	,	,	PUNCT
eurjchem-2084	579	99	y.	y.	PROPN
eurjchem-2084	579	100	;	;	PUNCT
eurjchem-2084	579	101	liu	liu	PROPN
eurjchem-2084	579	102	,	,	PUNCT
eurjchem-2084	579	103	l.	l.	PROPN
eurjchem-2084	579	104	engineering	engineering	PROPN
eurjchem-2084	579	105	(	(	PUNCT
eurjchem-2084	579	106	beijing	beijing	PROPN
eurjchem-2084	579	107	)	)	PUNCT
eurjchem-2084	579	108	2020	2020	NUM
eurjchem-2084	579	109	,	,	PUNCT
eurjchem-2084	579	110	6	6	NUM
eurjchem-2084	579	111	(	(	PUNCT
eurjchem-2084	579	112	10	10	NUM
eurjchem-2084	579	113	)	)	PUNCT
eurjchem-2084	579	114	,	,	PUNCT
eurjchem-2084	579	115	1192–1198	1192–1198	NUM
eurjchem-2084	579	116	.	.	PUNCT
eurjchem-2084	580	1	[	[	X
eurjchem-2084	580	2	66	66	NUM
eurjchem-2084	580	3	]	]	PUNCT
eurjchem-2084	580	4	.	.	PUNCT
eurjchem-2084	581	1	li	li	PROPN
eurjchem-2084	581	2	h.	h.	PROPN
eurjchem-2084	581	3	;	;	PUNCT
eurjchem-2084	581	4	wang	wang	PROPN
eurjchem-2084	581	5	y.	y.	PROPN
eurjchem-2084	581	6	m.	m.	PROPN
eurjchem-2084	581	7	;	;	PUNCT
eurjchem-2084	581	8	xu	xu	PROPN
eurjchem-2084	581	9	j.	j.	PROPN
eurjchem-2084	581	10	y.	y.	PROPN
eurjchem-2084	581	11	;	;	PUNCT
eurjchem-2084	581	12	cao	cao	PROPN
eurjchem-2084	581	13	b.	b.	PROPN
eurjchem-2084	581	14	zhonghua	zhonghua	PROPN
eurjchem-2084	581	15	jie	jie	PROPN
eurjchem-2084	582	1	he	he	PRON
eurjchem-2084	582	2	he	he	PRON
eurjchem-2084	582	3	hu	hu	PROPN
eurjchem-2084	582	4	xi	xi	PROPN
eurjchem-2084	582	5	za	za	PROPN
eurjchem-2084	582	6	zhi	zhi	PROPN
eurjchem-2084	582	7	2020	2020	NUM
eurjchem-2084	582	8	,	,	PUNCT
eurjchem-2084	582	9	43	43	NUM
eurjchem-2084	582	10	(	(	PUNCT
eurjchem-2084	582	11	0	0	NUM
eurjchem-2084	582	12	)	)	PUNCT
eurjchem-2084	582	13	,	,	PUNCT
eurjchem-2084	582	14	e002	e002	NUM
eurjchem-2084	582	15	.	.	PUNCT
eurjchem-2084	583	1	[	[	X
eurjchem-2084	583	2	67	67	NUM
eurjchem-2084	583	3	]	]	PUNCT
eurjchem-2084	583	4	.	.	PUNCT
eurjchem-2084	584	1	holshue	holshue	PROPN
eurjchem-2084	584	2	,	,	PUNCT
eurjchem-2084	584	3	m.	m.	NOUN
eurjchem-2084	584	4	l.	l.	PROPN
eurjchem-2084	584	5	;	;	PUNCT
eurjchem-2084	584	6	debolt	debolt	NOUN
eurjchem-2084	584	7	,	,	PUNCT
eurjchem-2084	584	8	c.	c.	PROPN
eurjchem-2084	584	9	;	;	PUNCT
eurjchem-2084	584	10	lindquist	lindquist	PROPN
eurjchem-2084	584	11	,	,	PUNCT
eurjchem-2084	584	12	s.	s.	PROPN
eurjchem-2084	584	13	;	;	PUNCT
eurjchem-2084	584	14	lofy	lofy	PROPN
eurjchem-2084	584	15	,	,	PUNCT
eurjchem-2084	584	16	k.	k.	PROPN
eurjchem-2084	584	17	h.	h.	PROPN
eurjchem-2084	584	18	;	;	PUNCT
eurjchem-2084	584	19	wiesman	wiesman	NOUN
eurjchem-2084	584	20	,	,	PUNCT
eurjchem-2084	584	21	j.	j.	PROPN
eurjchem-2084	584	22	;	;	PUNCT
eurjchem-2084	584	23	bruce	bruce	PROPN
eurjchem-2084	584	24	,	,	PUNCT
eurjchem-2084	584	25	h.	h.	PROPN
eurjchem-2084	584	26	;	;	PUNCT
eurjchem-2084	584	27	spitters	spitter	NOUN
eurjchem-2084	584	28	,	,	PUNCT
eurjchem-2084	584	29	c.	c.	PROPN
eurjchem-2084	584	30	;	;	PUNCT
eurjchem-2084	584	31	ericson	ericson	PROPN
eurjchem-2084	584	32	,	,	PUNCT
eurjchem-2084	584	33	k.	k.	PROPN
eurjchem-2084	584	34	;	;	PUNCT
eurjchem-2084	584	35	wilkerson	wilkerson	PROPN
eurjchem-2084	584	36	,	,	PUNCT
eurjchem-2084	584	37	s.	s.	PROPN
eurjchem-2084	584	38	;	;	PUNCT
eurjchem-2084	584	39	tural	tural	ADJ
eurjchem-2084	584	40	,	,	PUNCT
eurjchem-2084	584	41	a.	a.	NOUN
eurjchem-2084	584	42	;	;	PUNCT
eurjchem-2084	584	43	diaz	diaz	PROPN
eurjchem-2084	584	44	,	,	PUNCT
eurjchem-2084	584	45	g.	g.	PROPN
eurjchem-2084	584	46	;	;	PUNCT
eurjchem-2084	584	47	cohn	cohn	PROPN
eurjchem-2084	584	48	,	,	PUNCT
eurjchem-2084	584	49	a.	a.	PROPN
eurjchem-2084	584	50	;	;	PUNCT
eurjchem-2084	584	51	fox	fox	PROPN
eurjchem-2084	584	52	,	,	PUNCT
eurjchem-2084	584	53	l.	l.	PROPN
eurjchem-2084	584	54	;	;	PUNCT
eurjchem-2084	584	55	patel	patel	PROPN
eurjchem-2084	584	56	,	,	PUNCT
eurjchem-2084	584	57	a.	a.	NOUN
eurjchem-2084	584	58	;	;	PUNCT
eurjchem-2084	584	59	gerber	gerber	PROPN
eurjchem-2084	584	60	,	,	PUNCT
eurjchem-2084	584	61	s.	s.	PROPN
eurjchem-2084	584	62	i.	i.	PROPN
eurjchem-2084	584	63	;	;	PUNCT
eurjchem-2084	584	64	kim	kim	PROPN
eurjchem-2084	584	65	,	,	PUNCT
eurjchem-2084	584	66	l.	l.	PROPN
eurjchem-2084	584	67	;	;	PUNCT
eurjchem-2084	584	68	tong	tong	PROPN
eurjchem-2084	584	69	,	,	PUNCT
eurjchem-2084	584	70	s.	s.	PROPN
eurjchem-2084	584	71	;	;	PUNCT
eurjchem-2084	584	72	lu	lu	PROPN
eurjchem-2084	584	73	,	,	PUNCT
eurjchem-2084	584	74	x.	x.	PROPN
eurjchem-2084	584	75	;	;	PUNCT
eurjchem-2084	584	76	lindstrom	lindstrom	PROPN
eurjchem-2084	584	77	,	,	PUNCT
eurjchem-2084	584	78	s.	s.	PROPN
eurjchem-2084	584	79	;	;	PUNCT
eurjchem-2084	584	80	pallansch	pallansch	PROPN
eurjchem-2084	584	81	,	,	PUNCT
eurjchem-2084	584	82	m.	m.	NOUN
eurjchem-2084	584	83	a.	a.	PROPN
eurjchem-2084	584	84	;	;	PUNCT
eurjchem-2084	584	85	weldon	weldon	PROPN
eurjchem-2084	584	86	,	,	PUNCT
eurjchem-2084	584	87	w.	w.	PROPN
eurjchem-2084	584	88	c.	c.	PROPN
eurjchem-2084	584	89	;	;	PUNCT
eurjchem-2084	584	90	biggs	biggs	PROPN
eurjchem-2084	584	91	,	,	PUNCT
eurjchem-2084	584	92	h.	h.	PROPN
eurjchem-2084	584	93	m.	m.	PROPN
eurjchem-2084	584	94	;	;	PUNCT
eurjchem-2084	584	95	uyeki	uyeki	PROPN
eurjchem-2084	584	96	,	,	PUNCT
eurjchem-2084	584	97	t.	t.	NOUN
eurjchem-2084	584	98	m.	m.	NOUN
eurjchem-2084	584	99	;	;	PUNCT
eurjchem-2084	584	100	pillai	pillai	PROPN
eurjchem-2084	584	101	,	,	PUNCT
eurjchem-2084	584	102	s.	s.	PROPN
eurjchem-2084	584	103	k.	k.	PROPN
eurjchem-2084	584	104	n.	n.	PROPN
eurjchem-2084	584	105	engl	engl	PROPN
eurjchem-2084	584	106	.	.	PUNCT
eurjchem-2084	585	1	j.	j.	PROPN
eurjchem-2084	585	2	med	med	PROPN
eurjchem-2084	585	3	.	.	PUNCT
eurjchem-2084	586	1	2020	2020	NUM
eurjchem-2084	586	2	,	,	PUNCT
eurjchem-2084	586	3	382	382	NUM
eurjchem-2084	586	4	(	(	PUNCT
eurjchem-2084	586	5	10	10	NUM
eurjchem-2084	586	6	)	)	PUNCT
eurjchem-2084	586	7	,	,	PUNCT
eurjchem-2084	587	1	929–936	929–936	NUM
eurjchem-2084	587	2	.	.	PUNCT
eurjchem-2084	588	1	[	[	X
eurjchem-2084	588	2	68	68	NUM
eurjchem-2084	588	3	]	]	PUNCT
eurjchem-2084	588	4	.	.	PUNCT
eurjchem-2084	589	1	beigel	beigel	PROPN
eurjchem-2084	589	2	,	,	PUNCT
eurjchem-2084	589	3	j.	j.	PROPN
eurjchem-2084	589	4	h.	h.	PROPN
eurjchem-2084	589	5	;	;	PUNCT
eurjchem-2084	589	6	tomashek	tomashek	PROPN
eurjchem-2084	589	7	,	,	PUNCT
eurjchem-2084	589	8	k.	k.	PROPN
eurjchem-2084	589	9	m.	m.	PROPN
eurjchem-2084	589	10	;	;	PUNCT
eurjchem-2084	589	11	dodd	dodd	PROPN
eurjchem-2084	589	12	,	,	PUNCT
eurjchem-2084	589	13	l.	l.	PROPN
eurjchem-2084	589	14	e.	e.	PROPN
eurjchem-2084	589	15	;	;	PUNCT
eurjchem-2084	589	16	mehta	mehta	PROPN
eurjchem-2084	589	17	,	,	PUNCT
eurjchem-2084	589	18	a.	a.	PROPN
eurjchem-2084	589	19	k.	k.	PROPN
eurjchem-2084	589	20	;	;	PUNCT
eurjchem-2084	589	21	zingman	zingman	PROPN
eurjchem-2084	589	22	,	,	PUNCT
eurjchem-2084	589	23	b.	b.	PROPN
eurjchem-2084	589	24	s.	s.	PROPN
eurjchem-2084	589	25	;	;	PUNCT
eurjchem-2084	589	26	kalil	kalil	PROPN
eurjchem-2084	589	27	,	,	PUNCT
eurjchem-2084	589	28	a.	a.	PROPN
eurjchem-2084	589	29	c.	c.	PROPN
eurjchem-2084	589	30	;	;	PUNCT
eurjchem-2084	589	31	hohmann	hohmann	PROPN
eurjchem-2084	589	32	,	,	PUNCT
eurjchem-2084	589	33	e.	e.	PROPN
eurjchem-2084	589	34	;	;	PUNCT
eurjchem-2084	589	35	chu	chu	PROPN
eurjchem-2084	589	36	,	,	PUNCT
eurjchem-2084	589	37	h.	h.	PROPN
eurjchem-2084	589	38	y.	y.	PROPN
eurjchem-2084	589	39	;	;	PUNCT
eurjchem-2084	589	40	luetkemeyer	luetkemeyer	PROPN
eurjchem-2084	589	41	,	,	PUNCT
eurjchem-2084	589	42	a.	a.	PROPN
eurjchem-2084	589	43	;	;	PUNCT
eurjchem-2084	589	44	kline	kline	PROPN
eurjchem-2084	589	45	,	,	PUNCT
eurjchem-2084	589	46	s.	s.	PROPN
eurjchem-2084	589	47	;	;	PUNCT
eurjchem-2084	589	48	lopez	lopez	PROPN
eurjchem-2084	589	49	de	de	PROPN
eurjchem-2084	589	50	castilla	castilla	PROPN
eurjchem-2084	589	51	,	,	PUNCT
eurjchem-2084	589	52	d.	d.	PROPN
eurjchem-2084	589	53	;	;	PUNCT
eurjchem-2084	589	54	finberg	finberg	PROPN
eurjchem-2084	589	55	,	,	PUNCT
eurjchem-2084	589	56	r.	r.	PROPN
eurjchem-2084	589	57	w.	w.	PROPN
eurjchem-2084	589	58	;	;	PUNCT
eurjchem-2084	589	59	dierberg	dierberg	PROPN
eurjchem-2084	589	60	,	,	PUNCT
eurjchem-2084	589	61	k.	k.	PROPN
eurjchem-2084	589	62	;	;	PUNCT
eurjchem-2084	589	63	tapson	tapson	PROPN
eurjchem-2084	589	64	,	,	PUNCT
eurjchem-2084	589	65	v.	v.	ADV
eurjchem-2084	589	66	;	;	PUNCT
eurjchem-2084	589	67	hsieh	hsieh	PROPN
eurjchem-2084	589	68	,	,	PUNCT
eurjchem-2084	589	69	l.	l.	PROPN
eurjchem-2084	589	70	;	;	PUNCT
eurjchem-2084	589	71	patterson	patterson	PROPN
eurjchem-2084	589	72	,	,	PUNCT
eurjchem-2084	589	73	t.	t.	PROPN
eurjchem-2084	589	74	f.	f.	PROPN
eurjchem-2084	589	75	;	;	PUNCT
eurjchem-2084	589	76	paredes	paredes	PROPN
eurjchem-2084	589	77	,	,	PUNCT
eurjchem-2084	589	78	r.	r.	PROPN
eurjchem-2084	589	79	;	;	PUNCT
eurjchem-2084	589	80	sweeney	sweeney	PROPN
eurjchem-2084	589	81	,	,	PUNCT
eurjchem-2084	589	82	d.	d.	PROPN
eurjchem-2084	589	83	a.	a.	PROPN
eurjchem-2084	589	84	;	;	PUNCT
eurjchem-2084	589	85	short	short	ADJ
eurjchem-2084	589	86	,	,	PUNCT
eurjchem-2084	589	87	w.	w.	PROPN
eurjchem-2084	589	88	r.	r.	PROPN
eurjchem-2084	589	89	;	;	PUNCT
eurjchem-2084	589	90	touloumi	touloumi	PROPN
eurjchem-2084	589	91	,	,	PUNCT
eurjchem-2084	589	92	g.	g.	PROPN
eurjchem-2084	589	93	;	;	PUNCT
eurjchem-2084	589	94	lye	lye	PROPN
eurjchem-2084	589	95	,	,	PUNCT
eurjchem-2084	589	96	d.	d.	PROPN
eurjchem-2084	589	97	c.	c.	PROPN
eurjchem-2084	589	98	;	;	PUNCT
eurjchem-2084	589	99	ohmagari	ohmagari	PROPN
eurjchem-2084	589	100	,	,	PUNCT
eurjchem-2084	589	101	n.	n.	NOUN
eurjchem-2084	589	102	;	;	PUNCT
eurjchem-2084	589	103	oh	oh	INTJ
eurjchem-2084	589	104	,	,	PUNCT
eurjchem-2084	589	105	m.-d	m.-d	PROPN
eurjchem-2084	589	106	.	.	PUNCT
eurjchem-2084	589	107	;	;	PUNCT
eurjchem-2084	589	108	ruiz	ruiz	NOUN
eurjchem-2084	589	109	-	-	PUNCT
eurjchem-2084	589	110	palacios	palacio	NOUN
eurjchem-2084	589	111	,	,	PUNCT
eurjchem-2084	589	112	g.	g.	PROPN
eurjchem-2084	589	113	m.	m.	PROPN
eurjchem-2084	589	114	;	;	PUNCT
eurjchem-2084	589	115	benfield	benfield	PROPN
eurjchem-2084	589	116	,	,	PUNCT
eurjchem-2084	589	117	t.	t.	PROPN
eurjchem-2084	589	118	;	;	PUNCT
eurjchem-2084	589	119	fätkenheuer	fätkenheuer	PROPN
eurjchem-2084	589	120	,	,	PUNCT
eurjchem-2084	589	121	g.	g.	PROPN
eurjchem-2084	589	122	;	;	PUNCT
eurjchem-2084	589	123	kortepeter	kortepeter	NOUN
eurjchem-2084	589	124	,	,	PUNCT
eurjchem-2084	589	125	m.	m.	NOUN
eurjchem-2084	589	126	g.	g.	PROPN
eurjchem-2084	589	127	;	;	PUNCT
eurjchem-2084	589	128	atmar	atmar	PROPN
eurjchem-2084	589	129	,	,	PUNCT
eurjchem-2084	589	130	r.	r.	PROPN
eurjchem-2084	589	131	l.	l.	PROPN
eurjchem-2084	589	132	;	;	PUNCT
eurjchem-2084	589	133	creech	creech	PROPN
eurjchem-2084	589	134	,	,	PUNCT
eurjchem-2084	589	135	c.	c.	PROPN
eurjchem-2084	589	136	b.	b.	PROPN
eurjchem-2084	589	137	;	;	PUNCT
eurjchem-2084	589	138	lundgren	lundgren	PROPN
eurjchem-2084	589	139	,	,	PUNCT
eurjchem-2084	589	140	j.	j.	PROPN
eurjchem-2084	589	141	;	;	PUNCT
eurjchem-2084	589	142	babiker	babiker	PROPN
eurjchem-2084	589	143	,	,	PUNCT
eurjchem-2084	589	144	a.	a.	PROPN
eurjchem-2084	589	145	g.	g.	PROPN
eurjchem-2084	589	146	;	;	PUNCT
eurjchem-2084	589	147	pett	pett	PROPN
eurjchem-2084	589	148	,	,	PUNCT
eurjchem-2084	589	149	s.	s.	PROPN
eurjchem-2084	589	150	;	;	PUNCT
eurjchem-2084	589	151	neaton	neaton	PROPN
eurjchem-2084	589	152	,	,	PUNCT
eurjchem-2084	589	153	j.	j.	PROPN
eurjchem-2084	589	154	d.	d.	PROPN
eurjchem-2084	589	155	;	;	PUNCT
eurjchem-2084	589	156	burgess	burgess	PROPN
eurjchem-2084	589	157	,	,	PUNCT
eurjchem-2084	589	158	t.	t.	PROPN
eurjchem-2084	589	159	h.	h.	PROPN
eurjchem-2084	589	160	;	;	PUNCT
eurjchem-2084	589	161	bonnett	bonnett	PROPN
eurjchem-2084	589	162	,	,	PUNCT
eurjchem-2084	589	163	t.	t.	PROPN
eurjchem-2084	589	164	;	;	PUNCT
eurjchem-2084	589	165	green	green	ADJ
eurjchem-2084	589	166	,	,	PUNCT
eurjchem-2084	589	167	m.	m.	NOUN
eurjchem-2084	589	168	;	;	PUNCT
eurjchem-2084	589	169	makowski	makowski	PROPN
eurjchem-2084	589	170	,	,	PUNCT
eurjchem-2084	589	171	m.	m.	NOUN
eurjchem-2084	589	172	;	;	PUNCT
eurjchem-2084	589	173	osinusi	osinusi	PROPN
eurjchem-2084	589	174	,	,	PUNCT
eurjchem-2084	589	175	a.	a.	NOUN
eurjchem-2084	589	176	;	;	PUNCT
eurjchem-2084	589	177	nayak	nayak	PROPN
eurjchem-2084	589	178	,	,	PUNCT
eurjchem-2084	589	179	s.	s.	PROPN
eurjchem-2084	589	180	;	;	PUNCT
eurjchem-2084	589	181	lane	lane	PROPN
eurjchem-2084	589	182	,	,	PUNCT
eurjchem-2084	589	183	h.	h.	PROPN
eurjchem-2084	589	184	c.	c.	PROPN
eurjchem-2084	589	185	n.	n.	PROPN
eurjchem-2084	589	186	engl	engl	PROPN
eurjchem-2084	589	187	.	.	PUNCT
eurjchem-2084	590	1	j.	j.	PROPN
eurjchem-2084	590	2	med	med	PROPN
eurjchem-2084	590	3	.	.	PUNCT
eurjchem-2084	591	1	2020	2020	NUM
eurjchem-2084	591	2	,	,	PUNCT
eurjchem-2084	591	3	383	383	NUM
eurjchem-2084	591	4	(	(	PUNCT
eurjchem-2084	591	5	19	19	NUM
eurjchem-2084	591	6	)	)	PUNCT
eurjchem-2084	591	7	,	,	PUNCT
eurjchem-2084	591	8	1813–1826	1813–1826	NUM
eurjchem-2084	591	9	.	.	PUNCT
eurjchem-2084	592	1	[	[	X
eurjchem-2084	592	2	69	69	NUM
eurjchem-2084	592	3	]	]	PUNCT
eurjchem-2084	592	4	.	.	PUNCT
eurjchem-2084	593	1	case	case	NOUN
eurjchem-2084	593	2	medical	medical	ADJ
eurjchem-2084	593	3	research	research	NOUN
eurjchem-2084	593	4	.	.	PUNCT
eurjchem-2084	594	1	case	case	NOUN
eurjchem-2084	594	2	medical	medical	ADJ
eurjchem-2084	594	3	research	research	NOUN
eurjchem-2084	594	4	2020	2020	NUM
eurjchem-2084	594	5	.	.	PUNCT
eurjchem-2084	595	1	https://doi.org/	https://doi.org/	VERB
eurjchem-2084	595	2	10.31525	10.31525	NUM
eurjchem-2084	595	3	/	/	SYM
eurjchem-2084	595	4	ct1	ct1	PROPN
eurjchem-2084	595	5	-	-	PUNCT
eurjchem-2084	595	6	nct04292730	nct04292730	NOUN
eurjchem-2084	595	7	(	(	PUNCT
eurjchem-2084	595	8	accessed	access	VERB
eurjchem-2084	595	9	december	december	PROPN
eurjchem-2084	595	10	9	9	NUM
eurjchem-2084	595	11	,	,	PUNCT
eurjchem-2084	595	12	2020	2020	NUM
eurjchem-2084	595	13	)	)	PUNCT
eurjchem-2084	595	14	.	.	PUNCT
eurjchem-2084	596	1	[	[	X
eurjchem-2084	596	2	70	70	NUM
eurjchem-2084	596	3	]	]	PUNCT
eurjchem-2084	596	4	.	.	PUNCT
eurjchem-2084	596	5	cao	cao	PROPN
eurjchem-2084	596	6	,	,	PUNCT
eurjchem-2084	596	7	b.	b.	PROPN
eurjchem-2084	596	8	;	;	PUNCT
eurjchem-2084	596	9	wang	wang	PROPN
eurjchem-2084	596	10	,	,	PUNCT
eurjchem-2084	596	11	y.	y.	PROPN
eurjchem-2084	596	12	;	;	PUNCT
eurjchem-2084	596	13	wen	wen	PROPN
eurjchem-2084	596	14	,	,	PUNCT
eurjchem-2084	596	15	d.	d.	PROPN
eurjchem-2084	596	16	;	;	PUNCT
eurjchem-2084	596	17	liu	liu	PROPN
eurjchem-2084	596	18	,	,	PUNCT
eurjchem-2084	596	19	w.	w.	PROPN
eurjchem-2084	596	20	;	;	PUNCT
eurjchem-2084	596	21	wang	wang	PROPN
eurjchem-2084	596	22	,	,	PUNCT
eurjchem-2084	596	23	j.	j.	PROPN
eurjchem-2084	596	24	;	;	PUNCT
eurjchem-2084	596	25	fan	fan	PROPN
eurjchem-2084	596	26	,	,	PUNCT
eurjchem-2084	596	27	g.	g.	PROPN
eurjchem-2084	596	28	;	;	PUNCT
eurjchem-2084	596	29	ruan	ruan	PROPN
eurjchem-2084	596	30	,	,	PUNCT
eurjchem-2084	596	31	l.	l.	PROPN
eurjchem-2084	596	32	;	;	PUNCT
eurjchem-2084	596	33	song	song	PROPN
eurjchem-2084	596	34	,	,	PUNCT
eurjchem-2084	596	35	b.	b.	PROPN
eurjchem-2084	596	36	;	;	PUNCT
eurjchem-2084	596	37	cai	cai	PROPN
eurjchem-2084	596	38	,	,	PUNCT
eurjchem-2084	596	39	y.	y.	PROPN
eurjchem-2084	596	40	;	;	PUNCT
eurjchem-2084	596	41	wei	wei	PROPN
eurjchem-2084	596	42	,	,	PUNCT
eurjchem-2084	596	43	m.	m.	NOUN
eurjchem-2084	596	44	;	;	PUNCT
eurjchem-2084	596	45	li	li	PROPN
eurjchem-2084	596	46	,	,	PUNCT
eurjchem-2084	596	47	x.	x.	PROPN
eurjchem-2084	596	48	;	;	PUNCT
eurjchem-2084	596	49	xia	xia	PROPN
eurjchem-2084	596	50	,	,	PUNCT
eurjchem-2084	596	51	j.	j.	PROPN
eurjchem-2084	596	52	;	;	PUNCT
eurjchem-2084	596	53	chen	chen	PROPN
eurjchem-2084	596	54	,	,	PUNCT
eurjchem-2084	596	55	n.	n.	PROPN
eurjchem-2084	596	56	;	;	PUNCT
eurjchem-2084	596	57	xiang	xiang	PROPN
eurjchem-2084	596	58	,	,	PUNCT
eurjchem-2084	596	59	j.	j.	PROPN
eurjchem-2084	596	60	;	;	PUNCT
eurjchem-2084	596	61	yu	yu	PROPN
eurjchem-2084	596	62	,	,	PUNCT
eurjchem-2084	596	63	t.	t.	PROPN
eurjchem-2084	596	64	;	;	PUNCT
eurjchem-2084	596	65	bai	bai	PROPN
eurjchem-2084	596	66	,	,	PUNCT
eurjchem-2084	596	67	t.	t.	PROPN
eurjchem-2084	596	68	;	;	PUNCT
eurjchem-2084	596	69	xie	xie	PROPN
eurjchem-2084	596	70	,	,	PUNCT
eurjchem-2084	596	71	x.	x.	PROPN
eurjchem-2084	596	72	;	;	PUNCT
eurjchem-2084	596	73	zhang	zhang	PROPN
eurjchem-2084	596	74	,	,	PUNCT
eurjchem-2084	596	75	l.	l.	PROPN
eurjchem-2084	596	76	;	;	PUNCT
eurjchem-2084	596	77	li	li	PROPN
eurjchem-2084	596	78	,	,	PUNCT
eurjchem-2084	596	79	c.	c.	PROPN
eurjchem-2084	596	80	;	;	PUNCT
eurjchem-2084	596	81	yuan	yuan	NOUN
eurjchem-2084	596	82	,	,	PUNCT
eurjchem-2084	596	83	y.	y.	PROPN
eurjchem-2084	596	84	;	;	PUNCT
eurjchem-2084	596	85	chen	chen	PROPN
eurjchem-2084	596	86	,	,	PUNCT
eurjchem-2084	596	87	h.	h.	PROPN
eurjchem-2084	596	88	;	;	PUNCT
eurjchem-2084	596	89	li	li	PROPN
eurjchem-2084	596	90	,	,	PUNCT
eurjchem-2084	596	91	h.	h.	PROPN
eurjchem-2084	596	92	;	;	PUNCT
eurjchem-2084	596	93	huang	huang	PROPN
eurjchem-2084	596	94	,	,	PUNCT
eurjchem-2084	596	95	h.	h.	PROPN
eurjchem-2084	596	96	;	;	PUNCT
eurjchem-2084	596	97	tu	tu	PROPN
eurjchem-2084	596	98	,	,	PUNCT
eurjchem-2084	596	99	s.	s.	PROPN
eurjchem-2084	596	100	;	;	PUNCT
eurjchem-2084	596	101	gong	gong	PROPN
eurjchem-2084	596	102	,	,	PUNCT
eurjchem-2084	596	103	f.	f.	PROPN
eurjchem-2084	596	104	;	;	PUNCT
eurjchem-2084	596	105	liu	liu	PROPN
eurjchem-2084	596	106	,	,	PUNCT
eurjchem-2084	596	107	y.	y.	PROPN
eurjchem-2084	596	108	;	;	PUNCT
eurjchem-2084	596	109	wei	wei	PROPN
eurjchem-2084	596	110	,	,	PUNCT
eurjchem-2084	596	111	y.	y.	PROPN
eurjchem-2084	596	112	;	;	PUNCT
eurjchem-2084	596	113	dong	dong	PROPN
eurjchem-2084	596	114	,	,	PUNCT
eurjchem-2084	596	115	c.	c.	PROPN
eurjchem-2084	596	116	;	;	PUNCT
eurjchem-2084	596	117	zhou	zhou	PROPN
eurjchem-2084	596	118	,	,	PUNCT
eurjchem-2084	596	119	f.	f.	PROPN
eurjchem-2084	596	120	;	;	PUNCT
eurjchem-2084	596	121	gu	gu	PROPN
eurjchem-2084	596	122	,	,	PUNCT
eurjchem-2084	596	123	x.	x.	PROPN
eurjchem-2084	596	124	;	;	PUNCT
eurjchem-2084	596	125	xu	xu	PROPN
eurjchem-2084	596	126	,	,	PUNCT
eurjchem-2084	596	127	j.	j.	PROPN
eurjchem-2084	596	128	;	;	PUNCT
eurjchem-2084	596	129	liu	liu	PROPN
eurjchem-2084	596	130	,	,	PUNCT
eurjchem-2084	596	131	z.	z.	PROPN
eurjchem-2084	596	132	;	;	PUNCT
eurjchem-2084	596	133	zhang	zhang	PROPN
eurjchem-2084	596	134	,	,	PUNCT
eurjchem-2084	596	135	y.	y.	PROPN
eurjchem-2084	596	136	;	;	PUNCT
eurjchem-2084	596	137	li	li	PROPN
eurjchem-2084	596	138	,	,	PUNCT
eurjchem-2084	596	139	h.	h.	PROPN
eurjchem-2084	596	140	;	;	PUNCT
eurjchem-2084	596	141	shang	shang	PROPN
eurjchem-2084	596	142	,	,	PUNCT
eurjchem-2084	596	143	l.	l.	PROPN
eurjchem-2084	596	144	;	;	PUNCT
eurjchem-2084	596	145	wang	wang	PROPN
eurjchem-2084	596	146	,	,	PUNCT
eurjchem-2084	596	147	k.	k.	PROPN
eurjchem-2084	596	148	;	;	PUNCT
eurjchem-2084	596	149	li	li	PROPN
eurjchem-2084	596	150	,	,	PUNCT
eurjchem-2084	596	151	k.	k.	PROPN
eurjchem-2084	596	152	;	;	PUNCT
eurjchem-2084	596	153	zhou	zhou	PROPN
eurjchem-2084	596	154	,	,	PUNCT
eurjchem-2084	596	155	x.	x.	PROPN
eurjchem-2084	596	156	;	;	PUNCT
eurjchem-2084	596	157	dong	dong	PROPN
eurjchem-2084	596	158	,	,	PUNCT
eurjchem-2084	596	159	x.	x.	PROPN
eurjchem-2084	596	160	;	;	PUNCT
eurjchem-2084	596	161	qu	qu	PROPN
eurjchem-2084	596	162	,	,	PUNCT
eurjchem-2084	596	163	z.	z.	PROPN
eurjchem-2084	596	164	;	;	PUNCT
eurjchem-2084	596	165	lu	lu	PROPN
eurjchem-2084	596	166	,	,	PUNCT
eurjchem-2084	596	167	s.	s.	PROPN
eurjchem-2084	596	168	;	;	PUNCT
eurjchem-2084	596	169	hu	hu	PROPN
eurjchem-2084	596	170	,	,	PUNCT
eurjchem-2084	596	171	x.	x.	PROPN
eurjchem-2084	596	172	;	;	PUNCT
eurjchem-2084	596	173	ruan	ruan	PROPN
eurjchem-2084	596	174	,	,	PUNCT
eurjchem-2084	596	175	s.	s.	PROPN
eurjchem-2084	596	176	;	;	PUNCT
eurjchem-2084	596	177	luo	luo	PROPN
eurjchem-2084	596	178	,	,	PUNCT
eurjchem-2084	596	179	s.	s.	PROPN
eurjchem-2084	596	180	;	;	PUNCT
eurjchem-2084	596	181	wu	wu	PROPN
eurjchem-2084	596	182	,	,	PUNCT
eurjchem-2084	596	183	j.	j.	PROPN
eurjchem-2084	596	184	;	;	PUNCT
eurjchem-2084	596	185	peng	peng	PROPN
eurjchem-2084	596	186	,	,	PUNCT
eurjchem-2084	596	187	l.	l.	PROPN
eurjchem-2084	596	188	;	;	PUNCT
eurjchem-2084	596	189	cheng	cheng	PROPN
eurjchem-2084	596	190	,	,	PUNCT
eurjchem-2084	596	191	f.	f.	PROPN
eurjchem-2084	596	192	;	;	PUNCT
eurjchem-2084	596	193	pan	pan	PROPN
eurjchem-2084	596	194	,	,	PUNCT
eurjchem-2084	596	195	l.	l.	PROPN
eurjchem-2084	596	196	;	;	PUNCT
eurjchem-2084	596	197	zou	zou	PROPN
eurjchem-2084	596	198	,	,	PUNCT
eurjchem-2084	596	199	j.	j.	PROPN
eurjchem-2084	596	200	;	;	PUNCT
eurjchem-2084	596	201	jia	jia	PROPN
eurjchem-2084	596	202	,	,	PUNCT
eurjchem-2084	596	203	c.	c.	PROPN
eurjchem-2084	596	204	;	;	PUNCT
eurjchem-2084	596	205	wang	wang	PROPN
eurjchem-2084	596	206	,	,	PUNCT
eurjchem-2084	596	207	j.	j.	PROPN
eurjchem-2084	596	208	;	;	PUNCT
eurjchem-2084	596	209	liu	liu	PROPN
eurjchem-2084	596	210	,	,	PUNCT
eurjchem-2084	596	211	x.	x.	PROPN
eurjchem-2084	596	212	;	;	PUNCT
eurjchem-2084	596	213	wang	wang	PROPN
eurjchem-2084	596	214	,	,	PUNCT
eurjchem-2084	596	215	s.	s.	PROPN
eurjchem-2084	596	216	;	;	PUNCT
eurjchem-2084	596	217	wu	wu	PROPN
eurjchem-2084	596	218	,	,	PUNCT
eurjchem-2084	596	219	x.	x.	PROPN
eurjchem-2084	596	220	;	;	PUNCT
eurjchem-2084	596	221	ge	ge	PROPN
eurjchem-2084	596	222	,	,	PUNCT
eurjchem-2084	596	223	q.	q.	PROPN
eurjchem-2084	596	224	;	;	PUNCT
eurjchem-2084	596	225	he	he	PRON
eurjchem-2084	596	226	,	,	PUNCT
eurjchem-2084	596	227	j.	j.	PROPN
eurjchem-2084	596	228	;	;	PUNCT
eurjchem-2084	596	229	zhan	zhan	PROPN
eurjchem-2084	596	230	,	,	PUNCT
eurjchem-2084	596	231	h.	h.	PROPN
eurjchem-2084	596	232	;	;	PUNCT
eurjchem-2084	596	233	qiu	qiu	PROPN
eurjchem-2084	596	234	,	,	PUNCT
eurjchem-2084	596	235	f.	f.	PROPN
eurjchem-2084	596	236	;	;	PUNCT
eurjchem-2084	596	237	guo	guo	PROPN
eurjchem-2084	596	238	,	,	PUNCT
eurjchem-2084	596	239	l.	l.	PROPN
eurjchem-2084	596	240	;	;	PUNCT
eurjchem-2084	596	241	huang	huang	PROPN
eurjchem-2084	596	242	,	,	PUNCT
eurjchem-2084	596	243	c.	c.	PROPN
eurjchem-2084	596	244	;	;	PUNCT
eurjchem-2084	596	245	jaki	jaki	PROPN
eurjchem-2084	596	246	,	,	PUNCT
eurjchem-2084	596	247	t.	t.	PROPN
eurjchem-2084	596	248	;	;	PUNCT
eurjchem-2084	596	249	hayden	hayden	PROPN
eurjchem-2084	596	250	,	,	PUNCT
eurjchem-2084	596	251	f.	f.	PROPN
eurjchem-2084	596	252	g.	g.	PROPN
eurjchem-2084	596	253	;	;	PUNCT
eurjchem-2084	596	254	horby	horby	PROPN
eurjchem-2084	596	255	,	,	PUNCT
eurjchem-2084	596	256	p.	p.	PROPN
eurjchem-2084	596	257	w.	w.	PROPN
eurjchem-2084	596	258	;	;	PUNCT
eurjchem-2084	596	259	zhang	zhang	PROPN
eurjchem-2084	596	260	,	,	PUNCT
eurjchem-2084	596	261	d.	d.	PROPN
eurjchem-2084	596	262	;	;	PUNCT
eurjchem-2084	596	263	wang	wang	PROPN
eurjchem-2084	596	264	,	,	PUNCT
eurjchem-2084	596	265	c.	c.	PROPN
eurjchem-2084	596	266	n.	n.	PROPN
eurjchem-2084	596	267	engl	engl	PROPN
eurjchem-2084	596	268	.	.	PUNCT
eurjchem-2084	597	1	j.	j.	PROPN
eurjchem-2084	597	2	med	med	PROPN
eurjchem-2084	597	3	.	.	PUNCT
eurjchem-2084	598	1	2020	2020	NUM
eurjchem-2084	598	2	,	,	PUNCT
eurjchem-2084	598	3	382	382	NUM
eurjchem-2084	598	4	(	(	PUNCT
eurjchem-2084	598	5	19	19	NUM
eurjchem-2084	598	6	)	)	PUNCT
eurjchem-2084	598	7	,	,	PUNCT
eurjchem-2084	598	8	1787–1799	1787–1799	NUM
eurjchem-2084	598	9	.	.	PUNCT
eurjchem-2084	599	1	[	[	X
eurjchem-2084	599	2	71	71	NUM
eurjchem-2084	599	3	]	]	PUNCT
eurjchem-2084	599	4	.	.	PUNCT
eurjchem-2084	599	5	hung	hung	PROPN
eurjchem-2084	599	6	,	,	PUNCT
eurjchem-2084	599	7	i.	i.	PROPN
eurjchem-2084	599	8	f.-n	f.-n	PROPN
eurjchem-2084	599	9	.	.	PUNCT
eurjchem-2084	599	10	;	;	PUNCT
eurjchem-2084	599	11	lung	lung	NOUN
eurjchem-2084	599	12	,	,	PUNCT
eurjchem-2084	599	13	k.-c	k.-c	PROPN
eurjchem-2084	599	14	.	.	PUNCT
eurjchem-2084	599	15	;	;	PUNCT
eurjchem-2084	600	1	tso	tso	PROPN
eurjchem-2084	600	2	,	,	PUNCT
eurjchem-2084	600	3	e.	e.	PROPN
eurjchem-2084	600	4	y.-k	y.-k	PROPN
eurjchem-2084	600	5	.	.	PUNCT
eurjchem-2084	600	6	;	;	PUNCT
eurjchem-2084	600	7	liu	liu	PROPN
eurjchem-2084	600	8	,	,	PUNCT
eurjchem-2084	600	9	r.	r.	PROPN
eurjchem-2084	600	10	;	;	PUNCT
eurjchem-2084	600	11	chung	chung	PROPN
eurjchem-2084	600	12	,	,	PUNCT
eurjchem-2084	600	13	t.	t.	PROPN
eurjchem-2084	600	14	w.-h	w.-h	NOUN
eurjchem-2084	600	15	.	.	PUNCT
eurjchem-2084	600	16	;	;	PUNCT
eurjchem-2084	600	17	chu	chu	PROPN
eurjchem-2084	600	18	,	,	PUNCT
eurjchem-2084	600	19	m.y	m.y	PROPN
eurjchem-2084	600	20	.	.	PROPN
eurjchem-2084	600	21	;	;	PUNCT
eurjchem-2084	600	22	ng	ng	PROPN
eurjchem-2084	600	23	,	,	PUNCT
eurjchem-2084	600	24	y.-y	y.-y	PROPN
eurjchem-2084	600	25	.	.	PUNCT
eurjchem-2084	600	26	;	;	PUNCT
eurjchem-2084	601	1	lo	lo	PROPN
eurjchem-2084	601	2	,	,	PUNCT
eurjchem-2084	601	3	j.	j.	PROPN
eurjchem-2084	601	4	;	;	PUNCT
eurjchem-2084	601	5	chan	chan	PROPN
eurjchem-2084	601	6	,	,	PUNCT
eurjchem-2084	601	7	j.	j.	PROPN
eurjchem-2084	601	8	;	;	PUNCT
eurjchem-2084	601	9	tam	tam	PROPN
eurjchem-2084	601	10	,	,	PUNCT
eurjchem-2084	601	11	a.	a.	PROPN
eurjchem-2084	601	12	r.	r.	PROPN
eurjchem-2084	601	13	;	;	PUNCT
eurjchem-2084	601	14	shum	shum	X
eurjchem-2084	601	15	,	,	PUNCT
eurjchem-2084	601	16	h.-p	h.-p	PROPN
eurjchem-2084	601	17	.	.	PUNCT
eurjchem-2084	601	18	;	;	PUNCT
eurjchem-2084	602	1	chan	chan	PROPN
eurjchem-2084	602	2	,	,	PUNCT
eurjchem-2084	602	3	v.	v.	PROPN
eurjchem-2084	602	4	;	;	PUNCT
eurjchem-2084	602	5	wu	wu	PROPN
eurjchem-2084	602	6	,	,	PUNCT
eurjchem-2084	602	7	a.	a.	PROPN
eurjchem-2084	602	8	k.l	k.l	PROPN
eurjchem-2084	602	9	.	.	PROPN
eurjchem-2084	602	10	;	;	PUNCT
eurjchem-2084	602	11	sin	sin	NOUN
eurjchem-2084	602	12	,	,	PUNCT
eurjchem-2084	602	13	k.-m	k.-m	PROPN
eurjchem-2084	602	14	.	.	PUNCT
eurjchem-2084	602	15	;	;	PUNCT
eurjchem-2084	602	16	leung	leung	PROPN
eurjchem-2084	602	17	,	,	PUNCT
eurjchem-2084	602	18	w.-s	w.-	NOUN
eurjchem-2084	602	19	.	.	PUNCT
eurjchem-2084	602	20	;	;	PUNCT
eurjchem-2084	602	21	law	law	NOUN
eurjchem-2084	602	22	,	,	PUNCT
eurjchem-2084	602	23	w.-l	w.-l	PROPN
eurjchem-2084	602	24	.	.	PUNCT
eurjchem-2084	602	25	;	;	PUNCT
eurjchem-2084	602	26	lung	lung	PROPN
eurjchem-2084	602	27	,	,	PUNCT
eurjchem-2084	602	28	d.	d.	PROPN
eurjchem-2084	602	29	c.	c.	PROPN
eurjchem-2084	602	30	;	;	PUNCT
eurjchem-2084	602	31	sin	sin	NOUN
eurjchem-2084	602	32	,	,	PUNCT
eurjchem-2084	602	33	s.	s.	PROPN
eurjchem-2084	602	34	;	;	PUNCT
eurjchem-2084	602	35	yeung	yeung	PROPN
eurjchem-2084	602	36	,	,	PUNCT
eurjchem-2084	602	37	p.	p.	PROPN
eurjchem-2084	602	38	;	;	PUNCT
eurjchem-2084	602	39	yip	yip	PROPN
eurjchem-2084	602	40	,	,	PUNCT
eurjchem-2084	603	1	https://doi.org/10.1128/%20msphere.00807-19	https://doi.org/10.1128/%20msphere.00807-19	PROPN
eurjchem-2084	603	2	https://doi.org/10.1128/%20msphere.00807-19	https://doi.org/10.1128/%20msphere.00807-19	PROPN
eurjchem-2084	603	3	https://doi.org/10.1128/jvi.00127-20	https://doi.org/10.1128/jvi.00127-20	PROPN
eurjchem-2084	603	4	https://doi.org/%2010.3389/fmicb.2020.01800	https://doi.org/%2010.3389/fmicb.2020.01800	PROPN
eurjchem-2084	603	5	https://doi.org/%2010.3389/fmicb.2020.01800	https://doi.org/%2010.3389/fmicb.2020.01800	PROPN
eurjchem-2084	603	6	https://virological.org/t/%20preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563	https://virological.org/t/%20preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563	PROPN
eurjchem-2084	603	7	https://virological.org/t/%20preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563	https://virological.org/t/%20preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563	PROPN
eurjchem-2084	603	8	https://virological.org/t/%20preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563	https://virological.org/t/%20preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563	PROPN
eurjchem-2084	603	9	https://doi.org/10.1101/%202020.12.29.424708	https://doi.org/10.1101/%202020.12.29.424708	NOUN
eurjchem-2084	603	10	https://doi.org/10.1101/%202020.12.29.424708	https://doi.org/10.1101/%202020.12.29.424708	VERB
eurjchem-2084	603	11	https://doi.org/10.1101/2020.01.31.%20929042	https://doi.org/10.1101/2020.01.31.%20929042	NUM
eurjchem-2084	603	12	https://doi.org/10.1101/2020.01.31.%20929042	https://doi.org/10.1101/2020.01.31.%20929042	PROPN
eurjchem-2084	603	13	https://doi.org/10.1128/jcm.02107-20	https://doi.org/10.1128/jcm.02107-20	NOUN
eurjchem-2084	603	14	https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html	https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html	PROPN
eurjchem-2084	603	15	https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html	https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html	PROPN
eurjchem-2084	603	16	https://doi.org/10.2139/ssrn.3636958	https://doi.org/10.2139/ssrn.3636958	NOUN
eurjchem-2084	603	17	https://doi.org/%2010.31525/ct1-nct04292730	https://doi.org/%2010.31525/ct1-nct04292730	X
eurjchem-2084	603	18	https://doi.org/%2010.31525/ct1-nct04292730	https://doi.org/%2010.31525/ct1-nct04292730	PROPN
eurjchem-2084	603	19	firdaus	firdaus	PROPN
eurjchem-2084	603	20	et	et	PROPN
eurjchem-2084	603	21	al	al	PROPN
eurjchem-2084	603	22	.	.	PUNCT
eurjchem-2084	603	23	/	/	SYM
eurjchem-2084	603	24	european	european	PROPN
eurjchem-2084	603	25	journal	journal	PROPN
eurjchem-2084	603	26	of	of	ADP
eurjchem-2084	603	27	chemistry	chemistry	NOUN
eurjchem-2084	603	28	12	12	NUM
eurjchem-2084	603	29	(	(	PUNCT
eurjchem-2084	603	30	2	2	NUM
eurjchem-2084	603	31	)	)	PUNCT
eurjchem-2084	603	32	(	(	PUNCT
eurjchem-2084	603	33	2021	2021	NUM
eurjchem-2084	603	34	)	)	PUNCT
eurjchem-2084	603	35	222	222	NUM
eurjchem-2084	603	36	-	-	SYM
eurjchem-2084	603	37	234	234	NUM
eurjchem-2084	603	38	233	233	NUM
eurjchem-2084	603	39	2021	2021	NUM
eurjchem-2084	603	40	–	–	PUNCT
eurjchem-2084	603	41	european	european	ADJ
eurjchem-2084	603	42	journal	journal	NOUN
eurjchem-2084	603	43	of	of	ADP
eurjchem-2084	603	44	chemistry	chemistry	NOUN
eurjchem-2084	603	45	–	–	PUNCT
eurjchem-2084	603	46	cc	cc	NOUN
eurjchem-2084	603	47	by	by	ADP
eurjchem-2084	603	48	nc	nc	PROPN
eurjchem-2084	603	49	–	–	PUNCT
eurjchem-2084	603	50	doi	doi	NOUN
eurjchem-2084	603	51	:	:	PUNCT
eurjchem-2084	603	52	10.5155	10.5155	NUM
eurjchem-2084	603	53	/	/	SYM
eurjchem-2084	603	54	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	603	55	-	-	PUNCT
eurjchem-2084	603	56	234.2084	234.2084	NUM
eurjchem-2084	603	57	c.	c.	NOUN
eurjchem-2084	603	58	c.-y	c.-y	NOUN
eurjchem-2084	603	59	.	.	PUNCT
eurjchem-2084	603	60	;	;	PUNCT
eurjchem-2084	603	61	zhang	zhang	PROPN
eurjchem-2084	603	62	,	,	PUNCT
eurjchem-2084	603	63	r.	r.	PROPN
eurjchem-2084	603	64	r.	r.	PROPN
eurjchem-2084	603	65	;	;	PUNCT
eurjchem-2084	603	66	fung	fung	PROPN
eurjchem-2084	603	67	,	,	PUNCT
eurjchem-2084	603	68	a.	a.	NOUN
eurjchem-2084	603	69	y.-f	y.-f	PROPN
eurjchem-2084	603	70	.	.	PUNCT
eurjchem-2084	603	71	;	;	PUNCT
eurjchem-2084	604	1	yan	yan	PROPN
eurjchem-2084	604	2	,	,	PUNCT
eurjchem-2084	604	3	e.	e.	PROPN
eurjchem-2084	604	4	y.-w	y.-w	PROPN
eurjchem-2084	604	5	.	.	PUNCT
eurjchem-2084	604	6	;	;	PUNCT
eurjchem-2084	604	7	leung	leung	PROPN
eurjchem-2084	604	8	,	,	PUNCT
eurjchem-2084	604	9	k.-h	k.-h	PROPN
eurjchem-2084	604	10	.	.	PUNCT
eurjchem-2084	604	11	;	;	PUNCT
eurjchem-2084	604	12	ip	ip	PROPN
eurjchem-2084	604	13	,	,	PUNCT
eurjchem-2084	604	14	j.	j.	PROPN
eurjchem-2084	604	15	d.	d.	PROPN
eurjchem-2084	604	16	;	;	PUNCT
eurjchem-2084	604	17	chu	chu	PROPN
eurjchem-2084	604	18	,	,	PUNCT
eurjchem-2084	604	19	a.	a.	NOUN
eurjchem-2084	604	20	w.-h	w.-h	PROPN
eurjchem-2084	604	21	.	.	PUNCT
eurjchem-2084	604	22	;	;	PUNCT
eurjchem-2084	604	23	chan	chan	PROPN
eurjchem-2084	604	24	,	,	PUNCT
eurjchem-2084	604	25	w.-m	w.-m	PROPN
eurjchem-2084	604	26	.	.	PUNCT
eurjchem-2084	604	27	;	;	PUNCT
eurjchem-2084	604	28	ng	ng	PROPN
eurjchem-2084	604	29	,	,	PUNCT
eurjchem-2084	604	30	a.	a.	NOUN
eurjchem-2084	604	31	c.-k	c.-k	PROPN
eurjchem-2084	604	32	.	.	PUNCT
eurjchem-2084	604	33	;	;	PUNCT
eurjchem-2084	604	34	lee	lee	PROPN
eurjchem-2084	604	35	,	,	PUNCT
eurjchem-2084	604	36	r.	r.	PROPN
eurjchem-2084	604	37	;	;	PUNCT
eurjchem-2084	604	38	fung	fung	PROPN
eurjchem-2084	604	39	,	,	PUNCT
eurjchem-2084	604	40	k.	k.	PROPN
eurjchem-2084	604	41	;	;	PUNCT
eurjchem-2084	604	42	yeung	yeung	PROPN
eurjchem-2084	604	43	,	,	PUNCT
eurjchem-2084	604	44	a.	a.	PROPN
eurjchem-2084	604	45	;	;	PUNCT
eurjchem-2084	604	46	wu	wu	PROPN
eurjchem-2084	604	47	,	,	PUNCT
eurjchem-2084	604	48	t.-c	t.-c	PROPN
eurjchem-2084	604	49	.	.	PUNCT
eurjchem-2084	604	50	;	;	PUNCT
eurjchem-2084	604	51	chan	chan	PROPN
eurjchem-2084	604	52	,	,	PUNCT
eurjchem-2084	604	53	j.	j.	PROPN
eurjchem-2084	604	54	w.-m	w.-m	PROPN
eurjchem-2084	604	55	.	.	PUNCT
eurjchem-2084	604	56	;	;	PUNCT
eurjchem-2084	604	57	yan	yan	PROPN
eurjchem-2084	604	58	,	,	PUNCT
eurjchem-2084	604	59	w.-w	w.-w	PROPN
eurjchem-2084	604	60	.	.	PUNCT
eurjchem-2084	604	61	;	;	PUNCT
eurjchem-2084	604	62	chan	chan	PROPN
eurjchem-2084	604	63	,	,	PUNCT
eurjchem-2084	604	64	w.-m	w.-m	PROPN
eurjchem-2084	604	65	.	.	PUNCT
eurjchem-2084	604	66	;	;	PUNCT
eurjchem-2084	604	67	chan	chan	PROPN
eurjchem-2084	604	68	,	,	PUNCT
eurjchem-2084	604	69	j.	j.	PROPN
eurjchem-2084	604	70	f.-w	f.-w	PROPN
eurjchem-2084	604	71	.	.	PROPN
eurjchem-2084	604	72	;	;	PUNCT
eurjchem-2084	604	73	lie	lie	NOUN
eurjchem-2084	604	74	,	,	PUNCT
eurjchem-2084	604	75	a.	a.	PROPN
eurjchem-2084	604	76	k.w	k.w	PROPN
eurjchem-2084	604	77	.	.	PROPN
eurjchem-2084	604	78	;	;	PUNCT
eurjchem-2084	604	79	tsang	tsang	PROPN
eurjchem-2084	604	80	,	,	PUNCT
eurjchem-2084	604	81	o.	o.	PROPN
eurjchem-2084	604	82	t.-y	t.-y	PROPN
eurjchem-2084	604	83	.	.	PUNCT
eurjchem-2084	604	84	;	;	PUNCT
eurjchem-2084	605	1	cheng	cheng	PROPN
eurjchem-2084	605	2	,	,	PUNCT
eurjchem-2084	605	3	v.	v.	ADP
eurjchem-2084	605	4	c.-c	c.-c	PROPN
eurjchem-2084	605	5	.	.	PUNCT
eurjchem-2084	605	6	;	;	PUNCT
eurjchem-2084	605	7	que	que	X
eurjchem-2084	605	8	,	,	PUNCT
eurjchem-2084	605	9	t.-l	t.-l	NOUN
eurjchem-2084	605	10	.	.	PUNCT
eurjchem-2084	605	11	;	;	PUNCT
eurjchem-2084	605	12	lau	lau	PROPN
eurjchem-2084	605	13	,	,	PUNCT
eurjchem-2084	605	14	c.-s	c.-	NOUN
eurjchem-2084	605	15	.	.	PUNCT
eurjchem-2084	605	16	;	;	PUNCT
eurjchem-2084	605	17	chan	chan	PROPN
eurjchem-2084	605	18	,	,	PUNCT
eurjchem-2084	605	19	k.-h	k.-h	PROPN
eurjchem-2084	605	20	.	.	PUNCT
eurjchem-2084	605	21	;	;	PUNCT
eurjchem-2084	605	22	to	to	PART
eurjchem-2084	605	23	,	,	PUNCT
eurjchem-2084	605	24	k.	k.	PROPN
eurjchem-2084	605	25	k.-w	k.-w	PROPN
eurjchem-2084	605	26	.	.	PUNCT
eurjchem-2084	605	27	;	;	PUNCT
eurjchem-2084	605	28	yuen	yuen	PROPN
eurjchem-2084	605	29	,	,	PUNCT
eurjchem-2084	605	30	k.-y	k.-y	NOUN
eurjchem-2084	605	31	.	.	PUNCT
eurjchem-2084	606	1	lancet	lancet	PROPN
eurjchem-2084	606	2	2020	2020	NUM
eurjchem-2084	606	3	,	,	PUNCT
eurjchem-2084	606	4	395	395	NUM
eurjchem-2084	606	5	(	(	PUNCT
eurjchem-2084	606	6	10238	10238	NUM
eurjchem-2084	606	7	)	)	PUNCT
eurjchem-2084	606	8	,	,	PUNCT
eurjchem-2084	606	9	1695–1704	1695–1704	NUM
eurjchem-2084	606	10	.	.	PUNCT
eurjchem-2084	607	1	[	[	X
eurjchem-2084	607	2	72	72	NUM
eurjchem-2084	607	3	]	]	PUNCT
eurjchem-2084	607	4	.	.	PUNCT
eurjchem-2084	608	1	lopinavir	lopinavir	PROPN
eurjchem-2084	608	2	/	/	SYM
eurjchem-2084	608	3	ritonavir	ritonavir	PROPN
eurjchem-2084	608	4	for	for	ADP
eurjchem-2084	608	5	the	the	DET
eurjchem-2084	608	6	treatment	treatment	NOUN
eurjchem-2084	608	7	of	of	ADP
eurjchem-2084	608	8	covid-19	covid-19	PROPN
eurjchem-2084	608	9	positive	positive	ADJ
eurjchem-2084	608	10	patients	patient	NOUN
eurjchem-2084	608	11	with	with	ADP
eurjchem-2084	608	12	cancer	cancer	NOUN
eurjchem-2084	608	13	and	and	CCONJ
eurjchem-2084	608	14	immune	immune	ADJ
eurjchem-2084	608	15	suppression	suppression	NOUN
eurjchem-2084	608	16	in	in	ADP
eurjchem-2084	608	17	the	the	DET
eurjchem-2084	608	18	last	last	ADJ
eurjchem-2084	608	19	year	year	NOUN
eurjchem-2084	608	20	https://clinicaltrials.gov/ct2/show/nct04455958	https://clinicaltrials.gov/ct2/show/nct04455958	INTJ
eurjchem-2084	609	1	(	(	PUNCT
eurjchem-2084	609	2	accessed	access	VERB
eurjchem-2084	609	3	december	december	PROPN
eurjchem-2084	609	4	9	9	NUM
eurjchem-2084	609	5	,	,	PUNCT
eurjchem-2084	609	6	2020	2020	NUM
eurjchem-2084	609	7	)	)	PUNCT
eurjchem-2084	609	8	.	.	PUNCT
eurjchem-2084	610	1	[	[	X
eurjchem-2084	610	2	73	73	NUM
eurjchem-2084	610	3	]	]	PUNCT
eurjchem-2084	610	4	.	.	PUNCT
eurjchem-2084	611	1	dong	dong	PROPN
eurjchem-2084	611	2	,	,	PUNCT
eurjchem-2084	611	3	l.	l.	PROPN
eurjchem-2084	611	4	;	;	PUNCT
eurjchem-2084	611	5	hu	hu	PROPN
eurjchem-2084	611	6	,	,	PUNCT
eurjchem-2084	611	7	s.	s.	PROPN
eurjchem-2084	611	8	;	;	PUNCT
eurjchem-2084	611	9	gao	gao	PROPN
eurjchem-2084	611	10	,	,	PUNCT
eurjchem-2084	611	11	j.	j.	PROPN
eurjchem-2084	611	12	drug	drug	PROPN
eurjchem-2084	611	13	discov	discov	PROPN
eurjchem-2084	611	14	.	.	PUNCT
eurjchem-2084	612	1	ther	ther	INTJ
eurjchem-2084	612	2	.	.	PUNCT
eurjchem-2084	613	1	2020	2020	NUM
eurjchem-2084	613	2	,	,	PUNCT
eurjchem-2084	613	3	14	14	NUM
eurjchem-2084	613	4	(	(	PUNCT
eurjchem-2084	613	5	1	1	NUM
eurjchem-2084	613	6	)	)	PUNCT
eurjchem-2084	613	7	,	,	PUNCT
eurjchem-2084	613	8	58–60	58–60	NOUN
eurjchem-2084	613	9	.	.	PUNCT
eurjchem-2084	614	1	[	[	X
eurjchem-2084	614	2	74	74	NUM
eurjchem-2084	614	3	]	]	PUNCT
eurjchem-2084	614	4	.	.	PUNCT
eurjchem-2084	615	1	lee	lee	PROPN
eurjchem-2084	615	2	,	,	PUNCT
eurjchem-2084	615	3	j.	j.	PROPN
eurjchem-2084	615	4	s.	s.	PROPN
eurjchem-2084	615	5	;	;	PUNCT
eurjchem-2084	615	6	shin	shin	PROPN
eurjchem-2084	615	7	,	,	PUNCT
eurjchem-2084	615	8	e.-c	e.-c	NOUN
eurjchem-2084	615	9	.	.	PUNCT
eurjchem-2084	616	1	nat	nat	PROPN
eurjchem-2084	616	2	.	.	PUNCT
eurjchem-2084	617	1	rev	rev	PROPN
eurjchem-2084	617	2	.	.	PROPN
eurjchem-2084	617	3	immunol	immunol	NOUN
eurjchem-2084	617	4	.	.	PUNCT
eurjchem-2084	618	1	2020	2020	NUM
eurjchem-2084	618	2	,	,	PUNCT
eurjchem-2084	618	3	20	20	NUM
eurjchem-2084	618	4	(	(	PUNCT
eurjchem-2084	618	5	10	10	NUM
eurjchem-2084	618	6	)	)	PUNCT
eurjchem-2084	618	7	,	,	PUNCT
eurjchem-2084	618	8	585–586	585–586	NUM
eurjchem-2084	618	9	.	.	PUNCT
eurjchem-2084	619	1	[	[	X
eurjchem-2084	619	2	75	75	NUM
eurjchem-2084	619	3	]	]	PUNCT
eurjchem-2084	619	4	.	.	PUNCT
eurjchem-2084	620	1	zhou	zhou	PROPN
eurjchem-2084	620	2	,	,	PUNCT
eurjchem-2084	620	3	q.	q.	PROPN
eurjchem-2084	620	4	;	;	PUNCT
eurjchem-2084	620	5	chen	chen	PROPN
eurjchem-2084	620	6	,	,	PUNCT
eurjchem-2084	620	7	v.	v.	PROPN
eurjchem-2084	620	8	;	;	PUNCT
eurjchem-2084	620	9	shannon	shannon	PROPN
eurjchem-2084	620	10	,	,	PUNCT
eurjchem-2084	620	11	c.	c.	PROPN
eurjchem-2084	620	12	p.	p.	PROPN
eurjchem-2084	620	13	;	;	PUNCT
eurjchem-2084	620	14	wei	wei	PROPN
eurjchem-2084	620	15	,	,	PUNCT
eurjchem-2084	620	16	x.-s	x.-s	PROPN
eurjchem-2084	620	17	.	.	PUNCT
eurjchem-2084	620	18	;	;	PUNCT
eurjchem-2084	620	19	xiang	xiang	PROPN
eurjchem-2084	620	20	,	,	PUNCT
eurjchem-2084	620	21	x.	x.	PROPN
eurjchem-2084	620	22	;	;	PUNCT
eurjchem-2084	620	23	wang	wang	PROPN
eurjchem-2084	620	24	,	,	PUNCT
eurjchem-2084	620	25	x.	x.	PROPN
eurjchem-2084	620	26	;	;	PUNCT
eurjchem-2084	620	27	wang	wang	PROPN
eurjchem-2084	620	28	,	,	PUNCT
eurjchem-2084	620	29	z.-h	z.-h	PROPN
eurjchem-2084	620	30	.	.	PUNCT
eurjchem-2084	620	31	;	;	PUNCT
eurjchem-2084	620	32	tebbutt	tebbutt	PROPN
eurjchem-2084	620	33	,	,	PUNCT
eurjchem-2084	620	34	s.	s.	PROPN
eurjchem-2084	620	35	j.	j.	PROPN
eurjchem-2084	620	36	;	;	PUNCT
eurjchem-2084	620	37	kollmann	kollmann	PROPN
eurjchem-2084	620	38	,	,	PUNCT
eurjchem-2084	620	39	t.	t.	PROPN
eurjchem-2084	620	40	r.	r.	PROPN
eurjchem-2084	620	41	;	;	PUNCT
eurjchem-2084	620	42	fish	fish	NOUN
eurjchem-2084	620	43	,	,	PUNCT
eurjchem-2084	620	44	e.	e.	PROPN
eurjchem-2084	620	45	n.	n.	PROPN
eurjchem-2084	620	46	front	front	PROPN
eurjchem-2084	620	47	.	.	PUNCT
eurjchem-2084	621	1	immunol	immunol	NOUN
eurjchem-2084	621	2	.	.	PUNCT
eurjchem-2084	622	1	2020	2020	NUM
eurjchem-2084	622	2	,	,	PUNCT
eurjchem-2084	622	3	11	11	NUM
eurjchem-2084	622	4	,	,	PUNCT
eurjchem-2084	622	5	1061	1061	NUM
eurjchem-2084	622	6	.	.	PUNCT
eurjchem-2084	623	1	[	[	X
eurjchem-2084	623	2	76	76	NUM
eurjchem-2084	623	3	]	]	PUNCT
eurjchem-2084	623	4	.	.	PUNCT
eurjchem-2084	624	1	colson	colson	PROPN
eurjchem-2084	624	2	,	,	PUNCT
eurjchem-2084	624	3	p.	p.	NOUN
eurjchem-2084	624	4	;	;	PUNCT
eurjchem-2084	624	5	rolain	rolain	PROPN
eurjchem-2084	624	6	,	,	PUNCT
eurjchem-2084	624	7	j.-m	j.-m	PROPN
eurjchem-2084	624	8	.	.	PUNCT
eurjchem-2084	624	9	;	;	PUNCT
eurjchem-2084	624	10	lagier	lagier	NOUN
eurjchem-2084	624	11	,	,	PUNCT
eurjchem-2084	624	12	j.-c	j.-c	PROPN
eurjchem-2084	624	13	.	.	PUNCT
eurjchem-2084	624	14	;	;	PUNCT
eurjchem-2084	624	15	brouqui	brouqui	NOUN
eurjchem-2084	624	16	,	,	PUNCT
eurjchem-2084	624	17	p.	p.	NOUN
eurjchem-2084	624	18	;	;	PUNCT
eurjchem-2084	624	19	raoult	raoult	VERB
eurjchem-2084	624	20	,	,	PUNCT
eurjchem-2084	624	21	d.	d.	PROPN
eurjchem-2084	624	22	int	int	PROPN
eurjchem-2084	624	23	.	.	PUNCT
eurjchem-2084	625	1	j.	j.	PROPN
eurjchem-2084	625	2	antimicrob	antimicrob	PROPN
eurjchem-2084	625	3	.	.	PUNCT
eurjchem-2084	626	1	agents	agent	NOUN
eurjchem-2084	626	2	2020	2020	NUM
eurjchem-2084	626	3	,	,	PUNCT
eurjchem-2084	626	4	55	55	NUM
eurjchem-2084	626	5	(	(	PUNCT
eurjchem-2084	626	6	4	4	NUM
eurjchem-2084	626	7	)	)	PUNCT
eurjchem-2084	626	8	,	,	PUNCT
eurjchem-2084	626	9	105932	105932	NUM
eurjchem-2084	626	10	.	.	PUNCT
eurjchem-2084	627	1	[	[	X
eurjchem-2084	627	2	77	77	NUM
eurjchem-2084	627	3	]	]	PUNCT
eurjchem-2084	627	4	.	.	PUNCT
eurjchem-2084	628	1	jie	jie	PROPN
eurjchem-2084	628	2	,	,	PUNCT
eurjchem-2084	628	3	z.	z.	PROPN
eurjchem-2084	628	4	;	;	PUNCT
eurjchem-2084	628	5	he	he	PRON
eurjchem-2084	628	6	,	,	PUNCT
eurjchem-2084	628	7	h.	h.	PROPN
eurjchem-2084	628	8	;	;	PUNCT
eurjchem-2084	628	9	xi	xi	PROPN
eurjchem-2084	628	10	,	,	PUNCT
eurjchem-2084	628	11	h.	h.	PROPN
eurjchem-2084	628	12	;	;	PUNCT
eurjchem-2084	628	13	zhi	zhi	PROPN
eurjchem-2084	628	14	,	,	PUNCT
eurjchem-2084	628	15	z.	z.	PROPN
eurjchem-2084	628	16	zhonghua	zhonghua	PROPN
eurjchem-2084	628	17	jie	jie	PROPN
eurjchem-2084	629	1	he	he	PRON
eurjchem-2084	629	2	he	he	PRON
eurjchem-2084	629	3	hu	hu	PROPN
eurjchem-2084	629	4	xi	xi	PROPN
eurjchem-2084	629	5	za	za	PROPN
eurjchem-2084	629	6	zhi	zhi	PROPN
eurjchem-2084	629	7	2020	2020	NUM
eurjchem-2084	629	8	,	,	PUNCT
eurjchem-2084	629	9	43	43	NUM
eurjchem-2084	629	10	(	(	PUNCT
eurjchem-2084	629	11	3	3	NUM
eurjchem-2084	629	12	)	)	PUNCT
eurjchem-2084	629	13	,	,	PUNCT
eurjchem-2084	629	14	185–188	185–188	NUM
eurjchem-2084	629	15	.	.	PUNCT
eurjchem-2084	630	1	[	[	X
eurjchem-2084	630	2	78	78	NUM
eurjchem-2084	630	3	]	]	PUNCT
eurjchem-2084	630	4	.	.	PUNCT
eurjchem-2084	631	1	gao	gao	PROPN
eurjchem-2084	631	2	,	,	PUNCT
eurjchem-2084	631	3	j.	j.	PROPN
eurjchem-2084	631	4	;	;	PUNCT
eurjchem-2084	631	5	tian	tian	PROPN
eurjchem-2084	631	6	,	,	PUNCT
eurjchem-2084	631	7	z.	z.	PROPN
eurjchem-2084	631	8	;	;	PUNCT
eurjchem-2084	631	9	yang	yang	PROPN
eurjchem-2084	631	10	,	,	PUNCT
eurjchem-2084	631	11	x.	x.	PROPN
eurjchem-2084	631	12	biosci	biosci	PROPN
eurjchem-2084	631	13	.	.	PUNCT
eurjchem-2084	632	1	trends	trend	NOUN
eurjchem-2084	632	2	2020	2020	NUM
eurjchem-2084	632	3	,	,	PUNCT
eurjchem-2084	632	4	14	14	NUM
eurjchem-2084	632	5	(	(	PUNCT
eurjchem-2084	632	6	1	1	NUM
eurjchem-2084	632	7	)	)	PUNCT
eurjchem-2084	632	8	,	,	PUNCT
eurjchem-2084	632	9	72–73	72–73	ADJ
eurjchem-2084	632	10	.	.	PUNCT
eurjchem-2084	633	1	[	[	X
eurjchem-2084	633	2	79	79	NUM
eurjchem-2084	633	3	]	]	PUNCT
eurjchem-2084	633	4	.	.	PUNCT
eurjchem-2084	634	1	gautret	gautret	NOUN
eurjchem-2084	634	2	,	,	PUNCT
eurjchem-2084	634	3	p.	p.	NOUN
eurjchem-2084	634	4	;	;	PUNCT
eurjchem-2084	634	5	lagier	lagier	NOUN
eurjchem-2084	634	6	,	,	PUNCT
eurjchem-2084	634	7	j.-c	j.-c	PROPN
eurjchem-2084	634	8	.	.	PUNCT
eurjchem-2084	634	9	;	;	PUNCT
eurjchem-2084	635	1	parola	parola	NOUN
eurjchem-2084	635	2	,	,	PUNCT
eurjchem-2084	635	3	p.	p.	PROPN
eurjchem-2084	635	4	;	;	PUNCT
eurjchem-2084	635	5	hoang	hoang	PROPN
eurjchem-2084	635	6	,	,	PUNCT
eurjchem-2084	635	7	v.	v.	PROPN
eurjchem-2084	635	8	t.	t.	PROPN
eurjchem-2084	635	9	;	;	PUNCT
eurjchem-2084	635	10	meddeb	meddeb	PROPN
eurjchem-2084	635	11	,	,	PUNCT
eurjchem-2084	635	12	l.	l.	PROPN
eurjchem-2084	635	13	;	;	PUNCT
eurjchem-2084	635	14	sevestre	sevestre	NOUN
eurjchem-2084	635	15	,	,	PUNCT
eurjchem-2084	635	16	j.	j.	PROPN
eurjchem-2084	635	17	;	;	PUNCT
eurjchem-2084	635	18	mailhe	mailhe	PROPN
eurjchem-2084	635	19	,	,	PUNCT
eurjchem-2084	635	20	m.	m.	NOUN
eurjchem-2084	635	21	;	;	PUNCT
eurjchem-2084	635	22	doudier	doudier	PROPN
eurjchem-2084	635	23	,	,	PUNCT
eurjchem-2084	635	24	b.	b.	PROPN
eurjchem-2084	635	25	;	;	PUNCT
eurjchem-2084	635	26	aubry	aubry	PROPN
eurjchem-2084	635	27	,	,	PUNCT
eurjchem-2084	635	28	c.	c.	PROPN
eurjchem-2084	635	29	;	;	PUNCT
eurjchem-2084	635	30	amrane	amrane	NOUN
eurjchem-2084	635	31	,	,	PUNCT
eurjchem-2084	635	32	s.	s.	PROPN
eurjchem-2084	635	33	;	;	PUNCT
eurjchem-2084	635	34	seng	seng	PROPN
eurjchem-2084	635	35	,	,	PUNCT
eurjchem-2084	635	36	p.	p.	NOUN
eurjchem-2084	635	37	;	;	PUNCT
eurjchem-2084	635	38	hocquart	hocquart	NOUN
eurjchem-2084	635	39	,	,	PUNCT
eurjchem-2084	635	40	m.	m.	NOUN
eurjchem-2084	635	41	;	;	PUNCT
eurjchem-2084	635	42	eldin	eldin	PROPN
eurjchem-2084	635	43	,	,	PUNCT
eurjchem-2084	635	44	c.	c.	NOUN
eurjchem-2084	635	45	;	;	PUNCT
eurjchem-2084	635	46	finance	finance	NOUN
eurjchem-2084	635	47	,	,	PUNCT
eurjchem-2084	635	48	j.	j.	PROPN
eurjchem-2084	635	49	;	;	PUNCT
eurjchem-2084	635	50	vieira	vieira	PROPN
eurjchem-2084	635	51	,	,	PUNCT
eurjchem-2084	635	52	v.	v.	PROPN
eurjchem-2084	635	53	e.	e.	PROPN
eurjchem-2084	635	54	;	;	PUNCT
eurjchem-2084	635	55	tissot	tissot	NOUN
eurjchem-2084	635	56	-	-	PUNCT
eurjchem-2084	635	57	dupont	dupont	NOUN
eurjchem-2084	635	58	,	,	PUNCT
eurjchem-2084	635	59	h.	h.	PROPN
eurjchem-2084	635	60	t.	t.	PROPN
eurjchem-2084	635	61	;	;	PUNCT
eurjchem-2084	635	62	honoré	honoré	PROPN
eurjchem-2084	635	63	,	,	PUNCT
eurjchem-2084	635	64	s.	s.	PROPN
eurjchem-2084	635	65	;	;	PUNCT
eurjchem-2084	635	66	stein	stein	PROPN
eurjchem-2084	635	67	,	,	PUNCT
eurjchem-2084	635	68	a.	a.	NOUN
eurjchem-2084	635	69	;	;	PUNCT
eurjchem-2084	635	70	million	million	NUM
eurjchem-2084	635	71	,	,	PUNCT
eurjchem-2084	635	72	m.	m.	NOUN
eurjchem-2084	635	73	;	;	PUNCT
eurjchem-2084	635	74	colson	colson	PROPN
eurjchem-2084	635	75	,	,	PUNCT
eurjchem-2084	635	76	p.	p.	NOUN
eurjchem-2084	635	77	;	;	PUNCT
eurjchem-2084	635	78	la	la	PROPN
eurjchem-2084	635	79	scola	scola	PROPN
eurjchem-2084	635	80	,	,	PUNCT
eurjchem-2084	635	81	b.	b.	PROPN
eurjchem-2084	635	82	;	;	PUNCT
eurjchem-2084	635	83	veit	veit	PROPN
eurjchem-2084	635	84	,	,	PUNCT
eurjchem-2084	635	85	v.	v.	ADV
eurjchem-2084	635	86	;	;	PUNCT
eurjchem-2084	635	87	jacquier	jacquier	NOUN
eurjchem-2084	635	88	,	,	PUNCT
eurjchem-2084	635	89	a.	a.	NOUN
eurjchem-2084	635	90	;	;	PUNCT
eurjchem-2084	635	91	deharo	deharo	NOUN
eurjchem-2084	635	92	,	,	PUNCT
eurjchem-2084	635	93	j.c	j.c	PROPN
eurjchem-2084	635	94	.	.	PROPN
eurjchem-2084	635	95	;	;	PUNCT
eurjchem-2084	635	96	drancourt	drancourt	PROPN
eurjchem-2084	635	97	,	,	PUNCT
eurjchem-2084	635	98	m.	m.	NOUN
eurjchem-2084	635	99	;	;	PUNCT
eurjchem-2084	635	100	fournier	fournier	NOUN
eurjchem-2084	635	101	,	,	PUNCT
eurjchem-2084	635	102	p.	p.	PROPN
eurjchem-2084	635	103	e.	e.	PROPN
eurjchem-2084	635	104	;	;	PUNCT
eurjchem-2084	635	105	rolain	rolain	PROPN
eurjchem-2084	635	106	,	,	PUNCT
eurjchem-2084	635	107	j.-m	j.-m	PROPN
eurjchem-2084	635	108	.	.	PUNCT
eurjchem-2084	635	109	;	;	PUNCT
eurjchem-2084	635	110	brouqui	brouqui	NOUN
eurjchem-2084	635	111	,	,	PUNCT
eurjchem-2084	635	112	p.	p.	NOUN
eurjchem-2084	635	113	;	;	PUNCT
eurjchem-2084	635	114	raoult	raoult	VERB
eurjchem-2084	635	115	,	,	PUNCT
eurjchem-2084	635	116	d.	d.	PROPN
eurjchem-2084	635	117	travel	travel	PROPN
eurjchem-2084	635	118	med	me	VERB
eurjchem-2084	635	119	.	.	PUNCT
eurjchem-2084	636	1	infect	infect	VERB
eurjchem-2084	636	2	.	.	PUNCT
eurjchem-2084	637	1	dis	dis	PROPN
eurjchem-2084	637	2	.	.	PUNCT
eurjchem-2084	638	1	2020	2020	NUM
eurjchem-2084	638	2	,	,	PUNCT
eurjchem-2084	638	3	34	34	NUM
eurjchem-2084	638	4	(	(	PUNCT
eurjchem-2084	638	5	101663	101663	NUM
eurjchem-2084	638	6	)	)	PUNCT
eurjchem-2084	638	7	,	,	PUNCT
eurjchem-2084	638	8	101663	101663	NUM
eurjchem-2084	638	9	.	.	PUNCT
eurjchem-2084	639	1	[	[	X
eurjchem-2084	639	2	80	80	NUM
eurjchem-2084	639	3	]	]	PUNCT
eurjchem-2084	639	4	.	.	PUNCT
eurjchem-2084	640	1	“	"	PUNCT
eurjchem-2084	640	2	solidarity	solidarity	NOUN
eurjchem-2084	640	3	”	"	PUNCT
eurjchem-2084	640	4	clinical	clinical	ADJ
eurjchem-2084	640	5	trial	trial	NOUN
eurjchem-2084	640	6	for	for	ADP
eurjchem-2084	640	7	covid-19	covid-19	PROPN
eurjchem-2084	640	8	treatments	treatment	NOUN
eurjchem-2084	640	9	https://www.who.int/emergencies/diseases/novel-coronavirus2019/global-research-on-novel-coronavirus-2019-ncov/solidarityclinical-trial-for-covid-19-treatments	https://www.who.int/emergencies/diseases/novel-coronavirus2019/global-research-on-novel-coronavirus-2019-ncov/solidarityclinical-trial-for-covid-19-treatment	NOUN
eurjchem-2084	640	10	(	(	PUNCT
eurjchem-2084	640	11	accessed	access	VERB
eurjchem-2084	640	12	december	december	PROPN
eurjchem-2084	640	13	9	9	NUM
eurjchem-2084	640	14	,	,	PUNCT
eurjchem-2084	640	15	2020	2020	NUM
eurjchem-2084	640	16	)	)	PUNCT
eurjchem-2084	640	17	.	.	PUNCT
eurjchem-2084	641	1	[	[	X
eurjchem-2084	641	2	81	81	NUM
eurjchem-2084	641	3	]	]	PUNCT
eurjchem-2084	641	4	.	.	PUNCT
eurjchem-2084	642	1	randomised	randomised	ADJ
eurjchem-2084	642	2	evaluation	evaluation	NOUN
eurjchem-2084	642	3	of	of	ADP
eurjchem-2084	642	4	covid-19	covid-19	PROPN
eurjchem-2084	642	5	therapy	therapy	NOUN
eurjchem-2084	642	6	full	full	ADJ
eurjchem-2084	642	7	text	text	NOUN
eurjchem-2084	642	8	view	view	NOUN
eurjchem-2084	642	9	clinicaltrials.gov	clinicaltrials.gov	PUNCT
eurjchem-2084	642	10	https://clinicaltrials.gov/ct2/show/	https://clinicaltrials.gov/ct2/show/	PROPN
eurjchem-2084	642	11	(	(	PUNCT
eurjchem-2084	642	12	accessed	access	VERB
eurjchem-2084	642	13	december	december	PROPN
eurjchem-2084	642	14	9	9	NUM
eurjchem-2084	642	15	,	,	PUNCT
eurjchem-2084	642	16	2020	2020	NUM
eurjchem-2084	642	17	)	)	PUNCT
eurjchem-2084	642	18	.	.	PUNCT
eurjchem-2084	643	1	[	[	X
eurjchem-2084	643	2	82	82	NUM
eurjchem-2084	643	3	]	]	PUNCT
eurjchem-2084	643	4	.	.	PUNCT
eurjchem-2084	643	5	mehra	mehra	PROPN
eurjchem-2084	643	6	,	,	PUNCT
eurjchem-2084	643	7	m.	m.	PROPN
eurjchem-2084	643	8	r.	r.	PROPN
eurjchem-2084	643	9	;	;	PUNCT
eurjchem-2084	643	10	ruschitzka	ruschitzka	PROPN
eurjchem-2084	643	11	,	,	PUNCT
eurjchem-2084	643	12	f.	f.	PROPN
eurjchem-2084	643	13	;	;	PUNCT
eurjchem-2084	643	14	patel	patel	PROPN
eurjchem-2084	643	15	,	,	PUNCT
eurjchem-2084	643	16	a.	a.	PROPN
eurjchem-2084	643	17	n.	n.	PROPN
eurjchem-2084	643	18	lancet	lancet	PROPN
eurjchem-2084	643	19	2020	2020	NUM
eurjchem-2084	643	20	,	,	PUNCT
eurjchem-2084	643	21	395	395	NUM
eurjchem-2084	643	22	(	(	PUNCT
eurjchem-2084	643	23	10240	10240	NUM
eurjchem-2084	643	24	)	)	PUNCT
eurjchem-2084	643	25	,	,	PUNCT
eurjchem-2084	643	26	1820	1820	NUM
eurjchem-2084	643	27	.	.	PUNCT
eurjchem-2084	644	1	[	[	X
eurjchem-2084	644	2	83	83	NUM
eurjchem-2084	644	3	]	]	SYM
eurjchem-2084	644	4	.	.	PUNCT
eurjchem-2084	644	5	torjesen	torjesen	PROPN
eurjchem-2084	644	6	,	,	PUNCT
eurjchem-2084	644	7	i.	i.	NOUN
eurjchem-2084	644	8	bmj	bmj	PROPN
eurjchem-2084	644	9	2020	2020	NUM
eurjchem-2084	644	10	,	,	PUNCT
eurjchem-2084	644	11	369	369	NUM
eurjchem-2084	644	12	,	,	PUNCT
eurjchem-2084	644	13	m2263	m2263	NOUN
eurjchem-2084	644	14	.	.	PUNCT
eurjchem-2084	645	1	[	[	X
eurjchem-2084	645	2	84	84	NUM
eurjchem-2084	645	3	]	]	PUNCT
eurjchem-2084	645	4	.	.	PUNCT
eurjchem-2084	646	1	evaluating	evaluate	VERB
eurjchem-2084	646	2	the	the	DET
eurjchem-2084	646	3	efficacy	efficacy	NOUN
eurjchem-2084	646	4	of	of	ADP
eurjchem-2084	646	5	hydroxychloroquine	hydroxychloroquine	PROPN
eurjchem-2084	646	6	and	and	CCONJ
eurjchem-2084	646	7	azithromycin	azithromycin	VERB
eurjchem-2084	646	8	to	to	PART
eurjchem-2084	646	9	prevent	prevent	VERB
eurjchem-2084	646	10	hospitalization	hospitalization	NOUN
eurjchem-2084	646	11	or	or	CCONJ
eurjchem-2084	646	12	death	death	NOUN
eurjchem-2084	646	13	in	in	ADP
eurjchem-2084	646	14	persons	person	NOUN
eurjchem-2084	646	15	with	with	ADP
eurjchem-2084	646	16	covid-19	covid-19	PROPN
eurjchem-2084	646	17	https://clinicaltrials.gov/ct2/show/nct04358068	https://clinicaltrials.gov/ct2/show/nct04358068	PUNCT
eurjchem-2084	646	18	(	(	PUNCT
eurjchem-2084	646	19	accessed	access	VERB
eurjchem-2084	646	20	december	december	PROPN
eurjchem-2084	646	21	9	9	NUM
eurjchem-2084	646	22	,	,	PUNCT
eurjchem-2084	646	23	2020	2020	NUM
eurjchem-2084	646	24	)	)	PUNCT
eurjchem-2084	646	25	.	.	PUNCT
eurjchem-2084	647	1	[	[	X
eurjchem-2084	647	2	85	85	NUM
eurjchem-2084	647	3	]	]	PUNCT
eurjchem-2084	647	4	.	.	PUNCT
eurjchem-2084	648	1	waldrop	waldrop	PROPN
eurjchem-2084	648	2	,	,	PUNCT
eurjchem-2084	648	3	t.	t.	PROPN
eurjchem-2084	648	4	;	;	PUNCT
eurjchem-2084	648	5	alsup	alsup	PROPN
eurjchem-2084	648	6	,	,	PUNCT
eurjchem-2084	648	7	d.	d.	PROPN
eurjchem-2084	648	8	;	;	PUNCT
eurjchem-2084	648	9	mclaughlin	mclaughlin	PROPN
eurjchem-2084	648	10	,	,	PUNCT
eurjchem-2084	648	11	e.	e.	PROPN
eurjchem-2084	648	12	c.	c.	PROPN
eurjchem-2084	648	13	here	here	ADV
eurjchem-2084	648	14	’s	’	VERB
eurjchem-2084	648	15	what	what	PRON
eurjchem-2084	648	16	you	you	PRON
eurjchem-2084	648	17	need	need	VERB
eurjchem-2084	648	18	to	to	PART
eurjchem-2084	648	19	know	know	VERB
eurjchem-2084	648	20	about	about	ADP
eurjchem-2084	648	21	chloroquine	chloroquine	NOUN
eurjchem-2084	648	22	.	.	PUNCT
eurjchem-2084	649	1	cnn	cnn	PROPN
eurjchem-2084	649	2	.	.	PUNCT
eurjchem-2084	650	1	march	march	PROPN
eurjchem-2084	650	2	24	24	NUM
eurjchem-2084	650	3	,	,	PUNCT
eurjchem-2084	650	4	2020	2020	NUM
eurjchem-2084	650	5	.	.	PUNCT
eurjchem-2084	651	1	https://edition.cnn.com/2020/03/23/health/arizona-coronaviruschloroquine-death/index.html	https://edition.cnn.com/2020/03/23/health/arizona-coronaviruschloroquine-death/index.html	PROPN
eurjchem-2084	651	2	(	(	PUNCT
eurjchem-2084	651	3	accessed	access	VERB
eurjchem-2084	651	4	december	december	PROPN
eurjchem-2084	651	5	9	9	NUM
eurjchem-2084	651	6	,	,	PUNCT
eurjchem-2084	651	7	2020	2020	NUM
eurjchem-2084	651	8	)	)	PUNCT
eurjchem-2084	651	9	.	.	PUNCT
eurjchem-2084	652	1	[	[	X
eurjchem-2084	652	2	86	86	NUM
eurjchem-2084	652	3	]	]	PUNCT
eurjchem-2084	652	4	.	.	PUNCT
eurjchem-2084	653	1	consortium	consortium	NOUN
eurjchem-2084	653	2	.	.	PUNCT
eurjchem-2084	654	1	lancet	lancet	PROPN
eurjchem-2084	654	2	2012	2012	NUM
eurjchem-2084	654	3	,	,	PUNCT
eurjchem-2084	654	4	379	379	NUM
eurjchem-2084	654	5	(	(	PUNCT
eurjchem-2084	654	6	9822	9822	NUM
eurjchem-2084	654	7	)	)	PUNCT
eurjchem-2084	654	8	,	,	PUNCT
eurjchem-2084	654	9	1214–1224	1214–1224	NUM
eurjchem-2084	654	10	.	.	PUNCT
eurjchem-2084	655	1	[	[	X
eurjchem-2084	655	2	87	87	NUM
eurjchem-2084	655	3	]	]	PUNCT
eurjchem-2084	655	4	.	.	PUNCT
eurjchem-2084	656	1	roche	roche	PROPN
eurjchem-2084	656	2	provides	provide	VERB
eurjchem-2084	656	3	an	an	DET
eurjchem-2084	656	4	update	update	NOUN
eurjchem-2084	656	5	on	on	ADP
eurjchem-2084	656	6	the	the	DET
eurjchem-2084	656	7	phase	phase	NOUN
eurjchem-2084	656	8	iii	iii	NUM
eurjchem-2084	656	9	covacta	covacta	NOUN
eurjchem-2084	656	10	trial	trial	NOUN
eurjchem-2084	656	11	of	of	ADP
eurjchem-2084	656	12	actemra	actemra	NOUN
eurjchem-2084	656	13	/	/	SYM
eurjchem-2084	656	14	roactemra	roactemra	NOUN
eurjchem-2084	656	15	in	in	ADP
eurjchem-2084	656	16	hospitalised	hospitalise	VERB
eurjchem-2084	656	17	patients	patient	NOUN
eurjchem-2084	656	18	with	with	ADP
eurjchem-2084	656	19	severe	severe	ADJ
eurjchem-2084	656	20	covid-19	covid-19	PROPN
eurjchem-2084	656	21	associated	associate	VERB
eurjchem-2084	656	22	pneumonia	pneumonia	NOUN
eurjchem-2084	656	23	https://www.roche.com/investors/updates/	https://www.roche.com/investors/updates/	PROPN
eurjchem-2084	656	24	inv-update-2020-07-29.htm	inv-update-2020-07-29.htm	PROPN
eurjchem-2084	656	25	(	(	PUNCT
eurjchem-2084	656	26	accessed	access	VERB
eurjchem-2084	656	27	december	december	PROPN
eurjchem-2084	656	28	9	9	NUM
eurjchem-2084	656	29	,	,	PUNCT
eurjchem-2084	656	30	2020	2020	NUM
eurjchem-2084	656	31	)	)	PUNCT
eurjchem-2084	656	32	.	.	PUNCT
eurjchem-2084	657	1	[	[	X
eurjchem-2084	657	2	88	88	NUM
eurjchem-2084	657	3	]	]	PUNCT
eurjchem-2084	657	4	.	.	PUNCT
eurjchem-2084	658	1	cortegiani	cortegiani	PROPN
eurjchem-2084	658	2	,	,	PUNCT
eurjchem-2084	658	3	a.	a.	NOUN
eurjchem-2084	658	4	;	;	PUNCT
eurjchem-2084	658	5	ippolito	ippolito	PROPN
eurjchem-2084	658	6	,	,	PUNCT
eurjchem-2084	658	7	m.	m.	NOUN
eurjchem-2084	658	8	;	;	PUNCT
eurjchem-2084	658	9	greco	greco	PROPN
eurjchem-2084	658	10	,	,	PUNCT
eurjchem-2084	658	11	m.	m.	NOUN
eurjchem-2084	658	12	;	;	PUNCT
eurjchem-2084	658	13	granone	granone	NOUN
eurjchem-2084	658	14	,	,	PUNCT
eurjchem-2084	658	15	v.	v.	ADV
eurjchem-2084	658	16	;	;	PUNCT
eurjchem-2084	658	17	protti	protti	NOUN
eurjchem-2084	658	18	,	,	PUNCT
eurjchem-2084	658	19	a.	a.	NOUN
eurjchem-2084	658	20	;	;	PUNCT
eurjchem-2084	658	21	gregoretti	gregoretti	PROPN
eurjchem-2084	658	22	,	,	PUNCT
eurjchem-2084	658	23	c.	c.	PROPN
eurjchem-2084	658	24	;	;	PUNCT
eurjchem-2084	658	25	giarratano	giarratano	NOUN
eurjchem-2084	658	26	,	,	PUNCT
eurjchem-2084	658	27	a.	a.	NOUN
eurjchem-2084	658	28	;	;	PUNCT
eurjchem-2084	658	29	einav	einav	NOUN
eurjchem-2084	658	30	,	,	PUNCT
eurjchem-2084	658	31	s.	s.	PROPN
eurjchem-2084	658	32	;	;	PUNCT
eurjchem-2084	658	33	cecconi	cecconi	NOUN
eurjchem-2084	658	34	,	,	PUNCT
eurjchem-2084	658	35	m.	m.	NOUN
eurjchem-2084	658	36	pulmonology	pulmonology	NOUN
eurjchem-2084	658	37	2021	2021	NUM
eurjchem-2084	658	38	,	,	PUNCT
eurjchem-2084	658	39	27	27	NUM
eurjchem-2084	658	40	(	(	PUNCT
eurjchem-2084	658	41	1	1	NUM
eurjchem-2084	658	42	)	)	PUNCT
eurjchem-2084	658	43	,	,	PUNCT
eurjchem-2084	658	44	52	52	NUM
eurjchem-2084	658	45	–	–	PUNCT
eurjchem-2084	658	46	66	66	NUM
eurjchem-2084	658	47	.	.	PUNCT
eurjchem-2084	659	1	[	[	X
eurjchem-2084	659	2	89	89	NUM
eurjchem-2084	659	3	]	]	PUNCT
eurjchem-2084	659	4	.	.	PUNCT
eurjchem-2084	660	1	organization	organization	PROPN
eurjchem-2084	660	2	,	,	PUNCT
eurjchem-2084	660	3	w.	w.	PROPN
eurjchem-2084	660	4	h.	h.	PROPN
eurjchem-2084	660	5	clinical	clinical	PROPN
eurjchem-2084	660	6	management	management	NOUN
eurjchem-2084	660	7	of	of	ADP
eurjchem-2084	660	8	covid-19	covid-19	PROPN
eurjchem-2084	660	9	:	:	PUNCT
eurjchem-2084	660	10	interim	interim	ADJ
eurjchem-2084	660	11	guidance	guidance	NOUN
eurjchem-2084	660	12	.	.	PUNCT
eurjchem-2084	661	1	world	world	PROPN
eurjchem-2084	661	2	health	health	PROPN
eurjchem-2084	661	3	organization	organization	NOUN
eurjchem-2084	661	4	2020	2020	NUM
eurjchem-2084	661	5	.	.	PUNCT
eurjchem-2084	662	1	[	[	X
eurjchem-2084	662	2	90	90	NUM
eurjchem-2084	662	3	]	]	PUNCT
eurjchem-2084	662	4	.	.	PUNCT
eurjchem-2084	663	1	chen	chen	PROPN
eurjchem-2084	663	2	,	,	PUNCT
eurjchem-2084	663	3	l.	l.	PROPN
eurjchem-2084	663	4	;	;	PUNCT
eurjchem-2084	663	5	xiong	xiong	PROPN
eurjchem-2084	663	6	,	,	PUNCT
eurjchem-2084	663	7	j.	j.	PROPN
eurjchem-2084	663	8	;	;	PUNCT
eurjchem-2084	663	9	bao	bao	PROPN
eurjchem-2084	663	10	,	,	PUNCT
eurjchem-2084	663	11	l.	l.	PROPN
eurjchem-2084	663	12	;	;	PUNCT
eurjchem-2084	663	13	shi	shi	PROPN
eurjchem-2084	663	14	,	,	PUNCT
eurjchem-2084	663	15	y.	y.	PROPN
eurjchem-2084	663	16	convalescent	convalescent	NOUN
eurjchem-2084	663	17	plasma	plasma	NOUN
eurjchem-2084	663	18	as	as	ADP
eurjchem-2084	663	19	a	a	DET
eurjchem-2084	663	20	potential	potential	ADJ
eurjchem-2084	663	21	therapy	therapy	NOUN
eurjchem-2084	663	22	for	for	ADP
eurjchem-2084	663	23	covid-19	covid-19	PROPN
eurjchem-2084	663	24	.	.	PUNCT
eurjchem-2084	664	1	lancet	lancet	PROPN
eurjchem-2084	664	2	infect	infect	PROPN
eurjchem-2084	664	3	.	.	PUNCT
eurjchem-2084	665	1	dis	dis	PROPN
eurjchem-2084	665	2	.	.	PUNCT
eurjchem-2084	666	1	2020	2020	NUM
eurjchem-2084	666	2	,	,	PUNCT
eurjchem-2084	666	3	20	20	NUM
eurjchem-2084	666	4	(	(	PUNCT
eurjchem-2084	666	5	4	4	NUM
eurjchem-2084	666	6	)	)	PUNCT
eurjchem-2084	666	7	,	,	PUNCT
eurjchem-2084	666	8	398–400	398–400	NUM
eurjchem-2084	666	9	.	.	PUNCT
eurjchem-2084	667	1	[	[	X
eurjchem-2084	667	2	91	91	NUM
eurjchem-2084	667	3	]	]	PUNCT
eurjchem-2084	667	4	.	.	PUNCT
eurjchem-2084	668	1	joyner	joyner	PROPN
eurjchem-2084	668	2	,	,	PUNCT
eurjchem-2084	668	3	m.	m.	PROPN
eurjchem-2084	668	4	j.	j.	PROPN
eurjchem-2084	668	5	;	;	PUNCT
eurjchem-2084	668	6	bruno	bruno	PROPN
eurjchem-2084	668	7	,	,	PUNCT
eurjchem-2084	668	8	k.	k.	PROPN
eurjchem-2084	668	9	a.	a.	PROPN
eurjchem-2084	668	10	;	;	PUNCT
eurjchem-2084	668	11	klassen	klassen	PROPN
eurjchem-2084	668	12	,	,	PUNCT
eurjchem-2084	668	13	s.	s.	PROPN
eurjchem-2084	668	14	a.	a.	PROPN
eurjchem-2084	668	15	;	;	PUNCT
eurjchem-2084	668	16	kunze	kunze	PROPN
eurjchem-2084	668	17	,	,	PUNCT
eurjchem-2084	668	18	k.	k.	PROPN
eurjchem-2084	668	19	l.	l.	PROPN
eurjchem-2084	668	20	;	;	PUNCT
eurjchem-2084	668	21	johnson	johnson	PROPN
eurjchem-2084	668	22	,	,	PUNCT
eurjchem-2084	668	23	p.	p.	PROPN
eurjchem-2084	668	24	w.	w.	PROPN
eurjchem-2084	668	25	;	;	PUNCT
eurjchem-2084	668	26	lesser	less	ADJ
eurjchem-2084	668	27	,	,	PUNCT
eurjchem-2084	668	28	e.	e.	PROPN
eurjchem-2084	668	29	r.	r.	PROPN
eurjchem-2084	668	30	;	;	PUNCT
eurjchem-2084	668	31	wiggins	wiggins	PROPN
eurjchem-2084	668	32	,	,	PUNCT
eurjchem-2084	668	33	c.	c.	PROPN
eurjchem-2084	668	34	c.	c.	PROPN
eurjchem-2084	668	35	;	;	PUNCT
eurjchem-2084	668	36	senefeld	senefeld	PROPN
eurjchem-2084	668	37	,	,	PUNCT
eurjchem-2084	668	38	j.	j.	PROPN
eurjchem-2084	668	39	w.	w.	PROPN
eurjchem-2084	668	40	;	;	PUNCT
eurjchem-2084	668	41	klompas	klompas	PROPN
eurjchem-2084	668	42	,	,	PUNCT
eurjchem-2084	668	43	a.	a.	NOUN
eurjchem-2084	668	44	m.	m.	NOUN
eurjchem-2084	668	45	;	;	PUNCT
eurjchem-2084	668	46	hodge	hodge	PROPN
eurjchem-2084	668	47	,	,	PUNCT
eurjchem-2084	668	48	d.	d.	PROPN
eurjchem-2084	668	49	o.	o.	PROPN
eurjchem-2084	668	50	;	;	PUNCT
eurjchem-2084	668	51	shepherd	shepherd	NOUN
eurjchem-2084	668	52	,	,	PUNCT
eurjchem-2084	668	53	j.	j.	PROPN
eurjchem-2084	668	54	r.	r.	PROPN
eurjchem-2084	668	55	a.	a.	PROPN
eurjchem-2084	668	56	;	;	PUNCT
eurjchem-2084	668	57	rea	rea	PROPN
eurjchem-2084	668	58	,	,	PUNCT
eurjchem-2084	668	59	r.	r.	PROPN
eurjchem-2084	668	60	f.	f.	PROPN
eurjchem-2084	668	61	;	;	PUNCT
eurjchem-2084	668	62	whelan	whelan	PROPN
eurjchem-2084	668	63	,	,	PUNCT
eurjchem-2084	668	64	e.	e.	PROPN
eurjchem-2084	668	65	r.	r.	PROPN
eurjchem-2084	668	66	;	;	PUNCT
eurjchem-2084	668	67	clayburn	clayburn	NOUN
eurjchem-2084	668	68	,	,	PUNCT
eurjchem-2084	668	69	a.	a.	PROPN
eurjchem-2084	668	70	j.	j.	PROPN
eurjchem-2084	668	71	;	;	PUNCT
eurjchem-2084	668	72	spiegel	spiegel	PROPN
eurjchem-2084	668	73	,	,	PUNCT
eurjchem-2084	668	74	m.	m.	PROPN
eurjchem-2084	668	75	r.	r.	PROPN
eurjchem-2084	668	76	;	;	PUNCT
eurjchem-2084	668	77	baker	baker	PROPN
eurjchem-2084	668	78	,	,	PUNCT
eurjchem-2084	668	79	s.	s.	PROPN
eurjchem-2084	668	80	e.	e.	PROPN
eurjchem-2084	668	81	;	;	PUNCT
eurjchem-2084	668	82	larson	larson	PROPN
eurjchem-2084	668	83	,	,	PUNCT
eurjchem-2084	668	84	k.	k.	PROPN
eurjchem-2084	668	85	f.	f.	PROPN
eurjchem-2084	668	86	;	;	PUNCT
eurjchem-2084	668	87	ripoll	ripoll	PROPN
eurjchem-2084	668	88	,	,	PUNCT
eurjchem-2084	668	89	j.	j.	PROPN
eurjchem-2084	668	90	g.	g.	PROPN
eurjchem-2084	668	91	;	;	PUNCT
eurjchem-2084	668	92	andersen	andersen	PROPN
eurjchem-2084	668	93	,	,	PUNCT
eurjchem-2084	668	94	k.	k.	PROPN
eurjchem-2084	668	95	j.	j.	PROPN
eurjchem-2084	668	96	;	;	PUNCT
eurjchem-2084	668	97	buras	buras	PROPN
eurjchem-2084	668	98	,	,	PUNCT
eurjchem-2084	668	99	m.	m.	PROPN
eurjchem-2084	668	100	r.	r.	PROPN
eurjchem-2084	668	101	;	;	PUNCT
eurjchem-2084	668	102	vogt	vogt	PROPN
eurjchem-2084	668	103	,	,	PUNCT
eurjchem-2084	668	104	m.	m.	NOUN
eurjchem-2084	668	105	n.	n.	PROPN
eurjchem-2084	668	106	p.	p.	PROPN
eurjchem-2084	668	107	;	;	PUNCT
eurjchem-2084	668	108	herasevich	herasevich	PROPN
eurjchem-2084	668	109	,	,	PUNCT
eurjchem-2084	668	110	v.	v.	PROPN
eurjchem-2084	668	111	;	;	PUNCT
eurjchem-2084	668	112	dennis	dennis	PROPN
eurjchem-2084	668	113	,	,	PUNCT
eurjchem-2084	668	114	j.	j.	PROPN
eurjchem-2084	668	115	j.	j.	PROPN
eurjchem-2084	668	116	;	;	PUNCT
eurjchem-2084	668	117	regimbal	regimbal	PROPN
eurjchem-2084	668	118	,	,	PUNCT
eurjchem-2084	668	119	r.	r.	PROPN
eurjchem-2084	668	120	j.	j.	PROPN
eurjchem-2084	668	121	;	;	PUNCT
eurjchem-2084	668	122	bauer	bauer	PROPN
eurjchem-2084	668	123	,	,	PUNCT
eurjchem-2084	668	124	p.	p.	PROPN
eurjchem-2084	668	125	r.	r.	PROPN
eurjchem-2084	668	126	;	;	PUNCT
eurjchem-2084	668	127	blair	blair	PROPN
eurjchem-2084	668	128	,	,	PUNCT
eurjchem-2084	668	129	j.	j.	PROPN
eurjchem-2084	668	130	e.	e.	PROPN
eurjchem-2084	668	131	;	;	PUNCT
eurjchem-2084	668	132	van	van	PROPN
eurjchem-2084	668	133	buskirk	buskirk	PROPN
eurjchem-2084	668	134	,	,	PUNCT
eurjchem-2084	668	135	c.	c.	PROPN
eurjchem-2084	668	136	m.	m.	NOUN
eurjchem-2084	668	137	;	;	PUNCT
eurjchem-2084	668	138	winters	winter	NOUN
eurjchem-2084	668	139	,	,	PUNCT
eurjchem-2084	668	140	j.	j.	PROPN
eurjchem-2084	668	141	l.	l.	PROPN
eurjchem-2084	668	142	;	;	PUNCT
eurjchem-2084	668	143	stubbs	stubbs	PROPN
eurjchem-2084	668	144	,	,	PUNCT
eurjchem-2084	668	145	j.	j.	PROPN
eurjchem-2084	668	146	r.	r.	PROPN
eurjchem-2084	668	147	;	;	PUNCT
eurjchem-2084	668	148	van	van	PROPN
eurjchem-2084	668	149	helmond	helmond	NOUN
eurjchem-2084	668	150	,	,	PUNCT
eurjchem-2084	668	151	n.	n.	PROPN
eurjchem-2084	668	152	;	;	PUNCT
eurjchem-2084	668	153	butterfield	butterfield	PROPN
eurjchem-2084	668	154	,	,	PUNCT
eurjchem-2084	668	155	b.	b.	PROPN
eurjchem-2084	668	156	p.	p.	PROPN
eurjchem-2084	668	157	;	;	PUNCT
eurjchem-2084	668	158	sexton	sexton	PROPN
eurjchem-2084	668	159	,	,	PUNCT
eurjchem-2084	668	160	m.	m.	NOUN
eurjchem-2084	668	161	a.	a.	PROPN
eurjchem-2084	668	162	;	;	PUNCT
eurjchem-2084	668	163	diaz	diaz	PROPN
eurjchem-2084	668	164	soto	soto	PROPN
eurjchem-2084	668	165	,	,	PUNCT
eurjchem-2084	668	166	j.	j.	PROPN
eurjchem-2084	668	167	c.	c.	PROPN
eurjchem-2084	668	168	;	;	PUNCT
eurjchem-2084	668	169	paneth	paneth	PROPN
eurjchem-2084	668	170	,	,	PUNCT
eurjchem-2084	668	171	n.	n.	PROPN
eurjchem-2084	668	172	s.	s.	PROPN
eurjchem-2084	668	173	;	;	PUNCT
eurjchem-2084	668	174	verdun	verdun	PROPN
eurjchem-2084	668	175	,	,	PUNCT
eurjchem-2084	668	176	n.	n.	PROPN
eurjchem-2084	668	177	c.	c.	PROPN
eurjchem-2084	668	178	;	;	PUNCT
eurjchem-2084	668	179	marks	mark	NOUN
eurjchem-2084	668	180	,	,	PUNCT
eurjchem-2084	668	181	p.	p.	PROPN
eurjchem-2084	668	182	;	;	PUNCT
eurjchem-2084	668	183	casadevall	casadevall	PROPN
eurjchem-2084	668	184	,	,	PUNCT
eurjchem-2084	668	185	a.	a.	NOUN
eurjchem-2084	668	186	;	;	PUNCT
eurjchem-2084	668	187	fairweather	fairweather	NOUN
eurjchem-2084	668	188	,	,	PUNCT
eurjchem-2084	668	189	d.	d.	PROPN
eurjchem-2084	668	190	;	;	PUNCT
eurjchem-2084	668	191	carter	carter	PROPN
eurjchem-2084	668	192	,	,	PUNCT
eurjchem-2084	668	193	r.	r.	PROPN
eurjchem-2084	668	194	e.	e.	PROPN
eurjchem-2084	668	195	;	;	PUNCT
eurjchem-2084	668	196	wright	wright	PROPN
eurjchem-2084	668	197	,	,	PUNCT
eurjchem-2084	668	198	r.	r.	PROPN
eurjchem-2084	668	199	s.	s.	PROPN
eurjchem-2084	668	200	mayo	mayo	PROPN
eurjchem-2084	668	201	clin	clin	PROPN
eurjchem-2084	668	202	.	.	PUNCT
eurjchem-2084	669	1	proc	proc	PROPN
eurjchem-2084	669	2	.	.	PUNCT
eurjchem-2084	670	1	2020	2020	NUM
eurjchem-2084	670	2	,	,	PUNCT
eurjchem-2084	670	3	95	95	NUM
eurjchem-2084	670	4	(	(	PUNCT
eurjchem-2084	670	5	9	9	NUM
eurjchem-2084	670	6	)	)	PUNCT
eurjchem-2084	670	7	,	,	PUNCT
eurjchem-2084	670	8	1888–1897	1888–1897	NUM
eurjchem-2084	670	9	.	.	PUNCT
eurjchem-2084	671	1	[	[	X
eurjchem-2084	671	2	92	92	NUM
eurjchem-2084	671	3	]	]	PUNCT
eurjchem-2084	671	4	.	.	PUNCT
eurjchem-2084	672	1	xia	xia	PROPN
eurjchem-2084	672	2	,	,	PUNCT
eurjchem-2084	672	3	x.	x.	PROPN
eurjchem-2084	672	4	;	;	PUNCT
eurjchem-2084	672	5	li	li	PROPN
eurjchem-2084	672	6	,	,	PUNCT
eurjchem-2084	672	7	k.	k.	PROPN
eurjchem-2084	672	8	;	;	PUNCT
eurjchem-2084	672	9	wu	wu	PROPN
eurjchem-2084	672	10	,	,	PUNCT
eurjchem-2084	672	11	l.	l.	PROPN
eurjchem-2084	672	12	;	;	PUNCT
eurjchem-2084	672	13	wang	wang	PROPN
eurjchem-2084	672	14	,	,	PUNCT
eurjchem-2084	672	15	z.	z.	PROPN
eurjchem-2084	672	16	;	;	PUNCT
eurjchem-2084	672	17	zhu	zhu	PROPN
eurjchem-2084	672	18	,	,	PUNCT
eurjchem-2084	672	19	m.	m.	NOUN
eurjchem-2084	672	20	;	;	PUNCT
eurjchem-2084	672	21	huang	huang	PROPN
eurjchem-2084	672	22	,	,	PUNCT
eurjchem-2084	672	23	b.	b.	PROPN
eurjchem-2084	672	24	;	;	PUNCT
eurjchem-2084	672	25	li	li	PROPN
eurjchem-2084	672	26	,	,	PUNCT
eurjchem-2084	672	27	j.	j.	PROPN
eurjchem-2084	672	28	;	;	PUNCT
eurjchem-2084	672	29	wang	wang	PROPN
eurjchem-2084	672	30	,	,	PUNCT
eurjchem-2084	672	31	z.	z.	PROPN
eurjchem-2084	672	32	;	;	PUNCT
eurjchem-2084	672	33	wu	wu	PROPN
eurjchem-2084	672	34	,	,	PUNCT
eurjchem-2084	672	35	w.	w.	PROPN
eurjchem-2084	672	36	;	;	PUNCT
eurjchem-2084	672	37	wu	wu	PROPN
eurjchem-2084	672	38	,	,	PUNCT
eurjchem-2084	672	39	m.	m.	NOUN
eurjchem-2084	672	40	;	;	PUNCT
eurjchem-2084	672	41	li	li	PROPN
eurjchem-2084	672	42	,	,	PUNCT
eurjchem-2084	672	43	w.	w.	PROPN
eurjchem-2084	672	44	;	;	PUNCT
eurjchem-2084	672	45	li	li	PROPN
eurjchem-2084	672	46	,	,	PUNCT
eurjchem-2084	672	47	l.	l.	PROPN
eurjchem-2084	672	48	;	;	PUNCT
eurjchem-2084	672	49	cai	cai	PROPN
eurjchem-2084	672	50	,	,	PUNCT
eurjchem-2084	672	51	y.	y.	PROPN
eurjchem-2084	672	52	;	;	PUNCT
eurjchem-2084	672	53	bosco	bosco	PROPN
eurjchem-2084	672	54	,	,	PUNCT
eurjchem-2084	672	55	b.	b.	PROPN
eurjchem-2084	672	56	;	;	PUNCT
eurjchem-2084	672	57	zhong	zhong	PROPN
eurjchem-2084	672	58	,	,	PUNCT
eurjchem-2084	672	59	a.	a.	PROPN
eurjchem-2084	672	60	;	;	PUNCT
eurjchem-2084	672	61	liu	liu	PROPN
eurjchem-2084	672	62	,	,	PUNCT
eurjchem-2084	672	63	x.	x.	PROPN
eurjchem-2084	672	64	;	;	PUNCT
eurjchem-2084	672	65	lv	lv	PROPN
eurjchem-2084	672	66	,	,	PUNCT
eurjchem-2084	672	67	t.	t.	PROPN
eurjchem-2084	672	68	;	;	PUNCT
eurjchem-2084	672	69	gan	gan	PROPN
eurjchem-2084	672	70	,	,	PUNCT
eurjchem-2084	672	71	z.	z.	PROPN
eurjchem-2084	672	72	;	;	PUNCT
eurjchem-2084	672	73	chen	chen	PROPN
eurjchem-2084	672	74	,	,	PUNCT
eurjchem-2084	672	75	g.	g.	PROPN
eurjchem-2084	672	76	;	;	PUNCT
eurjchem-2084	672	77	pan	pan	PROPN
eurjchem-2084	672	78	,	,	PUNCT
eurjchem-2084	672	79	y.	y.	PROPN
eurjchem-2084	672	80	;	;	PUNCT
eurjchem-2084	672	81	liu	liu	PROPN
eurjchem-2084	672	82	,	,	PUNCT
eurjchem-2084	672	83	c.	c.	PROPN
eurjchem-2084	672	84	;	;	PUNCT
eurjchem-2084	672	85	zhang	zhang	PROPN
eurjchem-2084	672	86	,	,	PUNCT
eurjchem-2084	672	87	k.	k.	PROPN
eurjchem-2084	672	88	;	;	PUNCT
eurjchem-2084	672	89	xu	xu	PROPN
eurjchem-2084	672	90	,	,	PUNCT
eurjchem-2084	672	91	x.	x.	PROPN
eurjchem-2084	672	92	;	;	PUNCT
eurjchem-2084	672	93	wang	wang	PROPN
eurjchem-2084	672	94	,	,	PUNCT
eurjchem-2084	672	95	c.	c.	PROPN
eurjchem-2084	672	96	;	;	PUNCT
eurjchem-2084	672	97	wang	wang	PROPN
eurjchem-2084	672	98	,	,	PUNCT
eurjchem-2084	672	99	q.	q.	PROPN
eurjchem-2084	672	100	blood	blood	NOUN
eurjchem-2084	672	101	2020	2020	NUM
eurjchem-2084	672	102	,	,	PUNCT
eurjchem-2084	672	103	136	136	NUM
eurjchem-2084	672	104	(	(	PUNCT
eurjchem-2084	672	105	6	6	NUM
eurjchem-2084	672	106	)	)	PUNCT
eurjchem-2084	672	107	,	,	PUNCT
eurjchem-2084	672	108	755–759	755–759	NUM
eurjchem-2084	672	109	.	.	PUNCT
eurjchem-2084	673	1	[	[	X
eurjchem-2084	673	2	93	93	NUM
eurjchem-2084	673	3	]	]	PUNCT
eurjchem-2084	673	4	.	.	PUNCT
eurjchem-2084	674	1	remy	remy	PROPN
eurjchem-2084	674	2	,	,	PUNCT
eurjchem-2084	674	3	v.	v.	PROPN
eurjchem-2084	674	4	;	;	PUNCT
eurjchem-2084	674	5	largeron	largeron	NOUN
eurjchem-2084	674	6	,	,	PUNCT
eurjchem-2084	674	7	n.	n.	NOUN
eurjchem-2084	674	8	;	;	PUNCT
eurjchem-2084	674	9	quilici	quilici	NOUN
eurjchem-2084	674	10	,	,	PUNCT
eurjchem-2084	674	11	s.	s.	PROPN
eurjchem-2084	674	12	;	;	PUNCT
eurjchem-2084	674	13	carroll	carroll	PROPN
eurjchem-2084	674	14	,	,	PUNCT
eurjchem-2084	674	15	s.	s.	PROPN
eurjchem-2084	674	16	value	value	PROPN
eurjchem-2084	674	17	health	health	PROPN
eurjchem-2084	674	18	2014	2014	NUM
eurjchem-2084	674	19	,	,	PUNCT
eurjchem-2084	674	20	17	17	NUM
eurjchem-2084	674	21	(	(	PUNCT
eurjchem-2084	674	22	7	7	NUM
eurjchem-2084	674	23	)	)	PUNCT
eurjchem-2084	674	24	,	,	PUNCT
eurjchem-2084	674	25	a450	a450	PROPN
eurjchem-2084	674	26	.	.	PUNCT
eurjchem-2084	675	1	[	[	X
eurjchem-2084	675	2	94	94	NUM
eurjchem-2084	675	3	]	]	PUNCT
eurjchem-2084	675	4	.	.	PUNCT
eurjchem-2084	676	1	neher	neher	PROPN
eurjchem-2084	676	2	,	,	PUNCT
eurjchem-2084	676	3	r.	r.	PROPN
eurjchem-2084	676	4	a.	a.	PROPN
eurjchem-2084	676	5	;	;	PUNCT
eurjchem-2084	676	6	dyrdak	dyrdak	PROPN
eurjchem-2084	676	7	,	,	PUNCT
eurjchem-2084	676	8	r.	r.	PROPN
eurjchem-2084	676	9	;	;	PUNCT
eurjchem-2084	676	10	druelle	druelle	PROPN
eurjchem-2084	676	11	,	,	PUNCT
eurjchem-2084	676	12	v.	v.	ADV
eurjchem-2084	676	13	;	;	PUNCT
eurjchem-2084	676	14	hodcroft	hodcroft	PROPN
eurjchem-2084	676	15	,	,	PUNCT
eurjchem-2084	676	16	e.	e.	PROPN
eurjchem-2084	676	17	b.	b.	PROPN
eurjchem-2084	676	18	;	;	PUNCT
eurjchem-2084	676	19	albert	albert	PROPN
eurjchem-2084	676	20	,	,	PUNCT
eurjchem-2084	676	21	j.	j.	PROPN
eurjchem-2084	676	22	swiss	swiss	PROPN
eurjchem-2084	676	23	med	med	PROPN
eurjchem-2084	676	24	.	.	PUNCT
eurjchem-2084	677	1	wkly	wkly	PROPN
eurjchem-2084	677	2	2020	2020	NUM
eurjchem-2084	677	3	,	,	PUNCT
eurjchem-2084	677	4	150	150	NUM
eurjchem-2084	677	5	,	,	PUNCT
eurjchem-2084	677	6	w20224	w20224	NOUN
eurjchem-2084	677	7	.	.	PUNCT
eurjchem-2084	678	1	[	[	X
eurjchem-2084	678	2	95	95	NUM
eurjchem-2084	678	3	]	]	PUNCT
eurjchem-2084	678	4	.	.	PUNCT
eurjchem-2084	679	1	zhang	zhang	PROPN
eurjchem-2084	679	2	,	,	PUNCT
eurjchem-2084	679	3	j.	j.	PROPN
eurjchem-2084	679	4	;	;	PUNCT
eurjchem-2084	679	5	zeng	zeng	PROPN
eurjchem-2084	679	6	,	,	PUNCT
eurjchem-2084	679	7	h.	h.	PROPN
eurjchem-2084	679	8	;	;	PUNCT
eurjchem-2084	679	9	gu	gu	PROPN
eurjchem-2084	679	10	,	,	PUNCT
eurjchem-2084	679	11	j.	j.	PROPN
eurjchem-2084	679	12	;	;	PUNCT
eurjchem-2084	679	13	li	li	PROPN
eurjchem-2084	679	14	,	,	PUNCT
eurjchem-2084	679	15	h.	h.	PROPN
eurjchem-2084	679	16	;	;	PUNCT
eurjchem-2084	679	17	zheng	zheng	PROPN
eurjchem-2084	679	18	,	,	PUNCT
eurjchem-2084	679	19	l.	l.	PROPN
eurjchem-2084	679	20	;	;	PUNCT
eurjchem-2084	679	21	zou	zou	PROPN
eurjchem-2084	679	22	,	,	PUNCT
eurjchem-2084	679	23	q.	q.	PROPN
eurjchem-2084	679	24	vaccines	vaccine	NOUN
eurjchem-2084	679	25	(	(	PUNCT
eurjchem-2084	679	26	basel	basel	PROPN
eurjchem-2084	679	27	)	)	PUNCT
eurjchem-2084	679	28	2020	2020	NUM
eurjchem-2084	679	29	,	,	PUNCT
eurjchem-2084	679	30	8	8	NUM
eurjchem-2084	679	31	(	(	PUNCT
eurjchem-2084	679	32	2	2	NUM
eurjchem-2084	679	33	)	)	PUNCT
eurjchem-2084	679	34	,	,	PUNCT
eurjchem-2084	679	35	153	153	NUM
eurjchem-2084	679	36	.	.	PUNCT
eurjchem-2084	680	1	[	[	X
eurjchem-2084	680	2	96	96	NUM
eurjchem-2084	680	3	]	]	PUNCT
eurjchem-2084	680	4	.	.	PUNCT
eurjchem-2084	681	1	singh	singh	PROPN
eurjchem-2084	681	2	,	,	PUNCT
eurjchem-2084	681	3	d.	d.	PROPN
eurjchem-2084	681	4	;	;	PUNCT
eurjchem-2084	681	5	yi	yi	PROPN
eurjchem-2084	681	6	,	,	PUNCT
eurjchem-2084	681	7	s.	s.	PROPN
eurjchem-2084	681	8	v.	v.	PROPN
eurjchem-2084	681	9	exp	exp	PROPN
eurjchem-2084	681	10	.	.	PROPN
eurjchem-2084	681	11	mol	mol	PROPN
eurjchem-2084	681	12	.	.	PROPN
eurjchem-2084	681	13	med	med	PROPN
eurjchem-2084	681	14	.	.	PROPN
eurjchem-2084	681	15	2021	2021	NUM
eurjchem-2084	681	16	.	.	PUNCT
eurjchem-2084	682	1	https://doi.org/10.1038/	https://doi.org/10.1038/	PROPN
eurjchem-2084	682	2	s12276	s12276	PROPN
eurjchem-2084	682	3	-	-	PUNCT
eurjchem-2084	682	4	021	021	NUM
eurjchem-2084	682	5	-	-	PUNCT
eurjchem-2084	682	6	00604	00604	NUM
eurjchem-2084	682	7	-	-	PUNCT
eurjchem-2084	682	8	z	z	NOUN
eurjchem-2084	683	1	[	[	X
eurjchem-2084	683	2	97	97	NUM
eurjchem-2084	683	3	]	]	PUNCT
eurjchem-2084	683	4	.	.	PUNCT
eurjchem-2084	684	1	sharma	sharma	PROPN
eurjchem-2084	684	2	,	,	PUNCT
eurjchem-2084	684	3	a.	a.	NOUN
eurjchem-2084	684	4	;	;	PUNCT
eurjchem-2084	684	5	krause	krause	PROPN
eurjchem-2084	684	6	,	,	PUNCT
eurjchem-2084	684	7	a.	a.	NOUN
eurjchem-2084	684	8	;	;	PUNCT
eurjchem-2084	684	9	worgall	worgall	NOUN
eurjchem-2084	684	10	,	,	PUNCT
eurjchem-2084	684	11	s.	s.	PROPN
eurjchem-2084	684	12	hum	hum	PROPN
eurjchem-2084	684	13	.	.	PUNCT
eurjchem-2084	685	1	vaccin	vaccin	PROPN
eurjchem-2084	685	2	.	.	PUNCT
eurjchem-2084	686	1	2011	2011	NUM
eurjchem-2084	686	2	,	,	PUNCT
eurjchem-2084	686	3	7	7	NUM
eurjchem-2084	686	4	(	(	PUNCT
eurjchem-2084	686	5	10	10	NUM
eurjchem-2084	686	6	)	)	PUNCT
eurjchem-2084	686	7	,	,	PUNCT
eurjchem-2084	686	8	999	999	NUM
eurjchem-2084	686	9	–	–	PUNCT
eurjchem-2084	686	10	1011	1011	NUM
eurjchem-2084	686	11	.	.	PUNCT
eurjchem-2084	687	1	[	[	X
eurjchem-2084	687	2	98	98	NUM
eurjchem-2084	687	3	]	]	PUNCT
eurjchem-2084	687	4	.	.	PUNCT
eurjchem-2084	688	1	pardi	pardi	PROPN
eurjchem-2084	688	2	,	,	PUNCT
eurjchem-2084	688	3	n.	n.	PROPN
eurjchem-2084	688	4	;	;	PUNCT
eurjchem-2084	688	5	hogan	hogan	PROPN
eurjchem-2084	688	6	,	,	PUNCT
eurjchem-2084	688	7	m.	m.	NOUN
eurjchem-2084	688	8	j.	j.	PROPN
eurjchem-2084	688	9	;	;	PUNCT
eurjchem-2084	688	10	porter	porter	PROPN
eurjchem-2084	688	11	,	,	PUNCT
eurjchem-2084	688	12	f.	f.	PROPN
eurjchem-2084	688	13	w.	w.	PROPN
eurjchem-2084	688	14	;	;	PUNCT
eurjchem-2084	688	15	weissman	weissman	PROPN
eurjchem-2084	688	16	,	,	PUNCT
eurjchem-2084	688	17	d.	d.	PROPN
eurjchem-2084	688	18	nat	nat	PROPN
eurjchem-2084	688	19	.	.	PUNCT
eurjchem-2084	689	1	rev	rev	PROPN
eurjchem-2084	689	2	.	.	PROPN
eurjchem-2084	689	3	drug	drug	NOUN
eurjchem-2084	689	4	discov	discov	NOUN
eurjchem-2084	689	5	.	.	PUNCT
eurjchem-2084	690	1	2018	2018	NUM
eurjchem-2084	690	2	,	,	PUNCT
eurjchem-2084	690	3	17	17	NUM
eurjchem-2084	690	4	(	(	PUNCT
eurjchem-2084	690	5	4	4	NUM
eurjchem-2084	690	6	)	)	PUNCT
eurjchem-2084	690	7	,	,	PUNCT
eurjchem-2084	690	8	261–279	261–279	NUM
eurjchem-2084	690	9	.	.	PUNCT
eurjchem-2084	691	1	[	[	X
eurjchem-2084	691	2	99	99	NUM
eurjchem-2084	691	3	]	]	PUNCT
eurjchem-2084	691	4	.	.	PUNCT
eurjchem-2084	692	1	jahanafrooz	jahanafrooz	PROPN
eurjchem-2084	692	2	,	,	PUNCT
eurjchem-2084	692	3	z.	z.	PROPN
eurjchem-2084	692	4	;	;	PUNCT
eurjchem-2084	692	5	baradaran	baradaran	PROPN
eurjchem-2084	692	6	,	,	PUNCT
eurjchem-2084	692	7	b.	b.	PROPN
eurjchem-2084	692	8	;	;	PUNCT
eurjchem-2084	692	9	mosafer	mosafer	NOUN
eurjchem-2084	692	10	,	,	PUNCT
eurjchem-2084	692	11	j.	j.	PROPN
eurjchem-2084	692	12	;	;	PUNCT
eurjchem-2084	692	13	hashemzaei	hashemzaei	PROPN
eurjchem-2084	692	14	,	,	PUNCT
eurjchem-2084	692	15	m.	m.	NOUN
eurjchem-2084	692	16	;	;	PUNCT
eurjchem-2084	692	17	rezaei	rezaei	PROPN
eurjchem-2084	692	18	,	,	PUNCT
eurjchem-2084	692	19	t.	t.	PROPN
eurjchem-2084	692	20	;	;	PUNCT
eurjchem-2084	693	1	mokhtarzadeh	mokhtarzadeh	PROPN
eurjchem-2084	693	2	,	,	PUNCT
eurjchem-2084	693	3	a.	a.	NOUN
eurjchem-2084	693	4	;	;	PUNCT
eurjchem-2084	693	5	hamblin	hamblin	PROPN
eurjchem-2084	693	6	,	,	PUNCT
eurjchem-2084	693	7	m.	m.	PROPN
eurjchem-2084	693	8	r.	r.	PROPN
eurjchem-2084	693	9	drug	drug	PROPN
eurjchem-2084	693	10	discov	discov	PROPN
eurjchem-2084	693	11	.	.	PUNCT
eurjchem-2084	694	1	today	today	NOUN
eurjchem-2084	694	2	2020	2020	NUM
eurjchem-2084	694	3	,	,	PUNCT
eurjchem-2084	694	4	25	25	NUM
eurjchem-2084	694	5	(	(	PUNCT
eurjchem-2084	694	6	3	3	NUM
eurjchem-2084	694	7	)	)	PUNCT
eurjchem-2084	694	8	,	,	PUNCT
eurjchem-2084	694	9	552–560	552–560	NUM
eurjchem-2084	694	10	.	.	PUNCT
eurjchem-2084	695	1	[	[	X
eurjchem-2084	695	2	100	100	NUM
eurjchem-2084	695	3	]	]	PUNCT
eurjchem-2084	695	4	.	.	PUNCT
eurjchem-2084	696	1	adnal	adnal	ADJ
eurjchem-2084	696	2	,	,	PUNCT
eurjchem-2084	696	3	m.	m.	NOUN
eurjchem-2084	696	4	pfizer	pfizer	NOUN
eurjchem-2084	696	5	concludes	conclude	VERB
eurjchem-2084	696	6	phase	phase	NOUN
eurjchem-2084	696	7	3	3	NUM
eurjchem-2084	696	8	study	study	NOUN
eurjchem-2084	696	9	of	of	ADP
eurjchem-2084	696	10	covid-19	covid-19	PROPN
eurjchem-2084	696	11	vaccine	vaccine	NOUN
eurjchem-2084	696	12	candidate	candidate	NOUN
eurjchem-2084	696	13	,	,	PUNCT
eurjchem-2084	696	14	says	say	VERB
eurjchem-2084	696	15	it	it	PRON
eurjchem-2084	696	16	’s	’	VERB
eurjchem-2084	696	17	95	95	NUM
eurjchem-2084	696	18	%	%	NOUN
eurjchem-2084	696	19	effective	effective	ADJ
eurjchem-2084	696	20	https://www.oneindia.com/	https://www.oneindia.com/	NOUN
eurjchem-2084	696	21	international	international	ADJ
eurjchem-2084	696	22	/	/	SYM
eurjchem-2084	696	23	pfizer	pfizer	NOUN
eurjchem-2084	696	24	-	-	PUNCT
eurjchem-2084	696	25	concludes	conclude	VERB
eurjchem-2084	696	26	-	-	PUNCT
eurjchem-2084	696	27	phase-3	phase-3	NUM
eurjchem-2084	696	28	-	-	PUNCT
eurjchem-2084	696	29	study	study	NOUN
eurjchem-2084	696	30	-	-	PUNCT
eurjchem-2084	696	31	of	of	ADP
eurjchem-2084	696	32	-	-	PUNCT
eurjchem-2084	696	33	covid-19	covid-19	NOUN
eurjchem-2084	696	34	-	-	PUNCT
eurjchem-2084	696	35	vaccinecandidate	vaccinecandidate	NOUN
eurjchem-2084	696	36	-	-	PUNCT
eurjchem-2084	696	37	says	say	VERB
eurjchem-2084	696	38	-	-	PUNCT
eurjchem-2084	696	39	it	it	PRON
eurjchem-2084	696	40	-	-	PUNCT
eurjchem-2084	696	41	s-95	s-95	NOUN
eurjchem-2084	696	42	-	-	PUNCT
eurjchem-2084	696	43	effective-3178319.html	effective-3178319.html	PRON
eurjchem-2084	696	44	(	(	PUNCT
eurjchem-2084	696	45	accessed	access	VERB
eurjchem-2084	696	46	december	december	PROPN
eurjchem-2084	696	47	9	9	NUM
eurjchem-2084	696	48	,	,	PUNCT
eurjchem-2084	696	49	2020	2020	NUM
eurjchem-2084	696	50	)	)	PUNCT
eurjchem-2084	696	51	.	.	PUNCT
eurjchem-2084	697	1	[	[	X
eurjchem-2084	697	2	101	101	NUM
eurjchem-2084	697	3	]	]	PUNCT
eurjchem-2084	697	4	.	.	PUNCT
eurjchem-2084	697	5	herper	herper	PROPN
eurjchem-2084	697	6	,	,	PUNCT
eurjchem-2084	697	7	m.	m.	NOUN
eurjchem-2084	697	8	;	;	PUNCT
eurjchem-2084	697	9	branswell	branswell	PROPN
eurjchem-2084	697	10	,	,	PUNCT
eurjchem-2084	697	11	h.	h.	PROPN
eurjchem-2084	697	12	;	;	PUNCT
eurjchem-2084	697	13	mcfarling	mcfarle	VERB
eurjchem-2084	697	14	,	,	PUNCT
eurjchem-2084	697	15	u.	u.	PROPN
eurjchem-2084	697	16	l.	l.	PROPN
eurjchem-2084	697	17	;	;	PUNCT
eurjchem-2084	697	18	florko	florko	PROPN
eurjchem-2084	697	19	,	,	PUNCT
eurjchem-2084	697	20	n.	n.	NOUN
eurjchem-2084	697	21	;	;	PUNCT
eurjchem-2084	697	22	st	st	PROPN
eurjchem-2084	697	23	.	.	PROPN
eurjchem-2084	697	24	fleur	fleur	PROPN
eurjchem-2084	697	25	,	,	PUNCT
eurjchem-2084	697	26	n.	n.	PROPN
eurjchem-2084	697	27	moderna	moderna	PROPN
eurjchem-2084	697	28	’s	’s	PART
eurjchem-2084	697	29	covid-19	covid-19	PROPN
eurjchem-2084	697	30	vaccine	vaccine	NOUN
eurjchem-2084	697	31	is	be	AUX
eurjchem-2084	697	32	strongly	strongly	ADV
eurjchem-2084	697	33	effective	effective	ADJ
eurjchem-2084	697	34	,	,	PUNCT
eurjchem-2084	697	35	early	early	ADJ
eurjchem-2084	697	36	look	look	NOUN
eurjchem-2084	697	37	at	at	ADP
eurjchem-2084	697	38	data	data	NOUN
eurjchem-2084	697	39	show	show	NOUN
eurjchem-2084	697	40	https://www.statnews.com/2020/11/16/modernas-covid-19vaccine-is-strongly-effective-early-look-at-data-show/	https://www.statnews.com/2020/11/16/modernas-covid-19vaccine-is-strongly-effective-early-look-at-data-show/	PROPN
eurjchem-2084	697	41	(	(	PUNCT
eurjchem-2084	697	42	accessed	access	VERB
eurjchem-2084	697	43	december	december	PROPN
eurjchem-2084	697	44	9	9	NUM
eurjchem-2084	697	45	,	,	PUNCT
eurjchem-2084	697	46	2020	2020	NUM
eurjchem-2084	697	47	)	)	PUNCT
eurjchem-2084	697	48	.	.	PUNCT
eurjchem-2084	698	1	[	[	X
eurjchem-2084	698	2	102	102	NUM
eurjchem-2084	698	3	]	]	PUNCT
eurjchem-2084	698	4	.	.	PUNCT
eurjchem-2084	699	1	burton	burton	PROPN
eurjchem-2084	699	2	,	,	PUNCT
eurjchem-2084	699	3	t.	t.	NOUN
eurjchem-2084	699	4	m.	m.	NOUN
eurjchem-2084	699	5	;	;	PUNCT
eurjchem-2084	699	6	hopkins	hopkins	PROPN
eurjchem-2084	699	7	,	,	PUNCT
eurjchem-2084	699	8	j.	j.	PROPN
eurjchem-2084	699	9	s.	s.	PROPN
eurjchem-2084	699	10	fda	fda	PROPN
eurjchem-2084	699	11	set	set	VERB
eurjchem-2084	699	12	to	to	PART
eurjchem-2084	699	13	release	release	VERB
eurjchem-2084	699	14	analyses	analysis	NOUN
eurjchem-2084	699	15	of	of	ADP
eurjchem-2084	699	16	the	the	DET
eurjchem-2084	699	17	pfizerbiontech	pfizerbiontech	ADJ
eurjchem-2084	699	18	covid-19	covid-19	PROPN
eurjchem-2084	699	19	vaccine	vaccine	NOUN
eurjchem-2084	699	20	.	.	PUNCT
eurjchem-2084	700	1	wall	wall	PROPN
eurjchem-2084	700	2	street	street	PROPN
eurjchem-2084	700	3	journal	journal	PROPN
eurjchem-2084	700	4	(	(	PUNCT
eurjchem-2084	700	5	eastern	eastern	ADJ
eurjchem-2084	700	6	ed	ed	NOUN
eurjchem-2084	700	7	.	.	PUNCT
eurjchem-2084	700	8	)	)	PUNCT
eurjchem-2084	700	9	.	.	PUNCT
eurjchem-2084	701	1	wsj.com	wsj.com	X
eurjchem-2084	701	2	december	december	PROPN
eurjchem-2084	701	3	8	8	NUM
eurjchem-2084	701	4	,	,	PUNCT
eurjchem-2084	701	5	2020	2020	NUM
eurjchem-2084	701	6	.	.	PUNCT
eurjchem-2084	702	1	https://www.wsj.com/articles/fda-set-to-releaseanalyses-of-the-pfizer-biontech-covid-19-vaccine-11607423403	https://www.wsj.com/articles/fda-set-to-releaseanalyses-of-the-pfizer-biontech-covid-19-vaccine-11607423403	NOUN
eurjchem-2084	702	2	(	(	PUNCT
eurjchem-2084	702	3	accessed	access	VERB
eurjchem-2084	702	4	december	december	PROPN
eurjchem-2084	702	5	9	9	NUM
eurjchem-2084	702	6	,	,	PUNCT
eurjchem-2084	702	7	2020	2020	NUM
eurjchem-2084	702	8	)	)	PUNCT
eurjchem-2084	702	9	.	.	PUNCT
eurjchem-2084	703	1	[	[	X
eurjchem-2084	703	2	103	103	NUM
eurjchem-2084	703	3	]	]	PUNCT
eurjchem-2084	703	4	.	.	PUNCT
eurjchem-2084	704	1	triggle	triggle	PROPN
eurjchem-2084	704	2	,	,	PUNCT
eurjchem-2084	704	3	j.	j.	PROPN
eurjchem-2084	704	4	g.	g.	PROPN
eurjchem-2084	704	5	a.	a.	PROPN
eurjchem-2084	704	6	covid-19	covid-19	PROPN
eurjchem-2084	704	7	:	:	PUNCT
eurjchem-2084	704	8	oxford	oxford	PROPN
eurjchem-2084	704	9	-	-	PUNCT
eurjchem-2084	704	10	astrazeneca	astrazeneca	NOUN
eurjchem-2084	704	11	vaccine	vaccine	NOUN
eurjchem-2084	704	12	approved	approve	VERB
eurjchem-2084	704	13	for	for	ADP
eurjchem-2084	704	14	use	use	NOUN
eurjchem-2084	704	15	in	in	ADP
eurjchem-2084	704	16	uk	uk	PROPN
eurjchem-2084	704	17	.	.	PUNCT
eurjchem-2084	705	1	bbc	bbc	PROPN
eurjchem-2084	705	2	.	.	PUNCT
eurjchem-2084	706	1	december	december	PROPN
eurjchem-2084	706	2	30	30	NUM
eurjchem-2084	706	3	,	,	PUNCT
eurjchem-2084	706	4	2020	2020	NUM
eurjchem-2084	706	5	.	.	PUNCT
eurjchem-2084	707	1	https://www.bbc.com/news/	https://www.bbc.com/news/	PROPN
eurjchem-2084	707	2	health-55280671	health-55280671	NOUN
eurjchem-2084	707	3	(	(	PUNCT
eurjchem-2084	707	4	accessed	access	VERB
eurjchem-2084	707	5	december	december	PROPN
eurjchem-2084	707	6	9	9	NUM
eurjchem-2084	707	7	,	,	PUNCT
eurjchem-2084	707	8	2020	2020	NUM
eurjchem-2084	707	9	)	)	PUNCT
eurjchem-2084	707	10	.	.	PUNCT
eurjchem-2084	708	1	[	[	X
eurjchem-2084	708	2	104	104	NUM
eurjchem-2084	708	3	]	]	PUNCT
eurjchem-2084	708	4	.	.	PUNCT
eurjchem-2084	709	1	liu	liu	PROPN
eurjchem-2084	709	2	,	,	PUNCT
eurjchem-2084	709	3	m.	m.	NOUN
eurjchem-2084	709	4	a.	a.	NOUN
eurjchem-2084	709	5	vaccines	vaccine	NOUN
eurjchem-2084	709	6	(	(	PUNCT
eurjchem-2084	709	7	basel	basel	PROPN
eurjchem-2084	709	8	)	)	PUNCT
eurjchem-2084	709	9	2019	2019	NUM
eurjchem-2084	709	10	,	,	PUNCT
eurjchem-2084	709	11	7	7	NUM
eurjchem-2084	709	12	(	(	PUNCT
eurjchem-2084	709	13	2	2	NUM
eurjchem-2084	709	14	)	)	PUNCT
eurjchem-2084	709	15	,	,	PUNCT
eurjchem-2084	709	16	37	37	NUM
eurjchem-2084	709	17	.	.	PUNCT
eurjchem-2084	710	1	[	[	X
eurjchem-2084	710	2	105	105	NUM
eurjchem-2084	710	3	]	]	PUNCT
eurjchem-2084	710	4	.	.	PUNCT
eurjchem-2084	711	1	azmi	azmi	PROPN
eurjchem-2084	711	2	,	,	PUNCT
eurjchem-2084	711	3	f.	f.	PROPN
eurjchem-2084	711	4	;	;	PUNCT
eurjchem-2084	711	5	ahmad	ahmad	PROPN
eurjchem-2084	711	6	fuaad	fuaad	PROPN
eurjchem-2084	711	7	,	,	PUNCT
eurjchem-2084	711	8	a.	a.	PROPN
eurjchem-2084	711	9	a.	a.	PROPN
eurjchem-2084	711	10	h.	h.	PROPN
eurjchem-2084	711	11	;	;	PUNCT
eurjchem-2084	711	12	skwarczynski	skwarczynski	NOUN
eurjchem-2084	711	13	,	,	PUNCT
eurjchem-2084	711	14	m.	m.	NOUN
eurjchem-2084	711	15	;	;	PUNCT
eurjchem-2084	711	16	toth	toth	PROPN
eurjchem-2084	711	17	,	,	PUNCT
eurjchem-2084	711	18	i.	i.	PROPN
eurjchem-2084	711	19	hum	hum	PROPN
eurjchem-2084	711	20	.	.	PUNCT
eurjchem-2084	712	1	vaccin	vaccin	PROPN
eurjchem-2084	712	2	.	.	PUNCT
eurjchem-2084	713	1	immunother	immunother	PROPN
eurjchem-2084	713	2	.	.	PUNCT
eurjchem-2084	714	1	2014	2014	NUM
eurjchem-2084	714	2	,	,	PUNCT
eurjchem-2084	714	3	10	10	NUM
eurjchem-2084	714	4	(	(	PUNCT
eurjchem-2084	714	5	3	3	NUM
eurjchem-2084	714	6	)	)	PUNCT
eurjchem-2084	714	7	,	,	PUNCT
eurjchem-2084	714	8	778–796	778–796	NUM
eurjchem-2084	714	9	.	.	PUNCT
eurjchem-2084	715	1	[	[	X
eurjchem-2084	715	2	106	106	NUM
eurjchem-2084	715	3	]	]	PUNCT
eurjchem-2084	715	4	.	.	PUNCT
eurjchem-2084	716	1	hassan	hassan	PROPN
eurjchem-2084	716	2	,	,	PUNCT
eurjchem-2084	716	3	a.	a.	PROPN
eurjchem-2084	716	4	o.	o.	PROPN
eurjchem-2084	716	5	;	;	PUNCT
eurjchem-2084	716	6	kafai	kafai	PROPN
eurjchem-2084	716	7	,	,	PUNCT
eurjchem-2084	716	8	n.	n.	PROPN
eurjchem-2084	716	9	m.	m.	NOUN
eurjchem-2084	716	10	;	;	PUNCT
eurjchem-2084	716	11	dmitriev	dmitriev	PROPN
eurjchem-2084	716	12	,	,	PUNCT
eurjchem-2084	716	13	i.	i.	PROPN
eurjchem-2084	716	14	p.	p.	PROPN
eurjchem-2084	716	15	;	;	PUNCT
eurjchem-2084	716	16	fox	fox	PROPN
eurjchem-2084	716	17	,	,	PUNCT
eurjchem-2084	716	18	j.	j.	PROPN
eurjchem-2084	716	19	m.	m.	PROPN
eurjchem-2084	716	20	;	;	PUNCT
eurjchem-2084	716	21	smith	smith	PROPN
eurjchem-2084	716	22	,	,	PUNCT
eurjchem-2084	716	23	b.	b.	PROPN
eurjchem-2084	716	24	k.	k.	PROPN
eurjchem-2084	716	25	;	;	PUNCT
eurjchem-2084	716	26	harvey	harvey	PROPN
eurjchem-2084	716	27	,	,	PUNCT
eurjchem-2084	716	28	i.	i.	PROPN
eurjchem-2084	716	29	b.	b.	PROPN
eurjchem-2084	716	30	;	;	PUNCT
eurjchem-2084	716	31	chen	chen	PROPN
eurjchem-2084	716	32	,	,	PUNCT
eurjchem-2084	716	33	r.	r.	PROPN
eurjchem-2084	716	34	e.	e.	PROPN
eurjchem-2084	716	35	;	;	PUNCT
eurjchem-2084	716	36	winkler	winkler	PROPN
eurjchem-2084	716	37	,	,	PUNCT
eurjchem-2084	716	38	e.	e.	PROPN
eurjchem-2084	716	39	s.	s.	PROPN
eurjchem-2084	716	40	;	;	PUNCT
eurjchem-2084	716	41	wessel	wessel	PROPN
eurjchem-2084	716	42	,	,	PUNCT
eurjchem-2084	716	43	a.	a.	PROPN
eurjchem-2084	716	44	w.	w.	PROPN
eurjchem-2084	716	45	;	;	PUNCT
eurjchem-2084	716	46	case	case	NOUN
eurjchem-2084	716	47	,	,	PUNCT
eurjchem-2084	716	48	j.	j.	PROPN
eurjchem-2084	716	49	b.	b.	PROPN
eurjchem-2084	716	50	;	;	PUNCT
eurjchem-2084	716	51	kashentseva	kashentseva	PROPN
eurjchem-2084	716	52	,	,	PUNCT
eurjchem-2084	716	53	e.	e.	PROPN
eurjchem-2084	716	54	;	;	PUNCT
eurjchem-2084	716	55	mccune	mccune	PROPN
eurjchem-2084	716	56	,	,	PUNCT
eurjchem-2084	716	57	b.	b.	PROPN
eurjchem-2084	716	58	t.	t.	PROPN
eurjchem-2084	716	59	;	;	PUNCT
eurjchem-2084	716	60	bailey	bailey	NOUN
eurjchem-2084	716	61	,	,	PUNCT
eurjchem-2084	716	62	a.	a.	PROPN
eurjchem-2084	716	63	l.	l.	PROPN
eurjchem-2084	716	64	;	;	PUNCT
eurjchem-2084	716	65	zhao	zhao	PROPN
eurjchem-2084	716	66	,	,	PUNCT
eurjchem-2084	716	67	h.	h.	PROPN
eurjchem-2084	716	68	;	;	PUNCT
eurjchem-2084	716	69	vanblargan	vanblargan	PROPN
eurjchem-2084	716	70	,	,	PUNCT
eurjchem-2084	716	71	l.	l.	PROPN
eurjchem-2084	716	72	a.	a.	PROPN
eurjchem-2084	716	73	;	;	PUNCT
eurjchem-2084	716	74	dai	dai	PROPN
eurjchem-2084	716	75	,	,	PUNCT
eurjchem-2084	716	76	y.-n	y.-n	PROPN
eurjchem-2084	716	77	.	.	PUNCT
eurjchem-2084	716	78	;	;	PUNCT
eurjchem-2084	717	1	ma	ma	PROPN
eurjchem-2084	717	2	,	,	PUNCT
eurjchem-2084	717	3	m.	m.	NOUN
eurjchem-2084	717	4	;	;	PUNCT
eurjchem-2084	717	5	adams	adams	PROPN
eurjchem-2084	717	6	,	,	PUNCT
eurjchem-2084	717	7	l.	l.	PROPN
eurjchem-2084	717	8	j.	j.	PROPN
eurjchem-2084	717	9	;	;	PUNCT
eurjchem-2084	717	10	shrihari	shrihari	ADJ
eurjchem-2084	717	11	,	,	PUNCT
eurjchem-2084	717	12	s.	s.	PROPN
eurjchem-2084	717	13	;	;	PUNCT
eurjchem-2084	717	14	danis	danis	PROPN
eurjchem-2084	717	15	,	,	PUNCT
eurjchem-2084	717	16	j.	j.	PROPN
eurjchem-2084	717	17	e.	e.	PROPN
eurjchem-2084	717	18	;	;	PUNCT
eurjchem-2084	717	19	gralinski	gralinski	PROPN
eurjchem-2084	717	20	,	,	PUNCT
eurjchem-2084	717	21	l.	l.	PROPN
eurjchem-2084	717	22	e.	e.	PROPN
eurjchem-2084	717	23	;	;	PUNCT
eurjchem-2084	718	1	hou	hou	PROPN
eurjchem-2084	718	2	,	,	PUNCT
eurjchem-2084	718	3	y.	y.	PROPN
eurjchem-2084	718	4	j.	j.	PROPN
eurjchem-2084	718	5	;	;	PUNCT
eurjchem-2084	718	6	schäfer	schäfer	NOUN
eurjchem-2084	718	7	,	,	PUNCT
eurjchem-2084	718	8	a.	a.	NOUN
eurjchem-2084	718	9	;	;	PUNCT
eurjchem-2084	718	10	kim	kim	PROPN
eurjchem-2084	718	11	,	,	PUNCT
eurjchem-2084	718	12	a.	a.	PROPN
eurjchem-2084	718	13	s.	s.	PROPN
eurjchem-2084	718	14	;	;	PUNCT
eurjchem-2084	718	15	keeler	keeler	PROPN
eurjchem-2084	718	16	,	,	PUNCT
eurjchem-2084	718	17	s.	s.	PROPN
eurjchem-2084	718	18	p.	p.	PROPN
eurjchem-2084	718	19	;	;	PUNCT
eurjchem-2084	718	20	weiskopf	weiskopf	ADV
eurjchem-2084	718	21	,	,	PUNCT
eurjchem-2084	718	22	d.	d.	PROPN
eurjchem-2084	718	23	;	;	PUNCT
eurjchem-2084	718	24	baric	baric	ADJ
eurjchem-2084	718	25	,	,	PUNCT
eurjchem-2084	718	26	r.	r.	PROPN
eurjchem-2084	718	27	s.	s.	PROPN
eurjchem-2084	718	28	;	;	PUNCT
eurjchem-2084	718	29	holtzman	holtzman	NOUN
eurjchem-2084	718	30	,	,	PUNCT
eurjchem-2084	718	31	m.	m.	NOUN
eurjchem-2084	718	32	j.	j.	PROPN
eurjchem-2084	718	33	;	;	PUNCT
eurjchem-2084	718	34	fremont	fremont	PROPN
eurjchem-2084	718	35	,	,	PUNCT
eurjchem-2084	718	36	d.	d.	PROPN
eurjchem-2084	718	37	h.	h.	PROPN
eurjchem-2084	718	38	;	;	PUNCT
eurjchem-2084	718	39	curiel	curiel	PROPN
eurjchem-2084	718	40	,	,	PUNCT
eurjchem-2084	718	41	d.	d.	PROPN
eurjchem-2084	718	42	t.	t.	PROPN
eurjchem-2084	718	43	;	;	PUNCT
eurjchem-2084	718	44	diamond	diamond	NOUN
eurjchem-2084	718	45	,	,	PUNCT
eurjchem-2084	718	46	m.	m.	NOUN
eurjchem-2084	718	47	s.	s.	PROPN
eurjchem-2084	718	48	cell	cell	PROPN
eurjchem-2084	718	49	2020	2020	NUM
eurjchem-2084	718	50	,	,	PUNCT
eurjchem-2084	718	51	183	183	NUM
eurjchem-2084	718	52	(	(	PUNCT
eurjchem-2084	718	53	1	1	NUM
eurjchem-2084	718	54	)	)	PUNCT
eurjchem-2084	718	55	,	,	PUNCT
eurjchem-2084	718	56	169	169	NUM
eurjchem-2084	718	57	-	-	SYM
eurjchem-2084	718	58	184.e13	184.e13	NUM
eurjchem-2084	718	59	.	.	PUNCT
eurjchem-2084	719	1	[	[	X
eurjchem-2084	719	2	107	107	NUM
eurjchem-2084	719	3	]	]	PUNCT
eurjchem-2084	719	4	.	.	PUNCT
eurjchem-2084	720	1	feng	feng	PROPN
eurjchem-2084	720	2	,	,	PUNCT
eurjchem-2084	720	3	l.	l.	PROPN
eurjchem-2084	720	4	;	;	PUNCT
eurjchem-2084	720	5	wang	wang	PROPN
eurjchem-2084	720	6	,	,	PUNCT
eurjchem-2084	720	7	q.	q.	PROPN
eurjchem-2084	720	8	;	;	PUNCT
eurjchem-2084	720	9	shan	shan	PROPN
eurjchem-2084	720	10	,	,	PUNCT
eurjchem-2084	720	11	c.	c.	PROPN
eurjchem-2084	720	12	;	;	PUNCT
eurjchem-2084	720	13	yang	yang	PROPN
eurjchem-2084	720	14	,	,	PUNCT
eurjchem-2084	720	15	c.	c.	PROPN
eurjchem-2084	720	16	;	;	PUNCT
eurjchem-2084	720	17	feng	feng	PROPN
eurjchem-2084	720	18	,	,	PUNCT
eurjchem-2084	720	19	y.	y.	PROPN
eurjchem-2084	720	20	;	;	PUNCT
eurjchem-2084	720	21	wu	wu	PROPN
eurjchem-2084	720	22	,	,	PUNCT
eurjchem-2084	720	23	j.	j.	PROPN
eurjchem-2084	720	24	;	;	PUNCT
eurjchem-2084	720	25	liu	liu	PROPN
eurjchem-2084	720	26	,	,	PUNCT
eurjchem-2084	720	27	x.	x.	PROPN
eurjchem-2084	720	28	;	;	PUNCT
eurjchem-2084	720	29	zhou	zhou	PROPN
eurjchem-2084	720	30	,	,	PUNCT
eurjchem-2084	720	31	y.	y.	PROPN
eurjchem-2084	720	32	;	;	PUNCT
eurjchem-2084	720	33	jiang	jiang	PROPN
eurjchem-2084	720	34	,	,	PUNCT
eurjchem-2084	720	35	r.	r.	PROPN
eurjchem-2084	720	36	;	;	PUNCT
eurjchem-2084	720	37	hu	hu	PROPN
eurjchem-2084	720	38	,	,	PUNCT
eurjchem-2084	720	39	p.	p.	PROPN
eurjchem-2084	720	40	;	;	PUNCT
eurjchem-2084	720	41	liu	liu	PROPN
eurjchem-2084	720	42	,	,	PUNCT
eurjchem-2084	720	43	x.	x.	PROPN
eurjchem-2084	720	44	;	;	PUNCT
eurjchem-2084	720	45	zhang	zhang	PROPN
eurjchem-2084	720	46	,	,	PUNCT
eurjchem-2084	720	47	f.	f.	PROPN
eurjchem-2084	720	48	;	;	PUNCT
eurjchem-2084	720	49	li	li	PROPN
eurjchem-2084	720	50	,	,	PUNCT
eurjchem-2084	720	51	p.	p.	PROPN
eurjchem-2084	720	52	;	;	PUNCT
eurjchem-2084	720	53	niu	niu	PROPN
eurjchem-2084	720	54	,	,	PUNCT
eurjchem-2084	720	55	x.	x.	NOUN
eurjchem-2084	720	56	;	;	PUNCT
eurjchem-2084	720	57	liu	liu	PROPN
eurjchem-2084	720	58	,	,	PUNCT
eurjchem-2084	720	59	y.	y.	PROPN
eurjchem-2084	720	60	;	;	PUNCT
eurjchem-2084	720	61	zheng	zheng	PROPN
eurjchem-2084	720	62	,	,	PUNCT
eurjchem-2084	720	63	x.	x.	PROPN
eurjchem-2084	720	64	;	;	PUNCT
eurjchem-2084	720	65	luo	luo	PROPN
eurjchem-2084	720	66	,	,	PUNCT
eurjchem-2084	720	67	j.	j.	PROPN
eurjchem-2084	720	68	;	;	PUNCT
eurjchem-2084	720	69	sun	sun	PROPN
eurjchem-2084	720	70	,	,	PUNCT
eurjchem-2084	720	71	j.	j.	PROPN
eurjchem-2084	720	72	;	;	PUNCT
eurjchem-2084	720	73	gu	gu	PROPN
eurjchem-2084	720	74	,	,	PUNCT
eurjchem-2084	720	75	y.	y.	PROPN
eurjchem-2084	720	76	;	;	PUNCT
eurjchem-2084	720	77	liu	liu	PROPN
eurjchem-2084	720	78	,	,	PUNCT
eurjchem-2084	720	79	b.	b.	PROPN
eurjchem-2084	720	80	;	;	PUNCT
eurjchem-2084	720	81	xu	xu	PROPN
eurjchem-2084	720	82	,	,	PUNCT
eurjchem-2084	720	83	y.	y.	PROPN
eurjchem-2084	720	84	;	;	PUNCT
eurjchem-2084	720	85	li	li	PROPN
eurjchem-2084	720	86	,	,	PUNCT
eurjchem-2084	720	87	c.	c.	PROPN
eurjchem-2084	720	88	;	;	PUNCT
eurjchem-2084	720	89	pan	pan	PROPN
eurjchem-2084	720	90	,	,	PUNCT
eurjchem-2084	720	91	w.	w.	PROPN
eurjchem-2084	720	92	;	;	PUNCT
eurjchem-2084	720	93	zhao	zhao	PROPN
eurjchem-2084	720	94	,	,	PUNCT
eurjchem-2084	720	95	j.	j.	PROPN
eurjchem-2084	720	96	;	;	PUNCT
eurjchem-2084	720	97	ke	ke	PROPN
eurjchem-2084	720	98	,	,	PUNCT
eurjchem-2084	720	99	c.	c.	PROPN
eurjchem-2084	720	100	;	;	PUNCT
eurjchem-2084	720	101	chen	chen	PROPN
eurjchem-2084	720	102	,	,	PUNCT
eurjchem-2084	720	103	x.	x.	PROPN
eurjchem-2084	720	104	;	;	PUNCT
eurjchem-2084	720	105	xu	xu	PROPN
eurjchem-2084	720	106	,	,	PUNCT
eurjchem-2084	720	107	t.	t.	PROPN
eurjchem-2084	720	108	;	;	PUNCT
eurjchem-2084	720	109	zhong	zhong	PROPN
eurjchem-2084	720	110	,	,	PUNCT
eurjchem-2084	720	111	n.	n.	PROPN
eurjchem-2084	720	112	;	;	PUNCT
eurjchem-2084	720	113	guan	guan	PROPN
eurjchem-2084	720	114	,	,	PUNCT
eurjchem-2084	720	115	s.	s.	PROPN
eurjchem-2084	720	116	;	;	PUNCT
eurjchem-2084	720	117	yuan	yuan	PROPN
eurjchem-2084	720	118	,	,	PUNCT
eurjchem-2084	720	119	z.	z.	PROPN
eurjchem-2084	720	120	;	;	PUNCT
eurjchem-2084	720	121	chen	chen	PROPN
eurjchem-2084	720	122	,	,	PUNCT
eurjchem-2084	720	123	l.	l.	PROPN
eurjchem-2084	720	124	nat	nat	PROPN
eurjchem-2084	720	125	.	.	PUNCT
eurjchem-2084	721	1	commun	commun	PROPN
eurjchem-2084	721	2	.	.	PUNCT
eurjchem-2084	722	1	2020	2020	NUM
eurjchem-2084	722	2	,	,	PUNCT
eurjchem-2084	722	3	11	11	NUM
eurjchem-2084	722	4	(	(	PUNCT
eurjchem-2084	722	5	1	1	NUM
eurjchem-2084	722	6	)	)	PUNCT
eurjchem-2084	722	7	,	,	PUNCT
eurjchem-2084	722	8	4207	4207	NUM
eurjchem-2084	722	9	.	.	PUNCT
eurjchem-2084	723	1	[	[	X
eurjchem-2084	723	2	108	108	NUM
eurjchem-2084	723	3	]	]	PUNCT
eurjchem-2084	723	4	.	.	PUNCT
eurjchem-2084	724	1	prasad	prasad	PROPN
eurjchem-2084	724	2	,	,	PUNCT
eurjchem-2084	724	3	a.	a.	NOUN
eurjchem-2084	724	4	;	;	PUNCT
eurjchem-2084	724	5	muthamilarasan	muthamilarasan	NUM
eurjchem-2084	724	6	,	,	PUNCT
eurjchem-2084	724	7	m.	m.	NOUN
eurjchem-2084	724	8	;	;	PUNCT
eurjchem-2084	724	9	prasad	prasad	PROPN
eurjchem-2084	724	10	,	,	PUNCT
eurjchem-2084	724	11	m.	m.	NOUN
eurjchem-2084	724	12	plant	plant	NOUN
eurjchem-2084	724	13	cell	cell	NOUN
eurjchem-2084	724	14	rep	rep	PROPN
eurjchem-2084	724	15	.	.	PROPN
eurjchem-2084	724	16	2020	2020	NUM
eurjchem-2084	724	17	,	,	PUNCT
eurjchem-2084	724	18	39	39	NUM
eurjchem-2084	724	19	(	(	PUNCT
eurjchem-2084	724	20	9	9	NUM
eurjchem-2084	724	21	)	)	PUNCT
eurjchem-2084	724	22	,	,	PUNCT
eurjchem-2084	724	23	1109–1114	1109–1114	NUM
eurjchem-2084	724	24	.	.	PUNCT
eurjchem-2084	725	1	[	[	X
eurjchem-2084	725	2	109	109	NUM
eurjchem-2084	725	3	]	]	PUNCT
eurjchem-2084	725	4	.	.	PUNCT
eurjchem-2084	725	5	silverman	silverman	PROPN
eurjchem-2084	725	6	,	,	PUNCT
eurjchem-2084	725	7	e.	e.	PROPN
eurjchem-2084	725	8	medicago	medicago	PROPN
eurjchem-2084	725	9	strikes	strike	VERB
eurjchem-2084	725	10	covid-19	covid-19	PROPN
eurjchem-2084	725	11	vaccine	vaccine	NOUN
eurjchem-2084	725	12	deals	deal	VERB
eurjchem-2084	725	13	with	with	ADP
eurjchem-2084	725	14	gsk	gsk	NOUN
eurjchem-2084	725	15	,	,	PUNCT
eurjchem-2084	725	16	dynavax	dynavax	PROPN
eurjchem-2084	725	17	https://www.statnews.com/pharmalot/2020/07/09/	https://www.statnews.com/pharmalot/2020/07/09/	NUM
eurjchem-2084	725	18	covid19	covid19	NOUN
eurjchem-2084	725	19	-	-	PUNCT
eurjchem-2084	725	20	coronavirus	coronavirus	NOUN
eurjchem-2084	725	21	-	-	PUNCT
eurjchem-2084	725	22	pandemic	pandemic	ADJ
eurjchem-2084	725	23	-	-	PUNCT
eurjchem-2084	725	24	vaccines	vaccine	NOUN
eurjchem-2084	725	25	-	-	PUNCT
eurjchem-2084	725	26	medicago	medicago	NOUN
eurjchem-2084	725	27	-	-	PUNCT
eurjchem-2084	725	28	glaxo	glaxo	NOUN
eurjchem-2084	725	29	-	-	PUNCT
eurjchem-2084	725	30	dynavax/	dynavax/	PROPN
eurjchem-2084	725	31	(	(	PUNCT
eurjchem-2084	725	32	accessed	access	VERB
eurjchem-2084	725	33	december	december	PROPN
eurjchem-2084	725	34	9	9	NUM
eurjchem-2084	725	35	,	,	PUNCT
eurjchem-2084	725	36	2020	2020	NUM
eurjchem-2084	725	37	)	)	PUNCT
eurjchem-2084	725	38	.	.	PUNCT
eurjchem-2084	726	1	[	[	X
eurjchem-2084	726	2	110	110	NUM
eurjchem-2084	726	3	]	]	PUNCT
eurjchem-2084	726	4	.	.	PUNCT
eurjchem-2084	727	1	rajapaksha	rajapaksha	PROPN
eurjchem-2084	727	2	,	,	PUNCT
eurjchem-2084	727	3	h.	h.	PROPN
eurjchem-2084	727	4	;	;	PUNCT
eurjchem-2084	727	5	perera	perera	PROPN
eurjchem-2084	727	6	,	,	PUNCT
eurjchem-2084	727	7	b.	b.	PROPN
eurjchem-2084	727	8	t.	t.	PROPN
eurjchem-2084	727	9	;	;	PUNCT
eurjchem-2084	727	10	meepage	meepage	NOUN
eurjchem-2084	727	11	,	,	PUNCT
eurjchem-2084	727	12	j.	j.	PROPN
eurjchem-2084	727	13	;	;	PUNCT
eurjchem-2084	727	14	perera	perera	PROPN
eurjchem-2084	727	15	,	,	PUNCT
eurjchem-2084	727	16	r.	r.	PROPN
eurjchem-2084	727	17	t.	t.	PROPN
eurjchem-2084	727	18	;	;	PUNCT
eurjchem-2084	727	19	dissanayake	dissanayake	PROPN
eurjchem-2084	727	20	,	,	PUNCT
eurjchem-2084	727	21	c.	c.	PROPN
eurjchem-2084	727	22	eur	eur	PROPN
eurjchem-2084	727	23	.	.	PUNCT
eurjchem-2084	728	1	j.	j.	PROPN
eurjchem-2084	728	2	chem	chem	PROPN
eurjchem-2084	728	3	.	.	PUNCT
eurjchem-2084	729	1	2020	2020	NUM
eurjchem-2084	729	2	,	,	PUNCT
eurjchem-2084	729	3	11	11	NUM
eurjchem-2084	729	4	(	(	PUNCT
eurjchem-2084	729	5	4	4	NUM
eurjchem-2084	729	6	)	)	PUNCT
eurjchem-2084	729	7	,	,	PUNCT
eurjchem-2084	729	8	351–363	351–363	NUM
eurjchem-2084	729	9	.	.	PUNCT
eurjchem-2084	730	1	[	[	X
eurjchem-2084	730	2	111	111	NUM
eurjchem-2084	730	3	]	]	PUNCT
eurjchem-2084	730	4	.	.	PUNCT
eurjchem-2084	731	1	chen	chen	PROPN
eurjchem-2084	731	2	,	,	PUNCT
eurjchem-2084	731	3	c.	c.	PROPN
eurjchem-2084	731	4	;	;	PUNCT
eurjchem-2084	731	5	zhang	zhang	PROPN
eurjchem-2084	731	6	,	,	PUNCT
eurjchem-2084	731	7	y.	y.	PROPN
eurjchem-2084	731	8	;	;	PUNCT
eurjchem-2084	731	9	huang	huang	PROPN
eurjchem-2084	731	10	,	,	PUNCT
eurjchem-2084	731	11	j.	j.	PROPN
eurjchem-2084	731	12	;	;	PUNCT
eurjchem-2084	731	13	yin	yin	PROPN
eurjchem-2084	731	14	,	,	PUNCT
eurjchem-2084	731	15	p.	p.	PROPN
eurjchem-2084	731	16	;	;	PUNCT
eurjchem-2084	731	17	cheng	cheng	PROPN
eurjchem-2084	731	18	,	,	PUNCT
eurjchem-2084	731	19	z.	z.	PROPN
eurjchem-2084	731	20	;	;	PUNCT
eurjchem-2084	731	21	wu	wu	PROPN
eurjchem-2084	731	22	,	,	PUNCT
eurjchem-2084	731	23	j.	j.	PROPN
eurjchem-2084	731	24	;	;	PUNCT
eurjchem-2084	731	25	chen	chen	PROPN
eurjchem-2084	731	26	,	,	PUNCT
eurjchem-2084	731	27	s.	s.	PROPN
eurjchem-2084	731	28	;	;	PUNCT
eurjchem-2084	731	29	zhang	zhang	PROPN
eurjchem-2084	731	30	,	,	PUNCT
eurjchem-2084	731	31	y.	y.	PROPN
eurjchem-2084	731	32	;	;	PUNCT
eurjchem-2084	731	33	chen	chen	PROPN
eurjchem-2084	731	34	,	,	PUNCT
eurjchem-2084	731	35	b.	b.	PROPN
eurjchem-2084	731	36	;	;	PUNCT
eurjchem-2084	731	37	lu	lu	PROPN
eurjchem-2084	731	38	,	,	PUNCT
eurjchem-2084	731	39	m.	m.	NOUN
eurjchem-2084	731	40	;	;	PUNCT
eurjchem-2084	731	41	luo	luo	PROPN
eurjchem-2084	731	42	,	,	PUNCT
eurjchem-2084	731	43	y.	y.	PROPN
eurjchem-2084	731	44	;	;	PUNCT
eurjchem-2084	731	45	ju	ju	PROPN
eurjchem-2084	731	46	,	,	PUNCT
eurjchem-2084	731	47	l.	l.	PROPN
eurjchem-2084	731	48	;	;	PUNCT
eurjchem-2084	731	49	zhang	zhang	PROPN
eurjchem-2084	731	50	,	,	PUNCT
eurjchem-2084	731	51	j.	j.	PROPN
eurjchem-2084	731	52	;	;	PUNCT
eurjchem-2084	731	53	wang	wang	PROPN
eurjchem-2084	731	54	,	,	PUNCT
eurjchem-2084	731	55	x.	x.	PROPN
eurjchem-2084	731	56	biorxiv	biorxiv	PROPN
eurjchem-2084	731	57	,	,	PUNCT
eurjchem-2084	731	58	2020	2020	NUM
eurjchem-2084	731	59	.	.	PUNCT
eurjchem-2084	732	1	https://doi.org/10.1101/2020.03.17.20037432	https://doi.org/10.1101/2020.03.17.20037432	PROPN
eurjchem-2084	732	2	[	[	X
eurjchem-2084	732	3	112	112	NUM
eurjchem-2084	732	4	]	]	PUNCT
eurjchem-2084	732	5	.	.	PUNCT
eurjchem-2084	733	1	wang	wang	PROPN
eurjchem-2084	733	2	,	,	PUNCT
eurjchem-2084	733	3	y.	y.	PROPN
eurjchem-2084	733	4	;	;	PUNCT
eurjchem-2084	733	5	zhang	zhang	PROPN
eurjchem-2084	733	6	,	,	PUNCT
eurjchem-2084	733	7	d.	d.	PROPN
eurjchem-2084	733	8	;	;	PUNCT
eurjchem-2084	733	9	du	du	PROPN
eurjchem-2084	733	10	,	,	PUNCT
eurjchem-2084	733	11	g.	g.	PROPN
eurjchem-2084	733	12	;	;	PUNCT
eurjchem-2084	733	13	du	du	PROPN
eurjchem-2084	733	14	,	,	PUNCT
eurjchem-2084	733	15	r.	r.	PROPN
eurjchem-2084	733	16	;	;	PUNCT
eurjchem-2084	733	17	zhao	zhao	PROPN
eurjchem-2084	733	18	,	,	PUNCT
eurjchem-2084	733	19	j.	j.	PROPN
eurjchem-2084	733	20	;	;	PUNCT
eurjchem-2084	733	21	jin	jin	PROPN
eurjchem-2084	733	22	,	,	PUNCT
eurjchem-2084	733	23	y.	y.	PROPN
eurjchem-2084	733	24	;	;	PUNCT
eurjchem-2084	733	25	fu	fu	PROPN
eurjchem-2084	733	26	,	,	PUNCT
eurjchem-2084	733	27	s.	s.	PROPN
eurjchem-2084	733	28	;	;	PUNCT
eurjchem-2084	733	29	gao	gao	PROPN
eurjchem-2084	733	30	,	,	PUNCT
eurjchem-2084	733	31	l.	l.	PROPN
eurjchem-2084	733	32	;	;	PUNCT
eurjchem-2084	733	33	cheng	cheng	PROPN
eurjchem-2084	733	34	,	,	PUNCT
eurjchem-2084	733	35	z.	z.	PROPN
eurjchem-2084	733	36	;	;	PUNCT
eurjchem-2084	733	37	lu	lu	PROPN
eurjchem-2084	733	38	,	,	PUNCT
eurjchem-2084	733	39	q.	q.	PROPN
eurjchem-2084	733	40	;	;	PUNCT
eurjchem-2084	733	41	hu	hu	PROPN
eurjchem-2084	733	42	,	,	PUNCT
eurjchem-2084	733	43	y.	y.	PROPN
eurjchem-2084	733	44	;	;	PUNCT
eurjchem-2084	733	45	luo	luo	PROPN
eurjchem-2084	733	46	,	,	PUNCT
eurjchem-2084	733	47	g.	g.	PROPN
eurjchem-2084	733	48	;	;	PUNCT
eurjchem-2084	733	49	wang	wang	PROPN
eurjchem-2084	733	50	,	,	PUNCT
eurjchem-2084	733	51	k.	k.	PROPN
eurjchem-2084	733	52	;	;	PUNCT
eurjchem-2084	733	53	lu	lu	PROPN
eurjchem-2084	733	54	,	,	PUNCT
eurjchem-2084	733	55	y.	y.	PROPN
eurjchem-2084	733	56	;	;	PUNCT
eurjchem-2084	733	57	li	li	PROPN
eurjchem-2084	733	58	,	,	PUNCT
eurjchem-2084	733	59	h.	h.	PROPN
eurjchem-2084	733	60	;	;	PUNCT
eurjchem-2084	733	61	wang	wang	PROPN
eurjchem-2084	733	62	,	,	PUNCT
eurjchem-2084	733	63	s.	s.	PROPN
eurjchem-2084	733	64	;	;	PUNCT
eurjchem-2084	733	65	ruan	ruan	PROPN
eurjchem-2084	733	66	,	,	PUNCT
eurjchem-2084	733	67	s.	s.	PROPN
eurjchem-2084	733	68	;	;	PUNCT
eurjchem-2084	733	69	yang	yang	PROPN
eurjchem-2084	733	70	,	,	PUNCT
eurjchem-2084	733	71	c.	c.	PROPN
eurjchem-2084	733	72	;	;	PUNCT
eurjchem-2084	733	73	mei	mei	PROPN
eurjchem-2084	733	74	,	,	PUNCT
eurjchem-2084	733	75	c.	c.	PROPN
eurjchem-2084	733	76	;	;	PUNCT
eurjchem-2084	733	77	wang	wang	PROPN
eurjchem-2084	733	78	,	,	PUNCT
eurjchem-2084	733	79	y.	y.	PROPN
eurjchem-2084	733	80	;	;	PUNCT
eurjchem-2084	733	81	ding	ding	NOUN
eurjchem-2084	733	82	,	,	PUNCT
eurjchem-2084	733	83	d.	d.	PROPN
eurjchem-2084	733	84	;	;	PUNCT
eurjchem-2084	733	85	wu	wu	PROPN
eurjchem-2084	733	86	,	,	PUNCT
eurjchem-2084	733	87	f.	f.	PROPN
eurjchem-2084	733	88	;	;	PUNCT
eurjchem-2084	733	89	tang	tang	PROPN
eurjchem-2084	733	90	,	,	PUNCT
eurjchem-2084	733	91	x.	x.	NOUN
eurjchem-2084	733	92	;	;	PUNCT
eurjchem-2084	733	93	ye	ye	PRON
eurjchem-2084	733	94	,	,	PUNCT
eurjchem-2084	733	95	x.	x.	NOUN
eurjchem-2084	733	96	;	;	PUNCT
eurjchem-2084	733	97	ye	ye	PRON
eurjchem-2084	733	98	,	,	PUNCT
eurjchem-2084	733	99	y.	y.	PROPN
eurjchem-2084	733	100	;	;	PUNCT
eurjchem-2084	733	101	liu	liu	PROPN
eurjchem-2084	733	102	,	,	PUNCT
eurjchem-2084	733	103	b.	b.	PROPN
eurjchem-2084	733	104	;	;	PUNCT
eurjchem-2084	733	105	yang	yang	PROPN
eurjchem-2084	733	106	,	,	PUNCT
eurjchem-2084	733	107	j.	j.	PROPN
eurjchem-2084	733	108	;	;	PUNCT
eurjchem-2084	733	109	yin	yin	PROPN
eurjchem-2084	733	110	,	,	PUNCT
eurjchem-2084	733	111	w.	w.	PROPN
eurjchem-2084	733	112	;	;	PUNCT
eurjchem-2084	733	113	wang	wang	PROPN
eurjchem-2084	733	114	,	,	PUNCT
eurjchem-2084	733	115	a.	a.	PROPN
eurjchem-2084	733	116	;	;	PUNCT
eurjchem-2084	733	117	fan	fan	PROPN
eurjchem-2084	733	118	,	,	PUNCT
eurjchem-2084	733	119	g.	g.	PROPN
eurjchem-2084	733	120	;	;	PUNCT
eurjchem-2084	733	121	zhou	zhou	PROPN
eurjchem-2084	733	122	,	,	PUNCT
eurjchem-2084	733	123	f.	f.	PROPN
eurjchem-2084	733	124	;	;	PUNCT
eurjchem-2084	733	125	liu	liu	PROPN
eurjchem-2084	733	126	,	,	PUNCT
eurjchem-2084	733	127	z.	z.	PROPN
eurjchem-2084	733	128	;	;	PUNCT
eurjchem-2084	733	129	gu	gu	NOUN
eurjchem-2084	733	130	,	,	PUNCT
eurjchem-2084	733	131	x.	x.	PROPN
eurjchem-2084	733	132	;	;	PUNCT
eurjchem-2084	733	133	xu	xu	PROPN
eurjchem-2084	733	134	,	,	PUNCT
eurjchem-2084	733	135	j.	j.	PROPN
eurjchem-2084	733	136	;	;	PUNCT
eurjchem-2084	733	137	shang	shang	PROPN
eurjchem-2084	733	138	,	,	PUNCT
eurjchem-2084	733	139	l.	l.	PROPN
eurjchem-2084	733	140	;	;	PUNCT
eurjchem-2084	733	141	zhang	zhang	PROPN
eurjchem-2084	733	142	,	,	PUNCT
eurjchem-2084	733	143	y.	y.	PROPN
eurjchem-2084	733	144	;	;	PUNCT
eurjchem-2084	733	145	cao	cao	PROPN
eurjchem-2084	733	146	,	,	PUNCT
eurjchem-2084	733	147	l.	l.	PROPN
eurjchem-2084	733	148	;	;	PUNCT
eurjchem-2084	733	149	guo	guo	PROPN
eurjchem-2084	733	150	,	,	PUNCT
eurjchem-2084	733	151	t.	t.	PROPN
eurjchem-2084	733	152	;	;	PUNCT
eurjchem-2084	733	153	wan	wan	PROPN
eurjchem-2084	733	154	,	,	PUNCT
eurjchem-2084	733	155	y.	y.	PROPN
eurjchem-2084	733	156	;	;	PUNCT
eurjchem-2084	733	157	qin	qin	PROPN
eurjchem-2084	733	158	,	,	PUNCT
eurjchem-2084	733	159	h.	h.	PROPN
eurjchem-2084	733	160	;	;	PUNCT
eurjchem-2084	733	161	jiang	jiang	PROPN
eurjchem-2084	733	162	,	,	PUNCT
eurjchem-2084	733	163	y.	y.	PROPN
eurjchem-2084	733	164	;	;	PUNCT
eurjchem-2084	733	165	jaki	jaki	PROPN
eurjchem-2084	733	166	,	,	PUNCT
eurjchem-2084	733	167	t.	t.	PROPN
eurjchem-2084	733	168	;	;	PUNCT
eurjchem-2084	733	169	hayden	hayden	PROPN
eurjchem-2084	733	170	,	,	PUNCT
eurjchem-2084	733	171	f.	f.	PROPN
eurjchem-2084	733	172	g.	g.	PROPN
eurjchem-2084	733	173	;	;	PUNCT
eurjchem-2084	733	174	horby	horby	PROPN
eurjchem-2084	733	175	,	,	PUNCT
eurjchem-2084	733	176	p.	p.	PROPN
eurjchem-2084	733	177	w.	w.	PROPN
eurjchem-2084	733	178	;	;	PUNCT
eurjchem-2084	733	179	cao	cao	PROPN
eurjchem-2084	733	180	,	,	PUNCT
eurjchem-2084	733	181	b.	b.	PROPN
eurjchem-2084	733	182	;	;	PUNCT
eurjchem-2084	733	183	wang	wang	PROPN
eurjchem-2084	733	184	,	,	PUNCT
eurjchem-2084	733	185	c.	c.	PROPN
eurjchem-2084	733	186	lancet	lancet	PROPN
eurjchem-2084	733	187	2020	2020	NUM
eurjchem-2084	733	188	,	,	PUNCT
eurjchem-2084	733	189	395	395	NUM
eurjchem-2084	733	190	(	(	PUNCT
eurjchem-2084	733	191	10236	10236	NUM
eurjchem-2084	733	192	)	)	PUNCT
eurjchem-2084	733	193	,	,	PUNCT
eurjchem-2084	733	194	1569	1569	NUM
eurjchem-2084	733	195	–	–	PUNCT
eurjchem-2084	733	196	1578	1578	NUM
eurjchem-2084	733	197	.	.	PUNCT
eurjchem-2084	734	1	[	[	X
eurjchem-2084	734	2	113	113	NUM
eurjchem-2084	734	3	]	]	PUNCT
eurjchem-2084	734	4	.	.	PUNCT
eurjchem-2084	735	1	gautret	gautret	NOUN
eurjchem-2084	735	2	,	,	PUNCT
eurjchem-2084	735	3	p.	p.	NOUN
eurjchem-2084	735	4	;	;	PUNCT
eurjchem-2084	735	5	lagier	lagier	NOUN
eurjchem-2084	735	6	,	,	PUNCT
eurjchem-2084	735	7	j.-c	j.-c	PROPN
eurjchem-2084	735	8	.	.	PUNCT
eurjchem-2084	735	9	;	;	PUNCT
eurjchem-2084	736	1	parola	parola	NOUN
eurjchem-2084	736	2	,	,	PUNCT
eurjchem-2084	736	3	p.	p.	PROPN
eurjchem-2084	736	4	;	;	PUNCT
eurjchem-2084	736	5	hoang	hoang	PROPN
eurjchem-2084	736	6	,	,	PUNCT
eurjchem-2084	736	7	v.	v.	PROPN
eurjchem-2084	736	8	t.	t.	PROPN
eurjchem-2084	736	9	;	;	PUNCT
eurjchem-2084	736	10	meddeb	meddeb	PROPN
eurjchem-2084	736	11	,	,	PUNCT
eurjchem-2084	736	12	l.	l.	PROPN
eurjchem-2084	736	13	;	;	PUNCT
eurjchem-2084	736	14	mailhe	mailhe	PROPN
eurjchem-2084	736	15	,	,	PUNCT
eurjchem-2084	736	16	m.	m.	NOUN
eurjchem-2084	736	17	;	;	PUNCT
eurjchem-2084	736	18	doudier	doudier	PROPN
eurjchem-2084	736	19	,	,	PUNCT
eurjchem-2084	736	20	b.	b.	PROPN
eurjchem-2084	736	21	;	;	PUNCT
eurjchem-2084	736	22	courjon	courjon	PROPN
eurjchem-2084	736	23	,	,	PUNCT
eurjchem-2084	736	24	j.	j.	PROPN
eurjchem-2084	736	25	;	;	PUNCT
eurjchem-2084	736	26	giordanengo	giordanengo	PROPN
eurjchem-2084	736	27	,	,	PUNCT
eurjchem-2084	736	28	v.	v.	PROPN
eurjchem-2084	736	29	;	;	PUNCT
eurjchem-2084	736	30	vieira	vieira	PROPN
eurjchem-2084	736	31	,	,	PUNCT
eurjchem-2084	736	32	v.	v.	PROPN
eurjchem-2084	736	33	e.	e.	PROPN
eurjchem-2084	736	34	;	;	PUNCT
eurjchem-2084	736	35	tissot	tissot	PROPN
eurjchem-2084	736	36	dupont	dupont	PROPN
eurjchem-2084	736	37	,	,	PUNCT
eurjchem-2084	736	38	h.	h.	PROPN
eurjchem-2084	736	39	;	;	PUNCT
eurjchem-2084	736	40	honoré	honoré	PROPN
eurjchem-2084	736	41	,	,	PUNCT
eurjchem-2084	736	42	s.	s.	PROPN
eurjchem-2084	736	43	;	;	PUNCT
eurjchem-2084	736	44	colson	colson	PROPN
eurjchem-2084	736	45	,	,	PUNCT
eurjchem-2084	736	46	p.	p.	PROPN
eurjchem-2084	736	47	;	;	PUNCT
eurjchem-2084	736	48	chabrière	chabrière	PROPN
eurjchem-2084	736	49	,	,	PUNCT
eurjchem-2084	736	50	e.	e.	PROPN
eurjchem-2084	736	51	;	;	PUNCT
eurjchem-2084	736	52	la	la	PROPN
eurjchem-2084	736	53	scola	scola	PROPN
eurjchem-2084	736	54	,	,	PUNCT
eurjchem-2084	736	55	b.	b.	PROPN
eurjchem-2084	736	56	;	;	PUNCT
eurjchem-2084	736	57	rolain	rolain	PROPN
eurjchem-2084	736	58	,	,	PUNCT
eurjchem-2084	736	59	j.-m	j.-m	PROPN
eurjchem-2084	736	60	.	.	PUNCT
eurjchem-2084	736	61	;	;	PUNCT
eurjchem-2084	736	62	brouqui	brouqui	NOUN
eurjchem-2084	736	63	,	,	PUNCT
eurjchem-2084	736	64	p.	p.	NOUN
eurjchem-2084	736	65	;	;	PUNCT
eurjchem-2084	736	66	raoult	raoult	VERB
eurjchem-2084	736	67	,	,	PUNCT
eurjchem-2084	736	68	d.	d.	PROPN
eurjchem-2084	736	69	int	int	PROPN
eurjchem-2084	736	70	.	.	PUNCT
eurjchem-2084	737	1	j.	j.	PROPN
eurjchem-2084	737	2	antimicrob	antimicrob	PROPN
eurjchem-2084	737	3	.	.	PUNCT
eurjchem-2084	738	1	agents	agent	NOUN
eurjchem-2084	738	2	2020	2020	NUM
eurjchem-2084	738	3	,	,	PUNCT
eurjchem-2084	738	4	56	56	NUM
eurjchem-2084	738	5	(	(	PUNCT
eurjchem-2084	738	6	1	1	NUM
eurjchem-2084	738	7	)	)	PUNCT
eurjchem-2084	738	8	,	,	PUNCT
eurjchem-2084	738	9	105949	105949	NUM
eurjchem-2084	738	10	.	.	PUNCT
eurjchem-2084	739	1	[	[	X
eurjchem-2084	739	2	114	114	NUM
eurjchem-2084	739	3	]	]	PUNCT
eurjchem-2084	739	4	.	.	PUNCT
eurjchem-2084	740	1	guaraldi	guaraldi	PROPN
eurjchem-2084	740	2	,	,	PUNCT
eurjchem-2084	740	3	g.	g.	PROPN
eurjchem-2084	740	4	;	;	PUNCT
eurjchem-2084	740	5	meschiari	meschiari	PROPN
eurjchem-2084	740	6	,	,	PUNCT
eurjchem-2084	740	7	m.	m.	NOUN
eurjchem-2084	740	8	;	;	PUNCT
eurjchem-2084	740	9	cozzi	cozzi	NOUN
eurjchem-2084	740	10	-	-	PUNCT
eurjchem-2084	740	11	lepri	lepri	ADJ
eurjchem-2084	740	12	,	,	PUNCT
eurjchem-2084	740	13	a.	a.	NOUN
eurjchem-2084	740	14	;	;	PUNCT
eurjchem-2084	740	15	milic	milic	ADJ
eurjchem-2084	740	16	,	,	PUNCT
eurjchem-2084	740	17	j.	j.	PROPN
eurjchem-2084	740	18	;	;	PUNCT
eurjchem-2084	740	19	tonelli	tonelli	PROPN
eurjchem-2084	740	20	,	,	PUNCT
eurjchem-2084	740	21	r.	r.	PROPN
eurjchem-2084	740	22	;	;	PUNCT
eurjchem-2084	740	23	menozzi	menozzi	NOUN
eurjchem-2084	740	24	,	,	PUNCT
eurjchem-2084	740	25	m.	m.	NOUN
eurjchem-2084	740	26	;	;	PUNCT
eurjchem-2084	740	27	franceschini	franceschini	PROPN
eurjchem-2084	740	28	,	,	PUNCT
eurjchem-2084	740	29	e.	e.	PROPN
eurjchem-2084	740	30	;	;	PUNCT
eurjchem-2084	740	31	cuomo	cuomo	PROPN
eurjchem-2084	740	32	,	,	PUNCT
eurjchem-2084	740	33	g.	g.	PROPN
eurjchem-2084	740	34	;	;	PUNCT
eurjchem-2084	740	35	orlando	orlando	PROPN
eurjchem-2084	740	36	,	,	PUNCT
eurjchem-2084	740	37	g.	g.	PROPN
eurjchem-2084	740	38	;	;	PUNCT
eurjchem-2084	740	39	borghi	borghi	PROPN
eurjchem-2084	740	40	,	,	PUNCT
eurjchem-2084	740	41	v.	v.	PROPN
eurjchem-2084	740	42	;	;	PUNCT
eurjchem-2084	740	43	santoro	santoro	PROPN
eurjchem-2084	740	44	,	,	PUNCT
eurjchem-2084	740	45	a.	a.	NOUN
eurjchem-2084	740	46	;	;	PUNCT
eurjchem-2084	740	47	di	di	X
eurjchem-2084	740	48	gaetano	gaetano	PROPN
eurjchem-2084	740	49	,	,	PUNCT
eurjchem-2084	740	50	m.	m.	NOUN
eurjchem-2084	740	51	;	;	PUNCT
eurjchem-2084	740	52	puzzolante	puzzolante	NOUN
eurjchem-2084	740	53	,	,	PUNCT
eurjchem-2084	740	54	c.	c.	PROPN
eurjchem-2084	740	55	;	;	PUNCT
eurjchem-2084	740	56	carli	carli	PROPN
eurjchem-2084	740	57	,	,	PUNCT
eurjchem-2084	740	58	f.	f.	PROPN
eurjchem-2084	740	59	;	;	PUNCT
eurjchem-2084	740	60	bedini	bedini	PROPN
eurjchem-2084	740	61	,	,	PUNCT
eurjchem-2084	740	62	a.	a.	NOUN
eurjchem-2084	740	63	;	;	PUNCT
eurjchem-2084	740	64	corradi	corradi	PROPN
eurjchem-2084	740	65	,	,	PUNCT
eurjchem-2084	740	66	l.	l.	PROPN
eurjchem-2084	740	67	;	;	PUNCT
eurjchem-2084	740	68	fantini	fantini	PROPN
eurjchem-2084	740	69	,	,	PUNCT
eurjchem-2084	740	70	r.	r.	PROPN
eurjchem-2084	740	71	;	;	PUNCT
eurjchem-2084	740	72	castaniere	castaniere	PROPN
eurjchem-2084	740	73	,	,	PUNCT
eurjchem-2084	740	74	i.	i.	NOUN
eurjchem-2084	740	75	;	;	PUNCT
eurjchem-2084	740	76	tabbì	tabbì	NOUN
eurjchem-2084	740	77	,	,	PUNCT
eurjchem-2084	740	78	l.	l.	PROPN
eurjchem-2084	740	79	;	;	PUNCT
eurjchem-2084	740	80	girardis	girardis	PROPN
eurjchem-2084	740	81	,	,	PUNCT
eurjchem-2084	740	82	m.	m.	NOUN
eurjchem-2084	740	83	;	;	PUNCT
eurjchem-2084	740	84	tedeschi	tedeschi	PROPN
eurjchem-2084	740	85	,	,	PUNCT
eurjchem-2084	740	86	s.	s.	PROPN
eurjchem-2084	740	87	;	;	PUNCT
eurjchem-2084	740	88	giannella	giannella	NOUN
eurjchem-2084	740	89	,	,	PUNCT
eurjchem-2084	740	90	m.	m.	NOUN
eurjchem-2084	740	91	;	;	PUNCT
eurjchem-2084	740	92	bartoletti	bartoletti	PROPN
eurjchem-2084	740	93	,	,	PUNCT
eurjchem-2084	740	94	m.	m.	NOUN
eurjchem-2084	740	95	;	;	PUNCT
eurjchem-2084	740	96	pascale	pascale	PROPN
eurjchem-2084	740	97	,	,	PUNCT
eurjchem-2084	740	98	r.	r.	PROPN
eurjchem-2084	740	99	;	;	PUNCT
eurjchem-2084	740	100	dolci	dolci	ADJ
eurjchem-2084	740	101	,	,	PUNCT
eurjchem-2084	740	102	g.	g.	PROPN
eurjchem-2084	740	103	;	;	PUNCT
eurjchem-2084	740	104	brugioni	brugioni	PROPN
eurjchem-2084	740	105	,	,	PUNCT
eurjchem-2084	740	106	l.	l.	PROPN
eurjchem-2084	740	107	;	;	PUNCT
eurjchem-2084	740	108	pietrangelo	pietrangelo	PROPN
eurjchem-2084	740	109	,	,	PUNCT
eurjchem-2084	740	110	a.	a.	NOUN
eurjchem-2084	740	111	;	;	PUNCT
eurjchem-2084	740	112	cossarizza	cossarizza	PROPN
eurjchem-2084	740	113	,	,	PUNCT
eurjchem-2084	740	114	a.	a.	NOUN
eurjchem-2084	740	115	;	;	PUNCT
eurjchem-2084	740	116	pea	pea	NOUN
eurjchem-2084	740	117	,	,	PUNCT
eurjchem-2084	740	118	f.	f.	PROPN
eurjchem-2084	740	119	;	;	PUNCT
eurjchem-2084	740	120	clini	clini	PROPN
eurjchem-2084	740	121	,	,	PUNCT
eurjchem-2084	740	122	e.	e.	PROPN
eurjchem-2084	740	123	;	;	PUNCT
eurjchem-2084	740	124	salvarani	salvarani	PROPN
eurjchem-2084	740	125	,	,	PUNCT
eurjchem-2084	740	126	c.	c.	PROPN
eurjchem-2084	740	127	;	;	PUNCT
eurjchem-2084	740	128	massari	massari	PROPN
eurjchem-2084	740	129	,	,	PUNCT
eurjchem-2084	740	130	m.	m.	NOUN
eurjchem-2084	740	131	;	;	PUNCT
eurjchem-2084	740	132	viale	viale	NOUN
eurjchem-2084	740	133	,	,	PUNCT
eurjchem-2084	740	134	p.	p.	PROPN
eurjchem-2084	740	135	l.	l.	PROPN
eurjchem-2084	740	136	;	;	PUNCT
eurjchem-2084	740	137	mussini	mussini	PROPN
eurjchem-2084	740	138	,	,	PUNCT
eurjchem-2084	740	139	c.	c.	PROPN
eurjchem-2084	740	140	lancet	lancet	PROPN
eurjchem-2084	740	141	rheumatol	rheumatol	NOUN
eurjchem-2084	740	142	2020	2020	NUM
eurjchem-2084	740	143	,	,	PUNCT
eurjchem-2084	740	144	2	2	NUM
eurjchem-2084	740	145	(	(	PUNCT
eurjchem-2084	740	146	8)	8)	NUM
eurjchem-2084	740	147	,	,	PUNCT
eurjchem-2084	740	148	e474	e474	PROPN
eurjchem-2084	740	149	–	–	PUNCT
eurjchem-2084	740	150	e484	e484	PROPN
eurjchem-2084	740	151	.	.	PUNCT
eurjchem-2084	741	1	[	[	X
eurjchem-2084	741	2	115	115	NUM
eurjchem-2084	741	3	]	]	PUNCT
eurjchem-2084	741	4	.	.	PUNCT
eurjchem-2084	742	1	liu	liu	PROPN
eurjchem-2084	742	2	,	,	PUNCT
eurjchem-2084	742	3	s.	s.	PROPN
eurjchem-2084	742	4	t.	t.	PROPN
eurjchem-2084	742	5	h.	h.	PROPN
eurjchem-2084	742	6	;	;	PUNCT
eurjchem-2084	742	7	lin	lin	PROPN
eurjchem-2084	742	8	,	,	PUNCT
eurjchem-2084	742	9	h.-m	h.-m	NOUN
eurjchem-2084	742	10	.	.	PUNCT
eurjchem-2084	742	11	;	;	PUNCT
eurjchem-2084	742	12	baine	baine	PROPN
eurjchem-2084	742	13	,	,	PUNCT
eurjchem-2084	742	14	i.	i.	PROPN
eurjchem-2084	742	15	;	;	PUNCT
eurjchem-2084	742	16	wajnberg	wajnberg	PROPN
eurjchem-2084	742	17	,	,	PUNCT
eurjchem-2084	742	18	a.	a.	NOUN
eurjchem-2084	742	19	;	;	PUNCT
eurjchem-2084	742	20	gumprecht	gumprecht	PROPN
eurjchem-2084	742	21	,	,	PUNCT
eurjchem-2084	742	22	j.	j.	PROPN
eurjchem-2084	742	23	p.	p.	PROPN
eurjchem-2084	742	24	;	;	PUNCT
eurjchem-2084	742	25	rahman	rahman	PROPN
eurjchem-2084	742	26	,	,	PUNCT
eurjchem-2084	742	27	f.	f.	PROPN
eurjchem-2084	742	28	;	;	PUNCT
eurjchem-2084	742	29	rodriguez	rodriguez	PROPN
eurjchem-2084	742	30	,	,	PUNCT
eurjchem-2084	742	31	d.	d.	PROPN
eurjchem-2084	742	32	;	;	PUNCT
eurjchem-2084	742	33	tandon	tandon	PROPN
eurjchem-2084	742	34	,	,	PUNCT
eurjchem-2084	742	35	p.	p.	NOUN
eurjchem-2084	742	36	;	;	PUNCT
eurjchem-2084	742	37	bassily	bassily	ADV
eurjchem-2084	742	38	-	-	PUNCT
eurjchem-2084	742	39	marcus	marcus	PROPN
eurjchem-2084	742	40	,	,	PUNCT
eurjchem-2084	742	41	a.	a.	NOUN
eurjchem-2084	742	42	;	;	PUNCT
eurjchem-2084	742	43	bander	bander	NOUN
eurjchem-2084	742	44	,	,	PUNCT
eurjchem-2084	742	45	j.	j.	PROPN
eurjchem-2084	742	46	;	;	PUNCT
eurjchem-2084	742	47	sanky	sanky	PROPN
eurjchem-2084	742	48	,	,	PUNCT
eurjchem-2084	742	49	c.	c.	PROPN
eurjchem-2084	742	50	;	;	PUNCT
eurjchem-2084	742	51	dupper	dupper	PROPN
eurjchem-2084	742	52	,	,	PUNCT
eurjchem-2084	742	53	a.	a.	NOUN
eurjchem-2084	742	54	;	;	PUNCT
eurjchem-2084	742	55	zheng	zheng	PROPN
eurjchem-2084	742	56	,	,	PUNCT
eurjchem-2084	742	57	a.	a.	NOUN
eurjchem-2084	742	58	;	;	PUNCT
eurjchem-2084	742	59	nguyen	nguyen	PROPN
eurjchem-2084	742	60	,	,	PUNCT
eurjchem-2084	742	61	f.	f.	PROPN
eurjchem-2084	742	62	t.	t.	PROPN
eurjchem-2084	742	63	;	;	PUNCT
eurjchem-2084	742	64	amanat	amanat	PROPN
eurjchem-2084	742	65	,	,	PUNCT
eurjchem-2084	742	66	f.	f.	PROPN
eurjchem-2084	742	67	;	;	PUNCT
eurjchem-2084	742	68	stadlbauer	stadlbauer	PROPN
eurjchem-2084	742	69	,	,	PUNCT
eurjchem-2084	742	70	d.	d.	PROPN
eurjchem-2084	742	71	;	;	PUNCT
eurjchem-2084	742	72	altman	altman	PROPN
eurjchem-2084	742	73	,	,	PUNCT
eurjchem-2084	742	74	d.	d.	PROPN
eurjchem-2084	742	75	r.	r.	PROPN
eurjchem-2084	742	76	;	;	PUNCT
eurjchem-2084	742	77	chen	chen	PROPN
eurjchem-2084	742	78	,	,	PUNCT
eurjchem-2084	742	79	b.	b.	PROPN
eurjchem-2084	742	80	k.	k.	PROPN
eurjchem-2084	742	81	;	;	PUNCT
eurjchem-2084	742	82	krammer	krammer	PROPN
eurjchem-2084	742	83	,	,	PUNCT
eurjchem-2084	742	84	f.	f.	PROPN
eurjchem-2084	742	85	;	;	PUNCT
eurjchem-2084	742	86	mendu	mendu	NOUN
eurjchem-2084	742	87	,	,	PUNCT
eurjchem-2084	742	88	d.	d.	PROPN
eurjchem-2084	742	89	r.	r.	PROPN
eurjchem-2084	742	90	;	;	PUNCT
eurjchem-2084	742	91	firpobetancourt	firpobetancourt	PROPN
eurjchem-2084	742	92	,	,	PUNCT
eurjchem-2084	742	93	a.	a.	NOUN
eurjchem-2084	742	94	;	;	PUNCT
eurjchem-2084	742	95	levin	levin	PROPN
eurjchem-2084	742	96	,	,	PUNCT
eurjchem-2084	742	97	m.	m.	NOUN
eurjchem-2084	742	98	a.	a.	PROPN
eurjchem-2084	742	99	;	;	PUNCT
eurjchem-2084	742	100	bagiella	bagiella	PROPN
eurjchem-2084	742	101	,	,	PUNCT
eurjchem-2084	742	102	e.	e.	PROPN
eurjchem-2084	742	103	;	;	PUNCT
eurjchem-2084	742	104	casadevall	casadevall	PROPN
eurjchem-2084	742	105	,	,	PUNCT
eurjchem-2084	742	106	a.	a.	NOUN
eurjchem-2084	742	107	;	;	PUNCT
eurjchem-2084	742	108	cordon	cordon	ADJ
eurjchem-2084	742	109	-	-	PUNCT
eurjchem-2084	742	110	cardo	cardo	NOUN
eurjchem-2084	742	111	,	,	PUNCT
eurjchem-2084	742	112	c.	c.	PROPN
eurjchem-2084	742	113	;	;	PUNCT
eurjchem-2084	742	114	jhang	jhang	PROPN
eurjchem-2084	742	115	,	,	PUNCT
eurjchem-2084	742	116	j.	j.	PROPN
eurjchem-2084	742	117	s.	s.	PROPN
eurjchem-2084	742	118	;	;	PUNCT
eurjchem-2084	742	119	arinsburg	arinsburg	PROPN
eurjchem-2084	742	120	,	,	PUNCT
eurjchem-2084	742	121	s.	s.	PROPN
eurjchem-2084	742	122	a.	a.	PROPN
eurjchem-2084	742	123	;	;	PUNCT
eurjchem-2084	742	124	reich	reich	PROPN
eurjchem-2084	742	125	,	,	PUNCT
eurjchem-2084	742	126	d.	d.	PROPN
eurjchem-2084	742	127	l.	l.	PROPN
eurjchem-2084	742	128	;	;	PUNCT
eurjchem-2084	742	129	aberg	aberg	ADV
eurjchem-2084	742	130	,	,	PUNCT
eurjchem-2084	742	131	j.	j.	PROPN
eurjchem-2084	742	132	a.	a.	PROPN
eurjchem-2084	742	133	;	;	PUNCT
eurjchem-2084	742	134	bouvier	bouvier	X
eurjchem-2084	742	135	,	,	PUNCT
eurjchem-2084	742	136	n.	n.	PROPN
eurjchem-2084	742	137	m.	m.	PROPN
eurjchem-2084	742	138	nat	nat	PROPN
eurjchem-2084	742	139	.	.	PUNCT
eurjchem-2084	743	1	med	med	PROPN
eurjchem-2084	743	2	.	.	PUNCT
eurjchem-2084	744	1	2020	2020	NUM
eurjchem-2084	744	2	,	,	PUNCT
eurjchem-2084	744	3	26	26	NUM
eurjchem-2084	744	4	(	(	PUNCT
eurjchem-2084	744	5	11	11	NUM
eurjchem-2084	744	6	)	)	PUNCT
eurjchem-2084	744	7	,	,	PUNCT
eurjchem-2084	744	8	1708–1713	1708–1713	NUM
eurjchem-2084	744	9	.	.	PUNCT
eurjchem-2084	745	1	[	[	X
eurjchem-2084	745	2	116	116	NUM
eurjchem-2084	745	3	]	]	PUNCT
eurjchem-2084	745	4	.	.	PUNCT
eurjchem-2084	746	1	whole	whole	ADJ
eurjchem-2084	746	2	-	-	PUNCT
eurjchem-2084	746	3	virion	virion	NOUN
eurjchem-2084	746	4	inactivated	inactivated	ADJ
eurjchem-2084	746	5	sars	sar	NOUN
eurjchem-2084	746	6	-	-	PUNCT
eurjchem-2084	746	7	cov-2	cov-2	PART
eurjchem-2084	746	8	vaccine	vaccine	NOUN
eurjchem-2084	746	9	(	(	PUNCT
eurjchem-2084	746	10	bbv152	bbv152	PROPN
eurjchem-2084	746	11	)	)	PUNCT
eurjchem-2084	746	12	for	for	ADP
eurjchem-2084	746	13	covid19	covid19	NOUN
eurjchem-2084	746	14	in	in	ADP
eurjchem-2084	746	15	healthy	healthy	ADJ
eurjchem-2084	746	16	volunteers	volunteer	NOUN
eurjchem-2084	746	17	full	full	ADJ
eurjchem-2084	746	18	text	text	NOUN
eurjchem-2084	746	19	view	view	NOUN
eurjchem-2084	746	20	clinicaltrials.gov	clinicaltrials.gov	X
eurjchem-2084	746	21	https://clinicaltrials.gov/ct2/show/nct04471519	https://clinicaltrials.gov/ct2/show/nct04471519	PUNCT
eurjchem-2084	746	22	(	(	PUNCT
eurjchem-2084	746	23	accessed	access	VERB
eurjchem-2084	746	24	december	december	PROPN
eurjchem-2084	746	25	9	9	NUM
eurjchem-2084	746	26	,	,	PUNCT
eurjchem-2084	746	27	2020	2020	NUM
eurjchem-2084	746	28	)	)	PUNCT
eurjchem-2084	746	29	.	.	PUNCT
eurjchem-2084	747	1	[	[	X
eurjchem-2084	747	2	117	117	NUM
eurjchem-2084	747	3	]	]	PUNCT
eurjchem-2084	747	4	.	.	PUNCT
eurjchem-2084	748	1	clinical	clinical	ADJ
eurjchem-2084	748	2	trial	trial	NOUN
eurjchem-2084	748	3	of	of	ADP
eurjchem-2084	748	4	efficacy	efficacy	NOUN
eurjchem-2084	748	5	and	and	CCONJ
eurjchem-2084	748	6	safety	safety	NOUN
eurjchem-2084	748	7	of	of	ADP
eurjchem-2084	748	8	sinovac	sinovac	PROPN
eurjchem-2084	748	9	’s	’s	PART
eurjchem-2084	748	10	adsorbed	adsorb	VERB
eurjchem-2084	748	11	covid-19	covid-19	PROPN
eurjchem-2084	748	12	(	(	PUNCT
eurjchem-2084	748	13	inactivated	inactivated	ADJ
eurjchem-2084	748	14	)	)	PUNCT
eurjchem-2084	748	15	vaccine	vaccine	NOUN
eurjchem-2084	748	16	in	in	ADP
eurjchem-2084	748	17	healthcare	healthcare	PROPN
eurjchem-2084	748	18	professionals	professional	NOUN
eurjchem-2084	748	19	full	full	ADJ
eurjchem-2084	748	20	text	text	NOUN
eurjchem-2084	748	21	view	view	NOUN
eurjchem-2084	748	22	clinicaltrials.gov	clinicaltrials.gov	X
eurjchem-2084	748	23	https://clinicaltrials.gov/ct2/show/nct04456595	https://clinicaltrials.gov/ct2/show/nct04456595	PRON
eurjchem-2084	748	24	(	(	PUNCT
eurjchem-2084	748	25	accessed	access	VERB
eurjchem-2084	748	26	december	december	PROPN
eurjchem-2084	748	27	9	9	NUM
eurjchem-2084	748	28	,	,	PUNCT
eurjchem-2084	748	29	2020	2020	NUM
eurjchem-2084	748	30	)	)	PUNCT
eurjchem-2084	748	31	.	.	PUNCT
eurjchem-2084	749	1	[	[	X
eurjchem-2084	749	2	118	118	NUM
eurjchem-2084	749	3	]	]	PUNCT
eurjchem-2084	749	4	.	.	PUNCT
eurjchem-2084	750	1	a	a	DET
eurjchem-2084	750	2	study	study	NOUN
eurjchem-2084	750	3	to	to	PART
eurjchem-2084	750	4	evaluate	evaluate	VERB
eurjchem-2084	750	5	the	the	DET
eurjchem-2084	750	6	efficacy	efficacy	NOUN
eurjchem-2084	750	7	,	,	PUNCT
eurjchem-2084	750	8	safety	safety	NOUN
eurjchem-2084	750	9	and	and	CCONJ
eurjchem-2084	750	10	immunogenicity	immunogenicity	NOUN
eurjchem-2084	750	11	of	of	ADP
eurjchem-2084	750	12	inactivated	inactivated	ADJ
eurjchem-2084	750	13	sars	sar	NOUN
eurjchem-2084	750	14	-	-	PUNCT
eurjchem-2084	750	15	cov-2	cov-2	NOUN
eurjchem-2084	750	16	vaccines	vaccine	NOUN
eurjchem-2084	750	17	(	(	PUNCT
eurjchem-2084	750	18	vero	vero	PROPN
eurjchem-2084	750	19	cell	cell	NOUN
eurjchem-2084	750	20	)	)	PUNCT
eurjchem-2084	750	21	in	in	ADP
eurjchem-2084	750	22	healthy	healthy	ADJ
eurjchem-2084	750	23	population	population	NOUN
eurjchem-2084	750	24	aged	aged	ADJ
eurjchem-2084	750	25	18	18	NUM
eurjchem-2084	750	26	years	year	NOUN
eurjchem-2084	750	27	old	old	ADJ
eurjchem-2084	750	28	and	and	CCONJ
eurjchem-2084	750	29	above	above	ADP
eurjchem-2084	750	30	full	full	ADJ
eurjchem-2084	750	31	text	text	NOUN
eurjchem-2084	750	32	view	view	NOUN
eurjchem-2084	750	33	clinicaltrials.gov	clinicaltrials.gov	X
eurjchem-2084	750	34	https://clinicaltrials.gov/ct2/show/nct04510207	https://clinicaltrials.gov/ct2/show/nct04510207	PROPN
eurjchem-2084	750	35	(	(	PUNCT
eurjchem-2084	750	36	accessed	access	VERB
eurjchem-2084	750	37	december	december	PROPN
eurjchem-2084	750	38	9	9	NUM
eurjchem-2084	750	39	,	,	PUNCT
eurjchem-2084	750	40	2020	2020	NUM
eurjchem-2084	750	41	)	)	PUNCT
eurjchem-2084	750	42	.	.	PUNCT
eurjchem-2084	751	1	[	[	X
eurjchem-2084	751	2	119	119	NUM
eurjchem-2084	751	3	]	]	PUNCT
eurjchem-2084	751	4	.	.	PUNCT
eurjchem-2084	752	1	phase	phase	NOUN
eurjchem-2084	752	2	iii	iii	NUM
eurjchem-2084	752	3	double	double	ADJ
eurjchem-2084	752	4	-	-	PUNCT
eurjchem-2084	752	5	blind	blind	ADJ
eurjchem-2084	752	6	,	,	PUNCT
eurjchem-2084	752	7	placebo	placebo	NOUN
eurjchem-2084	752	8	-	-	PUNCT
eurjchem-2084	752	9	controlled	control	VERB
eurjchem-2084	752	10	study	study	NOUN
eurjchem-2084	752	11	of	of	ADP
eurjchem-2084	752	12	azd1222	azd1222	NOUN
eurjchem-2084	752	13	for	for	ADP
eurjchem-2084	752	14	the	the	DET
eurjchem-2084	752	15	prevention	prevention	NOUN
eurjchem-2084	752	16	of	of	ADP
eurjchem-2084	752	17	covid-19	covid-19	PROPN
eurjchem-2084	752	18	in	in	ADP
eurjchem-2084	752	19	adults	adult	NOUN
eurjchem-2084	752	20	https://clinicaltrials.gov/ct2/	https://clinicaltrials.gov/ct2/	VERB
eurjchem-2084	752	21	show	show	NOUN
eurjchem-2084	752	22	/	/	SYM
eurjchem-2084	752	23	nct04516746	nct04516746	NOUN
eurjchem-2084	752	24	(	(	PUNCT
eurjchem-2084	752	25	accessed	access	VERB
eurjchem-2084	752	26	december	december	PROPN
eurjchem-2084	752	27	9	9	NUM
eurjchem-2084	752	28	,	,	PUNCT
eurjchem-2084	752	29	2020	2020	NUM
eurjchem-2084	752	30	)	)	PUNCT
eurjchem-2084	752	31	.	.	PUNCT
eurjchem-2084	753	1	https://clinicaltrials.gov/ct2/show/nct04455958	https://clinicaltrials.gov/ct2/show/nct04455958	PUNCT
eurjchem-2084	754	1	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatment	NOUN
eurjchem-2084	754	2	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatment	NOUN
eurjchem-2084	754	3	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments	https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatment	NOUN
eurjchem-2084	754	4	https://clinicaltrials.gov/ct2/show/	https://clinicaltrials.gov/ct2/show/	PROPN
eurjchem-2084	754	5	https://clinicaltrials.gov/ct2/show/nct04358068	https://clinicaltrials.gov/ct2/show/nct04358068	PUNCT
eurjchem-2084	754	6	https://edition.cnn.com/2020/03/23/health/arizona-coronavirus-chloroquine-death/index.html	https://edition.cnn.com/2020/03/23/health/arizona-coronavirus-chloroquine-death/index.html	PROPN
eurjchem-2084	754	7	https://edition.cnn.com/2020/03/23/health/arizona-coronavirus-chloroquine-death/index.html	https://edition.cnn.com/2020/03/23/health/arizona-coronavirus-chloroquine-death/index.html	PROPN
eurjchem-2084	755	1	https://www.roche.com/investors/updates/%20inv-update-2020-07-29.htm	https://www.roche.com/investors/updates/%20inv-update-2020-07-29.htm	PROPN
eurjchem-2084	755	2	https://www.roche.com/investors/updates/%20inv-update-2020-07-29.htm	https://www.roche.com/investors/updates/%20inv-update-2020-07-29.htm	PROPN
eurjchem-2084	755	3	https://doi.org/10.1038/%20s12276-021-00604-z	https://doi.org/10.1038/%20s12276-021-00604-z	PROPN
eurjchem-2084	755	4	https://doi.org/10.1038/%20s12276-021-00604-z	https://doi.org/10.1038/%20s12276-021-00604-z	PROPN
eurjchem-2084	755	5	https://www.oneindia.com/%20international/pfizer-concludes-phase-3-study-of-covid-19-vaccine-candidate-says-it-s-95-effective-3178319.html	https://www.oneindia.com/%20international/pfizer-concludes-phase-3-study-of-covid-19-vaccine-candidate-says-it-s-95-effective-3178319.html	VERB
eurjchem-2084	755	6	https://www.oneindia.com/%20international/pfizer-concludes-phase-3-study-of-covid-19-vaccine-candidate-says-it-s-95-effective-3178319.html	https://www.oneindia.com/%20international/pfizer-concludes-phase-3-study-of-covid-19-vaccine-candidate-says-it-s-95-effective-3178319.html	PROPN
eurjchem-2084	755	7	https://www.oneindia.com/%20international/pfizer-concludes-phase-3-study-of-covid-19-vaccine-candidate-says-it-s-95-effective-3178319.html	https://www.oneindia.com/%20international/pfizer-concludes-phase-3-study-of-covid-19-vaccine-candidate-says-it-s-95-effective-3178319.html	PROPN
eurjchem-2084	755	8	https://www.statnews.com/2020/11/16/modernas-covid-19-vaccine-is-strongly-effective-early-look-at-data-show/	https://www.statnews.com/2020/11/16/modernas-covid-19-vaccine-is-strongly-effective-early-look-at-data-show/	PROPN
eurjchem-2084	755	9	https://www.statnews.com/2020/11/16/modernas-covid-19-vaccine-is-strongly-effective-early-look-at-data-show/	https://www.statnews.com/2020/11/16/modernas-covid-19-vaccine-is-strongly-effective-early-look-at-data-show/	PROPN
eurjchem-2084	755	10	https://www.wsj.com/articles/fda-set-to-release-analyses-of-the-pfizer-biontech-covid-19-vaccine-11607423403	https://www.wsj.com/articles/fda-set-to-release-analyses-of-the-pfizer-biontech-covid-19-vaccine-11607423403	PROPN
eurjchem-2084	755	11	https://www.wsj.com/articles/fda-set-to-release-analyses-of-the-pfizer-biontech-covid-19-vaccine-11607423403	https://www.wsj.com/articles/fda-set-to-release-analyses-of-the-pfizer-biontech-covid-19-vaccine-11607423403	VERB
eurjchem-2084	755	12	https://www.bbc.com/news/%20health-55280671	https://www.bbc.com/news/%20health-55280671	PROPN
eurjchem-2084	755	13	https://www.bbc.com/news/%20health-55280671	https://www.bbc.com/news/%20health-55280671	PROPN
eurjchem-2084	755	14	https://www.statnews.com/pharmalot/2020/07/09/%20covid19-coronavirus-pandemic-vaccines-medicago-glaxo-dynavax/	https://www.statnews.com/pharmalot/2020/07/09/%20covid19-coronavirus-pandemic-vaccines-medicago-glaxo-dynavax/	PROPN
eurjchem-2084	755	15	https://www.statnews.com/pharmalot/2020/07/09/%20covid19-coronavirus-pandemic-vaccines-medicago-glaxo-dynavax/	https://www.statnews.com/pharmalot/2020/07/09/%20covid19-coronavirus-pandemic-vaccines-medicago-glaxo-dynavax/	PROPN
eurjchem-2084	755	16	https://doi.org/10.1101/2020.03.17.20037432	https://doi.org/10.1101/2020.03.17.20037432	PROPN
eurjchem-2084	755	17	https://clinicaltrials.gov/ct2/show/nct04471519	https://clinicaltrials.gov/ct2/show/nct04471519	PUNCT
eurjchem-2084	755	18	https://clinicaltrials.gov/ct2/show/nct04456595	https://clinicaltrials.gov/ct2/show/nct04456595	PROPN
eurjchem-2084	755	19	https://clinicaltrials.gov/ct2/show/nct04510207	https://clinicaltrials.gov/ct2/show/nct04510207	X
eurjchem-2084	755	20	https://clinicaltrials.gov/ct2/%20show/nct04516746	https://clinicaltrials.gov/ct2/%20show/nct04516746	PROPN
eurjchem-2084	755	21	https://clinicaltrials.gov/ct2/%20show/nct04516746	https://clinicaltrials.gov/ct2/%20show/nct04516746	PROPN
eurjchem-2084	755	22	234	234	NUM
eurjchem-2084	755	23	firdaus	firdaus	PROPN
eurjchem-2084	755	24	et	et	PROPN
eurjchem-2084	755	25	al	al	PROPN
eurjchem-2084	755	26	.	.	PUNCT
eurjchem-2084	755	27	/	/	SYM
eurjchem-2084	755	28	european	european	PROPN
eurjchem-2084	755	29	journal	journal	PROPN
eurjchem-2084	755	30	of	of	ADP
eurjchem-2084	755	31	chemistry	chemistry	NOUN
eurjchem-2084	755	32	12	12	NUM
eurjchem-2084	755	33	(	(	PUNCT
eurjchem-2084	755	34	2	2	NUM
eurjchem-2084	755	35	)	)	PUNCT
eurjchem-2084	755	36	(	(	PUNCT
eurjchem-2084	755	37	2021	2021	NUM
eurjchem-2084	755	38	)	)	PUNCT
eurjchem-2084	755	39	222	222	NUM
eurjchem-2084	755	40	-	-	SYM
eurjchem-2084	755	41	234	234	NUM
eurjchem-2084	755	42	2021	2021	NUM
eurjchem-2084	755	43	–	–	PUNCT
eurjchem-2084	755	44	european	european	ADJ
eurjchem-2084	755	45	journal	journal	NOUN
eurjchem-2084	755	46	of	of	ADP
eurjchem-2084	755	47	chemistry	chemistry	NOUN
eurjchem-2084	755	48	–	–	PUNCT
eurjchem-2084	755	49	cc	cc	NOUN
eurjchem-2084	755	50	by	by	ADP
eurjchem-2084	755	51	nc	nc	PROPN
eurjchem-2084	755	52	–	–	PUNCT
eurjchem-2084	755	53	doi	doi	NOUN
eurjchem-2084	755	54	:	:	PUNCT
eurjchem-2084	755	55	10.5155	10.5155	NUM
eurjchem-2084	755	56	/	/	SYM
eurjchem-2084	755	57	eurjchem.12.2.222	eurjchem.12.2.222	NOUN
eurjchem-2084	755	58	-	-	PUNCT
eurjchem-2084	755	59	234.2084	234.2084	NOUN
eurjchem-2084	756	1	[	[	X
eurjchem-2084	757	1	120	120	NUM
eurjchem-2084	757	2	]	]	PUNCT
eurjchem-2084	757	3	.	.	PUNCT
eurjchem-2084	758	1	phase	phase	NOUN
eurjchem-2084	758	2	iii	iii	NUM
eurjchem-2084	758	3	trial	trial	NOUN
eurjchem-2084	758	4	of	of	ADP
eurjchem-2084	758	5	a	a	DET
eurjchem-2084	758	6	covid-19	covid-19	PROPN
eurjchem-2084	758	7	vaccine	vaccine	NOUN
eurjchem-2084	758	8	of	of	ADP
eurjchem-2084	758	9	adenovirus	adenovirus	NOUN
eurjchem-2084	758	10	vector	vector	NOUN
eurjchem-2084	758	11	in	in	ADP
eurjchem-2084	758	12	adults	adult	NOUN
eurjchem-2084	758	13	18	18	NUM
eurjchem-2084	758	14	years	year	NOUN
eurjchem-2084	758	15	old	old	ADJ
eurjchem-2084	758	16	and	and	CCONJ
eurjchem-2084	758	17	above	above	ADP
eurjchem-2084	758	18	https://clinicaltrials.gov/	https://clinicaltrials.gov/	PROPN
eurjchem-2084	758	19	ct2	ct2	PROPN
eurjchem-2084	758	20	/	/	SYM
eurjchem-2084	758	21	show/	show/	NUM
eurjchem-2084	758	22	nct04526990	nct04526990	NOUN
eurjchem-2084	758	23	(	(	PUNCT
eurjchem-2084	758	24	accessed	access	VERB
eurjchem-2084	758	25	december	december	PROPN
eurjchem-2084	758	26	9	9	NUM
eurjchem-2084	758	27	,	,	PUNCT
eurjchem-2084	758	28	2020	2020	NUM
eurjchem-2084	758	29	)	)	PUNCT
eurjchem-2084	759	1	.	.	PUNCT
eurjchem-2084	760	1	[	[	X
eurjchem-2084	760	2	121	121	NUM
eurjchem-2084	760	3	]	]	PUNCT
eurjchem-2084	760	4	.	.	PUNCT
eurjchem-2084	761	1	a	a	DET
eurjchem-2084	761	2	study	study	NOUN
eurjchem-2084	761	3	of	of	ADP
eurjchem-2084	761	4	ad26.cov2.s	ad26.cov2.s	NUM
eurjchem-2084	761	5	in	in	ADP
eurjchem-2084	761	6	adults	adult	NOUN
eurjchem-2084	761	7	(	(	PUNCT
eurjchem-2084	761	8	covid-19	covid-19	PROPN
eurjchem-2084	761	9	)	)	PUNCT
eurjchem-2084	761	10	https://clinicaltrials	https://clinicaltrial	NOUN
eurjchem-2084	761	11	.	.	PUNCT
eurjchem-2084	762	1	gov	gov	PROPN
eurjchem-2084	762	2	/	/	SYM
eurjchem-2084	762	3	ct2	ct2	PROPN
eurjchem-2084	762	4	/	/	SYM
eurjchem-2084	762	5	show	show	NOUN
eurjchem-2084	762	6	/	/	SYM
eurjchem-2084	762	7	nct04436276	nct04436276	NOUN
eurjchem-2084	762	8	(	(	PUNCT
eurjchem-2084	762	9	accessed	access	VERB
eurjchem-2084	762	10	december	december	PROPN
eurjchem-2084	762	11	9	9	NUM
eurjchem-2084	762	12	,	,	PUNCT
eurjchem-2084	762	13	2020	2020	NUM
eurjchem-2084	762	14	)	)	PUNCT
eurjchem-2084	762	15	.	.	PUNCT
eurjchem-2084	763	1	[	[	X
eurjchem-2084	763	2	122	122	NUM
eurjchem-2084	763	3	]	]	PUNCT
eurjchem-2084	763	4	.	.	PUNCT
eurjchem-2084	764	1	clinical	clinical	ADJ
eurjchem-2084	764	2	trial	trial	NOUN
eurjchem-2084	764	3	to	to	PART
eurjchem-2084	764	4	evaluate	evaluate	VERB
eurjchem-2084	764	5	the	the	DET
eurjchem-2084	764	6	safety	safety	NOUN
eurjchem-2084	764	7	and	and	CCONJ
eurjchem-2084	764	8	immunogenicity	immunogenicity	NOUN
eurjchem-2084	764	9	of	of	ADP
eurjchem-2084	764	10	the	the	DET
eurjchem-2084	764	11	covid-19	covid-19	PROPN
eurjchem-2084	764	12	vaccine	vaccine	NOUN
eurjchem-2084	764	13	full	full	ADJ
eurjchem-2084	764	14	text	text	NOUN
eurjchem-2084	764	15	view	view	NOUN
eurjchem-2084	764	16	clinicaltrials.gov	clinicaltrials.gov	X
eurjchem-2084	764	17	https://clinicaltrials.gov/ct2/show/nct04497298	https://clinicaltrials.gov/ct2/show/nct04497298	NOUN
eurjchem-2084	764	18	(	(	PUNCT
eurjchem-2084	764	19	accessed	access	VERB
eurjchem-2084	764	20	december	december	PROPN
eurjchem-2084	764	21	9	9	NUM
eurjchem-2084	764	22	,	,	PUNCT
eurjchem-2084	764	23	2020	2020	NUM
eurjchem-2084	764	24	)	)	PUNCT
eurjchem-2084	764	25	.	.	PUNCT
eurjchem-2084	765	1	[	[	X
eurjchem-2084	765	2	123	123	NUM
eurjchem-2084	765	3	]	]	PUNCT
eurjchem-2084	765	4	.	.	PUNCT
eurjchem-2084	766	1	clinical	clinical	ADJ
eurjchem-2084	766	2	trial	trial	NOUN
eurjchem-2084	766	3	of	of	ADP
eurjchem-2084	766	4	efficacy	efficacy	NOUN
eurjchem-2084	766	5	,	,	PUNCT
eurjchem-2084	766	6	safety	safety	NOUN
eurjchem-2084	766	7	,	,	PUNCT
eurjchem-2084	766	8	and	and	CCONJ
eurjchem-2084	766	9	immunogenicity	immunogenicity	NOUN
eurjchem-2084	766	10	of	of	ADP
eurjchem-2084	766	11	gam	gam	NOUN
eurjchem-2084	766	12	-	-	PUNCT
eurjchem-2084	766	13	covidvac	covidvac	NOUN
eurjchem-2084	766	14	vaccine	vaccine	NOUN
eurjchem-2084	766	15	against	against	ADP
eurjchem-2084	766	16	covid-19	covid-19	PROPN
eurjchem-2084	766	17	full	full	ADJ
eurjchem-2084	766	18	text	text	NOUN
eurjchem-2084	766	19	view	view	NOUN
eurjchem-2084	766	20	clinicaltrials.gov	clinicaltrials.gov	X
eurjchem-2084	766	21	https://clinicaltrials.gov/ct2/show/nct04530396	https://clinicaltrials.gov/ct2/show/nct04530396	VERB
eurjchem-2084	766	22	(	(	PUNCT
eurjchem-2084	766	23	accessed	access	VERB
eurjchem-2084	766	24	december	december	PROPN
eurjchem-2084	766	25	9	9	NUM
eurjchem-2084	766	26	,	,	PUNCT
eurjchem-2084	766	27	2020	2020	NUM
eurjchem-2084	766	28	)	)	PUNCT
eurjchem-2084	766	29	.	.	PUNCT
eurjchem-2084	767	1	[	[	X
eurjchem-2084	767	2	124	124	NUM
eurjchem-2084	767	3	]	]	PUNCT
eurjchem-2084	767	4	.	.	PUNCT
eurjchem-2084	768	1	a	a	DET
eurjchem-2084	768	2	study	study	NOUN
eurjchem-2084	768	3	to	to	PART
eurjchem-2084	768	4	evaluate	evaluate	VERB
eurjchem-2084	768	5	the	the	DET
eurjchem-2084	768	6	safety	safety	NOUN
eurjchem-2084	768	7	,	,	PUNCT
eurjchem-2084	768	8	reactogenicity	reactogenicity	NOUN
eurjchem-2084	768	9	,	,	PUNCT
eurjchem-2084	768	10	and	and	CCONJ
eurjchem-2084	768	11	effectiveness	effectiveness	NOUN
eurjchem-2084	768	12	of	of	ADP
eurjchem-2084	768	13	mrna-1273	mrna-1273	ADJ
eurjchem-2084	768	14	vaccine	vaccine	NOUN
eurjchem-2084	768	15	in	in	ADP
eurjchem-2084	768	16	adolescents	adolescent	NOUN
eurjchem-2084	768	17	12	12	NUM
eurjchem-2084	768	18	to	to	ADP
eurjchem-2084	768	19	<	<	X
eurjchem-2084	768	20	18	18	NUM
eurjchem-2084	768	21	years	year	NOUN
eurjchem-2084	768	22	old	old	ADJ
eurjchem-2084	768	23	to	to	PART
eurjchem-2084	768	24	prevent	prevent	VERB
eurjchem-2084	768	25	covid-19	covid-19	PROPN
eurjchem-2084	768	26	full	full	ADJ
eurjchem-2084	768	27	text	text	NOUN
eurjchem-2084	768	28	view	view	NOUN
eurjchem-2084	768	29	clinicaltrials.gov	clinicaltrials.gov	PUNCT
eurjchem-2084	768	30	https://clinicaltrials	https://clinicaltrial	NOUN
eurjchem-2084	768	31	.gov	.gov	ADJ
eurjchem-2084	768	32	/	/	SYM
eurjchem-2084	768	33	ct2	ct2	PROPN
eurjchem-2084	768	34	/	/	SYM
eurjchem-2084	768	35	show	show	NOUN
eurjchem-2084	768	36	/	/	SYM
eurjchem-2084	768	37	nct04649151	nct04649151	NOUN
eurjchem-2084	768	38	(	(	PUNCT
eurjchem-2084	768	39	accessed	access	VERB
eurjchem-2084	768	40	december	december	PROPN
eurjchem-2084	768	41	9	9	NUM
eurjchem-2084	768	42	,	,	PUNCT
eurjchem-2084	768	43	2020	2020	NUM
eurjchem-2084	768	44	)	)	PUNCT
eurjchem-2084	768	45	.	.	PUNCT
eurjchem-2084	769	1	[	[	X
eurjchem-2084	769	2	125	125	NUM
eurjchem-2084	769	3	]	]	PUNCT
eurjchem-2084	769	4	.	.	PUNCT
eurjchem-2084	770	1	study	study	VERB
eurjchem-2084	770	2	to	to	PART
eurjchem-2084	770	3	describe	describe	VERB
eurjchem-2084	770	4	the	the	DET
eurjchem-2084	770	5	safety	safety	NOUN
eurjchem-2084	770	6	,	,	PUNCT
eurjchem-2084	770	7	tolerability	tolerability	NOUN
eurjchem-2084	770	8	,	,	PUNCT
eurjchem-2084	770	9	immunogenicity	immunogenicity	NOUN
eurjchem-2084	770	10	,	,	PUNCT
eurjchem-2084	770	11	and	and	CCONJ
eurjchem-2084	770	12	efficacy	efficacy	NOUN
eurjchem-2084	770	13	of	of	ADP
eurjchem-2084	770	14	rna	rna	NOUN
eurjchem-2084	770	15	vaccine	vaccine	NOUN
eurjchem-2084	770	16	candidates	candidate	NOUN
eurjchem-2084	770	17	against	against	ADP
eurjchem-2084	770	18	covid-19	covid-19	PROPN
eurjchem-2084	770	19	in	in	ADP
eurjchem-2084	770	20	healthy	healthy	ADJ
eurjchem-2084	770	21	individuals	individual	NOUN
eurjchem-2084	770	22	https://www.clinicaltrials.gov/ct2/show/nct04368728	https://www.clinicaltrials.gov/ct2/show/nct04368728	PROPN
eurjchem-2084	770	23	(	(	PUNCT
eurjchem-2084	770	24	accessed	access	VERB
eurjchem-2084	770	25	december	december	PROPN
eurjchem-2084	770	26	9	9	NUM
eurjchem-2084	770	27	,	,	PUNCT
eurjchem-2084	770	28	2020	2020	NUM
eurjchem-2084	770	29	)	)	PUNCT
eurjchem-2084	770	30	.	.	PUNCT
eurjchem-2084	771	1	[	[	X
eurjchem-2084	771	2	126	126	NUM
eurjchem-2084	771	3	]	]	PUNCT
eurjchem-2084	771	4	.	.	PUNCT
eurjchem-2084	772	1	a	a	DET
eurjchem-2084	772	2	dose	dose	NOUN
eurjchem-2084	772	3	-	-	PUNCT
eurjchem-2084	772	4	confirmation	confirmation	NOUN
eurjchem-2084	772	5	study	study	NOUN
eurjchem-2084	772	6	to	to	PART
eurjchem-2084	772	7	evaluate	evaluate	VERB
eurjchem-2084	772	8	the	the	DET
eurjchem-2084	772	9	safety	safety	NOUN
eurjchem-2084	772	10	,	,	PUNCT
eurjchem-2084	772	11	reactogenicity	reactogenicity	NOUN
eurjchem-2084	772	12	and	and	CCONJ
eurjchem-2084	772	13	immunogenicity	immunogenicity	NOUN
eurjchem-2084	772	14	of	of	ADP
eurjchem-2084	772	15	vaccine	vaccine	NOUN
eurjchem-2084	772	16	cvncov	cvncov	ADP
eurjchem-2084	772	17	in	in	ADP
eurjchem-2084	772	18	healthy	healthy	ADJ
eurjchem-2084	772	19	adults	adult	NOUN
eurjchem-2084	772	20	for	for	ADP
eurjchem-2084	772	21	covid19	covid19	NOUN
eurjchem-2084	772	22	https://clinicaltrials.gov/ct2/show/nct04515147	https://clinicaltrials.gov/ct2/show/nct04515147	PUNCT
eurjchem-2084	772	23	(	(	PUNCT
eurjchem-2084	772	24	accessed	access	VERB
eurjchem-2084	772	25	december	december	PROPN
eurjchem-2084	772	26	9	9	NUM
eurjchem-2084	772	27	,	,	PUNCT
eurjchem-2084	772	28	2020	2020	NUM
eurjchem-2084	772	29	)	)	PUNCT
eurjchem-2084	772	30	.	.	PUNCT
eurjchem-2084	773	1	[	[	X
eurjchem-2084	773	2	127	127	NUM
eurjchem-2084	773	3	]	]	PUNCT
eurjchem-2084	773	4	.	.	PUNCT
eurjchem-2084	774	1	ascending	ascend	VERB
eurjchem-2084	774	2	dose	dose	NOUN
eurjchem-2084	774	3	study	study	NOUN
eurjchem-2084	774	4	of	of	ADP
eurjchem-2084	774	5	investigational	investigational	ADJ
eurjchem-2084	774	6	sars	sar	NOUN
eurjchem-2084	774	7	-	-	PUNCT
eurjchem-2084	774	8	cov-2	cov-2	PART
eurjchem-2084	774	9	vaccine	vaccine	NOUN
eurjchem-2084	774	10	arct021	arct021	PROPN
eurjchem-2084	774	11	in	in	ADP
eurjchem-2084	774	12	healthy	healthy	ADJ
eurjchem-2084	774	13	adult	adult	NOUN
eurjchem-2084	774	14	subjects	subject	NOUN
eurjchem-2084	774	15	https://clinicaltrials.gov/	https://clinicaltrials.gov/	VERB
eurjchem-2084	774	16	ct2	ct2	PROPN
eurjchem-2084	774	17	/	/	SYM
eurjchem-2084	774	18	show	show	NOUN
eurjchem-2084	774	19	/	/	SYM
eurjchem-2084	774	20	nct04480957	nct04480957	NOUN
eurjchem-2084	774	21	(	(	PUNCT
eurjchem-2084	774	22	accessed	access	VERB
eurjchem-2084	774	23	december	december	PROPN
eurjchem-2084	774	24	9	9	NUM
eurjchem-2084	774	25	,	,	PUNCT
eurjchem-2084	774	26	2020	2020	NUM
eurjchem-2084	774	27	)	)	PUNCT
eurjchem-2084	774	28	.	.	PUNCT
eurjchem-2084	775	1	[	[	X
eurjchem-2084	775	2	128	128	NUM
eurjchem-2084	775	3	]	]	PUNCT
eurjchem-2084	775	4	.	.	PUNCT
eurjchem-2084	776	1	ward	ward	PROPN
eurjchem-2084	776	2	,	,	PUNCT
eurjchem-2084	776	3	d.	d.	PROPN
eurjchem-2084	776	4	;	;	PUNCT
eurjchem-2084	776	5	mccormack	mccormack	PROPN
eurjchem-2084	776	6	,	,	PUNCT
eurjchem-2084	776	7	s.	s.	PROPN
eurjchem-2084	776	8	clinical	clinical	ADJ
eurjchem-2084	776	9	trial	trial	NOUN
eurjchem-2084	776	10	to	to	PART
eurjchem-2084	776	11	assess	assess	VERB
eurjchem-2084	776	12	the	the	DET
eurjchem-2084	776	13	safety	safety	NOUN
eurjchem-2084	776	14	of	of	ADP
eurjchem-2084	776	15	a	a	DET
eurjchem-2084	776	16	coronavirus	coronavirus	NOUN
eurjchem-2084	776	17	vaccine	vaccine	NOUN
eurjchem-2084	776	18	in	in	ADP
eurjchem-2084	776	19	healthy	healthy	ADJ
eurjchem-2084	776	20	men	man	NOUN
eurjchem-2084	776	21	and	and	CCONJ
eurjchem-2084	776	22	women	woman	NOUN
eurjchem-2084	776	23	2020	2020	NUM
eurjchem-2084	776	24	.	.	PUNCT
eurjchem-2084	777	1	https://doi.org/10.1186/isrctn17072692	https://doi.org/10.1186/isrctn17072692	PROPN
eurjchem-2084	777	2	(	(	PUNCT
eurjchem-2084	777	3	accessed	access	VERB
eurjchem-2084	777	4	december	december	PROPN
eurjchem-2084	777	5	9	9	NUM
eurjchem-2084	777	6	,	,	PUNCT
eurjchem-2084	777	7	2020	2020	NUM
eurjchem-2084	777	8	)	)	PUNCT
eurjchem-2084	777	9	.	.	PUNCT
eurjchem-2084	778	1	[	[	X
eurjchem-2084	778	2	129	129	NUM
eurjchem-2084	778	3	]	]	PUNCT
eurjchem-2084	778	4	.	.	PUNCT
eurjchem-2084	779	1	ctri	ctri	PROPN
eurjchem-2084	779	2	http://ctri.nic.in/clinicaltrials/pmaindet2.php?trialid=45306	http://ctri.nic.in/clinicaltrials/pmaindet2.php?trialid=45306	PROPN
eurjchem-2084	779	3	&	&	CCONJ
eurjchem-2084	779	4	enchid=&username	enchid=&username	NOUN
eurjchem-2084	779	5	=	=	NOUN
eurjchem-2084	779	6	vaccine	vaccine	NOUN
eurjchem-2084	779	7	(	(	PUNCT
eurjchem-2084	779	8	accessed	access	VERB
eurjchem-2084	779	9	december	december	PROPN
eurjchem-2084	779	10	9	9	NUM
eurjchem-2084	779	11	,	,	PUNCT
eurjchem-2084	779	12	2020	2020	NUM
eurjchem-2084	779	13	)	)	PUNCT
eurjchem-2084	779	14	.	.	PUNCT
eurjchem-2084	780	1	[	[	X
eurjchem-2084	780	2	130	130	NUM
eurjchem-2084	780	3	]	]	PUNCT
eurjchem-2084	780	4	.	.	PUNCT
eurjchem-2084	781	1	safety	safety	NOUN
eurjchem-2084	781	2	and	and	CCONJ
eurjchem-2084	781	3	immunogenicity	immunogenicity	NOUN
eurjchem-2084	781	4	study	study	NOUN
eurjchem-2084	781	5	of	of	ADP
eurjchem-2084	781	6	gx-19	gx-19	ADJ
eurjchem-2084	781	7	,	,	PUNCT
eurjchem-2084	781	8	a	a	DET
eurjchem-2084	781	9	covid-19	covid-19	PROPN
eurjchem-2084	781	10	preventive	preventive	ADJ
eurjchem-2084	781	11	dna	dna	NOUN
eurjchem-2084	781	12	vaccine	vaccine	NOUN
eurjchem-2084	781	13	in	in	ADP
eurjchem-2084	781	14	healthy	healthy	ADJ
eurjchem-2084	781	15	adults	adult	NOUN
eurjchem-2084	781	16	https://clinicaltrials.gov/	https://clinicaltrials.gov/	PROPN
eurjchem-2084	781	17	ct2	ct2	PROPN
eurjchem-2084	781	18	/	/	SYM
eurjchem-2084	781	19	show	show	PROPN
eurjchem-2084	781	20	/	/	SYM
eurjchem-2084	781	21	nct04445389	nct04445389	NOUN
eurjchem-2084	781	22	(	(	PUNCT
eurjchem-2084	781	23	accessed	access	VERB
eurjchem-2084	781	24	december	december	PROPN
eurjchem-2084	781	25	9	9	NUM
eurjchem-2084	781	26	,	,	PUNCT
eurjchem-2084	781	27	2020	2020	NUM
eurjchem-2084	781	28	)	)	PUNCT
eurjchem-2084	781	29	.	.	PUNCT
eurjchem-2084	782	1	[	[	X
eurjchem-2084	782	2	131	131	NUM
eurjchem-2084	782	3	]	]	PUNCT
eurjchem-2084	782	4	.	.	PUNCT
eurjchem-2084	783	1	safety	safety	NOUN
eurjchem-2084	783	2	,	,	PUNCT
eurjchem-2084	783	3	tolerability	tolerability	NOUN
eurjchem-2084	783	4	and	and	CCONJ
eurjchem-2084	783	5	immunogenicity	immunogenicity	NOUN
eurjchem-2084	783	6	of	of	ADP
eurjchem-2084	783	7	ino-4800	ino-4800	NOUN
eurjchem-2084	783	8	followed	follow	VERB
eurjchem-2084	783	9	by	by	ADP
eurjchem-2084	783	10	electroporation	electroporation	NOUN
eurjchem-2084	783	11	in	in	ADP
eurjchem-2084	783	12	healthy	healthy	ADJ
eurjchem-2084	783	13	volunteers	volunteer	NOUN
eurjchem-2084	783	14	for	for	ADP
eurjchem-2084	783	15	covid19	covid19	NOUN
eurjchem-2084	783	16	https://clinicaltrials.gov/ct2/show/nct04447781	https://clinicaltrials.gov/ct2/show/nct04447781	X
eurjchem-2084	783	17	(	(	PUNCT
eurjchem-2084	783	18	accessed	access	VERB
eurjchem-2084	783	19	december	december	PROPN
eurjchem-2084	783	20	9	9	NUM
eurjchem-2084	783	21	,	,	PUNCT
eurjchem-2084	783	22	2020	2020	NUM
eurjchem-2084	783	23	)	)	PUNCT
eurjchem-2084	783	24	.	.	PUNCT
eurjchem-2084	784	1	[	[	X
eurjchem-2084	784	2	132	132	NUM
eurjchem-2084	784	3	]	]	PUNCT
eurjchem-2084	784	4	.	.	PUNCT
eurjchem-2084	785	1	study	study	NOUN
eurjchem-2084	785	2	of	of	ADP
eurjchem-2084	785	3	covid-19	covid-19	PROPN
eurjchem-2084	785	4	dna	dna	PROPN
eurjchem-2084	785	5	vaccine	vaccine	NOUN
eurjchem-2084	785	6	(	(	PUNCT
eurjchem-2084	785	7	ag0301	ag0301	NOUN
eurjchem-2084	785	8	-	-	PUNCT
eurjchem-2084	785	9	covid19	covid19	NOUN
eurjchem-2084	785	10	)	)	PUNCT
eurjchem-2084	785	11	https://clinicaltrials.gov/ct2/show/nct04463472	https://clinicaltrials.gov/ct2/show/nct04463472	PUNCT
eurjchem-2084	786	1	(	(	PUNCT
eurjchem-2084	786	2	accessed	access	VERB
eurjchem-2084	786	3	december	december	PROPN
eurjchem-2084	786	4	9	9	NUM
eurjchem-2084	786	5	,	,	PUNCT
eurjchem-2084	786	6	2020	2020	NUM
eurjchem-2084	786	7	)	)	PUNCT
eurjchem-2084	786	8	.	.	PUNCT
eurjchem-2084	787	1	[	[	X
eurjchem-2084	787	2	133	133	NUM
eurjchem-2084	787	3	]	]	PUNCT
eurjchem-2084	787	4	.	.	PUNCT
eurjchem-2084	788	1	evaluation	evaluation	NOUN
eurjchem-2084	788	2	of	of	ADP
eurjchem-2084	788	3	the	the	DET
eurjchem-2084	788	4	safety	safety	NOUN
eurjchem-2084	788	5	and	and	CCONJ
eurjchem-2084	788	6	immunogenicity	immunogenicity	NOUN
eurjchem-2084	788	7	of	of	ADP
eurjchem-2084	788	8	a	a	DET
eurjchem-2084	788	9	sars	sar	NOUN
eurjchem-2084	788	10	-	-	PUNCT
eurjchem-2084	788	11	cov-2	cov-2	NOUN
eurjchem-2084	788	12	rs	rs	NOUN
eurjchem-2084	788	13	nanoparticle	nanoparticle	NOUN
eurjchem-2084	788	14	vaccine	vaccine	NOUN
eurjchem-2084	788	15	with	with	ADP
eurjchem-2084	788	16	/	/	SYM
eurjchem-2084	788	17	without	without	ADP
eurjchem-2084	788	18	matrix	matrix	NOUN
eurjchem-2084	788	19	-	-	PUNCT
eurjchem-2084	788	20	m	m	NOUN
eurjchem-2084	788	21	adjuvant	adjuvant	ADJ
eurjchem-2084	788	22	https://clinicaltrials.gov/ct2/show/nct04368988	https://clinicaltrials.gov/ct2/show/nct04368988	PROPN
eurjchem-2084	788	23	(	(	PUNCT
eurjchem-2084	788	24	accessed	access	VERB
eurjchem-2084	788	25	december	december	PROPN
eurjchem-2084	788	26	9	9	NUM
eurjchem-2084	788	27	,	,	PUNCT
eurjchem-2084	788	28	2020	2020	NUM
eurjchem-2084	788	29	)	)	PUNCT
eurjchem-2084	788	30	.	.	PUNCT
eurjchem-2084	789	1	[	[	X
eurjchem-2084	789	2	134	134	NUM
eurjchem-2084	789	3	]	]	PUNCT
eurjchem-2084	789	4	.	.	PUNCT
eurjchem-2084	789	5	kbp-201	kbp-201	PROPN
eurjchem-2084	789	6	covid-19	covid-19	PROPN
eurjchem-2084	789	7	vaccine	vaccine	NOUN
eurjchem-2084	789	8	trial	trial	NOUN
eurjchem-2084	789	9	in	in	ADP
eurjchem-2084	789	10	healthy	healthy	ADJ
eurjchem-2084	789	11	volunteers	volunteer	NOUN
eurjchem-2084	789	12	https://clinicaltrials.gov/ct2/show/nct04473690	https://clinicaltrials.gov/ct2/show/nct04473690	PUNCT
eurjchem-2084	790	1	(	(	PUNCT
eurjchem-2084	790	2	accessed	access	VERB
eurjchem-2084	790	3	december	december	PROPN
eurjchem-2084	790	4	9	9	NUM
eurjchem-2084	790	5	,	,	PUNCT
eurjchem-2084	790	6	2020	2020	NUM
eurjchem-2084	790	7	)	)	PUNCT
eurjchem-2084	790	8	.	.	PUNCT
eurjchem-2084	791	1	[	[	X
eurjchem-2084	791	2	135	135	NUM
eurjchem-2084	791	3	]	]	PUNCT
eurjchem-2084	791	4	.	.	PUNCT
eurjchem-2084	792	1	a	a	DET
eurjchem-2084	792	2	phase	phase	NOUN
eurjchem-2084	792	3	iii	iii	NUM
eurjchem-2084	792	4	clinical	clinical	ADJ
eurjchem-2084	792	5	trial	trial	NOUN
eurjchem-2084	792	6	to	to	PART
eurjchem-2084	792	7	determine	determine	VERB
eurjchem-2084	792	8	the	the	DET
eurjchem-2084	792	9	safety	safety	NOUN
eurjchem-2084	792	10	and	and	CCONJ
eurjchem-2084	792	11	efficacy	efficacy	NOUN
eurjchem-2084	792	12	of	of	ADP
eurjchem-2084	792	13	zf2001	zf2001	PROPN
eurjchem-2084	792	14	for	for	ADP
eurjchem-2084	792	15	prevention	prevention	NOUN
eurjchem-2084	792	16	of	of	ADP
eurjchem-2084	792	17	covid-19	covid-19	PROPN
eurjchem-2084	792	18	https://clinicaltrials.gov/	https://clinicaltrials.gov/	PROPN
eurjchem-2084	792	19	ct2	ct2	PROPN
eurjchem-2084	792	20	/	/	SYM
eurjchem-2084	792	21	show	show	NOUN
eurjchem-2084	792	22	/	/	SYM
eurjchem-2084	792	23	nct04646590	nct04646590	NOUN
eurjchem-2084	792	24	(	(	PUNCT
eurjchem-2084	792	25	accessed	access	VERB
eurjchem-2084	792	26	december	december	PROPN
eurjchem-2084	792	27	9	9	NUM
eurjchem-2084	792	28	,	,	PUNCT
eurjchem-2084	792	29	2020	2020	NUM
eurjchem-2084	792	30	)	)	PUNCT
eurjchem-2084	792	31	.	.	PUNCT
eurjchem-2084	793	1	[	[	X
eurjchem-2084	793	2	136	136	NUM
eurjchem-2084	793	3	]	]	PUNCT
eurjchem-2084	793	4	.	.	PUNCT
eurjchem-2084	794	1	monovalent	monovalent	NOUN
eurjchem-2084	794	2	recombinant	recombinant	ADJ
eurjchem-2084	794	3	covid19	covid19	NOUN
eurjchem-2084	794	4	vaccine	vaccine	NOUN
eurjchem-2084	794	5	full	full	ADJ
eurjchem-2084	794	6	text	text	NOUN
eurjchem-2084	794	7	view	view	NOUN
eurjchem-2084	794	8	clinicaltrials.gov	clinicaltrials.gov	X
eurjchem-2084	794	9	https://clinicaltrials.gov/ct2/show/nct04453852	https://clinicaltrials.gov/ct2/show/nct04453852	NUM
eurjchem-2084	794	10	(	(	PUNCT
eurjchem-2084	794	11	accessed	access	VERB
eurjchem-2084	794	12	december	december	PROPN
eurjchem-2084	794	13	9	9	NUM
eurjchem-2084	794	14	,	,	PUNCT
eurjchem-2084	794	15	2020	2020	NUM
eurjchem-2084	794	16	)	)	PUNCT
eurjchem-2084	794	17	.	.	PUNCT
eurjchem-2084	795	1	[	[	X
eurjchem-2084	795	2	137	137	NUM
eurjchem-2084	795	3	]	]	PUNCT
eurjchem-2084	795	4	.	.	PUNCT
eurjchem-2084	796	1	study	study	NOUN
eurjchem-2084	796	2	of	of	ADP
eurjchem-2084	796	3	a	a	DET
eurjchem-2084	796	4	recombinant	recombinant	ADJ
eurjchem-2084	796	5	coronavirus	coronavirus	NOUN
eurjchem-2084	796	6	-	-	PUNCT
eurjchem-2084	796	7	like	like	ADJ
eurjchem-2084	796	8	particle	particle	NOUN
eurjchem-2084	796	9	covid-19	covid-19	PROPN
eurjchem-2084	796	10	vaccine	vaccine	NOUN
eurjchem-2084	796	11	in	in	ADP
eurjchem-2084	796	12	adults	adult	NOUN
eurjchem-2084	796	13	https://clinicaltrials.gov/ct2/show/nct04636697	https://clinicaltrials.gov/ct2/show/nct04636697	PUNCT
eurjchem-2084	796	14	(	(	PUNCT
eurjchem-2084	796	15	accessed	access	VERB
eurjchem-2084	796	16	december	december	PROPN
eurjchem-2084	796	17	9	9	NUM
eurjchem-2084	796	18	,	,	PUNCT
eurjchem-2084	796	19	2020	2020	NUM
eurjchem-2084	796	20	)	)	PUNCT
eurjchem-2084	796	21	.	.	PUNCT
eurjchem-2084	797	1	copyright	copyright	NOUN
eurjchem-2084	797	2	©	©	PROPN
eurjchem-2084	797	3	2021	2021	NUM
eurjchem-2084	797	4	by	by	ADP
eurjchem-2084	797	5	authors	author	NOUN
eurjchem-2084	797	6	.	.	PUNCT
eurjchem-2084	798	1	this	this	DET
eurjchem-2084	798	2	work	work	NOUN
eurjchem-2084	798	3	is	be	AUX
eurjchem-2084	798	4	published	publish	VERB
eurjchem-2084	798	5	and	and	CCONJ
eurjchem-2084	798	6	licensed	license	VERB
eurjchem-2084	798	7	by	by	ADP
eurjchem-2084	798	8	atlanta	atlanta	PROPN
eurjchem-2084	798	9	publishing	publishing	PROPN
eurjchem-2084	798	10	house	house	PROPN
eurjchem-2084	798	11	llc	llc	PROPN
eurjchem-2084	798	12	,	,	PUNCT
eurjchem-2084	798	13	atlanta	atlanta	PROPN
eurjchem-2084	798	14	,	,	PUNCT
eurjchem-2084	798	15	ga	ga	PROPN
eurjchem-2084	798	16	,	,	PUNCT
eurjchem-2084	798	17	usa	usa	PROPN
eurjchem-2084	798	18	.	.	PUNCT
eurjchem-2084	799	1	the	the	DET
eurjchem-2084	799	2	full	full	ADJ
eurjchem-2084	799	3	terms	term	NOUN
eurjchem-2084	799	4	of	of	ADP
eurjchem-2084	799	5	this	this	DET
eurjchem-2084	799	6	license	license	NOUN
eurjchem-2084	799	7	are	be	AUX
eurjchem-2084	799	8	available	available	ADJ
eurjchem-2084	799	9	at	at	ADP
eurjchem-2084	799	10	http://www.eurjchem.com/index.php/eurjchem/pages/view/terms	http://www.eurjchem.com/index.php/eurjchem/pages/view/term	NOUN
eurjchem-2084	799	11	and	and	CCONJ
eurjchem-2084	799	12	incorporate	incorporate	VERB
eurjchem-2084	799	13	the	the	DET
eurjchem-2084	799	14	creative	creative	ADJ
eurjchem-2084	799	15	commons	common	NOUN
eurjchem-2084	799	16	attribution	attribution	NOUN
eurjchem-2084	799	17	-	-	PUNCT
eurjchem-2084	799	18	non	non	ADJ
eurjchem-2084	799	19	commercial	commercial	NOUN
eurjchem-2084	799	20	(	(	PUNCT
eurjchem-2084	799	21	cc	cc	NOUN
eurjchem-2084	799	22	by	by	ADP
eurjchem-2084	799	23	nc	nc	PROPN
eurjchem-2084	799	24	)	)	PUNCT
eurjchem-2084	799	25	(	(	PUNCT
eurjchem-2084	799	26	international	international	ADJ
eurjchem-2084	799	27	,	,	PUNCT
eurjchem-2084	799	28	v4.0	v4.0	NOUN
eurjchem-2084	799	29	)	)	PUNCT
eurjchem-2084	799	30	license	license	NOUN
eurjchem-2084	799	31	(	(	PUNCT
eurjchem-2084	799	32	http://creativecommons.org/licenses/by-nc/4.0	http://creativecommons.org/licenses/by-nc/4.0	NOUN
eurjchem-2084	799	33	)	)	PUNCT
eurjchem-2084	799	34	.	.	PUNCT
eurjchem-2084	800	1	by	by	ADP
eurjchem-2084	800	2	accessing	access	VERB
eurjchem-2084	800	3	the	the	DET
eurjchem-2084	800	4	work	work	NOUN
eurjchem-2084	800	5	,	,	PUNCT
eurjchem-2084	800	6	you	you	PRON
eurjchem-2084	800	7	hereby	hereby	ADV
eurjchem-2084	800	8	accept	accept	VERB
eurjchem-2084	800	9	the	the	DET
eurjchem-2084	800	10	terms	term	NOUN
eurjchem-2084	800	11	.	.	PUNCT
eurjchem-2084	801	1	this	this	PRON
eurjchem-2084	801	2	is	be	AUX
eurjchem-2084	801	3	an	an	DET
eurjchem-2084	801	4	open	open	ADJ
eurjchem-2084	801	5	access	access	NOUN
eurjchem-2084	801	6	article	article	NOUN
eurjchem-2084	801	7	distributed	distribute	VERB
eurjchem-2084	801	8	under	under	ADP
eurjchem-2084	801	9	the	the	DET
eurjchem-2084	801	10	terms	term	NOUN
eurjchem-2084	801	11	and	and	CCONJ
eurjchem-2084	801	12	conditions	condition	NOUN
eurjchem-2084	801	13	of	of	ADP
eurjchem-2084	801	14	the	the	DET
eurjchem-2084	801	15	cc	cc	PROPN
eurjchem-2084	801	16	by	by	ADP
eurjchem-2084	801	17	nc	nc	PROPN
eurjchem-2084	801	18	license	license	PROPN
eurjchem-2084	801	19	,	,	PUNCT
eurjchem-2084	801	20	which	which	PRON
eurjchem-2084	801	21	permits	permit	VERB
eurjchem-2084	801	22	unrestricted	unrestricted	ADJ
eurjchem-2084	801	23	non	non	ADJ
eurjchem-2084	801	24	-	-	ADJ
eurjchem-2084	801	25	commercial	commercial	ADJ
eurjchem-2084	801	26	use	use	NOUN
eurjchem-2084	801	27	,	,	PUNCT
eurjchem-2084	801	28	distribution	distribution	NOUN
eurjchem-2084	801	29	,	,	PUNCT
eurjchem-2084	801	30	and	and	CCONJ
eurjchem-2084	801	31	reproduction	reproduction	NOUN
eurjchem-2084	801	32	in	in	ADP
eurjchem-2084	801	33	any	any	DET
eurjchem-2084	801	34	medium	medium	NOUN
eurjchem-2084	801	35	,	,	PUNCT
eurjchem-2084	801	36	provided	provide	VERB
eurjchem-2084	801	37	the	the	DET
eurjchem-2084	801	38	original	original	ADJ
eurjchem-2084	801	39	work	work	NOUN
eurjchem-2084	801	40	is	be	AUX
eurjchem-2084	801	41	properly	properly	ADV
eurjchem-2084	801	42	cited	cite	VERB
eurjchem-2084	801	43	without	without	ADP
eurjchem-2084	801	44	any	any	DET
eurjchem-2084	801	45	further	further	ADJ
eurjchem-2084	801	46	permission	permission	NOUN
eurjchem-2084	801	47	from	from	ADP
eurjchem-2084	801	48	atlanta	atlanta	PROPN
eurjchem-2084	801	49	publishing	publishing	PROPN
eurjchem-2084	801	50	house	house	PROPN
eurjchem-2084	801	51	llc	llc	PROPN
eurjchem-2084	801	52	(	(	PUNCT
eurjchem-2084	801	53	european	european	PROPN
eurjchem-2084	801	54	journal	journal	PROPN
eurjchem-2084	801	55	of	of	ADP
eurjchem-2084	801	56	chemistry	chemistry	NOUN
eurjchem-2084	801	57	)	)	PUNCT
eurjchem-2084	801	58	.	.	PUNCT
eurjchem-2084	802	1	no	no	DET
eurjchem-2084	802	2	use	use	NOUN
eurjchem-2084	802	3	,	,	PUNCT
eurjchem-2084	802	4	distribution	distribution	NOUN
eurjchem-2084	802	5	or	or	CCONJ
eurjchem-2084	802	6	reproduction	reproduction	NOUN
eurjchem-2084	802	7	is	be	AUX
eurjchem-2084	802	8	permitted	permit	VERB
eurjchem-2084	802	9	which	which	PRON
eurjchem-2084	802	10	does	do	AUX
eurjchem-2084	802	11	not	not	PART
eurjchem-2084	802	12	comply	comply	VERB
eurjchem-2084	802	13	with	with	ADP
eurjchem-2084	802	14	these	these	DET
eurjchem-2084	802	15	terms	term	NOUN
eurjchem-2084	802	16	.	.	PUNCT
eurjchem-2084	803	1	permissions	permission	NOUN
eurjchem-2084	803	2	for	for	ADP
eurjchem-2084	803	3	commercial	commercial	ADJ
eurjchem-2084	803	4	use	use	NOUN
eurjchem-2084	803	5	of	of	ADP
eurjchem-2084	803	6	this	this	DET
eurjchem-2084	803	7	work	work	NOUN
eurjchem-2084	803	8	beyond	beyond	ADP
eurjchem-2084	803	9	the	the	DET
eurjchem-2084	803	10	scope	scope	NOUN
eurjchem-2084	803	11	of	of	ADP
eurjchem-2084	803	12	the	the	DET
eurjchem-2084	803	13	license	license	NOUN
eurjchem-2084	803	14	(	(	PUNCT
eurjchem-2084	803	15	http://www.eurjchem.com/index.php/eurjchem/pages/view/terms	http://www.eurjchem.com/index.php/eurjchem/pages/view/term	NOUN
eurjchem-2084	803	16	)	)	PUNCT
eurjchem-2084	803	17	are	be	AUX
eurjchem-2084	803	18	administered	administer	VERB
eurjchem-2084	803	19	by	by	ADP
eurjchem-2084	803	20	atlanta	atlanta	PROPN
eurjchem-2084	803	21	publishing	publishing	PROPN
eurjchem-2084	803	22	house	house	PROPN
eurjchem-2084	803	23	llc	llc	PROPN
eurjchem-2084	803	24	(	(	PUNCT
eurjchem-2084	803	25	european	european	PROPN
eurjchem-2084	803	26	journal	journal	PROPN
eurjchem-2084	803	27	of	of	ADP
eurjchem-2084	803	28	chemistry	chemistry	NOUN
eurjchem-2084	803	29	)	)	PUNCT
eurjchem-2084	803	30	.	.	PUNCT
eurjchem-2084	804	1	https://clinicaltrials.gov/%20ct2/show/%20nct04526990	https://clinicaltrials.gov/%20ct2/show/%20nct04526990	PROPN
eurjchem-2084	805	1	https://clinicaltrials.gov/%20ct2/show/%20nct04526990	https://clinicaltrials.gov/%20ct2/show/%20nct04526990	PRON
eurjchem-2084	805	2	https://clinicaltrials.gov/ct2/show/nct04497298	https://clinicaltrials.gov/ct2/show/nct04497298	NOUN
eurjchem-2084	805	3	https://clinicaltrials.gov/ct2/show/nct04530396	https://clinicaltrials.gov/ct2/show/nct04530396	PROPN
eurjchem-2084	805	4	https://www.clinicaltrials.gov/ct2/show/nct04368728	https://www.clinicaltrials.gov/ct2/show/nct04368728	PROPN
eurjchem-2084	805	5	https://clinicaltrials.gov/ct2/show/nct04515147	https://clinicaltrials.gov/ct2/show/nct04515147	NOUN
eurjchem-2084	805	6	https://clinicaltrials.gov/%20ct2/show/nct04480957	https://clinicaltrials.gov/%20ct2/show/nct04480957	PROPN
eurjchem-2084	805	7	https://clinicaltrials.gov/%20ct2/show/nct04480957	https://clinicaltrials.gov/%20ct2/show/nct04480957	PROPN
eurjchem-2084	805	8	https://doi.org/10.1186/isrctn17072692	https://doi.org/10.1186/isrctn17072692	PROPN
eurjchem-2084	805	9	http://ctri.nic.in/clinicaltrials/pmaindet2.php?trialid=45306%20&enchid=&username=vaccine	http://ctri.nic.in/clinicaltrials/pmaindet2.php?trialid=45306%20&enchid=&username=vaccine	PROPN
eurjchem-2084	805	10	http://ctri.nic.in/clinicaltrials/pmaindet2.php?trialid=45306%20&enchid=&username=vaccine	http://ctri.nic.in/clinicaltrials/pmaindet2.php?trialid=45306%20&enchid=&username=vaccine	PROPN
eurjchem-2084	805	11	https://clinicaltrials.gov/%20ct2/show/nct04445389	https://clinicaltrials.gov/%20ct2/show/nct04445389	ADP
eurjchem-2084	805	12	https://clinicaltrials.gov/%20ct2/show/nct04445389	https://clinicaltrials.gov/%20ct2/show/nct04445389	PUNCT
eurjchem-2084	805	13	https://clinicaltrials.gov/ct2/show/nct04447781	https://clinicaltrials.gov/ct2/show/nct04447781	PUNCT
eurjchem-2084	805	14	https://clinicaltrials.gov/ct2/show/nct04463472	https://clinicaltrials.gov/ct2/show/nct04463472	PROPN
eurjchem-2084	805	15	https://clinicaltrials.gov/ct2/show/nct04368988	https://clinicaltrials.gov/ct2/show/nct04368988	X
eurjchem-2084	805	16	https://clinicaltrials.gov/ct2/show/nct04473690	https://clinicaltrials.gov/ct2/show/nct04473690	PUNCT
eurjchem-2084	806	1	https://clinicaltrials.gov/%20ct2/show/nct04646590	https://clinicaltrials.gov/%20ct2/show/nct04646590	PROPN
eurjchem-2084	807	1	https://clinicaltrials.gov/%20ct2/show/nct04646590	https://clinicaltrials.gov/%20ct2/show/nct04646590	PROPN
eurjchem-2084	807	2	https://clinicaltrials.gov/ct2/show/nct04453852	https://clinicaltrials.gov/ct2/show/nct04453852	NUM
eurjchem-2084	807	3	https://clinicaltrials.gov/ct2/show/nct04636697	https://clinicaltrials.gov/ct2/show/nct04636697	PUNCT
eurjchem-2084	808	1	http://www.eurjchem.com/index.php/eurjchem/pages/view/terms	http://www.eurjchem.com/index.php/eurjchem/pages/view/term	NOUN
eurjchem-2084	808	2	http://creativecommons.org/licenses/by-nc/4.0	http://creativecommons.org/licenses/by-nc/4.0	PROPN
eurjchem-2084	808	3	http://www.eurjchem.com/index.php/eurjchem/pages/view/terms	http://www.eurjchem.com/index.php/eurjchem/pages/view/term	NOUN
eurjchem-2084	808	4	1	1	NUM
eurjchem-2084	808	5	.	.	PUNCT
eurjchem-2084	808	6	introduction	introduction	NOUN
eurjchem-2084	808	7	2	2	NUM
eurjchem-2084	808	8	.	.	PUNCT
eurjchem-2084	809	1	epidemiology	epidemiology	NOUN
eurjchem-2084	809	2	3	3	NUM
eurjchem-2084	809	3	.	.	PUNCT
eurjchem-2084	809	4	methodology	methodology	NOUN
eurjchem-2084	809	5	4	4	NUM
eurjchem-2084	809	6	.	.	PUNCT
eurjchem-2084	809	7	results	result	VERB
eurjchem-2084	809	8	5	5	NUM
eurjchem-2084	809	9	.	.	PUNCT
eurjchem-2084	810	1	the	the	DET
eurjchem-2084	810	2	2019	2019	NUM
eurjchem-2084	810	3	pandemic	pandemic	ADJ
eurjchem-2084	810	4	virus	virus	NOUN
eurjchem-2084	810	5	5.1	5.1	NUM
eurjchem-2084	810	6	.	.	PUNCT
eurjchem-2084	811	1	genomic	genomic	ADJ
eurjchem-2084	811	2	divergence	divergence	NOUN
eurjchem-2084	811	3	of	of	ADP
eurjchem-2084	811	4	viruses	virus	NOUN
eurjchem-2084	811	5	(	(	PUNCT
eurjchem-2084	811	6	difference	difference	NOUN
eurjchem-2084	811	7	in	in	ADP
eurjchem-2084	811	8	existing	exist	VERB
eurjchem-2084	811	9	and	and	CCONJ
eurjchem-2084	811	10	original	original	ADJ
eurjchem-2084	811	11	strains	strain	NOUN
eurjchem-2084	811	12	)	)	PUNCT
eurjchem-2084	811	13	5.2	5.2	NUM
eurjchem-2084	811	14	.	.	PUNCT
eurjchem-2084	812	1	infection	infection	NOUN
eurjchem-2084	812	2	mechanism	mechanism	NOUN
eurjchem-2084	812	3	of	of	ADP
eurjchem-2084	812	4	virus	virus	NOUN
eurjchem-2084	812	5	5.3	5.3	NUM
eurjchem-2084	812	6	.	.	PUNCT
eurjchem-2084	813	1	pathogenicity	pathogenicity	NOUN
eurjchem-2084	813	2	of	of	ADP
eurjchem-2084	813	3	virus	virus	NOUN
eurjchem-2084	813	4	5.4	5.4	NUM
eurjchem-2084	813	5	.	.	PUNCT
eurjchem-2084	814	1	how	how	SCONJ
eurjchem-2084	814	2	does	do	AUX
eurjchem-2084	814	3	the	the	DET
eurjchem-2084	814	4	immune	immune	ADJ
eurjchem-2084	814	5	system	system	NOUN
eurjchem-2084	814	6	respond	respond	VERB
eurjchem-2084	814	7	to	to	ADP
eurjchem-2084	814	8	the	the	DET
eurjchem-2084	814	9	virus	virus	NOUN
eurjchem-2084	814	10	?	?	PUNCT
eurjchem-2084	815	1	6	6	NUM
eurjchem-2084	815	2	.	.	X
eurjchem-2084	815	3	viral	viral	ADJ
eurjchem-2084	815	4	infection	infection	NOUN
eurjchem-2084	815	5	into	into	ADP
eurjchem-2084	815	6	global	global	ADJ
eurjchem-2084	815	7	pandemic	pandemic	ADJ
eurjchem-2084	815	8	6.1	6.1	NUM
eurjchem-2084	815	9	.	.	PUNCT
eurjchem-2084	815	10	virus	virus	NOUN
eurjchem-2084	815	11	and	and	CCONJ
eurjchem-2084	815	12	demography	demography	NOUN
eurjchem-2084	815	13	:	:	PUNCT
eurjchem-2084	815	14	who	who	PRON
eurjchem-2084	815	15	are	be	AUX
eurjchem-2084	815	16	at	at	ADP
eurjchem-2084	815	17	risk	risk	NOUN
eurjchem-2084	815	18	?	?	PUNCT
eurjchem-2084	816	1	6.2	6.2	NUM
eurjchem-2084	816	2	.	.	PUNCT
eurjchem-2084	817	1	strive	strive	ADJ
eurjchem-2084	817	2	of	of	ADP
eurjchem-2084	817	3	the	the	DET
eurjchem-2084	817	4	scientific	scientific	ADJ
eurjchem-2084	817	5	community	community	NOUN
eurjchem-2084	817	6	against	against	ADP
eurjchem-2084	817	7	pandemic	pandemic	ADJ
eurjchem-2084	817	8	viruses	virus	NOUN
eurjchem-2084	817	9	6.2.1	6.2.1	NOUN
eurjchem-2084	817	10	.	.	PUNCT
eurjchem-2084	818	1	antivirals	antiviral	NOUN
eurjchem-2084	818	2	in	in	ADP
eurjchem-2084	818	3	the	the	DET
eurjchem-2084	818	4	treatment	treatment	NOUN
eurjchem-2084	818	5	of	of	ADP
eurjchem-2084	818	6	covid-19	covid-19	PROPN
eurjchem-2084	818	7	6.2.2	6.2.2	PROPN
eurjchem-2084	818	8	.	.	PUNCT
eurjchem-2084	819	1	anti	anti	ADJ
eurjchem-2084	819	2	-	-	ADJ
eurjchem-2084	819	3	malarial	malarial	ADJ
eurjchem-2084	819	4	in	in	ADP
eurjchem-2084	819	5	the	the	DET
eurjchem-2084	819	6	treatment	treatment	NOUN
eurjchem-2084	819	7	of	of	ADP
eurjchem-2084	819	8	covid-19	covid-19	PROPN
eurjchem-2084	819	9	:	:	PUNCT
eurjchem-2084	819	10	expectations	expectation	NOUN
eurjchem-2084	819	11	and	and	CCONJ
eurjchem-2084	819	12	reality	reality	NOUN
eurjchem-2084	819	13	6.2.3	6.2.3	NUM
eurjchem-2084	819	14	.	.	PUNCT
eurjchem-2084	820	1	hydroxychloroquine	hydroxychloroquine	PROPN
eurjchem-2084	820	2	in	in	ADP
eurjchem-2084	820	3	treatment	treatment	NOUN
eurjchem-2084	820	4	of	of	ADP
eurjchem-2084	820	5	covid-19	covid-19	PROPN
eurjchem-2084	820	6	6.2.4	6.2.4	NUM
eurjchem-2084	820	7	.	.	PUNCT
eurjchem-2084	821	1	tocilizumab	tocilizumab	NOUN
eurjchem-2084	821	2	mystery	mystery	NOUN
eurjchem-2084	821	3	in	in	ADP
eurjchem-2084	821	4	covid-19	covid-19	PROPN
eurjchem-2084	821	5	6.2.5	6.2.5	NUM
eurjchem-2084	821	6	.	.	PUNCT
eurjchem-2084	822	1	potential	potential	ADJ
eurjchem-2084	822	2	role	role	NOUN
eurjchem-2084	822	3	of	of	ADP
eurjchem-2084	822	4	convalescent	convalescent	NOUN
eurjchem-2084	822	5	plasma	plasma	NOUN
eurjchem-2084	822	6	therapy	therapy	NOUN
eurjchem-2084	822	7	in	in	ADP
eurjchem-2084	822	8	covid-19	covid-19	PROPN
eurjchem-2084	822	9	7	7	NUM
eurjchem-2084	822	10	.	.	PUNCT
eurjchem-2084	823	1	vaccines	vaccine	NOUN
eurjchem-2084	823	2	in	in	ADP
eurjchem-2084	823	3	infectious	infectious	ADJ
eurjchem-2084	823	4	diseases	disease	NOUN
eurjchem-2084	823	5	8	8	NUM
eurjchem-2084	823	6	.	.	PUNCT
eurjchem-2084	824	1	conclusion	conclusion	NOUN
eurjchem-2084	824	2	disclosure	disclosure	NOUN
eurjchem-2084	824	3	statement	statement	NOUN
eurjchem-2084	824	4	orcid	orcid	PROPN
eurjchem-2084	824	5	references	reference	NOUN
eurjchem-2084	824	6	printfield10	printfield10	NOUN
eurjchem-2084	824	7	:	:	PUNCT
eurjchem-2084	824	8	printfield11	printfield11	NOUN
eurjchem-2084	824	9	:	:	PUNCT
eurjchem-2084	824	10	printfield12	printfield12	PROPN
eurjchem-2084	824	11	:	:	PUNCT
eurjchem-2084	824	12	printfield13	printfield13	VERB
eurjchem-2084	824	13	:	:	PUNCT
eurjchem-2084	824	14	printfield14	printfield14	NOUN
eurjchem-2084	824	15	:	:	PUNCT
eurjchem-2084	824	16	printfield15	printfield15	NOUN
eurjchem-2084	824	17	:	:	PUNCT
eurjchem-2084	824	18	printfield16	printfield16	ADJ
eurjchem-2084	824	19	:	:	PUNCT
eurjchem-2084	824	20	printfield17	printfield17	NOUN
eurjchem-2084	824	21	:	:	PUNCT
eurjchem-2084	824	22	printfield18	printfield18	NOUN
eurjchem-2084	824	23	:	:	PUNCT
eurjchem-2084	824	24	printfield19	printfield19	NOUN
eurjchem-2084	824	25	:	:	PUNCT
eurjchem-2084	824	26	printfield110	printfield110	PROPN
eurjchem-2084	824	27	:	:	PUNCT
eurjchem-2084	825	1	printfield111	printfield111	PROPN
eurjchem-2084	825	2	:	:	PUNCT
eurjchem-2084	825	3	printfield112	printfield112	PROPN
eurjchem-2084	825	4	:	:	PUNCT
eurjchem-2084	825	5	printfield20	printfield20	PROPN
eurjchem-2084	825	6	:	:	PUNCT
eurjchem-2084	825	7	printfield21	printfield21	ADJ
eurjchem-2084	825	8	:	:	PUNCT
eurjchem-2084	825	9	printfield22	printfield22	NOUN
eurjchem-2084	825	10	:	:	PUNCT
eurjchem-2084	825	11	printfield23	printfield23	NOUN
eurjchem-2084	825	12	:	:	PUNCT
eurjchem-2084	825	13	printfield24	printfield24	NOUN
eurjchem-2084	825	14	:	:	PUNCT
eurjchem-2084	825	15	printfield25	printfield25	NOUN
eurjchem-2084	825	16	:	:	PUNCT
eurjchem-2084	825	17	printfield26	printfield26	ADJ
eurjchem-2084	825	18	:	:	PUNCT
eurjchem-2084	825	19	printfield27	printfield27	NOUN
eurjchem-2084	825	20	:	:	PUNCT
eurjchem-2084	825	21	printfield28	printfield28	NOUN
eurjchem-2084	825	22	:	:	PUNCT
eurjchem-2084	825	23	printfield29	printfield29	ADV
eurjchem-2084	825	24	:	:	PUNCT
eurjchem-2084	825	25	printfield210	printfield210	PROPN
eurjchem-2084	825	26	:	:	PUNCT
eurjchem-2084	825	27	printfield211	printfield211	PROPN
eurjchem-2084	825	28	:	:	PUNCT
eurjchem-2084	825	29	printfield212	printfield212	PROPN
eurjchem-2084	825	30	:	:	PUNCT